[{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"63323-454-01","generic_name":"Morphine Sulfate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA204223"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-454","63323-452","63323-455","63323-458","63323-451"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731993","1732006","1732011","1732136","2003714"],"spl_id":["f5584ff8-f338-4d14-b29e-e37b3978b747"],"spl_set_id":["582f42e5-444e-4246-af8c-e7e28097c69a"],"package_ndc":["63323-452-00","63323-452-01","63323-454-00","63323-454-01","63323-455-00","63323-455-01","63323-458-00","63323-458-01","63323-451-00","63323-451-01"],"unii":["X3P646A2J0"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 4 mg/1 mL (NDC 63323-454-01)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"65162-024-09","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA202830"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["65162-024","65162-023","65162-025","65162-026","65162-027","65162-028"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850"],"spl_id":["4cc5e658-25c6-4a58-a93a-6e35242d6de4"],"spl_set_id":["c11cb3b6-3dff-477b-a249-b4c3118edc5f"],"package_ndc":["65162-023-09","65162-024-09","65162-025-09","65162-026-09","65162-027-09","65162-028-09"],"unii":["SJT761GEGS"]},"update_date":"10/06/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 65162-024-09)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"discontinued_date":"05/21/2026","update_type":"New","initial_posting_date":"05/21/2026","package_ndc":"65219-086-20","generic_name":"Gadoterate Meglumine Injection","contact_info":"Marketed by Fresenius Kabi, USA; Customer service: 888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA215304"],"brand_name":["GADOTERATE MEGLUMINE"],"generic_name":["GADOTERATE MEGLUMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-086","65219-080","65219-082","65219-084"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOTERATE MEGLUMINE"],"spl_id":["f05922b7-99d4-48c7-972a-7966bbbbc3b4"],"spl_set_id":["e0655aac-9508-4141-94f5-fcca6af1c41d"],"package_ndc":["65219-080-01","65219-080-05","65219-082-01","65219-082-10","65219-084-01","65219-084-15","65219-086-01","65219-086-20"],"unii":["L0ND3981AG"]},"update_date":"05/21/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"43066-555-24","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA208532"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["43066-555","43066-557"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["5ae6fcf6-cd01-4b89-af44-962f5452fe72"],"spl_set_id":["aea9a3ad-c244-42be-9cd3-5df83fe2b522"],"package_ndc":["43066-555-24","43066-557-12"],"unii":["1018WH7F9I"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-288-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-288","63323-286","63323-287","63323-285"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","905191","1734084","1734086","1734090","1734091","1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484"],"spl_id":["cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c","75465ceb-e894-487d-aa80-671fa0841fce"],"spl_set_id":["23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6","56dfabf7-f7a8-4601-b17a-cb16fb995b0f"],"package_ndc":["63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95","63323-288-25","63323-288-27"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-286-23","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-286","63323-285","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cb6583ff-cde4-4280-aa5b-0bea2b844792","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","cb6583ff-cde4-4280-aa5b-0bea2b844792","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-51","63323-286-55","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 5 mg/1 mL (NDC 63323-286-23)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"0054-0660-25","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Available on allocation","openfda":{"application_number":["ANDA202827"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-0660","0054-0370","0054-0371","0054-0372","0054-0373","0054-0374","0054-0375"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"],"spl_set_id":["6740a621-9bec-4178-a4fc-a3fc89f34e0a"],"package_ndc":["0054-0660-25","0054-0370-25","0054-0371-25","0054-0372-25","0054-0373-25","0054-0374-25","0054-0375-25"],"unii":["SJT761GEGS"]},"update_date":"05/12/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0054-0660-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"12/01/2025","update_type":"New","initial_posting_date":"12/01/2025","package_ndc":"59212-111-14","generic_name":"Nilutamide Tablet","contact_info":"847-283-7921","related_info":"Product to expire in March 2026; Discontinuation of the manufacture of the drug","update_date":"12/01/2025","therapeutic_category":["Oncology"],"dosage_form":"Tablet","presentation":"Nilandron, Tablet, 150 mg (NDC 59212-111-14)","company_name":"Advanz Pharma (US) Corp.","status":"To Be Discontinued"},{"discontinued_date":"07/24/2026","update_type":"New","initial_posting_date":"07/24/2026","package_ndc":"0074-0522-60","generic_name":"Lopinavir and Ritonavir Tablet","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","update_date":"07/24/2026","therapeutic_category":["Antiviral"],"dosage_form":"Tablet","presentation":"Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-0522-60)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"discontinued_date":"11/13/2025","update_type":"New","initial_posting_date":"11/13/2025","package_ndc":"0228-2853-11","generic_name":"Guanfacine Hydrochloride Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA200881"],"brand_name":["GUANFACINE"],"generic_name":["GUANFACINE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2853","0228-2850","0228-2851","0228-2855"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GUANFACINE HYDROCHLORIDE"],"rxcui":["862006","862013","862019","862025"],"spl_id":["00143252-2b74-4b11-86ed-9b864635f129"],"spl_set_id":["3a171942-37af-430d-8b9d-bb678ca2be4b"],"package_ndc":["0228-2850-11","0228-2851-11","0228-2853-11","0228-2855-11"],"unii":["PML56A160O"]},"update_date":"11/13/2025","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Guanfacine Hydrochloride, Tablet, Extended Release, 3 mg (NDC 0228-2853-11)","company_name":"Actavis Pharma, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-1596-10","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1596","0409-1660","0409-1638","0409-1434","0409-7838","0409-7853","0409-7875"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["284397","309710","1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["3c5274fd-6597-4b88-babc-92e4e16c6329"],"spl_set_id":["548a88c0-afda-427e-75ac-5af0cfa2224c"],"package_ndc":["0409-1660-55","0409-1660-50","0409-1660-35","0409-1660-10","0409-1660-22","0409-1660-20","0409-1638-32","0409-1638-02","0409-1434-01","0409-1596-01","0409-1596-10","0409-7838-01","0409-7838-24","0409-7853-01","0409-7853-24","0409-7875-01","0409-7875-12"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-288-21","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-288","63323-286","63323-287","63323-285"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","905191","1734084","1734086","1734090","1734091","1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484"],"spl_id":["cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c","75465ceb-e894-487d-aa80-671fa0841fce"],"spl_set_id":["23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6","56dfabf7-f7a8-4601-b17a-cb16fb995b0f"],"package_ndc":["63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95","63323-288-25","63323-288-27"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0338-0004-02","generic_name":"Sterile Water Irrigant","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA017428"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0004","0338-0003"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["IRRIGATION"],"substance_name":["WATER"],"rxcui":["150985"],"spl_id":["97390588-b679-4caa-b7f3-3d2e11074d0e"],"spl_set_id":["ef3e79c5-3f58-4b36-a296-64b7d9a651c1"],"package_ndc":["0338-0003-44","0338-0003-46","0338-0003-47","0338-0004-02","0338-0004-03","0338-0004-04","0338-0004-05"],"unii":["059QF0KO0R"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology","Other","Pediatric"],"dosage_form":"Irrigant","presentation":"Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-02)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"72205-133-91","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"(855) 668-2369; customerservice@novadozpharma.com","availability":"Available","openfda":{"application_number":["ANDA218306"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-133","72205-132","72205-134","72205-135","72205-136","72205-137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"spl_set_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"package_ndc":["72205-132-91","72205-133-91","72205-134-91","72205-135-91","72205-136-91","72205-137-91"],"unii":["SJT761GEGS"]},"update_date":"09/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91)","company_name":"Novadoz Pharmaceuticals LLC","status":"Current"},{"discontinued_date":"12/01/2025","update_type":"New","initial_posting_date":"12/01/2025","package_ndc":"66993-066-02","generic_name":"Phenoxybenzamine Hydrochloride Capsule","contact_info":"847-283-7921","related_info":"Discontinuation of the manufacture of the drug","update_date":"12/01/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Dibenzyline, Capsule, 10 mg (NDC 66993-066-02)","company_name":"Advanz Pharma (US) Corp.","status":"To Be Discontinued"},{"discontinued_date":"08/25/2026","update_type":"New","initial_posting_date":"08/25/2026","package_ndc":"0378-1375-78","generic_name":"Mesalamine Capsule, Extended Release","contact_info":"800-796-9526","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA207271"],"brand_name":["MESALAMINE"],"generic_name":["MESALAMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-1375"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MESALAMINE"],"rxcui":["825130"],"spl_id":["20730160-16c5-4fee-90c9-9c28031ac8f8"],"spl_set_id":["c8b93ea3-0367-4605-b87f-06c3812ff3b7"],"package_ndc":["0378-1375-78"],"nui":["N0000175781","M0000971"],"pharm_class_epc":["Aminosalicylate [EPC]"],"pharm_class_cs":["Aminosalicylic Acids [CS]"],"unii":["4Q81I59GXC"]},"update_date":"08/25/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Capsule, Extended Release","presentation":"Mesalamine, Capsule, Extended Release, .375 g (NDC 0378-1375-78)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7090-12","generic_name":"Hydrocortisone Acetate Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["HYDROCORTISONE ACETATE"],"generic_name":["HYDROCORTISONE ACETATE"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7090","0574-7093"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["HYDROCORTISONE ACETATE"],"rxcui":["1291082","1291085"],"spl_id":["5ae35aec-6ba9-48b8-8b5f-c1b5accb9e1c"],"spl_set_id":["2fdb9940-6da8-49b0-a236-9817943f7a4b"],"package_ndc":["0574-7090-12","0574-7093-12"],"unii":["3X7931PO74"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction","Other"],"dosage_form":"Suppository","presentation":"Hydrocortisone Acetate, Suppository, 25 mg (NDC 0574-7090-12)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0017-48","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Unavailable","related_info":"Estimated recovery: December 2026","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0017","0338-0023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-48)","company_name":"Baxter Healthcare","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"0409-7299-25","generic_name":"Sodium Acetate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018893"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7299"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["1859490"],"spl_id":["013001c4-5584-4d8c-8bf6-917d2a919aa4","10c75a24-9542-431a-84f8-44611bc916df"],"spl_set_id":["ce9a7469-c4ba-4f60-8f7a-47ef0974316e","c91ede49-c7cc-47b7-0f93-e6841dd5916a"],"package_ndc":["0409-7299-45","0409-7299-25","0409-7299-83","0409-7299-73"],"unii":["NVG71ZZ7P0"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"05/08/2026","update_type":"New","initial_posting_date":"05/08/2026","package_ndc":"72143-321-30","generic_name":"Sulconazole Nitrate Solution","contact_info":"480-434-6670","related_info":"Discontinuation of the manufacture of the drug. Manufactured for JG Pharma","openfda":{"application_number":["NDA018738"],"brand_name":["SULCONAZOLE NITRATE"],"generic_name":["SULCONAZOLE NITRATE"],"manufacturer_name":["JG Pharma Inc."],"product_ndc":["72143-321"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TOPICAL"],"substance_name":["SULCONAZOLE NITRATE"],"rxcui":["313125"],"spl_id":["53b9389f-e8ec-e494-e063-6394a90a48bc"],"spl_set_id":["cf6f4340-940c-4a61-b675-456e3297d810"],"package_ndc":["72143-321-30"],"unii":["1T89100D5U"]},"update_date":"05/08/2026","therapeutic_category":["Dermatology"],"dosage_form":"Solution","presentation":"Sulconazole Nitrate, Solution, 30 mL (NDC 72143-321-30)","company_name":"Journey Medical Corporation","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"09/05/2018","package_ndc":"0641-6003-25","generic_name":"Lorazepam Injection","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["NDA018140"],"brand_name":["ATIVAN"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6003","0641-6002","0641-6001","0641-6000"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["206819","206820","238100","238101","1665188","1665190","1665326","1665327"],"spl_id":["fb40dcce-9da3-49b4-9bde-e01a17abeae6"],"spl_set_id":["5fc0e987-61c9-40c4-b0d5-fcea07c8733e"],"package_ndc":["0641-6003-01","0641-6003-25","0641-6002-01","0641-6002-10","0641-6001-01","0641-6001-25","0641-6000-01","0641-6000-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"10/14/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Ativan, Injection, 4 mg/1 mL (NDC 0641-6003-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"11/21/2025","update_type":"New","initial_posting_date":"11/21/2025","package_ndc":"62037-710-01","generic_name":"Potassium Chloride Tablet, Extended Release","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","update_date":"11/21/2025","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology"],"dosage_form":"Tablet","presentation":"Potassium Chloride, Tablet, Extended Release, 10 meq (NDC 62037-710-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"68025-098-10","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Temporary discontinuation of 100ct","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-098","68025-088","68025-089","68025-095","68025-096","68025-097","68025-084"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)","company_name":"Vertical Pharmaceuticals, LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"discontinued_date":"05/21/2026","update_type":"New","initial_posting_date":"05/21/2026","package_ndc":"67457-957-99","generic_name":"Iron Sucrose Injection","contact_info":"800-796-9526","related_info":"A business decision has been made to discontinue of 2.5mL presentation only. Continuity of supply is forecasted across all other presentations of Iron Sucrose: 67457-639-10 Iron Sucrose 20mg/mL 10mL SDV 5PK 67457-638-10 Iron Sucrose 20mg/mL 5mL SDV 10PK 67457-638-25 Iron Sucrose 20mg/mL 5mL SDV 25PK.","openfda":{"application_number":["ANDA212559"],"brand_name":["IRON SUCROSE"],"generic_name":["IRON SUCROSE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-957","67457-638","67457-639"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IRON SUCROSE"],"rxcui":["1741261","1741267","1741270"],"spl_id":["6ed21b25-9fbf-4a33-99e5-da98a4aa72bd"],"spl_set_id":["3f109bdb-a412-43b2-84c7-9dad05e85a71"],"package_ndc":["67457-957-99","67457-638-10","67457-638-25","67457-639-10"],"nui":["M0011718","N0000177913"],"pharm_class_cs":["Iron [CS]"],"pharm_class_epc":["Parenteral Iron Replacement [EPC]"],"unii":["FZ7NYF5N8L"]},"update_date":"05/21/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Iron Sucrose, Injection, 50 mg/2.5 mL (NDC 67457-957-99)","company_name":"Mylan Institutional, a Viatris Company","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0264-1510-31","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA016730"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-1510"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795609","1795616","1795618"],"spl_id":["638a41c3-0f07-4d1a-bb4e-1bab16e61266"],"spl_set_id":["60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5"],"package_ndc":["0264-1510-36","0264-1510-31","0264-1510-32"],"unii":["LX22YL083G"]},"update_date":"11/10/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-31)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/27/2023","package_ndc":"69945-094-20","generic_name":"Technetium TC-99M Pyrophosphate Kit Injection","contact_info":"888-744-1414","availability":"Limited Availability","related_info":"On allocation","openfda":{"application_number":["NDA017538"],"brand_name":["TECHNESCAN PYP"],"generic_name":["TECHNETIUM TC 99M PYROPHOSPHATE"],"manufacturer_name":["Curium US LLC"],"product_ndc":["69945-094"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM PYROPHOSPHATE","STANNOUS CHLORIDE"],"spl_id":["45358120-83e7-a04b-e063-6394a90af91e"],"spl_set_id":["304b63f4-a32e-4700-805d-5bc9f27e7d6a"],"package_ndc":["69945-094-01","69945-094-20"],"unii":["O352864B8Z","1BQV3749L5"]},"update_date":"11/02/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Technescan PYP, Injection, 11.9 mg/10 mL; 3.2 mg/10 mL (NDC 69945-094-20)","company_name":"Curium US LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/31/2018","change_date":"09/30/2026","package_ndc":"0641-6007-10","generic_name":"Bumetanide Injection","contact_info":"800-631-2174","resolved_note":"Available","openfda":{"application_number":["ANDA079196"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6007","0641-6008"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["fd0b9cd7-b786-44b0-8dc7-02ffd38576a4"],"spl_set_id":["681b5e9d-e2c7-4f29-aaad-e06d4a528c11"],"package_ndc":["0641-6007-01","0641-6007-10","0641-6008-01","0641-6008-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6007-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Resolved"},{"discontinued_date":"11/19/2025","update_type":"New","initial_posting_date":"11/19/2025","package_ndc":"0172-5241-60","generic_name":"Anagrelide Hydrochloride Capsule","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"11/19/2025","therapeutic_category":["Hematology"],"dosage_form":"Capsule","presentation":"Anagrelide Hydrochloride, Capsule, 0.5 mg (NDC 0172-5241-60)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"16729-138-16","generic_name":"Clonazepam Tablet","contact_info":"866-941-7875, option 2","resolved_note":"Available","openfda":{"application_number":["ANDA077147"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-138","16729-136","16729-137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["0e1e7f41-f78b-27cf-e063-6394a90a1ae0"],"spl_set_id":["ebc11109-e7bf-452d-b675-4b3236d54164"],"package_ndc":["16729-136-00","16729-136-16","16729-137-00","16729-137-16","16729-138-00","16729-138-16"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 16729-138-16)","company_name":"Accord Healthcare Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"06/06/2018","package_ndc":"0338-0069-10","generic_name":"Ketorolac Tromethamine Injection","contact_info":"888-229-0001","availability":"Unavailable","related_info":"Estimated recovery: December 2026","openfda":{"application_number":["ANDA209900"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0069","0338-0072","0338-0076"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["2da4dd8a-1b18-481d-b733-9c031d9ea7e3"],"spl_set_id":["4b58836d-9d58-4539-9691-9e11c505ef2a"],"package_ndc":["0338-0069-10","0338-0072-25","0338-0076-10"],"unii":["4EVE5946BQ"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0338-0069-10)","company_name":"Baxter Healthcare","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/11/2024","package_ndc":"0264-7387-50","generic_name":"Dextrose Monohydrate 70% Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019626"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-7387"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE"],"rxcui":["237656"],"spl_id":["594041d9-3c28-4439-9ffa-8e8148ffcf8c"],"spl_set_id":["8ccb10fe-75a5-440b-8cd4-b11f4e98f7b0"],"package_ndc":["0264-7387-50"],"unii":["IY9XDZ35W2"]},"update_date":"11/10/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0264-7387-50)","company_name":"B. Braun Medical Inc.","status":"Current"},{"discontinued_date":"05/05/2026","update_type":"New","initial_posting_date":"05/05/2026","package_ndc":"71288-723-52","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-824-8426","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA216039"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc"],"product_ndc":["71288-723","71288-726"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["0949c302-51ce-4fc9-8b99-1df94e693718"],"spl_set_id":["fe340f98-a0f3-446e-b281-47fd91c1e537"],"package_ndc":["71288-723-52","71288-726-52"],"unii":["7TQO7W3VT8"]},"update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)","company_name":"Kindos Pharmaceuticals Co. Ltd.","status":"To Be Discontinued"},{"discontinued_date":"05/08/2026","update_type":"New","initial_posting_date":"05/08/2026","package_ndc":"69489-721-30","generic_name":"Sulconazole Nitrate Solution","contact_info":"480-434-6670","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA018738"],"brand_name":["EXELDERM"],"generic_name":["SULCONAZOLE NITRATE"],"manufacturer_name":["Journey Medical Corporation"],"product_ndc":["69489-721"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TOPICAL"],"substance_name":["SULCONAZOLE NITRATE"],"rxcui":["208118","313125"],"spl_id":["53b92932-d626-2d66-e063-6294a90a8f6a"],"spl_set_id":["5b73e83e-8d3c-4d96-b4f6-9f854430add8"],"package_ndc":["69489-721-30","69489-721-05"],"unii":["1T89100D5U"]},"update_date":"05/08/2026","therapeutic_category":["Dermatology"],"dosage_form":"Solution","presentation":"Exelderm, Solution, 1.0% 30 mL (NDC 69489-721-30)","company_name":"Journey Medical Corporation","status":"To Be Discontinued"},{"discontinued_date":"12/22/2025","update_type":"New","initial_posting_date":"12/22/2025","package_ndc":"0832-0273-11","generic_name":"Morphine Sulfate Tablet","contact_info":"763-315-2000","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA210610"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Upsher-Smith Laboratories, LLC"],"product_ndc":["0832-0273","0832-0274"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892582","892672"],"spl_id":["46a682fc-0430-5a66-e063-6294a90a6179"],"spl_set_id":["5ceb3205-2f8d-4ba3-9f27-dc328bab4fa1"],"package_ndc":["0832-0273-11","0832-0274-11"],"unii":["X3P646A2J0"]},"update_date":"12/22/2025","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Tablet","presentation":"Morphine Sulfate, Tablet, 15 mg (NDC 0832-0273-11)","company_name":"Upsher-Smith Laboratories, LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-153-05","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-153","72888-497","72888-152","72888-154"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 72888-153-05)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"55150-161-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203082"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-161","55150-162","55150-163","55150-164","55150-165"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737562","1737566","1737568","1737757","1737761"],"spl_id":["bab2ea79-0aed-4f48-8b4e-f864f8b82fb8","d95a0a28-804f-44d2-aa31-01df376a3154"],"spl_set_id":["9916b09d-a116-469d-92d5-60e50ea9782b","89701fac-7536-4f16-87fb-f4cc121e74ee"],"package_ndc":["55150-161-09","55150-162-09","55150-163-00","55150-163-24","55150-164-09","55150-165-09","55150-161-02","55150-162-05","55150-163-30","55150-163-25","55150-164-02","55150-165-05"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02)","company_name":"Eugia US LLC","status":"Current"},{"discontinued_date":"12/10/2025","update_type":"New","initial_posting_date":"12/10/2025","package_ndc":"58468-0123-1","generic_name":"Doxercalciferol Injection","contact_info":"800-633-1610","related_info":"Discontinuation of the manufacture of the drug","update_date":"12/10/2025","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Hectorol, Injection, 4 mcg/2 mL injection 50 single-dose vials (NDC 58468-0123-1)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"70069-753-10","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Unavailable","related_info":"Estimated recovery: June 2027","openfda":{"application_number":["ANDA217792"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-753","70069-752"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["2b24af95-6f20-4945-bf8c-742f1d6f2721"],"spl_set_id":["bcaab86f-20f0-4482-8d73-e29b36dced58"],"package_ndc":["70069-752-25","70069-752-10","70069-752-01","70069-753-25","70069-753-01","70069-753-10"],"unii":["7TQO7W3VT8"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-10)","company_name":"Somerset Therapeutics, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/31/2018","change_date":"09/30/2026","package_ndc":"0641-6008-10","generic_name":"Bumetanide Injection","contact_info":"800-631-2174","resolved_note":"Available","openfda":{"application_number":["ANDA079196"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6008","0641-6007"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["fd0b9cd7-b786-44b0-8dc7-02ffd38576a4"],"spl_set_id":["681b5e9d-e2c7-4f29-aaad-e06d4a528c11"],"package_ndc":["0641-6007-01","0641-6007-10","0641-6008-01","0641-6008-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, .25 mg/1 mL (NDC 0641-6008-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Resolved"},{"discontinued_date":"04/28/2023","update_type":"New","initial_posting_date":"04/28/2023","change_date":"04/28/2023","package_ndc":"0069-4370-71","generic_name":"Prazosin Hydrochloride Capsule","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023","update_date":"04/28/2023","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Minipress, Capsule, 2 mg (NDC 0069-4370-71)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"05/15/2026","update_type":"New","initial_posting_date":"05/15/2026","package_ndc":"0574-0521-76","generic_name":"Activated Charcoal Oral Suspension","contact_info":"866-634-9120","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["M023"],"brand_name":["ACTIDOSE AQUA"],"generic_name":["ACTIVATED CHARCOAL"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-0521"],"product_type":["HUMAN OTC DRUG"],"route":["ORAL"],"substance_name":["ACTIVATED CHARCOAL"],"rxcui":["309150","1251411"],"spl_id":["bd250d66-b8ea-4cab-a8f2-d2913a157fc5"],"spl_set_id":["c85dc235-3f42-4361-9bd2-1aaff798ad75"],"package_ndc":["0574-0521-25","0574-0521-74","0574-0521-76"],"unii":["2P3VWU3H10"]},"update_date":"05/15/2026","therapeutic_category":["Other"],"dosage_form":"Oral Suspension","presentation":"Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-76)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4278-01","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA088328"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4278","0409-4713","0409-4279","0409-4776","0409-4282","0409-4277","0409-4276","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4278-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0955-1004-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["ENOXAPARIN SODIUM"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0955-1004","0955-1003","0955-1006","0955-1008","0955-1010","0955-1016","0955-1012","0955-1015"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854235","854238","854241","854245","854248","854252","854255"],"spl_id":["8f06a411-badb-483f-852d-8e6124acfa44"],"spl_set_id":["20635579-c92d-4f6c-a332-1096d51002f2"],"package_ndc":["0955-1003-01","0955-1003-10","0955-1004-01","0955-1004-10","0955-1006-01","0955-1006-10","0955-1008-01","0955-1008-10","0955-1010-01","0955-1010-10","0955-1016-01","0955-1012-01","0955-1012-10","0955-1015-01","0955-1015-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Enoxaparin Sodium, Injection, 40 mg/.4 mL (NDC 0955-1004-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0457-05","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017512"],"brand_name":["DIANEAL LOW CALCIUM WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0457","0941-0411","0941-0413","0941-0415","0941-0409","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0457-05)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1755-50","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1755","0409-1746","0409-1749","0409-1752","0409-2510","0409-7535","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 250 mg/50 mL (5 mg/mL 1:200,000) (NDC 0409-1755-50)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2023","package_ndc":"0143-9872-10","generic_name":"Propranolol Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA077760"],"brand_name":["PROPRANOLOL HYDROCHLORIDE"],"generic_name":["PROPRANOLOL HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9872"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["PROPRANOLOL HYDROCHLORIDE"],"rxcui":["856443"],"spl_id":["4432e36f-bed0-4e42-87aa-1330d1725963"],"spl_set_id":["91f2ff1d-68d8-4e83-a2db-618f0410ead7"],"package_ndc":["0143-9872-01","0143-9872-10"],"unii":["F8A3652H1V"]},"update_date":"10/14/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 0143-9872-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"43547-408-50","generic_name":"Clonazepam Tablet","contact_info":"For orders, Solco Healthcare 866-931-9829","resolved_note":"Available","openfda":{"application_number":["ANDA077856"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Solco Healthcare LLC"],"product_ndc":["43547-408","43547-406","43547-407"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["dc17b9d4-2890-4f6c-8476-daa39d0cbc9c"],"spl_set_id":["4acbb7a9-4db5-4497-b8db-9f358b3f6fb4"],"package_ndc":["43547-406-10","43547-406-50","43547-406-11","43547-407-10","43547-407-50","43547-407-11","43547-408-10","43547-408-50"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 43547-408-50)","company_name":"Prinston Pharmaceutical, Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"07/18/2023","package_ndc":"0169-2800-15","generic_name":"Liraglutide Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Liraglutide+Injection&st=d","contact_info":"833-493-4689","availability":"Limited Availability","related_info":"Product will be available until discontinuation in January 2027","openfda":{"application_number":["NDA206321"],"brand_name":["SAXENDA"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Novo Nordisk Pharmaceutical Industries, LP"],"product_ndc":["0169-2800"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["1598268","2735350"],"spl_id":["7e183945-550d-4b6a-bf4e-300193517cac"],"spl_set_id":["3946d389-0926-4f77-a708-0acb8153b143"],"package_ndc":["0169-2800-15","0169-2800-90","0169-2800-97"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"09/22/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)","company_name":"Novo Nordisk, Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-3178-03","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA089644"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3178","0409-1209","0409-3177","0409-3181","0409-3182","0409-3183","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0703-4244-01","generic_name":"Carboplatin Injection","contact_info":"800-545-8800","availability":"Unavailable","related_info":"Estimated recovery: January 2027","openfda":{"application_number":["ANDA077269"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-4244","0703-4246","0703-4248","0703-4239"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df","b943761e-6a46-45a0-bdb4-1fec1e101f8c"],"spl_set_id":["f330f5a2-2cad-402f-bcbb-26245a753276","e176b6ef-2ff6-498b-a9d8-7a634d147f37"],"package_ndc":["0703-4244-01","0703-4246-01","0703-4248-01","0703-4239-01","0703-4244-81","0703-4246-81","0703-4248-81","0703-4239-81"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4244-01)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0427-53","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020163"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0427","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0427-53)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/22/2020","package_ndc":"68001-313-56","generic_name":"Azacitidine Injection","contact_info":"800-545-8800","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA208216"],"brand_name":["AZACITIDINE"],"generic_name":["AZACITIDINE"],"manufacturer_name":["BluePoint Laboratories"],"product_ndc":["68001-313"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["AZACITIDINE"],"rxcui":["485246"],"spl_id":["36080e4e-a0fe-ba15-e063-6394a90aed5c"],"spl_set_id":["5f0f9ee3-a5b1-4a25-a34c-7f38c8433f4a"],"package_ndc":["68001-313-56"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["M801H13NRU"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Azacitidine, Injection, 100 mg (NDC 68001-313-56)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"06/08/2026","update_type":"New","initial_posting_date":"06/08/2026","package_ndc":"0069-2299-30","generic_name":"Dacomitinib Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA211288"],"brand_name":["VIZIMPRO"],"generic_name":["DACOMITINIB"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0069-2299","0069-0197","0069-1198"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DACOMITINIB"],"rxcui":["2058915","2058922","2058924","2058926","2058930","2058932"],"spl_id":["3ffd0da1-5601-4ecc-a8fb-f484693cb4c5"],"spl_set_id":["4ab27d2f-e385-4e9c-b324-fa69c10b855a"],"package_ndc":["0069-0197-30","0069-1198-30","0069-2299-30"],"unii":["5092U85G58"]},"update_date":"06/08/2026","therapeutic_category":["Oncology"],"dosage_form":"Tablet","presentation":"Vizimpro, Tablet, 45 mg (NDC 0069-2299-30)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"05/15/2026","update_type":"New","initial_posting_date":"05/15/2026","package_ndc":"0574-0520-76","generic_name":"Activated Charcoal Oral Suspension","contact_info":"866-634-9120","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["M023"],"brand_name":["ACTIDOSE"],"generic_name":["ACTIVATED CHARCOAL"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-0520"],"product_type":["HUMAN OTC DRUG"],"route":["ORAL"],"substance_name":["ACTIVATED CHARCOAL"],"rxcui":["309150","1251411"],"spl_id":["cf3da077-fe7d-4685-8c5c-f773bc88c88d"],"spl_set_id":["76e4fe6a-afd4-4f68-b12d-0b094f750615"],"package_ndc":["0574-0520-74","0574-0520-76"],"unii":["2P3VWU3H10"]},"update_date":"05/15/2026","therapeutic_category":["Other"],"dosage_form":"Oral Suspension","presentation":"Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-76)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"0409-9094-55","generic_name":"Fentanyl Citrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA019115"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9094","0409-9093"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735004","1735006","1735007","1735008","1735013"],"spl_id":["8ff8b8cf-1a31-46dc-b350-2b9cc700e6a6"],"spl_set_id":["bfa8018a-4cbc-434b-e09e-782872b0340a"],"package_ndc":["0409-9093-41","0409-9093-36","0409-9093-31","0409-9093-38","0409-9094-12","0409-9094-22","0409-9094-18","0409-9094-25","0409-9094-17","0409-9094-28","0409-9094-16","0409-9094-31","0409-9094-41","0409-9094-61","0409-9094-44","0409-9094-55"],"unii":["MUN5LYG46H"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 2,500 mcg/50 mL (50 mcg/mL) Single Dose Glass Fliptop Vial (NDC 0409-9094-55)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"25021-115-06","generic_name":"Clindamycin Phosphate Injection","contact_info":"866-625-1618","availability":"Limited Availability","related_info":"Selling through remaining short-dated inventory (Dec 2026).","openfda":{"application_number":["ANDA090108"],"brand_name":["CLINDAMYCIN"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-115"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["1737244","1737578","1737581"],"spl_id":["ca8ce6e9-feae-4a33-a380-64061313d704"],"spl_set_id":["7a6967b3-5563-4bed-9eee-d400f800e799"],"package_ndc":["25021-115-02","25021-115-04","25021-115-06"],"unii":["EH6D7113I8"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-06)","company_name":"Sagent Pharmaceuticals","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"61703-262-05","generic_name":"Carboplatin Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA076517"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-262","61703-360","61703-150","61703-600"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["5aa72c15-8033-4559-b257-373371b18958"],"spl_set_id":["47677091-fd20-49af-933c-c9dd2be21de9"],"package_ndc":["61703-360-18","61703-150-05","61703-262-05","61703-600-05"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/09/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-262-05)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"43066-013-10","generic_name":"Rocuronium Bromide Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA091115"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["43066-013","43066-007"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["9e0317de-2d78-4fd8-8926-4c7b476f3ed4"],"spl_set_id":["31e15c3f-aefa-4379-b684-7707744fe40d"],"package_ndc":["43066-007-10","43066-013-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 43066-013-10)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/08/2019","package_ndc":"63323-165-30","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA084916"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-165"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["1116927","1812194"],"spl_id":["1815f54a-5637-45bc-a582-3e62350935ba","9dd90418-e564-4bc5-9077-506a1c2c1bce"],"spl_set_id":["2b626a48-c7aa-4443-9164-a08ff069ccd1","4fedef4f-ec96-4f36-b2f0-01e243e3b89e"],"package_ndc":["63323-165-11","63323-165-51","63323-165-13","63323-165-53","63323-165-02","63323-165-01","63323-165-03","63323-165-05","63323-165-30","63323-165-16","63323-165-26"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-30)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0378-6859-77","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA202835"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-6859","0378-6854","0378-6855","0378-6856","0378-6857","0378-6858","0378-6860"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["6e77cd71-95ae-4fa8-830b-ab62b714e4b9"],"spl_set_id":["efbde0f6-b848-4664-b741-c6c630e66108"],"package_ndc":["0378-6854-77","0378-6855-77","0378-6856-77","0378-6857-77","0378-6858-77","0378-6859-77","0378-6860-77"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0378-6859-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/20/2023","package_ndc":"0641-6030-01","generic_name":"Fentanyl Citrate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.","openfda":{"application_number":["NDA019101"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6030","0641-6024","0641-6027","0641-6025","0641-6028","0641-6026","0641-6029","0641-6247","0641-6248","0641-6249"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270","2474269","2629337"],"spl_id":["4eb40afd-eae7-4006-8934-4e1d43d59ea7"],"spl_set_id":["ce5db1c2-feb1-4ad2-847a-d02e865bd47e"],"package_ndc":["0641-6024-01","0641-6024-10","0641-6027-01","0641-6027-25","0641-6025-01","0641-6025-10","0641-6028-01","0641-6028-10","0641-6028-25","0641-6026-01","0641-6026-05","0641-6029-01","0641-6029-25","0641-6030-01","0641-6247-01","0641-6247-25","0641-6248-01","0641-6248-10","0641-6249-01","0641-6249-10"],"unii":["MUN5LYG46H"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6030-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"70069-021-25","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"732-554-1019","availability":"Available","openfda":{"application_number":["ANDA207442"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-021"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["1812079"],"spl_id":["73618326-ff56-4a30-9d6d-6b019b61c2cd"],"spl_set_id":["799028e2-c0e4-494f-89ff-1b786babc34a"],"package_ndc":["70069-021-01","70069-021-25"],"unii":["AI9376Y64P"]},"update_date":"10/27/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/17/2015","package_ndc":"21586-012-02","generic_name":"Cefotaxime Sodium Powder, for Solution","related_info_link":"https://www.fda.gov/media/193116/download?attachment","contact_info":"800-881-3550","availability":"Available","openfda":{"brand_name":["CEFOTAXIME"],"generic_name":["CEFOTAXIME INJECTION"],"manufacturer_name":["SteriMax Inc."],"product_ndc":["21586-012","21586-011"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CEFOTAXIME SODIUM"],"rxcui":["1656313","1656318"],"spl_id":["7a77a18a-3d8c-4bac-8d21-54a88db396f6"],"spl_set_id":["8efe3bd0-c43a-2bd6-e053-2a95a90a92fa"],"package_ndc":["21586-011-01","21586-011-02","21586-012-01","21586-012-02"],"unii":["258J72S7TZ"]},"update_date":"06/15/2026","therapeutic_category":["Anti-Infective","Pediatric"],"dosage_form":"Powder, For Solution","presentation":"Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02)","company_name":"SteriMax, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"0409-1403-10","generic_name":"Rocuronium Bromide Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA205656"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1403","0409-5160"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["f01f9986-43f9-40e8-9506-11bfe78f9242"],"spl_set_id":["f01f9986-43f9-40e8-9506-11bfe78f9242"],"package_ndc":["0409-1403-05","0409-1403-10","0409-5160-01","0409-5160-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-1403-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"76045-0212-10","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release January 2027. Check wholesalers for inventory.","update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-0212-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"70010-114-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"877-770-3183","availability":"Unavailable","related_info":"Estimated recovery: December 2026","openfda":{"application_number":["ANDA215771"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Granules Pharmaceuticals Inc."],"product_ndc":["70010-114","70010-111","70010-112","70010-113","70010-115","70010-116","70010-117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["56c7c921-e560-c5ad-e063-6294a90a4c81"],"spl_set_id":["b0b4eccc-34c7-483d-966f-82d588358e1b"],"package_ndc":["70010-111-01","70010-111-03","70010-112-01","70010-112-03","70010-113-01","70010-113-03","70010-114-01","70010-114-03","70010-115-01","70010-115-03","70010-116-01","70010-116-03","70010-117-01","70010-117-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/28/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 70010-114-01)","company_name":"Granules Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"08/03/2022","package_ndc":"62135-737-90","generic_name":"Flurazepam Hydrochloride Capsule","contact_info":"845-268-5000 Ext. 510","availability":"Available","openfda":{"application_number":["ANDA072369"],"brand_name":["FLURAZEPAM HYDROCHLORIDE"],"generic_name":["FLURAZEPAM HYDROCHLORIDE"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-737","62135-736"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FLURAZEPAM HYDROCHLORIDE"],"rxcui":["1298088","1298091"],"spl_id":["25893c92-c8f1-567a-e063-6294a90a00d4"],"spl_set_id":["8f476891-1346-4e8c-ac1b-f8cbdc64f5a1"],"package_ndc":["62135-736-30","62135-736-90","62135-737-30","62135-737-90"],"unii":["756RDM536M"]},"update_date":"09/15/2026","therapeutic_category":["Neurology","Other"],"dosage_form":"Capsule","presentation":"Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"discontinued_date":"10/14/2026","update_type":"New","initial_posting_date":"10/14/2026","package_ndc":"83634-600-02","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"See Related Information section below for customer service information","related_info":"Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229","openfda":{"application_number":["ANDA209065"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["Avenacy Inc."],"product_ndc":["83634-600"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710"],"spl_id":["f036291f-40af-44b9-8a7f-d4475788ea63"],"spl_set_id":["eee6145b-d83f-4596-92d3-733934d8a3a4"],"package_ndc":["83634-600-41","83634-600-02"],"unii":["1018WH7F9I"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)","company_name":"Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)","status":"To Be Discontinued"},{"discontinued_date":"02/25/2026","update_type":"New","initial_posting_date":"02/25/2026","package_ndc":"0009-0395-14","generic_name":"Clindamycin Hydrochloride Capsule","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050162"],"brand_name":["CLEOCIN HYDROCHLORIDE"],"generic_name":["CLINDAMYCIN HYDROCHLORIDE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0395","0009-0331","0009-0225"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLINDAMYCIN HYDROCHLORIDE"],"rxcui":["197518","284215","309329","748746","748748","748750"],"spl_id":["3cdb1eb4-26cd-495d-b9d2-0ad980fadc2b"],"spl_set_id":["df9a2a41-b132-4f43-8940-b2d773b1369a"],"package_ndc":["0009-0331-02","0009-0225-02","0009-0395-14"],"unii":["T20OQ1YN1W"]},"update_date":"02/25/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"06/04/2026","update_type":"New","initial_posting_date":"06/04/2026","package_ndc":"0169-4307-30","generic_name":"Semaglutide Tablet","contact_info":"833-493-4689","related_info":"Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.","openfda":{"application_number":["NDA213051"],"brand_name":["RYBELSUS"],"generic_name":["ORAL SEMAGLUTIDE"],"manufacturer_name":["Novo Nordisk Pharmaceutical Industries, LP"],"product_ndc":["0169-4307","0169-1715","0169-1704","0169-1709","0169-4303","0169-4314","0169-4815","0169-4804","0169-4809"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["SEMAGLUTIDE"],"rxcui":["2200644","2200650","2200652","2200654","2200656","2200658","2707547","2707549","2707551","2707553","2707555","2707557","2736944","2736946","2736948"],"spl_id":["6834044a-22f1-4f35-b846-b3448ee84c16"],"spl_set_id":["27f15fac-7d98-4114-a2ec-92494a91da98"],"package_ndc":["0169-1715-30","0169-1715-90","0169-1704-30","0169-1709-30","0169-4303-01","0169-4303-13","0169-4303-90","0169-4303-93","0169-4303-30","0169-4303-99","0169-4307-01","0169-4307-13","0169-4307-30","0169-4314-01","0169-4314-13","0169-4314-30","0169-4815-30","0169-4815-90","0169-4804-30","0169-4809-30"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["53AXN4NNHX"]},"update_date":"06/04/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Rybelsus, Tablet, 7 mg (NDC 0169-4307-30)","company_name":"Novo Nordisk, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"55150-209-02","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA205867"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-209","55150-296","55150-297"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710","1718906","1718909"],"spl_id":["a1eab62d-fcef-4b83-9266-3c5f7a05927b"],"spl_set_id":["8c162541-986b-4b30-866c-b2631ba2c975"],"package_ndc":["55150-209-02","55150-296-10","55150-297-10"],"unii":["1018WH7F9I"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"64850-554-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-852-6657","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA218604"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-554","64850-550","64850-551","64850-552","64850-553","64850-555","64850-556"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["2d33f701-8067-4a48-98cc-4e7dacaf3cc4"],"spl_set_id":["0e024b69-567c-4b40-9c3e-a2daec34256c"],"package_ndc":["64850-550-01","64850-551-01","64850-552-01","64850-553-01","64850-554-01","64850-555-01","64850-556-01"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 64850-554-01)","company_name":"Elite Laboratories, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"05/21/2026","update_type":"New","initial_posting_date":"05/21/2026","package_ndc":"65219-082-10","generic_name":"Gadoterate Meglumine Injection","contact_info":"Marketed by Fresenius Kabi, USA; Customer service: 888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA215304"],"brand_name":["GADOTERATE MEGLUMINE"],"generic_name":["GADOTERATE MEGLUMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-082","65219-080","65219-084","65219-086"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOTERATE MEGLUMINE"],"spl_id":["f05922b7-99d4-48c7-972a-7966bbbbc3b4"],"spl_set_id":["e0655aac-9508-4141-94f5-fcca6af1c41d"],"package_ndc":["65219-080-01","65219-080-05","65219-082-01","65219-082-10","65219-084-01","65219-084-15","65219-086-01","65219-086-20"],"unii":["L0ND3981AG"]},"update_date":"05/21/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"discontinued_date":"06/05/2026","update_type":"New","initial_posting_date":"06/05/2026","package_ndc":"71225-126-05","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"800-461-7449","related_info":"Discontinuation of the manufacture of the drug","update_date":"06/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05)","company_name":"Slayback Pharma","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0406-8893-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA040440"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-8893","0406-8891","0406-8884","0406-8892","0406-8885","0406-8894"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["0d3fb5ba-ff79-4862-bc1d-45b8343e115b"],"spl_set_id":["72ddd1c9-ddbd-4c95-acd9-003189a353a3"],"package_ndc":["0406-8891-01","0406-8884-01","0406-8892-01","0406-8885-01","0406-8893-01","0406-8894-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0406-8893-01)","company_name":"SpecGx LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"0409-3299-25","generic_name":"Sodium Acetate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018893"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3299"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["237371"],"spl_id":["4e6137c2-6b7c-4882-985c-03b591b6c046","b7a713f4-3c97-484b-b182-2824e1e944bb"],"spl_set_id":["abc41ed1-9512-4bea-9295-1a9ca134b6c2","c3be2468-45e8-4ecc-a30b-e966743a563f"],"package_ndc":["0409-3299-15","0409-3299-05","0409-3299-16","0409-3299-06","0409-3299-45","0409-3299-25","0409-3299-46","0409-3299-26"],"unii":["NVG71ZZ7P0"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"47781-178-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA207388"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 15 MG,CLL"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-178","47781-174","47781-175","47781-176","47781-177","47781-179","47781-180"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AMPHETAMINE ASPARTATE MONOHYDRATE","AMPHETAMINE SULFATE","DEXTROAMPHETAMINE SACCHARATE","DEXTROAMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["eb490273-9334-1ae5-dd32-658e7fb0b40e"],"spl_set_id":["c907301d-e24d-9609-5529-fed14f94549f"],"package_ndc":["47781-174-30","47781-174-05","47781-174-01","47781-175-30","47781-175-05","47781-175-01","47781-176-30","47781-176-05","47781-176-01","47781-177-30","47781-177-05","47781-177-01","47781-178-30","47781-178-05","47781-178-01","47781-179-30","47781-179-05","47781-179-01","47781-180-30","47781-180-05","47781-180-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 15mg (NDC 47781-178-01)","company_name":"Alvogen","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-118-01","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA208510"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-118","59417-101","59417-102","59417-103","59417-104","59417-105","59417-106","59417-107","59417-115","59417-116","59417-117","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"discontinued_date":"11/19/2025","update_type":"New","initial_posting_date":"11/19/2025","package_ndc":"0591-0347-01","generic_name":"Hydrochlorothiazide Capsule","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020504"],"brand_name":["HYDROCHLOROTHIAZIDE"],"generic_name":["HYDROCHLOROTHIAZIDE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0591-0347"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["HYDROCHLOROTHIAZIDE"],"rxcui":["199903"],"spl_id":["aea91439-5b06-44b8-a92f-e75c13847c5d"],"spl_set_id":["a3eb7294-f913-434b-896c-da028bfebc73"],"package_ndc":["0591-0347-01","0591-0347-05"],"nui":["N0000175359","N0000175419","M0471776"],"pharm_class_pe":["Increased Diuresis [PE]"],"pharm_class_epc":["Thiazide Diuretic [EPC]"],"pharm_class_cs":["Thiazides [CS]"],"unii":["0J48LPH2TH"]},"update_date":"11/19/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Microzide, Capsule, 12.5 mg (NDC 0591-0347-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/01/2022","package_ndc":"0990-7930-02","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Limited Availability","related_info":"On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA018080"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7930","0990-7923","0990-7922"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"43547-406-11","generic_name":"Clonazepam Tablet","contact_info":"For orders, Solco Healthcare 866-931-9829","resolved_note":"Available","openfda":{"application_number":["ANDA077856"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Solco Healthcare LLC"],"product_ndc":["43547-406","43547-407","43547-408"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["dc17b9d4-2890-4f6c-8476-daa39d0cbc9c"],"spl_set_id":["4acbb7a9-4db5-4497-b8db-9f358b3f6fb4"],"package_ndc":["43547-406-10","43547-406-50","43547-406-11","43547-407-10","43547-407-50","43547-407-11","43547-408-10","43547-408-50"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 43547-406-11)","company_name":"Prinston Pharmaceutical, Inc.","status":"Resolved"},{"discontinued_date":"12/03/2025","update_type":"New","initial_posting_date":"12/03/2025","package_ndc":"0409-7101-02","generic_name":"Sodium Chloride 0.9% Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA019465"],"brand_name":["SODIUM CHLORIDE"],"generic_name":["SODIUM CHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7101","0409-7132"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM CHLORIDE"],"rxcui":["1807547","1807631","1807632","1807633"],"spl_id":["147cbba6-2ead-49c4-bce7-4e9c65b303c9"],"spl_set_id":["a2a964f7-c3ec-4dfb-e3a0-6d8136a80397"],"package_ndc":["0409-7101-68","0409-7101-66","0409-7101-69","0409-7101-67","0409-7101-04","0409-7101-02","0409-7132-68","0409-7132-66","0409-7132-69","0409-7132-67","0409-7132-04","0409-7132-02"],"unii":["451W47IQ8X"]},"update_date":"12/03/2025","therapeutic_category":["Gastroenterology","Other","Renal"],"dosage_form":"Injection","presentation":"Sodium Chloride 0.9%, Injection, 250 mL  ADD-Vantage® Flexible Container (NDC 0409-7101-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0017-41","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0017","0338-0023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-41)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"62175-311-37","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"844-834-0530","availability":"Unavailable","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA091695"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Lannett Company, Inc."],"product_ndc":["62175-311","62175-310","62175-312","62175-313"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["2001564","2001565","2001566","2001568"],"spl_id":["8b133cd2-e3c6-4742-b402-2393b56ffc93"],"spl_set_id":["3d1f5aff-5d39-496c-b5ed-7f3c70ec641c"],"package_ndc":["62175-310-37","62175-311-37","62175-312-37","62175-313-37"],"unii":["4B3SC438HI"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62175-311-37)","company_name":"Lannett Company, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"02/24/2026","update_type":"New","initial_posting_date":"02/24/2026","package_ndc":"50742-401-02","generic_name":"Irinotecan Hydrochloride Injection","contact_info":"866-321-5031","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"02/24/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Irinotecan Hydrochloride, Injection, 40 mg/2 mL (NDC 50742-401-02)","company_name":"Ingenus Pharmaceuticals LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0990-7923-36","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7923","0990-7922","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-36)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"discontinued_date":"04/28/2026","update_type":"New","initial_posting_date":"04/28/2026","package_ndc":"70370-5025-1","generic_name":"Crinecerfont Capsule","contact_info":"858-617-7600","related_info":"Neurocrine is discontinuing only the 25 mg soft gel capsule dose strength (NDC 70370-5025-01). The 50mg and 100mg soft gel capsule dose strength (NDC 70370-5050-1 and 70370-5100-1), and 50 mg/mL oral solution will continue to be marketed (NDC 70370-5250-1).","update_date":"04/28/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Capsule","presentation":"Crenessity, Capsule, 25 mg (NDC 70370-5025-1)","company_name":"Neurocrine Biosciences, Inc.","status":"To Be Discontinued"},{"discontinued_date":"04/06/2026","update_type":"New","initial_posting_date":"04/06/2026","package_ndc":"64380-844-06","generic_name":"Ursodiol Capsule","contact_info":"877-244-9825","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA210344"],"brand_name":["URSODIOL"],"generic_name":["URSODIOL"],"manufacturer_name":["Strides Pharma Science Limited"],"product_ndc":["64380-844"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["URSODIOL"],"rxcui":["858747"],"spl_id":["20f4357a-edf9-4326-804f-9c72aae8e113"],"spl_set_id":["9a6c1928-2d52-4d9a-8e83-f71892a7e98d"],"package_ndc":["64380-844-06","64380-844-07","64380-844-04"],"nui":["N0000175802","M0002475"],"pharm_class_epc":["Bile Acid [EPC]"],"pharm_class_cs":["Bile Acids and Salts [CS]"],"unii":["724L30Y2QR"]},"update_date":"04/06/2026","therapeutic_category":["Other"],"dosage_form":"Capsule","presentation":"Ursodiol, Capsule, 300 mg (NDC 64380-844-06)","company_name":"Strides Pharma Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2021","package_ndc":"71288-505-03","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-824-8426","availability":"Available","openfda":{"application_number":["ANDA204843"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-505"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710"],"spl_id":["aa312d38-51c9-4615-a1ad-7dd639394b0f"],"spl_set_id":["8fa36783-b94d-4084-8c41-40ee64192074"],"package_ndc":["71288-505-02","71288-505-03"],"unii":["1018WH7F9I"]},"update_date":"08/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)","company_name":"Meitheal Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"50458-585-01","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET","availability":"Available","openfda":{"application_number":["NDA021121"],"brand_name":["CONCERTA"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Janssen Pharmaceuticals, Inc."],"product_ndc":["50458-585","50458-588","50458-586","50458-587"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091157","1091170","1091172","1091185","1091187","1091210","1091212"],"spl_id":["64d7c1e1-e7ed-4d74-a44d-13b4da64af9a"],"spl_set_id":["1a88218c-5b18-4220-8f56-526de1a276cd"],"package_ndc":["50458-585-01","50458-588-01","50458-586-01","50458-587-01"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)","company_name":"Janssen Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"25021-701-01","generic_name":"Ketorolac Tromethamine Injection","contact_info":"833-291-9645","availability":"Available","openfda":{"application_number":["ANDA204216"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-701","25021-700"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["cb23332a-48fa-458b-93ab-c4eef189a051"],"spl_set_id":["62591551-a644-4b2c-a0de-982e906fabc3"],"package_ndc":["25021-700-01","25021-701-01","25021-701-02"],"unii":["4EVE5946BQ"]},"update_date":"10/21/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)","company_name":"Gland Pharma Limited","status":"Current"},{"discontinued_date":"02/20/2026","update_type":"New","initial_posting_date":"02/20/2026","package_ndc":"50742-431-08","generic_name":"Docetaxel Injection","contact_info":"866-321-5031","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"02/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Docetaxel, Injection, 10 mg/1 mL (NDC 50742-431-08)","company_name":"Ingenus Pharmaceuticals LLC","status":"To Be Discontinued"},{"discontinued_date":"02/20/2026","update_type":"New","initial_posting_date":"02/20/2026","package_ndc":"68001-573-41","generic_name":"Decitabine Injection","contact_info":"866-321-5031","related_info":"Labeler: BluePoint Laboratories; Discontinuation of the manufacture of the drug","update_date":"02/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Decitabine, Injection, 50 mg (NDC 68001-573-41)","company_name":"Ingenus Pharmaceuticals LLC","status":"To Be Discontinued"},{"discontinued_date":"02/19/2026","update_type":"New","initial_posting_date":"02/19/2026","package_ndc":"0591-5544-01","generic_name":"Allopurinol Tablet","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA018877"],"brand_name":["ALLOPURINOL"],"generic_name":["ALLOPURINOL"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0591-5544","0591-5543"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ALLOPURINOL"],"rxcui":["197319","197320"],"spl_id":["f7e04d88-1d9b-47e6-a9ad-deb08af3c098"],"spl_set_id":["a80fe56f-8d03-423f-8e2a-7ec8c9e5045b"],"package_ndc":["0591-5543-01","0591-5543-10","0591-5544-01","0591-5544-05"],"nui":["N0000175698","N0000000206"],"pharm_class_epc":["Xanthine Oxidase Inhibitor [EPC]"],"pharm_class_moa":["Xanthine Oxidase Inhibitors [MoA]"],"unii":["63CZ7GJN5I"]},"update_date":"02/19/2026","therapeutic_category":["Oncology","Renal","Rheumatology"],"dosage_form":"Tablet","presentation":"Allopurinol, Tablet, 300 mg (NDC 0591-5544-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"06/15/2026","update_type":"New","initial_posting_date":"06/15/2026","package_ndc":"69238-1248-3","generic_name":"Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release","contact_info":"866-525-7270","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA208328"],"brand_name":["MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE"],"generic_name":["MEMANTINE AND DONEPEZIL"],"manufacturer_name":["Amneal Pharmaceuticals NY LLC"],"product_ndc":["69238-1248","69238-1247","69238-1552","69238-1553"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MEMANTINE HYDROCHLORIDE","DONEPEZIL HYDROCHLORIDE"],"rxcui":["1599803","1599805","1805420","1805425"],"spl_id":["acd577e1-312c-4d5a-85b5-bc50ef9de545"],"spl_set_id":["2335950c-be3b-4248-ad04-e9763aee47d2"],"package_ndc":["69238-1248-3","69238-1248-9","69238-1247-3","69238-1247-9","69238-1552-3","69238-1552-9","69238-1553-3","69238-1553-9"],"unii":["JY0WD0UA60","3O2T2PJ89D"]},"update_date":"06/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Capsule, Extended Release","presentation":"Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 14 mg (NDC 69238-1248-3)","company_name":"Amneal Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"04/02/2020","package_ndc":"76045-211-20","generic_name":"Midazolam Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA203460"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-211","76045-001","76045-002","76045-003"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["998211","1551393","1551395"],"spl_id":["ec9c9aee-b95f-4645-bf17-df7f1e3967d3"],"spl_set_id":["1cc9ba6e-fa1b-405e-9de8-720c567b2a73"],"package_ndc":["76045-211-00","76045-211-20","76045-001-00","76045-001-20","76045-002-00","76045-002-10","76045-003-00","76045-003-20"],"unii":["W7TTW573JJ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-201-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA088586"],"brand_name":["LIDOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-201","63323-202"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1737757"],"spl_id":["d19c26f4-1214-40f7-9680-43c885613306"],"spl_set_id":["cddb2b22-fce3-8967-6e54-dca3df5ac4b3"],"package_ndc":["63323-201-01","63323-201-02","63323-201-03","63323-201-10","63323-202-01","63323-202-02"],"unii":["V13007Z41A"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride In Plastic Container, Injection, 10 mg/1 mL (NDC 63323-201-02)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-0622-80","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-0622","0075-0624","0075-0620","0075-0621","0075-0623","0075-0626","0075-2912","0075-2915"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["cdb74d6d-1a74-4156-a52a-710c55cb2927"],"spl_set_id":["5017a927-2a24-4f27-89f9-27c805bf7d59"],"package_ndc":["0075-0624-01","0075-0624-30","0075-0620-01","0075-0620-40","0075-0621-01","0075-0621-60","0075-0622-01","0075-0622-80","0075-0623-03","0075-0623-00","0075-0626-03","0075-2912-00","0075-2912-01","0075-2915-00","0075-2915-01"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 80 mg/.8 mL (NDC 0075-0622-80)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"42023-187-10","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"800-828-9393","availability":"Unavailable","related_info":"Estimated recovery: TBD; Please check wholesalers for inventory","openfda":{"application_number":["ANDA208266"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["42023-187","42023-146","42023-186"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710","1718906","1718909"],"spl_id":["54174211-6684-4fb9-a605-be12b94e2948"],"spl_set_id":["1ee59985-4c1d-48f7-b8f9-5584c2d55e08"],"package_ndc":["42023-146-25","42023-186-20","42023-187-10"],"unii":["1018WH7F9I"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10)","company_name":"Par Health, USA LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-1165-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070585"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1165","0409-1159","0409-1160","0409-1162","0409-1163","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, Marcaine 75 mg/10 mL (7.5 mg/mL) (NDC 0409-1165-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/01/2022","package_ndc":"0264-7520-10","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019626"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-7520","0264-7510"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE, UNSPECIFIED FORM"],"rxcui":["1795477","1795480","1795481","1795607","1795610","1795612"],"spl_id":["4acb5988-64ad-4f83-bc8d-6f2117dfebbe"],"spl_set_id":["085614c7-ada4-4e2c-87c0-c9bc2f18365a"],"package_ndc":["0264-7510-00","0264-7510-10","0264-7510-20","0264-7520-00","0264-7520-10","0264-7520-20"],"unii":["IY9XDZ35W2"]},"update_date":"10/19/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-10)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0409-2596-05","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA075293"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2596","0409-2587"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["6c075a2d-b68b-41a7-aa0c-bcf9894e3f76"],"spl_set_id":["affecd4d-1f78-4bbe-5a8d-86849bbdc520"],"package_ndc":["0409-2587-04","0409-2587-05","0409-2596-13","0409-2596-03","0409-2596-15","0409-2596-05"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-2066-05","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA040078"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2066"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737761"],"spl_id":["c3ff0219-b020-4dd0-aa08-0784b215d479"],"spl_set_id":["9c18eaf1-4a0b-4916-70b2-88a827494711"],"package_ndc":["0409-2066-10","0409-2066-05"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 100 mg/5 mL (2%; 20 mg/mL) (NDC 0409-2066-05)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"0143-9311-10","generic_name":"Etomidate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Novaplus label","openfda":{"application_number":["ANDA202354"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9311","0143-9310"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["c15bd8c1-34e3-40f2-b31a-634136fe197c"],"spl_set_id":["4312e3c3-34de-4cb3-8abd-c24d24a4bea1"],"package_ndc":["0143-9310-01","0143-9310-10","0143-9311-01","0143-9311-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 0143-9311-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0781-3494-95","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"See Related Information section below for customer service information","availability":"Available","related_info":"Marketed by Sandoz Inc.; Customer service: 800-525-8747","openfda":{"application_number":["ANDA209065"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"manufacturer_name":["Sandoz Inc."],"product_ndc":["0781-3494","0781-3493","0781-3495"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718900","1718906","1718909"],"spl_id":["5a0d944c-af38-a3fd-e063-6294a90aed62"],"spl_set_id":["809e8f77-390f-4cc8-8c8a-4f67a249c9df"],"package_ndc":["0781-3493-95","0781-3494-95","0781-3495-95"],"unii":["1018WH7F9I"]},"update_date":"10/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"Current"},{"discontinued_date":"05/05/2026","update_type":"New","initial_posting_date":"05/05/2026","package_ndc":"71288-722-32","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-824-8426","related_info":"Discontinuation of the manufacture of the drug","update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)","company_name":"Kindos Pharmaceuticals Co. Ltd.","status":"To Be Discontinued"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-0626-03","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-0626","0075-0624","0075-0620","0075-0621","0075-0622","0075-0623","0075-2912","0075-2915"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["cdb74d6d-1a74-4156-a52a-710c55cb2927"],"spl_set_id":["5017a927-2a24-4f27-89f9-27c805bf7d59"],"package_ndc":["0075-0624-01","0075-0624-30","0075-0620-01","0075-0620-40","0075-0621-01","0075-0621-60","0075-0622-01","0075-0622-80","0075-0623-03","0075-0623-00","0075-0626-03","0075-2912-00","0075-2912-01","0075-2915-00","0075-2915-01"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 300 mg/3 mL (NDC 0075-0626-03)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-356-05","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-05)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"13107-069-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(866) 850-2876 or CustomerService@AurobindoUSA.com","availability":"Unavailable","related_info":"Estimated availability: April 2027","openfda":{"application_number":["ANDA202424"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Aurolife Pharma, LLC"],"product_ndc":["13107-069","13107-068","13107-070","13107-071","13107-072","13107-073","13107-074"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["44a9eb77-0896-4b62-9953-7121d97d6ffd"],"spl_set_id":["a582d57f-d191-4ca5-b105-585b2d8a0e3e"],"package_ndc":["13107-068-50","13107-068-01","13107-068-25","13107-068-05","13107-068-99","13107-069-50","13107-069-01","13107-069-25","13107-069-05","13107-069-99","13107-070-50","13107-070-01","13107-070-25","13107-070-05","13107-070-99","13107-071-50","13107-071-01","13107-071-25","13107-071-05","13107-071-99","13107-072-50","13107-072-01","13107-072-25","13107-072-05","13107-072-99","13107-073-50","13107-073-01","13107-073-25","13107-073-05","13107-073-99","13107-074-50","13107-074-01","13107-074-25","13107-074-05","13107-074-99"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/04/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 13107-069-01)","company_name":"Aurobindo Pharma USA","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"72516-013-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"855-257-0292","availability":"Unavailable","related_info":"Estimated recovery: April 2027","openfda":{"application_number":["ANDA210293"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Oryza Pharmaceuticals Inc."],"product_ndc":["72516-013","72516-016","72516-015","72516-014","72516-012","72516-011"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["5734011d-5044-b490-e063-6394a90a3174"],"spl_set_id":["acd27181-a3f3-4c38-85d8-029a4a82e7c2"],"package_ndc":["72516-016-01","72516-015-01","72516-014-01","72516-013-01","72516-012-01","72516-011-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 72516-013-01)","company_name":"Oryza Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"11534-191-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"732-382-6085 Monday to Friday 9 am to 3:45 pm","availability":"Available","openfda":{"application_number":["ANDA209799"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SUNRISE PHARMACEUTICAL, INC."],"product_ndc":["11534-191","11534-190","11534-192","11534-193","11534-194","11534-195","11534-196"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["60dcfbf6-d07a-4010-ae77-8a9ae4529828"],"spl_set_id":["ac102599-3a5b-4154-899e-6ff262be7ff7"],"package_ndc":["11534-190-01","11534-190-03","11534-191-01","11534-191-03","11534-192-01","11534-192-03","11534-193-01","11534-193-03","11534-194-01","11534-194-03","11534-195-01","11534-195-03","11534-196-01","11534-196-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/01/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 11534-191-01)","company_name":"Sunrise Pharmaceutical, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-0525-25","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","related_info":"Historical NDC: 0409-1610-50","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-0525","0409-1746","0409-1749","0409-1752","0409-1755","0409-2510","0409-7535","0409-1250","0409-5010","0409-1530","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, 250 mg/50 mL (NDC 0409-0525-25)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"08/13/2026","update_type":"New","initial_posting_date":"08/13/2026","package_ndc":"0228-2550-06","generic_name":"Diclofenac Sodium Tablet, Delayed Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA074514"],"brand_name":["DICLOFENAC SODIUM"],"generic_name":["DICLOFENAC SODIUM"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2550","0228-2551"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DICLOFENAC SODIUM"],"rxcui":["855906","855926"],"spl_id":["a1fbc994-b8a6-4759-be76-1cfd98275ca6"],"spl_set_id":["a57b897e-0cbe-4ac3-969f-b00357a0cfa8"],"package_ndc":["0228-2550-06","0228-2550-11","0228-2550-96","0228-2551-06","0228-2551-11","0228-2551-96"],"unii":["QTG126297Q"]},"update_date":"08/13/2026","therapeutic_category":["Musculoskeletal","Rheumatology"],"dosage_form":"Tablet","presentation":"Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-06)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"11/14/2025","update_type":"New","initial_posting_date":"11/14/2025","package_ndc":"0703-4094-01","generic_name":"Palonosetron Hydrochloride Injection","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA090713"],"brand_name":["PALONOSETRON HYDROCHLORIDE"],"generic_name":["PALONOSETRON HYDROCHLORIDE"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-4094"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["PALONOSETRON HYDROCHLORIDE"],"rxcui":["1728055"],"spl_id":["124fd0ad-cda6-4a00-9355-c4809c039c74"],"spl_set_id":["911783eb-91a8-4ef4-bd6f-809211e207d6"],"package_ndc":["0703-4094-01"],"unii":["23310D4I19"]},"update_date":"11/14/2025","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Palonosetron Hydrochloride, Injection, .25 mg/5 mL (NDC 0703-4094-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"11/01/2023","package_ndc":"60505-4740-1","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-706-5575","availability":"Available","openfda":{"application_number":["ANDA216944"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-4740","60505-4739","60505-4741","60505-4742","60505-4743","60505-4744","60505-4745"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0190bec9-05e4-0977-9548-2cc150b53e74"],"spl_set_id":["ecad4442-a644-18e3-6ff2-fdbac45eec47"],"package_ndc":["60505-4739-1","60505-4740-1","60505-4741-1","60505-4742-1","60505-4743-1","60505-4744-1","60505-4745-1"],"unii":["SJT761GEGS"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 60505-4740-1)","company_name":"Apotex Corp.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"63323-280-02","generic_name":"Furosemide Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA018902"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-280"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["9804efac-5457-417a-8de7-a688467759c0","64b3fb5f-3516-4e39-b74e-e0e402ed9c4d"],"spl_set_id":["3747bbcd-783d-4baa-bb5b-b6827bf390e3","c794c95a-654e-48fe-9596-201fc122ff75"],"package_ndc":["63323-280-41","63323-280-16","63323-280-43","63323-280-26","63323-280-45","63323-280-36","63323-280-01","63323-280-02","63323-280-03","63323-280-04","63323-280-05","63323-280-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-02)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/20/2026","package_ndc":"0338-0074-30","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0074","0338-9651","0338-9649","0338-9655","0338-9653","0338-0078","0338-0062","0338-0066","0338-0070","0338-0082"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795607","1795609","1795610","1795612","1795616"],"spl_id":["b28d6bb9-8496-48bd-b6aa-f67996d0829c"],"spl_set_id":["36e9478c-5df0-4b47-b97d-de3626d7cb29"],"package_ndc":["0338-9651-75","0338-9649-75","0338-9655-60","0338-9653-60","0338-0078-20","0338-0062-30","0338-0074-30","0338-0066-20","0338-0070-10","0338-0070-12","0338-0082-10","0338-0082-12"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0074-30)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"12/19/2025","update_type":"New","initial_posting_date":"12/19/2025","package_ndc":"54092-172-12","generic_name":"Carbamazepine Capsule, Extended Release","contact_info":"855-268-1825","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020712"],"brand_name":["CARBATROL"],"generic_name":["CARBAMAZEPINE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["54092-172","54092-171","54092-173"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CARBAMAZEPINE"],"rxcui":["200131","200133","308977","313931","388311","404742"],"spl_id":["4186c118-9875-4b12-b652-3fbfaf4e6622"],"spl_set_id":["bc03e499-5bac-4293-bff4-6864153a624d"],"package_ndc":["54092-171-12","54092-172-12","54092-173-12"],"nui":["N0000008486","N0000175751","N0000185506","N0000191266","N0000187064","N0000185507","N0000185607"],"pharm_class_pe":["Decreased Central Nervous System Disorganized Electrical Activity [PE]"],"pharm_class_epc":["Mood Stabilizer [EPC]"],"pharm_class_moa":["Cytochrome P450 3A4 Inducers [MoA]","Cytochrome P450 1A2 Inducers [MoA]","Cytochrome P450 2B6 Inducers [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 2C19 Inducers [MoA]"],"unii":["33CM23913M"]},"update_date":"12/19/2025","therapeutic_category":["Neurology"],"dosage_form":"Capsule, Extended Release","presentation":"Carbatrol, Capsule, Extended Release, 200 mg (NDC 54092-172-12)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/05/2022","package_ndc":"0409-6695-01","generic_name":"Etomidate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA018227"],"brand_name":["AMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6695"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008","1654009","1654011"],"spl_id":["3f83ed21-1b60-486c-8c70-1d5aa7553404"],"spl_set_id":["b7ed5bf8-ba75-44dc-8f81-96b4ad5766be"],"package_ndc":["0409-6695-11","0409-6695-01","0409-6695-12","0409-6695-02"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Amidate, Injection, 2 mg/1 mL (NDC 0409-6695-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"03/10/2026","update_type":"New","initial_posting_date":"03/10/2026","package_ndc":"49230-209-92","generic_name":"Peritoneal Dialysis Solution","contact_info":"800-323-5188","related_info":"The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.","openfda":{"application_number":["NDA020171"],"brand_name":["DELFLEX"],"generic_name":["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"],"manufacturer_name":["Fresenius Medical Care Renal Therapies Group, LLC"],"product_ndc":["49230-209","49230-206","49230-212"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","DEXTROSE MONOHYDRATE"],"spl_id":["5f14a0ea-a325-a154-e063-6294a90adf59","5f1497fe-4e1c-9711-e063-6294a90a75e5"],"spl_set_id":["bbc5b820-4973-11e2-a192-0002a5d5c51b","c29bdfa0-4976-11e2-939b-0002a5d5c51b"],"package_ndc":["49230-206-30","49230-206-32","49230-206-50","49230-206-52","49230-206-62","49230-209-30","49230-209-32","49230-209-50","49230-209-52","49230-209-62","49230-212-30","49230-212-32","49230-212-50","49230-212-52","49230-212-62","49230-206-92","49230-206-94","49230-206-95","49230-209-92","49230-209-94","49230-209-95","49230-212-92","49230-212-94","49230-212-95"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"03/10/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2L, 5/cs (NDC 49230-209-92)","company_name":"Fresenius Medical Care North America","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-101-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA021977"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-101","59417-102","59417-103","59417-104","59417-105","59417-106","59417-107","59417-115","59417-116","59417-117","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Vyvanse, Capsule, 10 mg (NDC 59417-101-10)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"0409-6102-10","generic_name":"Furosemide Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018667"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["e598e8a6-c854-48f5-a412-fb6a6783774a","981d5143-60cd-4987-9b47-dec24c10de42"],"spl_set_id":["aaced7a8-c3d7-4d66-8c07-aa407b8b3f35","39fd32f2-6bb7-4a65-d298-e48d26bc80c7"],"package_ndc":["0409-6102-35","0409-6102-25","0409-6102-36","0409-6102-26","0409-6102-37","0409-6102-27","0409-6102-19","0409-6102-02","0409-6102-18","0409-6102-04","0409-6102-20","0409-6102-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"08/13/2026","update_type":"New","initial_posting_date":"08/13/2026","package_ndc":"0228-2551-96","generic_name":"Diclofenac Sodium Tablet, Delayed Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA074514"],"brand_name":["DICLOFENAC SODIUM"],"generic_name":["DICLOFENAC SODIUM"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2551","0228-2550"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DICLOFENAC SODIUM"],"rxcui":["855906","855926"],"spl_id":["a1fbc994-b8a6-4759-be76-1cfd98275ca6"],"spl_set_id":["a57b897e-0cbe-4ac3-969f-b00357a0cfa8"],"package_ndc":["0228-2550-06","0228-2550-11","0228-2550-96","0228-2551-06","0228-2551-11","0228-2551-96"],"unii":["QTG126297Q"]},"update_date":"08/13/2026","therapeutic_category":["Musculoskeletal","Rheumatology"],"dosage_form":"Tablet","presentation":"Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-96)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"16729-295-34","generic_name":"Carboplatin Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA","openfda":{"application_number":["ANDA206775"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-295"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"spl_id":["5f9d65c8-75c4-6fb3-e063-6394a90a87cf"],"spl_set_id":["48aa7ef3-9f44-2a08-e054-00144ff88e88"],"package_ndc":["16729-295-31","16729-295-33","16729-295-34","16729-295-12","16729-295-38"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34)","company_name":"Accord Healthcare Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0527-0764-37","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215565"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-0764","0527-0760","0527-0761","0527-0762","0527-0763","0527-0765","0527-0766"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["391d7c4a-47df-41ce-b1ba-3c4758adf87f"],"spl_set_id":["f92497b5-baea-4760-b615-45a0b6184402"],"package_ndc":["0527-0760-37","0527-0761-37","0527-0762-37","0527-0763-37","0527-0764-37","0527-0765-37","0527-0766-37"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0527-0764-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"65862-618-90","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-850-2876","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA202725"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL HYDROCHLORIDE"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["65862-618","65862-617","65862-619","65862-620"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["5263abd5-ce46-4918-9bb0-9632861bcbc9"],"spl_set_id":["93e6e668-5306-4f26-81d8-cbc3a7a5e787"],"package_ndc":["65862-617-30","65862-617-90","65862-617-99","65862-617-55","65862-617-10","65862-617-78","65862-618-30","65862-618-90","65862-618-99","65862-618-55","65862-618-10","65862-618-78","65862-619-30","65862-619-90","65862-619-99","65862-619-19","65862-619-10","65862-619-78","65862-620-30","65862-620-90","65862-620-99","65862-620-39","65862-620-10","65862-620-78"],"unii":["33067B3N2M"]},"update_date":"11/04/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)","company_name":"Aurobindo Pharma USA","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"61703-408-25","generic_name":"Methotrexate Sodium Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA011719"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-408","61703-350"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1655956","1946772"],"spl_id":["6d38984b-4deb-42c3-bf1d-4e0b0c8887e6","db79ea57-58c9-4bd4-86df-9a23f3294ac8"],"spl_set_id":["0d63ba29-b692-41b4-87e8-351265c8273f","0e30eaef-5a09-4104-8a11-c32933eadeab"],"package_ndc":["61703-350-37","61703-350-38","61703-408-41","61703-350-09","61703-350-10","61703-408-25"],"unii":["3IG1E710ZN"]},"update_date":"11/09/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-25)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/14/2017","package_ndc":"63323-519-10","generic_name":"Heparin Sodium Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA212441"],"brand_name":["HEPARIN SODIUM"],"generic_name":["HEPARIN SODIUM"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-519"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["HEPARIN SODIUM"],"rxcui":["1658690","1658692"],"spl_id":["3bbbe74a-1246-41a6-9fc3-ca0230529b40"],"spl_set_id":["25b0ba06-3274-4a3f-8c39-42d13764ecdf"],"package_ndc":["63323-519-02","63323-519-77","63323-519-01","63323-519-10"],"unii":["ZZ45AB24CA"]},"update_date":"11/03/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-489-17","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-489","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0990-7171-17","generic_name":"Amino Acid Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA020041"],"brand_name":["AMINOSYN II"],"generic_name":["ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, HISTIDINE, PROLINE, SERINE, N-ACETYLTYROSINE, AND GLYCINE"],"manufacturer_name":["ICU Medical Inc."],"product_ndc":["0990-7171","0990-7172"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ISOLEUCINE","LEUCINE","LYSINE ACETATE","METHIONINE","PHENYLALANINE","THREONINE","TRYPTOPHAN","VALINE","ALANINE","ARGININE","ASPARTIC ACID","GLUTAMIC ACID","HISTIDINE","PROLINE","SERINE","ACETYL L-TYROSINE","GLYCINE"],"rxcui":["800188","800192","800237","800241"],"spl_id":["0c99ec81-2c27-4352-8dbe-d7ec9e0e80e4"],"spl_set_id":["5b426208-f090-4650-86c3-89040ba45c2d"],"package_ndc":["0990-7172-17","0990-7171-17"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["2ZD004190S","AE28F7PNPL","9DLQ4CIU6V","GMW67QNF9C","HG18B9YRS7","452VLY9402","TE7660XO1C","3KX376GY7L","30KYC7MIAI","4QD397987E","DA8G610ZO5","94ZLA3W45F","OF5P57N2ZX","8DUH1N11BX","TTL6G7LIWZ","47E5O17Y3R","04Y7590D77"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Aminosyn II 15% In Plastic Container, Injection, 0.15 (NDC 0990-7171-17)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"discontinued_date":"01/06/2026","update_type":"New","initial_posting_date":"01/06/2026","package_ndc":"49884-127-91","generic_name":"Everolimus Tablet","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"01/06/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, 7.5 mg (NDC 49884-127-91)","company_name":"Endo Pharmaceuticals, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"06/28/2022","package_ndc":"0143-9392-10","generic_name":"Remifentanil Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA210594"],"brand_name":["REMIFENTANIL HYDROCHLORIDE"],"generic_name":["REMIFENTANIL HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9392","0143-9391","0143-9393"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["REMIFENTANIL HYDROCHLORIDE"],"rxcui":["1729578","1729584","1729710"],"spl_id":["5c5e498b-d829-4f78-bcca-466631014767"],"spl_set_id":["9d289052-1eb6-4ba2-a3ca-d2e542a052ae"],"package_ndc":["0143-9391-01","0143-9391-10","0143-9392-01","0143-9392-10","0143-9393-01","0143-9393-10"],"unii":["5V444H5WIC"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Remifentanil Hydrochloride, Injection, 2 mg per vial (NDC 0143-9392-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"62037-725-01","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA076772"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["62037-725","62037-734","62037-726","62037-727"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210"],"spl_id":["24aa9277-3773-489d-8459-f9215140c53f"],"spl_set_id":["85ef422d-af27-4126-9841-6892af1871d6"],"package_ndc":["62037-725-01","62037-734-01","62037-726-01","62037-727-01"],"unii":["4B3SC438HI"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62037-725-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0555-0776-02","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0555-0776","0555-0971","0555-0775","0555-0972","0555-0777","0555-0973","0555-0974"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"],"spl_set_id":["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"],"package_ndc":["0555-0971-02","0555-0775-02","0555-0972-02","0555-0776-02","0555-0777-02","0555-0973-02","0555-0974-02"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0555-0776-02)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-483-27","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-483","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0703-4248-01","generic_name":"Carboplatin Injection","contact_info":"800-545-8800","availability":"Limited Availability","related_info":"Estimated recovery: March 2027","openfda":{"application_number":["ANDA077269"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-4248","0703-4244","0703-4246","0703-4239"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df","b943761e-6a46-45a0-bdb4-1fec1e101f8c"],"spl_set_id":["f330f5a2-2cad-402f-bcbb-26245a753276","e176b6ef-2ff6-498b-a9d8-7a634d147f37"],"package_ndc":["0703-4244-01","0703-4246-01","0703-4248-01","0703-4239-01","0703-4244-81","0703-4246-81","0703-4248-81","0703-4239-81"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4248-01)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-3182-03","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA089646"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3182","0409-1209","0409-3177","0409-3178","0409-3181","0409-3183","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/22/2021","package_ndc":"68180-659-07","generic_name":"Rifampin Capsule","contact_info":"866-587-4617","availability":"Available","openfda":{"application_number":["ANDA090034"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["Lupin Pharmaceuticals, Inc."],"product_ndc":["68180-659","68180-658"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAMPIN"],"rxcui":["198201","198202"],"spl_id":["5ed1edac-e11e-4f87-b390-e770a69a9b37"],"spl_set_id":["b56004f0-f23d-47f6-80c7-39884fccbccc"],"package_ndc":["68180-658-06","68180-658-01","68180-659-06","68180-659-07","68180-659-01"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"10/13/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Rifampin, Capsule, 300 mg (NDC 68180-659-07)","company_name":"Lupin Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"70121-1574-5","generic_name":"Methylprednisolone Acetate Injection","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA210043"],"brand_name":["METHYLPREDNISOLONE ACETATE"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["70121-1574","70121-1573"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743855"],"spl_id":["af4215ff-94ca-44f8-8506-3024e738cd13"],"spl_set_id":["d944240d-2c19-46ba-ad4f-3fbee7b8629c"],"package_ndc":["70121-1573-1","70121-1573-5","70121-1574-1","70121-1574-5"],"unii":["43502P7F0P"]},"update_date":"10/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-5)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-2634-50","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA078591"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2634"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["1724338","1724340","1724341"],"spl_id":["50886ad5-eeca-4fe7-beb0-01305f92c65d"],"spl_set_id":["3832ede8-d3fc-455d-ecab-3b77be5869f5"],"package_ndc":["0409-2634-10","0409-2634-01","0409-2634-25","0409-2634-05","0409-2634-50"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 500 mg/50 mL (10 mg/mL) (NDC 0409-2634-50)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"08/03/2022","package_ndc":"0378-4430-01","generic_name":"Flurazepam Hydrochloride Capsule","contact_info":"1-844-874-7464","availability":"Unavailable","related_info":"Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.","update_date":"09/01/2026","therapeutic_category":["Neurology","Other"],"dosage_form":"Capsule","presentation":"Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01)","company_name":"Rising Pharma Holdings, Inc.","shortage_reason":"Regulatory delay","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/21/2023","package_ndc":"0338-9549-50","generic_name":"Clindamycin Phosphate Injection","contact_info":"888-229-0001","availability":"Limited Availability","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["NDA208083"],"brand_name":["CLINDAMYCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-9549","0338-9545","0338-9553"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309335","309336","309339"],"spl_id":["b0a47c5e-911b-4b12-a0d1-a4425f173eec"],"spl_set_id":["44fa506b-90ac-42de-831b-5f3f1a500fc0"],"package_ndc":["0338-9545-50","0338-9545-24","0338-9549-50","0338-9549-24","0338-9553-50","0338-9553-24"],"unii":["EH6D7113I8"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9549-50)","company_name":"Baxter Healthcare","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"63323-806-50","generic_name":"Fentanyl Citrate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA210762"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-806"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270"],"spl_id":["341b092a-1f6f-40f1-98f2-9346bf2e1242"],"spl_set_id":["38d0c14a-a0c1-44cc-a939-0304eb8037d6"],"package_ndc":["63323-806-11","63323-806-01","63323-806-12","63323-806-02","63323-806-13","63323-806-05","63323-806-14","63323-806-20","63323-806-50"],"unii":["MUN5LYG46H"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-50)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/27/2018","package_ndc":"25021-671-87","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"Sagent: 866-625-1618","availability":"Available","related_info":"Marketed by Sagent Pharmaceuticals","openfda":{"application_number":["ANDA206166"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-671","25021-652"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734347","1734355","1734479","1734481"],"spl_id":["41f4446a-ca6e-465e-9a79-8c4f99eb1ac3","22d83514-0f7b-4671-ae6a-7ca47449c184"],"spl_set_id":["8c5c762f-d266-4b1a-809e-f11bfc89bc2d","9572b3de-684c-4028-a577-5aa69ba6b02d"],"package_ndc":["25021-671-82","25021-671-87","25021-652-82","25021-652-87","25021-671-66","25021-671-67"],"unii":["V910P86109"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87)","company_name":"InfoRLife SA","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0409-2308-50","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA075857"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2308","0409-2305","0409-0001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666800","1666814","1666823","1666798"],"spl_id":["2f69c5b1-6505-42dc-8bb3-edbd9b6c0781","8954486a-8512-4831-8178-0b49f1efb73e"],"spl_set_id":["b95415fa-17c2-42ab-a6b0-e628d01c94ed","1abda8b8-48a8-4995-af86-39220d1aa240"],"package_ndc":["0409-2305-55","0409-2305-50","0409-2308-69","0409-2308-49","0409-2308-70","0409-2308-50","0409-2305-16","0409-2305-17","0409-2305-04","0409-2305-05","0409-2308-21","0409-2308-01","0409-2308-22","0409-2308-02","0409-0001-01","0409-0001-25"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 10 mg/2 mL (5 mg/mL) Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2308-50)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"04/07/2026","update_type":"New","initial_posting_date":"04/07/2026","package_ndc":"61958-1701-1","generic_name":"Idelalisib Tablet","contact_info":"800-445-3235","related_info":"Discontinuation in the manufacturing of the drug","openfda":{"application_number":["NDA205858"],"brand_name":["ZYDELIG"],"generic_name":["IDELALISIB"],"manufacturer_name":["Gilead Sciences, Inc."],"product_ndc":["61958-1701","61958-1702"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["IDELALISIB"],"rxcui":["1544465","1544471","1544473","1544475"],"spl_id":["131deed3-54eb-44c8-aab5-5e93c70db69f"],"spl_set_id":["efbdafa9-d18c-4e85-b4a2-1e620fc74e50"],"package_ndc":["61958-1701-1","61958-1702-1"],"nui":["N0000175605","N0000175082","N0000190114"],"pharm_class_epc":["Kinase Inhibitor [EPC]"],"pharm_class_moa":["Kinase Inhibitors [MoA]","Cytochrome P450 3A Inhibitors [MoA]"],"unii":["YG57I8T5M0"]},"update_date":"04/07/2026","therapeutic_category":["Oncology"],"dosage_form":"Tablet","presentation":"Zydelig, Tablet, 100 mg (NDC 61958-1701-1)","company_name":"Gilead Sciences, Inc.","status":"To Be Discontinued"},{"discontinued_date":"08/14/2026","update_type":"New","initial_posting_date":"08/14/2026","package_ndc":"63323-715-05","generic_name":"Fulvestrant Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA210326"],"brand_name":["FULVESTRANT"],"generic_name":["FULVESTRANT"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-715"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["FULVESTRANT"],"rxcui":["727762"],"spl_id":["c584c51e-3ce0-4682-a4dd-d0ac149201a8"],"spl_set_id":["fabe9bd8-ac23-4df1-a89a-223d5cd38914"],"package_ndc":["63323-715-01","63323-715-05"],"nui":["N0000175582","N0000000145","N0000000168"],"pharm_class_epc":["Estrogen Receptor Antagonist [EPC]"],"pharm_class_moa":["Estrogen Receptor Antagonists [MoA]","Selective Estrogen Receptor Modulators [MoA]"],"unii":["22X328QOC4"]},"update_date":"08/14/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Fulvestrant, Injection, 250 mg per 5mL (NDC 63323-715-05)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/27/2023","change_date":"11/04/2026","package_ndc":"72888-153-01","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-153","72888-497","72888-152","72888-154"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 72888-153-01)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"72266-146-10","generic_name":"Etomidate Injection","contact_info":"833-291-9645","availability":"Available","related_info":"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.","openfda":{"application_number":["ANDA209058"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE INJECTION"],"manufacturer_name":["Fosun Pharma USA Inc"],"product_ndc":["72266-146","72266-147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["2b365133-b609-3285-e063-6394a90a69a6"],"spl_set_id":["8b6c54d8-3f3f-4290-841c-976bea01086f"],"package_ndc":["72266-146-01","72266-146-10","72266-147-01","72266-147-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 72266-146-10)","company_name":"Gland Pharma Limited","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-285-61","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-285","63323-286","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/02/2020","package_ndc":"63323-412-25","generic_name":"Midazolam Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA075154"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-412","63323-411"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["9814447b-a93e-42ad-b57e-5db0a5b7f552"],"spl_set_id":["a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"],"package_ndc":["63323-411-22","63323-411-27","63323-411-15","63323-411-12","63323-411-18","63323-411-25","63323-411-13","63323-411-10","63323-412-18","63323-412-25","63323-412-03","63323-412-02","63323-412-06","63323-412-05","63323-412-13","63323-412-10"],"unii":["W7TTW573JJ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"10/19/2026","update_type":"New","initial_posting_date":"10/19/2026","package_ndc":"49702-204-13","generic_name":"Lamivudine Tablet","contact_info":"800-844-8872","related_info":"The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020564"],"brand_name":["EPIVIR"],"generic_name":["LAMIVUDINE"],"manufacturer_name":["ViiV Healthcare Company"],"product_ndc":["49702-204","49702-203","49702-205"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LAMIVUDINE"],"rxcui":["152931","152932","199147","199148","349491","352230"],"spl_id":["38eff3e4-ae02-40be-9f8a-5e2d99113447"],"spl_set_id":["89226149-47fa-4f7d-bb1f-1aa7034486b8"],"package_ndc":["49702-203-18","49702-204-13","49702-205-48"],"nui":["N0000175656","N0000175462","N0000009947"],"pharm_class_epc":["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]","Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"],"pharm_class_moa":["Nucleoside Reverse Transcriptase Inhibitors [MoA]"],"unii":["2T8Q726O95"]},"update_date":"10/19/2026","therapeutic_category":["Antiviral"],"dosage_form":"Tablet","presentation":"Epivir, Tablet, 300 mg (NDC 49702-204-13)","company_name":"ViiV Healthcare Company","status":"To Be Discontinued"},{"discontinued_date":"07/30/2026","update_type":"New","initial_posting_date":"07/30/2026","package_ndc":"63323-578-01","generic_name":"Glycopyrrolate Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA209328"],"brand_name":["GLYCOPYRROLATE"],"generic_name":["GLYCOPYRROLATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-578"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["GLYCOPYRROLATE"],"rxcui":["238212","1731582","1731590"],"spl_id":["779dc924-ecc3-41cc-8cf9-a7354db4f763","d528572e-598b-4c0e-b280-b083c73c017f"],"spl_set_id":["54458620-d888-4df6-ae4b-78c3dfed3423","ccafb5c2-86dd-4bb2-883a-c13e3171227c"],"package_ndc":["63323-578-03","63323-578-01","63323-578-04","63323-578-02","63323-578-07","63323-578-05","63323-578-18","63323-578-20","63323-578-41","63323-578-11","63323-578-42","63323-578-12"],"unii":["V92SO9WP2I"]},"update_date":"07/30/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Glycopyrrolate, Injection, .2 mg/1 mL (NDC 63323-578-01)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"63323-516-10","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA040572"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-516","63323-506"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696","1812079"],"spl_id":["2ce90eb7-067d-4f1c-9184-c250e387e533"],"spl_set_id":["cca2c160-9188-48e8-9505-49a52388dcb7"],"package_ndc":["63323-506-00","63323-506-01","63323-506-03","63323-506-13","63323-516-01","63323-516-10"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 63323-516-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"55150-322-25","generic_name":"Furosemide Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA212174"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-322","55150-323","55150-324"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["9bb2ffa4-0891-4197-a970-90b178bbfad9"],"spl_set_id":["421aa6d5-623b-4dc2-abd5-bb9e7765bf37"],"package_ndc":["55150-322-01","55150-322-25","55150-323-01","55150-323-25","55150-324-01","55150-324-25"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"10/19/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 20 mg/2 mL (NDC 55150-322-25)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/23/2021","package_ndc":"64253-020-30","generic_name":"Sterile Water Injection","contact_info":"630-682-4600","availability":"Available","openfda":{"application_number":["ANDA211188"],"brand_name":["STERILE WATER"],"generic_name":["STERILE WATER FOR INJECTION"],"manufacturer_name":["Medefil, Inc."],"product_ndc":["64253-020"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["2b39b41d-419a-dab8-e063-6394a90a319a"],"spl_set_id":["99e99a50-82d5-aff6-e053-2a95a90a8c56"],"package_ndc":["64253-020-21","64253-020-23","64253-020-30","64253-020-35","64253-020-52","64253-020-25","64253-020-91"],"unii":["059QF0KO0R"]},"update_date":"11/02/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water, Injection, 10 mL/10 mL (NDC 64253-020-30)","company_name":"Medefil, Inc.","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-353-30","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-30)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"discontinued_date":"01/13/2026","update_type":"New","initial_posting_date":"01/13/2026","package_ndc":"61314-454-36","generic_name":"Adalimumab-adaz Injection","contact_info":"800-525-8747","related_info":"Equivalent Sandoz format is available.","openfda":{"application_number":["BLA761071"],"brand_name":["HYRIMOZ"],"generic_name":["ADALIMUMAB-ADAZ"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["61314-454","61314-473","61314-476","61314-509","61314-517","61314-531"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ADALIMUMAB"],"rxcui":["2641644","2641650","2641653","2641654","2641655","2641658","2641660","2641661","2641662","2641663","2641664","2641665","2641666","2641667","2641668","2641669","2641670","2641671","2641672","2641673"],"spl_id":["48b7e44a-945f-487d-b2fd-3da13d6d6fdb"],"spl_set_id":["1ac7d061-3380-468c-b077-c05f8dfbc829"],"package_ndc":["61314-454-20","61314-454-36","61314-454-68","61314-473-64","61314-473-20","61314-473-92","61314-476-64","61314-509-64","61314-517-36","61314-454-96","61314-473-96","61314-531-64","61314-454-94","61314-473-94"],"nui":["N0000175610","N0000175451","M0001357"],"pharm_class_epc":["Tumor Necrosis Factor Blocker [EPC]"],"pharm_class_moa":["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"],"pharm_class_cs":["Antibodies, Monoclonal [CS]"],"unii":["FYS6T7F842"]},"update_date":"01/13/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-36)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"76045-009-11","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA019034"],"brand_name":["DILAUDID"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-009","76045-010","76045-121"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1872265","1872269","1872752","2277368","2277370"],"spl_id":["002d5650-24df-4b60-a5ce-e7adc091026f"],"spl_set_id":["9eebd88a-5632-460f-b7b6-26c8a180540d"],"package_ndc":["76045-009-96","76045-009-06","76045-009-01","76045-009-11","76045-010-01","76045-010-11","76045-121-01","76045-121-11"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-11)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"16729-432-93","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","update_date":"09/15/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93)","company_name":"Accord Healthcare Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"0409-9094-28","generic_name":"Fentanyl Citrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA019115"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9094","0409-9093"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735004","1735006","1735007","1735008","1735013"],"spl_id":["8ff8b8cf-1a31-46dc-b350-2b9cc700e6a6"],"spl_set_id":["bfa8018a-4cbc-434b-e09e-782872b0340a"],"package_ndc":["0409-9093-41","0409-9093-36","0409-9093-31","0409-9093-38","0409-9094-12","0409-9094-22","0409-9094-18","0409-9094-25","0409-9094-17","0409-9094-28","0409-9094-16","0409-9094-31","0409-9094-41","0409-9094-61","0409-9094-44","0409-9094-55"],"unii":["MUN5LYG46H"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 500 mcg/10 mL (50 ug/1 mL) (NDC 0409-9094-28)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/12/2022","package_ndc":"0703-4636-01","generic_name":"Streptozocin Powder, For Solution","contact_info":"800-545-8800","availability":"Unavailable","related_info":"Estimated recovery: TBD","update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Powder, For Solution","presentation":"Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/24/2025","change_date":"08/27/2026","package_ndc":"82154-0451-4","generic_name":"Peginterferon alfa-2a Injection","contact_info":"800-506-8501, email: medinfo.us@pharmaand.com","resolved_note":"(NDC 82154-0451-4) – Available","openfda":{"application_number":["BLA103964"],"brand_name":["PEGASYS"],"generic_name":["PEGINTERFERON ALFA-2A"],"manufacturer_name":["pharmaand GmbH"],"product_ndc":["82154-0451","82154-0449"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["PEGINTERFERON ALFA-2A"],"rxcui":["351270","352297","731326","731328"],"spl_id":["5df7144e-dde3-c0ef-e063-6394a90a99c7"],"spl_set_id":["d9290e5b-6d40-2318-e053-2995a90a9916"],"package_ndc":["82154-0449-1","82154-0451-4"],"nui":["N0000175521","M0025711"],"pharm_class_epc":["Interferon alpha [EPC]"],"pharm_class_cs":["Interferon-alpha [CS]"],"unii":["Q46947FE7K"]},"update_date":"08/27/2026","therapeutic_category":["Antiviral"],"dosage_form":"Injection","presentation":"Pegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4)","company_name":"pharmaand GmbH (pharma&)","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"83634-651-20","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"Avenacy, LLC: 877-283-6229","availability":"Available","related_info":"Distributed by Avenacy, LLC","openfda":{"application_number":["ANDA219535"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Avenacy, LLC"],"product_ndc":["83634-651","83634-653"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1737562","1737566","1737568"],"spl_id":["8fb1dd7b-f349-4a64-96c1-bd72bf748f3b"],"spl_set_id":["46480253-29b9-4d7f-98ed-10377929026b"],"package_ndc":["83634-653-41","83634-653-02","83634-653-42","83634-653-05","83634-653-43","83634-653-30","83634-651-41","83634-651-10","83634-651-42","83634-651-20","83634-651-43","83634-651-50"],"unii":["V13007Z41A"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 200 mg/20 mL (NDC 83634-651-20)","company_name":"Anthea Pharma","status":"Current"},{"discontinued_date":"09/29/2026","update_type":"New","initial_posting_date":"09/29/2026","package_ndc":"0006-0032-01","generic_name":"Ivermectin Tablet","contact_info":"800-672-6372","related_info":"Product will be discontinued on 10/31/2026","openfda":{"application_number":["NDA050742"],"brand_name":["STROMECTOL"],"generic_name":["IVERMECTIN"],"manufacturer_name":["Merck Sharp & Dohme LLC"],"product_ndc":["0006-0032"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["IVERMECTIN"],"rxcui":["261314","311207"],"spl_id":["21f446cf-c0bf-48a5-a535-9d376bc365a9"],"spl_set_id":["681888c9-af79-4b7d-ae80-c3f4f6f1effd"],"package_ndc":["0006-0032-20","0006-0032-01"],"nui":["N0000175484","N0000181811"],"pharm_class_epc":["Antiparasitic [EPC]","Pediculicide [EPC]"],"unii":["8883YP2R6D"]},"update_date":"09/29/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Tablet","presentation":"STROMECTOL, Tablet, 3 mg (NDC 0006-0032-01)","company_name":"Merck Sharp & Dohme LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/01/2022","package_ndc":"0990-7930-09","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Limited Availability","related_info":"On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA018080"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7930","0990-7923","0990-7922"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/31/2026","package_ndc":"0054-3298-63","generic_name":"Furosemide Oral Solution","contact_info":"800-631-2174","availability":"Available","openfda":{"application_number":["ANDA070433"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-3298","0054-4297","0054-8297","0054-4299","0054-8299","0054-4301","0054-8301","0054-3294"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FUROSEMIDE"],"rxcui":["197730","197731","197732","310429","313988"],"spl_id":["bc62ddda-7639-4090-99f0-7dd4d13518f3"],"spl_set_id":["9e493331-dddd-496e-abf8-61747fb67aba"],"package_ndc":["0054-4297-31","0054-4297-25","0054-8297-25","0054-4299-31","0054-4299-25","0054-8299-25","0054-4301-29","0054-4301-25","0054-8301-25","0054-3298-63","0054-3294-50","0054-3294-46"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"10/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Oral Solution","presentation":"Furosemide, Oral Solution, 40 mg/5 mL (NDC 0054-3298-63)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/13/2017","change_date":"09/30/2026","package_ndc":"83301-0080-2","generic_name":"Bumetanide Injection","contact_info":"800-673-9839","resolved_note":"Available","openfda":{"application_number":["ANDA219116"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Mullan Pharmaceutical Inc."],"product_ndc":["83301-0080","83301-0081"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["4c241a3e-649b-4414-e063-6294a90a3a32"],"spl_set_id":["b7cd724b-817b-4b45-8133-1ebf505867e7"],"package_ndc":["83301-0080-1","83301-0080-2","83301-0081-1","83301-0081-2"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, 1 mg/4 mL (0.25 mg/mL) (NDC 83301-0080-2)","company_name":"Mullan Pharmaceutical Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"62135-487-90","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com","availability":"Available","openfda":{"application_number":["ANDA076803"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-487","62135-484","62135-485","62135-486"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["09cd5cb9-4fdf-f133-e063-6294a90af691"],"spl_set_id":["dbc43dbd-94aa-40e2-a9ea-766110cc8687"],"package_ndc":["62135-484-60","62135-485-90","62135-486-90","62135-487-90"],"unii":["33067B3N2M"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 40 mg (NDC 62135-487-90)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"06/13/2018","package_ndc":"55150-254-10","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: late-November 2026; Check wholesalers for inventory","openfda":{"application_number":["ANDA207182"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-254","55150-251","55150-252","55150-255","55150-253","55150-256"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671"],"spl_id":["ccc38d8a-43fd-44c0-985e-32af9ed956ab","0b1f03c2-db2f-4f90-acc0-d73abd731bf6"],"spl_set_id":["ccc38d8a-43fd-44c0-985e-32af9ed956ab","ef782e5e-e2d7-465a-99c6-b12611f3158c"],"package_ndc":["55150-251-24","55150-252-24","55150-254-24","55150-255-24","55150-251-10","55150-252-20","55150-253-50","55150-254-10","55150-255-20","55150-256-50"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/06/2018","package_ndc":"72266-119-25","generic_name":"Ketorolac Tromethamine Injection","contact_info":"833-291-9645","availability":"Available","related_info":"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.","openfda":{"application_number":["ANDA204216"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["FOSUN PHARMA USA INC"],"product_ndc":["72266-119","72266-234","72266-118"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["4dc7a413-f46f-2537-e063-6294a90a9b8c"],"spl_set_id":["1aae6a4d-0909-4672-aa26-e3f2d8c4d413"],"package_ndc":["72266-234-01","72266-234-25","72266-118-01","72266-118-25","72266-119-01","72266-119-25"],"unii":["4EVE5946BQ"]},"update_date":"10/21/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-119-25)","company_name":"Gland Pharma Limited","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0017-10","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0017","0338-0023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-10)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"01/27/2026","update_type":"New","initial_posting_date":"01/27/2026","package_ndc":"0781-8017-31","generic_name":"Fluvastatin Sodium Tablet, Extended Release","contact_info":"800-525-8747","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA021192"],"brand_name":["FLUVASTATIN SODIUM ER"],"generic_name":["FLUVASTATIN SODIUM"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-8017"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FLUVASTATIN SODIUM"],"rxcui":["360507"],"spl_id":["37375ca6-3a81-4d10-9b39-9aee948e51a4"],"spl_set_id":["5ab4296c-87c2-4c64-b218-d620eef51310"],"package_ndc":["0781-8017-31","0781-8017-01"],"unii":["PYF7O1FV7F"]},"update_date":"01/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-31)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-464-31","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA070552","NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-464","63323-466","63323-462","63323-465","63323-467","63323-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724880","1724881","1725078","1725175","1724884","1724885","1725082","1725177","1672917","1672919","1673296","1673298","1012391","1012396","1012404","1012421","1012455","1012457"],"spl_id":["b41b5dbd-7aff-4d97-ac97-f4355393ee4e","d3ba9fb9-63c8-4597-bb0a-cd01d31a24b6","13a48007-3784-46f2-bd4d-da1004186b81","2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["e700eb7b-8b14-49c9-96b2-331f18776e45","b6bfc04a-1868-4630-9ca1-8c027af97ce3","dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175","eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-464-01","63323-464-17","63323-466-03","63323-466-17","63323-464-08","63323-464-38","63323-466-08","63323-466-38","63323-462-03","63323-462-38","63323-464-09","63323-464-39","63323-466-09","63323-466-39","63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/27/2018","package_ndc":"25021-671-67","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"Sagent: 866-625-1618","availability":"Unavailable","related_info":"Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals","openfda":{"application_number":["ANDA206166"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-671","25021-652"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734347","1734355","1734479","1734481"],"spl_id":["41f4446a-ca6e-465e-9a79-8c4f99eb1ac3","22d83514-0f7b-4671-ae6a-7ca47449c184"],"spl_set_id":["8c5c762f-d266-4b1a-809e-f11bfc89bc2d","9572b3de-684c-4028-a577-5aa69ba6b02d"],"package_ndc":["25021-671-82","25021-671-87","25021-652-82","25021-652-87","25021-671-66","25021-671-67"],"unii":["V910P86109"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67)","company_name":"InfoRLife SA","shortage_reason":"Other","status":"Current"},{"discontinued_date":"11/06/2026","update_type":"New","initial_posting_date":"11/06/2026","package_ndc":"0009-0107-04","generic_name":"Lincomycin Hydrochloride Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050317"],"brand_name":["LINCOCIN"],"generic_name":["LINCOMYCIN HYDROCHLORIDE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0107","0009-0555","0009-0104"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCONJUNCTIVAL"],"substance_name":["LINCOMYCIN HYDROCHLORIDE"],"rxcui":["102787","239212"],"spl_id":["7e2f3780-88ee-4971-a4ab-3d6cd972c42c"],"spl_set_id":["c01906fa-2c73-4c13-9765-2fd06628d263"],"package_ndc":["0009-0555-01","0009-0104-04","0009-0107-04"],"unii":["M6T05Z2B68"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Lincocin, Injection, 10 mL multiple dose vial (NDC 0009-0107-04)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4279-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA088329"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4279","0409-4713","0409-4278","0409-4776","0409-4282","0409-4277","0409-4276","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 300 mg/30 mL (1%; 10 mg/mL) (NDC 0409-4279-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"06/15/2026","update_type":"New","initial_posting_date":"06/15/2026","package_ndc":"69238-1247-3","generic_name":"Donepezil Hydrochloride; Memantine Hydrochloride Capsule, Extended Release","contact_info":"866-525-7270","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA208328"],"brand_name":["MEMANTINE AND DONEPEZIL HYDROCHLORIDES EXTENDED-RELEASE"],"generic_name":["MEMANTINE AND DONEPEZIL"],"manufacturer_name":["Amneal Pharmaceuticals NY LLC"],"product_ndc":["69238-1247","69238-1248","69238-1552","69238-1553"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MEMANTINE HYDROCHLORIDE","DONEPEZIL HYDROCHLORIDE"],"rxcui":["1599803","1599805","1805420","1805425"],"spl_id":["acd577e1-312c-4d5a-85b5-bc50ef9de545"],"spl_set_id":["2335950c-be3b-4248-ad04-e9763aee47d2"],"package_ndc":["69238-1248-3","69238-1248-9","69238-1247-3","69238-1247-9","69238-1552-3","69238-1552-9","69238-1553-3","69238-1553-9"],"unii":["JY0WD0UA60","3O2T2PJ89D"]},"update_date":"06/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Capsule, Extended Release","presentation":"Donepezil Hydrochloride; Memantine Hydrochloride, Capsule, Extended Release, 10 mg; 28 mg (NDC 69238-1247-3)","company_name":"Amneal Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0555-0972-02","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0555-0972","0555-0971","0555-0775","0555-0776","0555-0777","0555-0973","0555-0974"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"],"spl_set_id":["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"],"package_ndc":["0555-0971-02","0555-0775-02","0555-0972-02","0555-0776-02","0555-0777-02","0555-0973-02","0555-0974-02"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0555-0972-02)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-9045-01","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA071168"],"brand_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9045","0409-1159","0409-1160","0409-1162","0409-1163","0409-1165","0409-9043","0409-9046","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride with Epinephrine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-9045-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"04/09/2026","update_type":"New","initial_posting_date":"04/09/2026","package_ndc":"0069-3070-30","generic_name":"Azithromycin Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050784"],"brand_name":["ZITHROMAX"],"generic_name":["AZITHROMYCIN DIHYDRATE"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0069-3070","0069-3060","0069-3110","0069-3120","0069-3130","0069-3140","0069-4061"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AZITHROMYCIN DIHYDRATE"],"rxcui":["105260","141963","211307","212446","226827","248656","308459","308460","749780","749783","750149","750157"],"spl_id":["1c5f0fcc-88ce-47e9-a128-b7326b7a5a02"],"spl_set_id":["db52b91e-79f7-4cc1-9564-f2eee8e31c45"],"package_ndc":["0069-3060-30","0069-3060-75","0069-3060-86","0069-3070-30","0069-3070-75","0069-3110-19","0069-3120-19","0069-3130-19","0069-3140-19","0069-4061-01","0069-4061-75","0069-4061-89"],"unii":["5FD1131I7S"]},"update_date":"04/09/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Tablet","presentation":"Zithromax, Tablet, 500 mg (NDC 0069-3070-30)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0406-5114-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA211840"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-5114","0406-5111","0406-5112","0406-5113","0406-5115","0406-5116","0406-5117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["77f4cd3a-dca3-4995-8992-042e1dc91a00"],"spl_set_id":["806a1c15-0842-4787-b2ad-09a21fd96b37"],"package_ndc":["0406-5111-01","0406-5112-01","0406-5113-01","0406-5114-01","0406-5115-01","0406-5116-01","0406-5117-01"],"unii":["SJT761GEGS"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0406-5114-01)","company_name":"SpecGx LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"63323-486-17","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release not available at this time.  Check wholesalers for inventory.","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-486","63323-492","63323-491","63323-495","63323-485","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-17)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-0624-30","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-0624","0075-0620","0075-0621","0075-0622","0075-0623","0075-0626","0075-2912","0075-2915"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["cdb74d6d-1a74-4156-a52a-710c55cb2927"],"spl_set_id":["5017a927-2a24-4f27-89f9-27c805bf7d59"],"package_ndc":["0075-0624-01","0075-0624-30","0075-0620-01","0075-0620-40","0075-0621-01","0075-0621-60","0075-0622-01","0075-0622-80","0075-0623-03","0075-0623-00","0075-0626-03","0075-2912-00","0075-2912-01","0075-2915-00","0075-2915-01"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 30 mg/.3 mL (NDC 0075-0624-30)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"71288-203-05","generic_name":"Furosemide Injection","contact_info":"844-824-8426","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA212803"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-203"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["b06d36f6-507c-4b04-b79d-d6370a30a551","53a09c30-7295-4337-89a4-93d3748d6ea3"],"spl_set_id":["a2e3c748-28ce-4c50-a182-721912919840","3aadaca7-3661-4bfe-87f8-6368e4ab6536"],"package_ndc":["71288-203-02","71288-203-03","71288-203-04","71288-203-05","71288-203-10","71288-203-11","71288-203-91","71288-203-92","71288-203-93","71288-203-94"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"08/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-05)","company_name":"Meitheal Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"63323-462-37","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-462","63323-464","63323-466","63323-465","63323-467","63323-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1672917","1672919","1673296","1673298","1724880","1724881","1724884","1724885","1725078","1725082","1725175","1725177","1012391","1012396","1012404","1012421","1012455","1012457"],"spl_id":["13a48007-3784-46f2-bd4d-da1004186b81","2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175","eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-462-03","63323-462-38","63323-464-09","63323-464-39","63323-466-09","63323-466-39","63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-37)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"55150-197-20","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA205612"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-197","55150-195","55150-196","55150-198","55150-199","55150-200","55150-201"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734207","1734347","1734475","1734483"],"spl_id":["1e5f1368-058a-492c-b4b7-d9329a7745e2"],"spl_set_id":["3763b7b6-da49-4658-b93d-28f5da24d09e"],"package_ndc":["55150-195-20","55150-196-99","55150-197-20","55150-198-30","55150-199-20","55150-200-10","55150-201-20"],"unii":["V910P86109"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-197-20)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-116-01","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA208510"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-116","59417-101","59417-102","59417-103","59417-104","59417-105","59417-106","59417-107","59417-115","59417-117","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0378-6854-77","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA202835"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-6854","0378-6855","0378-6856","0378-6857","0378-6858","0378-6859","0378-6860"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["6e77cd71-95ae-4fa8-830b-ab62b714e4b9"],"spl_set_id":["efbde0f6-b848-4664-b741-c6c630e66108"],"package_ndc":["0378-6854-77","0378-6855-77","0378-6856-77","0378-6857-77","0378-6858-77","0378-6859-77","0378-6860-77"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0378-6854-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"67457-903-20","generic_name":"Etomidate Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA201044"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-903","67457-902"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["25fc0aef-d4b3-4b33-897c-81cc7cdae470"],"spl_set_id":["461e34d1-b862-4a02-9727-548c907aac48"],"package_ndc":["67457-902-00","67457-902-10","67457-903-00","67457-903-20"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 67457-903-20)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/12/2026","package_ndc":"10019-926-02","generic_name":"Ifosfamide Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA019763"],"brand_name":["IFOSFAMIDE"],"generic_name":["IFOSFAMIDE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["10019-926","10019-925"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IFOSFAMIDE"],"spl_id":["7259fc64-d1c1-4e26-b531-d2e40f0d24fb"],"spl_set_id":["91e433a9-6800-43a6-ac13-a49a04a5aecd"],"package_ndc":["10019-925-82","10019-925-01","10019-926-16","10019-926-02"],"nui":["N0000000236","N0000175558"],"pharm_class_moa":["Alkylating Activity [MoA]"],"pharm_class_epc":["Alkylating Drug [EPC]"],"unii":["UM20QQM95Y"]},"update_date":"11/03/2026","therapeutic_category":["Oncology","Pediatric"],"dosage_form":"Injection","presentation":"Ifosfamide, Injection, 3 g/60 mL (NDC 10019-926-02)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"10/30/2026","update_type":"New","initial_posting_date":"10/30/2026","package_ndc":"0338-1301-41","generic_name":"Cefepime Hydrochloride Injection","contact_info":"888-229-0001","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050817"],"brand_name":["CEFEPIME"],"generic_name":["CEFEPIME"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1301"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CEFEPIME HYDROCHLORIDE"],"rxcui":["1665088","1665093"],"spl_id":["535caad0-ae02-4ceb-b4d1-192222633719"],"spl_set_id":["be5f8ca6-7232-423a-a2d5-cccb7abe7921"],"package_ndc":["0338-1301-41","0338-1301-48"],"unii":["I8X1O0607P"]},"update_date":"10/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cefepime Hydrochloride in Plastic Container, Injection, 1g/50 mL (NDC 0338-1301-41)","company_name":"Baxter Healthcare","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"71357-009-10","generic_name":"Sodium Acetate Injection","contact_info":"833-251-8463","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA214805"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE INJECTION, USP, 400 MEQ/100 ML"],"manufacturer_name":["MILLA PHARMACEUTICALS INC."],"product_ndc":["71357-009","71357-007","71357-008"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE"],"rxcui":["237371","312965"],"spl_id":["47d8d0e7-6db5-950d-e063-6294a90ab1bf"],"spl_set_id":["1ea1466d-a492-4056-e063-6394a90a80bf"],"package_ndc":["71357-007-01","71357-007-10","71357-008-01","71357-008-10","71357-009-01","71357-009-10"],"unii":["4550K0SC9B"]},"update_date":"10/15/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10)","company_name":"Milla Pharmaceuticals","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"72205-135-91","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"(855) 668-2369; customerservice@novadozpharma.com","availability":"Available","openfda":{"application_number":["ANDA218306"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-135","72205-132","72205-133","72205-134","72205-136","72205-137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"spl_set_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"package_ndc":["72205-132-91","72205-133-91","72205-134-91","72205-135-91","72205-136-91","72205-137-91"],"unii":["SJT761GEGS"]},"update_date":"09/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91)","company_name":"Novadoz Pharmaceuticals LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0406-5111-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA211840"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-5111","0406-5112","0406-5113","0406-5114","0406-5115","0406-5116","0406-5117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["77f4cd3a-dca3-4995-8992-042e1dc91a00"],"spl_set_id":["806a1c15-0842-4787-b2ad-09a21fd96b37"],"package_ndc":["0406-5111-01","0406-5112-01","0406-5113-01","0406-5114-01","0406-5115-01","0406-5116-01","0406-5117-01"],"unii":["SJT761GEGS"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0406-5111-01)","company_name":"SpecGx LLC","status":"Current"},{"discontinued_date":"01/06/2026","update_type":"New","initial_posting_date":"01/06/2026","package_ndc":"49884-125-91","generic_name":"Everolimus Tablet","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"01/06/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, 5 mg (NDC 49884-125-91)","company_name":"Endo Pharmaceuticals, Inc.","status":"To Be Discontinued"},{"discontinued_date":"01/09/2026","update_type":"New","initial_posting_date":"01/09/2026","package_ndc":"63323-469-05","generic_name":"Haloperidol Decanoate Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA074893"],"brand_name":["HALOPERIDOL DECANOATE"],"generic_name":["HALOPERIDOL DECANOATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-469","63323-471"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["HALOPERIDOL DECANOATE"],"rxcui":["859867","859871","1719803","1719862"],"spl_id":["86dff2aa-2ab3-42fc-989e-619b13ace573"],"spl_set_id":["ca9896e0-fb2e-46a4-8700-20d144c14764"],"package_ndc":["63323-469-01","63323-469-05","63323-471-01","63323-471-05"],"unii":["AC20PJ4101"]},"update_date":"01/09/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Injection","presentation":"Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-05)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"discontinued_date":"11/13/2025","update_type":"New","initial_posting_date":"11/13/2025","package_ndc":"0480-5795-08","generic_name":"Cetrorelix Acetate Injection","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","update_date":"11/13/2025","therapeutic_category":["Reproductive"],"dosage_form":"Injection","presentation":"Cetrorelix Acetate, Injection, Kit (NDC 0480-5795-08)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"11/14/2025","update_type":"New","initial_posting_date":"11/14/2025","package_ndc":"0169-7703-21","generic_name":"Somatropin Injection","contact_info":"833-493-4689","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["BLA021148"],"brand_name":["NORDITROPIN"],"generic_name":["SOMATROPIN"],"manufacturer_name":["Novo Nordisk"],"product_ndc":["0169-7703","0169-7704","0169-7705","0169-7708"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["SOMATROPIN"],"rxcui":["847243","847245","847247","847348","849850","849851","1736262","1736329"],"spl_id":["b67c2419-4feb-4ce1-b97e-88760a8e1aee"],"spl_set_id":["1058e17c-9261-459c-a3e6-fae38d196c14"],"package_ndc":["0169-7704-21","0169-7704-92","0169-7705-21","0169-7705-92","0169-7708-21","0169-7708-92","0169-7703-11","0169-7703-91","0169-7703-21","0169-7703-92"],"nui":["N0000175606","M0028842"],"pharm_class_epc":["Recombinant Human Growth Hormone [EPC]"],"pharm_class_cs":["Human Growth Hormone [CS]"],"unii":["NQX9KB6PCL"]},"update_date":"11/14/2025","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Norditropin, Injection, 30 mg/3 mL (NDC 0169-7703-21)","company_name":"Novo Nordisk, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"09/05/2018","package_ndc":"0641-6044-25","generic_name":"Lorazepam Injection","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["NDA018140"],"brand_name":["LORAZEPAM"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6044","0641-6046","0641-6045","0641-6047"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["238100","238101","1665188","1665326"],"spl_id":["7c73dbc6-2623-4443-9b05-97dec7a0be2e"],"spl_set_id":["e9b54e42-04cf-4c62-90e1-36f7b31a4e81"],"package_ndc":["0641-6044-01","0641-6044-25","0641-6046-01","0641-6046-10","0641-6045-01","0641-6045-25","0641-6047-01","0641-6047-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"10/14/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6044-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0480-3564-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA202802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Teva Pharmaceuticals, Inc."],"product_ndc":["0480-3564","0480-3565","0480-3566","0480-3567","0480-3568","0480-3569","0480-3570"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["7a1feaa2-6b58-4aff-a45b-533ee3174e53"],"spl_set_id":["c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fc"],"package_ndc":["0480-3565-01","0480-3566-01","0480-3567-01","0480-3568-01","0480-3569-01","0480-3570-01","0480-3564-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0480-3564-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"72516-011-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"855-257-0292","availability":"Unavailable","related_info":"Estimated recovery: April 2027","openfda":{"application_number":["ANDA210293"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Oryza Pharmaceuticals Inc."],"product_ndc":["72516-011","72516-016","72516-015","72516-014","72516-013","72516-012"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["5734011d-5044-b490-e063-6394a90a3174"],"spl_set_id":["acd27181-a3f3-4c38-85d8-029a4a82e7c2"],"package_ndc":["72516-016-01","72516-015-01","72516-014-01","72516-013-01","72516-012-01","72516-011-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 72516-011-01)","company_name":"Oryza Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"04/29/2026","update_type":"New","initial_posting_date":"04/29/2026","package_ndc":"49884-563-11","generic_name":"Lamotrigine Tablet, Extended Release","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/29/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Lamotrigine, Tablet, Extended Release, 100 mg (NDC 49884-563-11)","company_name":"Par Health, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"16729-137-00","generic_name":"Clonazepam Tablet","contact_info":"866-941-7875, option 2","resolved_note":"Available","openfda":{"application_number":["ANDA077147"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-137","16729-136","16729-138"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["0e1e7f41-f78b-27cf-e063-6394a90a1ae0"],"spl_set_id":["ebc11109-e7bf-452d-b675-4b3236d54164"],"package_ndc":["16729-136-00","16729-136-16","16729-137-00","16729-137-16","16729-138-00","16729-138-16"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 16729-137-00)","company_name":"Accord Healthcare Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"11/23/2021","package_ndc":"0487-6105-01","generic_name":"Sterile Water Injection","contact_info":"800-443-4313","availability":"Limited Availability","related_info":"Small amount of inventory available with 12/31/2026 dating","openfda":{"application_number":["ANDA211222"],"brand_name":["STERILE WATER"],"generic_name":["STERILE WATER"],"manufacturer_name":["Nephron Pharmaceuticals Corporation"],"product_ndc":["0487-6105"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["514fb199-56e4-ed37-e063-6294a90a1848"],"spl_set_id":["bc04a883-babc-87a6-e053-2995a90a3dfd"],"package_ndc":["0487-6105-01"],"unii":["059QF0KO0R"]},"update_date":"08/04/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water, Injection, 1 mL/1 mL (NDC 0487-6105-01)","company_name":"Nephron Pharmaceuticals Corporation","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"05/30/2025","package_ndc":"0409-1178-30","generic_name":"Meperidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021171"],"brand_name":["DEMEROL"],"generic_name":["MEPERIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1178","0409-1181","0409-1176","0409-1179","0409-1180","0409-1362","0409-1418"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["MEPERIDINE HYDROCHLORIDE"],"rxcui":["860792","861463","861473","861493","861494","861522","861529","861617","1242106","1242503","2539186","2539188","2539191","2539192"],"spl_id":["b6935f73-7b93-496d-871b-de6f9b379649"],"spl_set_id":["b31d1308-28c3-43f4-e0a6-2f3ed76b8975"],"package_ndc":["0409-1181-30","0409-1176-03","0409-1176-30","0409-1178-03","0409-1178-30","0409-1179-03","0409-1179-30","0409-1180-59","0409-1180-69","0409-1362-11","0409-1362-01","0409-1418-11","0409-1418-01"],"unii":["N8E7F7Q170"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Demerol, Injection, 50 mg/1 mL (NDC 0409-1178-30)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"09/05/2018","package_ndc":"0641-6000-10","generic_name":"Lorazepam Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA018140"],"brand_name":["ATIVAN"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6000","0641-6003","0641-6002","0641-6001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["206819","206820","238100","238101","1665188","1665190","1665326","1665327"],"spl_id":["fb40dcce-9da3-49b4-9bde-e01a17abeae6"],"spl_set_id":["5fc0e987-61c9-40c4-b0d5-fcea07c8733e"],"package_ndc":["0641-6003-01","0641-6003-25","0641-6002-01","0641-6002-10","0641-6001-01","0641-6001-25","0641-6000-01","0641-6000-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"10/14/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Ativan, Injection, 2 mg/1 mL (NDC 0641-6000-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/07/2020","package_ndc":"63323-280-10","generic_name":"Furosemide Injection","contact_info":"888-386-1300","availability":"Available","related_info":"7 mos expiry (6/30/2027) available on request. Check wholesaler for inventory.","openfda":{"application_number":["NDA018902"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-280"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["9804efac-5457-417a-8de7-a688467759c0","64b3fb5f-3516-4e39-b74e-e0e402ed9c4d"],"spl_set_id":["3747bbcd-783d-4baa-bb5b-b6827bf390e3","c794c95a-654e-48fe-9596-201fc122ff75"],"package_ndc":["63323-280-41","63323-280-16","63323-280-43","63323-280-26","63323-280-45","63323-280-36","63323-280-01","63323-280-02","63323-280-03","63323-280-04","63323-280-05","63323-280-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/01/2017","package_ndc":"0409-1805-01","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA200403"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1805","0409-1283","0409-1312","0409-4264"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1724383","1724644","2675350"],"spl_id":["766e302a-2d03-4d93-b237-2348b57ee517"],"spl_set_id":["f9ca2ef5-46d8-475a-a26e-f7c8becd6db7"],"package_ndc":["0409-1283-17","0409-1283-37","0409-1312-16","0409-1312-36","0409-4264-11","0409-4264-01","0409-1805-10","0409-1805-01"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 0.25 mg/ 0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-1805-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/03/2023","package_ndc":"0037-0678-96","generic_name":"Cromolyn Sodium Concentrate","contact_info":"(800) 796-9526","availability":"Available","openfda":{"application_number":["NDA020479"],"brand_name":["GASTROCROM"],"generic_name":["CROMOLYN SODIUM"],"manufacturer_name":["Viatris Specialty LLC"],"product_ndc":["0037-0678"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CROMOLYN SODIUM"],"rxcui":["831261","831269"],"spl_id":["15aec235-80e7-4d95-b48c-bbca69b4b04d"],"spl_set_id":["00623958-a8fe-47d1-a0d2-0aa4e2f7966e"],"package_ndc":["0037-0678-08","0037-0678-96"],"unii":["Q2WXR1I0PK"]},"update_date":"11/03/2026","therapeutic_category":["Pulmonary/Allergy"],"dosage_form":"Concentrate","presentation":"Gastrocrom, Concentrate, 20 mg/1 mL (NDC 0037-0678-96)","company_name":"Mylan Specialty, a Viatris Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/31/2018","change_date":"09/30/2026","package_ndc":"65219-572-10","generic_name":"Bumetanide Injection","contact_info":"888-386-1300","resolved_note":"Available","openfda":{"application_number":["ANDA216434"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-572","65219-570"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["aaff61c4-203b-4905-9138-0f98959ad013"],"spl_set_id":["a007f3aa-3977-4be3-a9a2-db3d458bca58"],"package_ndc":["65219-570-01","65219-570-04","65219-572-01","65219-572-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, .25 mg/1 mL (NDC 65219-572-10)","company_name":"Fresenius Kabi USA, LLC","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"13811-700-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Allocation to current contracted customers","openfda":{"application_number":["NDA216117"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Trigen Laboratories, LLC"],"product_ndc":["13811-700","13811-711"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["2605796","2605798"],"spl_id":["ba649db4-df0d-4587-8370-3f866e66e54b"],"spl_set_id":["dd8d7b6e-c23d-4e16-bb53-959e9127ebc6"],"package_ndc":["13811-711-30","13811-700-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)","company_name":"Trigen Laboratories, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"11/19/2025","update_type":"New","initial_posting_date":"11/19/2025","package_ndc":"0172-5240-60","generic_name":"Anagrelide Hydrochloride Capsule","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"11/19/2025","therapeutic_category":["Hematology"],"dosage_form":"Capsule","presentation":"Anagrelide Hydrochloride, Capsule, 1 mg (NDC 0172-5240-60)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"04/07/2020","package_ndc":"0409-6102-26","generic_name":"Furosemide Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA018667"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["e598e8a6-c854-48f5-a412-fb6a6783774a","981d5143-60cd-4987-9b47-dec24c10de42"],"spl_set_id":["aaced7a8-c3d7-4d66-8c07-aa407b8b3f35","39fd32f2-6bb7-4a65-d298-e48d26bc80c7"],"package_ndc":["0409-6102-35","0409-6102-25","0409-6102-36","0409-6102-26","0409-6102-37","0409-6102-27","0409-6102-19","0409-6102-02","0409-6102-18","0409-6102-04","0409-6102-20","0409-6102-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-26)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"11/13/2025","update_type":"New","initial_posting_date":"11/13/2025","package_ndc":"51759-523-21","generic_name":"Adalimumab-ryvk Kit","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["BLA761299"],"brand_name":["SIMLANDI"],"generic_name":["ADALIMUMAB-RYVK"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["51759-523","51759-402","51759-386","51759-412","51759-274"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["797544","2677780","2677787","2688819","2688823","2688826","2688827","2688828","2688829","2706644","2706645"],"spl_id":["021cc6a0-a2e6-4e30-95dc-065c64b7fe70"],"spl_set_id":["12f609c9-2088-bb05-e063-6394a90a9ecc"],"package_ndc":["51759-402-02","51759-402-17","51759-513-21","65517-0002-1","51759-386-22","51759-497-31","51759-412-22","51759-624-31","51759-523-21","51759-634-31","51759-274-17","51759-384-21"]},"update_date":"11/13/2025","therapeutic_category":["Rheumatology"],"presentation":"Simlandi, Kit, Kit (NDC 51759-523-21)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"06/13/2018","package_ndc":"0143-9594-25","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["ANDA084625"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9594","0143-9595"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737566","1737761"],"spl_id":["a7da0a25-5efb-48fa-9063-f7c0423f820f"],"spl_set_id":["1631e5ca-03d0-4d3b-91e3-2dc14f4eb0e1"],"package_ndc":["0143-9595-01","0143-9595-25","0143-9594-01","0143-9594-25"],"unii":["V13007Z41A"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"42806-339-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(718) 276-8600 ext. 3","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040444"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Epic Pharma, LLC"],"product_ndc":["42806-339","42806-341","42806-343","42806-344","42806-345"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961"],"spl_id":["f11301e2-3b5d-468d-b44c-45839e7e5dfb"],"spl_set_id":["1757e132-061d-4773-89ed-fdc77f69008f"],"package_ndc":["42806-339-01","42806-341-01","42806-343-01","42806-344-01","42806-345-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 42806-339-01)","company_name":"Epic Pharma, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"71288-726-52","generic_name":"Bupivacaine Hydrochloride Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d","contact_info":"844-824-8426","availability":"Limited Availability","related_info":"Meitheal Pharmaceuticals is distributor/labeler","openfda":{"application_number":["ANDA216039"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc"],"product_ndc":["71288-726","71288-723"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["0949c302-51ce-4fc9-8b99-1df94e693718"],"spl_set_id":["fe340f98-a0f3-446e-b281-47fd91c1e537"],"package_ndc":["71288-723-52","71288-726-52"],"unii":["7TQO7W3VT8"]},"update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)","company_name":"Kindos Pharmaceuticals Co. Ltd.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"discontinued_date":"02/24/2026","update_type":"New","initial_posting_date":"02/24/2026","package_ndc":"50742-438-10","generic_name":"Arsenic Trioxide Injection","contact_info":"866-321-5031","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA209315"],"brand_name":["ARSENIC TRIOXIDE"],"generic_name":["ARSENIC TRIOXIDE"],"manufacturer_name":["Ingenus Pharmaceuticals, LLC"],"product_ndc":["50742-438"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ARSENIC TRIOXIDE"],"rxcui":["829926"],"spl_id":["c5fa4ad7-39fa-472e-be5f-cf39164bd49d"],"spl_set_id":["c99b01b4-67ff-4793-8375-fe3a21c6c9be"],"package_ndc":["50742-438-10"],"unii":["S7V92P67HO"]},"update_date":"02/24/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 50742-438-10)","company_name":"Ingenus Pharmaceuticals LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"13811-708-10","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Allocation to current contracted customers","openfda":{"application_number":["ANDA205327"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Trigen Laboratories, LLC"],"product_ndc":["13811-708","13811-709","13811-706","13811-707","13811-710"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461"],"spl_id":["0944cf70-d59a-483b-9698-e96ef955a65a"],"spl_set_id":["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"],"package_ndc":["13811-709-10","13811-706-10","13811-707-10","13811-708-10","13811-710-10","13811-710-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 13811-708-10)","company_name":"Trigen Laboratories, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/01/2017","package_ndc":"0703-0113-03","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"800-545-8800","availability":"Limited Availability","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA078591"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-0113","0703-0110","0703-0018"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["1724338","1724340","1724341"],"spl_id":["540b835a-db66-417c-8507-0c1ed05c95bf"],"spl_set_id":["f0b78db9-a38c-41bb-8233-5e93f7f18c5c"],"package_ndc":["0703-0110-01","0703-0110-03","0703-0113-01","0703-0113-03","0703-0018-01"],"unii":["L960UP2KRW"]},"update_date":"11/02/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0113-03)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-048-88","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-818-4555","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA214484"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-048","57664-047","57664-046","57664-049","57664-050","57664-051","57664-052","57664-083","57664-084","57664-085","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 57664-048-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"0409-1283-31","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery and Estimated Recovery: December 2026","openfda":{"application_number":["NDA200403"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1283","0409-1312","0409-4264","0409-1805","0409-2552","0409-3356","0409-2540","0409-3365","0409-1304"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1724383","1724644","2675350","897653","897753","897758","1724276"],"spl_id":["766e302a-2d03-4d93-b237-2348b57ee517","a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"],"spl_set_id":["f9ca2ef5-46d8-475a-a26e-f7c8becd6db7","e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"],"package_ndc":["0409-1283-17","0409-1283-37","0409-1312-16","0409-1312-36","0409-4264-11","0409-4264-01","0409-1805-10","0409-1805-01","0409-2552-11","0409-2552-01","0409-3356-11","0409-3356-01","0409-2540-11","0409-2540-01","0409-3365-11","0409-3365-01","0409-3365-10","0409-1283-03","0409-1283-31","0409-1312-03","0409-1312-30","0409-1304-03","0409-1304-31"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 1 mg/1 mL Syringes (NDC 0409-1283-31)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"42023-146-25","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"800-828-9393","availability":"Unavailable","related_info":"Please check wholesalers for inventory","openfda":{"application_number":["ANDA203972"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["42023-146","42023-186","42023-187"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710","1718906","1718909"],"spl_id":["54174211-6684-4fb9-a605-be12b94e2948"],"spl_set_id":["1ee59985-4c1d-48f7-b8f9-5584c2d55e08"],"package_ndc":["42023-146-25","42023-186-20","42023-187-10"],"unii":["1018WH7F9I"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25)","company_name":"Par Health, USA LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-5010-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-5010","0409-1746","0409-1749","0409-1752","0409-1755","0409-2510","0409-7535","0409-1250","0409-1530","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-5010-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"68025-095-10","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Temporary discontinuation of 100ct","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-095","68025-088","68025-089","68025-096","68025-097","68025-084","68025-098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-10)","company_name":"Vertical Pharmaceuticals, LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"68025-096-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Available","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-096","68025-088","68025-089","68025-095","68025-097","68025-084","68025-098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-30)","company_name":"Vertical Pharmaceuticals, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0555-0775-02","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0555-0775","0555-0971","0555-0972","0555-0776","0555-0777","0555-0973","0555-0974"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"],"spl_set_id":["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"],"package_ndc":["0555-0971-02","0555-0775-02","0555-0972-02","0555-0776-02","0555-0777-02","0555-0973-02","0555-0974-02"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0555-0775-02)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0054-0372-25","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Available on allocation","openfda":{"application_number":["ANDA202827"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-0372","0054-0660","0054-0370","0054-0371","0054-0373","0054-0374","0054-0375"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"],"spl_set_id":["6740a621-9bec-4178-a4fc-a3fc89f34e0a"],"package_ndc":["0054-0660-25","0054-0370-25","0054-0371-25","0054-0372-25","0054-0373-25","0054-0374-25","0054-0375-25"],"unii":["SJT761GEGS"]},"update_date":"10/14/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0054-0372-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/18/2023","package_ndc":"0143-9144-03","generic_name":"Liraglutide Injection","contact_info":"800-631-2174","availability":"Available","openfda":{"application_number":["ANDA215503"],"brand_name":["LIRAGLUTIDE"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9144"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["897122"],"spl_id":["4e2acb7a-d32d-49d3-b59b-39332b5809f3"],"spl_set_id":["2100ec49-57b2-4330-ab5f-057ce9b7e4d0"],"package_ndc":["0143-9144-01","0143-9144-03","0143-9144-02"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"10/14/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-03)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"55150-297-10","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA210321"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-297","55150-209","55150-296"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710","1718906","1718909"],"spl_id":["a1eab62d-fcef-4b83-9266-3c5f7a05927b"],"spl_set_id":["8c162541-986b-4b30-866c-b2631ba2c975"],"package_ndc":["55150-209-02","55150-296-10","55150-297-10"],"unii":["1018WH7F9I"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1746-10","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1746","0409-1749","0409-1752","0409-1755","0409-2510","0409-7535","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 25 mg/10 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-3475-01","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery and Estimated Recovery: December 2026","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-3475","0009-3073"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743781","1743855","1743856"],"spl_id":["742fcec7-8db3-4cc6-b276-42587a993810"],"spl_set_id":["9a7b3837-e038-48bf-97e9-78ad463760dc"],"package_ndc":["0009-3073-01","0009-3073-03","0009-3475-01","0009-3475-03"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-01)","company_name":"Pfizer Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0641-6061-25","generic_name":"Midazolam Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["ANDA075243"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6061","0641-6057","0641-6059","0641-6056","0641-6063","0641-6060"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["559c03fb-24ea-4b7b-8afd-e33cb3a2340a"],"spl_set_id":["575d8bf0-7af7-427c-a231-966e2a5e070d"],"package_ndc":["0641-6057-01","0641-6057-10","0641-6057-25","0641-6059-01","0641-6059-10","0641-6056-01","0641-6056-10","0641-6061-01","0641-6061-10","0641-6061-25","0641-6063-01","0641-6063-10","0641-6063-25","0641-6060-01","0641-6060-10"],"unii":["W7TTW573JJ"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/12/2026","package_ndc":"10019-925-01","generic_name":"Ifosfamide Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA019763"],"brand_name":["IFOSFAMIDE"],"generic_name":["IFOSFAMIDE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["10019-925","10019-926"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IFOSFAMIDE"],"spl_id":["7259fc64-d1c1-4e26-b531-d2e40f0d24fb"],"spl_set_id":["91e433a9-6800-43a6-ac13-a49a04a5aecd"],"package_ndc":["10019-925-82","10019-925-01","10019-926-16","10019-926-02"],"nui":["N0000000236","N0000175558"],"pharm_class_moa":["Alkylating Activity [MoA]"],"pharm_class_epc":["Alkylating Drug [EPC]"],"unii":["UM20QQM95Y"]},"update_date":"11/03/2026","therapeutic_category":["Oncology","Pediatric"],"dosage_form":"Injection","presentation":"Ifosfamide, Injection, 1 g/20 mL (NDC 10019-925-01)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"12/08/2025","update_type":"New","initial_posting_date":"12/08/2025","package_ndc":"0781-9404-95","generic_name":"Ampicillin Sodium Injection","contact_info":"800-525-8747","related_info":"Discontinuation of private label only","openfda":{"application_number":["ANDA061395"],"brand_name":["AMPICILLIN"],"generic_name":["AMPICILLIN SODIUM"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-9404","0781-9401","0781-9402","0781-9407","0781-9408"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["AMPICILLIN SODIUM"],"rxcui":["308207","1721473","1721474","1721475","1721476"],"spl_id":["a3ddae6c-ac4c-425f-82b0-eb388d92bc0e"],"spl_set_id":["b371e1a5-1fef-4df2-8940-c4fc02b9e2f0"],"package_ndc":["0781-9401-78","0781-9401-95","0781-9402-78","0781-9402-95","0781-9407-78","0781-9407-95","0781-9404-85","0781-9404-95","0781-9408-80","0781-9408-95"],"unii":["JFN36L5S8K"]},"update_date":"12/08/2025","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Ampicillin Sodium, Injection, 1 g (NDC 0781-9404-95)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-162-02","generic_name":"Ketorolac Tromethamine Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release not available at this time.  Check wholesalers for inventory.","openfda":{"application_number":["ANDA075784"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-162","63323-161"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["2b1c6066-d9e0-40a0-ade5-776fc35a3626","55ed7afb-db66-4b28-939b-db45b55bf058","ab476c4c-2c72-47b1-bf42-7a89703b0dd4"],"spl_set_id":["ccf905ca-e164-4779-9485-2d139c821bad","950b7295-3f68-4027-ac2b-2f7d0f5f8ef9","d1920335-8e45-4960-b6e9-e6f1f9e6820c"],"package_ndc":["63323-161-41","63323-161-16","63323-162-43","63323-162-16","63323-162-45","63323-162-26","63323-161-21","63323-161-12","63323-162-23","63323-162-12","63323-162-25","63323-162-14","63323-161-00","63323-161-01","63323-162-11","63323-162-51","63323-162-00","63323-162-01","63323-162-03","63323-162-02"],"unii":["4EVE5946BQ"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-02)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0264-7510-00","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019626"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-7510","0264-7520"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE, UNSPECIFIED FORM"],"rxcui":["1795477","1795480","1795481","1795607","1795610","1795612"],"spl_id":["4acb5988-64ad-4f83-bc8d-6f2117dfebbe"],"spl_set_id":["085614c7-ada4-4e2c-87c0-c9bc2f18365a"],"package_ndc":["0264-7510-00","0264-7510-10","0264-7510-20","0264-7520-00","0264-7520-10","0264-7520-20"],"unii":["IY9XDZ35W2"]},"update_date":"10/19/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-00)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"61703-339-18","generic_name":"Carboplatin Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027","openfda":{"application_number":["ANDA076517"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-339"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["0ddf4411-7138-412a-908a-fadf22bdfb79"],"spl_set_id":["c3ae9880-44bb-4f4e-93d8-8a5e21708a30"],"package_ndc":["61703-339-18","61703-339-22","61703-339-50","61703-339-56"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/09/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-339-18)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/03/2017","package_ndc":"0641-6019-10","generic_name":"Morphine Sulfate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["NDA018565"],"brand_name":["DURAMORPH"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6019","0641-6020"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRATHECAL","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892473","892489","1728783","1728800"],"spl_id":["aa74af85-7068-4254-9a79-c7f3792044a6"],"spl_set_id":["ebb18761-e5c4-4238-bb84-f9549f500210"],"package_ndc":["0641-6020-01","0641-6020-10","0641-6019-01","0641-6019-10"],"unii":["X3P646A2J0"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Duramorph, Injection, 1 mg/1 mL (NDC 0641-6019-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"11/17/2025","update_type":"New","initial_posting_date":"11/17/2025","package_ndc":"78206-170-01","generic_name":"Montelukast Sodium Tablet, Chewable","contact_info":"844-674-3200","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020830"],"brand_name":["SINGULAIR"],"generic_name":["MONTELUKAST SODIUM"],"manufacturer_name":["Organon LLC"],"product_ndc":["78206-170","78206-171","78206-173","78206-172"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MONTELUKAST SODIUM"],"rxcui":["153892","153893","200224","242438","261367","311759","351246","404406"],"spl_id":["57a12189-3bb3-4a5d-b5fe-fc57db87c134"],"spl_set_id":["482dcc92-b47f-4ea6-854a-f5ac2aea7842"],"package_ndc":["78206-171-01","78206-170-01","78206-173-01","78206-172-01","78206-172-02"],"unii":["U1O3J18SFL"]},"update_date":"11/17/2025","therapeutic_category":["Pulmonary/Allergy"],"dosage_form":"Tablet, Chewable","presentation":"Singulair, Tablet, Chewable, 4 mg (NDC 78206-170-01)","company_name":"Organon","status":"To Be Discontinued"},{"discontinued_date":"04/29/2026","update_type":"New","initial_posting_date":"04/29/2026","package_ndc":"49884-562-11","generic_name":"Lamotrigine Tablet, Extended Release","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/29/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Lamotrigine, Tablet, Extended Release, 50 mg (NDC 49884-562-11)","company_name":"Par Health, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-084-88","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"800-818-4555","availability":"Available","openfda":{"application_number":["ANDA214134"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-084","57664-047","57664-046","57664-048","57664-049","57664-050","57664-051","57664-052","57664-083","57664-085","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88)","company_name":"Sun Pharmaceutical Industries, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"42858-165-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-827-0616","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA215330"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Rhodes Pharmaceuticals LLC"],"product_ndc":["42858-165","42858-161","42858-162","42858-163","42858-164","42858-166","42858-167"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0002e227-1109-4ecc-a8c5-4b4f11fac3cc"],"spl_set_id":["d918b40d-a461-41bc-b6c0-83dc76c28e32"],"package_ndc":["42858-161-01","42858-162-01","42858-163-01","42858-164-01","42858-165-01","42858-166-01","42858-167-01"],"unii":["SJT761GEGS"]},"update_date":"06/24/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 42858-165-01)","company_name":"Rhodes Pharmaceuticals L.P.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/11/2024","package_ndc":"0338-0719-06","generic_name":"Dextrose Monohydrate 70% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA020047"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0719"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["237656"],"spl_id":["fa107ac2-32b9-452f-b26c-0a5df79e31ab"],"spl_set_id":["0332f34a-7038-47cc-ba59-d55cad6b73ca"],"package_ndc":["0338-0719-06"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"60505-6282-7","generic_name":"Carboplatin Injection","contact_info":"Apotex Inc.: 800-706-5575","related_info":"Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA077861"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-6282"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["0e68e276-b0df-4f03-e063-6394a90a22b9"],"spl_set_id":["1c275825-0275-4c73-b650-e4c1519f13b8"],"package_ndc":["60505-6282-1","60505-6282-3","60505-6282-6","60505-6282-7"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"06/01/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-7)","company_name":"Teyro Labs","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"16729-512-43","generic_name":"Atropine Sulfate Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA213424"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-512"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ENDOTRACHEAL","INTRAMEDULLARY","INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190776"],"spl_id":["275def6c-5b2d-918b-e063-6294a90aa71f"],"spl_set_id":["f3cb74e9-b4ac-4efe-bd8e-8a71970ee7c7"],"package_ndc":["16729-512-05","16729-512-43"],"unii":["03J5ZE7KA5"]},"update_date":"10/03/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-512-43)","company_name":"Accord Healthcare Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Revised","initial_posting_date":"08/27/2026","package_ndc":"0409-0801-01","generic_name":"Pentostatin Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA020122"],"brand_name":["NIPENT"],"generic_name":["PENTOSTATIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-0801"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["PENTOSTATIN"],"rxcui":["105607","240573"],"spl_id":["9090cd4d-7071-4409-a8fd-a7b56589661c"],"spl_set_id":["674e0e6d-46ed-4868-9196-04019d667716"],"package_ndc":["0409-0801-01"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["395575MZO7"]},"update_date":"10/21/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Nipent, Injection, 10 mg, single dose vial (NDC 0409-0801-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"06/13/2018","package_ndc":"0143-9595-25","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Product temporarily on backorder.  Additional lots will be available in the November 2026 timeframe.","openfda":{"application_number":["ANDA084625"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9595","0143-9594"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737566","1737761"],"spl_id":["a7da0a25-5efb-48fa-9063-f7c0423f820f"],"spl_set_id":["1631e5ca-03d0-4d3b-91e3-2dc14f4eb0e1"],"package_ndc":["0143-9595-01","0143-9595-25","0143-9594-01","0143-9594-25"],"unii":["V13007Z41A"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"01/20/2026","update_type":"New","initial_posting_date":"01/20/2026","package_ndc":"49702-260-55","generic_name":"Maraviroc Solution","contact_info":"877-844-8872","related_info":"The anticipated date that GSK will cease distribution of the product is approximately August 1, 2026.","openfda":{"application_number":["NDA208984"],"brand_name":["SELZENTRY"],"generic_name":["MARAVIROC"],"manufacturer_name":["ViiV Healthcare Company"],"product_ndc":["49702-260","49702-223","49702-224"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["728223","728225","729201","729203","1857921","1857925"],"spl_id":["bd98c45d-446e-4023-882c-9c36d612f5a5"],"spl_set_id":["46f30ac5-c96b-429e-976d-8c5ee1c0761b"],"package_ndc":["49702-223-18","49702-224-18","49702-260-55"],"nui":["N0000175572","N0000175445"],"pharm_class_epc":["CCR5 Co-receptor Antagonist [EPC]"],"pharm_class_moa":["Chemokine Co-receptor 5 Antagonists [MoA]"],"unii":["MD6P741W8A"]},"update_date":"01/20/2026","therapeutic_category":["Antiviral"],"dosage_form":"Solution","presentation":"Selzentry, Solution, 20 mg/mL Oral Solution Kit | 230 mL Oral Solution per Bottle | 1 Bottle per Carton  (NDC 49702-260-55)","company_name":"ViiV Healthcare Company","status":"To Be Discontinued"},{"discontinued_date":"06/08/2026","update_type":"New","initial_posting_date":"06/08/2026","package_ndc":"0088-2162-33","generic_name":"Leflunomide Tablet","contact_info":"800-981-2491","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020905"],"brand_name":["ARAVA"],"generic_name":["LEFLUNOMIDE"],"manufacturer_name":["sanofi-aventis U.S. LLC"],"product_ndc":["0088-2162","0088-2160","0088-2161"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LEFLUNOMIDE"],"rxcui":["205284","205285","205286","213377","213379","213380"],"spl_id":["765327c7-cb5b-4637-84da-4fd9a024ad96"],"spl_set_id":["320f63f2-fac3-4aee-aff8-85724e00ef52"],"package_ndc":["0088-2160-30","0088-2161-30","0088-2162-33"],"nui":["N0000175713"],"pharm_class_epc":["Antirheumatic Agent [EPC]"],"unii":["G162GK9U4W"]},"update_date":"06/08/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Tablet","presentation":"Arava, Tablet, 100 mg (NDC 0088-2162-33)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0955-1008-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["ENOXAPARIN SODIUM"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0955-1008","0955-1003","0955-1004","0955-1006","0955-1010","0955-1016","0955-1012","0955-1015"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854235","854238","854241","854245","854248","854252","854255"],"spl_id":["8f06a411-badb-483f-852d-8e6124acfa44"],"spl_set_id":["20635579-c92d-4f6c-a332-1096d51002f2"],"package_ndc":["0955-1003-01","0955-1003-10","0955-1004-01","0955-1004-10","0955-1006-01","0955-1006-10","0955-1008-01","0955-1008-10","0955-1010-01","0955-1010-10","0955-1016-01","0955-1012-01","0955-1012-10","0955-1015-01","0955-1015-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Enoxaparin Sodium, Injection, 80 mg/.8 mL (NDC 0955-1008-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"discontinued_date":"02/10/2026","update_type":"New","initial_posting_date":"02/10/2026","package_ndc":"63323-340-20","generic_name":"Cefepime Hydrochloride Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug.","openfda":{"application_number":["ANDA065441"],"brand_name":["CEFEPIME"],"generic_name":["CEFEPIME"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-340","63323-326"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CEFEPIME HYDROCHLORIDE"],"rxcui":["1665088","1665093"],"spl_id":["8c2fbf43-34bd-49d1-bda8-a2191c8bc54b"],"spl_set_id":["5e1695e0-1310-4cd8-a5da-ad1a7dcd1792"],"package_ndc":["63323-326-21","63323-326-20","63323-340-21","63323-340-20"],"unii":["I8X1O0607P"]},"update_date":"02/10/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"discontinued_date":"01/20/2026","update_type":"New","initial_posting_date":"01/20/2026","package_ndc":"65219-434-20","generic_name":"Piperacillin and Tazobactam Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA203719"],"brand_name":["PIPERACILLIN AND TAZOBACTAM"],"generic_name":["PIPERACILLIN AND TAZOBACTAM"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-434","65219-436","65219-259"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["PIPERACILLIN SODIUM","TAZOBACTAM SODIUM"],"rxcui":["1659131","1659137","1659149"],"spl_id":["3a3e13da-9eda-44fc-b274-119722634878"],"spl_set_id":["a798faf5-cd97-4e35-a700-94c372978c46"],"package_ndc":["65219-434-02","65219-434-20","65219-436-02","65219-436-20","65219-259-05","65219-259-45"],"unii":["M98T69Q7HP","UXA545ABTT"]},"update_date":"01/20/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Piperacillin and Tazobactam, Injection, 2.25 g vial (NDC 65219-434-20)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"discontinued_date":"03/24/2026","update_type":"New","initial_posting_date":"03/24/2026","package_ndc":"0074-7098-06","generic_name":"Pilocarpine Hydrochloride Ophthalmic Solution","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/24/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Ophthalmic Solution","presentation":"Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-06)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"discontinued_date":"05/14/2026","update_type":"New","initial_posting_date":"05/14/2026","package_ndc":"0480-7250-46","generic_name":"Liraglutide Injection","contact_info":"888-838-2872","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA214568"],"brand_name":["LIRAGLUTIDE"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Teva Pharmaceuticals, Inc."],"product_ndc":["0480-7250"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["2735350"],"spl_id":["4df44cd9-cb11-46b6-ba6c-88ff963ec414"],"spl_set_id":["625ac780-70a9-41e4-a892-bcba0f803f1c"],"package_ndc":["0480-7250-46"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"05/14/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Liraglutide, Injection, 6 mg/1 mL (NDC 0480-7250-46)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"57664-606-88","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-818-4555","availability":"Unavailable","related_info":"Currently not marketed","update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 57664-606-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"76329-3390-1","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"800-423-4136","availability":"Available","openfda":{"application_number":["ANDA083173"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["International Medication Systems, Limited"],"product_ndc":["76329-3390"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1012068"],"spl_id":["3d910bb6-792f-41f3-8b28-b33bcbec5ccb"],"spl_set_id":["5d3e9984-cef9-46f2-a6c9-3be8b26f45b3"],"package_ndc":["76329-3390-1"],"unii":["V13007Z41A"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 76329-3390-1)","company_name":"Amphastar Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-3181-01","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: August 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA089645"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3181","0409-1209","0409-3177","0409-3178","0409-3182","0409-3183","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0338-0502-06","generic_name":"Amino Acid Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA020512"],"brand_name":["CLINISOL"],"generic_name":["LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0502"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LYSINE ACETATE","LEUCINE","PHENYLALANINE","VALINE","HISTIDINE","ISOLEUCINE","METHIONINE","THREONINE","TRYPTOPHAN","ALANINE","ARGININE","GLYCINE","PROLINE","GLUTAMIC ACID","SERINE","ASPARTIC ACID","TYROSINE"],"rxcui":["800584","800588"],"spl_id":["dfb5b2ef-1ef5-4a8b-bb77-13d85708e50f"],"spl_set_id":["65ffc962-7538-41ea-9afb-4af5fbce4c5b"],"package_ndc":["0338-0502-03","0338-0502-06"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["TTL6G7LIWZ","GMW67QNF9C","47E5O17Y3R","HG18B9YRS7","4QD397987E","04Y7590D77","AE28F7PNPL","2ZD004190S","8DUH1N11BX","OF5P57N2ZX","94ZLA3W45F","TE7660XO1C","9DLQ4CIU6V","3KX376GY7L","452VLY9402","30KYC7MIAI","42HK56048U"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-06)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/28/2022","package_ndc":"72078-036-05","generic_name":"Remifentanil Hydrochloride Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["NDA020630"],"brand_name":["ULTIVA"],"generic_name":["REMIFENTANIL HYDROCHLORIDE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["72078-036","72078-034","72078-035"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["REMIFENTANIL HYDROCHLORIDE"],"rxcui":["1729578","1729581","1729584","1729586","1729710","1729712"],"spl_id":["f41b6542-9305-43e7-bbbc-52c7ee2cb0dc"],"spl_set_id":["8b4c8696-e23e-4c51-a4d2-babab5bd945a"],"package_ndc":["72078-034-00","72078-034-01","72078-035-00","72078-035-02","72078-036-00","72078-036-05"],"unii":["5V444H5WIC"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ultiva, Injection, 5 mg (NDC 72078-036-05)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"discontinued_date":"03/19/2026","update_type":"New","initial_posting_date":"03/19/2026","package_ndc":"64764-805-30","generic_name":"Ramelteon Tablet","contact_info":"877-825-3327","related_info":"Product is expected to be available through June 2027.","openfda":{"application_number":["NDA021782"],"brand_name":["ROZEREM"],"generic_name":["RAMELTEON"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["64764-805"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RAMELTEON"],"rxcui":["577348","603162"],"spl_id":["2021e7fb-108a-4783-9a37-8bc05bf28b28"],"spl_set_id":["9de82310-70e8-47b9-b1fc-6c6848b99455"],"package_ndc":["64764-805-30","64764-805-10","64764-805-22"],"nui":["N0000175743","N0000000250"],"pharm_class_epc":["Melatonin Receptor Agonist [EPC]"],"pharm_class_moa":["Melatonin Receptor Agonists [MoA]"],"unii":["901AS54I69"]},"update_date":"03/19/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Rozerem, Tablet, 8 mg (NDC 64764-805-30)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"42858-166-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-827-0616","availability":"Available","openfda":{"application_number":["ANDA215330"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Rhodes Pharmaceuticals LLC"],"product_ndc":["42858-166","42858-161","42858-162","42858-163","42858-164","42858-165","42858-167"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0002e227-1109-4ecc-a8c5-4b4f11fac3cc"],"spl_set_id":["d918b40d-a461-41bc-b6c0-83dc76c28e32"],"package_ndc":["42858-161-01","42858-162-01","42858-163-01","42858-164-01","42858-165-01","42858-166-01","42858-167-01"],"unii":["SJT761GEGS"]},"update_date":"06/24/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 42858-166-01)","company_name":"Rhodes Pharmaceuticals L.P.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"64253-400-91","generic_name":"Atropine Sulfate Injection","contact_info":"630-682-4600","availability":"Available","openfda":{"application_number":["ANDA214970"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE INJECTION"],"manufacturer_name":["Medefil, Inc."],"product_ndc":["64253-400"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190546"],"spl_id":["46a6a31f-46ab-a437-e063-6394a90a4ad0"],"spl_set_id":["fbfdf718-befe-ad22-e053-6294a90a3715"],"package_ndc":["64253-400-30","64253-400-91"],"unii":["03J5ZE7KA5"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 64253-400-91)","company_name":"Medefil, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/13/2018","package_ndc":"55150-256-50","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA207182"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-256","55150-251","55150-252","55150-253","55150-254","55150-255"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671"],"spl_id":["0b1f03c2-db2f-4f90-acc0-d73abd731bf6"],"spl_set_id":["ef782e5e-e2d7-465a-99c6-b12611f3158c"],"package_ndc":["55150-251-10","55150-252-20","55150-253-50","55150-254-10","55150-255-20","55150-256-50"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"63323-808-11","generic_name":"Fentanyl Citrate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA212086"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-808","63323-810"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["2474267","2474269"],"spl_id":["a47a3a31-e293-49d5-b6bc-950303525a64"],"spl_set_id":["0c10e465-4117-48ba-a454-23ccb7a3fcc7"],"package_ndc":["63323-808-01","63323-808-11","63323-810-00","63323-810-20"],"unii":["MUN5LYG46H"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 63323-808-11)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-154-05","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-154","72888-497","72888-152","72888-153"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 72888-154-05)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"discontinued_date":"07/24/2026","update_type":"New","initial_posting_date":"07/24/2026","package_ndc":"0074-2340-30","generic_name":"Ritonavir Tablet","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA022417"],"brand_name":["NORVIR"],"generic_name":["RITONAVIR"],"manufacturer_name":["AbbVie Inc."],"product_ndc":["0074-2340","0074-3333","0074-1940","0074-3399"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RITONAVIR"],"rxcui":["152971","199249","900575","900577","1926066","1926069"],"spl_id":["08f28b14-eabc-4a9a-b066-d8eda837e9e4"],"spl_set_id":["2849298e-de6e-47bb-8194-56e075b33fc3"],"package_ndc":["0074-3333-30","0074-1940-63","0074-3399-30","0074-2340-30"],"nui":["N0000000246","N0000191001","N0000175889","N0000190114","N0000182137","N0000185607","N0000190118","N0000185503","N0000190113","N0000182141","N0000191266","N0000185507","N0000187064","N0000190117"],"pharm_class_moa":["HIV Protease Inhibitors [MoA]","Cytochrome P450 3A Inhibitors [MoA]","Cytochrome P450 2D6 Inhibitors [MoA]","Cytochrome P450 2C19 Inducers [MoA]","Cytochrome P450 3A Inducers [MoA]","P-Glycoprotein Inhibitors [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]","Cytochrome P450 3A4 Inhibitors [MoA]","Cytochrome P450 1A2 Inducers [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 2B6 Inducers [MoA]","UDP Glucuronosyltransferases Inducers [MoA]"],"pharm_class_epc":["Cytochrome P450 3A Inhibitor [EPC]","Protease Inhibitor [EPC]"],"unii":["O3J8G9O825"]},"update_date":"07/24/2026","therapeutic_category":["Antiviral"],"dosage_form":"Tablet","presentation":"Norvir, Tablet, 100 mg (NDC 0074-2340-30)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/26/2024","package_ndc":"70726-0303-1","generic_name":"Riluzole Oral Suspension","contact_info":"610-937-6172","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA209080"],"brand_name":["TIGLUTIK"],"generic_name":["RILUZOLE"],"manufacturer_name":["EDW PHARMA, INC"],"product_ndc":["70726-0303"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RILUZOLE"],"rxcui":["2058147","2059266"],"spl_id":["57997dd0-4d88-c2e5-e063-6394a90ae8ae"],"spl_set_id":["75d68f19-4208-109e-e053-2991aa0ac857"],"package_ndc":["70726-0303-2","70726-0303-1"],"nui":["N0000175740","M0483511"],"pharm_class_epc":["Benzothiazole [EPC]"],"pharm_class_cs":["Benzothiazoles [CS]"],"unii":["7LJ087RS6F"]},"update_date":"10/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Oral Suspension","presentation":"Tiglutik, Oral Suspension, 50 mg/10 mL (NDC 70726-0303-1)","company_name":"EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0378-6855-77","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA202835"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-6855","0378-6854","0378-6856","0378-6857","0378-6858","0378-6859","0378-6860"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["6e77cd71-95ae-4fa8-830b-ab62b714e4b9"],"spl_set_id":["efbde0f6-b848-4664-b741-c6c630e66108"],"package_ndc":["0378-6854-77","0378-6855-77","0378-6856-77","0378-6857-77","0378-6858-77","0378-6859-77","0378-6860-77"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0378-6855-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"Current"},{"discontinued_date":"12/22/2025","update_type":"New","initial_posting_date":"12/22/2025","package_ndc":"0002-8011-27","generic_name":"Mirikizumab-mrkz Injection","contact_info":"800-545-5979","related_info":"A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-3116-11) will remain.","openfda":{"application_number":["BLA761279"],"brand_name":["OMVOH"],"generic_name":["MIRIKIZUMAB-MRKZ"],"manufacturer_name":["Eli Lilly and Company"],"product_ndc":["0002-8011","0002-7575","0002-8870","0002-7717","0002-7722","0002-3116","0002-1442"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["MIRIKIZUMAB"],"rxcui":["2668391","2668398","2668405","2668410","2680728","2680732","2703047","2703048","2703049","2703050","2703051","2703052","2703053","2703054"],"spl_id":["3553ca93-cbe0-4286-b806-a423598eb42a"],"spl_set_id":["472cbe04-263e-433d-9a0f-58c1b50b715a"],"package_ndc":["0002-7575-01","0002-8011-01","0002-8011-27","0002-8011-61","0002-8870-01","0002-8870-27","0002-7717-11","0002-7717-61","0002-3116-01","0002-7722-11","0002-1442-01","0002-3116-11","0002-3116-61","0002-1442-11"],"nui":["N0000192799","N0000192798"],"pharm_class_epc":["Interleukin-23 Antagonist [EPC]"],"pharm_class_moa":["Interleukin-23 Antagonists [MoA]"],"unii":["Z7HVY03PHP"]},"update_date":"12/22/2025","therapeutic_category":["Gastroenterology","Other"],"dosage_form":"Injection","presentation":"Omvoh, Injection, 100 mg/1 mL (NDC 0002-8011-27)","company_name":"Eli Lilly and Co.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0054-0370-25","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Available on allocation","openfda":{"application_number":["ANDA202827"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-0370","0054-0660","0054-0371","0054-0372","0054-0373","0054-0374","0054-0375"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"],"spl_set_id":["6740a621-9bec-4178-a4fc-a3fc89f34e0a"],"package_ndc":["0054-0660-25","0054-0370-25","0054-0371-25","0054-0372-25","0054-0373-25","0054-0374-25","0054-0375-25"],"unii":["SJT761GEGS"]},"update_date":"10/14/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0054-0370-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"07/27/2026","update_type":"New","initial_posting_date":"07/27/2026","package_ndc":"0173-0716-22","generic_name":"Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered","contact_info":"888-825-5249","related_info":"The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026.  The 120 dose presentation of this product will still be available.","openfda":{"application_number":["NDA021254"],"brand_name":["ADVAIR HFA"],"generic_name":["FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"],"manufacturer_name":["GlaxoSmithKline LLC"],"product_ndc":["0173-0716","0173-0715","0173-0717"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RESPIRATORY (INHALATION)"],"substance_name":["FLUTICASONE PROPIONATE","SALMETEROL XINAFOATE"],"rxcui":["896231","896235","896236","896237","896239","896243","896244","896245","896267","896271","896272","896273"],"spl_id":["bea52e57-aa75-4dce-8cfb-a163bbc22be2"],"spl_set_id":["dfaca6f9-3277-47b2-319d-1377917cb54c"],"package_ndc":["0173-0715-20","0173-0715-22","0173-0716-20","0173-0716-22","0173-0717-20","0173-0717-22"],"unii":["6EW8Q962A5","O2GMZ0LF5W"]},"update_date":"07/27/2026","therapeutic_category":["Pulmonary/Allergy"],"presentation":"Advair HFA, Aerosol, Metered, 115 ug; 21 ug (NDC 0173-0716-22)","company_name":"GlaxoSmithKline","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"0093-3212-01","generic_name":"Clonazepam Tablet","contact_info":"800-545-8800","resolved_note":"Available","openfda":{"application_number":["ANDA074569"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-3212","0093-0832","0093-3213"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["d6abe4e3-7699-4ead-95f4-739a961b23ad"],"spl_set_id":["8069b1a0-7c06-4252-b44e-e2eef065d9b8"],"package_ndc":["0093-0832-01","0093-0832-05","0093-3212-01","0093-3212-05","0093-3213-01","0093-3213-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 0093-3212-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"0143-9251-10","generic_name":"Rocuronium Bromide Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be available. Product will be made available as it is released.","openfda":{"application_number":["ANDA204679"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9251","0143-9250"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["51fc5473-b651-4c85-83ff-7edc65a6cef2"],"spl_set_id":["d3a172a5-01ab-47d8-92ac-a8539b1d4dc4"],"package_ndc":["0143-9250-01","0143-9250-10","0143-9251-01","0143-9251-10"],"unii":["I65MW4OFHZ"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9251-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-285-20","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-285","63323-286","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0406-5112-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA211840"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-5112","0406-5111","0406-5113","0406-5114","0406-5115","0406-5116","0406-5117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["77f4cd3a-dca3-4995-8992-042e1dc91a00"],"spl_set_id":["806a1c15-0842-4787-b2ad-09a21fd96b37"],"package_ndc":["0406-5111-01","0406-5112-01","0406-5113-01","0406-5114-01","0406-5115-01","0406-5116-01","0406-5117-01"],"unii":["SJT761GEGS"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0406-5112-01)","company_name":"SpecGx LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"0409-3299-05","generic_name":"Sodium Acetate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018893"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3299"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["237371"],"spl_id":["4e6137c2-6b7c-4882-985c-03b591b6c046","b7a713f4-3c97-484b-b182-2824e1e944bb"],"spl_set_id":["abc41ed1-9512-4bea-9295-1a9ca134b6c2","c3be2468-45e8-4ecc-a30b-e966743a563f"],"package_ndc":["0409-3299-15","0409-3299-05","0409-3299-16","0409-3299-06","0409-3299-45","0409-3299-25","0409-3299-46","0409-3299-26"],"unii":["NVG71ZZ7P0"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"12/01/2025","update_type":"New","initial_posting_date":"12/01/2025","package_ndc":"66993-212-38","generic_name":"Nilutamide Tablet","contact_info":"847-283-7921","related_info":"Product to expire in March 2026; Discontinuation of the manufacture of the drug","update_date":"12/01/2025","therapeutic_category":["Oncology"],"dosage_form":"Tablet","presentation":"Nilandron, Tablet, 150 mg (NDC 66993-212-38)","company_name":"Advanz Pharma (US) Corp.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"13107-072-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(866) 850-2876 OR CustomerService@AurobindoUSA.com","availability":"Unavailable","related_info":"Estimated availability: April 2027","openfda":{"application_number":["ANDA202424"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Aurolife Pharma, LLC"],"product_ndc":["13107-072","13107-068","13107-069","13107-070","13107-071","13107-073","13107-074"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["44a9eb77-0896-4b62-9953-7121d97d6ffd"],"spl_set_id":["a582d57f-d191-4ca5-b105-585b2d8a0e3e"],"package_ndc":["13107-068-50","13107-068-01","13107-068-25","13107-068-05","13107-068-99","13107-069-50","13107-069-01","13107-069-25","13107-069-05","13107-069-99","13107-070-50","13107-070-01","13107-070-25","13107-070-05","13107-070-99","13107-071-50","13107-071-01","13107-071-25","13107-071-05","13107-071-99","13107-072-50","13107-072-01","13107-072-25","13107-072-05","13107-072-99","13107-073-50","13107-073-01","13107-073-25","13107-073-05","13107-073-99","13107-074-50","13107-074-01","13107-074-25","13107-074-05","13107-074-99"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/04/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 13107-072-01)","company_name":"Aurobindo Pharma USA","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"65219-281-02","generic_name":"Gadobutrol Injection","contact_info":"888-386-1300","related_info":"Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA","openfda":{"application_number":["ANDA215061"],"brand_name":["GADOBUTROL"],"generic_name":["GADOBUTROL"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-281"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOBUTROL"],"spl_id":["490c8c3e-3195-40af-8f34-40d8df2719c3"],"spl_set_id":["007696d0-4b62-4937-9640-4ad619504df4"],"package_ndc":["65219-281-00","65219-281-02","65219-281-03","65219-281-07","65219-281-08","65219-281-10","65219-281-05","65219-281-15"],"nui":["N0000183362","N0000175862"],"pharm_class_epc":["Gadolinium-based Contrast Agent [EPC]"],"pharm_class_moa":["Magnetic Resonance Contrast Activity [MoA]"],"unii":["1BJ477IO2L"]},"update_date":"06/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-02)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"0009-0870-26","generic_name":"Clindamycin Phosphate Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050441"],"brand_name":["CLEOCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0870","0009-0775","0009-0902","0009-0728","0009-3124","0009-3447","0009-3381","0009-3375","0009-3382","0009-6582"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309339","685574","685576","685578","706461","1737244","1737245","1737578","1737579","1737581","1737582","205964","309335","309336"],"spl_id":["fa11e62e-4625-4e9c-8676-f318b1cb890f"],"spl_set_id":["05a75685-0af5-407c-ac57-e380c882b49d"],"package_ndc":["0009-0870-21","0009-0870-26","0009-0775-20","0009-0775-26","0009-0902-11","0009-0902-18","0009-0728-05","0009-0728-09","0009-3124-01","0009-3124-03","0009-3447-01","0009-3447-03","0009-3381-01","0009-3381-02","0009-3375-01","0009-3375-02","0009-3382-01","0009-3382-02","0009-6582-02","0009-6582-01"],"unii":["EH6D7113I8"]},"update_date":"06/01/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial (NDC 0009-0870-26)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"02/27/2026","update_type":"New","initial_posting_date":"02/27/2026","package_ndc":"53746-468-19","generic_name":"Clindamycin Palmitate Hydrochloride Injection","contact_info":"866-525-7270","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA203513"],"brand_name":["CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC)"],"generic_name":["CLINDAMYCIN PALMITATE HYDROCHLORIDE"],"manufacturer_name":["Amneal Pharmaceuticals of New York LLC"],"product_ndc":["53746-468"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLINDAMYCIN PALMITATE HYDROCHLORIDE"],"rxcui":["562266"],"spl_id":["bacc9e9f-6a9f-4a68-b2ec-131ed86205ec"],"spl_set_id":["faf67eb8-1fd7-4b2c-a55b-24ba664c0dce"],"package_ndc":["53746-468-19"],"unii":["VN9A8JM7M7"]},"update_date":"02/27/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)","company_name":"Amneal Pharmaceuticals","status":"To Be Discontinued"},{"discontinued_date":"03/10/2026","update_type":"New","initial_posting_date":"03/10/2026","package_ndc":"46163-206-92","generic_name":"Peritoneal Dialysis Solution","contact_info":"800-323-5188","related_info":"The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.","openfda":{"application_number":["NDA020171"],"brand_name":["DELFLEX"],"generic_name":["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"],"manufacturer_name":["Fresenius Medical Care de Mexico, S.A. de C.V."],"product_ndc":["46163-206","46163-209","46163-212"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"spl_id":["5f14959c-adcd-923c-e063-6294a90ab6de"],"spl_set_id":["a98facd6-9daa-4d37-8209-63a0599dbfaa"],"package_ndc":["46163-209-92","46163-209-94","46163-209-95","46163-212-95","46163-212-92","46163-212-94","46163-206-92","46163-206-94","46163-206-95"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"03/10/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2L, 5/cs (NDC 46163-206-92)","company_name":"Fresenius Medical Care North America","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"05/03/2022","package_ndc":"17478-050-01","generic_name":"Sufentanil Citrate Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Not currently manufactured","update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"08/13/2026","update_type":"New","initial_posting_date":"08/13/2026","package_ndc":"65649-400-01","generic_name":"Polyethylene glycol 3350, Sodium Ascorbate, Sodium Sulfate Anhydrous, Ascorbic Acid, Sodium Chloride, and Potassium Chloride  Oral Solution","contact_info":"800-321-4576","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA209381"],"brand_name":["PLENVU"],"generic_name":["POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE"],"manufacturer_name":["Salix Pharmaceuticals, Inc"],"product_ndc":["65649-400"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["2045233","2045243","2045244","2045245"],"spl_id":["4919e150-c34f-4ad3-8137-42f8cf91b997"],"spl_set_id":["79f930fa-5674-4f30-8ae8-9448d6243797"],"package_ndc":["65649-400-02","65649-400-01"]},"update_date":"08/13/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Oral Solution","presentation":"Plenvu, Oral Solution, KIT (NDC 65649-400-01)","company_name":"Salix Pharmaceuticals, a division of Bausch Health US, LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"0527-4662-37","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-4662","0527-4661","0527-4663","0527-4664","0527-4665","0527-4666","0527-4667"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["164b5658-3c14-44f5-b10a-839909184984"],"spl_set_id":["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"],"package_ndc":["0527-4661-37","0527-4662-37","0527-4663-37","0527-4664-37","0527-4665-37","0527-4666-37","0527-4667-37"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0527-4662-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"discontinued_date":"08/10/2026","update_type":"New","initial_posting_date":"08/10/2026","package_ndc":"0093-9364-10","generic_name":"Glyburide Tablet","contact_info":"800-633-1610","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017532"],"brand_name":["GLYBURIDE"],"generic_name":["GLYBURIDE"],"manufacturer_name":["TEVA Pharmaceuticals USA Inc"],"product_ndc":["0093-9364","0093-9477","0093-9433"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GLYBURIDE"],"rxcui":["197737","310534","310537"],"spl_id":["84b83205-8813-494e-933e-a70697393744"],"spl_set_id":["50d16f1d-c814-4411-8749-62561321ecce"],"package_ndc":["0093-9477-53","0093-9433-01","0093-9433-05","0093-9364-01","0093-9364-05","0093-9364-10"],"nui":["N0000175608","M0020795"],"pharm_class_epc":["Sulfonylurea [EPC]"],"pharm_class_cs":["Sulfonylurea Compounds [CS]"],"unii":["SX6K58TVWC"]},"update_date":"08/10/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Diabeta, Tablet, 5 mg (NDC 0093-9364-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"43547-407-50","generic_name":"Clonazepam Tablet","contact_info":"For orders, Solco Healthcare 866-931-9829","resolved_note":"Available","openfda":{"application_number":["ANDA077856"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Solco Healthcare LLC"],"product_ndc":["43547-407","43547-406","43547-408"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["dc17b9d4-2890-4f6c-8476-daa39d0cbc9c"],"spl_set_id":["4acbb7a9-4db5-4497-b8db-9f358b3f6fb4"],"package_ndc":["43547-406-10","43547-406-50","43547-406-11","43547-407-10","43547-407-50","43547-407-11","43547-408-10","43547-408-50"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 43547-407-50)","company_name":"Prinston Pharmaceutical, Inc.","status":"Resolved"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"43547-406-50","generic_name":"Clonazepam Tablet","contact_info":"For orders, Solco Healthcare 866-931-9829","resolved_note":"Available","openfda":{"application_number":["ANDA077856"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Solco Healthcare LLC"],"product_ndc":["43547-406","43547-407","43547-408"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["dc17b9d4-2890-4f6c-8476-daa39d0cbc9c"],"spl_set_id":["4acbb7a9-4db5-4497-b8db-9f358b3f6fb4"],"package_ndc":["43547-406-10","43547-406-50","43547-406-11","43547-407-10","43547-407-50","43547-407-11","43547-408-10","43547-408-50"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 43547-406-50)","company_name":"Prinston Pharmaceutical, Inc.","status":"Resolved"},{"discontinued_date":"01/30/2026","update_type":"New","initial_posting_date":"01/30/2026","package_ndc":"57664-655-88","generic_name":"Pindolol Tablet","contact_info":"800-818-4555","related_info":"Discontinuation of the manufacture of the drug; Expiry date of last distributed batch January 2027","openfda":{"application_number":["ANDA074063"],"brand_name":["PINDOLOL"],"generic_name":["PINDOLOL"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-655","57664-656"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["PINDOLOL"],"rxcui":["198104","198105"],"spl_id":["4d3c89dd-e947-5f23-e063-6294a90aeb1f"],"spl_set_id":["b331a73f-bf7b-4442-8901-36d016530279"],"package_ndc":["57664-656-88","57664-655-88"],"nui":["N0000000161","N0000175556"],"pharm_class_moa":["Adrenergic beta-Antagonists [MoA]"],"pharm_class_epc":["beta-Adrenergic Blocker [EPC]"],"unii":["BJ4HF6IU1D"]},"update_date":"01/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Pindolol, Tablet, 5 mg (NDC 57664-655-88)","company_name":"Sun Pharmaceutical Industries, Inc.","status":"To Be Discontinued"},{"discontinued_date":"04/15/2026","update_type":"New","initial_posting_date":"04/15/2026","package_ndc":"0093-8076-56","generic_name":"Tiagabine Hydrochloride Tablet","contact_info":"888-838-2872","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Tiagabine Hydrochloride, Tablet, 16mg 30 count (NDC 0093-8076-56)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/01/2020","package_ndc":"16729-484-90","generic_name":"Atropine Sulfate Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA212868"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Accord Healthcare, Inc.,"],"product_ndc":["16729-484","16729-483"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190546","1190551","1190552"],"spl_id":["4082a1cf-1e1b-6f40-e063-6294a90aec06"],"spl_set_id":["c82cb295-ffce-47d6-97ad-a8aa723f4e4f"],"package_ndc":["16729-483-03","16729-483-31","16729-484-90","16729-484-31","16729-484-45","16729-484-03"],"unii":["03J5ZE7KA5"]},"update_date":"10/17/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, .1 mg/1 mL (NDC 16729-484-90)","company_name":"Accord Healthcare Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"43547-604-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-931-9829","availability":"Limited Availability","related_info":"On allocation","openfda":{"application_number":["ANDA216266"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE CAPSULES"],"manufacturer_name":["Solco Healthcare US,LLC"],"product_ndc":["43547-604","43547-602","43547-603","43547-605","43547-606","43547-607","43547-608"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["d6435613-e052-4b4f-8bf7-4acb7458d8df"],"spl_set_id":["68b10d9f-ca3e-493d-a309-45f1d7e08061"],"package_ndc":["43547-602-10","43547-603-10","43547-604-10","43547-605-10","43547-606-10","43547-607-10","43547-608-10"],"unii":["SJT761GEGS"]},"update_date":"06/29/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 43547-604-10)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"06/12/2026","package_ndc":"0143-9531-01","generic_name":"Ifosfamide Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Additional lots will be available in the November 2026 timeframe.  Product will be made available as it is released.","openfda":{"application_number":["ANDA076619"],"brand_name":["IFOSFAMIDE"],"generic_name":["IFOSFAMIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9531","0143-9530"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IFOSFAMIDE"],"rxcui":["1791597","1791599"],"spl_id":["517c3bf6-41f5-4199-a17e-1f46b120cb1e"],"spl_set_id":["c90ab05f-8fe5-437e-a1c0-8b11ef63291e"],"package_ndc":["0143-9531-01","0143-9530-01"],"nui":["N0000000236","N0000175558"],"pharm_class_moa":["Alkylating Activity [MoA]"],"pharm_class_epc":["Alkylating Drug [EPC]"],"unii":["UM20QQM95Y"]},"update_date":"10/14/2026","therapeutic_category":["Oncology","Pediatric"],"dosage_form":"Injection","presentation":"Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9531-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/12/2021","package_ndc":"0053-6871-00","generic_name":"Desmopressin Acetate Spray","contact_info":"888-337-7464","availability":"Unavailable","related_info":"Estimated recovery: TBD","update_date":"05/01/2026","therapeutic_category":["Hematology"],"dosage_form":"Spray","presentation":"Stimate, Spray, 1.5 mg/1 mL (NDC 0053-6871-00)","company_name":"Ferring","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/03/2023","package_ndc":"81665-104-96","generic_name":"Cromolyn Sodium Concentrate","contact_info":"Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 or customerservice@omniviumpharma.com","availability":"Available","related_info":"Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195","openfda":{"application_number":["ANDA209264"],"brand_name":["CROMOLYN SODIUM"],"generic_name":["CROMOLYN SODIUM"],"manufacturer_name":["Omnivium Pharmaceuticals LLC"],"product_ndc":["81665-104"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CROMOLYN SODIUM"],"rxcui":["831261"],"spl_id":["fd09b0f1-907c-4d4d-a693-9756efd60f20"],"spl_set_id":["a742664b-265e-49f9-9744-d04e1fb620ae"],"package_ndc":["81665-104-96"],"unii":["Q2WXR1I0PK"]},"update_date":"11/02/2026","therapeutic_category":["Pulmonary/Allergy"],"dosage_form":"Concentrate","presentation":"Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 81665-104-96)","company_name":"Ailex Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/28/2022","package_ndc":"72078-034-01","generic_name":"Remifentanil Hydrochloride Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["NDA020630"],"brand_name":["ULTIVA"],"generic_name":["REMIFENTANIL HYDROCHLORIDE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["72078-034","72078-035","72078-036"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["REMIFENTANIL HYDROCHLORIDE"],"rxcui":["1729578","1729581","1729584","1729586","1729710","1729712"],"spl_id":["f41b6542-9305-43e7-bbbc-52c7ee2cb0dc"],"spl_set_id":["8b4c8696-e23e-4c51-a4d2-babab5bd945a"],"package_ndc":["72078-034-00","72078-034-01","72078-035-00","72078-035-02","72078-036-00","72078-036-05"],"unii":["5V444H5WIC"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ultiva, Injection, 1 mg/1 mL (NDC 72078-034-01)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-472-17","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA070554"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-472","63323-463","63323-461","63323-468"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012413","1012417","1724786","1724787","1724809","1724810","1867594","1867596","1867618","1867620"],"spl_id":["cc1f6507-eb3e-4398-a1d3-0c56a2099e6b"],"spl_set_id":["bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb"],"package_ndc":["63323-472-03","63323-472-17","63323-472-01","63323-472-37","63323-463-01","63323-463-57","63323-461-01","63323-461-57","63323-468-02","63323-468-37","63323-468-01","63323-468-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/21/2023","package_ndc":"0641-0929-25","generic_name":"Promethazine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA083312"],"brand_name":["PROMETHAZINE HYDROCHLORIDE"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-0929","0641-0928"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992460","992858"],"spl_id":["9f14d3f5-ad01-44b5-a2b7-16ed5f501f87"],"spl_set_id":["4bf3912c-8339-401e-9711-dad6acf15f11"],"package_ndc":["0641-0928-21","0641-0928-25","0641-0929-21","0641-0929-25"],"unii":["R61ZEH7I1I"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Pediatric","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-0929-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"72205-132-91","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"(855) 668-2369; customerservice@novadozpharma.com","availability":"Available","openfda":{"application_number":["ANDA218306"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-132","72205-133","72205-134","72205-135","72205-136","72205-137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"spl_set_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"package_ndc":["72205-132-91","72205-133-91","72205-134-91","72205-135-91","72205-136-91","72205-137-91"],"unii":["SJT761GEGS"]},"update_date":"09/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91)","company_name":"Novadoz Pharmaceuticals LLC","status":"Current"},{"discontinued_date":"02/27/2026","update_type":"New","initial_posting_date":"02/27/2026","package_ndc":"50458-290-01","generic_name":"Itraconazole Capsule","contact_info":"800-JANSSEN (1-800-526-7736)","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020083"],"brand_name":["SPORANOX"],"generic_name":["ITRACONAZOLE"],"manufacturer_name":["Janssen Pharmaceuticals, Inc."],"product_ndc":["50458-290"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ITRACONAZOLE"],"rxcui":["311204","833164"],"spl_id":["a79c080b-711a-4a15-af92-ff0c60cbfdf1"],"spl_set_id":["a4d555fa-787c-40fb-bb7d-b0d4f7318fd0"],"package_ndc":["50458-290-01","50458-290-04","50458-290-28"],"nui":["N0000175487","M0002083","N0000182141","N0000185503","N0000190113"],"pharm_class_epc":["Azole Antifungal [EPC]"],"pharm_class_cs":["Azoles [CS]"],"pharm_class_moa":["Cytochrome P450 3A4 Inhibitors [MoA]","P-Glycoprotein Inhibitors [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]"],"unii":["304NUG5GF4"]},"update_date":"02/27/2026","therapeutic_category":["Anti-Infective","Other"],"dosage_form":"Capsule","presentation":"Sporanox, Capsule, 100 mg (NDC 50458-290-01)","company_name":"Janssen Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/08/2019","package_ndc":"63323-165-01","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA084916"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-165"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["1116927","1812194"],"spl_id":["1815f54a-5637-45bc-a582-3e62350935ba","9dd90418-e564-4bc5-9077-506a1c2c1bce"],"spl_set_id":["2b626a48-c7aa-4443-9164-a08ff069ccd1","4fedef4f-ec96-4f36-b2f0-01e243e3b89e"],"package_ndc":["63323-165-11","63323-165-51","63323-165-13","63323-165-53","63323-165-02","63323-165-01","63323-165-03","63323-165-05","63323-165-30","63323-165-16","63323-165-26"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-01)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"05/27/2026","update_type":"New","initial_posting_date":"05/27/2026","package_ndc":"16729-710-45","generic_name":"Dehydrated Alcohol Injection, Solution","contact_info":"866-941-7875","related_info":"Accord is transitioning to the 5-pack configuration (NDC 16729-710-53).","openfda":{"application_number":["ANDA217845"],"brand_name":["DEHYDRATED ALCOHOL"],"generic_name":["ALCOHOL"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-710"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERCUTANEOUS"],"substance_name":["ALCOHOL"],"rxcui":["2048982"],"spl_id":["52566f68-6e40-af49-e063-6394a90a01ad"],"spl_set_id":["07fa92f7-d752-42e3-a572-b552461c4389"],"package_ndc":["16729-710-31","16729-710-53","16729-710-45"],"unii":["3K9958V90M"]},"update_date":"05/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dehydrated Alcohol, Injection, Solution, 1 mL/1 mL (10 pack) (NDC 16729-710-45)","company_name":"Accord Healthcare Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/26/2024","package_ndc":"70726-0304-1","generic_name":"Riluzole Oral Suspension","related_info_link":"https://www.fda.gov/media/185611/download?attachment","contact_info":"610-937-6172","availability":"Available","openfda":{"brand_name":["TEGLUTIK"],"generic_name":["RILUZOLE"],"manufacturer_name":["EDW PHARMA, INC"],"product_ndc":["70726-0304"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RILUZOLE"],"rxcui":["2058147","2675565"],"spl_id":["4746bd79-5116-423c-e063-6394a90a17e1"],"spl_set_id":["0f2b5cfc-a23d-699a-e063-6394a90a67d1"],"package_ndc":["70726-0304-1"],"nui":["N0000175740","M0483511"],"pharm_class_epc":["Benzothiazole [EPC]"],"pharm_class_cs":["Benzothiazoles [CS]"],"unii":["7LJ087RS6F"]},"update_date":"10/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Oral Suspension","presentation":"Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0304-1)","company_name":"EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"70069-752-25","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA217792"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-752","70069-753"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["2b24af95-6f20-4945-bf8c-742f1d6f2721"],"spl_set_id":["bcaab86f-20f0-4482-8d73-e29b36dced58"],"package_ndc":["70069-752-25","70069-752-10","70069-752-01","70069-753-25","70069-753-01","70069-753-10"],"unii":["7TQO7W3VT8"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"63323-426-10","generic_name":"Rocuronium Bromide Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA078651"],"brand_name":["ROCURONIUM"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-426"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["d6e2ff8d-838d-4c27-8e73-230548b09d63","3f4d5e11-2c14-4406-8954-04dba2fc65ff"],"spl_set_id":["f1933332-1ae0-4dc1-be4c-694849e6c9f9","fb9524b2-c353-4747-8954-7ca2529eabb2"],"package_ndc":["63323-426-02","63323-426-05","63323-426-01","63323-426-10","63323-426-12","63323-426-15"],"unii":["I65MW4OFHZ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"05/30/2025","package_ndc":"0641-6053-25","generic_name":"Meperidine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["ANDA080445"],"brand_name":["MEPERIDINE HYDROCHLORIDE"],"generic_name":["MEPERIDINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6053","0641-6054","0641-6052"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["MEPERIDINE HYDROCHLORIDE"],"rxcui":["861476","1665685","1665697"],"spl_id":["9566d54d-7343-4695-94ff-8b5f2d384c81"],"spl_set_id":["e0e998da-f056-4fce-be8e-ed60cf3b461b"],"package_ndc":["0641-6053-01","0641-6053-25","0641-6054-01","0641-6054-25","0641-6052-01","0641-6052-25"],"unii":["N8E7F7Q170"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Meperidine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-6053-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0555-0971-02","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0555-0971","0555-0775","0555-0972","0555-0776","0555-0777","0555-0973","0555-0974"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"],"spl_set_id":["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"],"package_ndc":["0555-0971-02","0555-0775-02","0555-0972-02","0555-0776-02","0555-0777-02","0555-0973-02","0555-0974-02"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0555-0971-02)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"70121-1389-7","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA207551"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["70121-1389","70121-1388"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["af193b53-1488-401f-8f06-cc193297c4a8"],"spl_set_id":["eb1ba463-ab42-4f49-9ebe-3ad5af108326"],"package_ndc":["70121-1388-1","70121-1388-8","70121-1389-1","70121-1389-7"],"unii":["1018WH7F9I"]},"update_date":"10/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"67457-924-50","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA212571"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-924","67457-925"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["e4cda7fa-dac8-4de7-abc1-d1fd622795d8"],"spl_set_id":["f140de5a-f13d-46b4-a742-049c63e474f5"],"package_ndc":["67457-924-00","67457-924-50","67457-925-00","67457-925-10"],"unii":["1018WH7F9I"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-286-20","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-286","63323-285","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cb6583ff-cde4-4280-aa5b-0bea2b844792","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","cb6583ff-cde4-4280-aa5b-0bea2b844792","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-51","63323-286-55","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 5 mg/1 mL (NDC 63323-286-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"discontinued_date":"12/04/2025","update_type":"New","initial_posting_date":"12/04/2025","package_ndc":"0093-7353-01","generic_name":"Calcitriol Capsule","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug","openfda":{"application_number":["ANDA075765"],"brand_name":["CALCITRIOL"],"generic_name":["CALCITRIOL"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-7353","0093-7352"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CALCITRIOL"],"rxcui":["308867","308868"],"spl_id":["9e6df585-e3d1-4a89-bc02-8e4b223578c4"],"spl_set_id":["ec93b667-aad2-4e3a-adc6-952f070a0c0a"],"package_ndc":["0093-7352-01","0093-7353-01"],"nui":["M0004229","N0000175908"],"pharm_class_cs":["Cholecalciferol [CS]"],"pharm_class_epc":["Vitamin D3 Analog [EPC]"],"unii":["FXC9231JVH"]},"update_date":"12/04/2025","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Capsule","presentation":"Calcitriol, Capsule, .5 ug (NDC 0093-7353-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-061-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1019","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-061","70069-062","70069-063","70069-064","70069-065","70069-066","70069-067"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-10)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"0703-3675-01","generic_name":"Methotrexate Sodium Injection","contact_info":"800-545-8800","availability":"Unavailable","related_info":"Estimated Recovery: Novemeber 2026","openfda":{"application_number":["ANDA040843"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-3675","0703-3671","0703-3678"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL","INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1655956","1655959","1655960"],"spl_id":["e81074cc-12b4-4ac9-a5bb-749188989b2c"],"spl_set_id":["346ec9ce-dc98-4a55-b55e-d3af11f2d703"],"package_ndc":["0703-3671-01","0703-3675-01","0703-3678-01"],"unii":["3IG1E710ZN"]},"update_date":"11/02/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3675-01)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/14/2018","package_ndc":"65282-1605-1","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"978-657-0889 ext. 5231","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA208017"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"manufacturer_name":["Spectra Medical Devices, LLC"],"product_ndc":["65282-1605"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1737566"],"spl_id":["447bfde4-fff3-32a6-e063-6394a90a667e"],"spl_set_id":["e8ba012a-08a9-4f67-9f88-3284377e80be"],"package_ndc":["65282-1605-1"],"unii":["EC2CNF7XFP"]},"update_date":"10/08/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1)","company_name":"Spectra Medical Devices, LLC","shortage_reason":"Other","status":"Current"},{"discontinued_date":"04/21/2026","update_type":"New","initial_posting_date":"04/21/2026","package_ndc":"16729-239-93","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"866-941-7875, option 2","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA204023"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-239"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710"],"spl_id":["2de0daf8-b7a3-1dca-e063-6394a90a4d0a"],"spl_set_id":["2b9881f0-4a66-660f-e054-00144ff88e88"],"package_ndc":["16729-239-30","16729-239-93"],"unii":["1018WH7F9I"]},"update_date":"04/21/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)","company_name":"Accord Healthcare Inc.","status":"To Be Discontinued"},{"discontinued_date":"06/05/2026","update_type":"New","initial_posting_date":"06/05/2026","package_ndc":"71225-126-06","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"800-461-7449","related_info":"Discontinuation of the manufacture of the drug","update_date":"06/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06)","company_name":"Slayback Pharma","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-287-21","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-287","63323-286","63323-288","63323-285"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","905191","1734084","1734086","1734090","1734091","1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484"],"spl_id":["cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9"],"spl_set_id":["23d2d448-a744-4877-9f2d-7e57c198da89"],"package_ndc":["63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-21)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0424-51","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020183"],"brand_name":["DIANEAL LOW CALCIUM WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0424","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0424-51)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/01/2017","package_ndc":"0409-5555-01","generic_name":"Sodium Bicarbonate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: July 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA202981"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-5555"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["1868469"],"spl_id":["e3a44e63-8594-40b6-a3fa-d135b3149661","bcb3a2dc-1a3f-4ac7-8ea2-426f0771c246"],"spl_set_id":["0c24b592-4bc8-456f-acac-9c9525844a06","ea9f4498-0d43-4043-8dd1-f22537841c21"],"package_ndc":["0409-5555-11","0409-5555-01","0409-5555-12","0409-5555-02"],"unii":["8MDF5V39QO"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"25021-821-05","generic_name":"Methylprednisolone Acetate Injection","contact_info":"866-625-1618","availability":"Unavailable","related_info":"Estimated recovery: April 2027","openfda":{"application_number":["ANDA201835"],"brand_name":["METHYLPREDNISOLONE ACETATE"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-821","25021-820"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358610","1358617"],"spl_id":["f73618f0-0723-4d8b-8a8d-b9081acb44f9"],"spl_set_id":["f98314ea-a4e4-4f78-987b-3e9b45a08bb4"],"package_ndc":["25021-820-05","25021-820-10","25021-821-05"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 25021-821-05)","company_name":"Sagent Pharmaceuticals","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-492-57","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487","63323-493","63323-496"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029","1737636","1737637","1737640","1737641","1737763","1737764"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33","fa12a8e8-09fd-496f-8cc6-ffe0eb02e2df"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74","d5e0d06f-ba1e-44d4-aa89-39d6c146dc23"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26","63323-492-08","63323-492-97","63323-493-03","63323-493-97","63323-493-01","63323-493-91","63323-496-03","63323-496-97"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-57)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"70121-1389-1","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA207551"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["70121-1389","70121-1388"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["af193b53-1488-401f-8f06-cc193297c4a8"],"spl_set_id":["eb1ba463-ab42-4f49-9ebe-3ad5af108326"],"package_ndc":["70121-1388-1","70121-1388-8","70121-1389-1","70121-1389-7"],"unii":["1018WH7F9I"]},"update_date":"10/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0781-3495-95","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"See Related Information section below for customer service information","availability":"Available","related_info":"Marketed by Sandoz Inc.; Customer service: 800-525-8747","openfda":{"application_number":["ANDA209065"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"manufacturer_name":["Sandoz Inc."],"product_ndc":["0781-3495","0781-3493","0781-3494"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718900","1718906","1718909"],"spl_id":["5a0d944c-af38-a3fd-e063-6294a90aed62"],"spl_set_id":["809e8f77-390f-4cc8-8c8a-4f67a249c9df"],"package_ndc":["0781-3493-95","0781-3494-95","0781-3495-95"],"unii":["1018WH7F9I"]},"update_date":"10/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0338-0004-03","generic_name":"Sterile Water Irrigant","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA017428"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0004","0338-0003"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["IRRIGATION"],"substance_name":["WATER"],"rxcui":["150985"],"spl_id":["97390588-b679-4caa-b7f3-3d2e11074d0e"],"spl_set_id":["ef3e79c5-3f58-4b36-a296-64b7d9a651c1"],"package_ndc":["0338-0003-44","0338-0003-46","0338-0003-47","0338-0004-02","0338-0004-03","0338-0004-04","0338-0004-05"],"unii":["059QF0KO0R"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology","Other","Pediatric"],"dosage_form":"Irrigant","presentation":"Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-03)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"05/06/2026","update_type":"New","initial_posting_date":"05/06/2026","package_ndc":"0409-1208-01","generic_name":"Cisatracurium Besylate Injection","contact_info":"844-646-4398","related_info":"Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA203238"],"brand_name":["CISATRACURIUM BESYLATE"],"generic_name":["CISATRACURIUM BESYLATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1208","0409-1098","0409-1103"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CISATRACURIUM BESYLATE"],"rxcui":["199211","199212","1730194"],"spl_id":["55a7aed0-96b5-426a-a234-0a4418ade4f2"],"spl_set_id":["67908e20-044d-454d-9c51-bf106e817bd0"],"package_ndc":["0409-1098-12","0409-1098-02","0409-1103-11","0409-1103-01","0409-1208-11","0409-1208-01"],"unii":["80YS8O1MBS"]},"update_date":"05/06/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Cisatracurium Besylate, Injection, 20 mg/10 mL (2 mg/mL) Multidose Vial (NDC 0409-1208-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"discontinued_date":"04/15/2026","update_type":"New","initial_posting_date":"04/15/2026","package_ndc":"0093-5031-56","generic_name":"Tiagabine Hydrochloride Tablet","contact_info":"888-838-2872","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Tiagabine Hydrochloride, Tablet, 4mg 30 count (NDC 0093-5031-56)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/13/2022","package_ndc":"0409-0152-24","generic_name":"Metronidazole Injection","contact_info":"Sagent: 866-625-1618","availability":"Limited Availability","related_info":"Labeler: Hospira Inc.","openfda":{"application_number":["ANDA206191"],"brand_name":["METRONIDAZOLE"],"generic_name":["METRONIDAZOLE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-0152"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["METRONIDAZOLE"],"spl_id":["40e1e910-88a9-45f1-8165-10966a0ede9e"],"spl_set_id":["49360d6f-c8b3-420e-af75-154cf7b05255"],"package_ndc":["0409-0152-01","0409-0152-24"],"nui":["N0000175435","M0014907"],"pharm_class_epc":["Nitroimidazole Antimicrobial [EPC]"],"pharm_class_cs":["Nitroimidazoles [CS]"],"unii":["140QMO216E"]},"update_date":"11/02/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Metronidazole in Flexible Container, Injection, 500 mg/100 mL (NDC 0409-0152-24)","company_name":"InfoRLife SA","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"47781-563-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA214547"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-563","47781-562","47781-564","47781-565","47781-566","47781-567","47781-568"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["db02ec6b-f17f-ab22-b671-e1ddb90e017c"],"spl_set_id":["7f2dd6ee-3363-c87c-9693-ed838942556c"],"package_ndc":["47781-562-01","47781-563-01","47781-564-01","47781-565-01","47781-566-01","47781-567-01","47781-568-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 47781-563-01)","company_name":"Alvogen","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/14/2022","package_ndc":"65219-464-50","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA207449"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["FRESENIUS KABI USA, LLC"],"product_ndc":["65219-464","65219-456","65219-458","65219-460","65219-462"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795607","1795609","1795610","1795612","1795616"],"spl_id":["efc3b0c9-518a-47db-bb3e-ebdfd4646e9b"],"spl_set_id":["576a22d8-5f2f-497e-80ad-1842ca74bb53"],"package_ndc":["65219-456-05","65219-456-60","65219-464-05","65219-464-50","65219-458-05","65219-458-30","65219-460-05","65219-460-20","65219-462-05","65219-462-10"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-464-50)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"11534-193-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"732-382-6085 Monday to Friday 9 am to 3:45 pm","availability":"Available","openfda":{"application_number":["ANDA209799"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SUNRISE PHARMACEUTICAL, INC."],"product_ndc":["11534-193","11534-190","11534-191","11534-192","11534-194","11534-195","11534-196"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["60dcfbf6-d07a-4010-ae77-8a9ae4529828"],"spl_set_id":["ac102599-3a5b-4154-899e-6ff262be7ff7"],"package_ndc":["11534-190-01","11534-190-03","11534-191-01","11534-191-03","11534-192-01","11534-192-03","11534-193-01","11534-193-03","11534-194-01","11534-194-03","11534-195-01","11534-195-03","11534-196-01","11534-196-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/01/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 11534-193-01)","company_name":"Sunrise Pharmaceutical, Inc.","status":"Current"},{"discontinued_date":"11/05/2026","update_type":"New","initial_posting_date":"11/05/2026","package_ndc":"66302-467-60","generic_name":"Tadalafil Tablet","contact_info":"844-864-8437 or 800-545-5979","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA022332"],"brand_name":["ADCIRCA"],"generic_name":["TADALAFIL"],"manufacturer_name":["United Therapeutics Corporation"],"product_ndc":["66302-467"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["TADALAFIL"],"rxcui":["849866","2123194"],"spl_id":["76c30323-0981-499c-b552-1a43f01c89c8"],"spl_set_id":["ff61b237-be8e-461b-8114-78c52a8ad0ae"],"package_ndc":["66302-467-60"],"nui":["N0000175599","N0000020026"],"pharm_class_epc":["Phosphodiesterase 5 Inhibitor [EPC]"],"pharm_class_moa":["Phosphodiesterase 5 Inhibitors [MoA]"],"unii":["742SXX0ICT"]},"update_date":"11/05/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Adcirca, Tablet, 20 mg (NDC 66302-467-60)","company_name":"Eli Lilly and Co.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/21/2023","package_ndc":"0009-0775-26","generic_name":"Clindamycin Phosphate Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d","contact_info":"800-533-4535","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA050441"],"brand_name":["CLEOCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0775","0009-0870","0009-0902","0009-0728","0009-3124","0009-3447","0009-3381","0009-3375","0009-3382","0009-6582"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309339","685574","685576","685578","706461","1737244","1737245","1737578","1737579","1737581","1737582","205964","309335","309336"],"spl_id":["fa11e62e-4625-4e9c-8676-f318b1cb890f"],"spl_set_id":["05a75685-0af5-407c-ac57-e380c882b49d"],"package_ndc":["0009-0870-21","0009-0870-26","0009-0775-20","0009-0775-26","0009-0902-11","0009-0902-18","0009-0728-05","0009-0728-09","0009-3124-01","0009-3124-03","0009-3447-01","0009-3447-03","0009-3381-01","0009-3381-02","0009-3375-01","0009-3375-02","0009-3382-01","0009-3382-02","0009-6582-02","0009-6582-01"],"unii":["EH6D7113I8"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cleocin Phosphate, Injection, Cleocin Phosphate 600 mg/4 mL (150 mg/mL) (NDC 0009-0775-26)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"11/19/2025","update_type":"New","initial_posting_date":"11/19/2025","package_ndc":"0378-5815-77","generic_name":"Valsartan Tablet","contact_info":"800-796-9526","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA090866"],"brand_name":["VALSARTAN"],"generic_name":["VALSARTAN"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-5815","0378-5807","0378-5813","0378-5814"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["VALSARTAN"],"rxcui":["349199","349200","349201","349483"],"spl_id":["db5a1e1d-200e-4a60-a392-98e24e5dbc29"],"spl_set_id":["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"],"package_ndc":["0378-5807-93","0378-5813-77","0378-5814-77","0378-5815-77"],"nui":["N0000000070","N0000175561"],"pharm_class_moa":["Angiotensin 2 Receptor Antagonists [MoA]"],"pharm_class_epc":["Angiotensin 2 Receptor Blocker [EPC]"],"unii":["80M03YXJ7I"]},"update_date":"11/19/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Valsartan, Tablet, 320 mg (NDC 0378-5815-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"11/03/2017","package_ndc":"0641-6127-25","generic_name":"Morphine Sulfate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA205758"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6127","0641-6126","0641-6125"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731993","1732006","1732011"],"spl_id":["fb513d10-94f4-45f5-8b30-fa82ef83e4e2"],"spl_set_id":["6023606c-150c-40c5-9175-598efe2a56c3"],"package_ndc":["0641-6126-01","0641-6126-25","0641-6127-01","0641-6127-25","0641-6125-01","0641-6125-25"],"unii":["X3P646A2J0"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 10 mg/1 mL (NDC 0641-6127-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0406-5116-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA211840"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-5116","0406-5111","0406-5112","0406-5113","0406-5114","0406-5115","0406-5117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["77f4cd3a-dca3-4995-8992-042e1dc91a00"],"spl_set_id":["806a1c15-0842-4787-b2ad-09a21fd96b37"],"package_ndc":["0406-5111-01","0406-5112-01","0406-5113-01","0406-5114-01","0406-5115-01","0406-5116-01","0406-5117-01"],"unii":["SJT761GEGS"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0406-5116-01)","company_name":"SpecGx LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"11534-196-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"732-382-6085 Monday to Friday 9 am to 3:45 pm","availability":"Available","openfda":{"application_number":["ANDA209799"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SUNRISE PHARMACEUTICAL, INC."],"product_ndc":["11534-196","11534-190","11534-191","11534-192","11534-193","11534-194","11534-195"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["60dcfbf6-d07a-4010-ae77-8a9ae4529828"],"spl_set_id":["ac102599-3a5b-4154-899e-6ff262be7ff7"],"package_ndc":["11534-190-01","11534-190-03","11534-191-01","11534-191-03","11534-192-01","11534-192-03","11534-193-01","11534-193-03","11534-194-01","11534-194-03","11534-195-01","11534-195-03","11534-196-01","11534-196-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/01/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 11534-196-01)","company_name":"Sunrise Pharmaceutical, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/13/2022","package_ndc":"76329-3302-1","generic_name":"Dextrose Monohydrate 50% Injection","contact_info":"800-423-4136","availability":"Limited Availability","openfda":{"application_number":["ANDA203451"],"brand_name":["DEXTROSE MONOHYDRATE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["International Medication Systems, Limited"],"product_ndc":["76329-3302"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["727517"],"spl_id":["45b366a9-6c0c-4643-9951-4ff880b29c83"],"spl_set_id":["fcc7ac79-cd70-4f03-a4de-f051f9ca1f7d"],"package_ndc":["76329-3302-1"],"unii":["LX22YL083G"]},"update_date":"11/06/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 76329-3302-1)","company_name":"Amphastar Pharmaceuticals, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-465-57","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA018304"],"brand_name":["SENSORCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-465","63323-467","63323-460","63323-464","63323-466","63323-462"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012391","1012396","1012404","1012421","1012455","1012457","1672917","1672919","1673296","1673298","1724880","1724881","1724884","1724885","1725078","1725082","1725175","1725177"],"spl_id":["2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"03/27/2026","update_type":"New","initial_posting_date":"03/27/2026","package_ndc":"69238-1627-6","generic_name":"Dapsone Gel","contact_info":"866-525-7270","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA212701"],"brand_name":["DAPSONE"],"generic_name":["DASPONE"],"manufacturer_name":["Amneal Pharmaceuticals NY LLC"],"product_ndc":["69238-1627"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TOPICAL"],"substance_name":["DAPSONE"],"rxcui":["1741905"],"spl_id":["0622cdcc-1196-4a2f-8c85-6f34f0f97f9d"],"spl_set_id":["fba0b181-077a-4667-bde1-cf9592f120c2"],"package_ndc":["69238-1627-6","69238-1627-9"],"nui":["N0000175881","M0020791"],"pharm_class_epc":["Sulfone [EPC]"],"pharm_class_cs":["Sulfones [CS]"],"unii":["8W5C518302"]},"update_date":"03/27/2026","therapeutic_category":["Dermatology"],"dosage_form":"Gel","presentation":"Dapsone, Gel, 7.5% (NDC 69238-1627-6)","company_name":"Amneal Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1160-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070590"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1160","0409-1159","0409-1162","0409-1163","0409-1165","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"0517-1001-25","generic_name":"Atropine Sulfate Injection","contact_info":"800-645-1706","availability":"Available","openfda":{"application_number":["ANDA216120"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["American Regent, Inc."],"product_ndc":["0517-1001","0517-1004"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190795","1666781"],"spl_id":["1c500ed9-94a9-472c-bfb7-50e1fcfc31fb"],"spl_set_id":["6fee1727-52b7-4f73-ab45-ef47d6a1c5bb"],"package_ndc":["0517-1004-01","0517-1004-25","0517-1001-01","0517-1001-25"],"unii":["03J5ZE7KA5"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, 1 mg/1 mL (NDC 0517-1001-25)","company_name":"American Regent, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0527-4667-37","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-4667","0527-4661","0527-4662","0527-4663","0527-4664","0527-4665","0527-4666"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["164b5658-3c14-44f5-b10a-839909184984"],"spl_set_id":["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"],"package_ndc":["0527-4661-37","0527-4662-37","0527-4663-37","0527-4664-37","0527-4665-37","0527-4666-37","0527-4667-37"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0527-4667-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0409-1100-10","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA020201"],"brand_name":["DOBUTAMINE IN DEXTROSE"],"generic_name":["DOBUTAMINE IN DEXTROSE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1100","0409-0025","0409-0151"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"spl_id":["87242d06-99e3-4e91-b090-8a8cb0461908"],"spl_set_id":["9943a961-3b50-4847-8a84-d8414ce38daa"],"package_ndc":["0409-0025-01","0409-0025-10","0409-0151-01","0409-0151-10","0409-1100-01","0409-1100-10"],"unii":["0WR771DJXV"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 1,000 mg/250mL (4 mg/mL) (NDC 0409-1100-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"01/05/2026","update_type":"New","initial_posting_date":"01/05/2026","package_ndc":"0409-4350-03","generic_name":"Diltiazem Hydrochloride Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA075853"],"brand_name":["DILTIAZEM HYDROCHLORIDE"],"generic_name":["DILTIAZEM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4350","0409-1171"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DILTIAZEM HYDROCHLORIDE"],"rxcui":["1791230","1791240"],"spl_id":["9e518c0c-b7a9-457c-9ca5-6b6c132f985e"],"spl_set_id":["bba03666-ff4f-4bf6-fa92-78e1ec2d9073"],"package_ndc":["0409-1171-11","0409-1171-01","0409-1171-12","0409-1171-02","0409-4350-13","0409-4350-03"],"unii":["OLH94387TE"]},"update_date":"01/05/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Diltiazem Hydrochloride, Injection, 100 mg Single Dose ADD-Vantage® Glass Vial (NDC 0409-4350-03)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-171-10","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203895"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-171","55150-167","55150-168","55150-169","55150-170","55150-172","55150-249","55150-250"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404","1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["39649703-e633-4a20-ba71-0c04dbf8ff2a"],"spl_set_id":["ffecf450-1f01-4721-8e10-251385852612"],"package_ndc":["55150-167-10","55150-168-30","55150-169-10","55150-170-30","55150-171-10","55150-172-30","55150-249-50","55150-250-50"],"unii":["7TQO7W3VT8"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-171-10)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"67457-423-12","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA040803"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-423","67457-422","67457-421","67457-420"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRAVENOUS","SOFT TISSUE"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696","1116927","1812194"],"spl_id":["dd5c82b6-a194-462c-9626-34a9b410cfea"],"spl_set_id":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"package_ndc":["67457-423-00","67457-423-12","67457-422-00","67457-422-54","67457-421-00","67457-421-30","67457-420-00","67457-420-10"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-423-12)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"New","initial_posting_date":"02/20/2018","package_ndc":"31722-275-34","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-529-0430, customerservice@camberpharma.com","availability":"Available","openfda":{"application_number":["ANDA217821"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Camber Pharmaceuticals, Inc."],"product_ndc":["31722-275","31722-276","31722-277"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["4ea16f8e-77de-3ba7-e063-6394a90a5667"],"spl_set_id":["0e552e3a-cf52-4d74-9381-6cc1b29b4c90"],"package_ndc":["31722-275-10","31722-275-31","31722-275-32","31722-275-30","31722-275-33","31722-275-34","31722-275-35","31722-276-10","31722-276-31","31722-276-32","31722-276-30","31722-276-33","31722-276-34","31722-277-10","31722-277-31","31722-277-32","31722-277-30","31722-277-33","31722-277-34"],"unii":["7TQO7W3VT8"]},"update_date":"07/17/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-34)","company_name":"Aspiro Pharma Limited","status":"Current"},{"discontinued_date":"04/28/2023","update_type":"New","initial_posting_date":"04/28/2023","change_date":"04/28/2023","package_ndc":"0069-4310-71","generic_name":"Prazosin Hydrochloride Capsule","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug. Supply expected to exhaust in August 2023","update_date":"04/28/2023","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Minipress, Capsule, 1 mg (NDC 0069-4310-71)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"72205-137-91","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"(855) 668-2369; customerservice@novadozpharma.com","availability":"Available","openfda":{"application_number":["ANDA218306"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-137","72205-132","72205-133","72205-134","72205-135","72205-136"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"spl_set_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"package_ndc":["72205-132-91","72205-133-91","72205-134-91","72205-135-91","72205-136-91","72205-137-91"],"unii":["SJT761GEGS"]},"update_date":"09/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91)","company_name":"Novadoz Pharmaceuticals LLC","status":"Current"},{"discontinued_date":"01/12/2026","update_type":"New","initial_posting_date":"01/12/2026","package_ndc":"0378-0167-02","generic_name":"Doxycycline Hyclate Tablet","contact_info":"800-796-9526","related_info":"Discontinuation of the manufacture of the drug","update_date":"01/12/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Tablet","presentation":"Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-02)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-3177-01","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA089635"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3177","0409-1209","0409-3178","0409-3181","0409-3182","0409-3183","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"63323-463-57","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA070968"],"brand_name":["SENSORCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-463","63323-472","63323-461","63323-468"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012384","1012413","1012417","1724786","1724787","1724809","1724810","1867594","1867596","1867618","1867620"],"spl_id":["cc1f6507-eb3e-4398-a1d3-0c56a2099e6b"],"spl_set_id":["bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb"],"package_ndc":["63323-472-03","63323-472-17","63323-472-01","63323-472-37","63323-463-01","63323-463-57","63323-461-01","63323-461-57","63323-468-02","63323-468-37","63323-468-01","63323-468-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-463-57)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/10/2020","package_ndc":"83634-600-02","generic_name":"Dexmedetomidine Hydrochloride Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Dexmedetomidine%20Hydrochloride%20Injection&st=d","contact_info":"See Related Information section below for customer service information","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug; Distributed by Avenacy; Contact information: 877-283-6229","openfda":{"application_number":["ANDA209065"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["Avenacy Inc."],"product_ndc":["83634-600"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710"],"spl_id":["f036291f-40af-44b9-8a7f-d4475788ea63"],"spl_set_id":["eee6145b-d83f-4596-92d3-733934d8a3a4"],"package_ndc":["83634-600-41","83634-600-02"],"unii":["1018WH7F9I"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)","company_name":"Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0264-1933-10","generic_name":"Amino Acid Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019018"],"brand_name":["TROPHAMINE"],"generic_name":["ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, CYSTEINE HYDROCHLORIDE, HISTIDINE, TYROSINE, N-ACETYL-TYROSINE, ALANINE, ARGININE, PROLINE, SERINE, GLYCINE, ASPARTIC ACID, GLUTAMIC ACID, AND TAURINE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-1933"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ISOLEUCINE","LEUCINE","LYSINE ACETATE","METHIONINE","PHENYLALANINE","THREONINE","TRYPTOPHAN","VALINE","CYSTEINE HYDROCHLORIDE","HISTIDINE","TYROSINE","ACETYL L-TYROSINE","ALANINE","ARGININE","PROLINE","SERINE","GLYCINE","ASPARTIC ACID","GLUTAMIC ACID","TAURINE"],"rxcui":["800611","1189640"],"spl_id":["f6b74198-afd2-40c7-863f-37f90b49aa16"],"spl_set_id":["cb6d23ff-3ec5-445a-acbe-f88fd57949bf"],"package_ndc":["0264-1933-10"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["04Y7590D77","GMW67QNF9C","TTL6G7LIWZ","AE28F7PNPL","47E5O17Y3R","2ZD004190S","8DUH1N11BX","HG18B9YRS7","ZT934N0X4W","4QD397987E","42HK56048U","DA8G610ZO5","OF5P57N2ZX","94ZLA3W45F","9DLQ4CIU6V","452VLY9402","TE7660XO1C","30KYC7MIAI","3KX376GY7L","1EQV5MLY3D"]},"update_date":"11/10/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"TrophAmine 10%, Injection, 0.1 (NDC 0264-1933-10)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2023","package_ndc":"63323-604-01","generic_name":"Propranolol Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release: November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA075826"],"brand_name":["PROPRANOLOL"],"generic_name":["PROPRANOLOL HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-604"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["PROPRANOLOL HYDROCHLORIDE"],"rxcui":["856443"],"spl_id":["505851c4-b18c-4cd7-805c-4e923cc1fa7e"],"spl_set_id":["f14ea537-dd5c-4c78-9037-9a85e9e610ef"],"package_ndc":["63323-604-01"],"unii":["F8A3652H1V"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Propranolol Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-604-01)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"09/05/2018","package_ndc":"0641-6045-25","generic_name":"Lorazepam Injection","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["NDA018140"],"brand_name":["LORAZEPAM"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6045","0641-6044","0641-6046","0641-6047"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["238100","238101","1665188","1665326"],"spl_id":["7c73dbc6-2623-4443-9b05-97dec7a0be2e"],"spl_set_id":["e9b54e42-04cf-4c62-90e1-36f7b31a4e81"],"package_ndc":["0641-6044-01","0641-6044-25","0641-6046-01","0641-6046-10","0641-6045-01","0641-6045-25","0641-6047-01","0641-6047-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"10/14/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6045-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/14/2016","package_ndc":"63323-489-27","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-489","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-483-57","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-483","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0429-53","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020163"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0429","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0429-53)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"47781-179-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA207388"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 20 MG,CLL"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-179","47781-174","47781-175","47781-176","47781-177","47781-178","47781-180"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AMPHETAMINE ASPARTATE MONOHYDRATE","AMPHETAMINE SULFATE","DEXTROAMPHETAMINE SACCHARATE","DEXTROAMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["eb490273-9334-1ae5-dd32-658e7fb0b40e"],"spl_set_id":["c907301d-e24d-9609-5529-fed14f94549f"],"package_ndc":["47781-174-30","47781-174-05","47781-174-01","47781-175-30","47781-175-05","47781-175-01","47781-176-30","47781-176-05","47781-176-01","47781-177-30","47781-177-05","47781-177-01","47781-178-30","47781-178-05","47781-178-01","47781-179-30","47781-179-05","47781-179-01","47781-180-30","47781-180-05","47781-180-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 20mg (NDC 47781-179-01)","company_name":"Alvogen","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0415-06","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017512"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0415","0941-0411","0941-0413","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-06)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/22/2021","package_ndc":"42806-799-60","generic_name":"Rifampin Capsule","contact_info":"(718) 276-8600 ext. 3","availability":"Available","openfda":{"application_number":["ANDA064150"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["EPIC PHARMA, LLC"],"product_ndc":["42806-799","42806-801"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAMPIN"],"rxcui":["198201","198202"],"spl_id":["a4ac02e8-68ac-4e79-8ca5-0939dd002c87"],"spl_set_id":["0391f1e1-70d4-4b15-8b58-055bb6a385b8"],"package_ndc":["42806-801-30","42806-801-01","42806-799-30","42806-799-60","42806-799-01","42806-799-05"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Rifampin, Capsule, 300 mg (NDC 42806-799-60)","company_name":"Epic Pharma, LLC","status":"Current"},{"discontinued_date":"09/16/2026","update_type":"New","initial_posting_date":"09/16/2026","package_ndc":"54092-189-81","generic_name":"Mesalamine Capsule, Extended Release","contact_info":"877 825 3327","related_info":"Product is anticipated to be available until December 31, 2027","openfda":{"application_number":["NDA020049"],"brand_name":["PENTASA"],"generic_name":["MESALAMINE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["54092-189","54092-191"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MESALAMINE"],"rxcui":["206791","314092","476362","580286"],"spl_id":["d98da9dd-6bcf-469c-bf7c-080565f146ce"],"spl_set_id":["e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606"],"package_ndc":["54092-189-81","54092-191-12"],"nui":["N0000175781","M0000971"],"pharm_class_epc":["Aminosalicylate [EPC]"],"pharm_class_cs":["Aminosalicylic Acids [CS]"],"unii":["4Q81I59GXC"]},"update_date":"09/16/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Capsule, Extended Release","presentation":"Pentasa, Capsule, Extended Release, 250 mg (NDC 54092-189-81)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"0185-0853-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-525-8747","availability":"Limited Availability","related_info":"Estimated recovery: 1Q 2027","openfda":{"application_number":["ANDA040439"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0185-0853","0185-0831","0185-0842","0185-0864","0185-2099","0185-2098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577961"],"spl_id":["9a21fb59-a99c-4c63-91e8-4b5d72fbd9cd"],"spl_set_id":["288dafc4-fe6e-4891-832f-511022c87445"],"package_ndc":["0185-0831-01","0185-0842-01","0185-0853-01","0185-0864-01","0185-2099-01","0185-2098-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/09/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0185-0853-01)","company_name":"Sandoz Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"08/03/2022","package_ndc":"62135-736-30","generic_name":"Flurazepam Hydrochloride Capsule","contact_info":"845-268-5000 Ext. 510","availability":"Available","openfda":{"application_number":["ANDA072368"],"brand_name":["FLURAZEPAM HYDROCHLORIDE"],"generic_name":["FLURAZEPAM HYDROCHLORIDE"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-736","62135-737"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FLURAZEPAM HYDROCHLORIDE"],"rxcui":["1298088","1298091"],"spl_id":["25893c92-c8f1-567a-e063-6294a90a00d4"],"spl_set_id":["8f476891-1346-4e8c-ac1b-f8cbdc64f5a1"],"package_ndc":["62135-736-30","62135-736-90","62135-737-30","62135-737-90"],"unii":["756RDM536M"]},"update_date":"09/15/2026","therapeutic_category":["Neurology","Other"],"dosage_form":"Capsule","presentation":"Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"discontinued_date":"11/14/2025","update_type":"New","initial_posting_date":"11/14/2025","package_ndc":"0409-5092-16","generic_name":"Ceftazidime Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","update_date":"11/14/2025","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Tazicef, Injection, 1 g (NDC 0409-5092-16)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"discontinued_date":"01/13/2026","update_type":"New","initial_posting_date":"01/13/2026","package_ndc":"61314-531-64","generic_name":"Adalimumab-adaz Injection","contact_info":"800-525-8747","related_info":"Equivalent Sandoz format is available.","openfda":{"application_number":["BLA761071"],"brand_name":["HYRIMOZ"],"generic_name":["ADALIMUMAB-ADAZ"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["61314-531","61314-454","61314-473","61314-476","61314-509","61314-517"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["2641644","2641650","2641653","2641654","2641655","2641658","2641660","2641661","2641662","2641663","2641664","2641665","2641666","2641667","2641668","2641669","2641670","2641671","2641672","2641673"],"spl_id":["48b7e44a-945f-487d-b2fd-3da13d6d6fdb"],"spl_set_id":["1ac7d061-3380-468c-b077-c05f8dfbc829"],"package_ndc":["61314-454-20","61314-454-36","61314-454-68","61314-473-64","61314-473-20","61314-473-92","61314-476-64","61314-509-64","61314-517-36","61314-454-96","61314-473-96","61314-531-64","61314-454-94","61314-473-94"],"nui":["N0000175610","N0000175451","M0001357"],"pharm_class_epc":["Tumor Necrosis Factor Blocker [EPC]"],"pharm_class_moa":["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"],"pharm_class_cs":["Antibodies, Monoclonal [CS]"],"unii":["FYS6T7F842"]},"update_date":"01/13/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Hyrimoz, Injection, Kit (NDC 61314-531-64)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"16729-295-33","generic_name":"Carboplatin Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA","openfda":{"application_number":["ANDA206775"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-295"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"spl_id":["5f9d65c8-75c4-6fb3-e063-6394a90a87cf"],"spl_set_id":["48aa7ef3-9f44-2a08-e054-00144ff88e88"],"package_ndc":["16729-295-31","16729-295-33","16729-295-34","16729-295-12","16729-295-38"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)","company_name":"Accord Healthcare Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/21/2020","package_ndc":"16729-306-10","generic_name":"Azacitidine Injection","contact_info":"866-941-7875, option 2","availability":"Available","openfda":{"application_number":["ANDA207475"],"brand_name":["AZACITIDINE"],"generic_name":["AZACITIDINE"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-306"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["AZACITIDINE"],"rxcui":["485246"],"spl_id":["28604daf-46a3-ef6c-e063-6394a90a4b27"],"spl_set_id":["70140e11-33f1-2240-e053-2991aa0a0480"],"package_ndc":["16729-306-10"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["M801H13NRU"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Azacitidine, Injection, 100 mg (NDC 16729-306-10)","company_name":"Accord Healthcare Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"68025-097-10","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Temporary discontinuation of 100ct","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-097","68025-088","68025-089","68025-095","68025-096","68025-084","68025-098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)","company_name":"Vertical Pharmaceuticals, LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/07/2020","package_ndc":"16729-500-08","generic_name":"Furosemide Injection","contact_info":"866-941-7875","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA","openfda":{"application_number":["ANDA070017"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-500","16729-501","16729-502"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["1cfab300-d796-6a68-e063-6394a90a73f9"],"spl_set_id":["f6f64972-714c-4ee9-8a5e-9ffcab41a73b"],"package_ndc":["16729-500-30","16729-500-08","16729-501-64","16729-501-43","16729-502-03","16729-502-43"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/02/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 16729-500-08)","company_name":"Accord Healthcare Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"discontinued_date":"04/28/2026","update_type":"New","initial_posting_date":"04/28/2026","package_ndc":"25021-311-02","generic_name":"Furosemide Injection","contact_info":"Sagent Pharmaceuticals: 866-625-1618","related_info":"Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA213902"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-311"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["222ce48f-2856-4be2-b16f-6fca38c0dceb"],"spl_set_id":["d63c1277-dd7e-4d21-9e80-68143f55e2dc"],"package_ndc":["25021-311-02","25021-311-04","25021-311-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"04/28/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)","company_name":"Gland Pharma Limited","status":"To Be Discontinued"},{"discontinued_date":"03/26/2026","update_type":"New","initial_posting_date":"03/26/2026","package_ndc":"53746-468-19","generic_name":"Clindamycin Palmitate Hydrochloride Injection","contact_info":"866-525-7270","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA203513"],"brand_name":["CLINDAMYCIN PALMITATE HYDROCHLORIDE (PEDIATRIC)"],"generic_name":["CLINDAMYCIN PALMITATE HYDROCHLORIDE"],"manufacturer_name":["Amneal Pharmaceuticals of New York LLC"],"product_ndc":["53746-468"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLINDAMYCIN PALMITATE HYDROCHLORIDE"],"rxcui":["562266"],"spl_id":["bacc9e9f-6a9f-4a68-b2ec-131ed86205ec"],"spl_set_id":["faf67eb8-1fd7-4b2c-a55b-24ba664c0dce"],"package_ndc":["53746-468-19"],"unii":["VN9A8JM7M7"]},"update_date":"03/26/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Palmitate Hydrochloride, Injection, 75 mg/5 mL (NDC 53746-468-19)","company_name":"Amneal Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/01/2022","package_ndc":"0264-7520-20","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019626"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-7520","0264-7510"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE, UNSPECIFIED FORM"],"rxcui":["1795477","1795480","1795481","1795607","1795610","1795612"],"spl_id":["4acb5988-64ad-4f83-bc8d-6f2117dfebbe"],"spl_set_id":["085614c7-ada4-4e2c-87c0-c9bc2f18365a"],"package_ndc":["0264-7510-00","0264-7510-10","0264-7510-20","0264-7520-00","0264-7520-10","0264-7520-20"],"unii":["IY9XDZ35W2"]},"update_date":"10/19/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-20)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"New","initial_posting_date":"04/28/2023","package_ndc":"69339-365-15","generic_name":"Carboplatin Injection","contact_info":"Natco Pharma USA LLC: (201)786-6500","availability":"Available","related_info":"Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)","openfda":{"application_number":["ANDA077861"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Natco Pharma USA LLC"],"product_ndc":["69339-365","69339-364","69339-366","69339-367"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["4c89cedc-e48b-445c-ad05-54dbe60e4fb0"],"spl_set_id":["4c89cedc-e48b-445c-ad05-54dbe60e4fb0"],"package_ndc":["69339-364-05","69339-365-15","69339-366-45","69339-367-60"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 150 mg/15 mL (NDC 69339-365-15)","company_name":"Teyro Labs","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"43066-007-10","generic_name":"Rocuronium Bromide Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA091115"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["43066-007","43066-013"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["9e0317de-2d78-4fd8-8926-4c7b476f3ed4"],"spl_set_id":["31e15c3f-aefa-4379-b684-7707744fe40d"],"package_ndc":["43066-007-10","43066-013-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 43066-007-10)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7034-12","generic_name":"Aspirin Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["ASPIRIN"],"generic_name":["ASPIRIN"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7034"],"product_type":["HUMAN OTC DRUG"],"route":["RECTAL"],"substance_name":["ASPIRIN"],"rxcui":["198464"],"spl_id":["a6ca751c-7438-4a0f-adae-d176f73f4915"],"spl_set_id":["cce244aa-cd79-49c8-b68e-267f2bd0ef67"],"package_ndc":["0574-7034-12"],"nui":["N0000000160","N0000008836","M0001335","N0000175722","N0000175578","N0000008832"],"pharm_class_moa":["Cyclooxygenase Inhibitors [MoA]"],"pharm_class_pe":["Decreased Prostaglandin Production [PE]","Decreased Platelet Aggregation [PE]"],"pharm_class_cs":["Anti-Inflammatory Agents, Non-Steroidal [CS]"],"pharm_class_epc":["Nonsteroidal Anti-inflammatory Drug [EPC]","Platelet Aggregation Inhibitor [EPC]"],"unii":["R16CO5Y76E"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction","Cardiovascular"],"dosage_form":"Suppository","presentation":"Aspirin, Suppository, 300 mg (NDC 0574-7034-12)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"55150-323-25","generic_name":"Furosemide Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA212174"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-323","55150-322","55150-324"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["9bb2ffa4-0891-4197-a970-90b178bbfad9"],"spl_set_id":["421aa6d5-623b-4dc2-abd5-bb9e7765bf37"],"package_ndc":["55150-322-01","55150-322-25","55150-323-01","55150-323-25","55150-324-01","55150-324-25"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"10/19/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 40 mg/4 mL (NDC 55150-323-25)","company_name":"Eugia US LLC","status":"Current"},{"discontinued_date":"07/30/2026","update_type":"New","initial_posting_date":"07/30/2026","package_ndc":"63323-578-02","generic_name":"Glycopyrrolate Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA209328"],"brand_name":["GLYCOPYRROLATE"],"generic_name":["GLYCOPYRROLATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-578"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["GLYCOPYRROLATE"],"rxcui":["238212","1731582","1731590"],"spl_id":["779dc924-ecc3-41cc-8cf9-a7354db4f763","d528572e-598b-4c0e-b280-b083c73c017f"],"spl_set_id":["54458620-d888-4df6-ae4b-78c3dfed3423","ccafb5c2-86dd-4bb2-883a-c13e3171227c"],"package_ndc":["63323-578-03","63323-578-01","63323-578-04","63323-578-02","63323-578-07","63323-578-05","63323-578-18","63323-578-20","63323-578-41","63323-578-11","63323-578-42","63323-578-12"],"unii":["V92SO9WP2I"]},"update_date":"07/30/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Glycopyrrolate, Injection, 0.4 mg per 2 mL (NDC 63323-578-02)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"43547-407-10","generic_name":"Clonazepam Tablet","contact_info":"For orders, Solco Healthcare 866-931-9829","resolved_note":"Available","openfda":{"application_number":["ANDA077856"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Solco Healthcare LLC"],"product_ndc":["43547-407","43547-406","43547-408"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["dc17b9d4-2890-4f6c-8476-daa39d0cbc9c"],"spl_set_id":["4acbb7a9-4db5-4497-b8db-9f358b3f6fb4"],"package_ndc":["43547-406-10","43547-406-50","43547-406-11","43547-407-10","43547-407-50","43547-407-11","43547-408-10","43547-408-50"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 43547-407-10)","company_name":"Prinston Pharmaceutical, Inc.","status":"Resolved"},{"discontinued_date":"08/13/2026","update_type":"New","initial_posting_date":"08/13/2026","package_ndc":"0228-2550-11","generic_name":"Diclofenac Sodium Tablet, Delayed Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA074514"],"brand_name":["DICLOFENAC SODIUM"],"generic_name":["DICLOFENAC SODIUM"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2550","0228-2551"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DICLOFENAC SODIUM"],"rxcui":["855906","855926"],"spl_id":["a1fbc994-b8a6-4759-be76-1cfd98275ca6"],"spl_set_id":["a57b897e-0cbe-4ac3-969f-b00357a0cfa8"],"package_ndc":["0228-2550-06","0228-2550-11","0228-2550-96","0228-2551-06","0228-2551-11","0228-2551-96"],"unii":["QTG126297Q"]},"update_date":"08/13/2026","therapeutic_category":["Musculoskeletal","Rheumatology"],"dosage_form":"Tablet","presentation":"Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-11)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"0009-5095-06","generic_name":"Clindamycin Phosphate Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","update_date":"06/01/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial NovaPlus (NDC 0009-5095-06)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"0409-3189-10","generic_name":"Rocuronium Bromide Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA205656"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3189","0409-7037"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["c96726ef-f1fa-4ebb-ba33-3479c3902a8e"],"spl_set_id":["c96726ef-f1fa-4ebb-ba33-3479c3902a8e"],"package_ndc":["0409-3189-05","0409-3189-10","0409-7037-01","0409-7037-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-3189-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"45963-676-11","generic_name":"Metoprolol Succinate Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA204161"],"brand_name":["METOPROLOL SUCCINATE"],"generic_name":["METOPROLOL SUCCINATE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["45963-676","45963-709","45963-677","45963-678"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METOPROLOL SUCCINATE"],"rxcui":["866412","866419","866427","866436"],"spl_id":["a7e9a234-a8a6-4afe-ba8e-d569772bc39a"],"spl_set_id":["b798601e-a369-4c8b-8235-08900e1b751d"],"package_ndc":["45963-709-11","45963-709-96","45963-676-11","45963-676-96","45963-677-11","45963-677-96","45963-678-11"],"unii":["TH25PD4CCB"]},"update_date":"08/31/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-11)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"11/13/2025","update_type":"New","initial_posting_date":"11/13/2025","package_ndc":"0228-2850-11","generic_name":"Guanfacine Hydrochloride Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA200881"],"brand_name":["GUANFACINE"],"generic_name":["GUANFACINE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2850","0228-2851","0228-2853","0228-2855"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GUANFACINE HYDROCHLORIDE"],"rxcui":["862006","862013","862019","862025"],"spl_id":["00143252-2b74-4b11-86ed-9b864635f129"],"spl_set_id":["3a171942-37af-430d-8b9d-bb678ca2be4b"],"package_ndc":["0228-2850-11","0228-2851-11","0228-2853-11","0228-2855-11"],"unii":["PML56A160O"]},"update_date":"11/13/2025","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Guanfacine Hydrochloride, Tablet, Extended Release, 1 mg (NDC 0228-2850-11)","company_name":"Actavis Pharma, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"11/01/2017","package_ndc":"76045-121-11","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA019034"],"brand_name":["DILAUDID"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-121","76045-009","76045-010"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1872265","1872269","1872752","2277368","2277370"],"spl_id":["002d5650-24df-4b60-a5ce-e7adc091026f"],"spl_set_id":["9eebd88a-5632-460f-b7b6-26c8a180540d"],"package_ndc":["76045-009-96","76045-009-06","76045-009-01","76045-009-11","76045-010-01","76045-010-11","76045-121-01","76045-121-11"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Dilaudid, Injection, .2 mg/1 mL (NDC 76045-121-11)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"discontinued_date":"07/02/2026","update_type":"New","initial_posting_date":"07/02/2026","package_ndc":"0781-6172-86","generic_name":"Desflurane Liquid for Inhalation","contact_info":"Sandoz: 800-525-8747","related_info":"Discontinuation of the manufacture of the drug; Distributed by Sandoz, Inc.","openfda":{"application_number":["ANDA208234"],"brand_name":["DESFLURANE"],"generic_name":["DESFLURANE"],"manufacturer_name":["Sandoz Inc."],"product_ndc":["0781-6172"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RESPIRATORY (INHALATION)"],"substance_name":["DESFLURANE"],"rxcui":["562366"],"spl_id":["ecf9968e-58b0-4792-e053-2995a90aef25"],"spl_set_id":["21ba0e18-3dbc-4feb-a3a4-f6470c00910a"],"package_ndc":["0781-6172-22","0781-6172-86"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["CRS35BZ94Q"]},"update_date":"07/02/2026","therapeutic_category":["Anesthesia"],"presentation":"Desflurane, Liquid for Inhalation, 240 mL/240 mL (NDC 0781-6172-86)","company_name":"Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"11/06/2017","package_ndc":"0409-2344-88","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA074086"],"brand_name":["DOBUTAMINE"],"generic_name":["DOBUTAMINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2344"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"rxcui":["1812168"],"spl_id":["e71e9520-871b-479d-9652-1857fceca863","f6a67673-07a7-44e4-b05c-1f7e63326f79"],"spl_set_id":["dc537761-d5f4-488d-24ab-b2bcd2b17b7a","89becb0c-da60-4f43-0a98-29ff7a9eca58"],"package_ndc":["0409-2344-01","0409-2344-62","0409-2344-02","0409-2344-68","0409-2344-88"],"unii":["0WR771DJXV"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-88)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"0781-3289-09","generic_name":"Clindamycin Phosphate Injection","contact_info":"800-525-8747","availability":"Available","openfda":{"application_number":["ANDA201692"],"brand_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"generic_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-3289","0781-3288","0781-3290"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN"],"rxcui":["309335","309336","309339"],"spl_id":["b553b8ab-ef4d-40ae-a5fb-a6242f2ad30a"],"spl_set_id":["231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca"],"package_ndc":["0781-3288-91","0781-3288-09","0781-3289-91","0781-3289-09","0781-3290-91","0781-3290-09"],"nui":["N0000009982","N0000175443","M0515779","N0000175731"],"pharm_class_pe":["Decreased Sebaceous Gland Activity [PE]","Neuromuscular Blockade [PE]"],"pharm_class_epc":["Lincosamide Antibacterial [EPC]"],"pharm_class_cs":["Lincosamides [CS]"],"unii":["3U02EL437C"]},"update_date":"11/09/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 0781-3289-09)","company_name":"Sandoz Inc.","status":"Current"},{"discontinued_date":"06/04/2026","update_type":"New","initial_posting_date":"06/04/2026","package_ndc":"0169-4303-30","generic_name":"Semaglutide Tablet","contact_info":"833-493-4689","related_info":"Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.","openfda":{"application_number":["NDA213051"],"brand_name":["RYBELSUS"],"generic_name":["ORAL SEMAGLUTIDE"],"manufacturer_name":["Novo Nordisk Pharmaceutical Industries, LP"],"product_ndc":["0169-4303","0169-1715","0169-1704","0169-1709","0169-4307","0169-4314","0169-4815","0169-4804","0169-4809"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["SEMAGLUTIDE"],"rxcui":["2200644","2200650","2200652","2200654","2200656","2200658","2707547","2707549","2707551","2707553","2707555","2707557","2736944","2736946","2736948"],"spl_id":["6834044a-22f1-4f35-b846-b3448ee84c16"],"spl_set_id":["27f15fac-7d98-4114-a2ec-92494a91da98"],"package_ndc":["0169-1715-30","0169-1715-90","0169-1704-30","0169-1709-30","0169-4303-01","0169-4303-13","0169-4303-90","0169-4303-93","0169-4303-30","0169-4303-99","0169-4307-01","0169-4307-13","0169-4307-30","0169-4314-01","0169-4314-13","0169-4314-30","0169-4815-30","0169-4815-90","0169-4804-30","0169-4809-30"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["53AXN4NNHX"]},"update_date":"06/04/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Rybelsus, Tablet, 3 mg (NDC 0169-4303-30)","company_name":"Novo Nordisk, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"11/03/2017","package_ndc":"0641-6039-01","generic_name":"Morphine Sulfate Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Additional lots will be available in the November 2026 timeframe.  Product will be made available as it is released.","openfda":{"application_number":["NDA018565"],"brand_name":["INFUMORPH 200"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6039","0641-6040"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRATHECAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892652","1731522","1731998","1731999"],"spl_id":["b1c060cb-5c5b-495f-90b5-044e04f2a3f2"],"spl_set_id":["db9ac9e3-d761-4a99-9f34-4946ebe8f255"],"package_ndc":["0641-6039-01","0641-6040-01"],"unii":["X3P646A2J0"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Infumorph 200 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 10 mg/1 mL (NDC 0641-6039-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"63323-853-25","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA019034"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-853","63323-851","63323-852","63323-854"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897653","897753","1724276","1724338","1724340","1724341"],"spl_id":["2cfa0a3e-eb57-4dea-ae2c-0b91176f0f67"],"spl_set_id":["e034eb96-03e0-46e1-8b92-5e1f94555e7b"],"package_ndc":["63323-851-03","63323-851-10","63323-851-07","63323-851-15","63323-851-50","63323-852-03","63323-852-25","63323-853-03","63323-853-25","63323-854-03","63323-854-10"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 63323-853-25)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"62332-599-25","generic_name":"Ketorolac Tromethamine Injection","contact_info":"908-393-9604","availability":"Available","openfda":{"application_number":["ANDA214456"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Alembic Pharmaceuticals Inc."],"product_ndc":["62332-599","62332-600","62332-601"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["9030f496-5021-4454-ac16-dbb376315608"],"spl_set_id":["419cf756-3c96-4bb8-ae96-6aea5a5f3afd"],"package_ndc":["62332-599-01","62332-599-25","62332-600-01","62332-600-25","62332-601-02","62332-601-25"],"unii":["4EVE5946BQ"]},"update_date":"05/15/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 62332-599-25)","company_name":"Alembic Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"67457-925-10","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA212571"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-925","67457-924"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["e4cda7fa-dac8-4de7-abc1-d1fd622795d8"],"spl_set_id":["f140de5a-f13d-46b4-a742-049c63e474f5"],"package_ndc":["67457-924-00","67457-924-50","67457-925-00","67457-925-10"],"unii":["1018WH7F9I"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0527-1505-37)","update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0527-1505-37","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","company_name":"Lannett Company, Inc.","contact_info":"844-834-0530","availability":"Available","update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"status":"Current","dosage_form":"Tablet"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"0641-0367-25","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Product will be made available as it is released.","openfda":{"application_number":["ANDA087702"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-0367","0641-6145","0641-6146"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696","1116927","1812194"],"spl_id":["02bf3273-f0c8-448c-9f74-eb009fee9299"],"spl_set_id":["0277cc0a-2fd4-4605-a310-b613be84ee26"],"package_ndc":["0641-0367-21","0641-0367-25","0641-6145-01","0641-6145-25","0641-6146-01","0641-6146-10","0641-6146-25"],"unii":["AI9376Y64P"]},"update_date":"10/14/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 0641-0367-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"02/19/2026","update_type":"New","initial_posting_date":"02/19/2026","package_ndc":"0591-5543-10","generic_name":"Allopurinol Tablet","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA018832"],"brand_name":["ALLOPURINOL"],"generic_name":["ALLOPURINOL"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0591-5543","0591-5544"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ALLOPURINOL"],"rxcui":["197319","197320"],"spl_id":["f7e04d88-1d9b-47e6-a9ad-deb08af3c098"],"spl_set_id":["a80fe56f-8d03-423f-8e2a-7ec8c9e5045b"],"package_ndc":["0591-5543-01","0591-5543-10","0591-5544-01","0591-5544-05"],"nui":["N0000175698","N0000000206"],"pharm_class_epc":["Xanthine Oxidase Inhibitor [EPC]"],"pharm_class_moa":["Xanthine Oxidase Inhibitors [MoA]"],"unii":["63CZ7GJN5I"]},"update_date":"02/19/2026","therapeutic_category":["Oncology","Renal","Rheumatology"],"dosage_form":"Tablet","presentation":"Allopurinol, Tablet, 100 mg (NDC 0591-5543-10)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"0409-3815-12","generic_name":"Morphine Sulfate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA073510"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3815","0409-3814"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRATHECAL","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1728783","1728800"],"spl_id":["0a2ba20b-448f-4412-9899-b82040ebfa7d"],"spl_set_id":["1d181906-f3ec-4222-1883-e61577a3122e"],"package_ndc":["0409-3814-11","0409-3814-12","0409-3815-11","0409-3815-12"],"unii":["X3P646A2J0"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-3815-12)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/03/2017","change_date":"01/03/2025","package_ndc":"0641-0121-25","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.","update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-0121-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/26/2018","package_ndc":"25021-700-01","generic_name":"Ketorolac Tromethamine Injection","contact_info":"866-625-1618","availability":"Limited Availability","related_info":"Estimated recovery: Mid-November 2026, Product in transit and expected to arrive week of Nov 12th","openfda":{"application_number":["ANDA204216"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-700","25021-701"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["cb23332a-48fa-458b-93ab-c4eef189a051"],"spl_set_id":["62591551-a644-4b2c-a0de-982e906fabc3"],"package_ndc":["25021-700-01","25021-701-01","25021-701-02"],"unii":["4EVE5946BQ"]},"update_date":"11/06/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)","company_name":"Sagent Pharmaceuticals","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"72572-127-10","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"877-495-6856","availability":"Available","related_info":"Distributed by Civica","openfda":{"application_number":["ANDA212791"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["CIVICA, INC."],"product_ndc":["72572-127","72572-128"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["454867bb-b559-4c06-8ec4-bb1a5c691109"],"spl_set_id":["1faf1ac8-ff9b-4ed9-b562-06dab971173a"],"package_ndc":["72572-127-01","72572-127-10","72572-128-01","72572-128-08"],"unii":["1018WH7F9I"]},"update_date":"10/15/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10)","company_name":"Azurity Pharmaceuticals, Inc","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-3183-01","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA089651"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3183","0409-1209","0409-3177","0409-3178","0409-3181","0409-3182","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-1174-10","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1174","0409-1454","0409-3301","0409-2815"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["e1705533-5a85-441f-a95b-3cb88c47e482"],"spl_set_id":["4419162d-81d4-49bd-96de-1729440bdb74"],"package_ndc":["0409-1454-01","0409-1454-20","0409-3301-01","0409-3301-10","0409-1174-01","0409-1174-10","0409-2815-01"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2016","package_ndc":"71357-008-10","generic_name":"Sodium Acetate Injection","contact_info":"833-251-8463","availability":"Available","openfda":{"application_number":["ANDA214805"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE INJECTION, USP, 200 MEQ/100 ML"],"manufacturer_name":["MILLA PHARMACEUTICALS INC."],"product_ndc":["71357-008","71357-007","71357-009"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE"],"rxcui":["237371","312965"],"spl_id":["47d8d0e7-6db5-950d-e063-6294a90ab1bf"],"spl_set_id":["1ea1466d-a492-4056-e063-6394a90a80bf"],"package_ndc":["71357-007-01","71357-007-10","71357-008-01","71357-008-10","71357-009-01","71357-009-10"],"unii":["4550K0SC9B"]},"update_date":"10/15/2026","therapeutic_category":["Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10)","company_name":"Milla Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2020","package_ndc":"16729-483-03","generic_name":"Atropine Sulfate Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA212868"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Accord Healthcare, Inc.,"],"product_ndc":["16729-483","16729-484"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190546","1190551","1190552"],"spl_id":["4082a1cf-1e1b-6f40-e063-6294a90aec06"],"spl_set_id":["c82cb295-ffce-47d6-97ad-a8aa723f4e4f"],"package_ndc":["16729-483-03","16729-483-31","16729-484-90","16729-484-31","16729-484-45","16729-484-03"],"unii":["03J5ZE7KA5"]},"update_date":"10/17/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, .05 mg/1 mL (NDC 16729-483-03)","company_name":"Accord Healthcare Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/26/2018","package_ndc":"0409-3793-01","generic_name":"Ketorolac Tromethamine Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2027","openfda":{"application_number":["ANDA074802"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3793","0409-3795","0409-3796"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["4beb8ebd-934e-4181-8374-01be0bb80680"],"spl_set_id":["8accbb78-fc64-45d5-69b0-35c23a1d2a2e"],"package_ndc":["0409-3793-19","0409-3793-01","0409-3793-25","0409-3795-19","0409-3795-01","0409-3795-25","0409-3796-19","0409-3796-01","0409-3796-25"],"unii":["4EVE5946BQ"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0409-3793-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4276-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA088299"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4276","0409-4713","0409-4278","0409-4279","0409-4776","0409-4282","0409-4277","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride In Plastic Container, Injection, 500 mg/50 mL (1%; 10 mg/mL) (NDC 0409-4276-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/10/2020","package_ndc":"0143-9532-25","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional product will be made available as it is released.","openfda":{"application_number":["ANDA205046"],"brand_name":["DEXMEDETOMIDINE HCL"],"generic_name":["DEXMEDETOMIDINE HCL"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9532"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710"],"spl_id":["09161c32-f8f5-4846-b9b0-55a712fe7743"],"spl_set_id":["de6f01a2-9f2d-4c68-9c02-06643704acb1"],"package_ndc":["0143-9532-01","0143-9532-25"],"unii":["1018WH7F9I"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"72266-147-10","generic_name":"Etomidate Injection","contact_info":"833-291-9645","availability":"Available","related_info":"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.","openfda":{"application_number":["ANDA209058"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE INJECTION"],"manufacturer_name":["Fosun Pharma USA Inc"],"product_ndc":["72266-147","72266-146"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["2b365133-b609-3285-e063-6394a90a69a6"],"spl_set_id":["8b6c54d8-3f3f-4290-841c-976bea01086f"],"package_ndc":["72266-146-01","72266-146-10","72266-147-01","72266-147-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 72266-147-10)","company_name":"Gland Pharma Limited","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/14/2022","package_ndc":"65219-456-60","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholealers for inventory","openfda":{"application_number":["ANDA207449"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["FRESENIUS KABI USA, LLC"],"product_ndc":["65219-456","65219-464","65219-458","65219-460","65219-462"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795607","1795609","1795610","1795612","1795616"],"spl_id":["efc3b0c9-518a-47db-bb3e-ebdfd4646e9b"],"spl_set_id":["576a22d8-5f2f-497e-80ad-1842ca74bb53"],"package_ndc":["65219-456-05","65219-456-60","65219-464-05","65219-464-50","65219-458-05","65219-458-30","65219-460-05","65219-460-20","65219-462-05","65219-462-10"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-456-60)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/01/2017","package_ndc":"81298-7620-3","generic_name":"Sodium Bicarbonate Injection","contact_info":"833-268-5559","availability":"Available","openfda":{"application_number":["ANDA216042"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE INJECTION,"],"manufacturer_name":["Long Grove Pharmaceuticals, LLC"],"product_ndc":["81298-7620"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["1868486"],"spl_id":["1a255946-a137-4e13-8203-65dd80b34872"],"spl_set_id":["a26d709b-b294-4b02-9a88-7e840f099a33"],"package_ndc":["81298-7620-1","81298-7620-3"],"unii":["8MDF5V39QO"]},"update_date":"10/16/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3)","company_name":"Long Grove Pharmaceuticals LLC","status":"Current"},{"discontinued_date":"01/28/2026","update_type":"New","initial_posting_date":"01/28/2026","package_ndc":"0023-6118-03","generic_name":"Podofilox Topical Gel","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","update_date":"01/28/2026","therapeutic_category":["Dermatology","Other"],"dosage_form":"Topical Gel","presentation":"Condylox , Topical Gel, 0.5% (NDC 0023-6118-03)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"83634-653-30","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"Avenacy, LLC: 877-283-6229","availability":"Available","related_info":"Distributed by Avenacy, LLC","openfda":{"application_number":["ANDA219535"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Avenacy, LLC"],"product_ndc":["83634-653","83634-651"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1737562","1737566","1737568"],"spl_id":["8fb1dd7b-f349-4a64-96c1-bd72bf748f3b"],"spl_set_id":["46480253-29b9-4d7f-98ed-10377929026b"],"package_ndc":["83634-653-41","83634-653-02","83634-653-42","83634-653-05","83634-653-43","83634-653-30","83634-651-41","83634-651-10","83634-651-42","83634-651-20","83634-651-43","83634-651-50"],"unii":["V13007Z41A"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 300 mg/30 mL (NDC 83634-653-30)","company_name":"Anthea Pharma","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"63323-486-27","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-486","63323-492","63323-491","63323-495","63323-485","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-27)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"11534-194-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"732-382-6085 Monday to Friday 9 am to 3:45 pm","availability":"Available","openfda":{"application_number":["ANDA209799"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SUNRISE PHARMACEUTICAL, INC."],"product_ndc":["11534-194","11534-190","11534-191","11534-192","11534-193","11534-195","11534-196"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["60dcfbf6-d07a-4010-ae77-8a9ae4529828"],"spl_set_id":["ac102599-3a5b-4154-899e-6ff262be7ff7"],"package_ndc":["11534-190-01","11534-190-03","11534-191-01","11534-191-03","11534-192-01","11534-192-03","11534-193-01","11534-193-03","11534-194-01","11534-194-03","11534-195-01","11534-195-03","11534-196-01","11534-196-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/01/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 11534-194-01)","company_name":"Sunrise Pharmaceutical, Inc.","status":"Current"},{"discontinued_date":"01/27/2026","update_type":"New","initial_posting_date":"01/27/2026","package_ndc":"66758-211-31","generic_name":"Fluvastatin Sodium Tablet, Extended Release","contact_info":"800-525-8747","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA021192"],"brand_name":["LESCOL XL"],"generic_name":["FLUVASTATIN SODIUM"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["66758-211"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FLUVASTATIN SODIUM"],"rxcui":["360507","687048"],"spl_id":["726ea2db-f1b0-4b73-a515-02157db88a42"],"spl_set_id":["726ea2db-f1b0-4b73-a515-02157db88a42"],"package_ndc":["66758-211-01","66758-211-31"],"unii":["PYF7O1FV7F"]},"update_date":"01/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Lescol XL, Tablet, Extended Release, 80 mg (NDC 66758-211-31)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0338-1077-02","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA020255"],"brand_name":["DOBUTAMINE HYDROCHLORIDE IN DEXTROSE"],"generic_name":["DOBUTAMINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1077","0338-1073","0338-1075"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"rxcui":["309985","309986","309987"],"spl_id":["34c787c1-46f7-4264-951d-c88a34dca533"],"spl_set_id":["6b17b98b-e06d-42ed-925f-69aa2699dead"],"package_ndc":["0338-1073-02","0338-1075-02","0338-1077-02"],"unii":["0WR771DJXV"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/100 mL (NDC 0338-1077-02)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"05/04/2021","package_ndc":"59137-570-01","generic_name":"Triamcinolone Hexacetonide Injection","related_info_link":"https://www.fda.gov/files/drugs/published/hexatrione_dhcp_09-15-2026_with_pi.pdf","contact_info":"1-855-336-3322 Option 9","availability":"Available","openfda":{"brand_name":["HEXATRIONE 2%"],"generic_name":["TRIAMCINOLONE HEXACETONIDE"],"manufacturer_name":["Medexus Pharma, Inc."],"product_ndc":["59137-570"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR"],"substance_name":["TRIAMCINOLONE HEXACETONIDE"],"rxcui":["2539176","2539181"],"spl_id":["5b889707-a1a2-3fb8-e063-6294a90a3777"],"spl_set_id":["bc07ae9f-8a74-6bc8-e053-2995a90afc0d"],"package_ndc":["59137-570-01"],"unii":["I7GT1U99Y9"]},"update_date":"09/15/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Hexatrione, Injection, 40 mg/2 mL (NDC 59137-570-01)","company_name":"Medexus","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/21/2023","package_ndc":"39822-5550-6","generic_name":"Promethazine Hydrochloride Injection","contact_info":"866-390-4411","availability":"Unvailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040737"],"brand_name":["PROMETHAZINE HYDROCHLORIDE"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["XGen Pharmaceuticals DJB, Inc."],"product_ndc":["39822-5550"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992858"],"spl_id":["0e860109-725f-1c28-e063-6394a90a50ef"],"spl_set_id":["b6f6698f-f23c-452a-9b38-bbb96ab88ae4"],"package_ndc":["39822-5550-5","39822-5550-6"],"unii":["R61ZEH7I1I"]},"update_date":"09/22/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Other","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 39822-5550-6)","company_name":"XGen Pharmaceuticals DJB, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-495-07","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-495","63323-492","63323-491","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-07)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-046-88","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-818-4555","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA214484"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-046","57664-047","57664-048","57664-049","57664-050","57664-051","57664-052","57664-083","57664-084","57664-085","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 57664-046-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/13/2022","package_ndc":"0409-7517-16","generic_name":"Dextrose Monohydrate 50% Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: November 2026.  Estimated Recovery: March 2027.  Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA019445"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7517","0409-6648"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["727517","1795514"],"spl_id":["34b869af-c42d-457c-8b21-6215a4e07aff"],"spl_set_id":["4ed365da-4e62-4329-c1b9-c197ab4fb6e1"],"package_ndc":["0409-7517-66","0409-7517-16","0409-6648-16","0409-6648-02"],"unii":["LX22YL083G"]},"update_date":"10/27/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-7517-16)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"71288-203-11","generic_name":"Furosemide Injection","contact_info":"844-824-8426","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA212803"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-203"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["b06d36f6-507c-4b04-b79d-d6370a30a551","53a09c30-7295-4337-89a4-93d3748d6ea3"],"spl_set_id":["a2e3c748-28ce-4c50-a182-721912919840","3aadaca7-3661-4bfe-87f8-6368e4ab6536"],"package_ndc":["71288-203-02","71288-203-03","71288-203-04","71288-203-05","71288-203-10","71288-203-11","71288-203-91","71288-203-92","71288-203-93","71288-203-94"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"08/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 71288-203-11)","company_name":"Meitheal Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/06/2017","package_ndc":"0338-1007-03","generic_name":"Dopamine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Limited Availability","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["NDA019615"],"brand_name":["DOPAMINE HYDROCHLORIDE AND DEXTROSE"],"generic_name":["DOPAMINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1007","0338-1005","0338-1009"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1292887","1743869","1743871","1743877","1743879"],"spl_id":["edc9a091-4cb5-4ec7-b6f9-44d2d588bab9"],"spl_set_id":["cb97d4a0-89ed-407c-a763-209386b6f75c"],"package_ndc":["0338-1005-02","0338-1005-03","0338-1007-02","0338-1007-03","0338-1009-02"],"unii":["7L3E358N9L"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-03)","company_name":"Baxter Healthcare","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-1160-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070590"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1160","0409-1159","0409-1162","0409-1163","0409-1165","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, Marcaine 125 mg/50 mL (2.5 mg/mL) (NDC 0409-1160-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"09/18/2026","update_type":"New","initial_posting_date":"09/18/2026","package_ndc":"0378-9070-93","generic_name":"Rivastigmine Film, Extended Release","contact_info":"800-796-9526","related_info":"Discontinuation of the manufacture of the drug.","openfda":{"application_number":["ANDA205622"],"brand_name":["RIVASTIGMINE"],"generic_name":["RIVASTIGMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-9070","0378-9071","0378-9072"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TRANSDERMAL"],"substance_name":["RIVASTIGMINE"],"rxcui":["725021","725023","1308569"],"spl_id":["c1d8c8a9-87e9-4ca1-ba70-4a7467205fd4"],"spl_set_id":["4ab335d1-19ee-4cd9-9776-8086645d19e4"],"package_ndc":["0378-9070-16","0378-9070-93","0378-9071-16","0378-9071-93","0378-9072-16","0378-9072-93"],"nui":["N0000175723","N0000000177"],"pharm_class_epc":["Cholinesterase Inhibitor [EPC]"],"pharm_class_moa":["Cholinesterase Inhibitors [MoA]"],"unii":["PKI06M3IW0"]},"update_date":"09/18/2026","therapeutic_category":["Neurology"],"dosage_form":"Film, Extended Release","presentation":"Rivastigmine, Film, Extended Release, 4.6 mg/24 h (NDC 0378-9070-93)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"47781-568-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA214547"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-568","47781-562","47781-563","47781-564","47781-565","47781-566","47781-567"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["db02ec6b-f17f-ab22-b671-e1ddb90e017c"],"spl_set_id":["7f2dd6ee-3363-c87c-9693-ed838942556c"],"package_ndc":["47781-562-01","47781-563-01","47781-564-01","47781-565-01","47781-566-01","47781-567-01","47781-568-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 47781-568-01)","company_name":"Alvogen","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"70010-116-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"877-770-3183","availability":"Unavailable","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA215771"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Granules Pharmaceuticals Inc."],"product_ndc":["70010-116","70010-111","70010-112","70010-113","70010-114","70010-115","70010-117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["56c7c921-e560-c5ad-e063-6294a90a4c81"],"spl_set_id":["b0b4eccc-34c7-483d-966f-82d588358e1b"],"package_ndc":["70010-111-01","70010-111-03","70010-112-01","70010-112-03","70010-113-01","70010-113-03","70010-114-01","70010-114-03","70010-115-01","70010-115-03","70010-116-01","70010-116-03","70010-117-01","70010-117-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/28/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 70010-116-01)","company_name":"Granules Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"08/24/2026","update_type":"New","initial_posting_date":"08/24/2026","package_ndc":"0025-2732-31","generic_name":"Disopyramide Phosphate Capsule, Extended Release","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug","update_date":"08/24/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule, Extended Release","presentation":"Norpace CR, Capsule, Extended Release, 100 mg (NDC 0025-2732-31)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/14/2017","package_ndc":"0264-9872-00","generic_name":"Heparin Sodium Injection","contact_info":"800-227-2862","availability":"Limited Availability","related_info":"Estimated recovery: late Q4 2026; Manufacturing delays","openfda":{"application_number":["NDA019953"],"brand_name":["HEPARIN SODIUM IN SODIUM CHLORIDE"],"generic_name":["HEPARIN SODIUM IN SODIUM CHLORIDE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-9872"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["HEPARIN SODIUM"],"spl_id":["608baa6b-f42a-4ae7-ae88-7f2e2ae71aba"],"spl_set_id":["a3041c04-0ea8-4d36-81ce-c5091c906316"],"package_ndc":["0264-9872-10","0264-9872-00"],"unii":["ZZ45AB24CA"]},"update_date":"10/19/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00)","company_name":"B. Braun Medical Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"01/12/2026","update_type":"New","initial_posting_date":"01/12/2026","package_ndc":"0378-4615-01","generic_name":"Doxylamine Succinate and Pyridoxine  Hydrochloride Tablet, Delayed Release","contact_info":"800-796-9526","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"01/12/2026","therapeutic_category":["Other"],"dosage_form":"Tablet","presentation":"Doxylamine Succinate and Pyridoxine  Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"discontinued_date":"05/05/2026","update_type":"New","initial_posting_date":"05/05/2026","package_ndc":"71288-726-52","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-824-8426","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA216039"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc"],"product_ndc":["71288-726","71288-723"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["0949c302-51ce-4fc9-8b99-1df94e693718"],"spl_set_id":["fe340f98-a0f3-446e-b281-47fd91c1e537"],"package_ndc":["71288-723-52","71288-726-52"],"unii":["7TQO7W3VT8"]},"update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52)","company_name":"Kindos Pharmaceuticals Co. Ltd.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/15/2023","package_ndc":"65219-442-05","generic_name":"Rocuronium Bromide Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA217472"],"brand_name":["ROCURONIUM"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-442","65219-444","65219-695","65219-697"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["2720024","2720026"],"spl_id":["31c4c874-3d24-4c86-a301-ee9faf0b5c00"],"spl_set_id":["9a622308-7bda-4ca0-9de5-d6b3b4be3384"],"package_ndc":["65219-442-02","65219-442-05","65219-444-04","65219-444-10","65219-695-01","65219-695-05","65219-697-01","65219-697-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-442-05)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0527-4665-37","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-4665","0527-4661","0527-4662","0527-4663","0527-4664","0527-4666","0527-4667"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["164b5658-3c14-44f5-b10a-839909184984"],"spl_set_id":["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"],"package_ndc":["0527-4661-37","0527-4662-37","0527-4663-37","0527-4664-37","0527-4665-37","0527-4666-37","0527-4667-37"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0527-4665-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"64850-556-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-852-6657","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA218604"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-556","64850-550","64850-551","64850-552","64850-553","64850-554","64850-555"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["2d33f701-8067-4a48-98cc-4e7dacaf3cc4"],"spl_set_id":["0e024b69-567c-4b40-9c3e-a2daec34256c"],"package_ndc":["64850-550-01","64850-551-01","64850-552-01","64850-553-01","64850-554-01","64850-555-01","64850-556-01"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 64850-556-01)","company_name":"Elite Laboratories, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"12/10/2025","update_type":"New","initial_posting_date":"12/10/2025","package_ndc":"58468-0126-1","generic_name":"Doxercalciferol Injection","contact_info":"800-633-1610","related_info":"Discontinuation of the manufacture of the drug","update_date":"12/10/2025","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Hectorol, Injection, 2 mcg/mL injection 50 single-dose vials (NDC 58468-0126-1)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"76045-009-06","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA019034"],"brand_name":["DILAUDID"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-009","76045-010","76045-121"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1872265","1872269","1872752","2277368","2277370"],"spl_id":["002d5650-24df-4b60-a5ce-e7adc091026f"],"spl_set_id":["9eebd88a-5632-460f-b7b6-26c8a180540d"],"package_ndc":["76045-009-96","76045-009-06","76045-009-01","76045-009-11","76045-010-01","76045-010-11","76045-121-01","76045-121-11"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Dilaudid, Injection, 1 mg/1 mL (NDC 76045-009-06)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-8016-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-8016","0075-8013","0075-8014","0075-8018","0075-8020","0075-8030","0075-8022","0075-8025"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["006561fa-e16d-4129-9dde-89c109b51d8f"],"spl_set_id":["de6fb917-a94a-41ea-9d7d-937d4080ffcd"],"package_ndc":["0075-8013-01","0075-8013-10","0075-8014-01","0075-8014-10","0075-8016-01","0075-8016-10","0075-8018-01","0075-8018-10","0075-8020-01","0075-8020-10","0075-8030-01","0075-8022-01","0075-8022-10","0075-8025-01","0075-8025-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 60 mg/.6 mL (NDC 0075-8016-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"72266-263-10","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-217-8103","availability":"Available","related_info":"Distributed by Fosun Pharma USA Inc.","openfda":{"application_number":["ANDA091487"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fosun Pharma USA Inc."],"product_ndc":["72266-263","72266-264"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724880","1725078"],"spl_id":["55904ca6-a5ad-76ce-e063-6294a90ac5e0"],"spl_set_id":["3a996abe-0bb9-4590-e063-6394a90a0b60"],"package_ndc":["72266-263-10","72266-264-10"],"unii":["7TQO7W3VT8"]},"update_date":"09/18/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride PRESERVATIVE FREE, Injection, 2.5 mg/1 mL\n5mg / 1mL (NDC 72266-263-10)","company_name":"ONESOURCE SPECIALTY PTE LTD","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"65219-632-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","openfda":{"application_number":["ANDA212808"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["FRESENIUS KABI USA, LLC"],"product_ndc":["65219-632"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734347","1734355"],"spl_id":["7203f32f-2e48-4924-b882-d4f3863ae952"],"spl_set_id":["da4a7675-97bf-4d2a-9fdc-c1b4b2999126"],"package_ndc":["65219-632-02","65219-632-10","65219-632-04","65219-632-20"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"43547-607-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-931-9829","availability":"Limited Availability","related_info":"On allocation","openfda":{"application_number":["ANDA216266"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE CAPSULES"],"manufacturer_name":["Solco Healthcare US,LLC"],"product_ndc":["43547-607","43547-602","43547-603","43547-604","43547-605","43547-606","43547-608"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["d6435613-e052-4b4f-8bf7-4acb7458d8df"],"spl_set_id":["68b10d9f-ca3e-493d-a309-45f1d7e08061"],"package_ndc":["43547-602-10","43547-603-10","43547-604-10","43547-605-10","43547-606-10","43547-607-10","43547-608-10"],"unii":["SJT761GEGS"]},"update_date":"06/29/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 43547-607-10)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-120-01","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA208510"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-120","59417-101","59417-102","59417-103","59417-104","59417-105","59417-106","59417-107","59417-115","59417-116","59417-117","59417-118","59417-119"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-3178-01","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: February 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA089644"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3178","0409-1209","0409-3177","0409-3181","0409-3182","0409-3183","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-1312-30","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA200403"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1312","0409-1283","0409-4264","0409-1805","0409-2552","0409-3356","0409-2540","0409-3365","0409-1304"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1724383","1724644","2675350","897653","897753","897758","1724276"],"spl_id":["766e302a-2d03-4d93-b237-2348b57ee517","a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"],"spl_set_id":["f9ca2ef5-46d8-475a-a26e-f7c8becd6db7","e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"],"package_ndc":["0409-1283-17","0409-1283-37","0409-1312-16","0409-1312-36","0409-4264-11","0409-4264-01","0409-1805-10","0409-1805-01","0409-2552-11","0409-2552-01","0409-3356-11","0409-3356-01","0409-2540-11","0409-2540-01","0409-3365-11","0409-3365-01","0409-3365-10","0409-1283-03","0409-1283-31","0409-1312-03","0409-1312-30","0409-1304-03","0409-1304-31"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 2 mg/1 mL Syringes (NDC 0409-1312-30)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"55150-222-20","generic_name":"Etomidate Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA206126"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-222","55150-221"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["278b160e-cdc4-451e-9405-cb001f443680"],"spl_set_id":["0820f15a-046b-4185-a2b3-2e4051ee3d82"],"package_ndc":["55150-221-10","55150-222-20"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 40 mg/20 mL (NDC 55150-222-20)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"12/19/2025","update_type":"New","initial_posting_date":"12/19/2025","package_ndc":"54092-171-12","generic_name":"Carbamazepine Capsule, Extended Release","contact_info":"855-268-1825","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020712"],"brand_name":["CARBATROL"],"generic_name":["CARBAMAZEPINE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["54092-171","54092-172","54092-173"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CARBAMAZEPINE"],"rxcui":["200131","200133","308977","313931","388311","404742"],"spl_id":["4186c118-9875-4b12-b652-3fbfaf4e6622"],"spl_set_id":["bc03e499-5bac-4293-bff4-6864153a624d"],"package_ndc":["54092-171-12","54092-172-12","54092-173-12"],"nui":["N0000008486","N0000175751","N0000185506","N0000191266","N0000187064","N0000185507","N0000185607"],"pharm_class_pe":["Decreased Central Nervous System Disorganized Electrical Activity [PE]"],"pharm_class_epc":["Mood Stabilizer [EPC]"],"pharm_class_moa":["Cytochrome P450 3A4 Inducers [MoA]","Cytochrome P450 1A2 Inducers [MoA]","Cytochrome P450 2B6 Inducers [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 2C19 Inducers [MoA]"],"unii":["33CM23913M"]},"update_date":"12/19/2025","therapeutic_category":["Neurology"],"dosage_form":"Capsule, Extended Release","presentation":"Carbatrol, Capsule, Extended Release, 100 mg (NDC 54092-171-12)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/24/2017","package_ndc":"51754-5012-4","generic_name":"Sodium Bicarbonate Injection","contact_info":"828-758-5474 ext. 154","availability":"Available","openfda":{"application_number":["ANDA211091"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["Exela Pharma Sciences, LLC"],"product_ndc":["51754-5012","51754-5001","51754-5011","51754-5002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["807284","1868486","1923484","2198792"],"spl_id":["4da0ba66-756d-4b4d-8018-81ca16578ef1"],"spl_set_id":["e9698a4f-1a95-4f28-a945-e8009d1d6dd4"],"package_ndc":["51754-5001-5","51754-5001-4","51754-5011-4","51754-5002-5","51754-5012-4"],"unii":["8MDF5V39QO"]},"update_date":"10/15/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4)","company_name":"Exela Pharma Sciences, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"61703-350-10","generic_name":"Methotrexate Sodium Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA011719"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-350","61703-408"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1655956","1946772"],"spl_id":["6d38984b-4deb-42c3-bf1d-4e0b0c8887e6","db79ea57-58c9-4bd4-86df-9a23f3294ac8"],"spl_set_id":["0d63ba29-b692-41b4-87e8-351265c8273f","0e30eaef-5a09-4104-8a11-c32933eadeab"],"package_ndc":["61703-350-37","61703-350-38","61703-408-41","61703-350-09","61703-350-10","61703-408-25"],"unii":["3IG1E710ZN"]},"update_date":"11/09/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium, Injection, 50 mg/2 mL  (25 mg/mL) (NDC 61703-350-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"05/03/2018","package_ndc":"76329-8261-1","generic_name":"Lorazepam Injection","contact_info":"800-423-4136","availability":"Available","openfda":{"application_number":["ANDA076150"],"brand_name":["LORAZEPAM"],"generic_name":["LORAZEPAM"],"manufacturer_name":["International Medication Systems, Limited"],"product_ndc":["76329-8261"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["238100"],"spl_id":["b85a6695-55b9-4780-a803-33f8f2464138"],"spl_set_id":["7dda070d-7809-46c4-8592-eb4e4c509707"],"package_ndc":["76329-8261-1"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"11/06/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Lorazepam, Injection, 2 mg/1 mL (NDC 76329-8261-1)","company_name":"Amphastar Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-487-37","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-487","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/06/2018","package_ndc":"0641-6041-25","generic_name":"Ketorolac Tromethamine Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA075772"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6041","0641-6043","0641-6042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["25d6c438-45d2-4162-91c2-b5caa0f86bf3"],"spl_set_id":["0c2c75c9-ed7b-46a8-9543-429bf2d8f090"],"package_ndc":["0641-6043-01","0641-6043-25","0641-6042-01","0641-6042-25","0641-6041-01","0641-6041-25"],"unii":["4EVE5946BQ"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 0641-6041-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"72572-161-10","generic_name":"Etomidate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Distributed by Civica","openfda":{"application_number":["ANDA202354"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Civica, Inc."],"product_ndc":["72572-161","72572-160"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["380f0c88-03f8-4cfa-8823-4766c2f7700c"],"spl_set_id":["98002094-f065-4b5f-963f-2c34b5241316"],"package_ndc":["72572-160-01","72572-160-10","72572-161-01","72572-161-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 72572-161-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0703-4246-01","generic_name":"Carboplatin Injection","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA077269"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-4246","0703-4244","0703-4248","0703-4239"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df","b943761e-6a46-45a0-bdb4-1fec1e101f8c"],"spl_set_id":["f330f5a2-2cad-402f-bcbb-26245a753276","e176b6ef-2ff6-498b-a9d8-7a634d147f37"],"package_ndc":["0703-4244-01","0703-4246-01","0703-4248-01","0703-4239-01","0703-4244-81","0703-4246-81","0703-4248-81","0703-4239-81"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4246-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/27/2023","package_ndc":"45567-0060-2","generic_name":"Technetium TC-99M Pyrophosphate Kit Injection","contact_info":"800-818-4555","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA019039"],"brand_name":["KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE"],"generic_name":["TECHNETIUM TC99M PYROPHOSPHATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["45567-0060"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["TECHNETIUM TC-99M PYROPHOSPHATE"],"spl_id":["3010b45e-eed1-a5d0-e063-6294a90a40cf"],"spl_set_id":["1f0cbd23-2fb3-43b7-b8af-7de246151149"],"package_ndc":["45567-0060-1","45567-0060-2"],"nui":["N0000177914","N0000000205"],"pharm_class_epc":["Radioactive Diagnostic Agent [EPC]"],"pharm_class_moa":["Radiopharmaceutical Activity [MoA]"],"unii":["5L76I61H2B"]},"update_date":"10/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-2)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"70121-1573-5","generic_name":"Methylprednisolone Acetate Injection","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA210043"],"brand_name":["METHYLPREDNISOLONE ACETATE"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["70121-1573","70121-1574"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743855"],"spl_id":["af4215ff-94ca-44f8-8506-3024e738cd13"],"spl_set_id":["d944240d-2c19-46ba-ad4f-3fbee7b8629c"],"package_ndc":["70121-1573-1","70121-1573-5","70121-1574-1","70121-1574-5"],"unii":["43502P7F0P"]},"update_date":"10/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-5)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"62175-313-37","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"844-834-0530","availability":"Limited Availability","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA091695"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Lannett Company, Inc."],"product_ndc":["62175-313","62175-310","62175-311","62175-312"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["2001564","2001565","2001566","2001568"],"spl_id":["8b133cd2-e3c6-4742-b402-2393b56ffc93"],"spl_set_id":["3d1f5aff-5d39-496c-b5ed-7f3c70ec641c"],"package_ndc":["62175-310-37","62175-311-37","62175-312-37","62175-313-37"],"unii":["4B3SC438HI"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62175-313-37)","company_name":"Lannett Company, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"04/28/2026","update_type":"New","initial_posting_date":"04/28/2026","package_ndc":"25021-311-04","generic_name":"Furosemide Injection","contact_info":"Sagent Pharmaceuticals: 866-625-1618","related_info":"Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA213902"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-311"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["222ce48f-2856-4be2-b16f-6fca38c0dceb"],"spl_set_id":["d63c1277-dd7e-4d21-9e80-68143f55e2dc"],"package_ndc":["25021-311-02","25021-311-04","25021-311-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"04/28/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)","company_name":"Gland Pharma Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"76045-104-10","generic_name":"Ketorolac Tromethamine Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA203242"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-104","76045-105","76045-107","76045-209"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860113","860114","860115"],"spl_id":["0dab642d-7fcf-4301-8ac9-10e64a040c6b"],"spl_set_id":["3d88cbe6-5230-47aa-80af-0c41283d1f00"],"package_ndc":["76045-104-10","76045-105-20","76045-107-10","76045-209-00","76045-209-10"],"unii":["4EVE5946BQ"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 76045-104-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"0409-9094-61","generic_name":"Fentanyl Citrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA019115"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9094","0409-9093"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735004","1735006","1735007","1735008","1735013"],"spl_id":["8ff8b8cf-1a31-46dc-b350-2b9cc700e6a6"],"spl_set_id":["bfa8018a-4cbc-434b-e09e-782872b0340a"],"package_ndc":["0409-9093-41","0409-9093-36","0409-9093-31","0409-9093-38","0409-9094-12","0409-9094-22","0409-9094-18","0409-9094-25","0409-9094-17","0409-9094-28","0409-9094-16","0409-9094-31","0409-9094-41","0409-9094-61","0409-9094-44","0409-9094-55"],"unii":["MUN5LYG46H"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 2500 mcg/50 mL (50 ug/1 mL) (NDC 0409-9094-61)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"0338-9545-50","generic_name":"Clindamycin Phosphate Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA208083"],"brand_name":["CLINDAMYCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-9545","0338-9549","0338-9553"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309335","309336","309339"],"spl_id":["b0a47c5e-911b-4b12-a0d1-a4425f173eec"],"spl_set_id":["44fa506b-90ac-42de-831b-5f3f1a500fc0"],"package_ndc":["0338-9545-50","0338-9545-24","0338-9549-50","0338-9549-24","0338-9553-50","0338-9553-24"],"unii":["EH6D7113I8"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-9545-50)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"11/19/2025","update_type":"New","initial_posting_date":"11/19/2025","package_ndc":"0378-5813-77","generic_name":"Valsartan Tablet","contact_info":"800-796-9526","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA090866"],"brand_name":["VALSARTAN"],"generic_name":["VALSARTAN"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-5813","0378-5807","0378-5814","0378-5815"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["VALSARTAN"],"rxcui":["349199","349200","349201","349483"],"spl_id":["db5a1e1d-200e-4a60-a392-98e24e5dbc29"],"spl_set_id":["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"],"package_ndc":["0378-5807-93","0378-5813-77","0378-5814-77","0378-5815-77"],"nui":["N0000000070","N0000175561"],"pharm_class_moa":["Angiotensin 2 Receptor Antagonists [MoA]"],"pharm_class_epc":["Angiotensin 2 Receptor Blocker [EPC]"],"unii":["80M03YXJ7I"]},"update_date":"11/19/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Valsartan, Tablet, 80 mg (NDC 0378-5813-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"discontinued_date":"09/11/2026","update_type":"New","initial_posting_date":"09/11/2026","package_ndc":"42023-230-10","generic_name":"Micafungin Sodium Injection","contact_info":"800-828-9393","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"09/11/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Micafungin Sodium, Injection, 20 mg/1 mL (NDC 42023-230-10)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"50458-586-01","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET","availability":"Available","openfda":{"application_number":["NDA021121"],"brand_name":["CONCERTA"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Janssen Pharmaceuticals, Inc."],"product_ndc":["50458-586","50458-585","50458-588","50458-587"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091157","1091170","1091172","1091185","1091187","1091210","1091212"],"spl_id":["64d7c1e1-e7ed-4d74-a44d-13b4da64af9a"],"spl_set_id":["1a88218c-5b18-4220-8f56-526de1a276cd"],"package_ndc":["50458-585-01","50458-588-01","50458-586-01","50458-587-01"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Concerta, Tablet, Extended Release, 36 mg (NDC 50458-586-01)","company_name":"Janssen Pharmaceuticals","status":"Current"},{"discontinued_date":"07/30/2026","update_type":"New","initial_posting_date":"07/30/2026","package_ndc":"63323-578-05","generic_name":"Glycopyrrolate Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA209328"],"brand_name":["GLYCOPYRROLATE"],"generic_name":["GLYCOPYRROLATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-578"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["GLYCOPYRROLATE"],"rxcui":["238212","1731582","1731590"],"spl_id":["779dc924-ecc3-41cc-8cf9-a7354db4f763","d528572e-598b-4c0e-b280-b083c73c017f"],"spl_set_id":["54458620-d888-4df6-ae4b-78c3dfed3423","ccafb5c2-86dd-4bb2-883a-c13e3171227c"],"package_ndc":["63323-578-03","63323-578-01","63323-578-04","63323-578-02","63323-578-07","63323-578-05","63323-578-18","63323-578-20","63323-578-41","63323-578-11","63323-578-42","63323-578-12"],"unii":["V92SO9WP2I"]},"update_date":"07/30/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Glycopyrrolate, Injection, 1 mg per 5 mL (NDC 63323-578-05)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"discontinued_date":"06/08/2026","update_type":"New","initial_posting_date":"06/08/2026","package_ndc":"0955-1735-30","generic_name":"Leflunomide Tablet","contact_info":"800-981-2491","related_info":"Discontinuation of the manufacture of the drug","update_date":"06/08/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Tablet","presentation":"Leflunomide, Tablet, 10 mg (NDC 0955-1735-30)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"57844-112-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Unavailable","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA040422"],"brand_name":["ADDERALL"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["57844-112","57844-105","57844-117","57844-110","57844-115","57844-120","57844-130"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541365","541878","541879","541892","541894","577957","577960","577961","577962","687043","687045","1009145","1009147"],"spl_id":["79af1dc6-c7cf-41b1-a750-e9b47c2187ff"],"spl_set_id":["f22635fe-821d-4cde-aa12-419f8b53db81"],"package_ndc":["57844-105-01","57844-117-01","57844-110-01","57844-112-01","57844-115-01","57844-120-01","57844-130-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Adderall, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 57844-112-01)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-153-30","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-153","72888-497","72888-152","72888-154"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 72888-153-30)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1159-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070583"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1159","0409-1160","0409-1162","0409-1163","0409-1165","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1725078","1725082","1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1867594","1867596"],"spl_id":["fb58e702-b0da-4fa9-91f2-4580b2305950","6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["bb44c7e1-d911-4788-908f-09b7b271969b","02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-09","0409-1159-10","0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-1159-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-1893-01","generic_name":"Morphine Sulfate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 10 mg/1 mL Syringes (NDC 0409-1893-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"70069-641-25","generic_name":"Atropine Sulfate Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA215969"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-641","70069-631"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190795","1666781"],"spl_id":["7a8a5552-fe21-4d36-8396-b7c99f41b4c4"],"spl_set_id":["a6fac578-c7bc-4b3c-a454-7889cc819118"],"package_ndc":["70069-631-01","70069-631-25","70069-641-01","70069-641-25"],"unii":["03J5ZE7KA5"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, 1 mg/1 mL (NDC 70069-641-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/01/2017","package_ndc":"76045-010-11","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release not available at this time.  Check wholesalers for inventory.","openfda":{"application_number":["NDA019034"],"brand_name":["DILAUDID"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-010","76045-009","76045-121"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1872265","1872269","1872752","2277368","2277370"],"spl_id":["002d5650-24df-4b60-a5ce-e7adc091026f"],"spl_set_id":["9eebd88a-5632-460f-b7b6-26c8a180540d"],"package_ndc":["76045-009-96","76045-009-06","76045-009-01","76045-009-11","76045-010-01","76045-010-11","76045-121-01","76045-121-11"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Dilaudid, Injection, 2 mg/1 mL (NDC 76045-010-11)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-493-97","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-493","63323-492","63323-496"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737636","1737637","1737640","1737641","1737763","1737764"],"spl_id":["fa12a8e8-09fd-496f-8cc6-ffe0eb02e2df"],"spl_set_id":["d5e0d06f-ba1e-44d4-aa89-39d6c146dc23"],"package_ndc":["63323-492-08","63323-492-97","63323-493-03","63323-493-97","63323-493-01","63323-493-91","63323-496-03","63323-496-97"],"unii":["EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-97)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"36000-283-25","generic_name":"Furosemide Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA202747"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["36000-283","36000-063","36000-064","36000-065","36000-282","36000-284"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["b4c1ae97-0f6c-4ae1-858a-4e0ab8f1ce53"],"spl_set_id":["c71371a7-75c5-45b8-b762-8d782d4c71bc"],"package_ndc":["36000-063-05","36000-064-05","36000-065-05","36000-282-25","36000-283-25","36000-284-25"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 36000-283-25)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"63323-165-05","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA084916"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-165"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["1116927","1812194"],"spl_id":["1815f54a-5637-45bc-a582-3e62350935ba","9dd90418-e564-4bc5-9077-506a1c2c1bce"],"spl_set_id":["2b626a48-c7aa-4443-9164-a08ff069ccd1","4fedef4f-ec96-4f36-b2f0-01e243e3b89e"],"package_ndc":["63323-165-11","63323-165-51","63323-165-13","63323-165-53","63323-165-02","63323-165-01","63323-165-03","63323-165-05","63323-165-30","63323-165-16","63323-165-26"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 63323-165-05)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0338-1130-04","generic_name":"Amino Acid Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA075880"],"brand_name":["PREMASOL - SULFITE-FREE (AMINO ACID)"],"generic_name":["LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-1130","0338-1131"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LEUCINE","LYSINE ACETATE","ISOLEUCINE","VALINE","HISTIDINE","PHENYLALANINE","THREONINE","METHIONINE","TRYPTOPHAN","TYROSINE","ARGININE","PROLINE","ALANINE","GLUTAMIC ACID","SERINE","GLYCINE","ASPARTIC ACID","TAURINE","CYSTEINE HYDROCHLORIDE"],"rxcui":["801395","801398","801403","801405"],"spl_id":["c874a813-b145-4f7f-833e-97d6c4dd727c"],"spl_set_id":["9afdcc3e-0d06-47f4-86ca-40da48b2b02b"],"package_ndc":["0338-1130-03","0338-1130-04","0338-1130-06","0338-1131-03"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["GMW67QNF9C","TTL6G7LIWZ","04Y7590D77","HG18B9YRS7","4QD397987E","47E5O17Y3R","2ZD004190S","AE28F7PNPL","8DUH1N11BX","42HK56048U","94ZLA3W45F","9DLQ4CIU6V","OF5P57N2ZX","3KX376GY7L","452VLY9402","TE7660XO1C","30KYC7MIAI","1EQV5MLY3D","ZT934N0X4W"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-04)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-353-01","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-01)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0409-2596-03","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA075293"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2596","0409-2587"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["6c075a2d-b68b-41a7-aa0c-bcf9894e3f76"],"spl_set_id":["affecd4d-1f78-4bbe-5a8d-86849bbdc520"],"package_ndc":["0409-2587-04","0409-2587-05","0409-2596-13","0409-2596-03","0409-2596-15","0409-2596-05"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"62332-600-25","generic_name":"Ketorolac Tromethamine Injection","contact_info":"908-393-9604","availability":"Available","openfda":{"application_number":["ANDA214456"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Alembic Pharmaceuticals Inc."],"product_ndc":["62332-600","62332-599","62332-601"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["9030f496-5021-4454-ac16-dbb376315608"],"spl_set_id":["419cf756-3c96-4bb8-ae96-6aea5a5f3afd"],"package_ndc":["62332-599-01","62332-599-25","62332-600-01","62332-600-25","62332-601-02","62332-601-25"],"unii":["4EVE5946BQ"]},"update_date":"05/15/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 62332-600-25)","company_name":"Alembic Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2018","package_ndc":"73293-0001-2","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"intbiz@huons.com","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA212821"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Huons Co., Ltd."],"product_ndc":["73293-0001","73293-0004","73293-0005","73293-0003"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1737566","1737761"],"spl_id":["4711fd53-dad3-f117-e063-6394a90a8d3d"],"spl_set_id":["8ec2d256-fc4f-44f6-bee2-eef2bf3bf580"],"package_ndc":["73293-0004-1","73293-0004-2","73293-0005-1","73293-0005-2","73293-0001-1","73293-0001-2","73293-0003-1","73293-0003-2"],"unii":["V13007Z41A"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 73293-0001-2)","company_name":"Huons Co., Ltd. (South Korea)","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/04/2024","package_ndc":"0591-2888-30","generic_name":"Hydroxocobalamin Injection","contact_info":"800-545-8800","availability":"Unavailable","related_info":"Estimated recovery: mid-November 2026","openfda":{"application_number":["ANDA085998"],"brand_name":["HYDROXOCOBALAMIN"],"generic_name":["HYDROXOCOBALAMIN"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0591-2888"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["HYDROXOCOBALAMIN ACETATE"],"rxcui":["317106"],"spl_id":["c47477bf-6413-4699-ab77-c5441a9d1557"],"spl_set_id":["a3087a39-f218-4f16-a1e7-17c39bb2eb69"],"package_ndc":["0591-2888-30"],"unii":["S535M27N3Q"]},"update_date":"11/02/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Hydroxocobalamin, Injection, 1000 MCG/ML, 30 ML Multi-Dose Vial (NDC 0591-2888-30)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"16729-239-93","generic_name":"Dexmedetomidine Hydrochloride Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Dexmedetomidine%20Hydrochloride%20Injection&st=d","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA204023"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-239"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710"],"spl_id":["2de0daf8-b7a3-1dca-e063-6394a90a4d0a"],"spl_set_id":["2b9881f0-4a66-660f-e054-00144ff88e88"],"package_ndc":["16729-239-30","16729-239-93"],"unii":["1018WH7F9I"]},"update_date":"09/15/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)","company_name":"Accord Healthcare Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"New","initial_posting_date":"02/20/2018","package_ndc":"31722-276-32","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-529-0430, customerservice@camberpharma.com","availability":"Available","openfda":{"application_number":["ANDA217821"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Camber Pharmaceuticals, Inc."],"product_ndc":["31722-276","31722-275","31722-277"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["4ea16f8e-77de-3ba7-e063-6394a90a5667"],"spl_set_id":["0e552e3a-cf52-4d74-9381-6cc1b29b4c90"],"package_ndc":["31722-275-10","31722-275-31","31722-275-32","31722-275-30","31722-275-33","31722-275-34","31722-275-35","31722-276-10","31722-276-31","31722-276-32","31722-276-30","31722-276-33","31722-276-34","31722-277-10","31722-277-31","31722-277-32","31722-277-30","31722-277-33","31722-277-34"],"unii":["7TQO7W3VT8"]},"update_date":"07/17/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-32)","company_name":"Aspiro Pharma Limited","status":"Current"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"15054-0025-1","generic_name":"Palovarotene Capsule","contact_info":"(855)-463-5127","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA215559"],"brand_name":["SOHONOS"],"generic_name":["PALOVAROTENE"],"manufacturer_name":["Ipsen Biopharmaceuticals, Inc."],"product_ndc":["15054-0025","15054-0010","15054-0015","15054-0050","15054-0100"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["PALOVAROTENE"],"rxcui":["2663960","2663966","2663968","2663970","2663972","2663974","2663976","2663978","2663980","2663982"],"spl_id":["cf7687df-422d-4e5d-a576-c11767f3f485"],"spl_set_id":["67dce406-7cc4-4d66-92de-ad18b6df0625"],"package_ndc":["15054-0010-1","15054-0015-1","15054-0025-1","15054-0050-1","15054-0100-1"],"nui":["N0000175607","M0018962"],"pharm_class_epc":["Retinoid [EPC]"],"pharm_class_cs":["Retinoids [CS]"],"unii":["28K6I5M16G"]},"update_date":"08/31/2026","therapeutic_category":["Musculoskeletal"],"dosage_form":"Capsule","presentation":"SOHONOS, Capsule, 2.5 mg (NDC 15054-0025-1)","company_name":"Ipsen Biopharmaceuticals, Inc.","status":"To Be Discontinued"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-356-90","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-90)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/26/2018","package_ndc":"25021-701-02","generic_name":"Ketorolac Tromethamine Injection","contact_info":"866-625-1618","availability":"Unavailable","related_info":"Product in transit with expected delivery in December 2026","openfda":{"application_number":["ANDA204216"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-701","25021-700"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["cb23332a-48fa-458b-93ab-c4eef189a051"],"spl_set_id":["62591551-a644-4b2c-a0de-982e906fabc3"],"package_ndc":["25021-700-01","25021-701-01","25021-701-02"],"unii":["4EVE5946BQ"]},"update_date":"11/06/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)","company_name":"Sagent Pharmaceuticals","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/01/2023","package_ndc":"60505-4741-1","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-706-5575","availability":"Available","openfda":{"application_number":["ANDA216944"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-4741","60505-4739","60505-4740","60505-4742","60505-4743","60505-4744","60505-4745"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0190bec9-05e4-0977-9548-2cc150b53e74"],"spl_set_id":["ecad4442-a644-18e3-6ff2-fdbac45eec47"],"package_ndc":["60505-4739-1","60505-4740-1","60505-4741-1","60505-4742-1","60505-4743-1","60505-4744-1","60505-4745-1"],"unii":["SJT761GEGS"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 60505-4741-1)","company_name":"Apotex Corp.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/06/2018","package_ndc":"0338-0072-25","generic_name":"Ketorolac Tromethamine Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA209900"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0072","0338-0069","0338-0076"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["2da4dd8a-1b18-481d-b733-9c031d9ea7e3"],"spl_set_id":["4b58836d-9d58-4539-9691-9e11c505ef2a"],"package_ndc":["0338-0069-10","0338-0072-25","0338-0076-10"],"unii":["4EVE5946BQ"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0338-0072-25)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/01/2022","package_ndc":"0990-7930-03","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Limited Availability","related_info":"On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA018080"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7930","0990-7923","0990-7922"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0413-06","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017512"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0413","0941-0411","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-06)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"discontinued_date":"03/27/2026","update_type":"New","initial_posting_date":"03/27/2026","package_ndc":"0023-6150-04","generic_name":"Progesterone Vaginal Gel","contact_info":"800-678-1605","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020701"],"brand_name":["CRINONE"],"generic_name":["PROGESTERONE"],"manufacturer_name":["Allergan, Inc."],"product_ndc":["0023-6150","0023-6151"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["VAGINAL"],"substance_name":["PROGESTERONE"],"rxcui":["153579","153580","312643","312645"],"spl_id":["ab1523af-0bbb-4231-a12c-ac52e3ec91cd"],"spl_set_id":["75e97aa1-daa4-45f9-b2e2-1a371302914e"],"package_ndc":["0023-6150-04","0023-6151-08"],"nui":["M0017672","N0000175601"],"pharm_class_cs":["Progesterone [CS]"],"pharm_class_epc":["Progesterone [EPC]"],"unii":["4G7DS2Q64Y"]},"update_date":"03/27/2026","therapeutic_category":["Urology"],"dosage_form":"Vaginal Gel","presentation":"Crinone, Vaginal Gel, 4% (NDC 0023-6150-04)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"discontinued_date":"12/01/2025","update_type":"New","initial_posting_date":"12/01/2025","package_ndc":"59212-001-01","generic_name":"Phenoxybenzamine Hydrochloride Capsule","contact_info":"847-283-7921","related_info":"Discontinuation of the manufacture of the drug","update_date":"12/01/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Dibenzyline, Capsule, 10 mg (NDC 59212-001-01)","company_name":"Advanz Pharma (US) Corp.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"83634-653-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"Avenacy, LLC: 877-283-6229","availability":"Available","related_info":"Distributed by Avenacy, LLC","openfda":{"application_number":["ANDA219535"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Avenacy, LLC"],"product_ndc":["83634-653","83634-651"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1737562","1737566","1737568"],"spl_id":["8fb1dd7b-f349-4a64-96c1-bd72bf748f3b"],"spl_set_id":["46480253-29b9-4d7f-98ed-10377929026b"],"package_ndc":["83634-653-41","83634-653-02","83634-653-42","83634-653-05","83634-653-43","83634-653-30","83634-651-41","83634-651-10","83634-651-42","83634-651-20","83634-651-43","83634-651-50"],"unii":["V13007Z41A"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 20 mg/2 mL (NDC 83634-653-02)","company_name":"Anthea Pharma","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/01/2023","package_ndc":"60505-4742-1","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-706-5575","availability":"Available","openfda":{"application_number":["ANDA216944"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-4742","60505-4739","60505-4740","60505-4741","60505-4743","60505-4744","60505-4745"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0190bec9-05e4-0977-9548-2cc150b53e74"],"spl_set_id":["ecad4442-a644-18e3-6ff2-fdbac45eec47"],"package_ndc":["60505-4739-1","60505-4740-1","60505-4741-1","60505-4742-1","60505-4743-1","60505-4744-1","60505-4745-1"],"unii":["SJT761GEGS"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 60505-4742-1)","company_name":"Apotex Corp.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-162-05","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203082"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-162","55150-161","55150-163","55150-164","55150-165"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737562","1737566","1737568","1737757","1737761"],"spl_id":["bab2ea79-0aed-4f48-8b4e-f864f8b82fb8","d95a0a28-804f-44d2-aa31-01df376a3154"],"spl_set_id":["9916b09d-a116-469d-92d5-60e50ea9782b","89701fac-7536-4f16-87fb-f4cc121e74ee"],"package_ndc":["55150-161-09","55150-162-09","55150-163-00","55150-163-24","55150-164-09","55150-165-09","55150-161-02","55150-162-05","55150-163-30","55150-163-25","55150-164-02","55150-165-05"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0990-7923-37","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7923","0990-7922","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-37)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"discontinued_date":"02/20/2026","update_type":"New","initial_posting_date":"02/20/2026","package_ndc":"50742-447-45","generic_name":"Carboplatin Injection","contact_info":"866-321-5031","related_info":"Discontinuation of the manufacture of the drug","update_date":"02/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 450 mg/45 mL (NDC 50742-447-45)","company_name":"Ingenus Pharmaceuticals LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"62135-485-90","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com","availability":"Available","openfda":{"application_number":["ANDA076803"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-485","62135-484","62135-486","62135-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["09cd5cb9-4fdf-f133-e063-6294a90af691"],"spl_set_id":["dbc43dbd-94aa-40e2-a9ea-766110cc8687"],"package_ndc":["62135-484-60","62135-485-90","62135-486-90","62135-487-90"],"unii":["33067B3N2M"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 10 mg (NDC 62135-485-90)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"65862-161-90","generic_name":"Quinapril/Hydrochlorothiazide Tablet","contact_info":"866-850-2876","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA078450"],"brand_name":["QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"],"generic_name":["QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["65862-161","65862-162","65862-163"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE","HYDROCHLOROTHIAZIDE"],"rxcui":["310796","310797","310809"],"spl_id":["5842ecc2-874a-481b-8997-afa9d862dc5d"],"spl_set_id":["50a58159-9572-4445-9859-b392632597da"],"package_ndc":["65862-161-90","65862-162-30","65862-162-90","65862-163-90"],"nui":["N0000175359","N0000175419","M0471776"],"pharm_class_pe":["Increased Diuresis [PE]"],"pharm_class_epc":["Thiazide Diuretic [EPC]"],"pharm_class_cs":["Thiazides [CS]"],"unii":["0J48LPH2TH","33067B3N2M"]},"update_date":"11/04/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 65862-161-90)","company_name":"Aurobindo Pharma USA","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4282-01","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA088294"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4282","0409-4713","0409-4278","0409-4279","0409-4776","0409-4277","0409-4276","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 40 mg/2 mL (2%; 20 mg/mL) (NDC 0409-4282-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-103-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA021977"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-103","59417-101","59417-102","59417-104","59417-105","59417-106","59417-107","59417-115","59417-116","59417-117","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Vyvanse, Capsule, 30 mg (NDC 59417-103-10)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/25/2017","package_ndc":"0338-0409-03","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA018461"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND DEXTROSE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0409","0338-0411"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737723","1737742","1737744"],"spl_id":["9e9121a0-25dd-46ba-a2b7-6f71fc3ff9cd"],"spl_set_id":["f21512ea-c7c3-4766-b976-b2c0b5616bf0"],"package_ndc":["0338-0409-03","0338-0409-02","0338-0411-02"],"unii":["V13007Z41A"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"02/20/2026","update_type":"New","initial_posting_date":"02/20/2026","package_ndc":"50742-463-16","generic_name":"Docetaxel Injection","contact_info":"866-321-5031","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"02/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Docetaxel, Injection, 10 mg/1 mL (NDC 50742-463-16)","company_name":"Ingenus Pharmaceuticals LLC","status":"To Be Discontinued"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"0009-3051-02","generic_name":"Clindamycin Phosphate Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","update_date":"06/01/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cleocin Phosphate, Injection, 300 mg/2 mL (150 mg/mL); 2 mL Vial NovaPlus (NDC 0009-3051-02)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/22/2020","package_ndc":"55150-393-01","generic_name":"Azacitidine Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA215066"],"brand_name":["AZACITIDINE"],"generic_name":["AZACITIDINE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-393"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["AZACITIDINE"],"rxcui":["485246"],"spl_id":["e89b9510-86df-4095-b6d3-4eb05b613c4f"],"spl_set_id":["ecd108bd-bb5f-4b2e-ad91-210fca452e9b"],"package_ndc":["55150-393-01"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["M801H13NRU"]},"update_date":"10/19/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Azacitidine, Injection, 100 mg/4 mL (NDC 55150-393-01)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"06/28/2022","package_ndc":"63323-723-03","generic_name":"Remifentanil Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA206223"],"brand_name":["REMIFENTANIL HYDROCHLORIDE"],"generic_name":["REMIFENTANIL HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-723","63323-724","63323-725"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["REMIFENTANIL HYDROCHLORIDE"],"rxcui":["1729578","1729584","1729710"],"spl_id":["406a07e3-a3f8-4fef-901e-021d00743c40","2f27e51f-2b55-47ee-bd4a-001b71c60622"],"spl_set_id":["5b8025d2-3424-477b-9cff-3990a98c2a65","d2374b84-81c9-44f9-a4a9-1071281b2531"],"package_ndc":["63323-723-04","63323-723-06","63323-723-01","63323-723-03","63323-724-01","63323-724-05","63323-725-01","63323-725-10"],"unii":["5V444H5WIC"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-723-03)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"63323-486-57","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-486","63323-492","63323-491","63323-495","63323-485","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 20 mg/1 mL (NDC 63323-486-57)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-102-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA021977"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-102","59417-101","59417-103","59417-104","59417-105","59417-106","59417-107","59417-115","59417-116","59417-117","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Vyvanse, Capsule, 20 mg (NDC 59417-102-10)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4713-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA080408"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4713","0409-4278","0409-4279","0409-4776","0409-4282","0409-4277","0409-4276","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride Preservative Free, Injection, 50 mg/5 mL (1%; 10 mg/mL) (NDC 0409-4713-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-0623-00","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-0623","0075-0624","0075-0620","0075-0621","0075-0622","0075-0626","0075-2912","0075-2915"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["cdb74d6d-1a74-4156-a52a-710c55cb2927"],"spl_set_id":["5017a927-2a24-4f27-89f9-27c805bf7d59"],"package_ndc":["0075-0624-01","0075-0624-30","0075-0620-01","0075-0620-40","0075-0621-01","0075-0621-60","0075-0622-01","0075-0622-80","0075-0623-03","0075-0623-00","0075-0626-03","0075-2912-00","0075-2912-01","0075-2915-00","0075-2915-01"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 100 mg/1 mL (NDC 0075-0623-00)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/21/2023","package_ndc":"0338-3814-50","generic_name":"Clindamycin Phosphate Injection","contact_info":"888-229-0001","availability":"Unavailable","related_info":"Estimated recovery: January 2027","openfda":{"application_number":["ANDA208084"],"brand_name":["CLINDAMYCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-3814","0338-3410","0338-3612"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309335","309336","309339"],"spl_id":["c8906ab2-37d2-4fde-9784-0442bf7b9565"],"spl_set_id":["78832ac6-04c5-45e0-ae4d-f56d7920dda9"],"package_ndc":["0338-3410-50","0338-3410-24","0338-3612-50","0338-3612-24","0338-3814-50","0338-3814-24"],"unii":["EH6D7113I8"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-3814-50)","company_name":"Baxter Healthcare","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"0409-5160-10","generic_name":"Rocuronium Bromide Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA205656"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-5160","0409-1403"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["f01f9986-43f9-40e8-9506-11bfe78f9242"],"spl_set_id":["f01f9986-43f9-40e8-9506-11bfe78f9242"],"package_ndc":["0409-1403-05","0409-1403-10","0409-5160-01","0409-5160-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-5160-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/17/2021","package_ndc":"0068-0597-01","generic_name":"Rifampin Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Rifampin%20Injection&st=d","contact_info":"800-633-1610","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Rifadin, Injection, 600 mg (NDC 0068-0597-01)","company_name":"Sanofi-Aventis U.S. LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0480-3567-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA202802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Teva Pharmaceuticals, Inc."],"product_ndc":["0480-3567","0480-3565","0480-3566","0480-3568","0480-3569","0480-3570","0480-3564"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["7a1feaa2-6b58-4aff-a45b-533ee3174e53"],"spl_set_id":["c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fc"],"package_ndc":["0480-3565-01","0480-3566-01","0480-3567-01","0480-3568-01","0480-3569-01","0480-3570-01","0480-3564-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0480-3567-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/18/2023","package_ndc":"0480-3667-20","generic_name":"Liraglutide Injection","contact_info":"833-493-4689","availability":"Available","related_info":"Distributed by Teva","openfda":{"application_number":["NDA022341"],"brand_name":["LIRAGLUTIDE"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0480-3667"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["897122"],"spl_id":["57c9f463-a1b8-4efa-8982-40175cf6cf4f"],"spl_set_id":["14bf9812-14ee-46ce-93b1-686e4906cbbc"],"package_ndc":["0480-3667-19","0480-3667-22","0480-3667-20"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"09/22/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-20)","company_name":"Novo Nordisk, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/05/2022","package_ndc":"67457-902-10","generic_name":"Etomidate Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA201044"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-902","67457-903"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["25fc0aef-d4b3-4b33-897c-81cc7cdae470"],"spl_set_id":["461e34d1-b862-4a02-9727-548c907aac48"],"package_ndc":["67457-902-00","67457-902-10","67457-903-00","67457-903-20"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 67457-902-10)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/12/2021","package_ndc":"60505-0815-0","generic_name":"Desmopressin Acetate Spray","contact_info":"800-706-5575","availability":"Limited Availability","related_info":"Replenishment expected mid to late November 2026","openfda":{"application_number":["ANDA076703"],"brand_name":["DESMOPRESSIN ACETATE"],"generic_name":["DESMOPRESSIN ACETATE"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-0815"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["NASAL"],"substance_name":["DESMOPRESSIN ACETATE TRIHYDRATE"],"rxcui":["849506"],"spl_id":["30550e89-9eed-13de-c2dc-8faea284ffed"],"spl_set_id":["1ac423b8-27a6-4cef-4a82-c50bf81b4f49"],"package_ndc":["60505-0815-0"],"unii":["XB13HYU18U"]},"update_date":"10/15/2026","therapeutic_category":["Hematology"],"dosage_form":"Spray","presentation":"Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0)","company_name":"Apotex Corp.","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"70069-047-25","generic_name":"Sodium Acetate Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA219826"],"brand_name":["SODIUM ACETATE ANHYDROUS"],"generic_name":["SODIUM ACETATE ANHYDROUS"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-047","70069-048"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["237371"],"spl_id":["1aae3237-9555-442b-b962-619d23f7e00a"],"spl_set_id":["93edebd6-ef7f-483a-80b6-bfaf34ea5ded"],"package_ndc":["70069-047-25","70069-048-20"],"unii":["NVG71ZZ7P0"]},"update_date":"10/27/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"71288-718-11","generic_name":"Rocuronium Bromide Injection","contact_info":"844-824-8426","availability":"Available","openfda":{"application_number":["ANDA213453"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-718","71288-700"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["aad39c88-2e2c-49a6-aa13-de852483661f","37295b13-65a4-40fa-8d6c-53aeb45e2939"],"spl_set_id":["b23aa80e-2af2-4a66-92ed-b1c8863be704","b9abaf64-760d-43e0-8669-a9ca70feab11"],"package_ndc":["71288-700-91","71288-700-92","71288-718-91","71288-718-92","71288-700-05","71288-700-06","71288-718-10","71288-718-11"],"unii":["I65MW4OFHZ"]},"update_date":"08/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-718-11)","company_name":"Meitheal Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0480-3566-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA202802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Teva Pharmaceuticals, Inc."],"product_ndc":["0480-3566","0480-3565","0480-3567","0480-3568","0480-3569","0480-3570","0480-3564"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["7a1feaa2-6b58-4aff-a45b-533ee3174e53"],"spl_set_id":["c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fc"],"package_ndc":["0480-3565-01","0480-3566-01","0480-3567-01","0480-3568-01","0480-3569-01","0480-3570-01","0480-3564-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0054-0375-25","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Available on allocation","openfda":{"application_number":["ANDA202827"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-0375","0054-0660","0054-0370","0054-0371","0054-0372","0054-0373","0054-0374"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"],"spl_set_id":["6740a621-9bec-4178-a4fc-a3fc89f34e0a"],"package_ndc":["0054-0660-25","0054-0370-25","0054-0371-25","0054-0372-25","0054-0373-25","0054-0374-25","0054-0375-25"],"unii":["SJT761GEGS"]},"update_date":"10/14/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0054-0375-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"72516-012-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"855-257-0292","availability":"Unavailable","related_info":"Estimated recovery: April 2027","openfda":{"application_number":["ANDA210293"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Oryza Pharmaceuticals Inc."],"product_ndc":["72516-012","72516-016","72516-015","72516-014","72516-013","72516-011"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["5734011d-5044-b490-e063-6394a90a3174"],"spl_set_id":["acd27181-a3f3-4c38-85d8-029a4a82e7c2"],"package_ndc":["72516-016-01","72516-015-01","72516-014-01","72516-013-01","72516-012-01","72516-011-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 72516-012-01)","company_name":"Oryza Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/08/2019","package_ndc":"0641-6145-25","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Product temporarily on backorder.  Additional lots will be available in the November 2026 timeframe.","openfda":{"application_number":["ANDA084282"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6145","0641-0367","0641-6146"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRAVENOUS","SOFT TISSUE"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696","1116927","1812194"],"spl_id":["02bf3273-f0c8-448c-9f74-eb009fee9299"],"spl_set_id":["0277cc0a-2fd4-4605-a310-b613be84ee26"],"package_ndc":["0641-0367-21","0641-0367-25","0641-6145-01","0641-6145-25","0641-6146-01","0641-6146-10","0641-6146-25"],"unii":["AI9376Y64P"]},"update_date":"10/14/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6145-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"12/03/2025","update_type":"New","initial_posting_date":"12/03/2025","package_ndc":"0409-7101-67","generic_name":"Sodium Chloride 0.9% Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA019465"],"brand_name":["SODIUM CHLORIDE"],"generic_name":["SODIUM CHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7101","0409-7132"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM CHLORIDE"],"rxcui":["1807547","1807631","1807632","1807633"],"spl_id":["147cbba6-2ead-49c4-bce7-4e9c65b303c9"],"spl_set_id":["a2a964f7-c3ec-4dfb-e3a0-6d8136a80397"],"package_ndc":["0409-7101-68","0409-7101-66","0409-7101-69","0409-7101-67","0409-7101-04","0409-7101-02","0409-7132-68","0409-7132-66","0409-7132-69","0409-7132-67","0409-7132-04","0409-7132-02"],"unii":["451W47IQ8X"]},"update_date":"12/03/2025","therapeutic_category":["Gastroenterology","Other","Renal"],"dosage_form":"Injection","presentation":"Sodium Chloride 0.9%, Injection, 100 mL  ADD-Vantage® Flexible Container (NDC 0409-7101-67)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"55150-196-99","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA205612"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-196","55150-195","55150-197","55150-198","55150-199","55150-200","55150-201"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734207","1734347","1734475","1734483"],"spl_id":["1e5f1368-058a-492c-b4b7-d9329a7745e2"],"spl_set_id":["3763b7b6-da49-4658-b93d-28f5da24d09e"],"package_ndc":["55150-195-20","55150-196-99","55150-197-20","55150-198-30","55150-199-20","55150-200-10","55150-201-20"],"unii":["V910P86109"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-196-99)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"63323-122-50","generic_name":"Methotrexate Sodium Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesaler for inventory","openfda":{"application_number":["ANDA040266"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE SODIUM"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-122"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL","INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["311625"],"spl_id":["3d21237a-ef53-4592-bf06-0c739696203d"],"spl_set_id":["ec476b11-0b3c-4139-b1eb-a3daa76bc271"],"package_ndc":["63323-122-50"],"unii":["3IG1E710ZN"]},"update_date":"11/03/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-088-88","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"800-818-4555","availability":"Available","openfda":{"application_number":["ANDA214134"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-088","57664-047","57664-046","57664-048","57664-049","57664-050","57664-051","57664-052","57664-083","57664-084","57664-085","57664-086","57664-087"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88)","company_name":"Sun Pharmaceutical Industries, Inc.","status":"Current"},{"discontinued_date":"01/06/2026","update_type":"New","initial_posting_date":"01/06/2026","package_ndc":"49884-119-91","generic_name":"Everolimus Tablet","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"01/06/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, 2.5 mg (NDC 49884-119-91)","company_name":"Endo Pharmaceuticals, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-4596-20","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4596","0409-0155"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718907","1718909","1718910"],"spl_id":["b62d8928-1ce3-488e-a89f-d7085c5510a7"],"spl_set_id":["92b7ddaa-e45a-4b64-a802-bb5df8771dd6"],"package_ndc":["0409-4596-01","0409-4596-20","0409-0155-01","0409-0155-02"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/30/2020","package_ndc":"63323-494-05","generic_name":"Valproate Sodium Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA076539"],"brand_name":["VALPROATE SODIUM"],"generic_name":["VALPROATE SODIUM"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-494"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["VALPROATE SODIUM"],"rxcui":["1099648"],"spl_id":["f09a2148-edd9-4918-8359-7554ed263d3a","fff889dc-6006-43c2-be57-01b2a5724b26"],"spl_set_id":["3dfb6da1-f66a-4618-9f74-d2d6c16c0b58","c572ece7-03d3-4c2a-aeb5-61f2023b28ea"],"package_ndc":["63323-494-41","63323-494-16","63323-494-01","63323-494-05"],"unii":["5VOM6GYJ0D"]},"update_date":"11/03/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Valproate Sodium, Injection, 100 mg/1 mL (NDC 63323-494-05)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-285-65","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-285","63323-286","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"61703-124-40","generic_name":"Methotrexate Sodium Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA011719"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-124","61703-161"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1655956","1946772"],"spl_id":["46b278e8-a016-4a68-b1c1-570d1bbdc10e"],"spl_set_id":["bd287e89-32f9-4396-95fa-4b562869f476"],"package_ndc":["61703-124-40","61703-161-02","61703-161-05"],"unii":["3IG1E710ZN"]},"update_date":"11/09/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-124-40)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"09/16/2026","update_type":"New","initial_posting_date":"09/16/2026","package_ndc":"63323-760-20","generic_name":"Melphalan Hydrochloride Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA203393"],"brand_name":["MELPHALAN"],"generic_name":["MELPHALAN HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-760"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["311487"],"spl_id":["f3373f9b-1680-411c-922f-df58a559a6aa"],"spl_set_id":["e9c2efee-173d-4795-96d8-7aae5b3a3073"],"package_ndc":["63323-760-20","63323-761-20","63323-732-10"]},"update_date":"09/16/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Melphalan Hydrochloride, Injection, Kit (NDC 63323-760-20)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"04/07/2020","package_ndc":"63323-280-04","generic_name":"Furosemide Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA018902"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-280"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["9804efac-5457-417a-8de7-a688467759c0","64b3fb5f-3516-4e39-b74e-e0e402ed9c4d"],"spl_set_id":["3747bbcd-783d-4baa-bb5b-b6827bf390e3","c794c95a-654e-48fe-9596-201fc122ff75"],"package_ndc":["63323-280-41","63323-280-16","63323-280-43","63323-280-26","63323-280-45","63323-280-36","63323-280-01","63323-280-02","63323-280-03","63323-280-04","63323-280-05","63323-280-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 63323-280-04)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/01/2022","package_ndc":"0338-0023-03","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016694"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0023","0338-0017"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"05/21/2026","update_type":"New","initial_posting_date":"05/21/2026","package_ndc":"50242-085-27","generic_name":"Alteplase Injection","contact_info":"800-551-2231","related_info":"Discontinuation of the 100mg vial configuration","openfda":{"application_number":["BLA103172"],"brand_name":["ACTIVASE"],"generic_name":["ALTEPLASE"],"manufacturer_name":["Genentech, Inc."],"product_ndc":["50242-085","50242-044"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["1804799","1804802","1804804","1804806"],"spl_id":["48ed2eb6-728a-41d8-b024-6b34e75dc4dc"],"spl_set_id":["c669f77c-fa48-478b-a14b-80b20a0139c2"],"package_ndc":["50242-044-13","50242-085-27"]},"update_date":"05/21/2026","therapeutic_category":["Cardiovascular","Hematology","Neurology"],"dosage_form":"Injection","presentation":"Activase, Injection, 1 KIT in 1 CARTON (50242-085-27) * 100 mL in 1 VIAL, SINGLE-USE * 100 mL in 1 VIAL, SINGLE USE (NDC 50242-085-27)","company_name":"Genentech, Inc","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"0641-6261-01","generic_name":"Sodium Acetate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be available. Product will be made available as it is released.","openfda":{"application_number":["ANDA216920"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6261"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["1859490"],"spl_id":["3493d4c1-4f73-44e8-94bc-7b55fe4fd436"],"spl_set_id":["8a338072-6f1e-460c-b9ec-59cef4f3f597"],"package_ndc":["0641-6261-01"],"unii":["NVG71ZZ7P0"]},"update_date":"10/14/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"62037-726-01","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-545-8800","availability":"Limited Availability","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA076772"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["62037-726","62037-725","62037-734","62037-727"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210"],"spl_id":["24aa9277-3773-489d-8459-f9215140c53f"],"spl_set_id":["85ef422d-af27-4126-9841-6892af1871d6"],"package_ndc":["62037-725-01","62037-734-01","62037-726-01","62037-727-01"],"unii":["4B3SC438HI"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62037-726-01)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"57664-609-88","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-818-4555","availability":"Unavailable","related_info":"Currently not marketed","update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 57664-609-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/07/2020","package_ndc":"0409-6102-25","generic_name":"Furosemide Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA018667"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["e598e8a6-c854-48f5-a412-fb6a6783774a","981d5143-60cd-4987-9b47-dec24c10de42"],"spl_set_id":["aaced7a8-c3d7-4d66-8c07-aa407b8b3f35","39fd32f2-6bb7-4a65-d298-e48d26bc80c7"],"package_ndc":["0409-6102-35","0409-6102-25","0409-6102-36","0409-6102-26","0409-6102-37","0409-6102-27","0409-6102-19","0409-6102-02","0409-6102-18","0409-6102-04","0409-6102-20","0409-6102-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-25)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/14/2022","package_ndc":"65219-460-20","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA207449"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["FRESENIUS KABI USA, LLC"],"product_ndc":["65219-460","65219-456","65219-464","65219-458","65219-462"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795607","1795609","1795610","1795612","1795616"],"spl_id":["efc3b0c9-518a-47db-bb3e-ebdfd4646e9b"],"spl_set_id":["576a22d8-5f2f-497e-80ad-1842ca74bb53"],"package_ndc":["65219-456-05","65219-456-60","65219-464-05","65219-464-50","65219-458-05","65219-458-30","65219-460-05","65219-460-20","65219-462-05","65219-462-10"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-460-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"73293-0002-2","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"+82-2-854-4700 or via email intbiz@huons.com","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA212822"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Huons Co., Ltd."],"product_ndc":["73293-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBARACHNOID"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724784"],"spl_id":["2e641a0d-4d42-e7cd-e063-6394a90a47d4"],"spl_set_id":["2dc693df-3218-4a90-b3f7-21e80966a851"],"package_ndc":["73293-0002-1","73293-0002-2"],"unii":["7TQO7W3VT8"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2)","company_name":"Huons Co., Ltd","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"63323-943-10","generic_name":"Succinylcholine Chloride Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA211346"],"brand_name":["SUCCINYLCHOLINE CHLORIDE"],"generic_name":["SUCCINYLCHOLINE CHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-943"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["SUCCINYLCHOLINE CHLORIDE"],"rxcui":["1594589"],"spl_id":["28aa281f-6312-44cc-ab8e-480a5c8d1ffb"],"spl_set_id":["4e2d3394-c9e0-4191-ba0d-da21034c22b5"],"package_ndc":["63323-943-21","63323-943-10"],"unii":["I9L0DDD30I"]},"update_date":"07/23/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Succinylcholine Chloride, Injection, 20 mg/1 mL (NDC 63323-943-10)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0409-2308-49","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA075857"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2308","0409-2305","0409-0001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666800","1666814","1666823","1666798"],"spl_id":["2f69c5b1-6505-42dc-8bb3-edbd9b6c0781","8954486a-8512-4831-8178-0b49f1efb73e"],"spl_set_id":["b95415fa-17c2-42ab-a6b0-e628d01c94ed","1abda8b8-48a8-4995-af86-39220d1aa240"],"package_ndc":["0409-2305-55","0409-2305-50","0409-2308-69","0409-2308-49","0409-2308-70","0409-2308-50","0409-2305-16","0409-2305-17","0409-2305-04","0409-2305-05","0409-2308-21","0409-2308-01","0409-2308-22","0409-2308-02","0409-0001-01","0409-0001-25"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2308-49)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"25021-820-10","generic_name":"Methylprednisolone Acetate Injection","contact_info":"866-625-1618","availability":"Limited Availability","related_info":"Next supply due in March 2027","openfda":{"application_number":["ANDA201835"],"brand_name":["METHYLPREDNISOLONE ACETATE"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-820","25021-821"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358610","1358617"],"spl_id":["f73618f0-0723-4d8b-8a8d-b9081acb44f9"],"spl_set_id":["f98314ea-a4e4-4f78-987b-3e9b45a08bb4"],"package_ndc":["25021-820-05","25021-820-10","25021-821-05"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-10)","company_name":"Sagent Pharmaceuticals","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0555-0777-02","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0555-0777","0555-0971","0555-0775","0555-0972","0555-0776","0555-0973","0555-0974"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"],"spl_set_id":["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"],"package_ndc":["0555-0971-02","0555-0775-02","0555-0972-02","0555-0776-02","0555-0777-02","0555-0973-02","0555-0974-02"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0555-0777-02)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0409-0025-10","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA020201"],"brand_name":["DOBUTAMINE IN DEXTROSE"],"generic_name":["DOBUTAMINE IN DEXTROSE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-0025","0409-0151","0409-1100"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"spl_id":["87242d06-99e3-4e91-b090-8a8cb0461908"],"spl_set_id":["9943a961-3b50-4847-8a84-d8414ce38daa"],"package_ndc":["0409-0025-01","0409-0025-10","0409-0151-01","0409-0151-10","0409-1100-01","0409-1100-10"],"unii":["0WR771DJXV"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 250 mg/250mL (1 mg/mL) (NDC 0409-0025-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1530-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1530","0409-1746","0409-1749","0409-1752","0409-1755","0409-2510","0409-7535","0409-1250","0409-5010","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1530-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/31/2018","change_date":"09/30/2026","package_ndc":"65219-570-04","generic_name":"Bumetanide Injection","contact_info":"888-386-1300","resolved_note":"Available","openfda":{"application_number":["ANDA216434"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-570","65219-572"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["aaff61c4-203b-4905-9138-0f98959ad013"],"spl_set_id":["a007f3aa-3977-4be3-a9a2-db3d458bca58"],"package_ndc":["65219-570-01","65219-570-04","65219-572-01","65219-572-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, .25 mg/1 mL (NDC 65219-570-04)","company_name":"Fresenius Kabi USA, LLC","status":"Resolved"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"62037-734-01","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA076772"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["62037-734","62037-725","62037-726","62037-727"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210"],"spl_id":["24aa9277-3773-489d-8459-f9215140c53f"],"spl_set_id":["85ef422d-af27-4126-9841-6892af1871d6"],"package_ndc":["62037-725-01","62037-734-01","62037-726-01","62037-727-01"],"unii":["4B3SC438HI"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 62037-734-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/13/2022","package_ndc":"0338-1055-48","generic_name":"Metronidazole Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA018657"],"brand_name":["METRONIDAZOLE"],"generic_name":["METRONIDAZOLE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1055"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["METRONIDAZOLE"],"rxcui":["311683"],"spl_id":["7841a410-43a9-4c79-acee-b831b42da8a8"],"spl_set_id":["d2112f37-5080-4a19-bcc3-6386b49abe1d"],"package_ndc":["0338-1055-48"],"nui":["N0000175435","M0014907"],"pharm_class_epc":["Nitroimidazole Antimicrobial [EPC]"],"pharm_class_cs":["Nitroimidazoles [CS]"],"unii":["140QMO216E"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Flagyl I.v. Rtu In Plastic Container, Injection, 500 mg/100 mL (NDC 0338-1055-48)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/01/2017","package_ndc":"0703-0110-03","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA078591"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-0110","0703-0113","0703-0018"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["1724338","1724340","1724341"],"spl_id":["540b835a-db66-417c-8507-0c1ed05c95bf"],"spl_set_id":["f0b78db9-a38c-41bb-8233-5e93f7f18c5c"],"package_ndc":["0703-0110-01","0703-0110-03","0703-0113-01","0703-0113-03","0703-0018-01"],"unii":["L960UP2KRW"]},"update_date":"11/02/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0110-03)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0527-0761-37","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215565"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-0761","0527-0760","0527-0762","0527-0763","0527-0764","0527-0765","0527-0766"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["391d7c4a-47df-41ce-b1ba-3c4758adf87f"],"spl_set_id":["f92497b5-baea-4760-b615-45a0b6184402"],"package_ndc":["0527-0760-37","0527-0761-37","0527-0762-37","0527-0763-37","0527-0764-37","0527-0765-37","0527-0766-37"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0527-0761-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"83831-141-08","generic_name":"Carboplatin Injection","contact_info":"877-595-7337; customerservice@avyxa.com","availability":"Available","openfda":{"application_number":["NDA219921"],"brand_name":["KYXATA"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Avyxa Pharma, LLC"],"product_ndc":["83831-141","83831-140","83831-142"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195","2721602"],"spl_id":["5c711945-70be-42f4-b153-e1459dd9929c"],"spl_set_id":["f91c48da-68d1-4aa7-89b8-d84a3e8b629b"],"package_ndc":["83831-140-02","83831-141-08","83831-142-50"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)","company_name":"Avyxa Pharma, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-466-37","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA070553","NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-466","63323-464","63323-462","63323-465","63323-467","63323-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL","INFILTRATION"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724880","1724881","1725078","1725175","1724884","1724885","1725082","1725177","1672917","1672919","1673296","1673298","1012391","1012396","1012404","1012421","1012455","1012457"],"spl_id":["b41b5dbd-7aff-4d97-ac97-f4355393ee4e","d3ba9fb9-63c8-4597-bb0a-cd01d31a24b6","13a48007-3784-46f2-bd4d-da1004186b81","2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["e700eb7b-8b14-49c9-96b2-331f18776e45","b6bfc04a-1868-4630-9ca1-8c027af97ce3","dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175","eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-464-01","63323-464-17","63323-466-03","63323-466-17","63323-464-08","63323-464-38","63323-466-08","63323-466-38","63323-462-03","63323-462-38","63323-464-09","63323-464-39","63323-466-09","63323-466-39","63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"63323-412-02","generic_name":"Midazolam Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA075154"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-412","63323-411"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["9814447b-a93e-42ad-b57e-5db0a5b7f552"],"spl_set_id":["a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"],"package_ndc":["63323-411-22","63323-411-27","63323-411-15","63323-411-12","63323-411-18","63323-411-25","63323-411-13","63323-411-10","63323-412-18","63323-412-25","63323-412-03","63323-412-02","63323-412-06","63323-412-05","63323-412-13","63323-412-10"],"unii":["W7TTW573JJ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0006-5055-07","generic_name":"Molnupiravir Capsule","contact_info":"800-672-6372","related_info":"Discontinuation of the manufacture of the drug","update_date":"10/20/2026","therapeutic_category":["Antiviral"],"dosage_form":"Capsule","presentation":"Lagevrio, Capsule, 200 mg (NDC 0006-5055-07)","company_name":"Merck Sharp & Dohme LLC","status":"To Be Discontinued"},{"discontinued_date":"04/07/2026","update_type":"New","initial_posting_date":"04/07/2026","package_ndc":"61958-1702-1","generic_name":"Idelalisib Tablet","contact_info":"800-445-3235","related_info":"Discontinuation in the manufacturing of the drug","openfda":{"application_number":["NDA205858"],"brand_name":["ZYDELIG"],"generic_name":["IDELALISIB"],"manufacturer_name":["Gilead Sciences, Inc."],"product_ndc":["61958-1702","61958-1701"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["IDELALISIB"],"rxcui":["1544465","1544471","1544473","1544475"],"spl_id":["131deed3-54eb-44c8-aab5-5e93c70db69f"],"spl_set_id":["efbdafa9-d18c-4e85-b4a2-1e620fc74e50"],"package_ndc":["61958-1701-1","61958-1702-1"],"nui":["N0000175605","N0000175082","N0000190114"],"pharm_class_epc":["Kinase Inhibitor [EPC]"],"pharm_class_moa":["Kinase Inhibitors [MoA]","Cytochrome P450 3A Inhibitors [MoA]"],"unii":["YG57I8T5M0"]},"update_date":"04/07/2026","therapeutic_category":["Oncology"],"dosage_form":"Tablet","presentation":"Zydelig, Tablet, 150 mg (NDC 61958-1702-1)","company_name":"Gilead Sciences, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0338-1005-03","generic_name":"Dopamine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA019615"],"brand_name":["DOPAMINE HYDROCHLORIDE AND DEXTROSE"],"generic_name":["DOPAMINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1005","0338-1007","0338-1009"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1292887","1743869","1743871","1743877","1743879"],"spl_id":["edc9a091-4cb5-4ec7-b6f9-44d2d588bab9"],"spl_set_id":["cb97d4a0-89ed-407c-a763-209386b6f75c"],"package_ndc":["0338-1005-02","0338-1005-03","0338-1007-02","0338-1007-03","0338-1009-02"],"unii":["7L3E358N9L"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-03)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"63323-172-60","generic_name":"Carboplatin Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA077266"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-172"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["3a1dd588-13b0-4d58-8d46-3a25a4fc6b40"],"spl_set_id":["b4fa7aac-c9d2-4af4-a281-3e6cfc502ff6"],"package_ndc":["63323-172-60"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/03/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 10 mg/1 mL (NDC 63323-172-60)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"71288-725-32","generic_name":"Bupivacaine Hydrochloride Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d","contact_info":"844-824-8426","availability":"Limited Availability","related_info":"Meitheal Pharmaceuticals is distributor/labeler","update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)","company_name":"Kindos Pharmaceuticals Co. Ltd.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/02/2020","package_ndc":"0409-2305-50","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: December 2027; Estimated Recovery: March 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA075857"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2305","0409-2308","0409-0001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666800","1666814","1666823","1666798"],"spl_id":["2f69c5b1-6505-42dc-8bb3-edbd9b6c0781","8954486a-8512-4831-8178-0b49f1efb73e"],"spl_set_id":["b95415fa-17c2-42ab-a6b0-e628d01c94ed","1abda8b8-48a8-4995-af86-39220d1aa240"],"package_ndc":["0409-2305-55","0409-2305-50","0409-2308-69","0409-2308-49","0409-2308-70","0409-2308-50","0409-2305-16","0409-2305-17","0409-2305-04","0409-2305-05","0409-2308-21","0409-2308-01","0409-2308-22","0409-2308-02","0409-0001-01","0409-0001-25"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL  (1 mg/mL) Single Dose Glass Fliptop Vial Novaplus (NDC 0409-2305-50)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"0409-1630-10","generic_name":"Atropine Sulfate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA021146"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1630","0409-9630","0409-4910","0409-4911"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190546","1190551","1190552"],"spl_id":["3f33c683-46fb-40db-af0d-9211bc29d2a7"],"spl_set_id":["ad8916e7-206e-409e-2582-30d072845dd4"],"package_ndc":["0409-1630-15","0409-1630-10","0409-9630-15","0409-9630-05","0409-4910-11","0409-4910-34","0409-4911-11","0409-4911-34"],"unii":["03J5ZE7KA5"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, 1 mg/10 mL (0.1 mg/mL) Syringes (NDC 0409-1630-10)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"04/29/2026","update_type":"New","initial_posting_date":"04/29/2026","package_ndc":"49884-561-11","generic_name":"Lamotrigine Tablet, Extended Release","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/29/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Lamotrigine, Tablet, Extended Release, 25 mg (NDC 49884-561-11)","company_name":"Par Health, Inc.","status":"To Be Discontinued"},{"discontinued_date":"07/30/2026","update_type":"New","initial_posting_date":"07/30/2026","package_ndc":"0591-4550-22","generic_name":"Doxycycline Hyclate Tablet, Delayed Release","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA090134"],"brand_name":["DOXYCYCLINE HYCLATE"],"generic_name":["DOXYCYCLINE HYCLATE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0591-4550","0591-4575"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DOXYCYCLINE HYCLATE"],"rxcui":["1423080","1653433"],"spl_id":["304ae0bb-5f05-4389-8952-5a99391b8047"],"spl_set_id":["c2b08332-3256-4658-965a-ede3d973a388"],"package_ndc":["0591-4550-22","0591-4575-60"],"unii":["19XTS3T51U"]},"update_date":"07/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Tablet","presentation":"Doxycycline Hyclate, Tablet, Delayed Release, 50 mg (NDC 0591-4550-22)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"60505-6282-3","generic_name":"Carboplatin Injection","contact_info":"Apotex Inc.: 800-706-5575","related_info":"Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA077861"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-6282"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["0e68e276-b0df-4f03-e063-6394a90a22b9"],"spl_set_id":["1c275825-0275-4c73-b650-e4c1519f13b8"],"package_ndc":["60505-6282-1","60505-6282-3","60505-6282-6","60505-6282-7"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"06/01/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-3)","company_name":"Teyro Labs","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-460-37","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesaler for inventory","openfda":{"application_number":["NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-460","63323-465","63323-467","63323-464","63323-466","63323-462"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012391","1012396","1012404","1012421","1012455","1012457","1672917","1672919","1673296","1673298","1724880","1724881","1724884","1724885","1725078","1725082","1725175","1725177"],"spl_id":["2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 7.5 mg/1 mL; .005 mg/1 mL (NDC 63323-460-37)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-354-01","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-01)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/03/2017","package_ndc":"0641-6125-25","generic_name":"Morphine Sulfate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA205758"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6125","0641-6126","0641-6127"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731993","1732006","1732011"],"spl_id":["fb513d10-94f4-45f5-8b30-fa82ef83e4e2"],"spl_set_id":["6023606c-150c-40c5-9175-598efe2a56c3"],"package_ndc":["0641-6126-01","0641-6126-25","0641-6127-01","0641-6127-25","0641-6125-01","0641-6125-25"],"unii":["X3P646A2J0"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 4 mg/1 mL (NDC 0641-6125-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"83634-651-50","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"Avenacy, LLC: 877-283-6229","availability":"Available","related_info":"Distributed by Avenacy, LLC","openfda":{"application_number":["ANDA219535"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Avenacy, LLC"],"product_ndc":["83634-651","83634-653"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1737562","1737566","1737568"],"spl_id":["8fb1dd7b-f349-4a64-96c1-bd72bf748f3b"],"spl_set_id":["46480253-29b9-4d7f-98ed-10377929026b"],"package_ndc":["83634-653-41","83634-653-02","83634-653-42","83634-653-05","83634-653-43","83634-653-30","83634-651-41","83634-651-10","83634-651-42","83634-651-20","83634-651-43","83634-651-50"],"unii":["V13007Z41A"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 500 mg/50 mL (NDC 83634-651-50)","company_name":"Anthea Pharma","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/05/2022","package_ndc":"72485-509-10","generic_name":"Etomidate Injection","contact_info":"908-803-2586","availability":"Available","related_info":"Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586","openfda":{"application_number":["ANDA215028"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Armas Pharmaceuticals Inc."],"product_ndc":["72485-509","72485-508"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["7444860b-36c1-459d-94ba-d7301d9dc2ca"],"spl_set_id":["75467058-da52-48fa-8d4e-e1025ec7d461"],"package_ndc":["72485-508-01","72485-508-10","72485-509-01","72485-509-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"06/16/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/mL (NDC 72485-509-10)","company_name":"Caplin Steriles, Ltd.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0990-4178-03","generic_name":"Amino Acid Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Unavailable","related_info":"Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA019398"],"brand_name":["AMINOSYN-PF"],"generic_name":["ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, AND TYROSINE"],"manufacturer_name":["ICU Medical Inc."],"product_ndc":["0990-4178"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ISOLEUCINE","LEUCINE","LYSINE ACETATE","METHIONINE","PHENYLALANINE","THREONINE","TRYPTOPHAN","VALINE","ALANINE","ARGININE","ASPARTIC ACID","GLUTAMIC ACID","GLYCINE","HISTIDINE","PROLINE","SERINE","TAURINE","TYROSINE"],"rxcui":["831426","831430"],"spl_id":["33d8e12a-620f-41d0-bdca-3a18fc0c20cb"],"spl_set_id":["2d212e10-7e08-4aeb-b63f-dcc927897769"],"package_ndc":["0990-4178-03"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["04Y7590D77","GMW67QNF9C","TTL6G7LIWZ","AE28F7PNPL","47E5O17Y3R","2ZD004190S","8DUH1N11BX","HG18B9YRS7","OF5P57N2ZX","94ZLA3W45F","30KYC7MIAI","3KX376GY7L","TE7660XO1C","4QD397987E","9DLQ4CIU6V","452VLY9402","1EQV5MLY3D","42HK56048U"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Aminosyn-PF 7%, Injection, 0.07 (NDC 0990-4178-03)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"05/15/2026","update_type":"New","initial_posting_date":"05/15/2026","package_ndc":"0574-0521-74","generic_name":"Activated Charcoal Oral Suspension","contact_info":"866-634-9120","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["M023"],"brand_name":["ACTIDOSE AQUA"],"generic_name":["ACTIVATED CHARCOAL"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-0521"],"product_type":["HUMAN OTC DRUG"],"route":["ORAL"],"substance_name":["ACTIVATED CHARCOAL"],"rxcui":["309150","1251411"],"spl_id":["bd250d66-b8ea-4cab-a8f2-d2913a157fc5"],"spl_set_id":["c85dc235-3f42-4361-9bd2-1aaff798ad75"],"package_ndc":["0574-0521-25","0574-0521-74","0574-0521-76"],"unii":["2P3VWU3H10"]},"update_date":"05/15/2026","therapeutic_category":["Other"],"dosage_form":"Oral Suspension","presentation":"Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-74)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"63323-412-10","generic_name":"Midazolam Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA075154"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-412","63323-411"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["9814447b-a93e-42ad-b57e-5db0a5b7f552"],"spl_set_id":["a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"],"package_ndc":["63323-411-22","63323-411-27","63323-411-15","63323-411-12","63323-411-18","63323-411-25","63323-411-13","63323-411-10","63323-412-18","63323-412-25","63323-412-03","63323-412-02","63323-412-06","63323-412-05","63323-412-13","63323-412-10"],"unii":["W7TTW573JJ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/25/2022","change_date":"08/27/2026","package_ndc":"0487-9901-30","generic_name":"Albuterol Sulfate Solution","contact_info":"800-443-4313","resolved_note":"Available","openfda":{"application_number":["ANDA075664"],"brand_name":["ALBUTEROL SULFATE"],"generic_name":["ALBUTEROL SULFATE"],"manufacturer_name":["Nephron Pharmaceuticals Corporation"],"product_ndc":["0487-9901"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RESPIRATORY (INHALATION)"],"substance_name":["ALBUTEROL SULFATE"],"rxcui":["245314"],"spl_id":["51504ae6-7552-192a-e063-6294a90a0fbf"],"spl_set_id":["ecc00500-58b8-491f-80df-dc6c89a08cae"],"package_ndc":["0487-9901-30","0487-9901-02"],"unii":["021SEF3731"]},"update_date":"08/27/2026","therapeutic_category":["Pulmonary/Allergy","Pediatric"],"dosage_form":"Solution","presentation":"Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30)","company_name":"Nephron Pharmaceuticals Corporation","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"06/13/2018","package_ndc":"55150-255-20","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA207182"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-255","55150-251","55150-252","55150-254","55150-253","55150-256"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671"],"spl_id":["ccc38d8a-43fd-44c0-985e-32af9ed956ab","0b1f03c2-db2f-4f90-acc0-d73abd731bf6"],"spl_set_id":["ccc38d8a-43fd-44c0-985e-32af9ed956ab","ef782e5e-e2d7-465a-99c6-b12611f3158c"],"package_ndc":["55150-251-24","55150-252-24","55150-254-24","55150-255-24","55150-251-10","55150-252-20","55150-253-50","55150-254-10","55150-255-20","55150-256-50"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/05/2022","package_ndc":"65219-447-20","generic_name":"Etomidate Injection","contact_info":"800-551-7176","availability":"Available","related_info":"Check wholesalers for inventory; Marketed by Fresenius Kabi","openfda":{"application_number":["ANDA215028"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-447","65219-445"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["30488a7e-ea9e-4a27-95a9-a07149c50282"],"spl_set_id":["d07efb9e-5264-461d-96d8-e11fa71c5751"],"package_ndc":["65219-445-01","65219-445-10","65219-447-02","65219-447-20"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"06/16/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2mg/mL (NDC 65219-447-20)","company_name":"Caplin Steriles, Ltd.","status":"Current"},{"discontinued_date":"10/30/2026","update_type":"New","initial_posting_date":"10/30/2026","package_ndc":"0338-1301-48","generic_name":"Cefepime Hydrochloride Injection","contact_info":"888-229-0001","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050817"],"brand_name":["CEFEPIME"],"generic_name":["CEFEPIME"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1301"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CEFEPIME HYDROCHLORIDE"],"rxcui":["1665088","1665093"],"spl_id":["535caad0-ae02-4ceb-b4d1-192222633719"],"spl_set_id":["be5f8ca6-7232-423a-a2d5-cccb7abe7921"],"package_ndc":["0338-1301-41","0338-1301-48"],"unii":["I8X1O0607P"]},"update_date":"10/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cefepime Hydrochloride in Plastic Container, Injection, 2g/100mL (NDC 0338-1301-48)","company_name":"Baxter Healthcare","status":"To Be Discontinued"},{"discontinued_date":"10/30/2026","update_type":"New","initial_posting_date":"10/30/2026","package_ndc":"66758-087-70","generic_name":"Ciprofloxacin Hydrochloride and Hydrocortisone Otic Suspension/Drops","contact_info":"800-525-8747","related_info":"Discontinuation of the manufacturing of NDC 66758-087-70. Authorized generic is available under new NDC 0781-6218-70","openfda":{"application_number":["NDA020805"],"brand_name":["CIPRO HC"],"generic_name":["CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["66758-087"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["AURICULAR (OTIC)"],"substance_name":["CIPROFLOXACIN HYDROCHLORIDE","HYDROCORTISONE"],"rxcui":["213320","309305"],"spl_id":["7c5775a8-2754-4652-b57a-75bbf32dfbe6"],"spl_set_id":["b26594a3-2adf-4954-8be0-5bd6f8de9671"],"package_ndc":["66758-087-70"],"nui":["N0000175576","N0000175450"],"pharm_class_epc":["Corticosteroid [EPC]"],"pharm_class_moa":["Corticosteroid Hormone Receptor Agonists [MoA]"],"unii":["4BA73M5E37","WI4X0X7BPJ"]},"update_date":"10/30/2026","therapeutic_category":["Anti-Infective"],"presentation":"Cipro, Otic Suspension/Drops, 0.2% base, 1% (NDC 66758-087-70)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"04/26/2023","package_ndc":"60793-700-10","generic_name":"Penicillin G Benzathine Injection","related_info_link":"https://www.fda.gov/media/190713/download","contact_info":"800-533-4535","availability":"Unavailable","related_info":"Next Delivery: October 2027; Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA050141"],"brand_name":["BICILLIN L-A"],"generic_name":["PENICILLIN G BENZATHINE"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["60793-700","60793-701","60793-702"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["PENICILLIN G BENZATHINE"],"rxcui":["731564","731566","731567","731568","731570","731571"],"spl_id":["526e051e-d0fc-4f5d-886a-d61947aa8a7f"],"spl_set_id":["012d46f1-d0a0-4676-a879-cd320297ab16"],"package_ndc":["60793-700-01","60793-700-10","60793-701-02","60793-701-10","60793-702-04","60793-702-10"],"unii":["RIT82F58GK"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Bicillin L-A, Injection, 600000 [iU]/1 mL (NDC 60793-700-10)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"11/21/2025","update_type":"New","initial_posting_date":"11/21/2025","package_ndc":"62037-720-10","generic_name":"Potassium Chloride Tablet, Extended Release","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA075604"],"brand_name":["POTASSIUM CHLORIDE"],"generic_name":["POTASSIUM CHLORIDE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["62037-720","62037-710"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["POTASSIUM CHLORIDE"],"rxcui":["1801294","1801298"],"spl_id":["01fbdb24-0987-40f6-a920-f36349f6ba61"],"spl_set_id":["db002ae3-f54c-40a4-9cb4-e5681bf426e3"],"package_ndc":["62037-710-01","62037-720-01","62037-720-05","62037-720-10"],"unii":["660YQ98I10"]},"update_date":"11/21/2025","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology"],"dosage_form":"Tablet","presentation":"Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-10)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"08/25/2026","update_type":"New","initial_posting_date":"08/25/2026","package_ndc":"0169-2800-15","generic_name":"Liraglutide Injection","contact_info":"833-493-4689","related_info":"Product will be available until discontinuation in January 2027; Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA206321"],"brand_name":["SAXENDA"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Novo Nordisk Pharmaceutical Industries, LP"],"product_ndc":["0169-2800"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["1598268","2735350"],"spl_id":["7e183945-550d-4b6a-bf4e-300193517cac"],"spl_set_id":["3946d389-0926-4f77-a708-0acb8153b143"],"package_ndc":["0169-2800-15","0169-2800-90","0169-2800-97"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"08/25/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Saxenda, Injection, 6 mg/1 mL (NDC 0169-2800-15)","company_name":"Novo Nordisk, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"0185-2098-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-525-8747","availability":"Limited Availability","related_info":"Estimated recovery: 1Q 2027","openfda":{"application_number":["ANDA040439"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0185-2098","0185-0831","0185-0842","0185-0853","0185-0864","0185-2099"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577961"],"spl_id":["9a21fb59-a99c-4c63-91e8-4b5d72fbd9cd"],"spl_set_id":["288dafc4-fe6e-4891-832f-511022c87445"],"package_ndc":["0185-0831-01","0185-0842-01","0185-0853-01","0185-0864-01","0185-2099-01","0185-2098-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/09/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0185-2098-01)","company_name":"Sandoz Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"0338-3410-50","generic_name":"Clindamycin Phosphate Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA208084"],"brand_name":["CLINDAMYCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-3410","0338-3612","0338-3814"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309335","309336","309339"],"spl_id":["c8906ab2-37d2-4fde-9784-0442bf7b9565"],"spl_set_id":["78832ac6-04c5-45e0-ae4d-f56d7920dda9"],"package_ndc":["0338-3410-50","0338-3410-24","0338-3612-50","0338-3612-24","0338-3814-50","0338-3814-24"],"unii":["EH6D7113I8"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate, Injection, 300 mg/50 mL (NDC 0338-3410-50)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"16729-138-00","generic_name":"Clonazepam Tablet","contact_info":"866-941-7875, option 2","resolved_note":"Available","openfda":{"application_number":["ANDA077147"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-138","16729-136","16729-137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["0e1e7f41-f78b-27cf-e063-6394a90a1ae0"],"spl_set_id":["ebc11109-e7bf-452d-b675-4b3236d54164"],"package_ndc":["16729-136-00","16729-136-16","16729-137-00","16729-137-16","16729-138-00","16729-138-16"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 16729-138-00)","company_name":"Accord Healthcare Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"43547-411-09","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-931-9829","availability":"Unavailable","related_info":"Not available. Long-term backorder for all NDCs. No estimated release date at this time.","openfda":{"application_number":["ANDA205823"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Solco Healthcare US, LLC"],"product_ndc":["43547-411","43547-410","43547-412","43547-413"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["b8f1731a-cbac-4f64-a8d4-320b80b335e1"],"spl_set_id":["cd46691d-5593-4a9f-a937-999c6803e312"],"package_ndc":["43547-410-09","43547-411-09","43547-412-09","43547-413-09"],"unii":["33067B3N2M"]},"update_date":"06/29/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 10 mg (NDC 43547-411-09)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/22/2021","package_ndc":"42806-801-01","generic_name":"Rifampin Capsule","contact_info":"(718) 276-8600 ext. 3","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA064150"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["EPIC PHARMA, LLC"],"product_ndc":["42806-801","42806-799"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAMPIN"],"rxcui":["198201","198202"],"spl_id":["a4ac02e8-68ac-4e79-8ca5-0939dd002c87"],"spl_set_id":["0391f1e1-70d4-4b15-8b58-055bb6a385b8"],"package_ndc":["42806-801-30","42806-801-01","42806-799-30","42806-799-60","42806-799-01","42806-799-05"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Rifampin, Capsule, 150 mg (NDC 42806-801-01)","company_name":"Epic Pharma, LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"42858-164-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-827-0616","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA215330"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Rhodes Pharmaceuticals LLC"],"product_ndc":["42858-164","42858-161","42858-162","42858-163","42858-165","42858-166","42858-167"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0002e227-1109-4ecc-a8c5-4b4f11fac3cc"],"spl_set_id":["d918b40d-a461-41bc-b6c0-83dc76c28e32"],"package_ndc":["42858-161-01","42858-162-01","42858-163-01","42858-164-01","42858-165-01","42858-166-01","42858-167-01"],"unii":["SJT761GEGS"]},"update_date":"06/24/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 42858-164-01)","company_name":"Rhodes Pharmaceuticals L.P.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/07/2020","package_ndc":"16729-502-43","generic_name":"Furosemide Injection","contact_info":"866-941-7875","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA","openfda":{"application_number":["ANDA070017"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-502","16729-500","16729-501"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["1cfab300-d796-6a68-e063-6394a90a73f9"],"spl_set_id":["f6f64972-714c-4ee9-8a5e-9ffcab41a73b"],"package_ndc":["16729-500-30","16729-500-08","16729-501-64","16729-501-43","16729-502-03","16729-502-43"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/02/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 16729-502-43)","company_name":"Accord Healthcare Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-154-30","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-154","72888-497","72888-152","72888-153"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 72888-154-30)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"discontinued_date":"06/08/2026","update_type":"New","initial_posting_date":"06/08/2026","package_ndc":"0069-1198-30","generic_name":"Dacomitinib Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA211288"],"brand_name":["VIZIMPRO"],"generic_name":["DACOMITINIB"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0069-1198","0069-0197","0069-2299"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DACOMITINIB"],"rxcui":["2058915","2058922","2058924","2058926","2058930","2058932"],"spl_id":["3ffd0da1-5601-4ecc-a8fb-f484693cb4c5"],"spl_set_id":["4ab27d2f-e385-4e9c-b324-fa69c10b855a"],"package_ndc":["0069-0197-30","0069-1198-30","0069-2299-30"],"unii":["5092U85G58"]},"update_date":"06/08/2026","therapeutic_category":["Oncology"],"dosage_form":"Tablet","presentation":"Vizimpro, Tablet, 30 mg (NDC 0069-1198-30)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-353-90","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-90)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"55150-226-10","generic_name":"Rocuronium Bromide Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA206206"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-226","55150-225"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["1bb59a7e-d219-466c-abae-8a0680af9b8c"],"spl_set_id":["116385ea-69fc-4f44-b463-6210291032df"],"package_ndc":["55150-225-05","55150-226-10"],"unii":["I65MW4OFHZ"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 55150-226-10)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"65162-026-09","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA202830"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["65162-026","65162-023","65162-024","65162-025","65162-027","65162-028"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850"],"spl_id":["4cc5e658-25c6-4a58-a93a-6e35242d6de4"],"spl_set_id":["c11cb3b6-3dff-477b-a249-b4c3118edc5f"],"package_ndc":["65162-023-09","65162-024-09","65162-025-09","65162-026-09","65162-027-09","65162-028-09"],"unii":["SJT761GEGS"]},"update_date":"10/06/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 65162-026-09)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"36000-284-25","generic_name":"Furosemide Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA202747"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["36000-284","36000-063","36000-064","36000-065","36000-282","36000-283"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["b4c1ae97-0f6c-4ae1-858a-4e0ab8f1ce53"],"spl_set_id":["c71371a7-75c5-45b8-b762-8d782d4c71bc"],"package_ndc":["36000-063-05","36000-064-05","36000-065-05","36000-282-25","36000-283-25","36000-284-25"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 36000-284-25)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"0093-0832-01","generic_name":"Clonazepam Tablet","contact_info":"800-545-8800","resolved_note":"Available","openfda":{"application_number":["ANDA074569"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-0832","0093-3212","0093-3213"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["d6abe4e3-7699-4ead-95f4-739a961b23ad"],"spl_set_id":["8069b1a0-7c06-4252-b44e-e2eef065d9b8"],"package_ndc":["0093-0832-01","0093-0832-05","0093-3212-01","0093-3212-05","0093-3213-01","0093-3213-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 0093-0832-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"76045-0210-10","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Checkwholesalers for inventory","update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-0210-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"62135-669-90","generic_name":"Quinapril/Hydrochlorothiazide Tablet","contact_info":"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com","availability":"Available","openfda":{"application_number":["ANDA076374"],"brand_name":["QUINAPRIL AND HYDROCHLOROTHIAZIDE"],"generic_name":["QUINAPRIL AND HYDROCHLOROTHIAZIDE"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-669","62135-667","62135-668"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE","HYDROCHLOROTHIAZIDE"],"rxcui":["310796","310797","310809"],"spl_id":["0c3f4504-d57e-aa79-e063-6294a90ad5b8"],"spl_set_id":["2eae533f-d0af-47e8-a1f2-94bc8cc89b5a"],"package_ndc":["62135-667-90","62135-668-90","62135-669-90"],"nui":["N0000175359","N0000175419","M0471776"],"pharm_class_pe":["Increased Diuresis [PE]"],"pharm_class_epc":["Thiazide Diuretic [EPC]"],"pharm_class_cs":["Thiazides [CS]"],"unii":["0J48LPH2TH","33067B3N2M"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril/Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 62135-669-90)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-285-23","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-285","63323-286","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"07/24/2026","update_type":"New","initial_posting_date":"07/24/2026","package_ndc":"0074-6799-22","generic_name":"Lopinavir and Ritonavir Tablet","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","update_date":"07/24/2026","therapeutic_category":["Antiviral"],"dosage_form":"Tablet","presentation":"Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-6799-22)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"63323-851-10","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA019034"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-851","63323-852","63323-853","63323-854"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897653","897753","1724276","1724338","1724340","1724341"],"spl_id":["2cfa0a3e-eb57-4dea-ae2c-0b91176f0f67"],"spl_set_id":["e034eb96-03e0-46e1-8b92-5e1f94555e7b"],"package_ndc":["63323-851-03","63323-851-10","63323-851-07","63323-851-15","63323-851-50","63323-852-03","63323-852-25","63323-853-03","63323-853-25","63323-854-03","63323-854-10"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0338-9555-24","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA208532"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-9555","0338-9557"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["956f6a8c-cbb8-45de-9828-67f1ed7ab4e7"],"spl_set_id":["8ccb45a7-8290-469c-9644-a4dca967d88f"],"package_ndc":["0338-9555-24","0338-9557-12"],"unii":["1018WH7F9I"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-1660-50","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1660","0409-1638","0409-1434","0409-1596","0409-7838","0409-7853","0409-7875"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["284397","309710","1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["3c5274fd-6597-4b88-babc-92e4e16c6329"],"spl_set_id":["548a88c0-afda-427e-75ac-5af0cfa2224c"],"package_ndc":["0409-1660-55","0409-1660-50","0409-1660-35","0409-1660-10","0409-1660-22","0409-1660-20","0409-1638-32","0409-1638-02","0409-1434-01","0409-1596-01","0409-1596-10","0409-7838-01","0409-7838-24","0409-7853-01","0409-7853-24","0409-7875-01","0409-7875-12"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-064-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1019","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-064","70069-061","70069-062","70069-063","70069-065","70069-066","70069-067"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-10)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-067-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-067","70069-061","70069-062","70069-063","70069-064","70069-065","70069-066"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-10)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"discontinued_date":"10/22/2026","update_type":"New","initial_posting_date":"10/22/2026","package_ndc":"0378-6002-91","generic_name":"Metformin Hydrochloride Tablet, Extended Release","contact_info":"800-796-9526","related_info":"A business decision was made was discontinue manufacture of the drug product.","openfda":{"application_number":["ANDA200690"],"brand_name":["METFORMIN HYDROCHLORIDE"],"generic_name":["METFORMIN"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-6002","0378-6001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METFORMIN HYDROCHLORIDE"],"rxcui":["1807894","1807917"],"spl_id":["88a13bb5-a5b6-46be-b935-a4e2e187ea93"],"spl_set_id":["7e41818c-60e9-4bcf-9586-7bb8d33d5e89"],"package_ndc":["0378-6002-91","0378-6001-91"],"unii":["786Z46389E"]},"update_date":"10/22/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Metformin Hydrochloride, Tablet, Extended Release, 500 mg (NDC 0378-6002-91)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7224-06","generic_name":"Hydromorphone Hydrochloride Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7224"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897749"],"spl_id":["8c369b50-cf2a-4e30-a31c-ccf5f49ab920"],"spl_set_id":["1bfbba46-1979-4797-a29e-d67718131686"],"package_ndc":["0574-7224-06"],"unii":["L960UP2KRW"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Suppository","presentation":"Hydromorphone Hydrochloride, Suppository, 3 mg (NDC 0574-7224-06)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0017-11","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Unavailable","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0017","0338-0023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-11)","company_name":"Baxter Healthcare","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"47781-176-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA207388"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 10 MG,CLL"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-176","47781-174","47781-175","47781-177","47781-178","47781-179","47781-180"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AMPHETAMINE ASPARTATE MONOHYDRATE","AMPHETAMINE SULFATE","DEXTROAMPHETAMINE SACCHARATE","DEXTROAMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["eb490273-9334-1ae5-dd32-658e7fb0b40e"],"spl_set_id":["c907301d-e24d-9609-5529-fed14f94549f"],"package_ndc":["47781-174-30","47781-174-05","47781-174-01","47781-175-30","47781-175-05","47781-175-01","47781-176-30","47781-176-05","47781-176-01","47781-177-30","47781-177-05","47781-177-01","47781-178-30","47781-178-05","47781-178-01","47781-179-30","47781-179-05","47781-179-01","47781-180-30","47781-180-05","47781-180-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 10mg (NDC 47781-176-01)","company_name":"Alvogen","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/26/2023","package_ndc":"84383-110-01","generic_name":"Penicillin G Benzathine Injection","related_info_link":"https://www.fda.gov/media/193578/download","contact_info":"Mark Cuban Cost Plus Drug Company: 682-428-8081","availability":"Available","openfda":{"brand_name":["LENTOCILIN"],"generic_name":["PENICILLIN G BENZATHIN"],"manufacturer_name":["LABORATRIOS ATRAL, S.A."],"product_ndc":["84383-110"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["PENICILLIN G BENZATHINE"],"rxcui":["2671687","2684991"],"spl_id":["1a4e5124-618c-ce44-e063-6394a90a43e3"],"spl_set_id":["1a4e5124-618b-ce44-e063-6394a90a43e3"],"package_ndc":["84383-110-01"],"unii":["RIT82F58GK"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Lentocilin, Injection, 1200000 U/4 mL (NDC 84383-110-01)","company_name":"Laboratorios Atral","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2016","package_ndc":"63323-032-00","generic_name":"Sodium Acetate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA206687"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-032"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE"],"rxcui":["312965"],"spl_id":["37c19fc5-c1ce-4ea0-9cba-4cdf32112091"],"spl_set_id":["d7fabf08-d4e0-4bb5-8416-2e8ffe27c04b"],"package_ndc":["63323-032-04","63323-032-00"],"unii":["4550K0SC9B"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"16729-277-30","generic_name":"Methotrexate Sodium Injection","contact_info":"866-941-7875, option 2","availability":"Available","openfda":{"application_number":["ANDA040716"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-277"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL","INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS"],"substance_name":["METHOTREXATE"],"rxcui":["1655956","1655959","1655960"],"spl_id":["5aa89975-d1a1-19f1-e063-6294a90a4b3e"],"spl_set_id":["dd035a9f-cd40-4314-b9d8-2294b8a924e2"],"package_ndc":["16729-277-30","16729-277-03","16729-277-35"],"nui":["N0000175584","N0000000111"],"pharm_class_epc":["Folate Analog Metabolic Inhibitor [EPC]"],"pharm_class_moa":["Folic Acid Metabolism Inhibitors [MoA]"],"unii":["YL5FZ2Y5U1"]},"update_date":"11/02/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-30)","company_name":"Accord Healthcare Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/26/2018","package_ndc":"0409-3796-01","generic_name":"Ketorolac Tromethamine Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA074802"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3796","0409-3793","0409-3795"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["4beb8ebd-934e-4181-8374-01be0bb80680"],"spl_set_id":["8accbb78-fc64-45d5-69b0-35c23a1d2a2e"],"package_ndc":["0409-3793-19","0409-3793-01","0409-3793-25","0409-3795-19","0409-3795-01","0409-3795-25","0409-3796-19","0409-3796-01","0409-3796-25"],"unii":["4EVE5946BQ"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 60 mg/2 mL (30 mg/mL) (NDC 0409-3796-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0409-0042-12","generic_name":"Dopamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018826"],"brand_name":["DOPAMINE HYDROCHLORIDE IN DEXTROSE"],"generic_name":["DOPAMINE HYDROCHLORIDE IN DEXTROSE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-0042","0409-7809","0409-7810","0409-1858"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1292887","1743877","1743879"],"spl_id":["12a614df-d706-42a2-9020-5397700cc2e9"],"spl_set_id":["08f23f6e-150d-45ea-098e-f2edf64c21a1"],"package_ndc":["0409-7809-11","0409-7809-22","0409-7809-31","0409-7809-24","0409-7810-11","0409-7810-22","0409-0042-01","0409-0042-12","0409-1858-01","0409-1858-12"],"unii":["7L3E358N9L"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"43598-975-58","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"Distributed by DRL","availability":"Available","related_info":"Distributed by DRL","openfda":{"application_number":["ANDA209307"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Dr.Reddy's Laboratories Inc"],"product_ndc":["43598-975","43598-976"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["5785a11f-7784-4ae0-8029-f50b782eaf4a"],"spl_set_id":["d174c19d-56f1-4ef4-087c-23c26db8e40b"],"package_ndc":["43598-976-11","43598-976-58","43598-975-11","43598-975-58"],"unii":["1018WH7F9I"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58)","company_name":"Gland Pharma Limited","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"55150-199-20","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA205612"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-199","55150-195","55150-196","55150-197","55150-198","55150-200","55150-201"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734207","1734347","1734475","1734483"],"spl_id":["1e5f1368-058a-492c-b4b7-d9329a7745e2"],"spl_set_id":["3763b7b6-da49-4658-b93d-28f5da24d09e"],"package_ndc":["55150-195-20","55150-196-99","55150-197-20","55150-198-30","55150-199-20","55150-200-10","55150-201-20"],"unii":["V910P86109"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-199-20)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/24/2017","package_ndc":"63323-083-05","generic_name":"Sodium Bicarbonate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory.","openfda":{"application_number":["ANDA206688"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-083","63323-089"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["1868469","1868486"],"spl_id":["9def795c-abcf-483c-8b1d-e4374666efb2"],"spl_set_id":["0ab55004-bb63-436d-ad77-cd3796905370"],"package_ndc":["63323-083-03","63323-083-05","63323-089-25","63323-089-50"],"unii":["8MDF5V39QO"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"68025-084-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Available","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-084","68025-088","68025-089","68025-095","68025-096","68025-097","68025-098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)","company_name":"Vertical Pharmaceuticals, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-159-74","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA203040"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-159","55150-158","55150-160"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737566","1737568","1737757"],"spl_id":["cc439f66-fdd6-41f9-8a08-3f623898f20c"],"spl_set_id":["5524cbfd-d6e6-42eb-aaa5-22495e0a86b6"],"package_ndc":["55150-158-72","55150-159-74","55150-160-72"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-2912-01","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-2912","0075-0624","0075-0620","0075-0621","0075-0622","0075-0623","0075-0626","0075-2915"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["cdb74d6d-1a74-4156-a52a-710c55cb2927"],"spl_set_id":["5017a927-2a24-4f27-89f9-27c805bf7d59"],"package_ndc":["0075-0624-01","0075-0624-30","0075-0620-01","0075-0620-40","0075-0621-01","0075-0621-60","0075-0622-01","0075-0622-80","0075-0623-03","0075-0623-00","0075-0626-03","0075-2912-00","0075-2912-01","0075-2915-00","0075-2915-01"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 120 mg/.8 mL (NDC 0075-2912-01)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/01/2022","package_ndc":"0264-7520-00","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019626"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-7520","0264-7510"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE, UNSPECIFIED FORM"],"rxcui":["1795477","1795480","1795481","1795607","1795610","1795612"],"spl_id":["4acb5988-64ad-4f83-bc8d-6f2117dfebbe"],"spl_set_id":["085614c7-ada4-4e2c-87c0-c9bc2f18365a"],"package_ndc":["0264-7510-00","0264-7510-10","0264-7510-20","0264-7520-00","0264-7520-10","0264-7520-20"],"unii":["IY9XDZ35W2"]},"update_date":"10/19/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 10%, Injection, 10 g/100 mL (NDC 0264-7520-00)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"43547-410-09","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-931-9829","availability":"Unavailable","related_info":"Not available. Long-term backorder for all NDCs. No estimated release date at this time.","openfda":{"application_number":["ANDA205823"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Solco Healthcare US, LLC"],"product_ndc":["43547-410","43547-411","43547-412","43547-413"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["b8f1731a-cbac-4f64-a8d4-320b80b335e1"],"spl_set_id":["cd46691d-5593-4a9f-a937-999c6803e312"],"package_ndc":["43547-410-09","43547-411-09","43547-412-09","43547-413-09"],"unii":["33067B3N2M"]},"update_date":"06/29/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 5 mg (NDC 43547-410-09)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"05/08/2026","update_type":"New","initial_posting_date":"05/08/2026","package_ndc":"69489-721-05","generic_name":"Sulconazole Nitrate Solution","contact_info":"480-434-6670","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA018738"],"brand_name":["EXELDERM"],"generic_name":["SULCONAZOLE NITRATE"],"manufacturer_name":["Journey Medical Corporation"],"product_ndc":["69489-721"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TOPICAL"],"substance_name":["SULCONAZOLE NITRATE"],"rxcui":["208118","313125"],"spl_id":["53b92932-d626-2d66-e063-6294a90a8f6a"],"spl_set_id":["5b73e83e-8d3c-4d96-b4f6-9f854430add8"],"package_ndc":["69489-721-30","69489-721-05"],"unii":["1T89100D5U"]},"update_date":"05/08/2026","therapeutic_category":["Dermatology"],"dosage_form":"Solution","presentation":"Exelderm, Solution, 1.0% 5 mL (NDC 69489-721-05)","company_name":"Journey Medical Corporation","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-0280-51","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0280","0009-0274","0009-0306"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358510","1358512","1358610","1358612","1358617","1358619"],"spl_id":["267dd735-f800-4735-ba1c-d39d00f0cee5"],"spl_set_id":["823b0010-2b57-4e76-b5ac-4a8c2963438f"],"package_ndc":["0009-0274-01","0009-0280-02","0009-0280-51","0009-0280-03","0009-0280-52","0009-0306-02","0009-0306-12"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-51)","company_name":"Pfizer Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-4275-01","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA088325"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4275","0409-4713","0409-4278","0409-4279","0409-4776","0409-4282","0409-4277","0409-4276","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride In Plastic Container, Injection, 250 mg/50 mL (0.5%; 5 mg/mL) (NDC 0409-4275-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0955-1010-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["ENOXAPARIN SODIUM"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0955-1010","0955-1003","0955-1004","0955-1006","0955-1008","0955-1016","0955-1012","0955-1015"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854235","854238","854241","854245","854248","854252","854255"],"spl_id":["8f06a411-badb-483f-852d-8e6124acfa44"],"spl_set_id":["20635579-c92d-4f6c-a332-1096d51002f2"],"package_ndc":["0955-1003-01","0955-1003-10","0955-1004-01","0955-1004-10","0955-1006-01","0955-1006-10","0955-1008-01","0955-1008-10","0955-1010-01","0955-1010-10","0955-1016-01","0955-1012-01","0955-1012-10","0955-1015-01","0955-1015-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Enoxaparin Sodium, Injection, 100 mg/1 mL (NDC 0955-1010-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"discontinued_date":"09/10/2026","update_type":"New","initial_posting_date":"09/10/2026","package_ndc":"46163-212-95","generic_name":"Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution","contact_info":"800-323-5188","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020171"],"brand_name":["DELFLEX"],"generic_name":["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"],"manufacturer_name":["Fresenius Medical Care de Mexico, S.A. de C.V."],"product_ndc":["46163-212","46163-209","46163-206"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"spl_id":["5f14959c-adcd-923c-e063-6294a90ab6de"],"spl_set_id":["a98facd6-9daa-4d37-8209-63a0599dbfaa"],"package_ndc":["46163-209-92","46163-209-94","46163-209-95","46163-212-95","46163-212-92","46163-212-94","46163-206-92","46163-206-94","46163-206-95"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"09/10/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DELFLEX, Solution, 18.4 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 46163-212-95)","company_name":"Fresenius Medical Care North America","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/03/2025","package_ndc":"0574-4022-35","generic_name":"Bacitracin Ophthalmic Ointment","contact_info":"866-634-9120","availability":"Unavailable","related_info":"Shortage is estimated for 15 additional months","update_date":"10/23/2026","therapeutic_category":["Anti-Infective","Ophthalmology"],"dosage_form":"Ophthalmic Ointment","presentation":"Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)","company_name":"Padagis US LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"discontinued_date":"07/07/2026","update_type":"New","initial_posting_date":"07/07/2026","package_ndc":"0378-9651-50","generic_name":"Travoprost Ophthalmic Solution","contact_info":"877-446-3679","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA205050"],"brand_name":["TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"],"generic_name":["TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-9651"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["OPHTHALMIC"],"substance_name":["TRAVOPROST"],"rxcui":["284008"],"spl_id":["d78c5705-68ac-4363-b9ae-5facc60e2b79"],"spl_set_id":["00dc284f-fd96-423b-bb8f-b90ee13439bf"],"package_ndc":["0378-9651-32","0378-9651-50"],"nui":["N0000175454","M0017805"],"pharm_class_epc":["Prostaglandin Analog [EPC]"],"pharm_class_cs":["Prostaglandins [CS]"],"unii":["WJ68R08KX9"]},"update_date":"07/07/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Ophthalmic Solution","presentation":"Travoprost, Ophthalmic Solution, 0.004%, 5 mL (NDC 0378-9651-50)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"45963-678-11","generic_name":"Metoprolol Succinate Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA204161"],"brand_name":["METOPROLOL SUCCINATE"],"generic_name":["METOPROLOL SUCCINATE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["45963-678","45963-709","45963-676","45963-677"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METOPROLOL SUCCINATE"],"rxcui":["866412","866419","866427","866436"],"spl_id":["a7e9a234-a8a6-4afe-ba8e-d569772bc39a"],"spl_set_id":["b798601e-a369-4c8b-8235-08900e1b751d"],"package_ndc":["45963-709-11","45963-709-96","45963-676-11","45963-676-96","45963-677-11","45963-677-96","45963-678-11"],"unii":["TH25PD4CCB"]},"update_date":"08/31/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Metoprolol Succinate, Tablet, Extended Release, 200 mg (NDC 45963-678-11)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/18/2023","package_ndc":"71288-563-85","generic_name":"Liraglutide Injection","contact_info":"844-824-8426","availability":"Available","openfda":{"application_number":["ANDA218115"],"brand_name":["LIRAGLUTIDE"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-563"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["897122"],"spl_id":["a0bb0116-f90a-490b-9ca9-5bcd6210c763"],"spl_set_id":["0efc3a89-211a-4496-baab-e8265e07de2b"],"package_ndc":["71288-563-84","71288-563-85"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"08/27/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-85)","company_name":"Meitheal Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/05/2022","package_ndc":"0409-6695-02","generic_name":"Etomidate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA018227"],"brand_name":["AMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6695"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008","1654009","1654011"],"spl_id":["3f83ed21-1b60-486c-8c70-1d5aa7553404"],"spl_set_id":["b7ed5bf8-ba75-44dc-8f81-96b4ad5766be"],"package_ndc":["0409-6695-11","0409-6695-01","0409-6695-12","0409-6695-02"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Amidate, Injection, 2 mg/mL (NDC 0409-6695-02)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0527-0763-37","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215565"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-0763","0527-0760","0527-0761","0527-0762","0527-0764","0527-0765","0527-0766"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["391d7c4a-47df-41ce-b1ba-3c4758adf87f"],"spl_set_id":["f92497b5-baea-4760-b615-45a0b6184402"],"package_ndc":["0527-0760-37","0527-0761-37","0527-0762-37","0527-0763-37","0527-0764-37","0527-0765-37","0527-0766-37"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 0527-0763-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"discontinued_date":"12/10/2025","update_type":"New","initial_posting_date":"12/10/2025","package_ndc":"0025-1031-31","generic_name":"Spironolactone Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug.","openfda":{"application_number":["NDA012151"],"brand_name":["ALDACTONE"],"generic_name":["SPIRONOLACTONE"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0025-1031","0025-1001","0025-1041"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["SPIRONOLACTONE"],"rxcui":["198222","198223","200817","200820","200825","313096"],"spl_id":["22946678-dcad-4518-9bc6-cbdf51a38c16"],"spl_set_id":["0fed2822-3a03-4b64-9857-c682fcd462bc"],"package_ndc":["0025-1001-31","0025-1041-31","0025-1031-31"],"nui":["N0000175557","N0000011310"],"pharm_class_epc":["Aldosterone Antagonist [EPC]"],"pharm_class_moa":["Aldosterone Antagonists [MoA]"],"unii":["27O7W4T232"]},"update_date":"12/10/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Aldactone, Tablet, 100 mg (NDC 0025-1031-31)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-168-30","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203895"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-168","55150-167","55150-169","55150-170","55150-171","55150-172","55150-249","55150-250"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404","1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["39649703-e633-4a20-ba71-0c04dbf8ff2a"],"spl_set_id":["ffecf450-1f01-4721-8e10-251385852612"],"package_ndc":["55150-167-10","55150-168-30","55150-169-10","55150-170-30","55150-171-10","55150-172-30","55150-249-50","55150-250-50"],"unii":["7TQO7W3VT8"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-168-30)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"25021-661-10","generic_name":"Midazolam Hydrochloride Injection","contact_info":"Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618","availability":"Unavailable","related_info":"Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals","openfda":{"application_number":["ANDA090850"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-661"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311702"],"spl_id":["002ea282-09ba-4d79-8bd1-94c9859f442b"],"spl_set_id":["880cac48-5c0f-49a9-8aef-3c9770bf5d84"],"package_ndc":["25021-661-10"],"unii":["W7TTW573JJ"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10)","company_name":"Gland Pharma Limited","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"65162-028-09","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA202830"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["65162-028","65162-023","65162-024","65162-025","65162-026","65162-027"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850"],"spl_id":["4cc5e658-25c6-4a58-a93a-6e35242d6de4"],"spl_set_id":["c11cb3b6-3dff-477b-a249-b4c3118edc5f"],"package_ndc":["65162-023-09","65162-024-09","65162-025-09","65162-026-09","65162-027-09","65162-028-09"],"unii":["SJT761GEGS"]},"update_date":"10/06/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 65162-028-09)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"discontinued_date":"01/06/2026","update_type":"New","initial_posting_date":"01/06/2026","package_ndc":"49884-128-91","generic_name":"Everolimus Tablet","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"01/06/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, 10 mg (NDC 49884-128-91)","company_name":"Endo Pharmaceuticals, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-3182-02","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA089646"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3182","0409-1209","0409-3177","0409-3178","0409-3181","0409-3183","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"65862-163-90","generic_name":"Quinapril/Hydrochlorothiazide Tablet","contact_info":"866-850-2876","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA078450"],"brand_name":["QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"],"generic_name":["QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["65862-163","65862-161","65862-162"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE","HYDROCHLOROTHIAZIDE"],"rxcui":["310796","310797","310809"],"spl_id":["5842ecc2-874a-481b-8997-afa9d862dc5d"],"spl_set_id":["50a58159-9572-4445-9859-b392632597da"],"package_ndc":["65862-161-90","65862-162-30","65862-162-90","65862-163-90"],"nui":["N0000175359","N0000175419","M0471776"],"pharm_class_pe":["Increased Diuresis [PE]"],"pharm_class_epc":["Thiazide Diuretic [EPC]"],"pharm_class_cs":["Thiazides [CS]"],"unii":["0J48LPH2TH","33067B3N2M"]},"update_date":"11/04/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 25 mg; 20 mg (NDC 65862-163-90)","company_name":"Aurobindo Pharma USA","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1165-02","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070585"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1165","0409-1159","0409-1160","0409-1162","0409-1163","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 225 mg/30 mL (7.5 mg/mL) (NDC 0409-1165-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"0409-2022-01","generic_name":"Morphine Sulfate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA202515"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2022","0409-1896"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731537","1731545"],"spl_id":["6f2d5741-5543-4bea-8d1d-7e4889b634a0"],"spl_set_id":["ee8057d1-ed12-4e18-9efa-d83504abf612"],"package_ndc":["0409-1896-20","0409-2022-01"],"unii":["X3P646A2J0"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-2022-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-107-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA021977"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-107","59417-101","59417-102","59417-103","59417-104","59417-105","59417-106","59417-115","59417-116","59417-117","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Vyvanse, Capsule, 70 mg (NDC 59417-107-10)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"63323-806-01","generic_name":"Fentanyl Citrate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA210762"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-806"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270"],"spl_id":["341b092a-1f6f-40f1-98f2-9346bf2e1242"],"spl_set_id":["38d0c14a-a0c1-44cc-a939-0304eb8037d6"],"package_ndc":["63323-806-11","63323-806-01","63323-806-12","63323-806-02","63323-806-13","63323-806-05","63323-806-14","63323-806-20","63323-806-50"],"unii":["MUN5LYG46H"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-01)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"0409-9094-25","generic_name":"Fentanyl Citrate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026","openfda":{"application_number":["NDA019115"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9094","0409-9093"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735004","1735006","1735007","1735008","1735013"],"spl_id":["8ff8b8cf-1a31-46dc-b350-2b9cc700e6a6"],"spl_set_id":["bfa8018a-4cbc-434b-e09e-782872b0340a"],"package_ndc":["0409-9093-41","0409-9093-36","0409-9093-31","0409-9093-38","0409-9094-12","0409-9094-22","0409-9094-18","0409-9094-25","0409-9094-17","0409-9094-28","0409-9094-16","0409-9094-31","0409-9094-41","0409-9094-61","0409-9094-44","0409-9094-55"],"unii":["MUN5LYG46H"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 250 mcg/5 mL (50 ug/1 mL) (NDC 0409-9094-25)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0990-6139-22","generic_name":"Sterile Water Irrigant","related_info_link":"https://www.fda.gov/media/182619/download?attachment","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Unavailable","related_info":"Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","update_date":"11/03/2026","therapeutic_category":["Gastroenterology","Other","Pediatric"],"dosage_form":"Irrigant","presentation":"Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-22)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1761-62","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018692"],"brand_name":["MARCAINE SPINAL"],"generic_name":["BUPIVACAINE HYDROCHLORIDE IN DEXTROSE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1761"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBARACHNOID"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724784","1724792"],"spl_id":["ef77810e-d05c-4501-9512-10dbe0bc7f00"],"spl_set_id":["9679cc05-2f8a-4e88-53b5-6e9122c8b8c0"],"package_ndc":["0409-1761-19","0409-1761-02","0409-1761-18","0409-1761-62","0409-1761-05","0409-1761-10"],"unii":["7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Marcaine, Injection, 0.75% 15 mg/2 mL (NDC 0409-1761-62)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"04/14/2026","update_type":"New","initial_posting_date":"04/14/2026","package_ndc":"58914-301-80","generic_name":"Nitroglycerin Ointment","contact_info":"800-678-1605","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA021359"],"brand_name":["RECTIV"],"generic_name":["NITROGLYCERIN"],"manufacturer_name":["Allergan, Inc."],"product_ndc":["58914-301"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["NITROGLYCERIN"],"rxcui":["1114466","1114470"],"spl_id":["5af7594b-3ed9-ce68-e063-6394a90a006e"],"spl_set_id":["603aa9ed-54c4-4a35-ade4-690fa44850e4"],"package_ndc":["58914-301-80","58914-301-85"],"nui":["N0000175415","M0014874","N0000009909"],"pharm_class_epc":["Nitrate Vasodilator [EPC]"],"pharm_class_cs":["Nitrates [CS]"],"pharm_class_pe":["Vasodilation [PE]"],"unii":["G59M7S0WS3"]},"update_date":"04/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Ointment","presentation":"Rectiv, Ointment, 0.4% (NDC 58914-301-80)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/13/2023","package_ndc":"0143-9830-01","generic_name":"Methotrexate Sodium Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Additional lots will be available in the November 2026 timeframe.  Short Dated Prodcut Available.","openfda":{"application_number":["ANDA040632"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9830"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL","INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS"],"substance_name":["METHOTREXATE"],"rxcui":["311625"],"spl_id":["49eb25b2-c59c-4374-a216-076767fe1126"],"spl_set_id":["b080eb92-fc72-4ce6-a7ab-3f9ce2415526"],"package_ndc":["0143-9830-01"],"nui":["N0000175584","N0000000111"],"pharm_class_epc":["Folate Analog Metabolic Inhibitor [EPC]"],"pharm_class_moa":["Folic Acid Metabolism Inhibitors [MoA]"],"unii":["YL5FZ2Y5U1"]},"update_date":"10/14/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/31/2026","package_ndc":"0054-3294-50","generic_name":"Furosemide Oral Solution","contact_info":"800-631-2174","availability":"Available","openfda":{"application_number":["ANDA070434"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-3294","0054-4297","0054-8297","0054-4299","0054-8299","0054-4301","0054-8301","0054-3298"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FUROSEMIDE"],"rxcui":["197730","197731","197732","310429","313988"],"spl_id":["bc62ddda-7639-4090-99f0-7dd4d13518f3"],"spl_set_id":["9e493331-dddd-496e-abf8-61747fb67aba"],"package_ndc":["0054-4297-31","0054-4297-25","0054-8297-25","0054-4299-31","0054-4299-25","0054-8299-25","0054-4301-29","0054-4301-25","0054-8301-25","0054-3298-63","0054-3294-50","0054-3294-46"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"10/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Oral Solution","presentation":"Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-50)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"01/27/2026","update_type":"New","initial_posting_date":"01/27/2026","package_ndc":"0781-8017-01","generic_name":"Fluvastatin Sodium Tablet, Extended Release","contact_info":"800-525-8747","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA021192"],"brand_name":["FLUVASTATIN SODIUM ER"],"generic_name":["FLUVASTATIN SODIUM"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-8017"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FLUVASTATIN SODIUM"],"rxcui":["360507"],"spl_id":["37375ca6-3a81-4d10-9b39-9aee948e51a4"],"spl_set_id":["5ab4296c-87c2-4c64-b218-d620eef51310"],"package_ndc":["0781-8017-31","0781-8017-01"],"unii":["PYF7O1FV7F"]},"update_date":"01/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Fluvastatin Sodium, Tablet, Extended Release, 80 mg (NDC 0781-8017-01)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-064-01","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1019","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-064","70069-061","70069-062","70069-063","70069-065","70069-066","70069-067"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-01)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"70069-753-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Unavailable","related_info":"Estimated recovery: June 2027","openfda":{"application_number":["ANDA217792"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-753","70069-752"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["2b24af95-6f20-4945-bf8c-742f1d6f2721"],"spl_set_id":["bcaab86f-20f0-4482-8d73-e29b36dced58"],"package_ndc":["70069-752-25","70069-752-10","70069-752-01","70069-753-25","70069-753-01","70069-753-10"],"unii":["7TQO7W3VT8"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-01)","company_name":"Somerset Therapeutics, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/21/2023","package_ndc":"0641-1496-35","generic_name":"Promethazine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA083312"],"brand_name":["PROMETHAZINE HYDROCHLORIDE"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-1496","0641-1495"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992460","992858"],"spl_id":["80a400d2-d293-4180-bfa7-7a8ce0734bc5"],"spl_set_id":["13d9e59d-eadb-41d5-9f47-9c11a6efb31c"],"package_ndc":["0641-1495-31","0641-1495-35","0641-1496-31","0641-1496-35"],"unii":["R61ZEH7I1I"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Pediatric","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Promethazine Hydrochloride, Injection, 50 mg/1 mL (NDC 0641-1496-35)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/28/2025","package_ndc":"0574-2410-65","generic_name":"Methylphenidate Film, Extended Release","contact_info":"800-455-8070","availability":"Available","related_info":"Distributed by Padagis US LLC","openfda":{"application_number":["NDA021514"],"brand_name":["METHYLPHENIDATE TRANSDERMAL SYSTEM"],"generic_name":["METHYLPHENIDATE"],"manufacturer_name":["PADAGIS US LLC"],"product_ndc":["0574-2410","0574-2415","0574-2420","0574-2430"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TRANSDERMAL"],"substance_name":["METHYLPHENIDATE"],"rxcui":["753436","753438","753440","753441"],"spl_id":["b743ef45-2fc0-4086-8a02-6078e6a09eaa"],"spl_set_id":["7bcff873-1fc2-45bc-a8e4-5db4edeb9bfb"],"package_ndc":["0574-2410-65","0574-2415-65","0574-2420-65","0574-2430-65"],"nui":["N0000175739","N0000175729"],"pharm_class_epc":["Central Nervous System Stimulant [EPC]"],"pharm_class_pe":["Central Nervous System Stimulation [PE]"],"unii":["207ZZ9QZ49"]},"update_date":"10/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Film, Extended Release","presentation":"Methylphenidate, Film, Extended Release, 10 mg (NDC 0574-2410-65)","company_name":"Noven Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/12/2026","package_ndc":"0338-3991-01","generic_name":"Ifosfamide Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA019763"],"brand_name":["IFEX"],"generic_name":["IFOSFAMIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-3991","0338-3993"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IFOSFAMIDE"],"spl_id":["cf10cfa3-8614-4f9c-a0b4-f4fd4474d6ac"],"spl_set_id":["b7241707-7538-4d1a-91e7-3a25a91e0b9a"],"package_ndc":["0338-3991-01","0338-3993-01"],"nui":["N0000000236","N0000175558"],"pharm_class_moa":["Alkylating Activity [MoA]"],"pharm_class_epc":["Alkylating Drug [EPC]"],"unii":["UM20QQM95Y"]},"update_date":"11/03/2026","therapeutic_category":["Oncology","Pediatric"],"dosage_form":"Injection","presentation":"IFEX, Injection, 1 g/20 mL (NDC 0338-3991-01)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"71288-205-03","generic_name":"Furosemide Injection","contact_info":"844-824-8426","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA217501"],"brand_name":["HYDRALAZINE HYDROCHLORIDE"],"generic_name":["HYDRALAZINE HYDROCHLORIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-205"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["HYDRALAZINE HYDROCHLORIDE"],"rxcui":["966571"],"spl_id":["2926d221-0ca5-4379-ac53-773051ec5c79"],"spl_set_id":["f3c806a4-b971-421c-bcb9-9979c6d7aaec"],"package_ndc":["71288-205-01","71288-205-02"],"unii":["FD171B778Y"]},"update_date":"08/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/mL, 2 mL (NDC 71288-205-03)","company_name":"Meitheal Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/13/2017","change_date":"09/30/2026","package_ndc":"72205-101-07","generic_name":"Bumetanide Injection","contact_info":"855-668-2369; customerservice@novadozpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA215364"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-101","72205-102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["387edfd4-be85-41cd-8a6d-14e6a022b5a9"],"spl_set_id":["387edfd4-be85-41cd-8a6d-14e6a022b5a9"],"package_ndc":["72205-101-01","72205-101-07","72205-102-01","72205-102-07"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-101-07)","company_name":"MSN Laboratories Private Limited","status":"Resolved"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0427-52","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020163"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0427","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0427-52)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/18/2020","package_ndc":"59572-102-01","generic_name":"Azacitidine Injection","contact_info":"1-888-423-5436","availability":"Available","openfda":{"application_number":["NDA050794"],"brand_name":["VIDAZA"],"generic_name":["AZACITIDINE"],"manufacturer_name":["Celgene Corporation"],"product_ndc":["59572-102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["AZACITIDINE"],"rxcui":["485246","545206"],"spl_id":["8cba79e2-11fa-4eb9-87e7-827ca781fbf3"],"spl_set_id":["3495a71a-cc04-4776-851f-f185956f32af"],"package_ndc":["59572-102-01"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["M801H13NRU"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Vidaza, Injection, 100 mg (NDC 59572-102-01)","company_name":"Bristol Myers Squibb Co.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/15/2021","package_ndc":"0009-0306-02","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0306","0009-0274","0009-0280"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358510","1358512","1358610","1358612","1358617","1358619"],"spl_id":["267dd735-f800-4735-ba1c-d39d00f0cee5"],"spl_set_id":["823b0010-2b57-4e76-b5ac-4a8c2963438f"],"package_ndc":["0009-0274-01","0009-0280-02","0009-0280-51","0009-0280-03","0009-0280-52","0009-0306-02","0009-0306-12"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-02)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0555-0973-02","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0555-0973","0555-0971","0555-0775","0555-0972","0555-0776","0555-0777","0555-0974"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"],"spl_set_id":["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"],"package_ndc":["0555-0971-02","0555-0775-02","0555-0972-02","0555-0776-02","0555-0777-02","0555-0973-02","0555-0974-02"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 0555-0973-02)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"08/10/2026","update_type":"New","initial_posting_date":"08/10/2026","package_ndc":"0093-9364-01","generic_name":"Glyburide Tablet","contact_info":"800-633-1610","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017532"],"brand_name":["GLYBURIDE"],"generic_name":["GLYBURIDE"],"manufacturer_name":["TEVA Pharmaceuticals USA Inc"],"product_ndc":["0093-9364","0093-9477","0093-9433"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GLYBURIDE"],"rxcui":["197737","310534","310537"],"spl_id":["84b83205-8813-494e-933e-a70697393744"],"spl_set_id":["50d16f1d-c814-4411-8749-62561321ecce"],"package_ndc":["0093-9477-53","0093-9433-01","0093-9433-05","0093-9364-01","0093-9364-05","0093-9364-10"],"nui":["N0000175608","M0020795"],"pharm_class_epc":["Sulfonylurea [EPC]"],"pharm_class_cs":["Sulfonylurea Compounds [CS]"],"unii":["SX6K58TVWC"]},"update_date":"08/10/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Diabeta, Tablet, 5 mg (NDC 0093-9364-01)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"55150-198-30","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA205612"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-198","55150-195","55150-196","55150-197","55150-199","55150-200","55150-201"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734207","1734347","1734475","1734483"],"spl_id":["1e5f1368-058a-492c-b4b7-d9329a7745e2"],"spl_set_id":["3763b7b6-da49-4658-b93d-28f5da24d09e"],"package_ndc":["55150-195-20","55150-196-99","55150-197-20","55150-198-30","55150-199-20","55150-200-10","55150-201-20"],"unii":["V910P86109"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-198-30)","company_name":"Eugia US LLC","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0459-05","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017512"],"brand_name":["DIANEAL LOW CALCIUM WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0459","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0459-05)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"39822-4200-6","generic_name":"Rocuronium Bromide Injection","contact_info":"866-390-4411","availability":"Available","related_info":"Tamarang is the application holder and X-Gen is the distributor/labeler","openfda":{"application_number":["ANDA091115"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["XGen Pharmaceuticals DJB, Inc."],"product_ndc":["39822-4200"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["eedcfb07-4e23-3152-e053-2995a90a6e6a"],"spl_set_id":["b73f192c-2912-4ec3-9b4f-05a58d9b35ba"],"package_ndc":["39822-4200-1","39822-4200-2","39822-4200-5","39822-4200-6"],"unii":["I65MW4OFHZ"]},"update_date":"09/22/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 39822-4200-6)","company_name":"XGen Pharmaceuticals DJB, Inc.","status":"Current"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"45963-709-96","generic_name":"Metoprolol Succinate Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA204161"],"brand_name":["METOPROLOL SUCCINATE"],"generic_name":["METOPROLOL SUCCINATE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["45963-709","45963-676","45963-677","45963-678"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METOPROLOL SUCCINATE"],"rxcui":["866412","866419","866427","866436"],"spl_id":["a7e9a234-a8a6-4afe-ba8e-d569772bc39a"],"spl_set_id":["b798601e-a369-4c8b-8235-08900e1b751d"],"package_ndc":["45963-709-11","45963-709-96","45963-676-11","45963-676-96","45963-677-11","45963-677-96","45963-678-11"],"unii":["TH25PD4CCB"]},"update_date":"08/31/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-96)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"04/29/2026","update_type":"New","initial_posting_date":"04/29/2026","package_ndc":"49884-564-11","generic_name":"Lamotrigine Tablet, Extended Release","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/29/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Lamotrigine, Tablet, Extended Release, 200 mg (NDC 49884-564-11)","company_name":"Par Health, Inc.","status":"To Be Discontinued"},{"discontinued_date":"01/09/2026","update_type":"New","initial_posting_date":"01/09/2026","package_ndc":"63323-469-01","generic_name":"Haloperidol Decanoate Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA074893"],"brand_name":["HALOPERIDOL DECANOATE"],"generic_name":["HALOPERIDOL DECANOATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-469","63323-471"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["HALOPERIDOL DECANOATE"],"rxcui":["859867","859871","1719803","1719862"],"spl_id":["86dff2aa-2ab3-42fc-989e-619b13ace573"],"spl_set_id":["ca9896e0-fb2e-46a4-8700-20d144c14764"],"package_ndc":["63323-469-01","63323-469-05","63323-471-01","63323-471-05"],"unii":["AC20PJ4101"]},"update_date":"01/09/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Injection","presentation":"Haloperidol Decanoate, Injection, 50 mg/1 mL (NDC 63323-469-01)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-3812-01","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3812","0409-5738","0409-1541","0409-8126","0409-4208","0409-6581"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1672917","1672919","1673242","1673243","1867594","1867596","1867612","1867614"],"spl_id":["14ec85dc-0263-44d1-9267-66fa072cff8d"],"spl_set_id":["93cf0914-de08-4ec6-8f8c-d663243b9958"],"package_ndc":["0409-5738-01","0409-5738-10","0409-3812-01","0409-1541-01","0409-1541-10","0409-8126-01","0409-8126-10","0409-4208-01","0409-4208-10","0409-6581-01"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 125 mg/50 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Multiple Dose Vial Novaplus (NDC 0409-3812-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"61703-600-05","generic_name":"Carboplatin Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA077059"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-600","61703-360","61703-150","61703-262"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["5aa72c15-8033-4559-b257-373371b18958"],"spl_set_id":["47677091-fd20-49af-933c-c9dd2be21de9"],"package_ndc":["61703-360-18","61703-150-05","61703-262-05","61703-600-05"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/09/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-600-05)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/22/2020","package_ndc":"43066-015-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Limited Availability","related_info":"Check wholesalers for inventory; Marketed by Baxter","openfda":{"application_number":["ANDA212808"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["43066-015","43066-019","43066-023","43066-027"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734084","1734207","1734475","1734483"],"spl_id":["a8d08579-825f-40d9-b1e3-e47b73765ae6"],"spl_set_id":["781d4b7f-7556-4695-8d48-7772d7a0d8e9"],"package_ndc":["43066-015-01","43066-015-10","43066-019-01","43066-019-10","43066-023-01","43066-023-10","43066-027-01","43066-027-10"],"unii":["V910P86109"]},"update_date":"06/10/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 43066-015-10)","company_name":"Caplin Steriles, Ltd.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"44567-611-10","generic_name":"Midazolam Hydrochloride Injection","contact_info":"888-493-0861","availability":"Available","related_info":"Please check wholesalers and distributors for inventory.","openfda":{"application_number":["NDA211844"],"brand_name":["MIDAZOLAM IN SODIUM CHLORIDE"],"generic_name":["MIDAZOLAM"],"manufacturer_name":["WG Critical Care, LLC."],"product_ndc":["44567-611","44567-610"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MIDAZOLAM"],"rxcui":["2541170","2541171"],"spl_id":["eedc698f-65b8-4d19-9194-234f05634f71"],"spl_set_id":["f051776f-94c5-4e34-80ed-f45b9c36881e"],"package_ndc":["44567-610-01","44567-610-10","44567-611-01","44567-611-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["R60L0SM5BC"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10)","company_name":"WG Critical Care","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/13/2018","package_ndc":"0143-9577-10","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.","openfda":{"application_number":["ANDA080407"],"brand_name":["LIDOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9577","0143-9579","0143-9578","0143-9576","0143-9575","0143-9172","0143-9173"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671"],"spl_id":["e9b92d4d-8944-4235-8d77-3218f82f00a9"],"spl_set_id":["5523fdfe-69fd-49a5-b51f-73e2223d49a9"],"package_ndc":["0143-9579-01","0143-9579-25","0143-9578-01","0143-9578-10","0143-9577-01","0143-9577-10","0143-9576-01","0143-9576-25","0143-9575-01","0143-9575-10","0143-9172-01","0143-9172-10","0143-9173-01","0143-9173-10"],"unii":["V13007Z41A"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/01/2017","package_ndc":"0409-4264-01","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA200403"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4264","0409-1283","0409-1312","0409-1805"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1724383","1724644","2675350"],"spl_id":["766e302a-2d03-4d93-b237-2348b57ee517"],"spl_set_id":["f9ca2ef5-46d8-475a-a26e-f7c8becd6db7"],"package_ndc":["0409-1283-17","0409-1283-37","0409-1312-16","0409-1312-36","0409-4264-11","0409-4264-01","0409-1805-10","0409-1805-01"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 0.5 mg/0.5 mL NexJect™ Single-dose Syringe Luer Lock (no needle) (NDC 0409-4264-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1749-10","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1749","0409-1746","0409-1752","0409-1755","0409-2510","0409-7535","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 50 mg/10 mL (5 mg/mL 1:200,000) (NDC 0409-1749-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"25021-115-04","generic_name":"Clindamycin Phosphate Injection","contact_info":"866-625-1618","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA090108"],"brand_name":["CLINDAMYCIN"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-115"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["1737244","1737578","1737581"],"spl_id":["ca8ce6e9-feae-4a33-a380-64061313d704"],"spl_set_id":["7a6967b3-5563-4bed-9eee-d400f800e799"],"package_ndc":["25021-115-02","25021-115-04","25021-115-06"],"unii":["EH6D7113I8"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-04)","company_name":"Sagent Pharmaceuticals","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-062-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1019","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-062","70069-061","70069-063","70069-064","70069-065","70069-066","70069-067"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-10)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7110-12","generic_name":"Morphine Sulfate Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7110","0574-7112","0574-7114","0574-7116"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892516","892603","892678","894807"],"spl_id":["fa18ac09-a625-47aa-8cde-7051dc4d0c49"],"spl_set_id":["649d731b-962a-45df-b043-7e0781e8a530"],"package_ndc":["0574-7110-12","0574-7112-12","0574-7114-12","0574-7116-12"],"unii":["X3P646A2J0"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Suppository","presentation":"Morphine Sulfate, Suppository, 5 mg (NDC 0574-7110-12)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"63323-485-57","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-485","63323-492","63323-491","63323-495","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-57)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"63323-851-50","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA019034"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-851","63323-852","63323-853","63323-854"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897653","897753","1724276","1724338","1724340","1724341"],"spl_id":["2cfa0a3e-eb57-4dea-ae2c-0b91176f0f67"],"spl_set_id":["e034eb96-03e0-46e1-8b92-5e1f94555e7b"],"package_ndc":["63323-851-03","63323-851-10","63323-851-07","63323-851-15","63323-851-50","63323-852-03","63323-852-25","63323-853-03","63323-853-25","63323-854-03","63323-854-10"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-50)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"04/09/2026","update_type":"New","initial_posting_date":"04/09/2026","package_ndc":"0069-4061-01","generic_name":"Azithromycin Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050711"],"brand_name":["ZITHROMAX"],"generic_name":["AZITHROMYCIN DIHYDRATE"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0069-4061","0069-3060","0069-3070","0069-3110","0069-3120","0069-3130","0069-3140"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AZITHROMYCIN DIHYDRATE"],"rxcui":["105260","141963","211307","212446","226827","248656","308459","308460","749780","749783","750149","750157"],"spl_id":["1c5f0fcc-88ce-47e9-a128-b7326b7a5a02"],"spl_set_id":["db52b91e-79f7-4cc1-9564-f2eee8e31c45"],"package_ndc":["0069-3060-30","0069-3060-75","0069-3060-86","0069-3070-30","0069-3070-75","0069-3110-19","0069-3120-19","0069-3130-19","0069-3140-19","0069-4061-01","0069-4061-75","0069-4061-89"],"unii":["5FD1131I7S"]},"update_date":"04/09/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Tablet","presentation":"Zithromax, Tablet, 250 mg (NDC 0069-4061-01)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"67457-420-10","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA040802"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-420","67457-423","67457-422","67457-421"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696","1116927","1812194"],"spl_id":["dd5c82b6-a194-462c-9626-34a9b410cfea"],"spl_set_id":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"package_ndc":["67457-423-00","67457-423-12","67457-422-00","67457-422-54","67457-421-00","67457-421-30","67457-420-00","67457-420-10"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 67457-420-10)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7040-12","generic_name":"Belladonna and Opium Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["BELLADONNA AND OPIUM"],"generic_name":["ATROPA BELLADONNA AND OPIUM"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7040","0574-7045"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["ATROPA BELLADONNA","OPIUM"],"rxcui":["312104","312107"],"spl_id":["7b45a1d7-c3a5-4434-a848-45638cedd6e1"],"spl_set_id":["8301e76b-134a-43d2-a7dc-c600ccf2695c"],"package_ndc":["0574-7040-12","0574-7040-04","0574-7045-12","0574-7045-04"],"unii":["37M3MZ001L","WQZ3G9PF0H"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Suppository","presentation":"Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-355-01","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-01)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/18/2023","package_ndc":"0143-9144-02","generic_name":"Liraglutide Injection","contact_info":"800-631-2174","availability":"Available","openfda":{"application_number":["ANDA215503"],"brand_name":["LIRAGLUTIDE"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9144"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["897122"],"spl_id":["4e2acb7a-d32d-49d3-b59b-39332b5809f3"],"spl_set_id":["2100ec49-57b2-4330-ab5f-057ce9b7e4d0"],"package_ndc":["0143-9144-01","0143-9144-03","0143-9144-02"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"10/14/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Liraglutide, Injection, 6 mg/1 mL (NDC 0143-9144-02)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-162-01","generic_name":"Ketorolac Tromethamine Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release not available at this time.  Check wholesalers for inventory.","openfda":{"application_number":["ANDA075784"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-162","63323-161"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["2b1c6066-d9e0-40a0-ade5-776fc35a3626","55ed7afb-db66-4b28-939b-db45b55bf058","ab476c4c-2c72-47b1-bf42-7a89703b0dd4"],"spl_set_id":["ccf905ca-e164-4779-9485-2d139c821bad","950b7295-3f68-4027-ac2b-2f7d0f5f8ef9","d1920335-8e45-4960-b6e9-e6f1f9e6820c"],"package_ndc":["63323-161-41","63323-161-16","63323-162-43","63323-162-16","63323-162-45","63323-162-26","63323-161-21","63323-161-12","63323-162-23","63323-162-12","63323-162-25","63323-162-14","63323-161-00","63323-161-01","63323-162-11","63323-162-51","63323-162-00","63323-162-01","63323-162-03","63323-162-02"],"unii":["4EVE5946BQ"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 63323-162-01)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"61703-339-22","generic_name":"Carboplatin Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA076517"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-339"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["0ddf4411-7138-412a-908a-fadf22bdfb79"],"spl_set_id":["c3ae9880-44bb-4f4e-93d8-8a5e21708a30"],"package_ndc":["61703-339-18","61703-339-22","61703-339-50","61703-339-56"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/09/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-339-22)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-7875-12","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7875","0409-1660","0409-1638","0409-1434","0409-1596","0409-7838","0409-7853"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["284397","309710","1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["3c5274fd-6597-4b88-babc-92e4e16c6329"],"spl_set_id":["548a88c0-afda-427e-75ac-5af0cfa2224c"],"package_ndc":["0409-1660-55","0409-1660-50","0409-1660-35","0409-1660-10","0409-1660-22","0409-1660-20","0409-1638-32","0409-1638-02","0409-1434-01","0409-1596-01","0409-1596-10","0409-7838-01","0409-7838-24","0409-7853-01","0409-7853-24","0409-7875-01","0409-7875-12"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/01/2017","package_ndc":"0409-6625-35","generic_name":"Sodium Bicarbonate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA202432"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6625"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["1868486"],"spl_id":["dcc55d90-d55e-4e1a-9e48-5703cbc74a52","c39c0ef6-4140-4c6c-91c4-e43d67872b05"],"spl_set_id":["8664c7ce-707b-4c6c-9ce4-7160b5f877f8","084f5572-8c1f-4802-b179-ca0cc838fc68"],"package_ndc":["0409-6625-30","0409-6625-35","0409-6625-22","0409-6625-14"],"unii":["8MDF5V39QO"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"02/25/2026","update_type":"New","initial_posting_date":"02/25/2026","package_ndc":"63323-750-20","generic_name":"Oxaliplatin Injection","contact_info":"847-550-2300","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"02/25/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-20)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"01/11/2024","package_ndc":"42858-167-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-827-0616","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA215330"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Rhodes Pharmaceuticals LLC"],"product_ndc":["42858-167","42858-161","42858-162","42858-163","42858-164","42858-165","42858-166"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0002e227-1109-4ecc-a8c5-4b4f11fac3cc"],"spl_set_id":["d918b40d-a461-41bc-b6c0-83dc76c28e32"],"package_ndc":["42858-161-01","42858-162-01","42858-163-01","42858-164-01","42858-165-01","42858-166-01","42858-167-01"],"unii":["SJT761GEGS"]},"update_date":"06/24/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 42858-167-01)","company_name":"Rhodes Pharmaceuticals L.P.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"06/08/2026","update_type":"New","initial_posting_date":"06/08/2026","package_ndc":"0088-2161-30","generic_name":"Leflunomide Tablet","contact_info":"800-981-2491","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020905"],"brand_name":["ARAVA"],"generic_name":["LEFLUNOMIDE"],"manufacturer_name":["sanofi-aventis U.S. LLC"],"product_ndc":["0088-2161","0088-2160","0088-2162"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LEFLUNOMIDE"],"rxcui":["205284","205285","205286","213377","213379","213380"],"spl_id":["765327c7-cb5b-4637-84da-4fd9a024ad96"],"spl_set_id":["320f63f2-fac3-4aee-aff8-85724e00ef52"],"package_ndc":["0088-2160-30","0088-2161-30","0088-2162-33"],"nui":["N0000175713"],"pharm_class_epc":["Antirheumatic Agent [EPC]"],"unii":["G162GK9U4W"]},"update_date":"06/08/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Tablet","presentation":"Arava, Tablet, 20 mg (NDC 0088-2161-30)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"discontinued_date":"12/10/2025","update_type":"New","initial_posting_date":"12/10/2025","package_ndc":"0025-1001-31","generic_name":"Spironolactone Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug.","openfda":{"application_number":["NDA012151"],"brand_name":["ALDACTONE"],"generic_name":["SPIRONOLACTONE"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0025-1001","0025-1041","0025-1031"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["SPIRONOLACTONE"],"rxcui":["198222","198223","200817","200820","200825","313096"],"spl_id":["22946678-dcad-4518-9bc6-cbdf51a38c16"],"spl_set_id":["0fed2822-3a03-4b64-9857-c682fcd462bc"],"package_ndc":["0025-1001-31","0025-1041-31","0025-1031-31"],"nui":["N0000175557","N0000011310"],"pharm_class_epc":["Aldosterone Antagonist [EPC]"],"pharm_class_moa":["Aldosterone Antagonists [MoA]"],"unii":["27O7W4T232"]},"update_date":"12/10/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Aldactone, Tablet, 25 mg (NDC 0025-1001-31)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/01/2022","package_ndc":"63323-824-76","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA209448"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-824"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481"],"spl_id":["0591ab74-99a6-40ee-af96-80bc2ef423dc"],"spl_set_id":["3b8f2692-4371-4f1a-95af-b41842131fdd"],"package_ndc":["63323-824-24","63323-824-74","63323-824-25","63323-824-75","63323-824-26","63323-824-76"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/23/2021","package_ndc":"0409-4887-10","generic_name":"Sterile Water Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018801"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4887"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["055437a7-5be5-414a-a97a-946e2730fe12"],"spl_set_id":["2b9ea23a-f9e9-48a8-25b7-519e3bbd6828"],"package_ndc":["0409-4887-25","0409-4887-99","0409-4887-31","0409-4887-05","0409-4887-17","0409-4887-10","0409-4887-32","0409-4887-34","0409-4887-23","0409-4887-20","0409-4887-24","0409-4887-50"],"unii":["059QF0KO0R"]},"update_date":"11/09/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/21/2023","package_ndc":"0641-6085-25","generic_name":"Promethazine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA083312"],"brand_name":["PHENERGAN"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6085","0641-6084"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992460","992462","992858","992876"],"spl_id":["7d6e64fc-bbf2-4ea9-b866-8115c448e687"],"spl_set_id":["481866da-a712-48a5-853f-8e84aacaab6d"],"package_ndc":["0641-6084-01","0641-6084-25","0641-6085-01","0641-6085-25"],"unii":["R61ZEH7I1I"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Pediatric","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Phenergan, Injection, 50 mg/1 mL (NDC 0641-6085-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/01/2023","package_ndc":"60505-4739-1","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-706-5575","availability":"Available","openfda":{"application_number":["ANDA216944"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-4739","60505-4740","60505-4741","60505-4742","60505-4743","60505-4744","60505-4745"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0190bec9-05e4-0977-9548-2cc150b53e74"],"spl_set_id":["ecad4442-a644-18e3-6ff2-fdbac45eec47"],"package_ndc":["60505-4739-1","60505-4740-1","60505-4741-1","60505-4742-1","60505-4743-1","60505-4744-1","60505-4745-1"],"unii":["SJT761GEGS"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 60505-4739-1)","company_name":"Apotex Corp.","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-1323-05","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA040302"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1323","0409-9137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1012066","1012068"],"spl_id":["3c39bd9b-0be9-48cd-83dd-56162f4f4dfe"],"spl_set_id":["ad1ef0a8-88db-4648-c098-d009eaeb4e5b"],"package_ndc":["0409-1323-15","0409-1323-05","0409-9137-11","0409-9137-05"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 100 mg/5mL (2%,20 mg/1 mL) Syringes (NDC 0409-1323-05)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/17/2015","package_ndc":"0143-9931-25","generic_name":"Cefotaxime Sodium Powder, for Solution","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA065072"],"brand_name":["CEFOTAXIME"],"generic_name":["CEFOTAXIME"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9931","0143-9933","0143-9930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CEFOTAXIME SODIUM"],"rxcui":["309068","1656313","1656318"],"spl_id":["7e0897ec-2275-4438-9cc5-4c951e52ad97"],"spl_set_id":["ed23b6bc-32c7-4c50-a53d-313ae78e5623"],"package_ndc":["0143-9931-01","0143-9931-25","0143-9933-01","0143-9933-25","0143-9930-01","0143-9930-10"],"unii":["258J72S7TZ"]},"update_date":"10/14/2026","therapeutic_category":["Anti-Infective","Pediatric"],"dosage_form":"Powder, For Solution","presentation":"Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0990-7923-23","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7923","0990-7922","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-23)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"discontinued_date":"11/21/2025","update_type":"New","initial_posting_date":"11/21/2025","package_ndc":"0409-9633-05","generic_name":"Verapamil Hydrochloride Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","update_date":"11/21/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Verapamil Hydrochloride, Injection, 2.5 mg/1 mL (NDC 0409-9633-05)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"68180-557-09","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"Lupin Pharmaceuticals, Inc.","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA077690"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Lupin Pharmaceuticals, Inc."],"product_ndc":["68180-557","68180-556","68180-558","68180-554","68180-559"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["a9598a21-6f99-4c86-ace6-b5638da2bec8"],"spl_set_id":["8ded0773-3aec-4e89-9836-d22a5a84abf0"],"package_ndc":["68180-556-09","68180-557-09","68180-557-03","68180-558-09","68180-558-03","68180-554-09","68180-554-03","68180-559-03","68180-559-09"],"unii":["33067B3N2M"]},"update_date":"10/13/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 10 mg (NDC 68180-557-09)","company_name":"Lupin Pharmaceuticals, Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"43547-608-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-931-9829","availability":"Limited Availability","related_info":"On allocation","openfda":{"application_number":["ANDA216266"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE CAPSULES"],"manufacturer_name":["Solco Healthcare US,LLC"],"product_ndc":["43547-608","43547-602","43547-603","43547-604","43547-605","43547-606","43547-607"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["d6435613-e052-4b4f-8bf7-4acb7458d8df"],"spl_set_id":["68b10d9f-ca3e-493d-a309-45f1d7e08061"],"package_ndc":["43547-602-10","43547-603-10","43547-604-10","43547-605-10","43547-606-10","43547-607-10","43547-608-10"],"unii":["SJT761GEGS"]},"update_date":"06/29/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 43547-608-10)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0406-5115-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA211840"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-5115","0406-5111","0406-5112","0406-5113","0406-5114","0406-5116","0406-5117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["77f4cd3a-dca3-4995-8992-042e1dc91a00"],"spl_set_id":["806a1c15-0842-4787-b2ad-09a21fd96b37"],"package_ndc":["0406-5111-01","0406-5112-01","0406-5113-01","0406-5114-01","0406-5115-01","0406-5116-01","0406-5117-01"],"unii":["SJT761GEGS"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0406-5115-01)","company_name":"SpecGx LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0406-8885-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA040440"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-8885","0406-8891","0406-8884","0406-8892","0406-8893","0406-8894"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["0d3fb5ba-ff79-4862-bc1d-45b8343e115b"],"spl_set_id":["72ddd1c9-ddbd-4c95-acd9-003189a353a3"],"package_ndc":["0406-8891-01","0406-8884-01","0406-8892-01","0406-8885-01","0406-8893-01","0406-8894-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 0406-8885-01)","company_name":"SpecGx LLC","status":"Current"},{"discontinued_date":"08/13/2026","update_type":"New","initial_posting_date":"08/13/2026","package_ndc":"0228-2551-11","generic_name":"Diclofenac Sodium Tablet, Delayed Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA074514"],"brand_name":["DICLOFENAC SODIUM"],"generic_name":["DICLOFENAC SODIUM"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2551","0228-2550"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DICLOFENAC SODIUM"],"rxcui":["855906","855926"],"spl_id":["a1fbc994-b8a6-4759-be76-1cfd98275ca6"],"spl_set_id":["a57b897e-0cbe-4ac3-969f-b00357a0cfa8"],"package_ndc":["0228-2550-06","0228-2550-11","0228-2550-96","0228-2551-06","0228-2551-11","0228-2551-96"],"unii":["QTG126297Q"]},"update_date":"08/13/2026","therapeutic_category":["Musculoskeletal","Rheumatology"],"dosage_form":"Tablet","presentation":"Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-11)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1162-02","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070584"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1162","0409-1159","0409-1160","0409-1163","0409-1165","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-1162-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/18/2020","package_ndc":"0143-9606-01","generic_name":"Azacitidine Injection","contact_info":"1-800-631-2174","availability":"Unavailable","related_info":"Product temporarily on backorder.  Additional lots will be available the end of October 2026.","openfda":{"application_number":["ANDA209337"],"brand_name":["AZACITIDINE"],"generic_name":["AZACITIDINE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9606"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["AZACITIDINE"],"rxcui":["485246"],"spl_id":["592a688f-2e42-4e91-a3ea-34befe2a4e07"],"spl_set_id":["ff73515d-bd55-4eb5-992b-d2138c80887e"],"package_ndc":["0143-9606-01"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["M801H13NRU"]},"update_date":"10/14/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Azacitidine, Injection, 100 mg/ Vial (NDC 0143-9606-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"61703-408-41","generic_name":"Methotrexate Sodium Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA011719"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-408","61703-350"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1655956","1946772"],"spl_id":["6d38984b-4deb-42c3-bf1d-4e0b0c8887e6","db79ea57-58c9-4bd4-86df-9a23f3294ac8"],"spl_set_id":["0d63ba29-b692-41b4-87e8-351265c8273f","0e30eaef-5a09-4104-8a11-c32933eadeab"],"package_ndc":["61703-350-37","61703-350-38","61703-408-41","61703-350-09","61703-350-10","61703-408-25"],"unii":["3IG1E710ZN"]},"update_date":"11/09/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium, Injection, 1 g/40 mL (25 mg/mL) (NDC 61703-408-41)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"09/20/2023","package_ndc":"0527-4666-37","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-4666","0527-4661","0527-4662","0527-4663","0527-4664","0527-4665","0527-4667"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["164b5658-3c14-44f5-b10a-839909184984"],"spl_set_id":["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"],"package_ndc":["0527-4661-37","0527-4662-37","0527-4663-37","0527-4664-37","0527-4665-37","0527-4666-37","0527-4667-37"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0527-4666-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/23/2021","package_ndc":"0409-0024-10","generic_name":"Sterile Water Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018801"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-0024"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["7c1a069a-7b47-4a53-a3d6-24c528a3797e"],"spl_set_id":["3a6422e1-feee-4095-8883-2b0837039e6e"],"package_ndc":["0409-0024-01","0409-0024-10"],"unii":["059QF0KO0R"]},"update_date":"11/09/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water, Injection, 10 mL Single Dose Plastic Fliptop Vial Novaplus (NDC 0409-0024-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0338-1073-02","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA020255"],"brand_name":["DOBUTAMINE HYDROCHLORIDE IN DEXTROSE"],"generic_name":["DOBUTAMINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1073","0338-1075","0338-1077"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"rxcui":["309985","309986","309987"],"spl_id":["34c787c1-46f7-4264-951d-c88a34dca533"],"spl_set_id":["6b17b98b-e06d-42ed-925f-69aa2699dead"],"package_ndc":["0338-1073-02","0338-1075-02","0338-1077-02"],"unii":["0WR771DJXV"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 100 mg/100 mL (NDC 0338-1073-02)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"New","initial_posting_date":"02/20/2018","package_ndc":"31722-277-34","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-529-0430, customerservice@camberpharma.com","availability":"Available","openfda":{"application_number":["ANDA217821"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Camber Pharmaceuticals, Inc."],"product_ndc":["31722-277","31722-275","31722-276"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["4ea16f8e-77de-3ba7-e063-6394a90a5667"],"spl_set_id":["0e552e3a-cf52-4d74-9381-6cc1b29b4c90"],"package_ndc":["31722-275-10","31722-275-31","31722-275-32","31722-275-30","31722-275-33","31722-275-34","31722-275-35","31722-276-10","31722-276-31","31722-276-32","31722-276-30","31722-276-33","31722-276-34","31722-277-10","31722-277-31","31722-277-32","31722-277-30","31722-277-33","31722-277-34"],"unii":["7TQO7W3VT8"]},"update_date":"07/17/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-34)","company_name":"Aspiro Pharma Limited","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"67457-228-05","generic_name":"Rocuronium Bromide Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA079199"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-228"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["b65fbcab-781e-4706-a60b-a8eb4aeae0c1"],"spl_set_id":["f58803b0-f173-4997-b2f8-0f415b94dacf"],"package_ndc":["67457-228-00","67457-228-05","67457-228-99","67457-228-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"70121-1574-1","generic_name":"Methylprednisolone Acetate Injection","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA210043"],"brand_name":["METHYLPREDNISOLONE ACETATE"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["70121-1574","70121-1573"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743855"],"spl_id":["af4215ff-94ca-44f8-8506-3024e738cd13"],"spl_set_id":["d944240d-2c19-46ba-ad4f-3fbee7b8629c"],"package_ndc":["70121-1573-1","70121-1573-5","70121-1574-1","70121-1574-5"],"unii":["43502P7F0P"]},"update_date":"10/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 70121-1574-1)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-117-01","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA208510"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-117","59417-101","59417-102","59417-103","59417-104","59417-105","59417-106","59417-107","59417-115","59417-116","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-153-00","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-153","72888-497","72888-152","72888-154"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 72888-153-00)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-0621-60","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-0621","0075-0624","0075-0620","0075-0622","0075-0623","0075-0626","0075-2912","0075-2915"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["cdb74d6d-1a74-4156-a52a-710c55cb2927"],"spl_set_id":["5017a927-2a24-4f27-89f9-27c805bf7d59"],"package_ndc":["0075-0624-01","0075-0624-30","0075-0620-01","0075-0620-40","0075-0621-01","0075-0621-60","0075-0622-01","0075-0622-80","0075-0623-03","0075-0623-00","0075-0626-03","0075-2912-00","0075-2912-01","0075-2915-00","0075-2915-01"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 60 mg/.6 mL (NDC 0075-0621-60)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1541-10","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1541","0409-5738","0409-3812","0409-8126","0409-4208","0409-6581"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1672917","1672919","1673242","1673243","1867594","1867596","1867612","1867614"],"spl_id":["14ec85dc-0263-44d1-9267-66fa072cff8d"],"spl_set_id":["93cf0914-de08-4ec6-8f8c-d663243b9958"],"package_ndc":["0409-5738-01","0409-5738-10","0409-3812-01","0409-1541-01","0409-1541-10","0409-8126-01","0409-8126-10","0409-4208-01","0409-4208-10","0409-6581-01"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 75 mg/30 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial Novaplus (NDC 0409-1541-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/22/2020","package_ndc":"43066-023-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Limited Availability","related_info":"Limited supply; Check wholesalers for inventory; Marketed by Baxter","openfda":{"application_number":["ANDA212808"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["43066-023","43066-015","43066-019","43066-027"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734084","1734207","1734475","1734483"],"spl_id":["a8d08579-825f-40d9-b1e3-e47b73765ae6"],"spl_set_id":["781d4b7f-7556-4695-8d48-7772d7a0d8e9"],"package_ndc":["43066-015-01","43066-015-10","43066-019-01","43066-019-10","43066-023-01","43066-023-10","43066-027-01","43066-027-10"],"unii":["V910P86109"]},"update_date":"06/10/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-023-10)","company_name":"Caplin Steriles, Ltd.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/02/2020","package_ndc":"0409-0001-25","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: December 2026; Estimated Recovery: June 2027","openfda":{"application_number":["ANDA075857"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-0001","0409-2305","0409-2308"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666798","1666800","1666814","1666823"],"spl_id":["8954486a-8512-4831-8178-0b49f1efb73e"],"spl_set_id":["1abda8b8-48a8-4995-af86-39220d1aa240"],"package_ndc":["0409-2305-16","0409-2305-17","0409-2305-04","0409-2305-05","0409-2308-21","0409-2308-01","0409-2308-22","0409-2308-02","0409-0001-01","0409-0001-25"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"72205-136-91","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"(855) 668-2369; customerservice@novadozpharma.com","availability":"Available","openfda":{"application_number":["ANDA218306"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-136","72205-132","72205-133","72205-134","72205-135","72205-137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"spl_set_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"package_ndc":["72205-132-91","72205-133-91","72205-134-91","72205-135-91","72205-136-91","72205-137-91"],"unii":["SJT761GEGS"]},"update_date":"09/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91)","company_name":"Novadoz Pharmaceuticals LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"61269-610-10","generic_name":"Clonazepam Tablet","contact_info":"orders@h2-pharma.com","resolved_note":"Available","openfda":{"application_number":["NDA017533"],"brand_name":["KLONOPIN"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["H2-Pharma, LLC"],"product_ndc":["61269-610","61269-605","61269-620"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","206157","206159","206160"],"spl_id":["63cfdab9-fb3d-4c2b-bf88-8ba841dba839"],"spl_set_id":["cfa0d79a-843c-4b88-95a1-e9511d649ca1"],"package_ndc":["61269-605-10","61269-610-10","61269-620-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Klonopin, Tablet, 1 mg (NDC 61269-610-10)","company_name":"Cheplapharm Arzneimittel GmbH","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"72516-014-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"855-257-0292","availability":"Unavailable","related_info":"Estimated recovery: April 2027","openfda":{"application_number":["ANDA210293"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Oryza Pharmaceuticals Inc."],"product_ndc":["72516-014","72516-016","72516-015","72516-013","72516-012","72516-011"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["5734011d-5044-b490-e063-6394a90a3174"],"spl_set_id":["acd27181-a3f3-4c38-85d8-029a4a82e7c2"],"package_ndc":["72516-016-01","72516-015-01","72516-014-01","72516-013-01","72516-012-01","72516-011-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 72516-014-01)","company_name":"Oryza Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0338-0644-03","generic_name":"Amino Acid Injection","contact_info":"888-229-0001","availability":"Unavailable","related_info":"Estimated recovery: December 2026","openfda":{"application_number":["NDA018931"],"brand_name":["TRAVASOL"],"generic_name":["LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0644"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LEUCINE","PHENYLALANINE","LYSINE HYDROCHLORIDE","METHIONINE","ISOLEUCINE","VALINE","HISTIDINE","THREONINE","TRYPTOPHAN","ALANINE","GLYCINE","ARGININE","PROLINE","TYROSINE","SERINE"],"spl_id":["7a8e7bd6-f743-4779-907a-ad2917c2d341"],"spl_set_id":["8543b5be-0f43-4891-9e56-d7c39fe839b5"],"package_ndc":["0338-0644-03","0338-0644-04","0338-0644-06"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["GMW67QNF9C","47E5O17Y3R","JNJ23Q2COM","AE28F7PNPL","04Y7590D77","HG18B9YRS7","4QD397987E","2ZD004190S","8DUH1N11BX","OF5P57N2ZX","TE7660XO1C","94ZLA3W45F","9DLQ4CIU6V","42HK56048U","452VLY9402"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-03)","company_name":"Baxter Healthcare","shortage_reason":"Shortage of an inactive ingredient component","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/01/2017","package_ndc":"76329-3352-1","generic_name":"Sodium Bicarbonate Injection","contact_info":"800-423-4136","availability":"Limited Availability","related_info":"Available on allocation","openfda":{"application_number":["ANDA203449"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["International Medication Systems, Limited"],"product_ndc":["76329-3352"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["792582"],"spl_id":["74a86dc7-0929-40d0-9661-9f9063a8fd7d"],"spl_set_id":["77698221-a01d-4568-a7bc-d3d4e982875d"],"package_ndc":["76329-3352-1"],"unii":["8MDF5V39QO"]},"update_date":"11/06/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)","company_name":"Amphastar Pharmaceuticals, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"63323-411-25","generic_name":"Midazolam Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA075154"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-411","63323-412"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["9814447b-a93e-42ad-b57e-5db0a5b7f552"],"spl_set_id":["a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"],"package_ndc":["63323-411-22","63323-411-27","63323-411-15","63323-411-12","63323-411-18","63323-411-25","63323-411-13","63323-411-10","63323-412-18","63323-412-25","63323-412-03","63323-412-02","63323-412-06","63323-412-05","63323-412-13","63323-412-10"],"unii":["W7TTW573JJ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"09/05/2018","package_ndc":"0641-6046-10","generic_name":"Lorazepam Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA018140"],"brand_name":["LORAZEPAM"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6046","0641-6044","0641-6045","0641-6047"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["238100","238101","1665188","1665326"],"spl_id":["7c73dbc6-2623-4443-9b05-97dec7a0be2e"],"spl_set_id":["e9b54e42-04cf-4c62-90e1-36f7b31a4e81"],"package_ndc":["0641-6044-01","0641-6044-25","0641-6046-01","0641-6046-10","0641-6045-01","0641-6045-25","0641-6047-01","0641-6047-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"10/14/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Lorazepam, Injection, 2 mg/1 mL (NDC 0641-6046-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/13/2017","change_date":"09/30/2026","package_ndc":"72205-101-01","generic_name":"Bumetanide Injection","contact_info":"855-668-2369; customerservice@novadozpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA215364"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-101","72205-102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["387edfd4-be85-41cd-8a6d-14e6a022b5a9"],"spl_set_id":["387edfd4-be85-41cd-8a6d-14e6a022b5a9"],"package_ndc":["72205-101-01","72205-101-07","72205-102-01","72205-102-07"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, 0.25 mg/mL, 4mL (NDC 72205-101-01)","company_name":"MSN Laboratories Private Limited","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"0143-9310-10","generic_name":"Etomidate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Novaplus label","openfda":{"application_number":["ANDA202354"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9310","0143-9311"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["c15bd8c1-34e3-40f2-b31a-634136fe197c"],"spl_set_id":["4312e3c3-34de-4cb3-8abd-c24d24a4bea1"],"package_ndc":["0143-9310-01","0143-9310-10","0143-9311-01","0143-9311-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 0143-9310-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"54288-164-01","generic_name":"Carboplatin Injection","contact_info":"Distributed by BPI Labs, LLC;  Customer service number:  (727) 471-0850 Ext 270","availability":"Unavailable","related_info":"Discontinued; Distributed by BPI Labs, LLC","openfda":{"application_number":["ANDA207324"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["BPI Labs LLC"],"product_ndc":["54288-164","54288-165","54288-166","54288-167"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["c0a7463c-d90f-4060-a54e-6a4888e8af0e"],"spl_set_id":["5484d2f0-0cc2-4bba-8f26-c7f6539a9606"],"package_ndc":["54288-165-01","54288-166-01","54288-167-01","54288-164-01"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/21/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 50mg/5mL (NDC 54288-164-01)","company_name":"Gland Pharma Limited","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7045-12","generic_name":"Belladonna and Opium Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["BELLADONNA AND OPIUM"],"generic_name":["ATROPA BELLADONNA AND OPIUM"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7045","0574-7040"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["ATROPA BELLADONNA","OPIUM"],"rxcui":["312104","312107"],"spl_id":["7b45a1d7-c3a5-4434-a848-45638cedd6e1"],"spl_set_id":["8301e76b-134a-43d2-a7dc-c600ccf2695c"],"package_ndc":["0574-7040-12","0574-7040-04","0574-7045-12","0574-7045-04"],"unii":["37M3MZ001L","WQZ3G9PF0H"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Suppository","presentation":"Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-3814-12","generic_name":"Morphine Sulfate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA073509"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3814","0409-3815"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRATHECAL","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1728783","1728800"],"spl_id":["0a2ba20b-448f-4412-9899-b82040ebfa7d"],"spl_set_id":["1d181906-f3ec-4222-1883-e61577a3122e"],"package_ndc":["0409-3814-11","0409-3814-12","0409-3815-11","0409-3815-12"],"unii":["X3P646A2J0"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 5 mg/10 mL (0.5 mg/mL) (NDC 0409-3814-12)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"05/30/2025","package_ndc":"0409-1181-30","generic_name":"Meperidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021171"],"brand_name":["DEMEROL"],"generic_name":["MEPERIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1181","0409-1176","0409-1178","0409-1179","0409-1180","0409-1362","0409-1418"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["MEPERIDINE HYDROCHLORIDE"],"rxcui":["860792","861463","861473","861493","861494","861522","861529","861617","1242106","1242503","2539186","2539188","2539191","2539192"],"spl_id":["b6935f73-7b93-496d-871b-de6f9b379649"],"spl_set_id":["b31d1308-28c3-43f4-e0a6-2f3ed76b8975"],"package_ndc":["0409-1181-30","0409-1176-03","0409-1176-30","0409-1178-03","0409-1178-30","0409-1179-03","0409-1179-30","0409-1180-59","0409-1180-69","0409-1362-11","0409-1362-01","0409-1418-11","0409-1418-01"],"unii":["N8E7F7Q170"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Demerol, Injection, 50 mg/1 mL (NDC 0409-1181-30)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"0093-3213-01","generic_name":"Clonazepam Tablet","contact_info":"800-545-8800","resolved_note":"Available","openfda":{"application_number":["ANDA074569"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-3213","0093-0832","0093-3212"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["d6abe4e3-7699-4ead-95f4-739a961b23ad"],"spl_set_id":["8069b1a0-7c06-4252-b44e-e2eef065d9b8"],"package_ndc":["0093-0832-01","0093-0832-05","0093-3212-01","0093-3212-05","0093-3213-01","0093-3213-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 0093-3213-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"25021-311-10","generic_name":"Furosemide Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Furosemide%20Injection&st=d","contact_info":"866-625-1918","availability":"Unavailable","related_info":"Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product","openfda":{"application_number":["ANDA213902"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-311"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["222ce48f-2856-4be2-b16f-6fca38c0dceb"],"spl_set_id":["d63c1277-dd7e-4d21-9e80-68143f55e2dc"],"package_ndc":["25021-311-02","25021-311-04","25021-311-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"10/21/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)","company_name":"Gland Pharma Limited","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"New","initial_posting_date":"04/28/2023","package_ndc":"69339-367-60","generic_name":"Carboplatin Injection","contact_info":"Natco Pharma USA LLC: (201)786-6500","availability":"Available","related_info":"Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)","openfda":{"application_number":["ANDA077861"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Natco Pharma USA LLC"],"product_ndc":["69339-367","69339-364","69339-365","69339-366"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["4c89cedc-e48b-445c-ad05-54dbe60e4fb0"],"spl_set_id":["4c89cedc-e48b-445c-ad05-54dbe60e4fb0"],"package_ndc":["69339-364-05","69339-365-15","69339-366-45","69339-367-60"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 600 mg/60 mL (NDC 69339-367-60)","company_name":"Teyro Labs","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/23/2021","package_ndc":"0409-4887-50","generic_name":"Sterile Water Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018801"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4887"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["055437a7-5be5-414a-a97a-946e2730fe12"],"spl_set_id":["2b9ea23a-f9e9-48a8-25b7-519e3bbd6828"],"package_ndc":["0409-4887-25","0409-4887-99","0409-4887-31","0409-4887-05","0409-4887-17","0409-4887-10","0409-4887-32","0409-4887-34","0409-4887-23","0409-4887-20","0409-4887-24","0409-4887-50"],"unii":["059QF0KO0R"]},"update_date":"11/09/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-50)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-353-05","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 2.5 mg (NDC 13668-353-05)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"discontinued_date":"09/21/2026","update_type":"New","initial_posting_date":"09/21/2026","package_ndc":"63323-637-10","generic_name":"Arsenic Trioxide Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA208231"],"brand_name":["ARSENIC TRIOXIDE"],"generic_name":["ARSENIC TRIOXIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-637"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ARSENIC TRIOXIDE"],"rxcui":["829926"],"spl_id":["1ed1c170-ee7f-4f96-98dd-041657d3bdd8"],"spl_set_id":["a482eccd-8837-47ea-904d-2f2c294d10fa"],"package_ndc":["63323-637-03","63323-637-10"],"unii":["S7V92P67HO"]},"update_date":"09/21/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Arsenic Trioxide, Injection, 1 mg/1 mL (NDC 63323-637-10)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"63323-671-20","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Expected recovery: TBD","update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/14/2017","package_ndc":"63323-519-77","generic_name":"Heparin Sodium Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA212441"],"brand_name":["HEPARIN SODIUM"],"generic_name":["HEPARIN SODIUM"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-519"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["HEPARIN SODIUM"],"rxcui":["1658690","1658692"],"spl_id":["3bbbe74a-1246-41a6-9fc3-ca0230529b40"],"spl_set_id":["25b0ba06-3274-4a3f-8c39-42d13764ecdf"],"package_ndc":["63323-519-02","63323-519-77","63323-519-01","63323-519-10"],"unii":["ZZ45AB24CA"]},"update_date":"11/03/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"72572-074-24","generic_name":"Clindamycin Phosphate Injection","contact_info":"800-525-8747","availability":"Available","related_info":"Civica Label","openfda":{"application_number":["ANDA201692"],"brand_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"generic_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"manufacturer_name":["Civica, Inc."],"product_ndc":["72572-074","72572-076"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN"],"rxcui":["309335","309336"],"spl_id":["4711c157-19a5-4886-b468-8739876e67be"],"spl_set_id":["80217bd6-2bc4-401c-9345-22532b36a24f"],"package_ndc":["72572-074-01","72572-074-24","72572-076-01","72572-076-24"],"nui":["N0000009982","N0000175443","M0515779","N0000175731"],"pharm_class_pe":["Decreased Sebaceous Gland Activity [PE]","Neuromuscular Blockade [PE]"],"pharm_class_epc":["Lincosamide Antibacterial [EPC]"],"pharm_class_cs":["Lincosamides [CS]"],"unii":["3U02EL437C"]},"update_date":"11/09/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 12 mg/1 mL (NDC 72572-074-24)","company_name":"Sandoz Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"70069-752-10","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Unavailable","related_info":"Estimated recovery: June 2027","openfda":{"application_number":["ANDA217792"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-752","70069-753"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["2b24af95-6f20-4945-bf8c-742f1d6f2721"],"spl_set_id":["bcaab86f-20f0-4482-8d73-e29b36dced58"],"package_ndc":["70069-752-25","70069-752-10","70069-752-01","70069-753-25","70069-753-01","70069-753-10"],"unii":["7TQO7W3VT8"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-10)","company_name":"Somerset Therapeutics, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/24/2025","change_date":"08/27/2026","package_ndc":"82154-0449-1","generic_name":"Peginterferon alfa-2a Injection","contact_info":"800-506-8501, email: medinfo.us@pharmaand.com","resolved_note":"(NDC 82154-0451-4) – Available","openfda":{"application_number":["BLA103964"],"brand_name":["PEGASYS"],"generic_name":["PEGINTERFERON ALFA-2A"],"manufacturer_name":["pharmaand GmbH"],"product_ndc":["82154-0449","82154-0451"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["PEGINTERFERON ALFA-2A"],"rxcui":["351270","352297","731326","731328"],"spl_id":["5df7144e-dde3-c0ef-e063-6394a90a99c7"],"spl_set_id":["d9290e5b-6d40-2318-e053-2995a90a9916"],"package_ndc":["82154-0449-1","82154-0451-4"],"nui":["N0000175521","M0025711"],"pharm_class_epc":["Interferon alpha [EPC]"],"pharm_class_cs":["Interferon-alpha [CS]"],"unii":["Q46947FE7K"]},"update_date":"08/27/2026","therapeutic_category":["Antiviral"],"dosage_form":"Injection","presentation":"Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1)","company_name":"pharmaand GmbH (pharma&)","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"68025-096-10","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Available","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-096","68025-088","68025-089","68025-095","68025-097","68025-084","68025-098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)","company_name":"Vertical Pharmaceuticals, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-7535-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7535","0409-1746","0409-1749","0409-1752","0409-1755","0409-2510","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-7535-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"01/13/2026","update_type":"New","initial_posting_date":"01/13/2026","package_ndc":"61314-454-68","generic_name":"Adalimumab-adaz Injection","contact_info":"800-525-8747","related_info":"Equivalent Sandoz format is available.","openfda":{"application_number":["BLA761071"],"brand_name":["HYRIMOZ"],"generic_name":["ADALIMUMAB-ADAZ"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["61314-454","61314-473","61314-476","61314-509","61314-517","61314-531"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ADALIMUMAB"],"rxcui":["2641644","2641650","2641653","2641654","2641655","2641658","2641660","2641661","2641662","2641663","2641664","2641665","2641666","2641667","2641668","2641669","2641670","2641671","2641672","2641673"],"spl_id":["48b7e44a-945f-487d-b2fd-3da13d6d6fdb"],"spl_set_id":["1ac7d061-3380-468c-b077-c05f8dfbc829"],"package_ndc":["61314-454-20","61314-454-36","61314-454-68","61314-473-64","61314-473-20","61314-473-92","61314-476-64","61314-509-64","61314-517-36","61314-454-96","61314-473-96","61314-531-64","61314-454-94","61314-473-94"],"nui":["N0000175610","N0000175451","M0001357"],"pharm_class_epc":["Tumor Necrosis Factor Blocker [EPC]"],"pharm_class_moa":["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"],"pharm_class_cs":["Antibodies, Monoclonal [CS]"],"unii":["FYS6T7F842"]},"update_date":"01/13/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Hyrimoz, Injection, 80 mg/.8 mL (NDC 61314-454-68)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"76045-212-10","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release January 2027. Check wholesalers for inventory.","openfda":{"application_number":["ANDA209192"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-212","76045-109"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["2099700"],"spl_id":["6fd9ed0e-dddc-4e73-9442-49da54685f7b"],"spl_set_id":["4dd55929-fe0a-4884-ae0d-6f9435920eb7"],"package_ndc":["76045-109-01","76045-109-10","76045-212-00","76045-212-10"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 76045-212-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-6581-01","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6581","0409-5738","0409-3812","0409-1541","0409-8126","0409-4208"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1672917","1672919","1673242","1673243","1867594","1867596","1867612","1867614"],"spl_id":["14ec85dc-0263-44d1-9267-66fa072cff8d"],"spl_set_id":["93cf0914-de08-4ec6-8f8c-d663243b9958"],"package_ndc":["0409-5738-01","0409-5738-10","0409-3812-01","0409-1541-01","0409-1541-10","0409-8126-01","0409-8126-10","0409-4208-01","0409-4208-10","0409-6581-01"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine™ 0.5% 250 mg/50 mL (5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Multiple Dose Vial Novaplus (NDC 0409-6581-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"62135-486-90","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com","availability":"Available","openfda":{"application_number":["ANDA076803"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-486","62135-484","62135-485","62135-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["09cd5cb9-4fdf-f133-e063-6294a90af691"],"spl_set_id":["dbc43dbd-94aa-40e2-a9ea-766110cc8687"],"package_ndc":["62135-484-60","62135-485-90","62135-486-90","62135-487-90"],"unii":["33067B3N2M"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 20 mg (NDC 62135-486-90)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-3475-03","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-3475","0009-3073"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743781","1743855","1743856"],"spl_id":["742fcec7-8db3-4cc6-b276-42587a993810"],"spl_set_id":["9a7b3837-e038-48bf-97e9-78ad463760dc"],"package_ndc":["0009-3073-01","0009-3073-03","0009-3475-01","0009-3475-03"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-3475-03)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"52536-125-10","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"877-495-6856","availability":"Available","related_info":"Distributed by Wilshire Pharmaceuticals, Inc.","openfda":{"application_number":["ANDA212791"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Wilshire Pharmaceuticals, Inc."],"product_ndc":["52536-125","52536-126"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["8587e03d-0aed-4f70-8695-54db31bc08ab"],"spl_set_id":["f550d2ba-49ac-4a3b-95db-692b468af479"],"package_ndc":["52536-125-01","52536-125-10","52536-126-01","52536-126-08"],"unii":["1018WH7F9I"]},"update_date":"10/15/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10)","company_name":"Azurity Pharmaceuticals, Inc","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"57844-117-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["ADDERALL"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["57844-117","57844-105","57844-110","57844-112","57844-115","57844-120","57844-130"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541365","541878","541879","541892","541894","577957","577960","577961","577962","687043","687045","1009145","1009147"],"spl_id":["79af1dc6-c7cf-41b1-a750-e9b47c2187ff"],"spl_set_id":["f22635fe-821d-4cde-aa12-419f8b53db81"],"package_ndc":["57844-105-01","57844-117-01","57844-110-01","57844-112-01","57844-115-01","57844-120-01","57844-130-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Adderall, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 57844-117-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"63323-671-00","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Expected recovery: TBD","update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0338-0644-06","generic_name":"Amino Acid Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA018931"],"brand_name":["TRAVASOL"],"generic_name":["LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0644"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LEUCINE","PHENYLALANINE","LYSINE HYDROCHLORIDE","METHIONINE","ISOLEUCINE","VALINE","HISTIDINE","THREONINE","TRYPTOPHAN","ALANINE","GLYCINE","ARGININE","PROLINE","TYROSINE","SERINE"],"spl_id":["7a8e7bd6-f743-4779-907a-ad2917c2d341"],"spl_set_id":["8543b5be-0f43-4891-9e56-d7c39fe839b5"],"package_ndc":["0338-0644-03","0338-0644-04","0338-0644-06"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["GMW67QNF9C","47E5O17Y3R","JNJ23Q2COM","AE28F7PNPL","04Y7590D77","HG18B9YRS7","4QD397987E","2ZD004190S","8DUH1N11BX","OF5P57N2ZX","TE7660XO1C","94ZLA3W45F","9DLQ4CIU6V","42HK56048U","452VLY9402"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-06)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/27/2018","package_ndc":"25021-671-66","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"Sagent: 866-625-1618","availability":"Limited Availability","related_info":"Estimated recovery: TBD; Marketed by Sagent Pharmaceuticals","openfda":{"application_number":["ANDA206166"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-671","25021-652"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734347","1734355","1734479","1734481"],"spl_id":["41f4446a-ca6e-465e-9a79-8c4f99eb1ac3","22d83514-0f7b-4671-ae6a-7ca47449c184"],"spl_set_id":["8c5c762f-d266-4b1a-809e-f11bfc89bc2d","9572b3de-684c-4028-a577-5aa69ba6b02d"],"package_ndc":["25021-671-82","25021-671-87","25021-652-82","25021-652-87","25021-671-66","25021-671-67"],"unii":["V910P86109"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)","company_name":"InfoRLife SA","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/03/2017","package_ndc":"0641-6020-10","generic_name":"Morphine Sulfate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["NDA018565"],"brand_name":["DURAMORPH"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6020","0641-6019"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRATHECAL","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892473","892489","1728783","1728800"],"spl_id":["aa74af85-7068-4254-9a79-c7f3792044a6"],"spl_set_id":["ebb18761-e5c4-4238-bb84-f9549f500210"],"package_ndc":["0641-6020-01","0641-6020-10","0641-6019-01","0641-6019-10"],"unii":["X3P646A2J0"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Duramorph, Injection, .5 mg/1 mL (NDC 0641-6020-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"47781-180-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA207388"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 30 MG,CLL"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-180","47781-174","47781-175","47781-176","47781-177","47781-178","47781-179"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AMPHETAMINE ASPARTATE MONOHYDRATE","AMPHETAMINE SULFATE","DEXTROAMPHETAMINE SACCHARATE","DEXTROAMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["eb490273-9334-1ae5-dd32-658e7fb0b40e"],"spl_set_id":["c907301d-e24d-9609-5529-fed14f94549f"],"package_ndc":["47781-174-30","47781-174-05","47781-174-01","47781-175-30","47781-175-05","47781-175-01","47781-176-30","47781-176-05","47781-176-01","47781-177-30","47781-177-05","47781-177-01","47781-178-30","47781-178-05","47781-178-01","47781-179-30","47781-179-05","47781-179-01","47781-180-30","47781-180-05","47781-180-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 30mg (NDC 47781-180-01)","company_name":"Alvogen","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-2634-05","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA078591"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2634"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["1724338","1724340","1724341"],"spl_id":["50886ad5-eeca-4fe7-beb0-01305f92c65d"],"spl_set_id":["3832ede8-d3fc-455d-ecab-3b77be5869f5"],"package_ndc":["0409-2634-10","0409-2634-01","0409-2634-25","0409-2634-05","0409-2634-50"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 50 mg/5 mL (10 mg/mL) (NDC 0409-2634-05)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-2815-01","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2815","0409-1454","0409-3301","0409-1174"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["e1705533-5a85-441f-a95b-3cb88c47e482"],"spl_set_id":["4419162d-81d4-49bd-96de-1729440bdb74"],"package_ndc":["0409-1454-01","0409-1454-20","0409-3301-01","0409-3301-10","0409-1174-01","0409-1174-10","0409-2815-01"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"54288-166-01","generic_name":"Carboplatin Injection","contact_info":"Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270","availability":"Limited Availability","related_info":"Recovery estimated in late Q4 2026; Distributed by BPI Labs, LLC","openfda":{"application_number":["ANDA207324"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["BPI Labs LLC"],"product_ndc":["54288-166","54288-165","54288-167","54288-164"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["c0a7463c-d90f-4060-a54e-6a4888e8af0e"],"spl_set_id":["5484d2f0-0cc2-4bba-8f26-c7f6539a9606"],"package_ndc":["54288-165-01","54288-166-01","54288-167-01","54288-164-01"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/21/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 450mg/45mL (NDC 54288-166-01)","company_name":"Gland Pharma Limited","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"01/20/2026","update_type":"New","initial_posting_date":"01/20/2026","package_ndc":"0069-3150-83","generic_name":"Azithromycin Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug.","openfda":{"application_number":["NDA050733"],"brand_name":["ZITHROMAX"],"generic_name":["AZITHROMYCIN DIHYDRATE"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0069-3150"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["AZITHROMYCIN DIHYDRATE"],"rxcui":["1668238","1668240"],"spl_id":["73a19258-3cc4-49b1-8f18-e17fd418fe36"],"spl_set_id":["3b631aa1-2d46-40bc-a614-d698301ea4f9"],"package_ndc":["0069-3150-84","0069-3150-83"],"unii":["5FD1131I7S"]},"update_date":"01/20/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Zithromax IV, Injection, 500 mg/5 mL (NDC 0069-3150-83)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"16729-526-08","generic_name":"Atropine Sulfate Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Estimated availability: December 2026","update_date":"11/02/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, 1 mg/1 mL (NDC 16729-526-08)","company_name":"Accord Healthcare Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1746-30","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1746","0409-1749","0409-1752","0409-1755","0409-2510","0409-7535","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 75 mg/30 mL (2.5 mg/mL 1:200,000) (NDC 0409-1746-30)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"04/01/2026","update_type":"New","initial_posting_date":"04/01/2026","package_ndc":"61474-9711-1","generic_name":"Icosapent Ethyl Capsule","contact_info":"800-706-5575","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/01/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Icosapent Ethyl, Capsule, 1 g (NDC 61474-9711-1)","company_name":"Apotex Corp.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/14/2022","package_ndc":"0990-7922-61","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Limited Availability","related_info":"On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7922","0990-7923","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-61)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"0781-3423-94","generic_name":"Caspofungin Acetate Injection","contact_info":"Sandoz: 800-525-8747","related_info":"Marketed by Sandoz, Inc.; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA200833"],"brand_name":["CASPOFUNGIN ACETATE"],"generic_name":["CASPOFUNGIN ACETATE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-3423","0781-3421"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CASPOFUNGIN ACETATE"],"rxcui":["828539","828755"],"spl_id":["d70d52c0-6601-f632-e053-2995a90a9291"],"spl_set_id":["722facc6-d4ea-4975-b83e-3ae63df69ed2"],"package_ndc":["0781-3421-01","0781-3421-94","0781-3423-01","0781-3423-94"],"unii":["VUW370O5QE"]},"update_date":"06/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 0781-3423-94)","company_name":"Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"70069-048-20","generic_name":"Sodium Acetate Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA219826"],"brand_name":["SODIUM ACETATE ANHYDROUS"],"generic_name":["SODIUM ACETATE ANHYDROUS"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-048","70069-047"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["237371"],"spl_id":["1aae3237-9555-442b-b962-619d23f7e00a"],"spl_set_id":["93edebd6-ef7f-483a-80b6-bfaf34ea5ded"],"package_ndc":["70069-047-25","70069-048-20"],"unii":["NVG71ZZ7P0"]},"update_date":"10/27/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"discontinued_date":"03/13/2026","update_type":"New","initial_posting_date":"03/13/2026","package_ndc":"65219-284-12","generic_name":"Plerixafor Injection","contact_info":"888-391-6300 www.fresenius-kabi.com","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA022311"],"brand_name":["PLERIXAFOR"],"generic_name":["PLERIXAFOR"],"manufacturer_name":["Fresenius Kabi Usa, LLC"],"product_ndc":["65219-284"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["PLERIXAFOR"],"rxcui":["828700"],"spl_id":["ba468eca-fb47-497b-8aed-a1576249ea6a"],"spl_set_id":["5d670cb4-163e-498c-b5fa-c193ea9d55c0"],"package_ndc":["65219-284-12"],"nui":["N0000178326","N0000178324"],"pharm_class_epc":["Hematopoietic Stem Cell Mobilizer [EPC]"],"pharm_class_pe":["Increased Hematopoietic Stem Cell Mobilization [PE]"],"unii":["S915P5499N"]},"update_date":"03/13/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Plerixafor, Injection, 24 mg per 1.2 mL (20 mg per mL) (NDC 65219-284-12)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-1454-20","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1454","0409-3301","0409-1174","0409-2815"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["e1705533-5a85-441f-a95b-3cb88c47e482"],"spl_set_id":["4419162d-81d4-49bd-96de-1729440bdb74"],"package_ndc":["0409-1454-01","0409-1454-20","0409-3301-01","0409-3301-10","0409-1174-01","0409-1174-10","0409-2815-01"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/06/2018","package_ndc":"72266-118-25","generic_name":"Ketorolac Tromethamine Injection","contact_info":"833-291-9645","availability":"Available","related_info":"Distributed by Fosun Pharma USA, Inc.. To order, contact: 833-291-9645.","openfda":{"application_number":["ANDA204216"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["FOSUN PHARMA USA INC"],"product_ndc":["72266-118","72266-234","72266-119"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["4dc7a413-f46f-2537-e063-6294a90a9b8c"],"spl_set_id":["1aae6a4d-0909-4672-aa26-e3f2d8c4d413"],"package_ndc":["72266-234-01","72266-234-25","72266-118-01","72266-118-25","72266-119-01","72266-119-25"],"unii":["4EVE5946BQ"]},"update_date":"10/21/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 72266-118-25)","company_name":"Gland Pharma Limited","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-9664-40","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA020179"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-9664","0338-9666"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795609","1795616"],"spl_id":["a6356cbf-8553-405f-9c27-57a301e43fc9"],"spl_set_id":["bfc4224a-2fc9-4137-b4c6-9d2d6d948413"],"package_ndc":["0338-9664-40","0338-9666-35"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 2.5 g/50 mL (NDC 0338-9664-40)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-152-30","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-152","72888-497","72888-153","72888-154"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 72888-152-30)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"discontinued_date":"12/29/2025","update_type":"New","initial_posting_date":"12/29/2025","package_ndc":"69238-2391-1","generic_name":"Sodium Oxybate Solution","contact_info":"800-525-7270","related_info":"Discontinuation of the manufacture of the drug","update_date":"12/29/2025","therapeutic_category":["Psychiatry"],"dosage_form":"Solution","presentation":"Sodium Oxybate, Solution, .5 g/1 mL (NDC 69238-2391-1)","company_name":"Amneal Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/21/2023","package_ndc":"39822-5525-3","generic_name":"Promethazine Hydrochloride Injection","contact_info":"866-390-4411","availability":"Available","openfda":{"application_number":["ANDA040737"],"brand_name":["PROMETHAZINE HYDROCHLORIDE"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["XGen Pharmaceuticals DJB, Inc."],"product_ndc":["39822-5525"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992460"],"spl_id":["0e3526e1-38be-1d89-e063-6294a90a775d"],"spl_set_id":["1d02d52b-84bb-4e81-b352-125029eb39f6"],"package_ndc":["39822-5525-2","39822-5525-3"],"unii":["R61ZEH7I1I"]},"update_date":"09/22/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Other","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 39822-5525-3)","company_name":"XGen Pharmaceuticals DJB, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"61703-360-18","generic_name":"Carboplatin Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA076517"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-360","61703-150","61703-262","61703-600"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["5aa72c15-8033-4559-b257-373371b18958"],"spl_set_id":["47677091-fd20-49af-933c-c9dd2be21de9"],"package_ndc":["61703-360-18","61703-150-05","61703-262-05","61703-600-05"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/09/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) (NDC 61703-360-18)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"10/19/2026","update_type":"New","initial_posting_date":"10/19/2026","package_ndc":"49702-203-18","generic_name":"Lamivudine Tablet","contact_info":"800-844-8872","related_info":"The anticipated date that ViiV will cease distribution of the products is approximately April 15, 2027; Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020564"],"brand_name":["EPIVIR"],"generic_name":["LAMIVUDINE"],"manufacturer_name":["ViiV Healthcare Company"],"product_ndc":["49702-203","49702-204","49702-205"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LAMIVUDINE"],"rxcui":["152931","152932","199147","199148","349491","352230"],"spl_id":["38eff3e4-ae02-40be-9f8a-5e2d99113447"],"spl_set_id":["89226149-47fa-4f7d-bb1f-1aa7034486b8"],"package_ndc":["49702-203-18","49702-204-13","49702-205-48"],"nui":["N0000175656","N0000175462","N0000009947"],"pharm_class_epc":["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]","Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"],"pharm_class_moa":["Nucleoside Reverse Transcriptase Inhibitors [MoA]"],"unii":["2T8Q726O95"]},"update_date":"10/19/2026","therapeutic_category":["Antiviral"],"dosage_form":"Tablet","presentation":"Epivir, Tablet, 150 mg (NDC 49702-203-18)","company_name":"ViiV Healthcare Company","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"11/06/2017","package_ndc":"0409-7809-24","generic_name":"Dopamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA018826"],"brand_name":["DOPAMINE HYDROCHLORIDE IN DEXTROSE"],"generic_name":["DOPAMINE HYDROCHLORIDE IN DEXTROSE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7809","0409-7810","0409-0042","0409-1858"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1292887","1743877","1743879"],"spl_id":["12a614df-d706-42a2-9020-5397700cc2e9"],"spl_set_id":["08f23f6e-150d-45ea-098e-f2edf64c21a1"],"package_ndc":["0409-7809-11","0409-7809-22","0409-7809-31","0409-7809-24","0409-7810-11","0409-7810-22","0409-0042-01","0409-0042-12","0409-1858-01","0409-1858-12"],"unii":["7L3E358N9L"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/500 mL (1.6 mg/1 mL) (NDC 0409-7809-24)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"59651-723-99","generic_name":"Clonazepam Tablet","contact_info":"866-850-2876","resolved_note":"Available","openfda":{"application_number":["ANDA075150"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["59651-723","59651-722","59651-724"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"spl_set_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"package_ndc":["59651-722-01","59651-722-99","59651-723-01","59651-723-99","59651-724-01","59651-724-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 59651-723-99)","company_name":"Aurobindo Pharma USA","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"11/23/2021","package_ndc":"63323-178-76","generic_name":"Sterile Water Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA209689"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-178"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["WATER"],"spl_id":["d40f0ff2-4abf-4030-b4e1-2b85ad7448a0"],"spl_set_id":["b45e9f1d-9c48-4b46-8541-d846b89540df"],"package_ndc":["63323-178-76"],"unii":["059QF0KO0R"]},"update_date":"11/03/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water, Injection, 1000 mL/1000 mL (NDC 63323-178-76)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/28/2022","package_ndc":"0143-9391-10","generic_name":"Remifentanil Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA210594"],"brand_name":["REMIFENTANIL HYDROCHLORIDE"],"generic_name":["REMIFENTANIL HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9391","0143-9392","0143-9393"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["REMIFENTANIL HYDROCHLORIDE"],"rxcui":["1729578","1729584","1729710"],"spl_id":["5c5e498b-d829-4f78-bcca-466631014767"],"spl_set_id":["9d289052-1eb6-4ba2-a3ca-d2e542a052ae"],"package_ndc":["0143-9391-01","0143-9391-10","0143-9392-01","0143-9392-10","0143-9393-01","0143-9393-10"],"unii":["5V444H5WIC"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0017-38","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0017","0338-0023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-38)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"83634-651-10","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"Avenacy, LLC: 877-283-6229","availability":"Available","related_info":"Distributed by Avenacy, LLC","openfda":{"application_number":["ANDA219535"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Avenacy, LLC"],"product_ndc":["83634-651","83634-653"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1737562","1737566","1737568"],"spl_id":["8fb1dd7b-f349-4a64-96c1-bd72bf748f3b"],"spl_set_id":["46480253-29b9-4d7f-98ed-10377929026b"],"package_ndc":["83634-653-41","83634-653-02","83634-653-42","83634-653-05","83634-653-43","83634-653-30","83634-651-41","83634-651-10","83634-651-42","83634-651-20","83634-651-43","83634-651-50"],"unii":["V13007Z41A"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 100 mg/10 mL (NDC 83634-651-10)","company_name":"Anthea Pharma","status":"Current"},{"discontinued_date":"06/17/2026","update_type":"New","initial_posting_date":"06/17/2026","package_ndc":"61958-0601-1","generic_name":"Emtricitabine Capsule","contact_info":"800-445-3235","related_info":"Product expected to be available until March 2027","openfda":{"application_number":["NDA021500"],"brand_name":["EMTRIVA"],"generic_name":["EMTRICITABINE"],"manufacturer_name":["Gilead Sciences, Inc."],"product_ndc":["61958-0601","61958-0602"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["EMTRICITABINE"],"spl_id":["5fa131e8-fb3b-f4ac-e063-6294a90a2136"],"spl_set_id":["d6599395-3944-44f9-97f2-e0424c6b6a1f"],"package_ndc":["61958-0601-1","61958-0602-1"],"nui":["N0000175462","M0015066","N0000009947"],"pharm_class_epc":["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"],"pharm_class_cs":["Nucleosides [CS]"],"pharm_class_moa":["Nucleoside Reverse Transcriptase Inhibitors [MoA]"],"unii":["G70B4ETF4S"]},"update_date":"06/17/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Emtriva, Capsule, 200 mg (NDC 61958-0601-1)","company_name":"Gilead Sciences, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"0406-8894-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-325-8888","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040440"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-8894","0406-8891","0406-8884","0406-8892","0406-8885","0406-8893"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["0d3fb5ba-ff79-4862-bc1d-45b8343e115b"],"spl_set_id":["72ddd1c9-ddbd-4c95-acd9-003189a353a3"],"package_ndc":["0406-8891-01","0406-8884-01","0406-8892-01","0406-8885-01","0406-8893-01","0406-8894-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0406-8894-01)","company_name":"SpecGx LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"11/19/2025","update_type":"New","initial_posting_date":"11/19/2025","package_ndc":"0378-5807-93","generic_name":"Valsartan Tablet","contact_info":"800-796-9526","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA090866"],"brand_name":["VALSARTAN"],"generic_name":["VALSARTAN"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-5807","0378-5813","0378-5814","0378-5815"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["VALSARTAN"],"rxcui":["349199","349200","349201","349483"],"spl_id":["db5a1e1d-200e-4a60-a392-98e24e5dbc29"],"spl_set_id":["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"],"package_ndc":["0378-5807-93","0378-5813-77","0378-5814-77","0378-5815-77"],"nui":["N0000000070","N0000175561"],"pharm_class_moa":["Angiotensin 2 Receptor Antagonists [MoA]"],"pharm_class_epc":["Angiotensin 2 Receptor Blocker [EPC]"],"unii":["80M03YXJ7I"]},"update_date":"11/19/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Valsartan, Tablet, 40 mg (NDC 0378-5807-93)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"discontinued_date":"09/18/2026","update_type":"New","initial_posting_date":"09/18/2026","package_ndc":"50458-575-01","generic_name":"Rivaroxaban For Suspension","contact_info":"800-526-7736","related_info":"Business Decision","openfda":{"application_number":["NDA215859"],"brand_name":["XARELTO"],"generic_name":["RIVAROXABAN"],"manufacturer_name":["Janssen Pharmaceuticals, Inc."],"product_ndc":["50458-575","50458-577","50458-580","50458-578","50458-579","50458-584"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIVAROXABAN"],"rxcui":["1114198","1114202","1232082","1232084","1232086","1232088","1549682","1549683","2059015","2059017","2588062","2588066"],"spl_id":["5294926b-7812-41da-a0e8-56f492198450"],"spl_set_id":["10db92f9-2300-4a80-836b-673e1ae91610"],"package_ndc":["50458-577-60","50458-577-18","50458-577-14","50458-577-01","50458-577-10","50458-580-01","50458-580-10","50458-580-30","50458-580-07","50458-580-90","50458-578-01","50458-578-10","50458-578-30","50458-578-90","50458-578-14","50458-578-07","50458-579-01","50458-579-10","50458-579-30","50458-579-90","50458-579-99","50458-579-07","50458-579-89","50458-584-51","50458-584-52","50458-575-01"],"nui":["N0000175635","N0000175637"],"pharm_class_moa":["Factor Xa Inhibitors [MoA]"],"pharm_class_epc":["Factor Xa Inhibitor [EPC]"],"unii":["9NDF7JZ4M3"]},"update_date":"09/18/2026","therapeutic_category":["Hematology"],"presentation":"Xarelto, For Suspension, 155 mg (NDC 50458-575-01)","company_name":"Janssen Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"New","initial_posting_date":"04/28/2023","package_ndc":"69339-364-05","generic_name":"Carboplatin Injection","contact_info":"Natco Pharma USA LLC: (201)786-6500","availability":"Available","related_info":"Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)","openfda":{"application_number":["ANDA077861"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Natco Pharma USA LLC"],"product_ndc":["69339-364","69339-365","69339-366","69339-367"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["4c89cedc-e48b-445c-ad05-54dbe60e4fb0"],"spl_set_id":["4c89cedc-e48b-445c-ad05-54dbe60e4fb0"],"package_ndc":["69339-364-05","69339-365-15","69339-366-45","69339-367-60"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 50 mg/5 mL (NDC 69339-364-05)","company_name":"Teyro Labs","status":"Current"},{"update_type":"Revised","initial_posting_date":"06/13/2018","package_ndc":"55150-252-20","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: late October 2026; Check wholesalers for inventory","openfda":{"application_number":["ANDA207182"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-252","55150-251","55150-254","55150-255","55150-253","55150-256"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671"],"spl_id":["ccc38d8a-43fd-44c0-985e-32af9ed956ab","0b1f03c2-db2f-4f90-acc0-d73abd731bf6"],"spl_set_id":["ccc38d8a-43fd-44c0-985e-32af9ed956ab","ef782e5e-e2d7-465a-99c6-b12611f3158c"],"package_ndc":["55150-251-24","55150-252-24","55150-254-24","55150-255-24","55150-251-10","55150-252-20","55150-253-50","55150-254-10","55150-255-20","55150-256-50"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-8020-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-8020","0075-8013","0075-8014","0075-8016","0075-8018","0075-8030","0075-8022","0075-8025"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["006561fa-e16d-4129-9dde-89c109b51d8f"],"spl_set_id":["de6fb917-a94a-41ea-9d7d-937d4080ffcd"],"package_ndc":["0075-8013-01","0075-8013-10","0075-8014-01","0075-8014-10","0075-8016-01","0075-8016-10","0075-8018-01","0075-8018-10","0075-8020-01","0075-8020-10","0075-8030-01","0075-8022-01","0075-8022-10","0075-8025-01","0075-8025-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 100 mg/1 mL (NDC 0075-8020-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"70069-758-04","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA218112"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-758","70069-759"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1788947"],"spl_id":["6a1a2c33-1467-4eb0-adc6-6e21771fbf6b"],"spl_set_id":["649e777b-9b30-4f1e-9fb9-6bba57580976"],"package_ndc":["70069-758-04","70069-759-04"],"unii":["1018WH7F9I"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0338-1130-03","generic_name":"Amino Acid Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA075880"],"brand_name":["PREMASOL - SULFITE-FREE (AMINO ACID)"],"generic_name":["LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-1130","0338-1131"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LEUCINE","LYSINE ACETATE","ISOLEUCINE","VALINE","HISTIDINE","PHENYLALANINE","THREONINE","METHIONINE","TRYPTOPHAN","TYROSINE","ARGININE","PROLINE","ALANINE","GLUTAMIC ACID","SERINE","GLYCINE","ASPARTIC ACID","TAURINE","CYSTEINE HYDROCHLORIDE"],"rxcui":["801395","801398","801403","801405"],"spl_id":["c874a813-b145-4f7f-833e-97d6c4dd727c"],"spl_set_id":["9afdcc3e-0d06-47f4-86ca-40da48b2b02b"],"package_ndc":["0338-1130-03","0338-1130-04","0338-1130-06","0338-1131-03"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["GMW67QNF9C","TTL6G7LIWZ","04Y7590D77","HG18B9YRS7","4QD397987E","47E5O17Y3R","2ZD004190S","AE28F7PNPL","8DUH1N11BX","42HK56048U","94ZLA3W45F","9DLQ4CIU6V","OF5P57N2ZX","3KX376GY7L","452VLY9402","TE7660XO1C","30KYC7MIAI","1EQV5MLY3D","ZT934N0X4W"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-03)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/15/2023","package_ndc":"65219-444-10","generic_name":"Rocuronium Bromide Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA217472"],"brand_name":["ROCURONIUM"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-444","65219-442","65219-695","65219-697"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["2720024","2720026"],"spl_id":["31c4c874-3d24-4c86-a301-ee9faf0b5c00"],"spl_set_id":["9a622308-7bda-4ca0-9de5-d6b3b4be3384"],"package_ndc":["65219-442-02","65219-442-05","65219-444-04","65219-444-10","65219-695-01","65219-695-05","65219-697-01","65219-697-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-444-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0990-7922-55","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7922","0990-7923","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"discontinued_date":"03/26/2026","update_type":"New","initial_posting_date":"03/26/2026","package_ndc":"39822-0355-6","generic_name":"Lincomycin Hydrochloride Injection","contact_info":"866-390-4411","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"03/26/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Lincomycin Hydrochloride, Injection, 3 grams/10 mL vial x 10 count (NDC 39822-0355-6)","company_name":"XGen Pharmaceuticals DJB, Inc.","status":"To Be Discontinued"},{"discontinued_date":"04/28/2026","update_type":"New","initial_posting_date":"04/28/2026","package_ndc":"59676-570-01","generic_name":"Etravirine Tablet","contact_info":"800-526-7736","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA022187"],"brand_name":["INTELENCE"],"generic_name":["ETRAVIRINE"],"manufacturer_name":["Janssen Products LP"],"product_ndc":["59676-570","59676-571","59676-572"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ETRAVIRINE"],"rxcui":["754761","758555","1052658","1052660","1250721","1250723"],"spl_id":["02fc6f4f-330d-b32e-e063-6294a90a028a"],"spl_set_id":["6a9cbc29-9f15-4b24-8d86-206b82887f3d"],"package_ndc":["59676-570-01","59676-571-01","59676-572-01"],"nui":["N0000175463","N0000175460","N0000009948","N0000190118","N0000185504","N0000182140","N0000185503"],"pharm_class_epc":["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"],"pharm_class_moa":["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]","Cytochrome P450 3A Inducers [MoA]","Cytochrome P450 2C9 Inhibitors [MoA]","Cytochrome P450 2C19 Inhibitors [MoA]","P-Glycoprotein Inhibitors [MoA]"],"unii":["0C50HW4FO1"]},"update_date":"04/28/2026","therapeutic_category":["Antiviral"],"dosage_form":"Tablet","presentation":"Intelence, Tablet, 100 mg (NDC 59676-570-01)","company_name":"Janssen Research and Development","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"44567-600-04","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"WG Critical Care 888-493-0861","availability":"Available","related_info":"Marketed by WG Critical Care","openfda":{"application_number":["NDA206628"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["WG Critical Care, LLC"],"product_ndc":["44567-600","44567-601","44567-602","44567-603"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909","1788947"],"spl_id":["ee503974-3f79-46d7-845f-2d15444dc0b8"],"spl_set_id":["0d2710f2-ee47-4114-ab5c-8dca74cdcb8d"],"package_ndc":["44567-600-04","44567-601-04","44567-602-01","44567-602-24","44567-603-01","44567-603-24"],"unii":["1018WH7F9I"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04)","company_name":"HQ Specialty Pharma","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"71288-723-52","generic_name":"Bupivacaine Hydrochloride Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d","contact_info":"844-824-8426","availability":"Limited Availability","related_info":"Meitheal Pharmaceuticals is distributor/labeler","openfda":{"application_number":["ANDA216039"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc"],"product_ndc":["71288-723","71288-726"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["0949c302-51ce-4fc9-8b99-1df94e693718"],"spl_set_id":["fe340f98-a0f3-446e-b281-47fd91c1e537"],"package_ndc":["71288-723-52","71288-726-52"],"unii":["7TQO7W3VT8"]},"update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52)","company_name":"Kindos Pharmaceuticals Co. Ltd.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-286-31","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-286","63323-285","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cb6583ff-cde4-4280-aa5b-0bea2b844792","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","cb6583ff-cde4-4280-aa5b-0bea2b844792","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-51","63323-286-55","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 5 mg/1 mL (NDC 63323-286-31)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-482-17","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-482","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0406-5113-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA211840"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-5113","0406-5111","0406-5112","0406-5114","0406-5115","0406-5116","0406-5117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["77f4cd3a-dca3-4995-8992-042e1dc91a00"],"spl_set_id":["806a1c15-0842-4787-b2ad-09a21fd96b37"],"package_ndc":["0406-5111-01","0406-5112-01","0406-5113-01","0406-5114-01","0406-5115-01","0406-5116-01","0406-5117-01"],"unii":["SJT761GEGS"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0406-5113-01)","company_name":"SpecGx LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/20/2023","package_ndc":"0641-6025-10","generic_name":"Fentanyl Citrate Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Inventory available in vial presentations.","update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6025-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0990-7923-20","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7923","0990-7922","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-20)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-2510-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2510","0409-1746","0409-1749","0409-1752","0409-1755","0409-7535","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-2510-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/24/2017","package_ndc":"51754-5011-4","generic_name":"Sodium Bicarbonate Injection","contact_info":"828-758-5474 ext. 154","availability":"Available","openfda":{"application_number":["ANDA211091"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["Exela Pharma Sciences, LLC"],"product_ndc":["51754-5011","51754-5001","51754-5002","51754-5012"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["807284","1868486","1923484","2198792"],"spl_id":["4da0ba66-756d-4b4d-8018-81ca16578ef1"],"spl_set_id":["e9698a4f-1a95-4f28-a945-e8009d1d6dd4"],"package_ndc":["51754-5001-5","51754-5001-4","51754-5011-4","51754-5002-5","51754-5012-4"],"unii":["8MDF5V39QO"]},"update_date":"10/15/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4)","company_name":"Exela Pharma Sciences, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/17/2015","package_ndc":"0143-9930-10","generic_name":"Cefotaxime Sodium Powder, for Solution","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA065072"],"brand_name":["CEFOTAXIME"],"generic_name":["CEFOTAXIME"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9930","0143-9931","0143-9933"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CEFOTAXIME SODIUM"],"rxcui":["309068","1656313","1656318"],"spl_id":["7e0897ec-2275-4438-9cc5-4c951e52ad97"],"spl_set_id":["ed23b6bc-32c7-4c50-a53d-313ae78e5623"],"package_ndc":["0143-9931-01","0143-9931-25","0143-9933-01","0143-9933-25","0143-9930-01","0143-9930-10"],"unii":["258J72S7TZ"]},"update_date":"10/14/2026","therapeutic_category":["Anti-Infective","Pediatric"],"dosage_form":"Powder, For Solution","presentation":"Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-115-01","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA208510"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-115","59417-101","59417-102","59417-103","59417-104","59417-105","59417-106","59417-107","59417-116","59417-117","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"23155-473-42","generic_name":"Furosemide Injection","contact_info":"855-228-9470","availability":"Available","openfda":{"application_number":["ANDA203428"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."],"product_ndc":["23155-473"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["c14acada-333e-43bb-b1cf-81d569e3e918"],"spl_set_id":["1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec"],"package_ndc":["23155-473-31","23155-473-41","23155-473-32","23155-473-42","23155-473-43","23155-473-33","23155-473-44","23155-473-45"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/02/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-42)","company_name":"Avet Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0551-18","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA020179"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-0551"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795609","1795616"],"spl_id":["1abb6ba4-fa29-4807-8623-3bd98ac11440"],"spl_set_id":["7de48bdb-9a05-4f2a-bbff-dcfeb284ca6e"],"package_ndc":["0338-0551-11","0338-0551-18"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-18)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-9046-01","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA071170"],"brand_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9046","0409-1159","0409-1160","0409-1162","0409-1163","0409-1165","0409-9043","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride with Epinephrine, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-9046-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/27/2023","package_ndc":"45567-0060-1","generic_name":"Technetium TC-99M Pyrophosphate Kit Injection","contact_info":"800-818-4555","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA019039"],"brand_name":["KIT FOR THE PREPARATION OF TECHNETIUM TC99M PYROPHOSPHATE"],"generic_name":["TECHNETIUM TC99M PYROPHOSPHATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["45567-0060"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["TECHNETIUM TC-99M PYROPHOSPHATE"],"spl_id":["3010b45e-eed1-a5d0-e063-6294a90a40cf"],"spl_set_id":["1f0cbd23-2fb3-43b7-b8af-7de246151149"],"package_ndc":["45567-0060-1","45567-0060-2"],"nui":["N0000177914","N0000000205"],"pharm_class_epc":["Radioactive Diagnostic Agent [EPC]"],"pharm_class_moa":["Radiopharmaceutical Activity [MoA]"],"unii":["5L76I61H2B"]},"update_date":"10/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"CIS-PYRO, Injection, 12 mg/10 mL (NDC 45567-0060-1)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"10/14/2026","update_type":"New","initial_posting_date":"10/14/2026","package_ndc":"49884-283-02","generic_name":"Everolimus Tablet","contact_info":"800-828-9393","related_info":"A business decision was made to withdraw from sale.","openfda":{"application_number":["ANDA205775"],"brand_name":["EVEROLIMUS"],"generic_name":["EVEROLIMUS"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["49884-283","49884-158","49884-159","49884-160"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["EVEROLIMUS"],"rxcui":["977427","977434","977438","2056895"],"spl_id":["7523ed83-6f81-4cc8-b815-e646ffa1dd80"],"spl_set_id":["59cb86d5-8706-4619-b074-af253d3e0b68"],"package_ndc":["49884-158-52","49884-158-02","49884-159-52","49884-159-02","49884-160-52","49884-160-02","49884-283-52","49884-283-02"],"nui":["N0000175605","N0000175076","N0000182141","N0000182137","N0000175625","N0000175624","N0000175550"],"pharm_class_epc":["Kinase Inhibitor [EPC]","mTOR Inhibitor Immunosuppressant [EPC]"],"pharm_class_moa":["Protein Kinase Inhibitors [MoA]","Cytochrome P450 3A4 Inhibitors [MoA]","Cytochrome P450 2D6 Inhibitors [MoA]","mTOR Inhibitors [MoA]"],"pharm_class_pe":["Decreased Immunologic Activity [PE]"],"unii":["9HW64Q8G6G"]},"update_date":"10/14/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, 1 mg (NDC 49884-283-02)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"72205-134-91","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"(855) 668-2369; customerservice@novadozpharma.com","availability":"Available","openfda":{"application_number":["ANDA218306"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-134","72205-132","72205-133","72205-135","72205-136","72205-137"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"spl_set_id":["a79cb70c-0bfa-4d68-9a21-a5ef4bc3c811"],"package_ndc":["72205-132-91","72205-133-91","72205-134-91","72205-135-91","72205-136-91","72205-137-91"],"unii":["SJT761GEGS"]},"update_date":"09/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91)","company_name":"Novadoz Pharmaceuticals LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"57844-120-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["ADDERALL"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["57844-120","57844-105","57844-117","57844-110","57844-112","57844-115","57844-130"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541365","541878","541879","541892","541894","577957","577960","577961","577962","687043","687045","1009145","1009147"],"spl_id":["79af1dc6-c7cf-41b1-a750-e9b47c2187ff"],"spl_set_id":["f22635fe-821d-4cde-aa12-419f8b53db81"],"package_ndc":["57844-105-01","57844-117-01","57844-110-01","57844-112-01","57844-115-01","57844-120-01","57844-130-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Adderall, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 57844-120-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/06/2017","package_ndc":"0409-9104-20","generic_name":"Dopamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA018132"],"brand_name":["DOPAMINE HYDROCHLORIDE"],"generic_name":["DOPAMINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9104","0409-5820"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1743938","1743941"],"spl_id":["7a125e39-1ecb-4c76-931a-efc9b5921d1c"],"spl_set_id":["1f306ad2-3606-4525-5a8a-ce78f426c1a2"],"package_ndc":["0409-5820-11","0409-5820-01","0409-9104-21","0409-9104-20"],"unii":["7L3E358N9L"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride, Injection, 400 mg/10mL (40 mg/1 mL) (NDC 0409-9104-20)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"83831-142-50","generic_name":"Carboplatin Injection","contact_info":"877-595-7337; customerservice@avyxa.com","availability":"Available","openfda":{"application_number":["NDA219921"],"brand_name":["KYXATA"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Avyxa Pharma, LLC"],"product_ndc":["83831-142","83831-140","83831-141"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195","2721602"],"spl_id":["5c711945-70be-42f4-b153-e1459dd9929c"],"spl_set_id":["f91c48da-68d1-4aa7-89b8-d84a3e8b629b"],"package_ndc":["83831-140-02","83831-141-08","83831-142-50"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)","company_name":"Avyxa Pharma, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-250-50","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA207183"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-250","55150-167","55150-168","55150-169","55150-170","55150-171","55150-172","55150-249"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404","1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["39649703-e633-4a20-ba71-0c04dbf8ff2a"],"spl_set_id":["ffecf450-1f01-4721-8e10-251385852612"],"package_ndc":["55150-167-10","55150-168-30","55150-169-10","55150-170-30","55150-171-10","55150-172-30","55150-249-50","55150-250-50"],"unii":["7TQO7W3VT8"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0406-8884-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA040440"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-8884","0406-8891","0406-8892","0406-8885","0406-8893","0406-8894"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["0d3fb5ba-ff79-4862-bc1d-45b8343e115b"],"spl_set_id":["72ddd1c9-ddbd-4c95-acd9-003189a353a3"],"package_ndc":["0406-8891-01","0406-8884-01","0406-8892-01","0406-8885-01","0406-8893-01","0406-8894-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 0406-8884-01)","company_name":"SpecGx LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"09/05/2018","package_ndc":"0641-6002-10","generic_name":"Lorazepam Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA018140"],"brand_name":["ATIVAN"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6002","0641-6003","0641-6001","0641-6000"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["206819","206820","238100","238101","1665188","1665190","1665326","1665327"],"spl_id":["fb40dcce-9da3-49b4-9bde-e01a17abeae6"],"spl_set_id":["5fc0e987-61c9-40c4-b0d5-fcea07c8733e"],"package_ndc":["0641-6003-01","0641-6003-25","0641-6002-01","0641-6002-10","0641-6001-01","0641-6001-25","0641-6000-01","0641-6000-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"10/14/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Ativan, Injection, 4 mg/1 mL (NDC 0641-6002-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"65219-080-05","generic_name":"Gadoterate Meglumine Injection","contact_info":"888-386-1800","related_info":"Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA215304"],"brand_name":["GADOTERATE MEGLUMINE"],"generic_name":["GADOTERATE MEGLUMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-080","65219-082","65219-084","65219-086"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOTERATE MEGLUMINE"],"spl_id":["f05922b7-99d4-48c7-972a-7966bbbbc3b4"],"spl_set_id":["e0655aac-9508-4141-94f5-fcca6af1c41d"],"package_ndc":["65219-080-01","65219-080-05","65219-082-01","65219-082-10","65219-084-01","65219-084-15","65219-086-01","65219-086-20"],"unii":["L0ND3981AG"]},"update_date":"06/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-8025-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-8025","0075-8013","0075-8014","0075-8016","0075-8018","0075-8020","0075-8030","0075-8022"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["006561fa-e16d-4129-9dde-89c109b51d8f"],"spl_set_id":["de6fb917-a94a-41ea-9d7d-937d4080ffcd"],"package_ndc":["0075-8013-01","0075-8013-10","0075-8014-01","0075-8014-10","0075-8016-01","0075-8016-10","0075-8018-01","0075-8018-10","0075-8020-01","0075-8020-10","0075-8030-01","0075-8022-01","0075-8022-10","0075-8025-01","0075-8025-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 150 mg/1 mL (NDC 0075-8025-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0703-4239-01","generic_name":"Carboplatin Injection","contact_info":"800-545-8800","availability":"Limited Availability","related_info":"Estimated recovery: December 2028","openfda":{"application_number":["ANDA077269"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-4239","0703-4244","0703-4246","0703-4248"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["bed4c1cf-f3ef-4faa-b2a4-24ee9a9879df","b943761e-6a46-45a0-bdb4-1fec1e101f8c"],"spl_set_id":["f330f5a2-2cad-402f-bcbb-26245a753276","e176b6ef-2ff6-498b-a9d8-7a634d147f37"],"package_ndc":["0703-4244-01","0703-4246-01","0703-4248-01","0703-4239-01","0703-4244-81","0703-4246-81","0703-4248-81","0703-4239-81"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 10 mg/1 mL (NDC 0703-4239-01)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"New","initial_posting_date":"02/20/2018","package_ndc":"31722-275-32","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-529-0430, customerservice@camberpharma.com","availability":"Available","openfda":{"application_number":["ANDA217821"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Camber Pharmaceuticals, Inc."],"product_ndc":["31722-275","31722-276","31722-277"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["4ea16f8e-77de-3ba7-e063-6394a90a5667"],"spl_set_id":["0e552e3a-cf52-4d74-9381-6cc1b29b4c90"],"package_ndc":["31722-275-10","31722-275-31","31722-275-32","31722-275-30","31722-275-33","31722-275-34","31722-275-35","31722-276-10","31722-276-31","31722-276-32","31722-276-30","31722-276-33","31722-276-34","31722-277-10","31722-277-31","31722-277-32","31722-277-30","31722-277-33","31722-277-34"],"unii":["7TQO7W3VT8"]},"update_date":"07/17/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 31722-275-32)","company_name":"Aspiro Pharma Limited","status":"Current"},{"discontinued_date":"10/02/2026","update_type":"New","initial_posting_date":"10/02/2026","package_ndc":"0093-0264-30","generic_name":"Fluocinonide Ointment","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA073481"],"brand_name":["FLUOCINONIDE"],"generic_name":["FLUOCINONIDE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-0264","0093-0263","0093-0262"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TOPICAL"],"substance_name":["FLUOCINONIDE"],"rxcui":["103456","103457","1801283"],"spl_id":["c70aebe7-b63b-468a-ada5-dc1e60391277"],"spl_set_id":["986c1ba3-2103-4773-a35c-2c0121a01783"],"package_ndc":["0093-0263-15","0093-0263-30","0093-0263-92","0093-0262-15","0093-0262-30","0093-0262-92","0093-0264-15","0093-0264-30","0093-0264-92"],"nui":["N0000175576","N0000175450"],"pharm_class_epc":["Corticosteroid [EPC]"],"pharm_class_moa":["Corticosteroid Hormone Receptor Agonists [MoA]"],"unii":["2W4A77YPAN"]},"update_date":"10/02/2026","therapeutic_category":["Dermatology"],"dosage_form":"Ointment","presentation":"Fluocinonide, Ointment, .5 mg/1 g (NDC 0093-0264-30)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"04/08/2026","update_type":"New","initial_posting_date":"04/08/2026","package_ndc":"0006-3066-03","generic_name":"Aprepitant Oral Powder for Suspension","contact_info":"800-672-6372","related_info":"To be discontinued in approximately early-September 2026.","openfda":{"application_number":["NDA207865"],"brand_name":["EMEND"],"generic_name":["APREPITANT"],"manufacturer_name":["Merck Sharp & Dohme LLC"],"product_ndc":["0006-3066","0006-0461","0006-0462","0006-3862","0006-0464"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["APREPITANT"],"spl_id":["43036bb2-64fa-4838-be33-174867635516"],"spl_set_id":["696f9e80-9cae-403b-de9e-078343ce4713"],"package_ndc":["0006-0461-02","0006-0461-01","0006-0461-06","0006-0461-12","0006-0462-01","0006-0462-06","0006-3862-03","0006-3862-13","0006-0464-01","0006-0464-10","0006-0464-05","0006-3066-01","0006-3066-03"],"nui":["N0000010262","N0000175786","N0000182141","N0000185507","N0000185506"],"pharm_class_moa":["Neurokinin 1 Antagonists [MoA]","Cytochrome P450 3A4 Inhibitors [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 3A4 Inducers [MoA]"],"pharm_class_epc":["Substance P/Neurokinin-1 Receptor Antagonist [EPC]"],"unii":["1NF15YR6UY"]},"update_date":"04/08/2026","therapeutic_category":["Gastroenterology"],"presentation":"Emend, Oral Powder for Suspension, 125 mg (NDC 0006-3066-03)","company_name":"Merck Sharp & Dohme LLC","status":"To Be Discontinued"},{"discontinued_date":"05/07/2026","update_type":"New","initial_posting_date":"05/07/2026","package_ndc":"63323-574-86","generic_name":"Icatibant Acetate Injection","contact_info":"847-550-2300","related_info":"Discontinuation of the manufacturer of the drug","openfda":{"application_number":["ANDA208317"],"brand_name":["ICATIBANT"],"generic_name":["ICATIBANT"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-574"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ICATIBANT ACETATE"],"rxcui":["1148141"],"spl_id":["d1c9afa7-c4ac-4739-85f1-2ae82440210c"],"spl_set_id":["52c12c15-c00b-4efc-952d-1425c907706a"],"package_ndc":["63323-574-01","63323-574-86","63323-574-93"],"unii":["325O8467XK"]},"update_date":"05/07/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-86)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"discontinued_date":"03/02/2026","update_type":"New","initial_posting_date":"03/02/2026","package_ndc":"0093-7767-24","generic_name":"Everolimus Tablet","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/02/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, 5 mg (NDC 0093-7767-24)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"60505-6282-6","generic_name":"Carboplatin Injection","contact_info":"Apotex Inc.: 800-706-5575","related_info":"Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA077861"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-6282"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["0e68e276-b0df-4f03-e063-6394a90a22b9"],"spl_set_id":["1c275825-0275-4c73-b650-e4c1519f13b8"],"package_ndc":["60505-6282-1","60505-6282-3","60505-6282-6","60505-6282-7"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"06/01/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-6)","company_name":"Teyro Labs","status":"To Be Discontinued"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0411-07","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017512"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0411-07)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"65219-281-10","generic_name":"Gadobutrol Injection","contact_info":"888-386-1300","related_info":"Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA","openfda":{"application_number":["ANDA215061"],"brand_name":["GADOBUTROL"],"generic_name":["GADOBUTROL"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-281"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOBUTROL"],"spl_id":["490c8c3e-3195-40af-8f34-40d8df2719c3"],"spl_set_id":["007696d0-4b62-4937-9640-4ad619504df4"],"package_ndc":["65219-281-00","65219-281-02","65219-281-03","65219-281-07","65219-281-08","65219-281-10","65219-281-05","65219-281-15"],"nui":["N0000183362","N0000175862"],"pharm_class_epc":["Gadolinium-based Contrast Agent [EPC]"],"pharm_class_moa":["Magnetic Resonance Contrast Activity [MoA]"],"unii":["1BJ477IO2L"]},"update_date":"06/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-10)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"13811-709-10","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Allocation to current contracted customers","openfda":{"application_number":["ANDA205327"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Trigen Laboratories, LLC"],"product_ndc":["13811-709","13811-706","13811-707","13811-708","13811-710"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461"],"spl_id":["0944cf70-d59a-483b-9698-e96ef955a65a"],"spl_set_id":["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"],"package_ndc":["13811-709-10","13811-706-10","13811-707-10","13811-708-10","13811-710-10","13811-710-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)","company_name":"Trigen Laboratories, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"01/08/2026","update_type":"New","initial_posting_date":"01/08/2026","package_ndc":"0006-3516-59","generic_name":"Imipenem and Cilastatin Injection","contact_info":"800-672-6372","related_info":"To be discontinued approximately 11/30/2026","openfda":{"application_number":["NDA050587"],"brand_name":["PRIMAXIN IV"],"generic_name":["IMIPENEM AND CILASTATIN SODIUM"],"manufacturer_name":["Merck Sharp & Dohme LLC"],"product_ndc":["0006-3516","0006-3514","0006-3551","0006-3552"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IMIPENEM","CILASTATIN SODIUM"],"rxcui":["1726204","1726207","1726214","1726216"],"spl_id":["356d9feb-1498-4df7-80ad-5a935b238da6"],"spl_set_id":["f41d8abd-7792-4918-1b93-bd83ea01955e"],"package_ndc":["0006-3514-58","0006-3516-59","0006-3551-58","0006-3552-59"],"unii":["71OTZ9ZE0A","5428WXZ74M"]},"update_date":"01/08/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Primaxin, Injection, 500mg (NDC 0006-3516-59)","company_name":"Merck Sharp & Dohme Corp.","status":"To Be Discontinued"},{"discontinued_date":"10/01/2026","update_type":"New","initial_posting_date":"10/07/2026","package_ndc":"0603-3582-28","generic_name":"Felodipine Tablet, Extended Release","contact_info":"(800) 828-9393","related_info":"Discontinuation in the manufacturing of the drug product","openfda":{"application_number":["ANDA200815"],"brand_name":["FELODIPINE"],"generic_name":["FELODIPINE"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["0603-3582","0603-3581","0603-3583"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FELODIPINE"],"rxcui":["402695","402696","402698"],"spl_id":["02151da2-890e-4f84-94c8-6ce767d9ff12"],"spl_set_id":["55637724-8757-11de-8a39-0800200c9a66"],"package_ndc":["0603-3581-28","0603-3581-21","0603-3582-21","0603-3582-28","0603-3583-28","0603-3583-21"],"nui":["N0000000069","N0000175421","M0006414"],"pharm_class_moa":["Calcium Channel Antagonists [MoA]"],"pharm_class_epc":["Dihydropyridine Calcium Channel Blocker [EPC]"],"pharm_class_cs":["Dihydropyridines [CS]"],"unii":["OL961R6O2C"]},"update_date":"10/07/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-28)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"discontinued_date":"02/10/2026","update_type":"New","initial_posting_date":"02/10/2026","package_ndc":"63323-326-20","generic_name":"Cefepime Hydrochloride Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug.","openfda":{"application_number":["ANDA065441"],"brand_name":["CEFEPIME"],"generic_name":["CEFEPIME"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-326","63323-340"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CEFEPIME HYDROCHLORIDE"],"rxcui":["1665088","1665093"],"spl_id":["8c2fbf43-34bd-49d1-bda8-a2191c8bc54b"],"spl_set_id":["5e1695e0-1310-4cd8-a5da-ad1a7dcd1792"],"package_ndc":["63323-326-21","63323-326-20","63323-340-21","63323-340-20"],"unii":["I8X1O0607P"]},"update_date":"02/10/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"0009-0902-18","generic_name":"Clindamycin Phosphate Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050441"],"brand_name":["CLEOCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0902","0009-0870","0009-0775","0009-0728","0009-3124","0009-3447","0009-3381","0009-3375","0009-3382","0009-6582"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309339","685574","685576","685578","706461","1737244","1737245","1737578","1737579","1737581","1737582","205964","309335","309336"],"spl_id":["fa11e62e-4625-4e9c-8676-f318b1cb890f"],"spl_set_id":["05a75685-0af5-407c-ac57-e380c882b49d"],"package_ndc":["0009-0870-21","0009-0870-26","0009-0775-20","0009-0775-26","0009-0902-11","0009-0902-18","0009-0728-05","0009-0728-09","0009-3124-01","0009-3124-03","0009-3447-01","0009-3447-03","0009-3381-01","0009-3381-02","0009-3375-01","0009-3375-02","0009-3382-01","0009-3382-02","0009-6582-02","0009-6582-01"],"unii":["EH6D7113I8"]},"update_date":"06/01/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cleocin Phosphate, Injection, 900 mg/6 mL (150 mg/mL); 6 mL Vial (NDC 0009-0902-18)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-152-00","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-152","72888-497","72888-153","72888-154"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 72888-152-00)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"68025-098-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Available","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-098","68025-088","68025-089","68025-095","68025-096","68025-097","68025-084"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-30)","company_name":"Vertical Pharmaceuticals, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"64850-503-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"888-852-6657","availability":"Available","openfda":{"application_number":["ANDA211352"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-503","64850-500","64850-501","64850-502","64850-504","64850-505","64850-506"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["a41cf8e5-cb1b-488c-96b3-3bef8283d6c4"],"spl_set_id":["e677690f-790f-4626-ad78-097cdb6ea540"],"package_ndc":["64850-500-01","64850-500-05","64850-500-30","64850-501-01","64850-501-05","64850-501-30","64850-502-01","64850-502-05","64850-502-30","64850-503-01","64850-503-05","64850-503-30","64850-504-01","64850-504-05","64850-504-30","64850-505-01","64850-505-05","64850-505-30","64850-506-01","64850-506-05","64850-506-30"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.125 mg; 3.125 mg; 3.125 mg; 3.125 mg (NDC 64850-503-01)","company_name":"Elite Laboratories, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/20/2023","package_ndc":"0641-6027-25","generic_name":"Fentanyl Citrate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.","openfda":{"application_number":["NDA019101"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6027","0641-6024","0641-6025","0641-6028","0641-6026","0641-6029","0641-6030","0641-6247","0641-6248","0641-6249"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270","2474269","2629337"],"spl_id":["4eb40afd-eae7-4006-8934-4e1d43d59ea7"],"spl_set_id":["ce5db1c2-feb1-4ad2-847a-d02e865bd47e"],"package_ndc":["0641-6024-01","0641-6024-10","0641-6027-01","0641-6027-25","0641-6025-01","0641-6025-10","0641-6028-01","0641-6028-10","0641-6028-25","0641-6026-01","0641-6026-05","0641-6029-01","0641-6029-25","0641-6030-01","0641-6247-01","0641-6247-25","0641-6248-01","0641-6248-10","0641-6249-01","0641-6249-10"],"unii":["MUN5LYG46H"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6027-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0990-4179-05","generic_name":"Amino Acid Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Unavailable","related_info":"Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA019492"],"brand_name":["AMINOSYN-PF"],"generic_name":["ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, GLYCINE, HISTIDINE, PROLINE, SERINE, TAURINE, AND TYROSINE"],"manufacturer_name":["ICU Medical Inc."],"product_ndc":["0990-4179"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ISOLEUCINE","LEUCINE","LYSINE ACETATE","METHIONINE","PHENYLALANINE","THREONINE","TRYPTOPHAN","VALINE","ALANINE","ARGININE","ASPARTIC ACID","GLUTAMIC ACID","GLYCINE","HISTIDINE","PROLINE","SERINE","TAURINE","TYROSINE"],"rxcui":["800341","800345"],"spl_id":["549fb8fe-b1b4-4b40-b078-2511913c2d43"],"spl_set_id":["46e74ce4-cd7e-437f-bf54-ca9b98eb2663"],"package_ndc":["0990-4179-05"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["04Y7590D77","GMW67QNF9C","TTL6G7LIWZ","AE28F7PNPL","47E5O17Y3R","2ZD004190S","8DUH1N11BX","HG18B9YRS7","OF5P57N2ZX","94ZLA3W45F","30KYC7MIAI","3KX376GY7L","TE7660XO1C","4QD397987E","9DLQ4CIU6V","452VLY9402","1EQV5MLY3D","42HK56048U"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Aminosyn-PF 10%, Injection, 0.1 (NDC 0990-4179-05)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"0338-3612-50","generic_name":"Clindamycin Phosphate Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA208084"],"brand_name":["CLINDAMYCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-3612","0338-3410","0338-3814"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309335","309336","309339"],"spl_id":["c8906ab2-37d2-4fde-9784-0442bf7b9565"],"spl_set_id":["78832ac6-04c5-45e0-ae4d-f56d7920dda9"],"package_ndc":["0338-3410-50","0338-3410-24","0338-3612-50","0338-3612-24","0338-3814-50","0338-3814-24"],"unii":["EH6D7113I8"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate, Injection, 600 mg/50 mL (NDC 0338-3612-50)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"08/10/2026","update_type":"New","initial_posting_date":"08/10/2026","package_ndc":"0093-9477-53","generic_name":"Glyburide Tablet","contact_info":"800-633-1610","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017532"],"brand_name":["GLYBURIDE"],"generic_name":["GLYBURIDE"],"manufacturer_name":["TEVA Pharmaceuticals USA Inc"],"product_ndc":["0093-9477","0093-9433","0093-9364"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GLYBURIDE"],"rxcui":["197737","310534","310537"],"spl_id":["84b83205-8813-494e-933e-a70697393744"],"spl_set_id":["50d16f1d-c814-4411-8749-62561321ecce"],"package_ndc":["0093-9477-53","0093-9433-01","0093-9433-05","0093-9364-01","0093-9364-05","0093-9364-10"],"nui":["N0000175608","M0020795"],"pharm_class_epc":["Sulfonylurea [EPC]"],"pharm_class_cs":["Sulfonylurea Compounds [CS]"],"unii":["SX6K58TVWC"]},"update_date":"08/10/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Diabeta, Tablet, 1.25 mg (NDC 0093-9477-53)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-3073-23","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-3073","0009-3475"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE","INTRA-ARTICULAR"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743781","1743855","1743856"],"spl_id":["e4917f75-3e1c-4f3c-803d-d9ec65df06c7","742fcec7-8db3-4cc6-b276-42587a993810"],"spl_set_id":["bf1b104d-85cb-414d-a366-78068c82c883","9a7b3837-e038-48bf-97e9-78ad463760dc"],"package_ndc":["0009-3073-22","0009-3073-23","0009-3475-22","0009-3475-23","0009-3073-01","0009-3073-03","0009-3475-01","0009-3475-03"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-23)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-164-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203082"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-164","55150-161","55150-162","55150-163","55150-165"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737562","1737566","1737568","1737757","1737761"],"spl_id":["bab2ea79-0aed-4f48-8b4e-f864f8b82fb8","d95a0a28-804f-44d2-aa31-01df376a3154"],"spl_set_id":["9916b09d-a116-469d-92d5-60e50ea9782b","89701fac-7536-4f16-87fb-f4cc121e74ee"],"package_ndc":["55150-161-09","55150-162-09","55150-163-00","55150-163-24","55150-164-09","55150-165-09","55150-161-02","55150-162-05","55150-163-30","55150-163-25","55150-164-02","55150-165-05"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"0409-6102-02","generic_name":"Furosemide Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018667"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["e598e8a6-c854-48f5-a412-fb6a6783774a","981d5143-60cd-4987-9b47-dec24c10de42"],"spl_set_id":["aaced7a8-c3d7-4d66-8c07-aa407b8b3f35","39fd32f2-6bb7-4a65-d298-e48d26bc80c7"],"package_ndc":["0409-6102-35","0409-6102-25","0409-6102-36","0409-6102-26","0409-6102-37","0409-6102-27","0409-6102-19","0409-6102-02","0409-6102-18","0409-6102-04","0409-6102-20","0409-6102-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 20 mg/2 mL (10 mg/1 mL) (NDC 0409-6102-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-154-01","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-154","72888-497","72888-152","72888-153"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 72888-154-01)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"43547-408-10","generic_name":"Clonazepam Tablet","contact_info":"For orders, Solco Healthcare 866-931-9829","resolved_note":"Available","openfda":{"application_number":["ANDA077856"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Solco Healthcare LLC"],"product_ndc":["43547-408","43547-406","43547-407"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["dc17b9d4-2890-4f6c-8476-daa39d0cbc9c"],"spl_set_id":["4acbb7a9-4db5-4497-b8db-9f358b3f6fb4"],"package_ndc":["43547-406-10","43547-406-50","43547-406-11","43547-407-10","43547-407-50","43547-407-11","43547-408-10","43547-408-50"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 43547-408-10)","company_name":"Prinston Pharmaceutical, Inc.","status":"Resolved"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"61269-605-10","generic_name":"Clonazepam Tablet","contact_info":"orders@h2-pharma.com","resolved_note":"Available","openfda":{"application_number":["NDA017533"],"brand_name":["KLONOPIN"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["H2-Pharma, LLC"],"product_ndc":["61269-605","61269-610","61269-620"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","206157","206159","206160"],"spl_id":["63cfdab9-fb3d-4c2b-bf88-8ba841dba839"],"spl_set_id":["cfa0d79a-843c-4b88-95a1-e9511d649ca1"],"package_ndc":["61269-605-10","61269-610-10","61269-620-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Klonopin, Tablet, .5 mg (NDC 61269-605-10)","company_name":"Cheplapharm Arzneimittel GmbH","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0409-2305-17","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Next Estimated Delivery and Estimated Recovery: December 2026","openfda":{"application_number":["ANDA075857"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2305","0409-2308","0409-0001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666800","1666814","1666823","1666798"],"spl_id":["2f69c5b1-6505-42dc-8bb3-edbd9b6c0781","8954486a-8512-4831-8178-0b49f1efb73e"],"spl_set_id":["b95415fa-17c2-42ab-a6b0-e628d01c94ed","1abda8b8-48a8-4995-af86-39220d1aa240"],"package_ndc":["0409-2305-55","0409-2305-50","0409-2308-69","0409-2308-49","0409-2308-70","0409-2308-50","0409-2305-16","0409-2305-17","0409-2305-04","0409-2305-05","0409-2308-21","0409-2308-01","0409-2308-22","0409-2308-02","0409-0001-01","0409-0001-25"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/25/2017","package_ndc":"0264-9598-20","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019830"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND DEXTROSE"],"generic_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-9598","0264-9594"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","DEXTROSE MONOHYDRATE"],"rxcui":["1737723","1737742","1737744"],"spl_id":["9e352802-107c-4f90-babe-4f69c7dc892e"],"spl_set_id":["7dff29d9-522d-40eb-a9d9-42377912d640"],"package_ndc":["0264-9598-20","0264-9594-20","0264-9594-10"],"unii":["LX22YL083G","EC2CNF7XFP"]},"update_date":"11/10/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)","company_name":"B. Braun Medical Inc.","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"65219-084-15","generic_name":"Gadoterate Meglumine Injection","contact_info":"888-386-1800","related_info":"Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA215304"],"brand_name":["GADOTERATE MEGLUMINE"],"generic_name":["GADOTERATE MEGLUMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-084","65219-080","65219-082","65219-086"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOTERATE MEGLUMINE"],"spl_id":["f05922b7-99d4-48c7-972a-7966bbbbc3b4"],"spl_set_id":["e0655aac-9508-4141-94f5-fcca6af1c41d"],"package_ndc":["65219-080-01","65219-080-05","65219-082-01","65219-082-10","65219-084-01","65219-084-15","65219-086-01","65219-086-20"],"unii":["L0ND3981AG"]},"update_date":"06/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"0093-0832-05","generic_name":"Clonazepam Tablet","contact_info":"800-545-8800","resolved_note":"Available","openfda":{"application_number":["ANDA074569"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-0832","0093-3212","0093-3213"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["d6abe4e3-7699-4ead-95f4-739a961b23ad"],"spl_set_id":["8069b1a0-7c06-4252-b44e-e2eef065d9b8"],"package_ndc":["0093-0832-01","0093-0832-05","0093-3212-01","0093-3212-05","0093-3213-01","0093-3213-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 0093-0832-05)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"03/12/2021","package_ndc":"55566-2500-0","generic_name":"Desmopressin Acetate Spray","contact_info":"888-337-7464","availability":"Unavailable","related_info":"Estimated recovery: TBD","update_date":"05/01/2026","therapeutic_category":["Hematology"],"dosage_form":"Spray","presentation":"Ddavp, Spray, .1 ug/1 mL (NDC 55566-2500-0)","company_name":"Ferring","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-3365-10","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA200403"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3365","0409-2552","0409-3356","0409-2540","0409-1283","0409-1312","0409-1304"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897653","897753","897756","897757","897758","1724276","1724383","1724644"],"spl_id":["a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"],"spl_set_id":["e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"],"package_ndc":["0409-2552-11","0409-2552-01","0409-3356-11","0409-3356-01","0409-2540-11","0409-2540-01","0409-3365-11","0409-3365-01","0409-3365-10","0409-1283-03","0409-1283-31","0409-1312-03","0409-1312-30","0409-1304-03","0409-1304-31"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-3365-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"66794-162-02","generic_name":"Morphine Sulfate Injection","contact_info":"800-414-1901","availability":"Available","openfda":{"application_number":["ANDA204393"],"brand_name":["MITIGO"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Piramal Critical Care, Inc."],"product_ndc":["66794-162","66794-160"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRATHECAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731522","1731998","2055307","2055311"],"spl_id":["495a6a51-d35d-2b96-e063-6394a90ac5f3"],"spl_set_id":["728f3d83-9a63-0c1f-e053-2a91aa0ac7db"],"package_ndc":["66794-160-02","66794-162-02"],"unii":["X3P646A2J0"]},"update_date":"09/15/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Mitigo, Injection, 500 mg/20 mL (NDC 66794-162-02)","company_name":"Piramal Critical Care Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/18/2023","package_ndc":"0169-4060-12","generic_name":"Liraglutide Injection","contact_info":"833-493-4689","availability":"Limited Availability","related_info":"Estimated shortage duration: TBD","openfda":{"application_number":["NDA022341"],"brand_name":["VICTOZA"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Novo Nordisk"],"product_ndc":["0169-4060"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["897122","897126"],"spl_id":["0d10d10e-0fe0-47ee-b9da-628e34907e98"],"spl_set_id":["5a9ef4ea-c76a-4d34-a604-27c5b505f5a4"],"package_ndc":["0169-4060-13","0169-4060-12","0169-4060-90","0169-4060-97","0169-4060-98","0169-4060-99"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"09/22/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-12)","company_name":"Novo Nordisk, Inc.","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"57844-105-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["ADDERALL"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["57844-105","57844-117","57844-110","57844-112","57844-115","57844-120","57844-130"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541365","541878","541879","541892","541894","577957","577960","577961","577962","687043","687045","1009145","1009147"],"spl_id":["79af1dc6-c7cf-41b1-a750-e9b47c2187ff"],"spl_set_id":["f22635fe-821d-4cde-aa12-419f8b53db81"],"package_ndc":["57844-105-01","57844-117-01","57844-110-01","57844-112-01","57844-115-01","57844-120-01","57844-130-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Adderall, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 57844-105-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0338-9557-12","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA208532"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-9557","0338-9555"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["956f6a8c-cbb8-45de-9828-67f1ed7ab4e7"],"spl_set_id":["8ccb45a7-8290-469c-9644-a4dca967d88f"],"package_ndc":["0338-9555-24","0338-9557-12"],"unii":["1018WH7F9I"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"63323-506-01","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA040491"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-506","63323-516"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696","1812079"],"spl_id":["2ce90eb7-067d-4f1c-9184-c250e387e533","756dda45-ea6d-4c90-a14a-18a78bf186a6"],"spl_set_id":["cca2c160-9188-48e8-9505-49a52388dcb7","7cbd9005-7df2-47ee-adb3-7244c1c69bc3"],"package_ndc":["63323-506-00","63323-506-01","63323-506-03","63323-506-13","63323-516-01","63323-516-10","63323-506-41","63323-506-16"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 63323-506-01)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/12/2026","package_ndc":"63323-142-10","generic_name":"Ifosfamide Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA076078"],"brand_name":["IFOSFAMIDE"],"generic_name":["IFOSFAMIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-142"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IFOSFAMIDE"],"rxcui":["1791593"],"spl_id":["8f166a04-4395-4ea1-8eda-98274f1bfec3"],"spl_set_id":["a311a947-7b78-4226-bfe0-f4aa0be20e27"],"package_ndc":["63323-142-10"],"nui":["N0000000236","N0000175558"],"pharm_class_moa":["Alkylating Activity [MoA]"],"pharm_class_epc":["Alkylating Drug [EPC]"],"unii":["UM20QQM95Y"]},"update_date":"11/03/2026","therapeutic_category":["Oncology","Pediatric"],"dosage_form":"Injection","presentation":"Ifosfamide, Injection, 1 g/1 (NDC 63323-142-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"01/30/2026","update_type":"New","initial_posting_date":"01/30/2026","package_ndc":"57664-656-88","generic_name":"Pindolol Tablet","contact_info":"800-818-4555","related_info":"Discontinuation of the manufacture of the drug; Expiry date of last distributed batch October 2026","openfda":{"application_number":["ANDA074063"],"brand_name":["PINDOLOL"],"generic_name":["PINDOLOL"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-656","57664-655"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["PINDOLOL"],"rxcui":["198104","198105"],"spl_id":["4d3c89dd-e947-5f23-e063-6294a90aeb1f"],"spl_set_id":["b331a73f-bf7b-4442-8901-36d016530279"],"package_ndc":["57664-656-88","57664-655-88"],"nui":["N0000000161","N0000175556"],"pharm_class_moa":["Adrenergic beta-Antagonists [MoA]"],"pharm_class_epc":["beta-Adrenergic Blocker [EPC]"],"unii":["BJ4HF6IU1D"]},"update_date":"01/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Pindolol, Tablet, 10 mg (NDC 57664-656-88)","company_name":"Sun Pharmaceutical Industries, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0378-6860-77","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA202835"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-6860","0378-6854","0378-6855","0378-6856","0378-6857","0378-6858","0378-6859"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["6e77cd71-95ae-4fa8-830b-ab62b714e4b9"],"spl_set_id":["efbde0f6-b848-4664-b741-c6c630e66108"],"package_ndc":["0378-6854-77","0378-6855-77","0378-6856-77","0378-6857-77","0378-6858-77","0378-6859-77","0378-6860-77"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0378-6860-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/14/2017","package_ndc":"0264-9872-10","generic_name":"Heparin Sodium Injection","contact_info":"800-227-2862","availability":"Limited Availability","related_info":"Estimated recovery: late Q4 2026; Manufacturing delays","openfda":{"application_number":["NDA019953"],"brand_name":["HEPARIN SODIUM IN SODIUM CHLORIDE"],"generic_name":["HEPARIN SODIUM IN SODIUM CHLORIDE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-9872"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["HEPARIN SODIUM"],"spl_id":["608baa6b-f42a-4ae7-ae88-7f2e2ae71aba"],"spl_set_id":["a3041c04-0ea8-4d36-81ce-c5091c906316"],"package_ndc":["0264-9872-10","0264-9872-00"],"unii":["ZZ45AB24CA"]},"update_date":"10/19/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10)","company_name":"B. Braun Medical Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0017-31","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0017","0338-0023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-31)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/10/2020","package_ndc":"0409-3301-10","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3301","0409-1454","0409-1174","0409-2815"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["e1705533-5a85-441f-a95b-3cb88c47e482"],"spl_set_id":["4419162d-81d4-49bd-96de-1729440bdb74"],"package_ndc":["0409-1454-01","0409-1454-20","0409-3301-01","0409-3301-10","0409-1174-01","0409-1174-10","0409-2815-01"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"0093-3212-05","generic_name":"Clonazepam Tablet","contact_info":"800-545-8800","resolved_note":"Available","openfda":{"application_number":["ANDA074569"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-3212","0093-0832","0093-3213"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["d6abe4e3-7699-4ead-95f4-739a961b23ad"],"spl_set_id":["8069b1a0-7c06-4252-b44e-e2eef065d9b8"],"package_ndc":["0093-0832-01","0093-0832-05","0093-3212-01","0093-3212-05","0093-3213-01","0093-3213-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 0093-3212-05)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"06/28/2022","package_ndc":"72078-035-02","generic_name":"Remifentanil Hydrochloride Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["NDA020630"],"brand_name":["ULTIVA"],"generic_name":["REMIFENTANIL HYDROCHLORIDE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["72078-035","72078-034","72078-036"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["REMIFENTANIL HYDROCHLORIDE"],"rxcui":["1729578","1729581","1729584","1729586","1729710","1729712"],"spl_id":["f41b6542-9305-43e7-bbbc-52c7ee2cb0dc"],"spl_set_id":["8b4c8696-e23e-4c51-a4d2-babab5bd945a"],"package_ndc":["72078-034-00","72078-034-01","72078-035-00","72078-035-02","72078-036-00","72078-036-05"],"unii":["5V444H5WIC"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ultiva, Injection, 2 mg (NDC 72078-035-02)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"70010-115-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"877-770-3183","availability":"Unavailable","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA215771"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Granules Pharmaceuticals Inc."],"product_ndc":["70010-115","70010-111","70010-112","70010-113","70010-114","70010-116","70010-117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["56c7c921-e560-c5ad-e063-6294a90a4c81"],"spl_set_id":["b0b4eccc-34c7-483d-966f-82d588358e1b"],"package_ndc":["70010-111-01","70010-111-03","70010-112-01","70010-112-03","70010-113-01","70010-113-03","70010-114-01","70010-114-03","70010-115-01","70010-115-03","70010-116-01","70010-116-03","70010-117-01","70010-117-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/28/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 70010-115-01)","company_name":"Granules Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"04/01/2026","update_type":"New","initial_posting_date":"04/01/2026","package_ndc":"60429-005-12","generic_name":"Icosapent Ethyl Capsule","contact_info":"800-706-5575","related_info":"Discontinuation of the manufacture of the drug","openfda":{},"update_date":"04/01/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Icosapent Ethyl, Capsule, 1 g (NDC 60429-005-12)","company_name":"Apotex Corp.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0264-1510-32","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA016730"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-1510"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795609","1795616","1795618"],"spl_id":["638a41c3-0f07-4d1a-bb4e-1bab16e61266"],"spl_set_id":["60b6d7c3-0164-46c9-aa38-b5aa1c31a5d5"],"package_ndc":["0264-1510-36","0264-1510-31","0264-1510-32"],"unii":["LX22YL083G"]},"update_date":"11/10/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 0264-1510-32)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/01/2022","package_ndc":"0338-0023-02","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016694"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0023","0338-0017"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"01/01/2026","update_type":"New","initial_posting_date":"03/24/2026","package_ndc":"55513-800-60","generic_name":"Ivabradine Hydrochloride Tablet","contact_info":"1-800-772-6436","related_info":"Discontinuation of the manufacture of the drug product","openfda":{"application_number":["NDA206143"],"brand_name":["CORLANOR"],"generic_name":["IVABRADINE"],"manufacturer_name":["Amgen Inc"],"product_ndc":["55513-800","55513-810","55513-813"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["IVABRADINE HYDROCHLORIDE"],"rxcui":["1649485","1649491","1649493","1649495","2168592","2168596"],"spl_id":["8ab000cd-0258-489a-b1bb-4cc1ca359d6c"],"spl_set_id":["92018a65-38f6-45f7-91d4-a34921b81d0d"],"package_ndc":["55513-800-60","55513-800-99","55513-810-60","55513-813-01","55513-813-28"],"unii":["TP19837BZK"]},"update_date":"03/24/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Corlanor, Tablet, eq. 5 mg base (NDC 55513-800-60)","company_name":"Amgen Inc.","status":"To Be Discontinued"},{"discontinued_date":"07/24/2026","update_type":"New","initial_posting_date":"07/24/2026","package_ndc":"0074-3399-30","generic_name":"Ritonavir Oral Powder","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA209512"],"brand_name":["NORVIR"],"generic_name":["RITONAVIR"],"manufacturer_name":["AbbVie Inc."],"product_ndc":["0074-3399","0074-3333","0074-1940","0074-2340"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RITONAVIR"],"rxcui":["152971","199249","900575","900577","1926066","1926069"],"spl_id":["08f28b14-eabc-4a9a-b066-d8eda837e9e4"],"spl_set_id":["2849298e-de6e-47bb-8194-56e075b33fc3"],"package_ndc":["0074-3333-30","0074-1940-63","0074-3399-30","0074-2340-30"],"nui":["N0000000246","N0000191001","N0000175889","N0000190114","N0000182137","N0000185607","N0000190118","N0000185503","N0000190113","N0000182141","N0000191266","N0000185507","N0000187064","N0000190117"],"pharm_class_moa":["HIV Protease Inhibitors [MoA]","Cytochrome P450 3A Inhibitors [MoA]","Cytochrome P450 2D6 Inhibitors [MoA]","Cytochrome P450 2C19 Inducers [MoA]","Cytochrome P450 3A Inducers [MoA]","P-Glycoprotein Inhibitors [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]","Cytochrome P450 3A4 Inhibitors [MoA]","Cytochrome P450 1A2 Inducers [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 2B6 Inducers [MoA]","UDP Glucuronosyltransferases Inducers [MoA]"],"pharm_class_epc":["Cytochrome P450 3A Inhibitor [EPC]","Protease Inhibitor [EPC]"],"unii":["O3J8G9O825"]},"update_date":"07/24/2026","therapeutic_category":["Antiviral"],"dosage_form":"Oral Powder","presentation":"Norvir, Oral Powder, 100 mg (NDC 0074-3399-30)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"64850-555-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-852-6657","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA218604"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-555","64850-550","64850-551","64850-552","64850-553","64850-554","64850-556"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["2d33f701-8067-4a48-98cc-4e7dacaf3cc4"],"spl_set_id":["0e024b69-567c-4b40-9c3e-a2daec34256c"],"package_ndc":["64850-550-01","64850-551-01","64850-552-01","64850-553-01","64850-554-01","64850-555-01","64850-556-01"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 64850-555-01)","company_name":"Elite Laboratories, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"09/01/2026","update_type":"New","initial_posting_date":"09/01/2026","package_ndc":"0002-8980-05","generic_name":"Insulin Glargine-aglr Injection","contact_info":"800-545-5979","related_info":"A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.","openfda":{"application_number":["BLA761215"],"brand_name":["REZVOGLAR KWIKPEN"],"generic_name":["INSULIN GLARGINE-AGLR"],"manufacturer_name":["Eli Lilly and Company"],"product_ndc":["0002-8980"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["INSULIN GLARGINE"],"rxcui":["2589008","2589014"],"spl_id":["a9e95b4c-e280-4bef-a3dd-4907bfad6b4d"],"spl_set_id":["f6af8706-2058-4fe1-99c8-43684c20bfa2"],"package_ndc":["0002-8980-01","0002-8980-05"],"nui":["M0011417","N0000175453"],"pharm_class_cs":["Insulin [CS]"],"pharm_class_epc":["Insulin Analog [EPC]"],"unii":["2ZM8CX04RZ"]},"update_date":"09/01/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Rezvoglar, Injection, 100 [iU]/1 mL (NDC 0002-8980-05)","company_name":"Eli Lilly and Co.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0409-1858-12","generic_name":"Dopamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018826"],"brand_name":["DOPAMINE HYDROCHLORIDE IN DEXTROSE"],"generic_name":["DOPAMINE HYDROCHLORIDE IN DEXTROSE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1858","0409-7809","0409-7810","0409-0042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1292887","1743877","1743879"],"spl_id":["12a614df-d706-42a2-9020-5397700cc2e9"],"spl_set_id":["08f23f6e-150d-45ea-098e-f2edf64c21a1"],"package_ndc":["0409-7809-11","0409-7809-22","0409-7809-31","0409-7809-24","0409-7810-11","0409-7810-22","0409-0042-01","0409-0042-12","0409-1858-01","0409-1858-12"],"unii":["7L3E358N9L"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 800 mg/250 mL (3.2 mg/1 mL) (NDC 0409-1858-12)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/14/2022","package_ndc":"65219-458-30","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA207449"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["FRESENIUS KABI USA, LLC"],"product_ndc":["65219-458","65219-456","65219-464","65219-460","65219-462"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795607","1795609","1795610","1795612","1795616"],"spl_id":["efc3b0c9-518a-47db-bb3e-ebdfd4646e9b"],"spl_set_id":["576a22d8-5f2f-497e-80ad-1842ca74bb53"],"package_ndc":["65219-456-05","65219-456-60","65219-464-05","65219-464-50","65219-458-05","65219-458-30","65219-460-05","65219-460-20","65219-462-05","65219-462-10"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"43066-557-12","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA208532"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["43066-557","43066-555"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["5ae6fcf6-cd01-4b89-af44-962f5452fe72"],"spl_set_id":["aea9a3ad-c244-42be-9cd3-5df83fe2b522"],"package_ndc":["43066-555-24","43066-557-12"],"unii":["1018WH7F9I"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-287-20","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-287","63323-286","63323-288","63323-285"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","905191","1734084","1734086","1734090","1734091","1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484"],"spl_id":["cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9"],"spl_set_id":["23d2d448-a744-4877-9f2d-7e57c198da89"],"package_ndc":["63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 7.5 mg/1 mL (NDC 63323-287-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-119-01","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA208510"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-119","59417-101","59417-102","59417-103","59417-104","59417-105","59417-106","59417-107","59417-115","59417-116","59417-117","59417-118","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"64850-505-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"888-852-6657","availability":"Available","openfda":{"application_number":["ANDA211352"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-505","64850-500","64850-501","64850-502","64850-503","64850-504","64850-506"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["a41cf8e5-cb1b-488c-96b3-3bef8283d6c4"],"spl_set_id":["e677690f-790f-4626-ad78-097cdb6ea540"],"package_ndc":["64850-500-01","64850-500-05","64850-500-30","64850-501-01","64850-501-05","64850-501-30","64850-502-01","64850-502-05","64850-502-30","64850-503-01","64850-503-05","64850-503-30","64850-504-01","64850-504-05","64850-504-30","64850-505-01","64850-505-05","64850-505-30","64850-506-01","64850-506-05","64850-506-30"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 64850-505-01)","company_name":"Elite Laboratories, Inc.","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-2915-01","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-2915","0075-0624","0075-0620","0075-0621","0075-0622","0075-0623","0075-0626","0075-2912"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["cdb74d6d-1a74-4156-a52a-710c55cb2927"],"spl_set_id":["5017a927-2a24-4f27-89f9-27c805bf7d59"],"package_ndc":["0075-0624-01","0075-0624-30","0075-0620-01","0075-0620-40","0075-0621-01","0075-0621-60","0075-0622-01","0075-0622-80","0075-0623-03","0075-0623-00","0075-0626-03","0075-2912-00","0075-2912-01","0075-2915-00","0075-2915-01"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 150 mg/1 mL (NDC 0075-2915-01)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0409-0151-10","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA020201"],"brand_name":["DOBUTAMINE IN DEXTROSE"],"generic_name":["DOBUTAMINE IN DEXTROSE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-0151","0409-0025","0409-1100"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"spl_id":["87242d06-99e3-4e91-b090-8a8cb0461908"],"spl_set_id":["9943a961-3b50-4847-8a84-d8414ce38daa"],"package_ndc":["0409-0025-01","0409-0025-10","0409-0151-01","0409-0151-10","0409-1100-01","0409-1100-10"],"unii":["0WR771DJXV"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 500 mg/250mL (2 mg/mL) (NDC 0409-0151-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"64850-501-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"888-852-6657","availability":"Available","openfda":{"application_number":["ANDA211352"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-501","64850-500","64850-502","64850-503","64850-504","64850-505","64850-506"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["a41cf8e5-cb1b-488c-96b3-3bef8283d6c4"],"spl_set_id":["e677690f-790f-4626-ad78-097cdb6ea540"],"package_ndc":["64850-500-01","64850-500-05","64850-500-30","64850-501-01","64850-501-05","64850-501-30","64850-502-01","64850-502-05","64850-502-30","64850-503-01","64850-503-05","64850-503-30","64850-504-01","64850-504-05","64850-504-30","64850-505-01","64850-505-05","64850-505-30","64850-506-01","64850-506-05","64850-506-30"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 64850-501-01)","company_name":"Elite Laboratories, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-288-11","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-288","63323-286","63323-287","63323-285"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","905191","1734084","1734086","1734090","1734091","1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484"],"spl_id":["cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c","75465ceb-e894-487d-aa80-671fa0841fce"],"spl_set_id":["23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6","56dfabf7-f7a8-4601-b17a-cb16fb995b0f"],"package_ndc":["63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95","63323-288-25","63323-288-27"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"62175-312-37","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"844-834-0530","availability":"Unavailable","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA091695"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Lannett Company, Inc."],"product_ndc":["62175-312","62175-310","62175-311","62175-313"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["2001564","2001565","2001566","2001568"],"spl_id":["8b133cd2-e3c6-4742-b402-2393b56ffc93"],"spl_set_id":["3d1f5aff-5d39-496c-b5ed-7f3c70ec641c"],"package_ndc":["62175-310-37","62175-311-37","62175-312-37","62175-313-37"],"unii":["4B3SC438HI"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 62175-312-37)","company_name":"Lannett Company, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/25/2017","package_ndc":"0264-9594-10","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019830"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND DEXTROSE"],"generic_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-9594","0264-9598"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","DEXTROSE MONOHYDRATE"],"rxcui":["1737723","1737742","1737744"],"spl_id":["9e352802-107c-4f90-babe-4f69c7dc892e"],"spl_set_id":["7dff29d9-522d-40eb-a9d9-42377912d640"],"package_ndc":["0264-9598-20","0264-9594-20","0264-9594-10"],"unii":["LX22YL083G","EC2CNF7XFP"]},"update_date":"11/10/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)","company_name":"B. Braun Medical Inc.","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0955-1012-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["ENOXAPARIN SODIUM"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0955-1012","0955-1003","0955-1004","0955-1006","0955-1008","0955-1010","0955-1016","0955-1015"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854235","854238","854241","854245","854248","854252","854255"],"spl_id":["8f06a411-badb-483f-852d-8e6124acfa44"],"spl_set_id":["20635579-c92d-4f6c-a332-1096d51002f2"],"package_ndc":["0955-1003-01","0955-1003-10","0955-1004-01","0955-1004-10","0955-1006-01","0955-1006-10","0955-1008-01","0955-1008-10","0955-1010-01","0955-1010-10","0955-1016-01","0955-1012-01","0955-1012-10","0955-1015-01","0955-1015-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Enoxaparin Sodium, Injection, 120 mg/.8 mL (NDC 0955-1012-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0527-0760-37","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215565"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-0760","0527-0761","0527-0762","0527-0763","0527-0764","0527-0765","0527-0766"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["391d7c4a-47df-41ce-b1ba-3c4758adf87f"],"spl_set_id":["f92497b5-baea-4760-b615-45a0b6184402"],"package_ndc":["0527-0760-37","0527-0761-37","0527-0762-37","0527-0763-37","0527-0764-37","0527-0765-37","0527-0766-37"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0527-0760-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-9137-05","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA040302"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9137","0409-1323"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1012066","1012068"],"spl_id":["3c39bd9b-0be9-48cd-83dd-56162f4f4dfe"],"spl_set_id":["ad1ef0a8-88db-4648-c098-d009eaeb4e5b"],"package_ndc":["0409-1323-15","0409-1323-05","0409-9137-11","0409-9137-05"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride Preservative Free In Plastic Container, Injection, 50 mg/5mL (1%, 10 mg/1 mL) Syringes (NDC 0409-9137-05)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"0409-3299-26","generic_name":"Sodium Acetate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018893"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3299"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["237371"],"spl_id":["4e6137c2-6b7c-4882-985c-03b591b6c046","b7a713f4-3c97-484b-b182-2824e1e944bb"],"spl_set_id":["abc41ed1-9512-4bea-9295-1a9ca134b6c2","c3be2468-45e8-4ecc-a30b-e966743a563f"],"package_ndc":["0409-3299-15","0409-3299-05","0409-3299-16","0409-3299-06","0409-3299-45","0409-3299-25","0409-3299-46","0409-3299-26"],"unii":["NVG71ZZ7P0"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"50458-588-01","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET","availability":"Available","openfda":{"application_number":["NDA021121"],"brand_name":["CONCERTA"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Janssen Pharmaceuticals, Inc."],"product_ndc":["50458-588","50458-585","50458-586","50458-587"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091157","1091170","1091172","1091185","1091187","1091210","1091212"],"spl_id":["64d7c1e1-e7ed-4d74-a44d-13b4da64af9a"],"spl_set_id":["1a88218c-5b18-4220-8f56-526de1a276cd"],"package_ndc":["50458-585-01","50458-588-01","50458-586-01","50458-587-01"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Concerta, Tablet, Extended Release, 27 mg (NDC 50458-588-01)","company_name":"Janssen Pharmaceuticals","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"42858-161-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-827-0616","availability":"Available","openfda":{"application_number":["ANDA215330"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Rhodes Pharmaceuticals LLC"],"product_ndc":["42858-161","42858-162","42858-163","42858-164","42858-165","42858-166","42858-167"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0002e227-1109-4ecc-a8c5-4b4f11fac3cc"],"spl_set_id":["d918b40d-a461-41bc-b6c0-83dc76c28e32"],"package_ndc":["42858-161-01","42858-162-01","42858-163-01","42858-164-01","42858-165-01","42858-166-01","42858-167-01"],"unii":["SJT761GEGS"]},"update_date":"06/24/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 42858-161-01)","company_name":"Rhodes Pharmaceuticals L.P.","status":"Current"},{"discontinued_date":"10/14/2026","update_type":"New","initial_posting_date":"10/14/2026","package_ndc":"49884-158-02","generic_name":"Everolimus Tablet","contact_info":"800-828-9393","related_info":"A business decision was made to withdraw from sale.","update_date":"10/14/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, .25 mg (NDC 49884-158-02)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"discontinued_date":"01/12/2026","update_type":"New","initial_posting_date":"01/12/2026","package_ndc":"0378-0167-13","generic_name":"Doxycycline Hyclate Tablet","contact_info":"800-796-9526","related_info":"Discontinuation of the manufacture of the drug","update_date":"01/12/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Tablet","presentation":"Doxycycline Hyclate, Tablet, 100 mg (NDC 0378-0167-13)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-1638-02","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1638","0409-1660","0409-1434","0409-1596","0409-7838","0409-7853","0409-7875"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["284397","309710","1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["3c5274fd-6597-4b88-babc-92e4e16c6329"],"spl_set_id":["548a88c0-afda-427e-75ac-5af0cfa2224c"],"package_ndc":["0409-1660-55","0409-1660-50","0409-1660-35","0409-1660-10","0409-1660-22","0409-1660-20","0409-1638-32","0409-1638-02","0409-1434-01","0409-1596-01","0409-1596-10","0409-7838-01","0409-7838-24","0409-7853-01","0409-7853-24","0409-7875-01","0409-7875-12"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"0338-0004-04","generic_name":"Sterile Water Irrigant","contact_info":"888-229-0001","availability":"Limited Availability","related_info":"Estimated Recovery: February 2027","openfda":{"application_number":["NDA017428"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0004","0338-0003"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["IRRIGATION"],"substance_name":["WATER"],"rxcui":["150985"],"spl_id":["97390588-b679-4caa-b7f3-3d2e11074d0e"],"spl_set_id":["ef3e79c5-3f58-4b36-a296-64b7d9a651c1"],"package_ndc":["0338-0003-44","0338-0003-46","0338-0003-47","0338-0004-02","0338-0004-03","0338-0004-04","0338-0004-05"],"unii":["059QF0KO0R"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology","Other","Pediatric"],"dosage_form":"Irrigant","presentation":"Sterile Water, Irrigant, 100 mL/100 mL (NDC 0338-0004-04)","company_name":"Baxter Healthcare","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"63323-411-12","generic_name":"Midazolam Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA075154"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-411","63323-412"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["9814447b-a93e-42ad-b57e-5db0a5b7f552"],"spl_set_id":["a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"],"package_ndc":["63323-411-22","63323-411-27","63323-411-15","63323-411-12","63323-411-18","63323-411-25","63323-411-13","63323-411-10","63323-412-18","63323-412-25","63323-412-03","63323-412-02","63323-412-06","63323-412-05","63323-412-13","63323-412-10"],"unii":["W7TTW573JJ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"70010-111-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"877-770-3183","availability":"Unavailable","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA215771"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Granules Pharmaceuticals Inc."],"product_ndc":["70010-111","70010-112","70010-113","70010-114","70010-115","70010-116","70010-117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["56c7c921-e560-c5ad-e063-6294a90a4c81"],"spl_set_id":["b0b4eccc-34c7-483d-966f-82d588358e1b"],"package_ndc":["70010-111-01","70010-111-03","70010-112-01","70010-112-03","70010-113-01","70010-113-03","70010-114-01","70010-114-03","70010-115-01","70010-115-03","70010-116-01","70010-116-03","70010-117-01","70010-117-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/28/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 70010-111-01)","company_name":"Granules Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"63323-806-02","generic_name":"Fentanyl Citrate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA210762"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-806"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270"],"spl_id":["341b092a-1f6f-40f1-98f2-9346bf2e1242"],"spl_set_id":["38d0c14a-a0c1-44cc-a939-0304eb8037d6"],"package_ndc":["63323-806-11","63323-806-01","63323-806-12","63323-806-02","63323-806-13","63323-806-05","63323-806-14","63323-806-20","63323-806-50"],"unii":["MUN5LYG46H"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-02)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/05/2022","package_ndc":"72485-508-10","generic_name":"Etomidate Injection","contact_info":"908-803-2586","availability":"Available","related_info":"Check wholesalers for inventory; Marketed by Armas Pharmaceuticals, Inc. 908-803-2586","openfda":{"application_number":["ANDA215028"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Armas Pharmaceuticals Inc."],"product_ndc":["72485-508","72485-509"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["7444860b-36c1-459d-94ba-d7301d9dc2ca"],"spl_set_id":["75467058-da52-48fa-8d4e-e1025ec7d461"],"package_ndc":["72485-508-01","72485-508-10","72485-509-01","72485-509-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"06/16/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/mL (NDC 72485-508-10)","company_name":"Caplin Steriles, Ltd.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"47781-565-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA214547"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-565","47781-562","47781-563","47781-564","47781-566","47781-567","47781-568"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["db02ec6b-f17f-ab22-b671-e1ddb90e017c"],"spl_set_id":["7f2dd6ee-3363-c87c-9693-ed838942556c"],"package_ndc":["47781-562-01","47781-563-01","47781-564-01","47781-565-01","47781-566-01","47781-567-01","47781-568-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 47781-565-01)","company_name":"Alvogen","status":"Current"},{"discontinued_date":"03/27/2026","update_type":"New","initial_posting_date":"03/27/2026","package_ndc":"72607-100-00","generic_name":"Tazemetostat Hydrobromide Tablet","contact_info":"(855)-463-5127","related_info":"Discontinuation of the manufacture of the drug product","openfda":{"application_number":["NDA211723"],"brand_name":["TAZVERIK"],"generic_name":["TAZEMETOSTAT"],"manufacturer_name":["Epizyme, Inc."],"product_ndc":["72607-100"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["TAZEMETOSTAT HYDROBROMIDE"],"rxcui":["2274384","2274390"],"spl_id":["c4bd8d8a-22c1-4911-a9b4-7368582d8e5d"],"spl_set_id":["7db07b5f-4e22-467c-9c0a-f830b08dbb1d"],"package_ndc":["72607-100-00"],"unii":["6P89T5M073"]},"update_date":"03/27/2026","therapeutic_category":["Oncology"],"dosage_form":"Tablet","presentation":"Tazverik, Tablet, 200 mg (NDC 72607-100-00)","company_name":"Epizyme, Inc. (An Ipsen Company)","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"04/02/2020","package_ndc":"0409-2308-02","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: December 2026; Estimated Recovery: March 2027","openfda":{"application_number":["ANDA075857"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2308","0409-2305","0409-0001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666800","1666814","1666823","1666798"],"spl_id":["2f69c5b1-6505-42dc-8bb3-edbd9b6c0781","8954486a-8512-4831-8178-0b49f1efb73e"],"spl_set_id":["b95415fa-17c2-42ab-a6b0-e628d01c94ed","1abda8b8-48a8-4995-af86-39220d1aa240"],"package_ndc":["0409-2305-55","0409-2305-50","0409-2308-69","0409-2308-49","0409-2308-70","0409-2308-50","0409-2305-16","0409-2305-17","0409-2305-04","0409-2305-05","0409-2308-21","0409-2308-01","0409-2308-22","0409-2308-02","0409-0001-01","0409-0001-25"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0378-6856-77","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA202835"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-6856","0378-6854","0378-6855","0378-6857","0378-6858","0378-6859","0378-6860"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["6e77cd71-95ae-4fa8-830b-ab62b714e4b9"],"spl_set_id":["efbde0f6-b848-4664-b741-c6c630e66108"],"package_ndc":["0378-6854-77","0378-6855-77","0378-6856-77","0378-6857-77","0378-6858-77","0378-6859-77","0378-6860-77"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0378-6856-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/31/2026","package_ndc":"0054-3294-46","generic_name":"Furosemide Oral Solution","contact_info":"800-631-2174","availability":"Available","openfda":{"application_number":["ANDA070434"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-3294","0054-4297","0054-8297","0054-4299","0054-8299","0054-4301","0054-8301","0054-3298"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FUROSEMIDE"],"rxcui":["197730","197731","197732","310429","313988"],"spl_id":["bc62ddda-7639-4090-99f0-7dd4d13518f3"],"spl_set_id":["9e493331-dddd-496e-abf8-61747fb67aba"],"package_ndc":["0054-4297-31","0054-4297-25","0054-8297-25","0054-4299-31","0054-4299-25","0054-8299-25","0054-4301-29","0054-4301-25","0054-8301-25","0054-3298-63","0054-3294-50","0054-3294-46"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"10/27/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Oral Solution","presentation":"Furosemide, Oral Solution, 10 mg/1 mL (NDC 0054-3294-46)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/05/2022","package_ndc":"65219-445-10","generic_name":"Etomidate Injection","contact_info":"800-551-7176","availability":"Available","related_info":"Check wholesalers for inventory; Marketed by Fresenius Kabi","openfda":{"application_number":["ANDA215028"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-445","65219-447"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["446487f1-002e-41d3-846a-67570e797171","30488a7e-ea9e-4a27-95a9-a07149c50282"],"spl_set_id":["f38fad46-f2dd-4692-a2a9-a13d0a717bf8","d07efb9e-5264-461d-96d8-e11fa71c5751"],"package_ndc":["65219-445-12","65219-445-22","65219-445-01","65219-445-10","65219-447-02","65219-447-20"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"06/16/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2mg/1 mL (NDC 65219-445-10)","company_name":"Caplin Steriles, Ltd.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0017-18","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0017","0338-0023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-18)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-467-57","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA018304"],"brand_name":["SENSORCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-467","63323-465","63323-460","63323-464","63323-466","63323-462"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012391","1012396","1012404","1012421","1012455","1012457","1672917","1672919","1673296","1673298","1724880","1724881","1724884","1724885","1725078","1725082","1725175","1725177"],"spl_id":["2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-356-30","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-30)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"43547-603-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-931-9829","availability":"Limited Availability","related_info":"On allocation","openfda":{"application_number":["ANDA216266"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE CAPSULES"],"manufacturer_name":["Solco Healthcare US,LLC"],"product_ndc":["43547-603","43547-602","43547-604","43547-605","43547-606","43547-607","43547-608"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["d6435613-e052-4b4f-8bf7-4acb7458d8df"],"spl_set_id":["68b10d9f-ca3e-493d-a309-45f1d7e08061"],"package_ndc":["43547-602-10","43547-603-10","43547-604-10","43547-605-10","43547-606-10","43547-607-10","43547-608-10"],"unii":["SJT761GEGS"]},"update_date":"06/29/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 43547-603-10)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"06/12/2026","package_ndc":"0338-3993-01","generic_name":"Ifosfamide Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA019763"],"brand_name":["IFEX"],"generic_name":["IFOSFAMIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-3993","0338-3991"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IFOSFAMIDE"],"spl_id":["cf10cfa3-8614-4f9c-a0b4-f4fd4474d6ac"],"spl_set_id":["b7241707-7538-4d1a-91e7-3a25a91e0b9a"],"package_ndc":["0338-3991-01","0338-3993-01"],"nui":["N0000000236","N0000175558"],"pharm_class_moa":["Alkylating Activity [MoA]"],"pharm_class_epc":["Alkylating Drug [EPC]"],"unii":["UM20QQM95Y"]},"update_date":"11/03/2026","therapeutic_category":["Oncology","Pediatric"],"dosage_form":"Injection","presentation":"IFEX, Injection, 3 g/60 mL (NDC 0338-3993-01)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"0185-0842-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-525-8747","availability":"Limited Availability","related_info":"Estimated recovery: 1Q 2027","openfda":{"application_number":["ANDA040439"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0185-0842","0185-0831","0185-0853","0185-0864","0185-2099","0185-2098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577961"],"spl_id":["9a21fb59-a99c-4c63-91e8-4b5d72fbd9cd"],"spl_set_id":["288dafc4-fe6e-4891-832f-511022c87445"],"package_ndc":["0185-0831-01","0185-0842-01","0185-0853-01","0185-0864-01","0185-2099-01","0185-2098-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/09/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0185-0842-01)","company_name":"Sandoz Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/14/2022","package_ndc":"0990-7922-03","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Limited Availability","related_info":"On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7922","0990-7923","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-172-30","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203895"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-172","55150-167","55150-168","55150-169","55150-170","55150-171","55150-249","55150-250"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404","1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["39649703-e633-4a20-ba71-0c04dbf8ff2a"],"spl_set_id":["ffecf450-1f01-4721-8e10-251385852612"],"package_ndc":["55150-167-10","55150-168-30","55150-169-10","55150-170-30","55150-171-10","55150-172-30","55150-249-50","55150-250-50"],"unii":["7TQO7W3VT8"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 55150-172-30)","company_name":"Eugia US LLC","status":"Current"},{"discontinued_date":"03/10/2026","update_type":"New","initial_posting_date":"03/10/2026","package_ndc":"49230-209-94","generic_name":"Peritoneal Dialysis Solution","contact_info":"800-323-5188","related_info":"The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.","openfda":{"application_number":["NDA020171"],"brand_name":["DELFLEX"],"generic_name":["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"],"manufacturer_name":["Fresenius Medical Care Renal Therapies Group, LLC"],"product_ndc":["49230-209","49230-206","49230-212"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE","DEXTROSE MONOHYDRATE"],"spl_id":["5f14a0ea-a325-a154-e063-6294a90adf59","5f1497fe-4e1c-9711-e063-6294a90a75e5"],"spl_set_id":["bbc5b820-4973-11e2-a192-0002a5d5c51b","c29bdfa0-4976-11e2-939b-0002a5d5c51b"],"package_ndc":["49230-206-30","49230-206-32","49230-206-50","49230-206-52","49230-206-62","49230-209-30","49230-209-32","49230-209-50","49230-209-52","49230-209-62","49230-212-30","49230-212-32","49230-212-50","49230-212-52","49230-212-62","49230-206-92","49230-206-94","49230-206-95","49230-209-92","49230-209-94","49230-209-95","49230-212-92","49230-212-94","49230-212-95"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"03/10/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DELFLEX® w/Dextrose, Solution, 2.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-209-94)","company_name":"Fresenius Medical Care North America","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"64850-551-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-852-6657","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA218604"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-551","64850-550","64850-552","64850-553","64850-554","64850-555","64850-556"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["2d33f701-8067-4a48-98cc-4e7dacaf3cc4"],"spl_set_id":["0e024b69-567c-4b40-9c3e-a2daec34256c"],"package_ndc":["64850-550-01","64850-551-01","64850-552-01","64850-553-01","64850-554-01","64850-555-01","64850-556-01"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 64850-551-01)","company_name":"Elite Laboratories, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"0555-0974-02","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Limited Availability","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA040422"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0555-0974","0555-0971","0555-0775","0555-0972","0555-0776","0555-0777","0555-0973"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["88468f3d-7d03-4cee-aabf-3abc8c9b5e38"],"spl_set_id":["cffbbb15-d776-41ae-a8a6-687f2c07bfa4"],"package_ndc":["0555-0971-02","0555-0775-02","0555-0972-02","0555-0776-02","0555-0777-02","0555-0973-02","0555-0974-02"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0555-0974-02)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/07/2020","package_ndc":"16729-501-43","generic_name":"Furosemide Injection","contact_info":"866-941-7875","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA","openfda":{"application_number":["ANDA070017"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-501","16729-500","16729-502"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["1cfab300-d796-6a68-e063-6394a90a73f9"],"spl_set_id":["f6f64972-714c-4ee9-8a5e-9ffcab41a73b"],"package_ndc":["16729-500-30","16729-500-08","16729-501-64","16729-501-43","16729-502-03","16729-502-43"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/02/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 16729-501-43)","company_name":"Accord Healthcare Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-8014-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-8014","0075-8013","0075-8016","0075-8018","0075-8020","0075-8030","0075-8022","0075-8025"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["006561fa-e16d-4129-9dde-89c109b51d8f"],"spl_set_id":["de6fb917-a94a-41ea-9d7d-937d4080ffcd"],"package_ndc":["0075-8013-01","0075-8013-10","0075-8014-01","0075-8014-10","0075-8016-01","0075-8016-10","0075-8018-01","0075-8018-10","0075-8020-01","0075-8020-10","0075-8030-01","0075-8022-01","0075-8022-10","0075-8025-01","0075-8025-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 40 mg/.4 mL (NDC 0075-8014-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"discontinued_date":"05/05/2026","update_type":"New","initial_posting_date":"05/05/2026","package_ndc":"71288-725-32","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-824-8426","related_info":"Discontinuation of the manufacture of the drug","update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-725-32)","company_name":"Kindos Pharmaceuticals Co. Ltd.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"65862-620-90","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-850-2876","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA202725"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL HYDROCHLORIDE"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["65862-620","65862-617","65862-618","65862-619"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["5263abd5-ce46-4918-9bb0-9632861bcbc9"],"spl_set_id":["93e6e668-5306-4f26-81d8-cbc3a7a5e787"],"package_ndc":["65862-617-30","65862-617-90","65862-617-99","65862-617-55","65862-617-10","65862-617-78","65862-618-30","65862-618-90","65862-618-99","65862-618-55","65862-618-10","65862-618-78","65862-619-30","65862-619-90","65862-619-99","65862-619-19","65862-619-10","65862-619-78","65862-620-30","65862-620-90","65862-620-99","65862-620-39","65862-620-10","65862-620-78"],"unii":["33067B3N2M"]},"update_date":"11/04/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 40 mg (NDC 65862-620-90)","company_name":"Aurobindo Pharma USA","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/28/2025","package_ndc":"0574-2420-65","generic_name":"Methylphenidate Film, Extended Release","contact_info":"800-455-8070","availability":"Available","related_info":"Distributed by Padagis US LLC","openfda":{"application_number":["NDA021514"],"brand_name":["METHYLPHENIDATE TRANSDERMAL SYSTEM"],"generic_name":["METHYLPHENIDATE"],"manufacturer_name":["PADAGIS US LLC"],"product_ndc":["0574-2420","0574-2410","0574-2415","0574-2430"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TRANSDERMAL"],"substance_name":["METHYLPHENIDATE"],"rxcui":["753436","753438","753440","753441"],"spl_id":["b743ef45-2fc0-4086-8a02-6078e6a09eaa"],"spl_set_id":["7bcff873-1fc2-45bc-a8e4-5db4edeb9bfb"],"package_ndc":["0574-2410-65","0574-2415-65","0574-2420-65","0574-2430-65"],"nui":["N0000175739","N0000175729"],"pharm_class_epc":["Central Nervous System Stimulant [EPC]"],"pharm_class_pe":["Central Nervous System Stimulation [PE]"],"unii":["207ZZ9QZ49"]},"update_date":"10/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Film, Extended Release","presentation":"Methylphenidate, Film, Extended Release, 20 mg (NDC 0574-2420-65)","company_name":"Noven Pharmaceuticals, Inc.","status":"Current"},{"discontinued_date":"02/27/2026","update_type":"New","initial_posting_date":"02/27/2026","package_ndc":"10147-1700-3","generic_name":"Itraconazole Capsule","contact_info":"800-JANSSEN (1-800-526-7736)","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020083"],"brand_name":["ITRACONAZOLE"],"generic_name":["ITRACONAZOLE"],"manufacturer_name":["Patriot Pharmaceuticals"],"product_ndc":["10147-1700"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ITRACONAZOLE"],"rxcui":["311204"],"spl_id":["2cca3625-96e8-34cf-e063-6294a90ac975"],"spl_set_id":["6242b7ad-eaa0-a524-b6e0-ec33e63407db"],"package_ndc":["10147-1700-3","10147-1700-7"],"nui":["N0000175487","M0002083","N0000182141","N0000185503","N0000190113"],"pharm_class_epc":["Azole Antifungal [EPC]"],"pharm_class_cs":["Azoles [CS]"],"pharm_class_moa":["Cytochrome P450 3A4 Inhibitors [MoA]","P-Glycoprotein Inhibitors [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]"],"unii":["304NUG5GF4"]},"update_date":"02/27/2026","therapeutic_category":["Anti-Infective","Other"],"dosage_form":"Capsule","presentation":"Sporanox, Capsule, 100 mg (NDC 10147-1700-3)","company_name":"Janssen Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"55150-324-25","generic_name":"Furosemide Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA212174"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-324","55150-322","55150-323"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["9bb2ffa4-0891-4197-a970-90b178bbfad9"],"spl_set_id":["421aa6d5-623b-4dc2-abd5-bb9e7765bf37"],"package_ndc":["55150-322-01","55150-322-25","55150-323-01","55150-323-25","55150-324-01","55150-324-25"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"10/19/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 100 mg/10 mL (NDC 55150-324-25)","company_name":"Eugia US LLC","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0955-1016-01","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["ENOXAPARIN SODIUM"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0955-1016","0955-1003","0955-1004","0955-1006","0955-1008","0955-1010","0955-1012","0955-1015"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854235","854238","854241","854245","854248","854252","854255"],"spl_id":["8f06a411-badb-483f-852d-8e6124acfa44"],"spl_set_id":["20635579-c92d-4f6c-a332-1096d51002f2"],"package_ndc":["0955-1003-01","0955-1003-10","0955-1004-01","0955-1004-10","0955-1006-01","0955-1006-10","0955-1008-01","0955-1008-10","0955-1010-01","0955-1010-10","0955-1016-01","0955-1012-01","0955-1012-10","0955-1015-01","0955-1015-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Enoxaparin Sodium, Injection, 300 mg/3 mL (NDC 0955-1016-01)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-468-17","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA070966"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-468","63323-472","63323-463","63323-461"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1867594","1867596","1867618","1867620","1012377","1012384","1012413","1012417","1724786","1724787","1724809","1724810"],"spl_id":["b671015d-f620-4930-a890-5e27a40ae42f","cc1f6507-eb3e-4398-a1d3-0c56a2099e6b"],"spl_set_id":["b671015d-f620-4930-a890-5e27a40ae42f","bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb"],"package_ndc":["63323-468-08","63323-468-38","63323-472-03","63323-472-17","63323-472-01","63323-472-37","63323-463-01","63323-463-57","63323-461-01","63323-461-57","63323-468-02","63323-468-37","63323-468-01","63323-468-17"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-17)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"06/28/2022","package_ndc":"0143-9393-10","generic_name":"Remifentanil Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA210594"],"brand_name":["REMIFENTANIL HYDROCHLORIDE"],"generic_name":["REMIFENTANIL HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9393","0143-9391","0143-9392"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["REMIFENTANIL HYDROCHLORIDE"],"rxcui":["1729578","1729584","1729710"],"spl_id":["5c5e498b-d829-4f78-bcca-466631014767"],"spl_set_id":["9d289052-1eb6-4ba2-a3ca-d2e542a052ae"],"package_ndc":["0143-9391-01","0143-9391-10","0143-9392-01","0143-9392-10","0143-9393-01","0143-9393-10"],"unii":["5V444H5WIC"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Remifentanil Hydrochloride, Injection, 5 mg per vial (NDC 0143-9393-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-3073-01","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-3073","0009-3475"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE","INTRA-ARTICULAR"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743781","1743855","1743856"],"spl_id":["e4917f75-3e1c-4f3c-803d-d9ec65df06c7","742fcec7-8db3-4cc6-b276-42587a993810"],"spl_set_id":["bf1b104d-85cb-414d-a366-78068c82c883","9a7b3837-e038-48bf-97e9-78ad463760dc"],"package_ndc":["0009-3073-22","0009-3073-23","0009-3475-22","0009-3475-23","0009-3073-01","0009-3073-03","0009-3475-01","0009-3475-03"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-01)","company_name":"Pfizer Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"04/29/2026","update_type":"New","initial_posting_date":"04/29/2026","package_ndc":"49884-604-11","generic_name":"Lamotrigine Tablet, Extended Release","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/29/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11)","company_name":"Par Health, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/01/2017","package_ndc":"63323-854-10","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA019034"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-854","63323-851","63323-852","63323-853"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897653","897753","1724276","1724338","1724340","1724341"],"spl_id":["2cfa0a3e-eb57-4dea-ae2c-0b91176f0f67"],"spl_set_id":["e034eb96-03e0-46e1-8b92-5e1f94555e7b"],"package_ndc":["63323-851-03","63323-851-10","63323-851-07","63323-851-15","63323-851-50","63323-852-03","63323-852-25","63323-853-03","63323-853-25","63323-854-03","63323-854-10"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 4 mg/1 mL (NDC 63323-854-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/28/2022","package_ndc":"63323-725-10","generic_name":"Remifentanil Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA206223"],"brand_name":["REMIFENTANIL HYDROCHLORIDE"],"generic_name":["REMIFENTANIL HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-725","63323-723","63323-724"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["REMIFENTANIL HYDROCHLORIDE"],"rxcui":["1729578","1729584","1729710"],"spl_id":["2f27e51f-2b55-47ee-bd4a-001b71c60622"],"spl_set_id":["d2374b84-81c9-44f9-a4a9-1071281b2531"],"package_ndc":["63323-723-01","63323-723-03","63323-724-01","63323-724-05","63323-725-01","63323-725-10"],"unii":["5V444H5WIC"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-725-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-0280-02","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: November 2026; Estimated Recovery: December 2026","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0280","0009-0274","0009-0306"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358510","1358512","1358610","1358612","1358617","1358619"],"spl_id":["267dd735-f800-4735-ba1c-d39d00f0cee5"],"spl_set_id":["823b0010-2b57-4e76-b5ac-4a8c2963438f"],"package_ndc":["0009-0274-01","0009-0280-02","0009-0280-51","0009-0280-03","0009-0280-52","0009-0306-02","0009-0306-12"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-02)","company_name":"Pfizer Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"25021-701-02","generic_name":"Ketorolac Tromethamine Injection","contact_info":"833-291-9645","availability":"Available","openfda":{"application_number":["ANDA204216"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-701","25021-700"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["cb23332a-48fa-458b-93ab-c4eef189a051"],"spl_set_id":["62591551-a644-4b2c-a0de-982e906fabc3"],"package_ndc":["25021-700-01","25021-701-01","25021-701-02"],"unii":["4EVE5946BQ"]},"update_date":"10/21/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-02)","company_name":"Gland Pharma Limited","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-8013-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-8013","0075-8014","0075-8016","0075-8018","0075-8020","0075-8030","0075-8022","0075-8025"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["006561fa-e16d-4129-9dde-89c109b51d8f"],"spl_set_id":["de6fb917-a94a-41ea-9d7d-937d4080ffcd"],"package_ndc":["0075-8013-01","0075-8013-10","0075-8014-01","0075-8014-10","0075-8016-01","0075-8016-10","0075-8018-01","0075-8018-10","0075-8020-01","0075-8020-10","0075-8030-01","0075-8022-01","0075-8022-10","0075-8025-01","0075-8025-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 30 mg/.3 mL (NDC 0075-8013-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-464-17","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA070552","NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-464","63323-466","63323-462","63323-465","63323-467","63323-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724880","1724881","1725078","1725175","1724884","1724885","1725082","1725177","1672917","1672919","1673296","1673298","1012391","1012396","1012404","1012421","1012455","1012457"],"spl_id":["b41b5dbd-7aff-4d97-ac97-f4355393ee4e","d3ba9fb9-63c8-4597-bb0a-cd01d31a24b6","13a48007-3784-46f2-bd4d-da1004186b81","2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["e700eb7b-8b14-49c9-96b2-331f18776e45","b6bfc04a-1868-4630-9ca1-8c027af97ce3","dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175","eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-464-01","63323-464-17","63323-466-03","63323-466-17","63323-464-08","63323-464-38","63323-466-08","63323-466-38","63323-462-03","63323-462-38","63323-464-09","63323-464-39","63323-466-09","63323-466-39","63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-170-30","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203895"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-170","55150-167","55150-168","55150-169","55150-171","55150-172","55150-249","55150-250"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404","1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["39649703-e633-4a20-ba71-0c04dbf8ff2a"],"spl_set_id":["ffecf450-1f01-4721-8e10-251385852612"],"package_ndc":["55150-167-10","55150-168-30","55150-169-10","55150-170-30","55150-171-10","55150-172-30","55150-249-50","55150-250-50"],"unii":["7TQO7W3VT8"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-170-30)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"13811-711-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Allocation to current contracted customers","openfda":{"application_number":["NDA216117"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Trigen Laboratories, LLC"],"product_ndc":["13811-711","13811-700"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["2605796","2605798"],"spl_id":["ba649db4-df0d-4587-8370-3f866e66e54b"],"spl_set_id":["dd8d7b6e-c23d-4e16-bb53-959e9127ebc6"],"package_ndc":["13811-711-30","13811-700-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 45 mg (NDC 13811-711-30)","company_name":"Trigen Laboratories, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"04/20/2026","update_type":"New","initial_posting_date":"04/20/2026","package_ndc":"0068-0597-01","generic_name":"Rifampin Injection","contact_info":"800-633-1610","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/20/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Rifadin, Injection, 600 mg/10 mL (NDC 0068-0597-01)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"45963-677-11","generic_name":"Metoprolol Succinate Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA204161"],"brand_name":["METOPROLOL SUCCINATE"],"generic_name":["METOPROLOL SUCCINATE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["45963-677","45963-709","45963-676","45963-678"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METOPROLOL SUCCINATE"],"rxcui":["866412","866419","866427","866436"],"spl_id":["a7e9a234-a8a6-4afe-ba8e-d569772bc39a"],"spl_set_id":["b798601e-a369-4c8b-8235-08900e1b751d"],"package_ndc":["45963-709-11","45963-709-96","45963-676-11","45963-676-96","45963-677-11","45963-677-96","45963-678-11"],"unii":["TH25PD4CCB"]},"update_date":"08/31/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-11)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"04/29/2026","update_type":"New","initial_posting_date":"04/29/2026","package_ndc":"49884-605-11","generic_name":"Lamotrigine Tablet, Extended Release","contact_info":"800-828-9393","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/29/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Lamotrigine, Tablet, Extended Release, 300 mg (NDC 49884-605-11)","company_name":"Par Health, Inc.","status":"To Be Discontinued"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0955-1015-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["ENOXAPARIN SODIUM"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0955-1015","0955-1003","0955-1004","0955-1006","0955-1008","0955-1010","0955-1016","0955-1012"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854235","854238","854241","854245","854248","854252","854255"],"spl_id":["8f06a411-badb-483f-852d-8e6124acfa44"],"spl_set_id":["20635579-c92d-4f6c-a332-1096d51002f2"],"package_ndc":["0955-1003-01","0955-1003-10","0955-1004-01","0955-1004-10","0955-1006-01","0955-1006-10","0955-1008-01","0955-1008-10","0955-1010-01","0955-1010-10","0955-1016-01","0955-1012-01","0955-1012-10","0955-1015-01","0955-1015-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Enoxaparin Sodium, Injection, 150 mg/1 mL (NDC 0955-1015-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-249-50","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA207183"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-249","55150-167","55150-168","55150-169","55150-170","55150-171","55150-172","55150-250"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404","1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["39649703-e633-4a20-ba71-0c04dbf8ff2a"],"spl_set_id":["ffecf450-1f01-4721-8e10-251385852612"],"package_ndc":["55150-167-10","55150-168-30","55150-169-10","55150-170-30","55150-171-10","55150-172-30","55150-249-50","55150-250-50"],"unii":["7TQO7W3VT8"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-461-57","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA070967"],"brand_name":["SENSORCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-461","63323-472","63323-463","63323-468"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012384","1012413","1012417","1724786","1724787","1724809","1724810","1867594","1867596","1867618","1867620"],"spl_id":["cc1f6507-eb3e-4398-a1d3-0c56a2099e6b"],"spl_set_id":["bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb"],"package_ndc":["63323-472-03","63323-472-17","63323-472-01","63323-472-37","63323-463-01","63323-463-57","63323-461-01","63323-461-57","63323-468-02","63323-468-37","63323-468-01","63323-468-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-461-57)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"68025-097-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Available","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-097","68025-088","68025-089","68025-095","68025-096","68025-084","68025-098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)","company_name":"Vertical Pharmaceuticals, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/15/2023","package_ndc":"66794-228-41","generic_name":"Rocuronium Bromide Injection","contact_info":"800-414-1901","availability":"Available","openfda":{"application_number":["ANDA210437"],"brand_name":["ROCURONIUM"],"generic_name":["ROCURONIUM"],"manufacturer_name":["Piramal Critical Care Inc"],"product_ndc":["66794-228","66794-229"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["3f9e12e4-d3c5-fba6-e063-6294a90a7fd6"],"spl_set_id":["98255b70-51f9-8d16-e053-2995a90a8f97"],"package_ndc":["66794-229-02","66794-229-41","66794-228-02","66794-228-41"],"unii":["I65MW4OFHZ"]},"update_date":"09/15/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 66794-228-41)","company_name":"Piramal Critical Care Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/06/2018","package_ndc":"76329-1912-1","generic_name":"Morphine Sulfate Injection","contact_info":"800-423-4136","availability":"Available","openfda":{"application_number":["ANDA202861"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["International Medication Systems, Limited"],"product_ndc":["76329-1912"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"spl_id":["99799101-d92b-485b-93ec-f2b5a2e5ca26"],"spl_set_id":["1034467f-d436-4b87-a902-c7e8885daa8a"],"package_ndc":["76329-1912-0","76329-1912-1"],"unii":["X3P646A2J0"]},"update_date":"11/06/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 1 mg/1 mL (NDC 76329-1912-1)","company_name":"Amphastar Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-485-27","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-485","63323-492","63323-491","63323-495","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 10 mg/1 mL (NDC 63323-485-27)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"10/14/2026","update_type":"New","initial_posting_date":"10/14/2026","package_ndc":"49884-159-02","generic_name":"Everolimus Tablet","contact_info":"800-828-9393","related_info":"A business decision was made to withdraw from sale.","openfda":{"application_number":["ANDA205775"],"brand_name":["EVEROLIMUS"],"generic_name":["EVEROLIMUS"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["49884-159","49884-158","49884-160","49884-283"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["EVEROLIMUS"],"rxcui":["977427","977434","977438","2056895"],"spl_id":["7523ed83-6f81-4cc8-b815-e646ffa1dd80"],"spl_set_id":["59cb86d5-8706-4619-b074-af253d3e0b68"],"package_ndc":["49884-158-52","49884-158-02","49884-159-52","49884-159-02","49884-160-52","49884-160-02","49884-283-52","49884-283-02"],"nui":["N0000175605","N0000175076","N0000182141","N0000182137","N0000175625","N0000175624","N0000175550"],"pharm_class_epc":["Kinase Inhibitor [EPC]","mTOR Inhibitor Immunosuppressant [EPC]"],"pharm_class_moa":["Protein Kinase Inhibitors [MoA]","Cytochrome P450 3A4 Inhibitors [MoA]","Cytochrome P450 2D6 Inhibitors [MoA]","mTOR Inhibitors [MoA]"],"pharm_class_pe":["Decreased Immunologic Activity [PE]"],"unii":["9HW64Q8G6G"]},"update_date":"10/14/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, .5 mg (NDC 49884-159-02)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"discontinued_date":"05/05/2026","update_type":"New","initial_posting_date":"05/05/2026","package_ndc":"71288-728-32","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-824-8426","related_info":"Discontinuation of the manufacture of the drug","update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)","company_name":"Kindos Pharmaceuticals Co. Ltd.","status":"To Be Discontinued"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0429-52","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020163"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0429","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0429-52)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0641-6060-10","generic_name":"Midazolam Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["ANDA075243"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6060","0641-6057","0641-6059","0641-6056","0641-6061","0641-6063"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["559c03fb-24ea-4b7b-8afd-e33cb3a2340a"],"spl_set_id":["575d8bf0-7af7-427c-a231-966e2a5e070d"],"package_ndc":["0641-6057-01","0641-6057-10","0641-6057-25","0641-6059-01","0641-6059-10","0641-6056-01","0641-6056-10","0641-6061-01","0641-6061-10","0641-6061-25","0641-6063-01","0641-6063-10","0641-6063-25","0641-6060-01","0641-6060-10"],"unii":["W7TTW573JJ"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-286-00","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-286","63323-285","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cb6583ff-cde4-4280-aa5b-0bea2b844792","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","cb6583ff-cde4-4280-aa5b-0bea2b844792","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-51","63323-286-55","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 5 mg/1 mL (NDC 63323-286-00)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"76045-004-11","generic_name":"Morphine Sulfate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA204223"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Fresenius Kabi, USA LLC"],"product_ndc":["76045-004","76045-238","76045-005","76045-006","76045-007","76045-008"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["894912","894914","998212","998213","1442790","2752697"],"spl_id":["e61f6eb4-cc71-47d3-b2f6-5e689c773779"],"spl_set_id":["1f53de80-efc8-4930-b3e3-fba0d026af05"],"package_ndc":["76045-238-01","76045-238-10","76045-004-01","76045-004-11","76045-005-01","76045-005-11","76045-006-01","76045-006-11","76045-007-01","76045-007-11","76045-008-01","76045-008-11"],"unii":["X3P646A2J0"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 2 mg/1 mL (NDC 76045-004-11)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4277-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA088327"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4277","0409-4713","0409-4278","0409-4279","0409-4776","0409-4282","0409-4276","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride In Plastic Container, Injection, 1,000 mg/50 mL (2%; 20 mg/mL) (NDC 0409-4277-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"63323-806-05","generic_name":"Fentanyl Citrate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA210762"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-806"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270"],"spl_id":["341b092a-1f6f-40f1-98f2-9346bf2e1242"],"spl_set_id":["38d0c14a-a0c1-44cc-a939-0304eb8037d6"],"package_ndc":["63323-806-11","63323-806-01","63323-806-12","63323-806-02","63323-806-13","63323-806-05","63323-806-14","63323-806-20","63323-806-50"],"unii":["MUN5LYG46H"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-05)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0411-06","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017512"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0411-06)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/17/2015","package_ndc":"21586-011-02","generic_name":"Cefotaxime Sodium Powder, for Solution","related_info_link":"https://www.fda.gov/media/193116/download?attachment","contact_info":"800-881-3550","availability":"Available","openfda":{"brand_name":["CEFOTAXIME"],"generic_name":["CEFOTAXIME INJECTION"],"manufacturer_name":["SteriMax Inc."],"product_ndc":["21586-011","21586-012"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CEFOTAXIME SODIUM"],"rxcui":["1656313","1656318"],"spl_id":["7a77a18a-3d8c-4bac-8d21-54a88db396f6"],"spl_set_id":["8efe3bd0-c43a-2bd6-e053-2a95a90a92fa"],"package_ndc":["21586-011-01","21586-011-02","21586-012-01","21586-012-02"],"unii":["258J72S7TZ"]},"update_date":"06/15/2026","therapeutic_category":["Anti-Infective","Pediatric"],"dosage_form":"Powder, For Solution","presentation":"Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02)","company_name":"SteriMax, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"66794-160-02","generic_name":"Morphine Sulfate Injection","contact_info":"800-414-1901","availability":"Available","openfda":{"application_number":["ANDA204393"],"brand_name":["MITIGO"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Piramal Critical Care, Inc."],"product_ndc":["66794-160","66794-162"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRATHECAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731522","1731998","2055307","2055311"],"spl_id":["495a6a51-d35d-2b96-e063-6394a90ac5f3"],"spl_set_id":["728f3d83-9a63-0c1f-e053-2a91aa0ac7db"],"package_ndc":["66794-160-02","66794-162-02"],"unii":["X3P646A2J0"]},"update_date":"09/15/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Mitigo, Injection, 200 mg/20 mL (NDC 66794-160-02)","company_name":"Piramal Critical Care Inc.","status":"Current"},{"discontinued_date":"10/14/2026","update_type":"New","initial_posting_date":"10/14/2026","package_ndc":"49884-160-02","generic_name":"Everolimus Tablet","contact_info":"800-828-9393","related_info":"A business decision was made to withdraw from sale.","update_date":"10/14/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, .75 mg (NDC 49884-160-02)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0409-07","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017512"],"brand_name":["DIANEAL LOW CALCIUM WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0409","0941-0411","0941-0413","0941-0415","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0409-07)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/17/2021","package_ndc":"63323-351-20","generic_name":"Rifampin Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA091181"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-351"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["RIFAMPIN"],"rxcui":["312821"],"spl_id":["60eb9c46-3c34-455b-a740-c03884565072"],"spl_set_id":["a1f9f1e2-dfc0-4d31-a13b-b656d897b791"],"package_ndc":["63323-351-20"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Rifampin, Injection, 600 mg (NDC 63323-351-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"23155-601-41","generic_name":"Midazolam Hydrochloride Injection","contact_info":"855-228-9470","availability":"Available","openfda":{"application_number":["ANDA090850"],"brand_name":["MIDAZOLAM HYDROCHLORIDE"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."],"product_ndc":["23155-601"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311702"],"spl_id":["e20feff9-3aca-4bc1-a5c3-44fff8a9459c"],"spl_set_id":["843cc25e-45ea-4372-ae34-843f805fa869"],"package_ndc":["23155-601-31","23155-601-41","23155-601-32","23155-601-42"],"unii":["W7TTW573JJ"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41)","company_name":"Avet Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/13/2018","package_ndc":"0143-9575-10","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled for manufacturing to meet demand.  Product will be made available as it is released.","openfda":{"application_number":["ANDA080407"],"brand_name":["LIDOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9575","0143-9579","0143-9578","0143-9577","0143-9576","0143-9172","0143-9173"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671"],"spl_id":["e9b92d4d-8944-4235-8d77-3218f82f00a9"],"spl_set_id":["5523fdfe-69fd-49a5-b51f-73e2223d49a9"],"package_ndc":["0143-9579-01","0143-9579-25","0143-9578-01","0143-9578-10","0143-9577-01","0143-9577-10","0143-9576-01","0143-9576-25","0143-9575-01","0143-9575-10","0143-9172-01","0143-9172-10","0143-9173-01","0143-9173-10"],"unii":["V13007Z41A"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/01/2017","package_ndc":"0641-6254-01","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Product temporarily on backorder.  Additional lots will be available in the November 2026 timeframe.","openfda":{"application_number":["NDA217812"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6254"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897745"],"spl_id":["68e84ae8-2bd5-4f57-abef-4d0cde3c4775"],"spl_set_id":["c729424e-e483-4bf8-b86c-ce56636dcffa"],"package_ndc":["0641-6254-01"],"unii":["L960UP2KRW"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0641-6254-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"10/02/2026","update_type":"New","initial_posting_date":"10/02/2026","package_ndc":"0093-0264-15","generic_name":"Fluocinonide Ointment","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA073481"],"brand_name":["FLUOCINONIDE"],"generic_name":["FLUOCINONIDE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-0264","0093-0263","0093-0262"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TOPICAL"],"substance_name":["FLUOCINONIDE"],"rxcui":["103456","103457","1801283"],"spl_id":["c70aebe7-b63b-468a-ada5-dc1e60391277"],"spl_set_id":["986c1ba3-2103-4773-a35c-2c0121a01783"],"package_ndc":["0093-0263-15","0093-0263-30","0093-0263-92","0093-0262-15","0093-0262-30","0093-0262-92","0093-0264-15","0093-0264-30","0093-0264-92"],"nui":["N0000175576","N0000175450"],"pharm_class_epc":["Corticosteroid [EPC]"],"pharm_class_moa":["Corticosteroid Hormone Receptor Agonists [MoA]"],"unii":["2W4A77YPAN"]},"update_date":"10/02/2026","therapeutic_category":["Dermatology"],"dosage_form":"Ointment","presentation":"Fluocinonide, Ointment, .5 mg/1 g (NDC 0093-0264-15)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"0009-0775-26","generic_name":"Clindamycin Phosphate Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050441"],"brand_name":["CLEOCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0775","0009-0870","0009-0902","0009-0728","0009-3124","0009-3447","0009-3381","0009-3375","0009-3382","0009-6582"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309339","685574","685576","685578","706461","1737244","1737245","1737578","1737579","1737581","1737582","205964","309335","309336"],"spl_id":["fa11e62e-4625-4e9c-8676-f318b1cb890f"],"spl_set_id":["05a75685-0af5-407c-ac57-e380c882b49d"],"package_ndc":["0009-0870-21","0009-0870-26","0009-0775-20","0009-0775-26","0009-0902-11","0009-0902-18","0009-0728-05","0009-0728-09","0009-3124-01","0009-3124-03","0009-3447-01","0009-3447-03","0009-3381-01","0009-3381-02","0009-3375-01","0009-3375-02","0009-3382-01","0009-3382-02","0009-6582-02","0009-6582-01"],"unii":["EH6D7113I8"]},"update_date":"06/01/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial (NDC 0009-0775-26)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"55150-195-20","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA205612"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-195","55150-196","55150-197","55150-198","55150-199","55150-200","55150-201"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734207","1734347","1734475","1734483"],"spl_id":["1e5f1368-058a-492c-b4b7-d9329a7745e2"],"spl_set_id":["3763b7b6-da49-4658-b93d-28f5da24d09e"],"package_ndc":["55150-195-20","55150-196-99","55150-197-20","55150-198-30","55150-199-20","55150-200-10","55150-201-20"],"unii":["V910P86109"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 55150-195-20)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7114-12","generic_name":"Morphine Sulfate Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7114","0574-7110","0574-7112","0574-7116"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892516","892603","892678","894807"],"spl_id":["fa18ac09-a625-47aa-8cde-7051dc4d0c49"],"spl_set_id":["649d731b-962a-45df-b043-7e0781e8a530"],"package_ndc":["0574-7110-12","0574-7112-12","0574-7114-12","0574-7116-12"],"unii":["X3P646A2J0"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Suppository","presentation":"Morphine Sulfate, Suppository, 20 mg (NDC 0574-7114-12)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-492-27","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487","63323-493","63323-496"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029","1737636","1737637","1737640","1737641","1737763","1737764"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33","fa12a8e8-09fd-496f-8cc6-ffe0eb02e2df"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74","d5e0d06f-ba1e-44d4-aa89-39d6c146dc23"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26","63323-492-08","63323-492-97","63323-493-03","63323-493-97","63323-493-01","63323-493-91","63323-496-03","63323-496-97"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-27)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/26/2018","package_ndc":"0409-3795-01","generic_name":"Ketorolac Tromethamine Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA074802"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3795","0409-3793","0409-3796"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["4beb8ebd-934e-4181-8374-01be0bb80680"],"spl_set_id":["8accbb78-fc64-45d5-69b0-35c23a1d2a2e"],"package_ndc":["0409-3793-19","0409-3793-01","0409-3793-25","0409-3795-19","0409-3795-01","0409-3795-25","0409-3796-19","0409-3796-01","0409-3796-25"],"unii":["4EVE5946BQ"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0409-3795-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"65219-281-07","generic_name":"Gadobutrol Injection","contact_info":"888-386-1300","related_info":"Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA","openfda":{"application_number":["ANDA215061"],"brand_name":["GADOBUTROL"],"generic_name":["GADOBUTROL"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-281"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOBUTROL"],"spl_id":["490c8c3e-3195-40af-8f34-40d8df2719c3"],"spl_set_id":["007696d0-4b62-4937-9640-4ad619504df4"],"package_ndc":["65219-281-00","65219-281-02","65219-281-03","65219-281-07","65219-281-08","65219-281-10","65219-281-05","65219-281-15"],"nui":["N0000183362","N0000175862"],"pharm_class_epc":["Gadolinium-based Contrast Agent [EPC]"],"pharm_class_moa":["Magnetic Resonance Contrast Activity [MoA]"],"unii":["1BJ477IO2L"]},"update_date":"06/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-07)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"43547-407-11","generic_name":"Clonazepam Tablet","contact_info":"For orders, Solco Healthcare 866-931-9829","resolved_note":"Available","openfda":{"application_number":["ANDA077856"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Solco Healthcare LLC"],"product_ndc":["43547-407","43547-406","43547-408"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["dc17b9d4-2890-4f6c-8476-daa39d0cbc9c"],"spl_set_id":["4acbb7a9-4db5-4497-b8db-9f358b3f6fb4"],"package_ndc":["43547-406-10","43547-406-50","43547-406-11","43547-407-10","43547-407-50","43547-407-11","43547-408-10","43547-408-50"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 43547-407-11)","company_name":"Prinston Pharmaceutical, Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-285-63","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-285","63323-286","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-355-30","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-30)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"47781-562-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA214547"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-562","47781-563","47781-564","47781-565","47781-566","47781-567","47781-568"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["db02ec6b-f17f-ab22-b671-e1ddb90e017c"],"spl_set_id":["7f2dd6ee-3363-c87c-9693-ed838942556c"],"package_ndc":["47781-562-01","47781-563-01","47781-564-01","47781-565-01","47781-566-01","47781-567-01","47781-568-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 47781-562-01)","company_name":"Alvogen","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4776-01","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA080408"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4776","0409-4713","0409-4278","0409-4279","0409-4282","0409-4277","0409-4276","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride Preservative Free, Injection, 300 mg/20 mL (1.5%; 15 mg/mL) (NDC 0409-4776-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"08/10/2026","update_type":"New","initial_posting_date":"08/10/2026","package_ndc":"0093-9433-01","generic_name":"Glyburide Tablet","contact_info":"800-633-1610","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017532"],"brand_name":["GLYBURIDE"],"generic_name":["GLYBURIDE"],"manufacturer_name":["TEVA Pharmaceuticals USA Inc"],"product_ndc":["0093-9433","0093-9477","0093-9364"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GLYBURIDE"],"rxcui":["197737","310534","310537"],"spl_id":["84b83205-8813-494e-933e-a70697393744"],"spl_set_id":["50d16f1d-c814-4411-8749-62561321ecce"],"package_ndc":["0093-9477-53","0093-9433-01","0093-9433-05","0093-9364-01","0093-9364-05","0093-9364-10"],"nui":["N0000175608","M0020795"],"pharm_class_epc":["Sulfonylurea [EPC]"],"pharm_class_cs":["Sulfonylurea Compounds [CS]"],"unii":["SX6K58TVWC"]},"update_date":"08/10/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Diabeta, Tablet, 2.5 mg (NDC 0093-9433-01)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/12/2021","package_ndc":"69918-501-05","generic_name":"Desmopressin Acetate Spray","contact_info":"888-337-7464","availability":"Unavailable","related_info":"Estimated recovery: TBD","update_date":"05/01/2026","therapeutic_category":["Hematology"],"dosage_form":"Spray","presentation":"Desmopressin Acetate, Spray, 10 ug/.1 mL (NDC 69918-501-05)","company_name":"Ferring","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"71357-002-10","generic_name":"Sodium Acetate Injection","contact_info":"833-251-8463","availability":"Available","openfda":{"application_number":["ANDA214805"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["MILLA PHARMACEUTICALS INC."],"product_ndc":["71357-002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE"],"rxcui":["1859490"],"spl_id":["2bdf8f55-9a63-bff7-e063-6394a90aafd0"],"spl_set_id":["1ea04916-78e5-4651-e063-6394a90ac4be"],"package_ndc":["71357-002-01","71357-002-10"],"unii":["4550K0SC9B"]},"update_date":"10/15/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)","company_name":"Milla Pharmaceuticals","status":"Current"},{"discontinued_date":"06/29/2026","update_type":"New","initial_posting_date":"06/29/2026","package_ndc":"25021-233-20","generic_name":"Oxaliplatin Injection","contact_info":"Sagent Pharmaceuticals: 866-625-1618","related_info":"Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA203869"],"brand_name":["OXALIPLATIN"],"generic_name":["OXALIPLATIN"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-233"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["OXALIPLATIN"],"rxcui":["1736776","1736781"],"spl_id":["c159050a-e588-4091-b9ee-ea502e1b9529"],"spl_set_id":["29a5d098-bfa7-4a65-bb4f-5daa1fef1c2f"],"package_ndc":["25021-233-10","25021-233-20"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["04ZR38536J"]},"update_date":"06/29/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-20)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/01/2023","package_ndc":"60505-4743-1","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-706-5575","availability":"Available","openfda":{"application_number":["ANDA216944"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-4743","60505-4739","60505-4740","60505-4741","60505-4742","60505-4744","60505-4745"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0190bec9-05e4-0977-9548-2cc150b53e74"],"spl_set_id":["ecad4442-a644-18e3-6ff2-fdbac45eec47"],"package_ndc":["60505-4739-1","60505-4740-1","60505-4741-1","60505-4742-1","60505-4743-1","60505-4744-1","60505-4745-1"],"unii":["SJT761GEGS"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 60505-4743-1)","company_name":"Apotex Corp.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-496-97","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-496","63323-492","63323-493"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737636","1737637","1737640","1737641","1737763","1737764"],"spl_id":["fa12a8e8-09fd-496f-8cc6-ffe0eb02e2df"],"spl_set_id":["d5e0d06f-ba1e-44d4-aa89-39d6c146dc23"],"package_ndc":["63323-492-08","63323-492-97","63323-493-03","63323-493-97","63323-493-01","63323-493-91","63323-496-03","63323-496-97"],"unii":["EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 20 mg/1 mL (NDC 63323-496-97)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"06/12/2026","package_ndc":"0143-9530-01","generic_name":"Ifosfamide Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Additional lots will be available in the November 2026 timeframe.  Product will be made available as it is released.","openfda":{"application_number":["ANDA076619"],"brand_name":["IFOSFAMIDE"],"generic_name":["IFOSFAMIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9530","0143-9531"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IFOSFAMIDE"],"rxcui":["1791597","1791599"],"spl_id":["517c3bf6-41f5-4199-a17e-1f46b120cb1e"],"spl_set_id":["c90ab05f-8fe5-437e-a1c0-8b11ef63291e"],"package_ndc":["0143-9531-01","0143-9530-01"],"nui":["N0000000236","N0000175558"],"pharm_class_moa":["Alkylating Activity [MoA]"],"pharm_class_epc":["Alkylating Drug [EPC]"],"unii":["UM20QQM95Y"]},"update_date":"10/14/2026","therapeutic_category":["Oncology","Pediatric"],"dosage_form":"Injection","presentation":"Ifosfamide, Injection, 50 mg/1 mL (NDC 0143-9530-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"70121-1388-8","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA207551"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["70121-1388","70121-1389"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["af193b53-1488-401f-8f06-cc193297c4a8"],"spl_set_id":["eb1ba463-ab42-4f49-9ebe-3ad5af108326"],"package_ndc":["70121-1388-1","70121-1388-8","70121-1389-1","70121-1389-7"],"unii":["1018WH7F9I"]},"update_date":"10/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/03/2021","package_ndc":"0409-3977-03","generic_name":"Sterile Water Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018802"],"brand_name":["BACTERIOSTATIC WATER"],"generic_name":["BACTERIOSTATIC WATER"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3977","0409-1093"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["dfac2c43-36b4-4fc0-a22d-f70c4aad5f97"],"spl_set_id":["87d6e9dc-fe3b-4593-ac9a-d7493d1959c7"],"package_ndc":["0409-3977-01","0409-3977-03","0409-1093-14","0409-1093-04"],"unii":["059QF0KO0R"]},"update_date":"11/09/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Bacteriostatic Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 0409-3977-03)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"03/10/2026","update_type":"New","initial_posting_date":"03/10/2026","package_ndc":"46163-212-92","generic_name":"Peritoneal Dialysis Solution","contact_info":"800-323-5188","related_info":"The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.","openfda":{"application_number":["NDA020171"],"brand_name":["DELFLEX"],"generic_name":["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"],"manufacturer_name":["Fresenius Medical Care de Mexico, S.A. de C.V."],"product_ndc":["46163-212","46163-209","46163-206"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"spl_id":["5f14959c-adcd-923c-e063-6294a90ab6de"],"spl_set_id":["a98facd6-9daa-4d37-8209-63a0599dbfaa"],"package_ndc":["46163-209-92","46163-209-94","46163-209-95","46163-212-95","46163-212-92","46163-212-94","46163-206-92","46163-206-94","46163-206-95"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"03/10/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2L, 5/cs (NDC 46163-212-92)","company_name":"Fresenius Medical Care North America","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-104-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA021977"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-104","59417-101","59417-102","59417-103","59417-105","59417-106","59417-107","59417-115","59417-116","59417-117","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Vyvanse, Capsule, 40 mg (NDC 59417-104-10)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/18/2023","package_ndc":"71288-563-84","generic_name":"Liraglutide Injection","contact_info":"844-824-8426","availability":"Available","openfda":{"application_number":["ANDA218115"],"brand_name":["LIRAGLUTIDE"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-563"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["897122"],"spl_id":["a0bb0116-f90a-490b-9ca9-5bcd6210c763"],"spl_set_id":["0efc3a89-211a-4496-baab-e8265e07de2b"],"package_ndc":["71288-563-84","71288-563-85"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"08/27/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Liraglutide, Injection, 6 mg/1 mL (NDC 71288-563-84)","company_name":"Meitheal Pharmaceuticals, Inc.","status":"Current"},{"discontinued_date":"02/27/2026","update_type":"New","initial_posting_date":"02/27/2026","package_ndc":"50458-290-04","generic_name":"Itraconazole Capsule","contact_info":"800-JANSSEN (1-800-526-7736)","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020083"],"brand_name":["SPORANOX"],"generic_name":["ITRACONAZOLE"],"manufacturer_name":["Janssen Pharmaceuticals, Inc."],"product_ndc":["50458-290"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ITRACONAZOLE"],"rxcui":["311204","833164"],"spl_id":["a79c080b-711a-4a15-af92-ff0c60cbfdf1"],"spl_set_id":["a4d555fa-787c-40fb-bb7d-b0d4f7318fd0"],"package_ndc":["50458-290-01","50458-290-04","50458-290-28"],"nui":["N0000175487","M0002083","N0000182141","N0000185503","N0000190113"],"pharm_class_epc":["Azole Antifungal [EPC]"],"pharm_class_cs":["Azoles [CS]"],"pharm_class_moa":["Cytochrome P450 3A4 Inhibitors [MoA]","P-Glycoprotein Inhibitors [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]"],"unii":["304NUG5GF4"]},"update_date":"02/27/2026","therapeutic_category":["Anti-Infective","Other"],"dosage_form":"Capsule","presentation":"Sporanox, Capsule, 100 mg (NDC 50458-290-04)","company_name":"Janssen Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"72572-128-08","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"877-495-6856","availability":"Available","related_info":"Distributed by Civica","openfda":{"application_number":["ANDA212791"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["CIVICA, INC."],"product_ndc":["72572-128","72572-127"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["454867bb-b559-4c06-8ec4-bb1a5c691109"],"spl_set_id":["1faf1ac8-ff9b-4ed9-b562-06dab971173a"],"package_ndc":["72572-127-01","72572-127-10","72572-128-01","72572-128-08"],"unii":["1018WH7F9I"]},"update_date":"10/15/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08)","company_name":"Azurity Pharmaceuticals, Inc","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/12/2022","package_ndc":"68118-100-01","generic_name":"Streptozocin Powder, For Solution","related_info_link":"https://www.fda.gov/media/194857/download","contact_info":"USSZTOrders@esteve.com","availability":"Available","update_date":"09/16/2026","therapeutic_category":["Oncology"],"dosage_form":"Powder, For Solution","presentation":"Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01)","company_name":"ESTEVE PHARMACEUTICALS, S.A.","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/21/2023","package_ndc":"0641-6083-25","generic_name":"Promethazine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA083312"],"brand_name":["PHENERGAN"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6083","0641-6082"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992460","992462","992858","992876"],"spl_id":["a64f0625-8d56-4994-8908-13614ca7b09f"],"spl_set_id":["6f7e47cc-f823-4336-8107-f980e3049617"],"package_ndc":["0641-6082-01","0641-6082-25","0641-6083-01","0641-6083-25"],"unii":["R61ZEH7I1I"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Pediatric","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Phenergan, Injection, 50 mg/1 mL (NDC 0641-6083-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0480-3568-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA202802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Teva Pharmaceuticals, Inc."],"product_ndc":["0480-3568","0480-3565","0480-3566","0480-3567","0480-3569","0480-3570","0480-3564"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["7a1feaa2-6b58-4aff-a45b-533ee3174e53"],"spl_set_id":["c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fc"],"package_ndc":["0480-3565-01","0480-3566-01","0480-3567-01","0480-3568-01","0480-3569-01","0480-3570-01","0480-3564-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0480-3568-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-049-88","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-818-4555","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA214484"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-049","57664-047","57664-046","57664-048","57664-050","57664-051","57664-052","57664-083","57664-084","57664-085","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 57664-049-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"64850-500-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"888-852-6657","availability":"Available","openfda":{"application_number":["ANDA211352"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-500","64850-501","64850-502","64850-503","64850-504","64850-505","64850-506"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["a41cf8e5-cb1b-488c-96b3-3bef8283d6c4"],"spl_set_id":["e677690f-790f-4626-ad78-097cdb6ea540"],"package_ndc":["64850-500-01","64850-500-05","64850-500-30","64850-501-01","64850-501-05","64850-501-30","64850-502-01","64850-502-05","64850-502-30","64850-503-01","64850-503-05","64850-503-30","64850-504-01","64850-504-05","64850-504-30","64850-505-01","64850-505-05","64850-505-30","64850-506-01","64850-506-05","64850-506-30"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 64850-500-01)","company_name":"Elite Laboratories, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"70121-1388-1","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"877-835-5472","availability":"Available","openfda":{"application_number":["ANDA207551"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["70121-1388","70121-1389"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["af193b53-1488-401f-8f06-cc193297c4a8"],"spl_set_id":["eb1ba463-ab42-4f49-9ebe-3ad5af108326"],"package_ndc":["70121-1388-1","70121-1388-8","70121-1389-1","70121-1389-7"],"unii":["1018WH7F9I"]},"update_date":"10/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/13/2017","change_date":"09/30/2026","package_ndc":"83301-0081-2","generic_name":"Bumetanide Injection","contact_info":"800-673-9839","resolved_note":"Available","openfda":{"application_number":["ANDA219116"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Mullan Pharmaceutical Inc."],"product_ndc":["83301-0081","83301-0080"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["4c241a3e-649b-4414-e063-6294a90a3a32"],"spl_set_id":["b7cd724b-817b-4b45-8133-1ebf505867e7"],"package_ndc":["83301-0080-1","83301-0080-2","83301-0081-1","83301-0081-2"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, 2.5 mg/10 mL (0.25 mg/mL) (NDC 83301-0081-2)","company_name":"Mullan Pharmaceutical Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"68180-554-09","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-587-4617","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA077690"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Lupin Pharmaceuticals, Inc."],"product_ndc":["68180-554","68180-556","68180-557","68180-558","68180-559"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["a9598a21-6f99-4c86-ace6-b5638da2bec8"],"spl_set_id":["8ded0773-3aec-4e89-9836-d22a5a84abf0"],"package_ndc":["68180-556-09","68180-557-09","68180-557-03","68180-558-09","68180-558-03","68180-554-09","68180-554-03","68180-559-03","68180-559-09"],"unii":["33067B3N2M"]},"update_date":"10/13/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 40 mg (NDC 68180-554-09)","company_name":"Lupin Pharmaceuticals, Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"discontinued_date":"12/08/2025","update_type":"New","initial_posting_date":"12/08/2025","package_ndc":"0781-9409-95","generic_name":"Ampicillin Sodium Injection","contact_info":"800-525-8747","related_info":"Discontinuation of private label only","openfda":{"application_number":["ANDA061395"],"brand_name":["AMPICILLIN"],"generic_name":["AMPICILLIN SODIUM"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-9409"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["AMPICILLIN SODIUM"],"rxcui":["789980"],"spl_id":["86e9a3cc-bc65-4d4f-916d-98c916588730"],"spl_set_id":["5308ddfa-4a5b-4f7b-83ce-9d1b528e050d"],"package_ndc":["0781-9409-46","0781-9409-95"],"unii":["JFN36L5S8K"]},"update_date":"12/08/2025","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Ampicillin Sodium, Injection, 10 g (NDC 0781-9409-95)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0054-0373-25","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Available on allocation","openfda":{"application_number":["ANDA202827"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-0373","0054-0660","0054-0370","0054-0371","0054-0372","0054-0374","0054-0375"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"],"spl_set_id":["6740a621-9bec-4178-a4fc-a3fc89f34e0a"],"package_ndc":["0054-0660-25","0054-0370-25","0054-0371-25","0054-0372-25","0054-0373-25","0054-0374-25","0054-0375-25"],"unii":["SJT761GEGS"]},"update_date":"10/14/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0054-0373-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-492-31","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487","63323-493","63323-496"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029","1737636","1737637","1737640","1737641","1737763","1737764"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33","fa12a8e8-09fd-496f-8cc6-ffe0eb02e2df"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74","d5e0d06f-ba1e-44d4-aa89-39d6c146dc23"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26","63323-492-08","63323-492-97","63323-493-03","63323-493-97","63323-493-01","63323-493-91","63323-496-03","63323-496-97"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-31)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/01/2022","package_ndc":"0990-7938-19","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Unavailable","related_info":"Product discontinued. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA018080"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7938"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477"],"spl_id":["19e8876b-0d2f-4524-85c9-9c8d682ab2c8"],"spl_set_id":["cb578dba-094c-4787-951d-763d12fd06e1"],"package_ndc":["0990-7938-19"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7938-19)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-466-17","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA070553","NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-466","63323-464","63323-462","63323-465","63323-467","63323-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL","INFILTRATION"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724880","1724881","1725078","1725175","1724884","1724885","1725082","1725177","1672917","1672919","1673296","1673298","1012391","1012396","1012404","1012421","1012455","1012457"],"spl_id":["b41b5dbd-7aff-4d97-ac97-f4355393ee4e","d3ba9fb9-63c8-4597-bb0a-cd01d31a24b6","13a48007-3784-46f2-bd4d-da1004186b81","2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["e700eb7b-8b14-49c9-96b2-331f18776e45","b6bfc04a-1868-4630-9ca1-8c027af97ce3","dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175","eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-464-01","63323-464-17","63323-466-03","63323-466-17","63323-464-08","63323-464-38","63323-466-08","63323-466-38","63323-462-03","63323-462-38","63323-464-09","63323-464-39","63323-466-09","63323-466-39","63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/22/2021","package_ndc":"42806-799-05","generic_name":"Rifampin Capsule","contact_info":"(718) 276-8600 ext. 3","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA064150"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["EPIC PHARMA, LLC"],"product_ndc":["42806-799","42806-801"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAMPIN"],"rxcui":["198201","198202"],"spl_id":["a4ac02e8-68ac-4e79-8ca5-0939dd002c87"],"spl_set_id":["0391f1e1-70d4-4b15-8b58-055bb6a385b8"],"package_ndc":["42806-801-30","42806-801-01","42806-799-30","42806-799-60","42806-799-01","42806-799-05"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Rifampin, Capsule, 300 mg (NDC 42806-799-05)","company_name":"Epic Pharma, LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"05/03/2018","package_ndc":"0641-6047-10","generic_name":"Lorazepam Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA018140"],"brand_name":["LORAZEPAM"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6047","0641-6044","0641-6046","0641-6045"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["238100","238101","1665188","1665326"],"spl_id":["7c73dbc6-2623-4443-9b05-97dec7a0be2e"],"spl_set_id":["e9b54e42-04cf-4c62-90e1-36f7b31a4e81"],"package_ndc":["0641-6044-01","0641-6044-25","0641-6046-01","0641-6046-10","0641-6045-01","0641-6045-25","0641-6047-01","0641-6047-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"10/14/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Lorazepam, Injection, 4 mg/1 mL (NDC 0641-6047-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-085-88","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"800-818-4555","availability":"Available","openfda":{"application_number":["ANDA214134"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-085","57664-047","57664-046","57664-048","57664-049","57664-050","57664-051","57664-052","57664-083","57664-084","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88)","company_name":"Sun Pharmaceutical Industries, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-492-37","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487","63323-493","63323-496"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029","1737636","1737637","1737640","1737641","1737763","1737764"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33","fa12a8e8-09fd-496f-8cc6-ffe0eb02e2df"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74","d5e0d06f-ba1e-44d4-aa89-39d6c146dc23"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26","63323-492-08","63323-492-97","63323-493-03","63323-493-97","63323-493-01","63323-493-91","63323-496-03","63323-496-97"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 10 mg/1 mL (NDC 63323-492-37)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/13/2022","package_ndc":"0409-6648-02","generic_name":"Dextrose Monohydrate 50% Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Next Delivery: November 2026; Estimated Recovery: December 2026. Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA019445"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6648","0409-7517"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["727517","1795514"],"spl_id":["34b869af-c42d-457c-8b21-6215a4e07aff"],"spl_set_id":["4ed365da-4e62-4329-c1b9-c197ab4fb6e1"],"package_ndc":["0409-7517-66","0409-7517-16","0409-6648-16","0409-6648-02"],"unii":["LX22YL083G"]},"update_date":"10/27/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 50%, Injection, 25 g/50 mL (NDC 0409-6648-02)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"05/15/2026","update_type":"New","initial_posting_date":"05/15/2026","package_ndc":"0574-0521-25","generic_name":"Activated Charcoal Oral Suspension","contact_info":"866-634-9120","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["M023"],"brand_name":["ACTIDOSE AQUA"],"generic_name":["ACTIVATED CHARCOAL"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-0521"],"product_type":["HUMAN OTC DRUG"],"route":["ORAL"],"substance_name":["ACTIVATED CHARCOAL"],"rxcui":["309150","1251411"],"spl_id":["bd250d66-b8ea-4cab-a8f2-d2913a157fc5"],"spl_set_id":["c85dc235-3f42-4361-9bd2-1aaff798ad75"],"package_ndc":["0574-0521-25","0574-0521-74","0574-0521-76"],"unii":["2P3VWU3H10"]},"update_date":"05/15/2026","therapeutic_category":["Other"],"dosage_form":"Oral Suspension","presentation":"Actidose Aqua, Oral Suspension, 208 mg/1 mL (NDC 0574-0521-25)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/27/2018","package_ndc":"25021-652-82","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"Sagent: 866-625-1618","availability":"Available","related_info":"Marketed by Sagent Pharmaceuticals","openfda":{"application_number":["ANDA206166"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-652","25021-671"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734347","1734355","1734479","1734481"],"spl_id":["41f4446a-ca6e-465e-9a79-8c4f99eb1ac3"],"spl_set_id":["8c5c762f-d266-4b1a-809e-f11bfc89bc2d"],"package_ndc":["25021-671-82","25021-671-87","25021-652-82","25021-652-87"],"unii":["V910P86109"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)","company_name":"InfoRLife SA","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"63323-123-10","generic_name":"Methotrexate Sodium Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesaler for inventory","openfda":{"application_number":["ANDA040263"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE SODIUM"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-123"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL","INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1946772"],"spl_id":["880c2caa-1b11-45ce-a54e-a3733da367f0"],"spl_set_id":["b585f621-f6c9-4735-ab61-bd1b401f3df0"],"package_ndc":["63323-123-10"],"unii":["3IG1E710ZN"]},"update_date":"11/03/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium, Injection, 25 mg/1 mL (NDC 63323-123-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"12/08/2025","update_type":"New","initial_posting_date":"12/08/2025","package_ndc":"0781-9408-95","generic_name":"Ampicillin Sodium Injection","contact_info":"800-525-8747","related_info":"Discontinuation of private label only","openfda":{"application_number":["ANDA061395"],"brand_name":["AMPICILLIN"],"generic_name":["AMPICILLIN SODIUM"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-9408","0781-9401","0781-9402","0781-9407","0781-9404"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["AMPICILLIN SODIUM"],"rxcui":["308207","1721473","1721474","1721475","1721476"],"spl_id":["a3ddae6c-ac4c-425f-82b0-eb388d92bc0e"],"spl_set_id":["b371e1a5-1fef-4df2-8940-c4fc02b9e2f0"],"package_ndc":["0781-9401-78","0781-9401-95","0781-9402-78","0781-9402-95","0781-9407-78","0781-9407-95","0781-9404-85","0781-9404-95","0781-9408-80","0781-9408-95"],"unii":["JFN36L5S8K"]},"update_date":"12/08/2025","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Ampicillin Sodium, Injection, 2 g (NDC 0781-9408-95)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"47781-564-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA214547"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-564","47781-562","47781-563","47781-565","47781-566","47781-567","47781-568"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["db02ec6b-f17f-ab22-b671-e1ddb90e017c"],"spl_set_id":["7f2dd6ee-3363-c87c-9693-ed838942556c"],"package_ndc":["47781-562-01","47781-563-01","47781-564-01","47781-565-01","47781-566-01","47781-567-01","47781-568-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 47781-564-01)","company_name":"Alvogen","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"11534-195-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"732-382-6085 Monday to Friday 9 am to 3:45 pm","availability":"Available","openfda":{"application_number":["ANDA209799"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SUNRISE PHARMACEUTICAL, INC."],"product_ndc":["11534-195","11534-190","11534-191","11534-192","11534-193","11534-194","11534-196"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["60dcfbf6-d07a-4010-ae77-8a9ae4529828"],"spl_set_id":["ac102599-3a5b-4154-899e-6ff262be7ff7"],"package_ndc":["11534-190-01","11534-190-03","11534-191-01","11534-191-03","11534-192-01","11534-192-03","11534-193-01","11534-193-03","11534-194-01","11534-194-03","11534-195-01","11534-195-03","11534-196-01","11534-196-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/01/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 11534-195-01)","company_name":"Sunrise Pharmaceutical, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"71288-722-32","generic_name":"Bupivacaine Hydrochloride Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d","contact_info":"844-824-8426","availability":"Limited Availability","related_info":"Meitheal Pharmaceuticals is distributor/labeler","update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32)","company_name":"Kindos Pharmaceuticals Co. Ltd.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/23/2021","package_ndc":"63323-185-10","generic_name":"Sterile Water Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA088400"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-185"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["42c6c812-706a-425b-b8cb-931006e40484"],"spl_set_id":["e71c6c83-d518-496c-b2ab-efd5987e4783"],"package_ndc":["63323-185-07","63323-185-10","63323-185-09","63323-185-50","63323-185-08","63323-185-20","63323-185-04","63323-185-05"],"unii":["059QF0KO0R"]},"update_date":"11/03/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"62037-727-01","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA076655"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["62037-727","62037-725","62037-734","62037-726"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210"],"spl_id":["24aa9277-3773-489d-8459-f9215140c53f"],"spl_set_id":["85ef422d-af27-4126-9841-6892af1871d6"],"package_ndc":["62037-725-01","62037-734-01","62037-726-01","62037-727-01"],"unii":["4B3SC438HI"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/25/2022","change_date":"08/27/2026","package_ndc":"76204-027-01","generic_name":"Albuterol Sulfate Solution","contact_info":"803-806-3300","resolved_note":"Available","openfda":{"application_number":["ANDA218386"],"brand_name":["ALBUTEROL SULFATE INHALATION SOLUTION, 0.5%"],"generic_name":["ALBUTEROL SULFATE"],"manufacturer_name":["Ritedose Pharmaceuticals, LLC"],"product_ndc":["76204-027"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RESPIRATORY (INHALATION)"],"substance_name":["ALBUTEROL SULFATE"],"rxcui":["245314"],"spl_id":["4e7f86ab-55bc-c123-e063-6394a90abd8d"],"spl_set_id":["fdb4ac5a-bf0d-4896-89f7-1828c081b79e"],"package_ndc":["76204-027-11","76204-027-01"],"unii":["021SEF3731"]},"update_date":"08/27/2026","therapeutic_category":["Pediatric","Pulmonary/Allergy"],"dosage_form":"Solution","presentation":"Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01)","company_name":"Ritedose Pharmaceuticals, LLC","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"65162-025-09","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA202830"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["65162-025","65162-023","65162-024","65162-026","65162-027","65162-028"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850"],"spl_id":["4cc5e658-25c6-4a58-a93a-6e35242d6de4"],"spl_set_id":["c11cb3b6-3dff-477b-a249-b4c3118edc5f"],"package_ndc":["65162-023-09","65162-024-09","65162-025-09","65162-026-09","65162-027-09","65162-028-09"],"unii":["SJT761GEGS"]},"update_date":"10/06/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 65162-025-09)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"discontinued_date":"08/24/2026","update_type":"New","initial_posting_date":"08/24/2026","package_ndc":"0025-2742-31","generic_name":"Disopyramide Phosphate Capsule, Extended Release","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug","update_date":"08/24/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule, Extended Release","presentation":"Norpace CR, Capsule, Extended Release, 150 mg (NDC 0025-2742-31)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-9045-17","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA071168"],"brand_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9045","0409-1159","0409-1160","0409-1162","0409-1163","0409-1165","0409-9043","0409-9046","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride with Epinephrine, Injection, 150 mg/30 mL (5 mg/mL) (NDC 0409-9045-17)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"01/27/2026","update_type":"New","initial_posting_date":"01/27/2026","package_ndc":"63323-970-02","generic_name":"Benztropine Mesylate Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA090233"],"brand_name":["BENZTROPINE MESYLATE"],"generic_name":["BENZTROPINE MESYLATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-970"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BENZTROPINE MESYLATE"],"rxcui":["885205"],"spl_id":["11222231-55b1-48ee-a8f8-3385f1a2eb36"],"spl_set_id":["b03bd28e-3b44-41e4-9a7e-28b9d7975245"],"package_ndc":["63323-970-02"],"unii":["WMJ8TL7510"]},"update_date":"01/27/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Benztropine Mesylate, Injection, 1 mg/1 mL (NDC 63323-970-02)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0641-6056-10","generic_name":"Midazolam Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA075243"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6056","0641-6057","0641-6059","0641-6061","0641-6063","0641-6060"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["559c03fb-24ea-4b7b-8afd-e33cb3a2340a"],"spl_set_id":["575d8bf0-7af7-427c-a231-966e2a5e070d"],"package_ndc":["0641-6057-01","0641-6057-10","0641-6057-25","0641-6059-01","0641-6059-10","0641-6056-01","0641-6056-10","0641-6061-01","0641-6061-10","0641-6061-25","0641-6063-01","0641-6063-10","0641-6063-25","0641-6060-01","0641-6060-10"],"unii":["W7TTW573JJ"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"0009-0051-01","generic_name":"Medroxyprogesterone Acetate Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug; Withdrawal from sale expected September 2026.","openfda":{"application_number":["NDA011839"],"brand_name":["PROVERA"],"generic_name":["MEDROXYPROGESTERONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0051","0009-0065","0009-0287"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MEDROXYPROGESTERONE ACETATE"],"rxcui":["1000114","1000124","1000135","1000139","1000141","1000145"],"spl_id":["ebcdf2fb-760c-4a9a-80a1-a0c6b21a891a"],"spl_set_id":["a586be28-96af-4fed-a13f-9b94fd4c7405"],"package_ndc":["0009-0065-01","0009-0287-01","0009-0051-01"],"unii":["C2QI4IOI2G"]},"update_date":"08/31/2026","therapeutic_category":["Urology"],"dosage_form":"Tablet","presentation":"PROVERA, Tablet, 10 mg (NDC 0009-0051-01)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"07/24/2026","update_type":"New","initial_posting_date":"07/24/2026","package_ndc":"0074-3008-60","generic_name":"Lopinavir and Ritonavir Tablet","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA021906"],"brand_name":["KALETRA"],"generic_name":["LOPINAVIR AND RITONAVIR"],"manufacturer_name":["AbbVie Inc."],"product_ndc":["0074-3008","0074-3956","0074-4014"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LOPINAVIR","RITONAVIR"],"rxcui":["311369","597730","746645","847741","847745","847749"],"spl_id":["36abdfba-ddc2-43ae-9173-903d66a23b23"],"spl_set_id":["8290add3-4449-4e58-6c97-8fe1eec972e3"],"package_ndc":["0074-3956-46","0074-4014-12","0074-3008-60"],"nui":["N0000000246","N0000175889","N0000185503","N0000190114","N0000190107","N0000191001","N0000182137","N0000185607","N0000190118","N0000190113","N0000182141","N0000191266","N0000185507","N0000187064","N0000190117"],"pharm_class_moa":["HIV Protease Inhibitors [MoA]","P-Glycoprotein Inhibitors [MoA]","Cytochrome P450 3A Inhibitors [MoA]","Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]","Cytochrome P450 2D6 Inhibitors [MoA]","Cytochrome P450 2C19 Inducers [MoA]","Cytochrome P450 3A Inducers [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]","Cytochrome P450 3A4 Inhibitors [MoA]","Cytochrome P450 1A2 Inducers [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 2B6 Inducers [MoA]","UDP Glucuronosyltransferases Inducers [MoA]"],"pharm_class_epc":["Protease Inhibitor [EPC]","Cytochrome P450 3A Inhibitor [EPC]"],"unii":["2494G1JF75","O3J8G9O825"]},"update_date":"07/24/2026","therapeutic_category":["Antiviral"],"dosage_form":"Tablet","presentation":"Kaletra, Tablet, 100 mg; 25 mg (NDC 0074-3008-60)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"discontinued_date":"12/10/2025","update_type":"New","initial_posting_date":"12/10/2025","package_ndc":"58468-0127-1","generic_name":"Doxercalciferol Injection","contact_info":"800-633-1610","related_info":"Discontinuation of the manufacture of the drug","update_date":"12/10/2025","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Hectorol, Injection, 4 mcg/2 mL injection 50 multiple-dose vials (NDC 58468-0127-1)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-462-31","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-462","63323-464","63323-466","63323-465","63323-467","63323-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1672917","1672919","1673296","1673298","1724880","1724881","1724884","1724885","1725078","1725082","1725175","1725177","1012391","1012396","1012404","1012421","1012455","1012457"],"spl_id":["13a48007-3784-46f2-bd4d-da1004186b81","2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175","eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-462-03","63323-462-38","63323-464-09","63323-464-39","63323-466-09","63323-466-39","63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-31)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-9042-01","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA071165"],"brand_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9042","0409-1159","0409-1160","0409-1162","0409-1163","0409-1165","0409-9043","0409-9046","0409-9045"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride with Epinephrine, Injection, 25 mg/10 mL (2.5 mg/mL) (NDC 0409-9042-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-354-05","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-05)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"57664-607-88","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-818-4555","availability":"Unavailable","related_info":"Currently not marketed","update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 57664-607-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"discontinued_date":"10/22/2026","update_type":"New","initial_posting_date":"10/22/2026","package_ndc":"0378-6001-91","generic_name":"Metformin Hydrochloride Tablet, Extended Release","contact_info":"800-796-9526","related_info":"A business decision was made was discontinue manufacture of the drug product.","openfda":{"application_number":["ANDA200690"],"brand_name":["METFORMIN HYDROCHLORIDE"],"generic_name":["METFORMIN"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-6001","0378-6002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METFORMIN HYDROCHLORIDE"],"rxcui":["1807894","1807917"],"spl_id":["88a13bb5-a5b6-46be-b935-a4e2e187ea93"],"spl_set_id":["7e41818c-60e9-4bcf-9586-7bb8d33d5e89"],"package_ndc":["0378-6002-91","0378-6001-91"],"unii":["786Z46389E"]},"update_date":"10/22/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Metformin Hydrochloride, Tablet, Extended Release, 1000 mg (NDC 0378-6001-91)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-488-37","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-488","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"02/10/2026","update_type":"New","initial_posting_date":"02/10/2026","package_ndc":"65649-311-12","generic_name":"Chlorothiazide Oral Suspension","contact_info":"800-321-4576","openfda":{"application_number":["NDA011870"],"brand_name":["DIURIL"],"generic_name":["CHLOROTHIAZIDE"],"manufacturer_name":["Salix Pharmaceuticals, Inc"],"product_ndc":["65649-311"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CHLOROTHIAZIDE"],"rxcui":["213439","309198"],"spl_id":["e311f727-9882-4c42-bd5b-e8e38ee54466"],"spl_set_id":["bd936e35-1af8-42da-bcc0-f22489d68574"],"package_ndc":["65649-311-12"],"nui":["N0000175359","N0000175419","M0471776"],"pharm_class_pe":["Increased Diuresis [PE]"],"pharm_class_epc":["Thiazide Diuretic [EPC]"],"pharm_class_cs":["Thiazides [CS]"],"unii":["77W477J15H"]},"update_date":"02/10/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Oral Suspension","presentation":"Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12)","company_name":"Salix Pharmaceuticals, a division of Bausch Health US, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0264-4500-05","generic_name":"Amino Acid Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["ANDA091112"],"brand_name":["PLENAMINE"],"generic_name":["LYSINE ACETATE, LEUCINE, PHENYLALANINE, VALINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, HISTIDINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, AND TYROSINE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-4500"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LYSINE ACETATE","LEUCINE","PHENYLALANINE","VALINE","ISOLEUCINE","METHIONINE","THREONINE","TRYPTOPHAN","ALANINE","ARGININE","GLYCINE","HISTIDINE","PROLINE","GLUTAMIC ACID","SERINE","ASPARTIC ACID","TYROSINE"],"rxcui":["800584","1601982"],"spl_id":["905f7c55-bf0d-4150-90ef-e8f1a5455bc1"],"spl_set_id":["a3244d1a-45b0-4e4c-bd96-f0632d761a1f"],"package_ndc":["0264-4500-00","0264-4500-05"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["TTL6G7LIWZ","GMW67QNF9C","47E5O17Y3R","HG18B9YRS7","04Y7590D77","AE28F7PNPL","2ZD004190S","8DUH1N11BX","OF5P57N2ZX","94ZLA3W45F","TE7660XO1C","4QD397987E","9DLQ4CIU6V","3KX376GY7L","452VLY9402","30KYC7MIAI","42HK56048U"]},"update_date":"11/10/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Plenamine, Injection, 0.15 (NDC 0264-4500-05)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/26/2023","package_ndc":"60793-701-10","generic_name":"Penicillin G Benzathine Injection","related_info_link":"https://www.fda.gov/media/190713/download","contact_info":"800-533-4535","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA050141"],"brand_name":["BICILLIN L-A"],"generic_name":["PENICILLIN G BENZATHINE"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["60793-701","60793-700","60793-702"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["PENICILLIN G BENZATHINE"],"rxcui":["731564","731566","731567","731568","731570","731571"],"spl_id":["526e051e-d0fc-4f5d-886a-d61947aa8a7f"],"spl_set_id":["012d46f1-d0a0-4676-a879-cd320297ab16"],"package_ndc":["60793-700-01","60793-700-10","60793-701-02","60793-701-10","60793-702-04","60793-702-10"],"unii":["RIT82F58GK"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Bicillin L-A, Injection, 1200000 [iU]/2 mL (NDC 60793-701-10)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/15/2021","package_ndc":"55150-313-01","generic_name":"Methylprednisolone Acetate Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA211930"],"brand_name":["METHYLPREDNISOLONE ACETATE"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-313","55150-314"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358610","1358617"],"spl_id":["25c5133c-ee17-4be0-88a3-d0231e38f5a0"],"spl_set_id":["a0cbcdb5-f657-49f7-8f86-cc5959d69db0"],"package_ndc":["55150-313-25","55150-313-01","55150-314-25","55150-314-01"],"unii":["43502P7F0P"]},"update_date":"10/19/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 55150-313-01)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"68025-089-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Available","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-089","68025-088","68025-095","68025-096","68025-097","68025-084","68025-098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 63 mg (NDC 68025-089-30)","company_name":"Vertical Pharmaceuticals, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"0185-2099-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-525-8747","availability":"Limited Availability","related_info":"Estimated recovery: 1Q 2027","openfda":{"application_number":["ANDA040439"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0185-2099","0185-0831","0185-0842","0185-0853","0185-0864","0185-2098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577961"],"spl_id":["9a21fb59-a99c-4c63-91e8-4b5d72fbd9cd"],"spl_set_id":["288dafc4-fe6e-4891-832f-511022c87445"],"package_ndc":["0185-0831-01","0185-0842-01","0185-0853-01","0185-0864-01","0185-2099-01","0185-2098-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/09/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0185-2099-01)","company_name":"Sandoz Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"16729-137-16","generic_name":"Clonazepam Tablet","contact_info":"866-941-7875, option 2","resolved_note":"Available","openfda":{"application_number":["ANDA077147"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-137","16729-136","16729-138"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["0e1e7f41-f78b-27cf-e063-6394a90a1ae0"],"spl_set_id":["ebc11109-e7bf-452d-b675-4b3236d54164"],"package_ndc":["16729-136-00","16729-136-16","16729-137-00","16729-137-16","16729-138-00","16729-138-16"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 16729-137-16)","company_name":"Accord Healthcare Inc.","status":"Resolved"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"55150-335-01","generic_name":"Carboplatin Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: late-October 2026. Check wholesalers for inventory","openfda":{"application_number":["ANDA205487"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-335","55150-333","55150-334","55150-386"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["6029d051-ee8d-44cc-8dae-b91c3385d4c3","5abfcb87-bb02-4384-9c9d-7d0e3e809311"],"spl_set_id":["f5fe9a20-47a5-45b9-ab06-c6158d9b6aca","5abfcb87-bb02-4384-9c9d-7d0e3e809311"],"package_ndc":["55150-333-01","55150-334-01","55150-335-01","55150-386-01","55150-335-00","55150-386-00"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/19/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 450 mg/45 mL (NDC 55150-335-01)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"43547-412-09","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-931-9829","availability":"Unavailable","related_info":"Not available. Long-term backorder for all NDCs. No estimated release date at this time.","openfda":{"application_number":["ANDA205823"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Solco Healthcare US, LLC"],"product_ndc":["43547-412","43547-410","43547-411","43547-413"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["b8f1731a-cbac-4f64-a8d4-320b80b335e1"],"spl_set_id":["cd46691d-5593-4a9f-a937-999c6803e312"],"package_ndc":["43547-410-09","43547-411-09","43547-412-09","43547-413-09"],"unii":["33067B3N2M"]},"update_date":"06/29/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 20 mg (NDC 43547-412-09)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"63323-580-20","generic_name":"Atropine Sulfate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA209260"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-580"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ENDOTRACHEAL","INTRAMEDULLARY","INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190776"],"spl_id":["8039a2a4-4c0a-4062-9ca5-78137ba74082"],"spl_set_id":["310c8a74-ea24-4357-8099-81e394b1634e"],"package_ndc":["63323-580-20"],"unii":["03J5ZE7KA5"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, .4 mg/1 mL (NDC 63323-580-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-0280-03","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0280","0009-0274","0009-0306"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358510","1358512","1358610","1358612","1358617","1358619"],"spl_id":["267dd735-f800-4735-ba1c-d39d00f0cee5"],"spl_set_id":["823b0010-2b57-4e76-b5ac-4a8c2963438f"],"package_ndc":["0009-0274-01","0009-0280-02","0009-0280-51","0009-0280-03","0009-0280-52","0009-0306-02","0009-0306-12"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-03)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"04/28/2026","update_type":"New","initial_posting_date":"04/28/2026","package_ndc":"25021-311-10","generic_name":"Furosemide Injection","contact_info":"866-625-1618","related_info":"Distributed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA213902"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-311"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["222ce48f-2856-4be2-b16f-6fca38c0dceb"],"spl_set_id":["d63c1277-dd7e-4d21-9e80-68143f55e2dc"],"package_ndc":["25021-311-02","25021-311-04","25021-311-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"04/28/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-10)","company_name":"Gland Pharma Limited","status":"To Be Discontinued"},{"discontinued_date":"06/08/2026","update_type":"New","initial_posting_date":"06/08/2026","package_ndc":"0069-0197-30","generic_name":"Dacomitinib Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA211288"],"brand_name":["VIZIMPRO"],"generic_name":["DACOMITINIB"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0069-0197","0069-1198","0069-2299"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DACOMITINIB"],"rxcui":["2058915","2058922","2058924","2058926","2058930","2058932"],"spl_id":["3ffd0da1-5601-4ecc-a8fb-f484693cb4c5"],"spl_set_id":["4ab27d2f-e385-4e9c-b324-fa69c10b855a"],"package_ndc":["0069-0197-30","0069-1198-30","0069-2299-30"],"unii":["5092U85G58"]},"update_date":"06/08/2026","therapeutic_category":["Oncology"],"dosage_form":"Tablet","presentation":"Vizimpro, Tablet, 15 mg (NDC 0069-0197-30)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"10/30/2026","update_type":"New","initial_posting_date":"10/30/2026","package_ndc":"0338-0096-06","generic_name":"Cefazolin in Dextrose Injection","contact_info":"888-229-0001","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA207131"],"brand_name":["CEFAZOLIN"],"generic_name":["CEFAZOLIN SODIUM"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0096","0338-3508","0338-3503"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CEFAZOLIN SODIUM"],"rxcui":["1665050","1665060","2630753"],"spl_id":["092b9ea3-0c78-4236-80c9-ff97d09fa14e"],"spl_set_id":["d91a8d13-99a0-4d87-88dc-71cbd37922b4"],"package_ndc":["0338-3508-41","0338-3503-41","0338-0096-06"],"unii":["P380M0454Z"]},"update_date":"10/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cefazolin in Dextrose, Injection, 3g/150mL (NDC 0338-0096-06)","company_name":"Baxter Healthcare","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"62135-668-90","generic_name":"Quinapril/Hydrochlorothiazide Tablet","contact_info":"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com","availability":"Available","openfda":{"application_number":["ANDA076374"],"brand_name":["QUINAPRIL AND HYDROCHLOROTHIAZIDE"],"generic_name":["QUINAPRIL AND HYDROCHLOROTHIAZIDE"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-668","62135-667","62135-669"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE","HYDROCHLOROTHIAZIDE"],"rxcui":["310796","310797","310809"],"spl_id":["0c3f4504-d57e-aa79-e063-6294a90ad5b8"],"spl_set_id":["2eae533f-d0af-47e8-a1f2-94bc8cc89b5a"],"package_ndc":["62135-667-90","62135-668-90","62135-669-90"],"nui":["N0000175359","N0000175419","M0471776"],"pharm_class_pe":["Increased Diuresis [PE]"],"pharm_class_epc":["Thiazide Diuretic [EPC]"],"pharm_class_cs":["Thiazides [CS]"],"unii":["0J48LPH2TH","33067B3N2M"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 62135-668-90)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"discontinued_date":"12/22/2025","update_type":"New","initial_posting_date":"12/22/2025","package_ndc":"0002-8870-27","generic_name":"Mirikizumab-mrkz Injection","contact_info":"800-545-5979","related_info":"A business decision was made to discontinue. Distribution will end April 2026. The 200 mg/2 mL injection presentation (NDC 0002-1442-11) will remain.","openfda":{"application_number":["BLA761279"],"brand_name":["OMVOH"],"generic_name":["MIRIKIZUMAB-MRKZ"],"manufacturer_name":["Eli Lilly and Company"],"product_ndc":["0002-8870","0002-7575","0002-8011","0002-7717","0002-7722","0002-3116","0002-1442"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["MIRIKIZUMAB"],"rxcui":["2668391","2668398","2668405","2668410","2680728","2680732","2703047","2703048","2703049","2703050","2703051","2703052","2703053","2703054"],"spl_id":["3553ca93-cbe0-4286-b806-a423598eb42a"],"spl_set_id":["472cbe04-263e-433d-9a0f-58c1b50b715a"],"package_ndc":["0002-7575-01","0002-8011-01","0002-8011-27","0002-8011-61","0002-8870-01","0002-8870-27","0002-7717-11","0002-7717-61","0002-3116-01","0002-7722-11","0002-1442-01","0002-3116-11","0002-3116-61","0002-1442-11"],"nui":["N0000192799","N0000192798"],"pharm_class_epc":["Interleukin-23 Antagonist [EPC]"],"pharm_class_moa":["Interleukin-23 Antagonists [MoA]"],"unii":["Z7HVY03PHP"]},"update_date":"12/22/2025","therapeutic_category":["Gastroenterology","Other"],"dosage_form":"Injection","presentation":"Omvoh, Injection, 100 mg/1 mL (NDC 0002-8870-27)","company_name":"Eli Lilly and Co.","status":"To Be Discontinued"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"45963-677-96","generic_name":"Metoprolol Succinate Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA204161"],"brand_name":["METOPROLOL SUCCINATE"],"generic_name":["METOPROLOL SUCCINATE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["45963-677","45963-709","45963-676","45963-678"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METOPROLOL SUCCINATE"],"rxcui":["866412","866419","866427","866436"],"spl_id":["a7e9a234-a8a6-4afe-ba8e-d569772bc39a"],"spl_set_id":["b798601e-a369-4c8b-8235-08900e1b751d"],"package_ndc":["45963-709-11","45963-709-96","45963-676-11","45963-676-96","45963-677-11","45963-677-96","45963-678-11"],"unii":["TH25PD4CCB"]},"update_date":"08/31/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Metoprolol Succinate, Tablet, Extended Release, 100 mg (NDC 45963-677-96)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"07/30/2026","update_type":"New","initial_posting_date":"07/30/2026","package_ndc":"65219-801-01","generic_name":"Glycopyrrolate Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA209328"],"brand_name":["GLYCOPYRROLATE"],"generic_name":["GLYCOPYRROLATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-801"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["GLYCOPYRROLATE"],"rxcui":["1731582"],"spl_id":["516b2ac1-7eab-4d63-a0d0-97245858a1d0"],"spl_set_id":["250eeef7-b1a9-45e7-a927-7807232e10be"],"package_ndc":["65219-801-00","65219-801-01"],"unii":["V92SO9WP2I"]},"update_date":"07/30/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Glycopyrrolate, Injection, 0.2 mg per 1 mL (NDC 65219-801-01)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"47781-174-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA207388"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS,CII"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AMPHETAMINE SULFATE TABLETS, 5 MG,CLL"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-174","47781-175","47781-176","47781-177","47781-178","47781-179","47781-180"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AMPHETAMINE ASPARTATE MONOHYDRATE","AMPHETAMINE SULFATE","DEXTROAMPHETAMINE SACCHARATE","DEXTROAMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["eb490273-9334-1ae5-dd32-658e7fb0b40e"],"spl_set_id":["c907301d-e24d-9609-5529-fed14f94549f"],"package_ndc":["47781-174-30","47781-174-05","47781-174-01","47781-175-30","47781-175-05","47781-175-01","47781-176-30","47781-176-05","47781-176-01","47781-177-30","47781-177-05","47781-177-01","47781-178-30","47781-178-05","47781-178-01","47781-179-30","47781-179-05","47781-179-01","47781-180-30","47781-180-05","47781-180-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5mg (NDC 47781-174-01)","company_name":"Alvogen","status":"Current"},{"discontinued_date":"11/14/2025","update_type":"New","initial_posting_date":"11/14/2025","package_ndc":"0409-5093-11","generic_name":"Ceftazidime Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","update_date":"11/14/2025","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Tazicef, Injection, 2 g (NDC 0409-5093-11)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/25/2020","change_date":"08/06/2026","package_ndc":"0088-2102-24","generic_name":"Rifapentine Tablet, Film Coated","contact_info":"800-633-1610 Option 7","resolved_note":"Available","openfda":{"application_number":["NDA021024"],"brand_name":["PRIFTIN"],"generic_name":["RIFAPENTINE"],"manufacturer_name":["sanofi-aventis U.S. LLC"],"product_ndc":["0088-2102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAPENTINE"],"rxcui":["242671","261101"],"spl_id":["83c11919-ca6d-49f5-8f9f-7b8405fcbaec"],"spl_set_id":["3a64fb70-b85e-43d9-8bcd-7e893f568ae1"],"package_ndc":["0088-2102-01","0088-2102-24"],"nui":["N0000175501","M0019113"],"pharm_class_epc":["Rifamycin Antimycobacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["XJM390A33U"]},"update_date":"08/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Tablet","presentation":"Priftin, Tablet, Film Coated, 150 mg (NDC 0088-2102-24)","company_name":"Sanofi-Aventis U.S. LLC","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"63323-455-01","generic_name":"Morphine Sulfate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA204223"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-455","63323-452","63323-454","63323-458","63323-451"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731993","1732006","1732011","1732136","2003714"],"spl_id":["f5584ff8-f338-4d14-b29e-e37b3978b747"],"spl_set_id":["582f42e5-444e-4246-af8c-e7e28097c69a"],"package_ndc":["63323-452-00","63323-452-01","63323-454-00","63323-454-01","63323-455-00","63323-455-01","63323-458-00","63323-458-01","63323-451-00","63323-451-01"],"unii":["X3P646A2J0"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 5 mg/1 mL (NDC 63323-455-01)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"25021-655-02","generic_name":"Midazolam Hydrochloride Injection","contact_info":"Avet Pharmaceuticals, Inc.: 855-228-9470; Sagent Pharmaceuticals: 866-625-1618","availability":"Unavailable","related_info":"Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals","openfda":{"application_number":["ANDA090696"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-655"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666798"],"spl_id":["943346c0-d98e-4ac2-a1a2-75427decf2fc"],"spl_set_id":["e22611dd-1830-40af-9139-7cdb07f5a426"],"package_ndc":["25021-655-02"],"unii":["W7TTW573JJ"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02)","company_name":"Gland Pharma Limited","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"63323-852-25","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA019034"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-852","63323-851","63323-853","63323-854"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897653","897753","1724276","1724338","1724340","1724341"],"spl_id":["2cfa0a3e-eb57-4dea-ae2c-0b91176f0f67"],"spl_set_id":["e034eb96-03e0-46e1-8b92-5e1f94555e7b"],"package_ndc":["63323-851-03","63323-851-10","63323-851-07","63323-851-15","63323-851-50","63323-852-03","63323-852-25","63323-853-03","63323-853-25","63323-854-03","63323-854-10"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-852-25)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-1660-20","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1660","0409-1638","0409-1434","0409-1596","0409-7838","0409-7853","0409-7875"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["284397","309710","1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["3c5274fd-6597-4b88-babc-92e4e16c6329"],"spl_set_id":["548a88c0-afda-427e-75ac-5af0cfa2224c"],"package_ndc":["0409-1660-55","0409-1660-50","0409-1660-35","0409-1660-10","0409-1660-22","0409-1660-20","0409-1638-32","0409-1638-02","0409-1434-01","0409-1596-01","0409-1596-10","0409-7838-01","0409-7838-24","0409-7853-01","0409-7853-24","0409-7875-01","0409-7875-12"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-152-05","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-152","72888-497","72888-153","72888-154"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 72888-152-05)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-064-25","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1019","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-064","70069-061","70069-062","70069-063","70069-065","70069-066","70069-067"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-064-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"discontinued_date":"03/24/2026","update_type":"New","initial_posting_date":"03/24/2026","package_ndc":"0074-7098-01","generic_name":"Pilocarpine Hydrochloride Ophthalmic Solution","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/24/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Ophthalmic Solution","presentation":"Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-01)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"63323-452-01","generic_name":"Morphine Sulfate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA204223"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-452","63323-454","63323-455","63323-458","63323-451"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731993","1732006","1732011","1732136","2003714"],"spl_id":["f5584ff8-f338-4d14-b29e-e37b3978b747"],"spl_set_id":["582f42e5-444e-4246-af8c-e7e28097c69a"],"package_ndc":["63323-452-00","63323-452-01","63323-454-00","63323-454-01","63323-455-00","63323-455-01","63323-458-00","63323-458-01","63323-451-00","63323-451-01"],"unii":["X3P646A2J0"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 2 mg/1 mL (NDC 63323-452-01)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/01/2017","package_ndc":"0703-0018-01","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA078591"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-0018","0703-0110","0703-0113"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["1724338","1724340","1724341"],"spl_id":["540b835a-db66-417c-8507-0c1ed05c95bf"],"spl_set_id":["f0b78db9-a38c-41bb-8233-5e93f7f18c5c"],"package_ndc":["0703-0110-01","0703-0110-03","0703-0113-01","0703-0113-03","0703-0018-01"],"unii":["L960UP2KRW"]},"update_date":"11/02/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"43598-976-58","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"Distributed by DRL","availability":"Available","related_info":"Distributed by DRL","openfda":{"application_number":["ANDA209307"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Dr.Reddy's Laboratories Inc"],"product_ndc":["43598-976","43598-975"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["5785a11f-7784-4ae0-8029-f50b782eaf4a"],"spl_set_id":["d174c19d-56f1-4ef4-087c-23c26db8e40b"],"package_ndc":["43598-976-11","43598-976-58","43598-975-11","43598-975-58"],"unii":["1018WH7F9I"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58)","company_name":"Gland Pharma Limited","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"59651-724-05","generic_name":"Clonazepam Tablet","contact_info":"866-850-2876","resolved_note":"Available","openfda":{"application_number":["ANDA075150"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["59651-724","59651-722","59651-723"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"spl_set_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"package_ndc":["59651-722-01","59651-722-99","59651-723-01","59651-723-99","59651-724-01","59651-724-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 59651-724-05)","company_name":"Aurobindo Pharma USA","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"55150-200-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA205612"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-200","55150-195","55150-196","55150-197","55150-198","55150-199","55150-201"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734207","1734347","1734475","1734483"],"spl_id":["1e5f1368-058a-492c-b4b7-d9329a7745e2"],"spl_set_id":["3763b7b6-da49-4658-b93d-28f5da24d09e"],"package_ndc":["55150-195-20","55150-196-99","55150-197-20","55150-198-30","55150-199-20","55150-200-10","55150-201-20"],"unii":["V910P86109"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-200-10)","company_name":"Eugia US LLC","status":"Current"},{"discontinued_date":"11/21/2025","update_type":"New","initial_posting_date":"11/21/2025","package_ndc":"62037-720-01","generic_name":"Potassium Chloride Tablet, Extended Release","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA075604"],"brand_name":["POTASSIUM CHLORIDE"],"generic_name":["POTASSIUM CHLORIDE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["62037-720","62037-710"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["POTASSIUM CHLORIDE"],"rxcui":["1801294","1801298"],"spl_id":["01fbdb24-0987-40f6-a920-f36349f6ba61"],"spl_set_id":["db002ae3-f54c-40a4-9cb4-e5681bf426e3"],"package_ndc":["62037-710-01","62037-720-01","62037-720-05","62037-720-10"],"unii":["660YQ98I10"]},"update_date":"11/21/2025","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology"],"dosage_form":"Tablet","presentation":"Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"76045-005-11","generic_name":"Morphine Sulfate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA204223"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Fresenius Kabi, USA LLC"],"product_ndc":["76045-005","76045-238","76045-004","76045-006","76045-007","76045-008"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["894912","894914","998212","998213","1442790","2752697"],"spl_id":["e61f6eb4-cc71-47d3-b2f6-5e689c773779"],"spl_set_id":["1f53de80-efc8-4930-b3e3-fba0d026af05"],"package_ndc":["76045-238-01","76045-238-10","76045-004-01","76045-004-11","76045-005-01","76045-005-11","76045-006-01","76045-006-11","76045-007-01","76045-007-11","76045-008-01","76045-008-11"],"unii":["X3P646A2J0"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 4 mg/1 mL (NDC 76045-005-11)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"62332-601-25","generic_name":"Ketorolac Tromethamine Injection","contact_info":"908-393-9604","availability":"Available","openfda":{"application_number":["ANDA214456"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Alembic Pharmaceuticals Inc."],"product_ndc":["62332-601","62332-599","62332-600"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["9030f496-5021-4454-ac16-dbb376315608"],"spl_set_id":["419cf756-3c96-4bb8-ae96-6aea5a5f3afd"],"package_ndc":["62332-599-01","62332-599-25","62332-600-01","62332-600-25","62332-601-02","62332-601-25"],"unii":["4EVE5946BQ"]},"update_date":"05/15/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 62332-601-25)","company_name":"Alembic Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/01/2022","package_ndc":"0338-0023-04","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016694"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0023","0338-0017"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/03/2023","package_ndc":"76204-025-96","generic_name":"Cromolyn Sodium Concentrate","contact_info":"Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 or customerservice@omniviumpharma.com","availability":"Limited Availability","related_info":"No longer manufactured, some supplies still available in supply chain. Distributed by Ritedose Pharmaceuticals, LLC (855) 806 3300","update_date":"11/02/2026","therapeutic_category":["Pulmonary/Allergy"],"dosage_form":"Concentrate","presentation":"Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 76204-025-96)","company_name":"Ailex Pharmaceuticals","shortage_reason":"Other","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7040-04","generic_name":"Belladonna and Opium Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["BELLADONNA AND OPIUM"],"generic_name":["ATROPA BELLADONNA AND OPIUM"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7040","0574-7045"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["ATROPA BELLADONNA","OPIUM"],"rxcui":["312104","312107"],"spl_id":["7b45a1d7-c3a5-4434-a848-45638cedd6e1"],"spl_set_id":["8301e76b-134a-43d2-a7dc-c600ccf2695c"],"package_ndc":["0574-7040-12","0574-7040-04","0574-7045-12","0574-7045-04"],"unii":["37M3MZ001L","WQZ3G9PF0H"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Suppository","presentation":"Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"discontinued_date":"01/20/2026","update_type":"New","initial_posting_date":"01/20/2026","package_ndc":"25357-025-03","generic_name":"Riboflavin 5-phosphate  Ophthalmic Solution","contact_info":"949-367-9600","related_info":"Discontinuing manufacture of the product as of July 2026.","openfda":{"application_number":["NDA203324"],"brand_name":["PHOTREXA CROSS-LINKING KIT"],"generic_name":["RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC"],"manufacturer_name":["Glaukos Corporation"],"product_ndc":["25357-025"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["1925825","1925830"],"spl_id":["c945d9a7-2e14-41c7-a209-e537aba21749"],"spl_set_id":["f82cfe92-1a24-11e3-8ffd-0800200c9a66"],"package_ndc":["25357-025-03"]},"update_date":"01/20/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Ophthalmic Solution","presentation":"Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)","company_name":"Glaukos Corporation","status":"To Be Discontinued"},{"discontinued_date":"04/10/2026","update_type":"New","initial_posting_date":"04/10/2026","package_ndc":"69238-2512-9","generic_name":"Nitrofurantoin Oral Suspension","contact_info":"866-525-7270","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA201679"],"brand_name":["NITROFURANTOIN"],"generic_name":["NITROFURANTOIN"],"manufacturer_name":["Amneal Pharmaceuticals NY LLC"],"product_ndc":["69238-2512"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["NITROFURANTOIN"],"rxcui":["311989"],"spl_id":["87af7ed1-6ae7-4eaf-ab35-d46d07549450"],"spl_set_id":["80129dba-5939-4292-bfd0-8d53ba165941"],"package_ndc":["69238-2512-9"],"nui":["N0000175494","M0014892"],"pharm_class_epc":["Nitrofuran Antibacterial [EPC]"],"pharm_class_cs":["Nitrofurans [CS]"],"unii":["927AH8112L"]},"update_date":"04/10/2026","therapeutic_category":["Anti-Infective","Other"],"dosage_form":"Oral Suspension","presentation":"Nitrofurantoin, Oral Suspension, 25 mg/5 mL (NDC 69238-2512-9)","company_name":"Amneal Pharmaceuticals","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/26/2018","package_ndc":"25021-701-01","generic_name":"Ketorolac Tromethamine Injection","contact_info":"866-625-1618","availability":"Available","openfda":{"application_number":["ANDA204216"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-701","25021-700"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["cb23332a-48fa-458b-93ab-c4eef189a051"],"spl_set_id":["62591551-a644-4b2c-a0de-982e906fabc3"],"package_ndc":["25021-700-01","25021-701-01","25021-701-02"],"unii":["4EVE5946BQ"]},"update_date":"11/06/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 25021-701-01)","company_name":"Sagent Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0264-7510-20","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019626"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-7510","0264-7520"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE, UNSPECIFIED FORM"],"rxcui":["1795477","1795480","1795481","1795607","1795610","1795612"],"spl_id":["4acb5988-64ad-4f83-bc8d-6f2117dfebbe"],"spl_set_id":["085614c7-ada4-4e2c-87c0-c9bc2f18365a"],"package_ndc":["0264-7510-00","0264-7510-10","0264-7510-20","0264-7520-00","0264-7520-10","0264-7520-20"],"unii":["IY9XDZ35W2"]},"update_date":"10/19/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-20)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"42806-341-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(718) 276-8600 ext. 3","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040444"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Epic Pharma, LLC"],"product_ndc":["42806-341","42806-339","42806-343","42806-344","42806-345"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961"],"spl_id":["f11301e2-3b5d-468d-b44c-45839e7e5dfb"],"spl_set_id":["1757e132-061d-4773-89ed-fdc77f69008f"],"package_ndc":["42806-339-01","42806-341-01","42806-343-01","42806-344-01","42806-345-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 42806-341-01)","company_name":"Epic Pharma, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0990-6139-03","generic_name":"Sterile Water Irrigant","related_info_link":"https://www.fda.gov/media/182619/download?attachment","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Unavailable","related_info":"Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","update_date":"11/03/2026","therapeutic_category":["Gastroenterology","Other","Pediatric"],"dosage_form":"Irrigant","presentation":"Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-6139-03)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/17/2021","package_ndc":"0068-0660-50","generic_name":"Rifampin Injection","related_info_link":"https://wcms-internet.fda.gov/media/196768/download?attachment","contact_info":"800-633-1610","availability":"Available","openfda":{"brand_name":["RIFADIN"],"generic_name":["RIFAMPICIN"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0068-0660"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["207436","312821"],"spl_id":["5cebbeae-b984-4e38-a050-896320bf049c"],"spl_set_id":["1b074c23-dd35-43c9-820c-0e603481fdd3"],"package_ndc":["0068-0660-50","0068-0600-01","0068-0610-10"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Rifadin, Injection, 600 mg (NDC 0068-0660-50)","company_name":"Sanofi-Aventis U.S. LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"0517-1004-25","generic_name":"Atropine Sulfate Injection","contact_info":"800-645-1706","availability":"Available","related_info":"On allocation","openfda":{"application_number":["ANDA216120"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["American Regent, Inc."],"product_ndc":["0517-1004","0517-1001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190795","1666781"],"spl_id":["1c500ed9-94a9-472c-bfb7-50e1fcfc31fb"],"spl_set_id":["6fee1727-52b7-4f73-ab45-ef47d6a1c5bb"],"package_ndc":["0517-1004-01","0517-1004-25","0517-1001-01","0517-1001-25"],"unii":["03J5ZE7KA5"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, .4 mg/1 mL (NDC 0517-1004-25)","company_name":"American Regent, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"83634-653-05","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"Avenacy, LLC: 877-283-6229","availability":"Available","related_info":"Distributed by Avenacy, LLC","openfda":{"application_number":["ANDA219535"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Avenacy, LLC"],"product_ndc":["83634-653","83634-651"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1737562","1737566","1737568"],"spl_id":["8fb1dd7b-f349-4a64-96c1-bd72bf748f3b"],"spl_set_id":["46480253-29b9-4d7f-98ed-10377929026b"],"package_ndc":["83634-653-41","83634-653-02","83634-653-42","83634-653-05","83634-653-43","83634-653-30","83634-651-41","83634-651-10","83634-651-42","83634-651-20","83634-651-43","83634-651-50"],"unii":["V13007Z41A"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05)","company_name":"Anthea Pharma","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/11/2024","package_ndc":"0990-7120-07","generic_name":"Dextrose Monohydrate 70% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA019893"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical Inc."],"product_ndc":["0990-7120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["237656"],"spl_id":["90d9a0b7-d5a5-4897-90ae-47679f28dac8"],"spl_set_id":["cdf35d11-fbc8-4f8e-85a8-33220312c0b4"],"package_ndc":["0990-7120-07"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"44567-602-24","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"WG Critical Care 888-493-0861","availability":"Available","related_info":"Marketed by WG Critical Care","openfda":{"application_number":["NDA206628"],"brand_name":["DEXMEDETOMIDINE IN DEXTROSE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["WG Critical Care, LLC"],"product_ndc":["44567-602","44567-600","44567-601","44567-603"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909","1788947"],"spl_id":["ee503974-3f79-46d7-845f-2d15444dc0b8"],"spl_set_id":["0d2710f2-ee47-4114-ab5c-8dca74cdcb8d"],"package_ndc":["44567-600-04","44567-601-04","44567-602-01","44567-602-24","44567-603-01","44567-603-24"],"unii":["1018WH7F9I"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24)","company_name":"HQ Specialty Pharma","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/13/2017","change_date":"09/30/2026","package_ndc":"72205-102-01","generic_name":"Bumetanide Injection","contact_info":"855-668-2369; customerservice@novadozpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA215364"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-102","72205-101"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["387edfd4-be85-41cd-8a6d-14e6a022b5a9"],"spl_set_id":["387edfd4-be85-41cd-8a6d-14e6a022b5a9"],"package_ndc":["72205-101-01","72205-101-07","72205-102-01","72205-102-07"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, 0.25 mg/mL, 10 mL (NDC 72205-102-01)","company_name":"MSN Laboratories Private Limited","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"66794-229-41","generic_name":"Rocuronium Bromide Injection","contact_info":"800-414-1901","availability":"Limited Availability","related_info":"On allocation","openfda":{"application_number":["ANDA210437"],"brand_name":["ROCURONIUM"],"generic_name":["ROCURONIUM"],"manufacturer_name":["Piramal Critical Care Inc"],"product_ndc":["66794-229","66794-228"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["3f9e12e4-d3c5-fba6-e063-6294a90a7fd6"],"spl_set_id":["98255b70-51f9-8d16-e053-2995a90a8f97"],"package_ndc":["66794-229-02","66794-229-41","66794-228-02","66794-228-41"],"unii":["I65MW4OFHZ"]},"update_date":"09/15/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 100 mg/10 mL (NDC 66794-229-41)","company_name":"Piramal Critical Care Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/21/2023","package_ndc":"0641-1495-35","generic_name":"Promethazine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Additional lots will be available in the November 2026 timeframe.  Product will be made available as it is released.","openfda":{"application_number":["ANDA083312"],"brand_name":["PROMETHAZINE HYDROCHLORIDE"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-1495","0641-1496"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992460","992858"],"spl_id":["80a400d2-d293-4180-bfa7-7a8ce0734bc5"],"spl_set_id":["13d9e59d-eadb-41d5-9f47-9c11a6efb31c"],"package_ndc":["0641-1495-31","0641-1495-35","0641-1496-31","0641-1496-35"],"unii":["R61ZEH7I1I"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Pediatric","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-1495-35)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-495-27","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-495","63323-492","63323-491","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 20 mg/1 mL (NDC 63323-495-27)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0527-1502-37)","update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"0527-1502-37","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","company_name":"Lannett Company, Inc.","contact_info":"844-834-0530","availability":"Available","update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"status":"Current","dosage_form":"Tablet"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0017-02","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0017","0338-0023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-02)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1749-29","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1749","0409-1746","0409-1752","0409-1755","0409-2510","0409-7535","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 150 mg/30 mL (5 mg/mL 1:200,000) (NDC 0409-1749-29)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-286-63","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-286","63323-285","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cb6583ff-cde4-4280-aa5b-0bea2b844792","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","cb6583ff-cde4-4280-aa5b-0bea2b844792","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-51","63323-286-55","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 5 mg/1 mL (NDC 63323-286-63)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"39822-4200-2","generic_name":"Rocuronium Bromide Injection","contact_info":"866-390-4411","availability":"Available","related_info":"Tamarang is the application holder and X-Gen is the distributor/labeler","openfda":{"application_number":["ANDA091115"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["XGen Pharmaceuticals DJB, Inc."],"product_ndc":["39822-4200"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["eedcfb07-4e23-3152-e053-2995a90a6e6a"],"spl_set_id":["b73f192c-2912-4ec3-9b4f-05a58d9b35ba"],"package_ndc":["39822-4200-1","39822-4200-2","39822-4200-5","39822-4200-6"],"unii":["I65MW4OFHZ"]},"update_date":"09/22/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 39822-4200-2)","company_name":"XGen Pharmaceuticals DJB, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/01/2023","package_ndc":"60505-4744-1","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-706-5575","availability":"Available","openfda":{"application_number":["ANDA216944"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-4744","60505-4739","60505-4740","60505-4741","60505-4742","60505-4743","60505-4745"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0190bec9-05e4-0977-9548-2cc150b53e74"],"spl_set_id":["ecad4442-a644-18e3-6ff2-fdbac45eec47"],"package_ndc":["60505-4739-1","60505-4740-1","60505-4741-1","60505-4742-1","60505-4743-1","60505-4744-1","60505-4745-1"],"unii":["SJT761GEGS"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 60505-4744-1)","company_name":"Apotex Corp.","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-3182-01","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA089646"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3182","0409-1209","0409-3177","0409-3178","0409-3181","0409-3183","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/06/2017","package_ndc":"0143-9254-25","generic_name":"Dopamine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Additional lots will be available in the November 2026 timeframe.  Product will be made available as it is released.","openfda":{"application_number":["ANDA207707"],"brand_name":["DOPAMINE HYDROCHLORIDE"],"generic_name":["DOPAMINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9254","0143-9252","0143-9253","0143-9255"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1743938","1743941","1743950","1743953"],"spl_id":["67349236-e8e3-45ec-a76d-2a0a150d8d59"],"spl_set_id":["0e499952-46c7-4172-8c70-186312e240a3"],"package_ndc":["0143-9252-01","0143-9252-25","0143-9253-01","0143-9253-25","0143-9254-01","0143-9254-25","0143-9255-01","0143-9255-25"],"unii":["7L3E358N9L"]},"update_date":"10/14/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9254-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"61703-150-05","generic_name":"Carboplatin Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: December 2026; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA076517"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-150","61703-360","61703-262","61703-600"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["5aa72c15-8033-4559-b257-373371b18958"],"spl_set_id":["47677091-fd20-49af-933c-c9dd2be21de9"],"package_ndc":["61703-360-18","61703-150-05","61703-262-05","61703-600-05"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/09/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 150 mg/15 mL (10 mg/mL) (NDC 61703-150-05)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-062-25","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1019","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-062","70069-061","70069-063","70069-064","70069-065","70069-066","70069-067"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-062-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-061-25","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1019","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-061","70069-062","70069-063","70069-064","70069-065","70069-066","70069-067"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 70069-061-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-051-88","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-818-4555","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA214484"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-051","57664-047","57664-046","57664-048","57664-049","57664-050","57664-052","57664-083","57664-084","57664-085","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 57664-051-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"0409-9094-22","generic_name":"Fentanyl Citrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA019115"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9094","0409-9093"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735004","1735006","1735007","1735008","1735013"],"spl_id":["8ff8b8cf-1a31-46dc-b350-2b9cc700e6a6"],"spl_set_id":["bfa8018a-4cbc-434b-e09e-782872b0340a"],"package_ndc":["0409-9093-41","0409-9093-36","0409-9093-31","0409-9093-38","0409-9094-12","0409-9094-22","0409-9094-18","0409-9094-25","0409-9094-17","0409-9094-28","0409-9094-16","0409-9094-31","0409-9094-41","0409-9094-61","0409-9094-44","0409-9094-55"],"unii":["MUN5LYG46H"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 100 mcg/2 mL (50 ug/1 mL) (NDC 0409-9094-22)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0955-1003-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["ENOXAPARIN SODIUM"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0955-1003","0955-1004","0955-1006","0955-1008","0955-1010","0955-1016","0955-1012","0955-1015"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854235","854238","854241","854245","854248","854252","854255"],"spl_id":["8f06a411-badb-483f-852d-8e6124acfa44"],"spl_set_id":["20635579-c92d-4f6c-a332-1096d51002f2"],"package_ndc":["0955-1003-01","0955-1003-10","0955-1004-01","0955-1004-10","0955-1006-01","0955-1006-10","0955-1008-01","0955-1008-10","0955-1010-01","0955-1010-10","0955-1016-01","0955-1012-01","0955-1012-10","0955-1015-01","0955-1015-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Enoxaparin Sodium, Injection, 30 mg/.3 mL (NDC 0955-1003-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/17/2015","package_ndc":"0143-9933-25","generic_name":"Cefotaxime Sodium Powder, for Solution","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA065072"],"brand_name":["CEFOTAXIME"],"generic_name":["CEFOTAXIME"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9933","0143-9931","0143-9930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CEFOTAXIME SODIUM"],"rxcui":["309068","1656313","1656318"],"spl_id":["7e0897ec-2275-4438-9cc5-4c951e52ad97"],"spl_set_id":["ed23b6bc-32c7-4c50-a53d-313ae78e5623"],"package_ndc":["0143-9931-01","0143-9931-25","0143-9933-01","0143-9933-25","0143-9930-01","0143-9930-10"],"unii":["258J72S7TZ"]},"update_date":"10/14/2026","therapeutic_category":["Anti-Infective","Pediatric"],"dosage_form":"Powder, For Solution","presentation":"Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"0409-3299-06","generic_name":"Sodium Acetate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018893"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3299"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["237371"],"spl_id":["4e6137c2-6b7c-4882-985c-03b591b6c046","b7a713f4-3c97-484b-b182-2824e1e944bb"],"spl_set_id":["abc41ed1-9512-4bea-9295-1a9ca134b6c2","c3be2468-45e8-4ecc-a30b-e966743a563f"],"package_ndc":["0409-3299-15","0409-3299-05","0409-3299-16","0409-3299-06","0409-3299-45","0409-3299-25","0409-3299-46","0409-3299-26"],"unii":["NVG71ZZ7P0"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/01/2017","package_ndc":"0409-6625-14","generic_name":"Sodium Bicarbonate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA202432"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6625"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["1868486"],"spl_id":["dcc55d90-d55e-4e1a-9e48-5703cbc74a52","c39c0ef6-4140-4c6c-91c4-e43d67872b05"],"spl_set_id":["8664c7ce-707b-4c6c-9ce4-7160b5f877f8","084f5572-8c1f-4802-b179-ca0cc838fc68"],"package_ndc":["0409-6625-30","0409-6625-35","0409-6625-22","0409-6625-14"],"unii":["8MDF5V39QO"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-105-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA021977"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-105","59417-101","59417-102","59417-103","59417-104","59417-106","59417-107","59417-115","59417-116","59417-117","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Vyvanse, Capsule, 50 mg (NDC 59417-105-10)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"discontinued_date":"07/27/2026","update_type":"New","initial_posting_date":"07/27/2026","package_ndc":"0173-0717-22","generic_name":"Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered","contact_info":"888-825-5249","related_info":"The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026.  The 120 dose presentation of this product will still be available.","openfda":{"application_number":["NDA021254"],"brand_name":["ADVAIR HFA"],"generic_name":["FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"],"manufacturer_name":["GlaxoSmithKline LLC"],"product_ndc":["0173-0717","0173-0715","0173-0716"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RESPIRATORY (INHALATION)"],"substance_name":["FLUTICASONE PROPIONATE","SALMETEROL XINAFOATE"],"rxcui":["896231","896235","896236","896237","896239","896243","896244","896245","896267","896271","896272","896273"],"spl_id":["bea52e57-aa75-4dce-8cfb-a163bbc22be2"],"spl_set_id":["dfaca6f9-3277-47b2-319d-1377917cb54c"],"package_ndc":["0173-0715-20","0173-0715-22","0173-0716-20","0173-0716-22","0173-0717-20","0173-0717-22"],"unii":["6EW8Q962A5","O2GMZ0LF5W"]},"update_date":"07/27/2026","therapeutic_category":["Pulmonary/Allergy"],"presentation":"Advair HFA, Aerosol, Metered, 230 ug; 21 ug (NDC 0173-0717-22)","company_name":"GlaxoSmithKline","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-3178-02","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: January 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA089644"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3178","0409-1209","0409-3177","0409-3181","0409-3182","0409-3183","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"0406-8891-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-325-8888","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040440"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-8891","0406-8884","0406-8892","0406-8885","0406-8893","0406-8894"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["0d3fb5ba-ff79-4862-bc1d-45b8343e115b"],"spl_set_id":["72ddd1c9-ddbd-4c95-acd9-003189a353a3"],"package_ndc":["0406-8891-01","0406-8884-01","0406-8892-01","0406-8885-01","0406-8893-01","0406-8894-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 0406-8891-01)","company_name":"SpecGx LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"05/03/2022","package_ndc":"17478-050-02","generic_name":"Sufentanil Citrate Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Not currently manufactured","update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-02)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/23/2021","package_ndc":"0641-6147-10","generic_name":"Sterile Water Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Additional lots will be available in the November 2026 timeframe.  Product will be made available as it is released.","openfda":{"application_number":["ANDA206369"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["081540ac-58cf-437f-ba1b-86d5264ec3dc"],"spl_set_id":["78ef7ad3-451d-43d0-a9b6-5cf0aadca003"],"package_ndc":["0641-6147-01","0641-6147-10","0641-6147-25"],"unii":["059QF0KO0R"]},"update_date":"10/14/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water, Injection, 1 mL/1 mL (NDC 0641-6147-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0480-3569-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA202802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Teva Pharmaceuticals, Inc."],"product_ndc":["0480-3569","0480-3565","0480-3566","0480-3567","0480-3568","0480-3570","0480-3564"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["7a1feaa2-6b58-4aff-a45b-533ee3174e53"],"spl_set_id":["c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fc"],"package_ndc":["0480-3565-01","0480-3566-01","0480-3567-01","0480-3568-01","0480-3569-01","0480-3570-01","0480-3564-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0480-3569-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"02/10/2026","update_type":"New","initial_posting_date":"02/10/2026","package_ndc":"0071-0737-20","generic_name":"Gemfibrozil Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug.","update_date":"02/10/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Lopid, Tablet, 600 mg (NDC 0071-0737-20)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"03/02/2026","update_type":"New","initial_posting_date":"03/02/2026","package_ndc":"0093-7769-24","generic_name":"Everolimus Tablet","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/02/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, 10 mg (NDC 0093-7769-24)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"59651-722-01","generic_name":"Clonazepam Tablet","contact_info":"866-850-2876","resolved_note":"Available","openfda":{"application_number":["ANDA075150"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["59651-722","59651-723","59651-724"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"spl_set_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"package_ndc":["59651-722-01","59651-722-99","59651-723-01","59651-723-99","59651-724-01","59651-724-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 59651-722-01)","company_name":"Aurobindo Pharma USA","status":"Resolved"},{"discontinued_date":"07/17/2026","update_type":"New","initial_posting_date":"07/17/2026","package_ndc":"0409-3578-01","generic_name":"Tobramycin Sulfate Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA063111"],"brand_name":["TOBRAMYCIN"],"generic_name":["TOBRAMYCIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3578"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["TOBRAMYCIN SULFATE"],"rxcui":["597823"],"spl_id":["d69232fd-aeae-44b9-9e43-2f2e5bd843be"],"spl_set_id":["c5a005b0-7b6f-4e30-df92-9a20b1ca66a1"],"package_ndc":["0409-3578-11","0409-3578-01"],"unii":["HJT0RXD7JK"]},"update_date":"07/17/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Tobramycin Sulfate, Injection, 80 mg/2 mL (40 mg/mL); 2 mL Multiple Dose Glass Fliptop Vial (NDC 0409-3578-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"discontinued_date":"04/15/2026","update_type":"New","initial_posting_date":"04/15/2026","package_ndc":"0093-8072-56","generic_name":"Tiagabine Hydrochloride Tablet","contact_info":"888-838-2872","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Tiagabine Hydrochloride, Tablet, 12mg 30 count (NDC 0093-8072-56)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"05/03/2018","package_ndc":"65219-368-02","generic_name":"Lorazepam Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA217598"],"brand_name":["LORAZEPAM"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-368"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["1665188"],"spl_id":["5cd2d0d8-9639-4e96-aafd-4991ad35fabc","462a13da-259a-40e7-bd5b-f7f42ae025b7"],"spl_set_id":["b2487467-a63f-48b5-b0de-3a6ce6672d50","462a13da-259a-40e7-bd5b-f7f42ae025b7"],"package_ndc":["65219-368-01","65219-368-02","65219-368-14","65219-368-24"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"11/03/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Lorazepam, Injection, 2 mg/1 mL (NDC 65219-368-02)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"11/13/2025","update_type":"New","initial_posting_date":"11/13/2025","package_ndc":"0228-2855-11","generic_name":"Guanfacine Hydrochloride Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA200881"],"brand_name":["GUANFACINE"],"generic_name":["GUANFACINE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2855","0228-2850","0228-2851","0228-2853"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GUANFACINE HYDROCHLORIDE"],"rxcui":["862006","862013","862019","862025"],"spl_id":["00143252-2b74-4b11-86ed-9b864635f129"],"spl_set_id":["3a171942-37af-430d-8b9d-bb678ca2be4b"],"package_ndc":["0228-2850-11","0228-2851-11","0228-2853-11","0228-2855-11"],"unii":["PML56A160O"]},"update_date":"11/13/2025","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Guanfacine Hydrochloride, Tablet, Extended Release, 4 mg (NDC 0228-2855-11)","company_name":"Actavis Pharma, Inc.","status":"To Be Discontinued"},{"discontinued_date":"10/01/2026","update_type":"New","initial_posting_date":"10/07/2026","package_ndc":"0603-3583-28","generic_name":"Felodipine Tablet, Film Coated, Extended Release","contact_info":"(800) 828-9393","related_info":"Discontinuation in the manufacturing of the drug product","openfda":{"application_number":["ANDA200815"],"brand_name":["FELODIPINE"],"generic_name":["FELODIPINE"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["0603-3583","0603-3581","0603-3582"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FELODIPINE"],"rxcui":["402695","402696","402698"],"spl_id":["02151da2-890e-4f84-94c8-6ce767d9ff12"],"spl_set_id":["55637724-8757-11de-8a39-0800200c9a66"],"package_ndc":["0603-3581-28","0603-3581-21","0603-3582-21","0603-3582-28","0603-3583-28","0603-3583-21"],"nui":["N0000000069","N0000175421","M0006414"],"pharm_class_moa":["Calcium Channel Antagonists [MoA]"],"pharm_class_epc":["Dihydropyridine Calcium Channel Blocker [EPC]"],"pharm_class_cs":["Dihydropyridines [CS]"],"unii":["OL961R6O2C"]},"update_date":"10/07/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Felodipine, Tablet, Film Coated, Extended Release, 10 mg (NDC 0603-3583-28)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"61269-620-10","generic_name":"Clonazepam Tablet","contact_info":"orders@h2-pharma.com","resolved_note":"Available","openfda":{"application_number":["NDA017533"],"brand_name":["KLONOPIN"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["H2-Pharma, LLC"],"product_ndc":["61269-620","61269-605","61269-610"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","206157","206159","206160"],"spl_id":["63cfdab9-fb3d-4c2b-bf88-8ba841dba839"],"spl_set_id":["cfa0d79a-843c-4b88-95a1-e9511d649ca1"],"package_ndc":["61269-605-10","61269-610-10","61269-620-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Klonopin, Tablet, 2 mg (NDC 61269-620-10)","company_name":"Cheplapharm Arzneimittel GmbH","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-472-37","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA070554"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-472","63323-463","63323-461","63323-468"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012413","1012417","1724786","1724787","1724809","1724810","1867594","1867596","1867618","1867620"],"spl_id":["cc1f6507-eb3e-4398-a1d3-0c56a2099e6b"],"spl_set_id":["bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb"],"package_ndc":["63323-472-03","63323-472-17","63323-472-01","63323-472-37","63323-463-01","63323-463-57","63323-461-01","63323-461-57","63323-468-02","63323-468-37","63323-468-01","63323-468-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"11/14/2025","update_type":"New","initial_posting_date":"11/14/2025","package_ndc":"0409-5017-01","generic_name":"Vancomycin Hydrochloride Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","update_date":"11/14/2025","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Vancomycin Hydrochloride, Injection, 10 g Vial NovaPlus (NDC 0409-5017-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"discontinued_date":"12/08/2025","update_type":"New","initial_posting_date":"12/08/2025","package_ndc":"0781-9412-92","generic_name":"Ampicillin Sodium Injection","contact_info":"800-525-8747","related_info":"Discontinuation of private label only","openfda":{"application_number":["ANDA062738"],"brand_name":["AMPICILLIN"],"generic_name":["AMPICILLIN SODIUM"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-9412","0781-9413"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["AMPICILLIN SODIUM"],"rxcui":["1721475","1721476"],"spl_id":["f1afd007-8e8c-40e2-b353-8def35a0ce8b"],"spl_set_id":["f77db491-31c4-4a7c-a114-0f3244c97090"],"package_ndc":["0781-9412-15","0781-9412-92","0781-9413-15","0781-9413-92"],"unii":["JFN36L5S8K"]},"update_date":"12/08/2025","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Ampicillin Sodium, Injection, 1 g (NDC 0781-9412-92)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7093-12","generic_name":"Hydrocortisone Acetate Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["HYDROCORTISONE ACETATE"],"generic_name":["HYDROCORTISONE ACETATE"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7093","0574-7090"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["HYDROCORTISONE ACETATE"],"rxcui":["1291082","1291085"],"spl_id":["5ae35aec-6ba9-48b8-8b5f-c1b5accb9e1c"],"spl_set_id":["2fdb9940-6da8-49b0-a236-9817943f7a4b"],"package_ndc":["0574-7090-12","0574-7093-12"],"unii":["3X7931PO74"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction","Other"],"dosage_form":"Suppository","presentation":"Hydrocortisone Acetate, Suppository, 30 mg (NDC 0574-7093-12)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/20/2023","package_ndc":"0641-6029-25","generic_name":"Fentanyl Citrate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.","openfda":{"application_number":["NDA019101"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6029","0641-6024","0641-6027","0641-6025","0641-6028","0641-6026","0641-6030","0641-6247","0641-6248","0641-6249"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270","2474269","2629337"],"spl_id":["4eb40afd-eae7-4006-8934-4e1d43d59ea7"],"spl_set_id":["ce5db1c2-feb1-4ad2-847a-d02e865bd47e"],"package_ndc":["0641-6024-01","0641-6024-10","0641-6027-01","0641-6027-25","0641-6025-01","0641-6025-10","0641-6028-01","0641-6028-10","0641-6028-25","0641-6026-01","0641-6026-05","0641-6029-01","0641-6029-25","0641-6030-01","0641-6247-01","0641-6247-25","0641-6248-01","0641-6248-10","0641-6249-01","0641-6249-10"],"unii":["MUN5LYG46H"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6029-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"0093-3213-05","generic_name":"Clonazepam Tablet","contact_info":"800-545-8800","resolved_note":"Available","openfda":{"application_number":["ANDA074569"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-3213","0093-0832","0093-3212"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["d6abe4e3-7699-4ead-95f4-739a961b23ad"],"spl_set_id":["8069b1a0-7c06-4252-b44e-e2eef065d9b8"],"package_ndc":["0093-0832-01","0093-0832-05","0093-3212-01","0093-3212-05","0093-3213-01","0093-3213-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 0093-3213-05)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1163-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070597"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1163","0409-1159","0409-1160","0409-1162","0409-1165","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 250 mg/50 mL (5 mg/mL) (NDC 0409-1163-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1162-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070584"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1162","0409-1159","0409-1160","0409-1163","0409-1165","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-1162-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"13811-706-10","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Allocation to current contracted customers","openfda":{"application_number":["ANDA205327"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Trigen Laboratories, LLC"],"product_ndc":["13811-706","13811-709","13811-707","13811-708","13811-710"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461"],"spl_id":["0944cf70-d59a-483b-9698-e96ef955a65a"],"spl_set_id":["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"],"package_ndc":["13811-709-10","13811-706-10","13811-707-10","13811-708-10","13811-710-10","13811-710-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)","company_name":"Trigen Laboratories, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"63323-851-15","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesaler for inventory","openfda":{"application_number":["NDA019034"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-851","63323-852","63323-853","63323-854"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897653","897753","1724276","1724338","1724340","1724341"],"spl_id":["2cfa0a3e-eb57-4dea-ae2c-0b91176f0f67"],"spl_set_id":["e034eb96-03e0-46e1-8b92-5e1f94555e7b"],"package_ndc":["63323-851-03","63323-851-10","63323-851-07","63323-851-15","63323-851-50","63323-852-03","63323-852-25","63323-853-03","63323-853-25","63323-854-03","63323-854-10"],"unii":["L960UP2KRW"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-851-15)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"08/03/2022","package_ndc":"62135-736-90","generic_name":"Flurazepam Hydrochloride Capsule","contact_info":"845-268-5000 Ext. 510","availability":"Available","openfda":{"application_number":["ANDA072368"],"brand_name":["FLURAZEPAM HYDROCHLORIDE"],"generic_name":["FLURAZEPAM HYDROCHLORIDE"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-736","62135-737"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FLURAZEPAM HYDROCHLORIDE"],"rxcui":["1298088","1298091"],"spl_id":["25893c92-c8f1-567a-e063-6294a90a00d4"],"spl_set_id":["8f476891-1346-4e8c-ac1b-f8cbdc64f5a1"],"package_ndc":["62135-736-30","62135-736-90","62135-737-30","62135-737-90"],"unii":["756RDM536M"]},"update_date":"09/15/2026","therapeutic_category":["Oncology","Other"],"dosage_form":"Capsule","presentation":"Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"57884-3151-1","generic_name":"Daptomycin Injection","contact_info":"609-395-8625 ext. 203","related_info":"Discontinuation of the manufacture of the drug","update_date":"06/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Daptomycin, Injection, 500 mg/10 mL (NDC 57884-3151-1)","company_name":"Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"70069-753-25","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Unavailable","related_info":"Estimated recovery: June 2027","openfda":{"application_number":["ANDA217792"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-753","70069-752"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["2b24af95-6f20-4945-bf8c-742f1d6f2721"],"spl_set_id":["bcaab86f-20f0-4482-8d73-e29b36dced58"],"package_ndc":["70069-752-25","70069-752-10","70069-752-01","70069-753-25","70069-753-01","70069-753-10"],"unii":["7TQO7W3VT8"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-753-25)","company_name":"Somerset Therapeutics, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"New","initial_posting_date":"02/20/2018","package_ndc":"31722-276-34","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-529-0430, customerservice@camberpharma.com","availability":"Available","openfda":{"application_number":["ANDA217821"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Camber Pharmaceuticals, Inc."],"product_ndc":["31722-276","31722-275","31722-277"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["4ea16f8e-77de-3ba7-e063-6394a90a5667"],"spl_set_id":["0e552e3a-cf52-4d74-9381-6cc1b29b4c90"],"package_ndc":["31722-275-10","31722-275-31","31722-275-32","31722-275-30","31722-275-33","31722-275-34","31722-275-35","31722-276-10","31722-276-31","31722-276-32","31722-276-30","31722-276-33","31722-276-34","31722-277-10","31722-277-31","31722-277-32","31722-277-30","31722-277-33","31722-277-34"],"unii":["7TQO7W3VT8"]},"update_date":"07/17/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 31722-276-34)","company_name":"Aspiro Pharma Limited","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0641-6057-25","generic_name":"Midazolam Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA075243"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6057","0641-6059","0641-6056","0641-6061","0641-6063","0641-6060"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["559c03fb-24ea-4b7b-8afd-e33cb3a2340a"],"spl_set_id":["575d8bf0-7af7-427c-a231-966e2a5e070d"],"package_ndc":["0641-6057-01","0641-6057-10","0641-6057-25","0641-6059-01","0641-6059-10","0641-6056-01","0641-6056-10","0641-6061-01","0641-6061-10","0641-6061-25","0641-6063-01","0641-6063-10","0641-6063-25","0641-6060-01","0641-6060-10"],"unii":["W7TTW573JJ"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/16/2026","package_ndc":"72336-032-01","generic_name":"Isocarboxazid Tablet","contact_info":"833.627.0070","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA011961"],"brand_name":["MARPLAN"],"generic_name":["ISOCARBOXAZID"],"manufacturer_name":["Lifsa Drugs LLC"],"product_ndc":["72336-032"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ISOCARBOXAZID"],"rxcui":["104837","201708"],"spl_id":["97745d9b-c2a6-45e3-9e1e-7fabec4681fb"],"spl_set_id":["95fde749-44ad-4668-86c4-0ff17bca0074"],"package_ndc":["72336-032-01"],"nui":["N0000175744","N0000000184"],"pharm_class_epc":["Monoamine Oxidase Inhibitor [EPC]"],"pharm_class_moa":["Monoamine Oxidase Inhibitors [MoA]"],"unii":["34237V843T"]},"update_date":"08/06/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Marplan, Tablet, 10 mg, 100 count bottle (NDC 72336-032-01)","company_name":"Lifsa Drugs LLC","shortage_reason":"Other","status":"Current"},{"discontinued_date":"05/21/2026","update_type":"New","initial_posting_date":"05/21/2026","package_ndc":"65219-080-05","generic_name":"Gadoterate Meglumine Injection","contact_info":"Marketed by Fresenius Kabi, USA; Customer service: 888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA215304"],"brand_name":["GADOTERATE MEGLUMINE"],"generic_name":["GADOTERATE MEGLUMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-080","65219-082","65219-084","65219-086"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOTERATE MEGLUMINE"],"spl_id":["f05922b7-99d4-48c7-972a-7966bbbbc3b4"],"spl_set_id":["e0655aac-9508-4141-94f5-fcca6af1c41d"],"package_ndc":["65219-080-01","65219-080-05","65219-082-01","65219-082-10","65219-084-01","65219-084-15","65219-086-01","65219-086-20"],"unii":["L0ND3981AG"]},"update_date":"05/21/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-080-05)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"63323-671-50","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0426-52","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020163"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0426","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0426-52)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0338-0499-06","generic_name":"Amino Acid Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA020849"],"brand_name":["PROSOL"],"generic_name":["VALINE, LYSINE, HISTIDINE, ISOLEUCINE, LEUCINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0499"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["VALINE","LYSINE ACETATE","HISTIDINE","ISOLEUCINE","LEUCINE","PHENYLALANINE","THREONINE","METHIONINE","TRYPTOPHAN","ALANINE","GLYCINE","ARGININE","PROLINE","GLUTAMIC ACID","SERINE","ASPARTIC ACID","TYROSINE"],"rxcui":["801133","801136"],"spl_id":["d9155d93-c6b9-46c8-96af-33b069a17f57"],"spl_set_id":["cc2ace81-5881-43f1-ba94-41b674adc2fc"],"package_ndc":["0338-0499-06"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["HG18B9YRS7","TTL6G7LIWZ","4QD397987E","04Y7590D77","GMW67QNF9C","47E5O17Y3R","2ZD004190S","AE28F7PNPL","8DUH1N11BX","OF5P57N2ZX","TE7660XO1C","94ZLA3W45F","9DLQ4CIU6V","3KX376GY7L","452VLY9402","30KYC7MIAI","42HK56048U"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER, Injection, 2.76 g/100 mL; 1.96 g/100 mL; 600 mg/100 mL; 1.02 g/100 mL; 2.06 g/100 mL; 1.18 g/100 mL; 1.08 g/100 mL; 1.08 g/100 mL; 1.35 g/100 mL; 760 mg/100 mL; 1 g/100 mL; 1.34 g/100 mL; 1.02 g/100 mL; 980 mg/100 mL; 320 mg/100 mL; 50 mg/100 mL; 1.44 g/100 mL (NDC 0338-0499-06)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-354-30","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-30)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-161-01","generic_name":"Ketorolac Tromethamine Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA075784"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-161","63323-162"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["2b1c6066-d9e0-40a0-ade5-776fc35a3626","55ed7afb-db66-4b28-939b-db45b55bf058","ab476c4c-2c72-47b1-bf42-7a89703b0dd4"],"spl_set_id":["ccf905ca-e164-4779-9485-2d139c821bad","950b7295-3f68-4027-ac2b-2f7d0f5f8ef9","d1920335-8e45-4960-b6e9-e6f1f9e6820c"],"package_ndc":["63323-161-41","63323-161-16","63323-162-43","63323-162-16","63323-162-45","63323-162-26","63323-161-21","63323-161-12","63323-162-23","63323-162-12","63323-162-25","63323-162-14","63323-161-00","63323-161-01","63323-162-11","63323-162-51","63323-162-00","63323-162-01","63323-162-03","63323-162-02"],"unii":["4EVE5946BQ"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 63323-161-01)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/14/2017","package_ndc":"0409-2222-12","generic_name":"Heparin Sodium Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018916"],"brand_name":["HEPARIN SODIUM"],"generic_name":["HEPARIN SODIUM"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2222","0409-7620","0409-1005"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["HEPARIN SODIUM"],"rxcui":["1658690","1658691","1658692"],"spl_id":["ecaae7d2-a76e-4eca-b045-6c88d7c2ab8f"],"spl_set_id":["32e34077-aff1-4ec7-f9b0-b8e240768fb8"],"package_ndc":["0409-7620-13","0409-7620-03","0409-7620-49","0409-7620-59","0409-1005-01","0409-1005-20","0409-2222-01","0409-2222-12"],"unii":["ZZ45AB24CA"]},"update_date":"11/09/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"52536-126-08","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"877-495-6856","availability":"Available","related_info":"Distributed by Wilshire Pharmaceuticals, Inc.","openfda":{"application_number":["ANDA212791"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Wilshire Pharmaceuticals, Inc."],"product_ndc":["52536-126","52536-125"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909"],"spl_id":["8587e03d-0aed-4f70-8695-54db31bc08ab"],"spl_set_id":["f550d2ba-49ac-4a3b-95db-692b468af479"],"package_ndc":["52536-125-01","52536-125-10","52536-126-01","52536-126-08"],"unii":["1018WH7F9I"]},"update_date":"10/15/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08)","company_name":"Azurity Pharmaceuticals, Inc","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0430-51","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020183"],"brand_name":["DIANEAL LOW CALCIUM WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0430","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0430-51)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-5738-10","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-5738","0409-3812","0409-1541","0409-8126","0409-4208","0409-6581"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1672917","1672919","1673242","1673243","1867594","1867596","1867612","1867614"],"spl_id":["14ec85dc-0263-44d1-9267-66fa072cff8d"],"spl_set_id":["93cf0914-de08-4ec6-8f8c-d663243b9958"],"package_ndc":["0409-5738-01","0409-5738-10","0409-3812-01","0409-1541-01","0409-1541-10","0409-8126-01","0409-8126-10","0409-4208-01","0409-4208-10","0409-6581-01"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine™ 0.25% 25 mg/10 mL (2.5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial Novaplus (NDC 0409-5738-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/26/2023","package_ndc":"60793-702-10","generic_name":"Penicillin G Benzathine Injection","related_info_link":"https://www.fda.gov/media/190713/download","contact_info":"800-533-4535","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA050141"],"brand_name":["BICILLIN L-A"],"generic_name":["PENICILLIN G BENZATHINE"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["60793-702","60793-700","60793-701"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["PENICILLIN G BENZATHINE"],"rxcui":["731564","731566","731567","731568","731570","731571"],"spl_id":["526e051e-d0fc-4f5d-886a-d61947aa8a7f"],"spl_set_id":["012d46f1-d0a0-4676-a879-cd320297ab16"],"package_ndc":["60793-700-01","60793-700-10","60793-701-02","60793-701-10","60793-702-04","60793-702-10"],"unii":["RIT82F58GK"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Bicillin L-A, Injection, 2400000 [iU]/4 mL (NDC 60793-702-10)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"06/08/2026","update_type":"New","initial_posting_date":"06/08/2026","package_ndc":"0088-2160-30","generic_name":"Leflunomide Tablet","contact_info":"800-981-2491","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020905"],"brand_name":["ARAVA"],"generic_name":["LEFLUNOMIDE"],"manufacturer_name":["sanofi-aventis U.S. LLC"],"product_ndc":["0088-2160","0088-2161","0088-2162"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LEFLUNOMIDE"],"rxcui":["205284","205285","205286","213377","213379","213380"],"spl_id":["765327c7-cb5b-4637-84da-4fd9a024ad96"],"spl_set_id":["320f63f2-fac3-4aee-aff8-85724e00ef52"],"package_ndc":["0088-2160-30","0088-2161-30","0088-2162-33"],"nui":["N0000175713"],"pharm_class_epc":["Antirheumatic Agent [EPC]"],"unii":["G162GK9U4W"]},"update_date":"06/08/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Tablet","presentation":"Arava, Tablet, 10 mg (NDC 0088-2160-30)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"discontinued_date":"09/01/2026","update_type":"New","initial_posting_date":"09/01/2026","package_ndc":"0002-8233-05","generic_name":"Insulin Lispro Protamine and Insulin Lispro Injection","contact_info":"800-545-5979","related_info":"A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.","openfda":{"application_number":["BLA021017"],"brand_name":["INSULIN LISPRO PROTAMINE AND INSULIN LISPRO INJECTABLE SUSPENSION MIX75/25 KWIKPEN"],"generic_name":["INSULIN LISPRO"],"manufacturer_name":["Eli Lilly and Company"],"product_ndc":["0002-8233"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["INSULIN LISPRO"],"rxcui":["847252"],"spl_id":["03dce3f6-da85-4635-9c62-478226005b60"],"spl_set_id":["e49f701d-c19f-4cb2-b63f-01a917b33abc"],"package_ndc":["0002-8233-01","0002-8233-05"],"nui":["N0000004931","N0000175453"],"pharm_class_cs":["Insulin [Chemical/Ingredient]"],"pharm_class_epc":["Insulin Analog [EPC]"],"unii":["GFX7QIS1II"]},"update_date":"09/01/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Humalog Mix 75/25, Injection, 100 [iU]/1 mL (NDC 0002-8233-05)","company_name":"Eli Lilly and Co.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"66794-230-42","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"855-273-0154","availability":"Available","related_info":"Marketed by Piramal Critical Care Inc.: 800-414-1901","openfda":{"application_number":["ANDA202126"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["Piramal Critical Care Inc"],"product_ndc":["66794-230"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710"],"spl_id":["5354326c-c6e7-cc50-e063-6294a90a7833"],"spl_set_id":["b93a71ed-0f9e-1ff9-e053-2995a90a789d"],"package_ndc":["66794-230-02","66794-230-42"],"unii":["1018WH7F9I"]},"update_date":"10/21/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42)","company_name":"Gland Pharma Limited","status":"Current"},{"discontinued_date":"05/06/2026","update_type":"New","initial_posting_date":"05/06/2026","package_ndc":"0409-1103-01","generic_name":"Cisatracurium Besylate Injection","contact_info":"844-646-4398","related_info":"Supply expected to exhaust late June 2026; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA203236"],"brand_name":["CISATRACURIUM BESYLATE"],"generic_name":["CISATRACURIUM BESYLATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1103","0409-1098","0409-1208"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CISATRACURIUM BESYLATE"],"rxcui":["199211","199212","1730194"],"spl_id":["55a7aed0-96b5-426a-a234-0a4418ade4f2"],"spl_set_id":["67908e20-044d-454d-9c51-bf106e817bd0"],"package_ndc":["0409-1098-12","0409-1098-02","0409-1103-11","0409-1103-01","0409-1208-11","0409-1208-01"],"unii":["80YS8O1MBS"]},"update_date":"05/06/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Cisatracurium Besylate, Injection, 200 mg/20ml (10 mg/mL) Single Dose Vial (NDC 0409-1103-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0415-07","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017512"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0415","0941-0411","0941-0413","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0415-07)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"discontinued_date":"03/24/2026","update_type":"New","initial_posting_date":"03/24/2026","package_ndc":"0074-7098-04","generic_name":"Pilocarpine Hydrochloride Ophthalmic Solution","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/24/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Ophthalmic Solution","presentation":"Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-04)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4283-01","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA088295"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4283"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RETROBULBAR","TOPICAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010844"],"spl_id":["a71b2924-e8ed-489e-9e31-017dc9c7f075"],"spl_set_id":["89a4bd73-89f4-4fd7-2c9f-921e1da8f96b"],"package_ndc":["0409-4283-11","0409-4283-25","0409-4283-01","0409-4283-05","0409-4283-10","0409-4283-15"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride Preservative Free, Injection, 200 mg/5 mL (4%; 40 mg/mL) (NDC 0409-4283-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-491-57","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-491","63323-492","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 5 mg/1 mL (NDC 63323-491-57)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"11534-190-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"732-382-6085 Monday to Friday 9 am to 3:45 pm","availability":"Available","openfda":{"application_number":["ANDA209799"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SUNRISE PHARMACEUTICAL, INC."],"product_ndc":["11534-190","11534-191","11534-192","11534-193","11534-194","11534-195","11534-196"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["60dcfbf6-d07a-4010-ae77-8a9ae4529828"],"spl_set_id":["ac102599-3a5b-4154-899e-6ff262be7ff7"],"package_ndc":["11534-190-01","11534-190-03","11534-191-01","11534-191-03","11534-192-01","11534-192-03","11534-193-01","11534-193-03","11534-194-01","11534-194-03","11534-195-01","11534-195-03","11534-196-01","11534-196-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/01/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 11534-190-01)","company_name":"Sunrise Pharmaceutical, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/21/2023","package_ndc":"0009-0902-18","generic_name":"Clindamycin Phosphate Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d","contact_info":"800-533-4535","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA050441"],"brand_name":["CLEOCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0902","0009-0870","0009-0775","0009-0728","0009-3124","0009-3447","0009-3381","0009-3375","0009-3382","0009-6582"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309339","685574","685576","685578","706461","1737244","1737245","1737578","1737579","1737581","1737582","205964","309335","309336"],"spl_id":["fa11e62e-4625-4e9c-8676-f318b1cb890f"],"spl_set_id":["05a75685-0af5-407c-ac57-e380c882b49d"],"package_ndc":["0009-0870-21","0009-0870-26","0009-0775-20","0009-0775-26","0009-0902-11","0009-0902-18","0009-0728-05","0009-0728-09","0009-3124-01","0009-3124-03","0009-3447-01","0009-3447-03","0009-3381-01","0009-3381-02","0009-3375-01","0009-3375-02","0009-3382-01","0009-3382-02","0009-6582-02","0009-6582-01"],"unii":["EH6D7113I8"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cleocin Phosphate, Injection, Cleocin Phosphate 900 mg/6 mL (150 mg/mL) (NDC 0009-0902-18)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"16729-295-31","generic_name":"Carboplatin Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA","openfda":{"application_number":["ANDA206775"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-295"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"spl_id":["5f9d65c8-75c4-6fb3-e063-6394a90a87cf"],"spl_set_id":["48aa7ef3-9f44-2a08-e054-00144ff88e88"],"package_ndc":["16729-295-31","16729-295-33","16729-295-34","16729-295-12","16729-295-38"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31)","company_name":"Accord Healthcare Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"43547-413-09","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-931-9829","availability":"Unavailable","related_info":"Not available. Long-term backorder for all NDCs. No estimated release date at this time.","openfda":{"application_number":["ANDA205823"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Solco Healthcare US, LLC"],"product_ndc":["43547-413","43547-410","43547-411","43547-412"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["b8f1731a-cbac-4f64-a8d4-320b80b335e1"],"spl_set_id":["cd46691d-5593-4a9f-a937-999c6803e312"],"package_ndc":["43547-410-09","43547-411-09","43547-412-09","43547-413-09"],"unii":["33067B3N2M"]},"update_date":"06/29/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 40 mg (NDC 43547-413-09)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"13107-073-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(866) 850-2876 or CustomerService@AurobindoUSA.com","availability":"Unavailable","related_info":"Estimated availability: April 2027","openfda":{"application_number":["ANDA202424"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Aurolife Pharma, LLC"],"product_ndc":["13107-073","13107-068","13107-069","13107-070","13107-071","13107-072","13107-074"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["44a9eb77-0896-4b62-9953-7121d97d6ffd"],"spl_set_id":["a582d57f-d191-4ca5-b105-585b2d8a0e3e"],"package_ndc":["13107-068-50","13107-068-01","13107-068-25","13107-068-05","13107-068-99","13107-069-50","13107-069-01","13107-069-25","13107-069-05","13107-069-99","13107-070-50","13107-070-01","13107-070-25","13107-070-05","13107-070-99","13107-071-50","13107-071-01","13107-071-25","13107-071-05","13107-071-99","13107-072-50","13107-072-01","13107-072-25","13107-072-05","13107-072-99","13107-073-50","13107-073-01","13107-073-25","13107-073-05","13107-073-99","13107-074-50","13107-074-01","13107-074-25","13107-074-05","13107-074-99"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/04/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 13107-073-01)","company_name":"Aurobindo Pharma USA","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"13107-068-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(866) 850-2876 or CustomerService@AurobindoUSA.com","availability":"Unavailable","related_info":"Estimated availability: April 2027","openfda":{"application_number":["ANDA202424"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Aurolife Pharma, LLC"],"product_ndc":["13107-068","13107-069","13107-070","13107-071","13107-072","13107-073","13107-074"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["44a9eb77-0896-4b62-9953-7121d97d6ffd"],"spl_set_id":["a582d57f-d191-4ca5-b105-585b2d8a0e3e"],"package_ndc":["13107-068-50","13107-068-01","13107-068-25","13107-068-05","13107-068-99","13107-069-50","13107-069-01","13107-069-25","13107-069-05","13107-069-99","13107-070-50","13107-070-01","13107-070-25","13107-070-05","13107-070-99","13107-071-50","13107-071-01","13107-071-25","13107-071-05","13107-071-99","13107-072-50","13107-072-01","13107-072-25","13107-072-05","13107-072-99","13107-073-50","13107-073-01","13107-073-25","13107-073-05","13107-073-99","13107-074-50","13107-074-01","13107-074-25","13107-074-05","13107-074-99"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/04/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 13107-068-01)","company_name":"Aurobindo Pharma USA","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/14/2022","package_ndc":"0990-7922-09","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Limited Availability","related_info":"On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7922","0990-7923","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"0143-9378-01","generic_name":"Daptomycin Injection","contact_info":"609-395-8625 ext. 203","related_info":"Discontinuation of the manufacture of the drug; Marketed by Hikma Pharmaceuticals USA, Inc.","update_date":"06/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Daptomycin, Injection, 500 mg/10 mL (NDC 0143-9378-01)","company_name":"Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)","status":"To Be Discontinued"},{"update_type":"New","initial_posting_date":"04/28/2023","package_ndc":"69339-366-45","generic_name":"Carboplatin Injection","contact_info":"Natco Pharma USA LLC: (201)786-6500","availability":"Available","related_info":"Wholesaler & Distributor through Marketing partner (Natco Pharma USA LLC)","openfda":{"application_number":["ANDA077861"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Natco Pharma USA LLC"],"product_ndc":["69339-366","69339-364","69339-365","69339-367"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["4c89cedc-e48b-445c-ad05-54dbe60e4fb0"],"spl_set_id":["4c89cedc-e48b-445c-ad05-54dbe60e4fb0"],"package_ndc":["69339-364-05","69339-365-15","69339-366-45","69339-367-60"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 450 mg/45 mL (NDC 69339-366-45)","company_name":"Teyro Labs","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"62135-667-90","generic_name":"Quinapril/Hydrochlorothiazide Tablet","contact_info":"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com","availability":"Available","openfda":{"application_number":["ANDA076374"],"brand_name":["QUINAPRIL AND HYDROCHLOROTHIAZIDE"],"generic_name":["QUINAPRIL AND HYDROCHLOROTHIAZIDE"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-667","62135-668","62135-669"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE","HYDROCHLOROTHIAZIDE"],"rxcui":["310796","310797","310809"],"spl_id":["0c3f4504-d57e-aa79-e063-6294a90ad5b8"],"spl_set_id":["2eae533f-d0af-47e8-a1f2-94bc8cc89b5a"],"package_ndc":["62135-667-90","62135-668-90","62135-669-90"],"nui":["N0000175359","N0000175419","M0471776"],"pharm_class_pe":["Increased Diuresis [PE]"],"pharm_class_epc":["Thiazide Diuretic [EPC]"],"pharm_class_cs":["Thiazides [CS]"],"unii":["0J48LPH2TH","33067B3N2M"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril/Hydrochlorothiazide, Tablet, 12.5 mg; 10 mg (NDC 62135-667-90)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"13107-074-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(866) 850-2876 OR CustomerService@AurobindoUSA.com","availability":"Unavailable","related_info":"Estimated availability: April 2027","openfda":{"application_number":["ANDA202424"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Aurolife Pharma, LLC"],"product_ndc":["13107-074","13107-068","13107-069","13107-070","13107-071","13107-072","13107-073"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["44a9eb77-0896-4b62-9953-7121d97d6ffd"],"spl_set_id":["a582d57f-d191-4ca5-b105-585b2d8a0e3e"],"package_ndc":["13107-068-50","13107-068-01","13107-068-25","13107-068-05","13107-068-99","13107-069-50","13107-069-01","13107-069-25","13107-069-05","13107-069-99","13107-070-50","13107-070-01","13107-070-25","13107-070-05","13107-070-99","13107-071-50","13107-071-01","13107-071-25","13107-071-05","13107-071-99","13107-072-50","13107-072-01","13107-072-25","13107-072-05","13107-072-99","13107-073-50","13107-073-01","13107-073-25","13107-073-05","13107-073-99","13107-074-50","13107-074-01","13107-074-25","13107-074-05","13107-074-99"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/04/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 13107-074-01)","company_name":"Aurobindo Pharma USA","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4282-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA088294"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4282","0409-4713","0409-4278","0409-4279","0409-4776","0409-4277","0409-4276","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 200 mg/10 mL (2%; 20 mg/mL) (NDC 0409-4282-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-487-17","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-487","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-482"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"67457-422-54","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA040803"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-422","67457-423","67457-421","67457-420"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRAVENOUS","SOFT TISSUE"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696","1116927","1812194"],"spl_id":["dd5c82b6-a194-462c-9626-34a9b410cfea"],"spl_set_id":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"package_ndc":["67457-423-00","67457-423-12","67457-422-00","67457-422-54","67457-421-00","67457-421-30","67457-420-00","67457-420-10"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-422-54)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"0781-3290-09","generic_name":"Clindamycin Phosphate Injection","contact_info":"800-525-8747","availability":"Available","openfda":{"application_number":["ANDA201692"],"brand_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"generic_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-3290","0781-3288","0781-3289"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN"],"rxcui":["309335","309336","309339"],"spl_id":["b553b8ab-ef4d-40ae-a5fb-a6242f2ad30a"],"spl_set_id":["231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca"],"package_ndc":["0781-3288-91","0781-3288-09","0781-3289-91","0781-3289-09","0781-3290-91","0781-3290-09"],"nui":["N0000009982","N0000175443","M0515779","N0000175731"],"pharm_class_pe":["Decreased Sebaceous Gland Activity [PE]","Neuromuscular Blockade [PE]"],"pharm_class_epc":["Lincosamide Antibacterial [EPC]"],"pharm_class_cs":["Lincosamides [CS]"],"unii":["3U02EL437C"]},"update_date":"11/09/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 0781-3290-09)","company_name":"Sandoz Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/26/2024","package_ndc":"70726-0305-1","generic_name":"Riluzole Oral Suspension","related_info_link":"https://www.fda.gov/media/177206/download","contact_info":"610-937-6172","availability":"Available","openfda":{"brand_name":["TEGLUTIK"],"generic_name":["RILUZOLE"],"manufacturer_name":["EDW PHARMA"],"product_ndc":["70726-0305"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RILUZOLE"],"rxcui":["2058147","2675565"],"spl_id":["4746c4d8-402a-0390-e063-6294a90a7fc2"],"spl_set_id":["125fdd37-02f7-a610-e063-6294a90a009d"],"package_ndc":["70726-0305-1"],"nui":["N0000175740","M0483511"],"pharm_class_epc":["Benzothiazole [EPC]"],"pharm_class_cs":["Benzothiazoles [CS]"],"unii":["7LJ087RS6F"]},"update_date":"10/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Oral Suspension","presentation":"Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0305-1)","company_name":"EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"43547-602-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-931-9829","availability":"Limited Availability","related_info":"On allocation","openfda":{"application_number":["ANDA216266"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE CAPSULES"],"manufacturer_name":["Solco Healthcare US,LLC"],"product_ndc":["43547-602","43547-603","43547-604","43547-605","43547-606","43547-607","43547-608"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["d6435613-e052-4b4f-8bf7-4acb7458d8df"],"spl_set_id":["68b10d9f-ca3e-493d-a309-45f1d7e08061"],"package_ndc":["43547-602-10","43547-603-10","43547-604-10","43547-605-10","43547-606-10","43547-607-10","43547-608-10"],"unii":["SJT761GEGS"]},"update_date":"06/29/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 43547-602-10)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"42858-163-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-827-0616","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA215330"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Rhodes Pharmaceuticals LLC"],"product_ndc":["42858-163","42858-161","42858-162","42858-164","42858-165","42858-166","42858-167"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0002e227-1109-4ecc-a8c5-4b4f11fac3cc"],"spl_set_id":["d918b40d-a461-41bc-b6c0-83dc76c28e32"],"package_ndc":["42858-161-01","42858-162-01","42858-163-01","42858-164-01","42858-165-01","42858-166-01","42858-167-01"],"unii":["SJT761GEGS"]},"update_date":"06/24/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 42858-163-01)","company_name":"Rhodes Pharmaceuticals L.P.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"10/01/2026","update_type":"New","initial_posting_date":"10/07/2026","package_ndc":"0603-3581-21","generic_name":"Felodipine Tablet, Extended Release","contact_info":"(800) 828-9393","related_info":"Discontinuation in the manufacturing of the drug product","openfda":{"application_number":["ANDA200815"],"brand_name":["FELODIPINE"],"generic_name":["FELODIPINE"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["0603-3581","0603-3582","0603-3583"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FELODIPINE"],"rxcui":["402695","402696","402698"],"spl_id":["02151da2-890e-4f84-94c8-6ce767d9ff12"],"spl_set_id":["55637724-8757-11de-8a39-0800200c9a66"],"package_ndc":["0603-3581-28","0603-3581-21","0603-3582-21","0603-3582-28","0603-3583-28","0603-3583-21"],"nui":["N0000000069","N0000175421","M0006414"],"pharm_class_moa":["Calcium Channel Antagonists [MoA]"],"pharm_class_epc":["Dihydropyridine Calcium Channel Blocker [EPC]"],"pharm_class_cs":["Dihydropyridines [CS]"],"unii":["OL961R6O2C"]},"update_date":"10/07/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-21)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-7838-24","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7838","0409-1660","0409-1638","0409-1434","0409-1596","0409-7853","0409-7875"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["284397","309710","1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["3c5274fd-6597-4b88-babc-92e4e16c6329"],"spl_set_id":["548a88c0-afda-427e-75ac-5af0cfa2224c"],"package_ndc":["0409-1660-55","0409-1660-50","0409-1660-35","0409-1660-10","0409-1660-22","0409-1660-20","0409-1638-32","0409-1638-02","0409-1434-01","0409-1596-01","0409-1596-10","0409-7838-01","0409-7838-24","0409-7853-01","0409-7853-24","0409-7875-01","0409-7875-12"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"70069-025-10","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA211036"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-025"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696"],"spl_id":["0fefe630-0e29-4d04-a083-eb3036f48100"],"spl_set_id":["5a1b0266-90c8-4176-a6b0-c4204d3c604e"],"package_ndc":["70069-025-10"],"unii":["AI9376Y64P"]},"update_date":"10/27/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 70069-025-10)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"55150-201-20","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA205612"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-201","55150-195","55150-196","55150-197","55150-198","55150-199","55150-200"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734207","1734347","1734475","1734483"],"spl_id":["1e5f1368-058a-492c-b4b7-d9329a7745e2"],"spl_set_id":["3763b7b6-da49-4658-b93d-28f5da24d09e"],"package_ndc":["55150-195-20","55150-196-99","55150-197-20","55150-198-30","55150-199-20","55150-200-10","55150-201-20"],"unii":["V910P86109"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-201-20)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"64850-550-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-852-6657","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA218604"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-550","64850-551","64850-552","64850-553","64850-554","64850-555","64850-556"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["2d33f701-8067-4a48-98cc-4e7dacaf3cc4"],"spl_set_id":["0e024b69-567c-4b40-9c3e-a2daec34256c"],"package_ndc":["64850-550-01","64850-551-01","64850-552-01","64850-553-01","64850-554-01","64850-555-01","64850-556-01"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 64850-550-01)","company_name":"Elite Laboratories, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-050-88","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-818-4555","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA214484"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-050","57664-047","57664-046","57664-048","57664-049","57664-051","57664-052","57664-083","57664-084","57664-085","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 57664-050-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"10/02/2026","update_type":"New","initial_posting_date":"10/02/2026","package_ndc":"0093-0264-92","generic_name":"Fluocinonide Ointment","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA073481"],"brand_name":["FLUOCINONIDE"],"generic_name":["FLUOCINONIDE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-0264","0093-0263","0093-0262"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TOPICAL"],"substance_name":["FLUOCINONIDE"],"rxcui":["103456","103457","1801283"],"spl_id":["c70aebe7-b63b-468a-ada5-dc1e60391277"],"spl_set_id":["986c1ba3-2103-4773-a35c-2c0121a01783"],"package_ndc":["0093-0263-15","0093-0263-30","0093-0263-92","0093-0262-15","0093-0262-30","0093-0262-92","0093-0264-15","0093-0264-30","0093-0264-92"],"nui":["N0000175576","N0000175450"],"pharm_class_epc":["Corticosteroid [EPC]"],"pharm_class_moa":["Corticosteroid Hormone Receptor Agonists [MoA]"],"unii":["2W4A77YPAN"]},"update_date":"10/02/2026","therapeutic_category":["Dermatology"],"dosage_form":"Ointment","presentation":"Fluocinonide, Ointment, .5 mg/1 g (NDC 0093-0264-92)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/01/2022","package_ndc":"63323-824-74","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA209448"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-824"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481"],"spl_id":["0591ab74-99a6-40ee-af96-80bc2ef423dc"],"spl_set_id":["3b8f2692-4371-4f1a-95af-b41842131fdd"],"package_ndc":["63323-824-24","63323-824-74","63323-824-25","63323-824-75","63323-824-26","63323-824-76"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-1434-01","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1434","0409-1660","0409-1638","0409-1596","0409-7838","0409-7853","0409-7875"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["284397","309710","1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["3c5274fd-6597-4b88-babc-92e4e16c6329"],"spl_set_id":["548a88c0-afda-427e-75ac-5af0cfa2224c"],"package_ndc":["0409-1660-55","0409-1660-50","0409-1660-35","0409-1660-10","0409-1660-22","0409-1660-20","0409-1638-32","0409-1638-02","0409-1434-01","0409-1596-01","0409-1596-10","0409-7838-01","0409-7838-24","0409-7853-01","0409-7853-24","0409-7875-01","0409-7875-12"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0990-7139-09","generic_name":"Sterile Water Irrigant","related_info_link":"https://www.fda.gov/media/182619/download?attachment","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Unavailable","related_info":"Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","update_date":"11/03/2026","therapeutic_category":["Gastroenterology","Other","Pediatric"],"dosage_form":"Irrigant","presentation":"Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-09)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"0143-9519-10","generic_name":"Methotrexate Sodium Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Additional lots will be available in the October 2026 timeframe.  Product will be made available as it is released.","openfda":{"application_number":["ANDA089340"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9519","0143-9518","0143-9517","0143-9516"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL","INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS"],"substance_name":["METHOTREXATE"],"rxcui":["1655959","1655960","1655967","1655968"],"spl_id":["3046ff78-3565-46d1-a88b-283e5ff6e7c3"],"spl_set_id":["3989d30d-56e5-4e8d-9379-c30fecc894f2"],"package_ndc":["0143-9519-10","0143-9518-01","0143-9517-01","0143-9516-01"],"nui":["N0000175584","N0000000111"],"pharm_class_epc":["Folate Analog Metabolic Inhibitor [EPC]"],"pharm_class_moa":["Folic Acid Metabolism Inhibitors [MoA]"],"unii":["YL5FZ2Y5U1"]},"update_date":"10/14/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate, Preservative Free, Injection, 25 mg/1 mL (NDC 0143-9519-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0054-0374-25","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Available on allocation","openfda":{"application_number":["ANDA202827"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-0374","0054-0660","0054-0370","0054-0371","0054-0372","0054-0373","0054-0375"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"],"spl_set_id":["6740a621-9bec-4178-a4fc-a3fc89f34e0a"],"package_ndc":["0054-0660-25","0054-0370-25","0054-0371-25","0054-0372-25","0054-0373-25","0054-0374-25","0054-0375-25"],"unii":["SJT761GEGS"]},"update_date":"10/14/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0054-0374-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"02/24/2026","update_type":"New","initial_posting_date":"02/24/2026","package_ndc":"63481-025-09","generic_name":"Frovatriptan Succinate Tablet","contact_info":"800-828-9393","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"02/24/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Frova, Tablet, 2.5 mg (NDC 63481-025-09)","company_name":"Endo Pharmaceuticals, Inc.","status":"To Be Discontinued"},{"discontinued_date":"08/13/2026","update_type":"New","initial_posting_date":"08/13/2026","package_ndc":"0228-2550-96","generic_name":"Diclofenac Sodium Tablet, Delayed Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA074514"],"brand_name":["DICLOFENAC SODIUM"],"generic_name":["DICLOFENAC SODIUM"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2550","0228-2551"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DICLOFENAC SODIUM"],"rxcui":["855906","855926"],"spl_id":["a1fbc994-b8a6-4759-be76-1cfd98275ca6"],"spl_set_id":["a57b897e-0cbe-4ac3-969f-b00357a0cfa8"],"package_ndc":["0228-2550-06","0228-2550-11","0228-2550-96","0228-2551-06","0228-2551-11","0228-2551-96"],"unii":["QTG126297Q"]},"update_date":"08/13/2026","therapeutic_category":["Musculoskeletal","Rheumatology"],"dosage_form":"Tablet","presentation":"Diclofenac Sodium, Tablet, Delayed Release, 50 mg (NDC 0228-2550-96)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/14/2022","package_ndc":"0990-7922-02","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Limited Availability","related_info":"On Allocation. Estimated Recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7922","0990-7923","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/13/2017","change_date":"09/30/2026","package_ndc":"72205-102-07","generic_name":"Bumetanide Injection","contact_info":"855-668-2369; customerservice@novadozpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA215364"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Novadoz Pharmaceuticals LLC"],"product_ndc":["72205-102","72205-101"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["387edfd4-be85-41cd-8a6d-14e6a022b5a9"],"spl_set_id":["387edfd4-be85-41cd-8a6d-14e6a022b5a9"],"package_ndc":["72205-101-01","72205-101-07","72205-102-01","72205-102-07"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, 0.25 mg/1 mL (NDC 72205-102-07)","company_name":"MSN Laboratories Private Limited","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/28/2025","package_ndc":"0574-2415-65","generic_name":"Methylphenidate Film, Extended Release","contact_info":"800-455-8070","availability":"Available","related_info":"Distributed by Padagis US LLC","openfda":{"application_number":["NDA021514"],"brand_name":["METHYLPHENIDATE TRANSDERMAL SYSTEM"],"generic_name":["METHYLPHENIDATE"],"manufacturer_name":["PADAGIS US LLC"],"product_ndc":["0574-2415","0574-2410","0574-2420","0574-2430"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TRANSDERMAL"],"substance_name":["METHYLPHENIDATE"],"rxcui":["753436","753438","753440","753441"],"spl_id":["b743ef45-2fc0-4086-8a02-6078e6a09eaa"],"spl_set_id":["7bcff873-1fc2-45bc-a8e4-5db4edeb9bfb"],"package_ndc":["0574-2410-65","0574-2415-65","0574-2420-65","0574-2430-65"],"nui":["N0000175739","N0000175729"],"pharm_class_epc":["Central Nervous System Stimulant [EPC]"],"pharm_class_pe":["Central Nervous System Stimulation [PE]"],"unii":["207ZZ9QZ49"]},"update_date":"10/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Film, Extended Release","presentation":"Methylphenidate, Film, Extended Release, 15 mg (NDC 0574-2415-65)","company_name":"Noven Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-087-88","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"800-818-4555","availability":"Available","openfda":{"application_number":["ANDA214134"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-087","57664-047","57664-046","57664-048","57664-049","57664-050","57664-051","57664-052","57664-083","57664-084","57664-085","57664-086","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88)","company_name":"Sun Pharmaceutical Industries, Inc.","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"65219-281-15","generic_name":"Gadobutrol Injection","contact_info":"888-386-1300","related_info":"Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA","openfda":{"application_number":["ANDA215061"],"brand_name":["GADOBUTROL"],"generic_name":["GADOBUTROL"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-281"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOBUTROL"],"spl_id":["490c8c3e-3195-40af-8f34-40d8df2719c3"],"spl_set_id":["007696d0-4b62-4937-9640-4ad619504df4"],"package_ndc":["65219-281-00","65219-281-02","65219-281-03","65219-281-07","65219-281-08","65219-281-10","65219-281-05","65219-281-15"],"nui":["N0000183362","N0000175862"],"pharm_class_epc":["Gadolinium-based Contrast Agent [EPC]"],"pharm_class_moa":["Magnetic Resonance Contrast Activity [MoA]"],"unii":["1BJ477IO2L"]},"update_date":"06/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-15)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0409-2344-01","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA074086"],"brand_name":["DOBUTAMINE"],"generic_name":["DOBUTAMINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2344"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"rxcui":["1812168"],"spl_id":["e71e9520-871b-479d-9652-1857fceca863","f6a67673-07a7-44e4-b05c-1f7e63326f79"],"spl_set_id":["dc537761-d5f4-488d-24ab-b2bcd2b17b7a","89becb0c-da60-4f43-0a98-29ff7a9eca58"],"package_ndc":["0409-2344-01","0409-2344-62","0409-2344-02","0409-2344-68","0409-2344-88"],"unii":["0WR771DJXV"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0551-11","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA020179"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-0551"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795609","1795616"],"spl_id":["1abb6ba4-fa29-4807-8623-3bd98ac11440"],"spl_set_id":["7de48bdb-9a05-4f2a-bbff-dcfeb284ca6e"],"package_ndc":["0338-0551-11","0338-0551-18"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0551-11)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-1752-50","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1752","0409-1746","0409-1749","0409-1755","0409-2510","0409-7535","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510","0409-2253"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine with Epinephrine 1:200,000 as the bitartrate 125 mg/50 mL (2.5 mg/mL 1:200,000) (NDC 0409-1752-50)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/15/2021","package_ndc":"0009-0306-12","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0306","0009-0274","0009-0280"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358510","1358512","1358610","1358612","1358617","1358619"],"spl_id":["267dd735-f800-4735-ba1c-d39d00f0cee5"],"spl_set_id":["823b0010-2b57-4e76-b5ac-4a8c2963438f"],"package_ndc":["0009-0274-01","0009-0280-02","0009-0280-51","0009-0280-03","0009-0280-52","0009-0306-02","0009-0306-12"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 80 mg/1 mL (NDC 0009-0306-12)","company_name":"Pfizer Inc.","status":"Current"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"0009-0065-01","generic_name":"Medroxyprogesterone Acetate Tablet","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug; Withdrawal from sale expected early October 2026.","openfda":{"application_number":["NDA011839"],"brand_name":["PROVERA"],"generic_name":["MEDROXYPROGESTERONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0065","0009-0287","0009-0051"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MEDROXYPROGESTERONE ACETATE"],"rxcui":["1000114","1000124","1000135","1000139","1000141","1000145"],"spl_id":["ebcdf2fb-760c-4a9a-80a1-a0c6b21a891a"],"spl_set_id":["a586be28-96af-4fed-a13f-9b94fd4c7405"],"package_ndc":["0009-0065-01","0009-0287-01","0009-0051-01"],"unii":["C2QI4IOI2G"]},"update_date":"08/31/2026","therapeutic_category":["Urology"],"dosage_form":"Tablet","presentation":"PROVERA, Tablet, 2.5 mg (NDC 0009-0065-01)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"09/01/2026","update_type":"New","initial_posting_date":"09/01/2026","package_ndc":"75987-050-06","generic_name":"Glycerol Phenylbutyrate Oral Liquid","contact_info":"800-772-6436","related_info":"Discontinuation in the manufacturing of the drug product","openfda":{"application_number":["NDA203284"],"brand_name":["RAVICTI"],"generic_name":["GLYCEROL PHENYLBUTYRATE"],"manufacturer_name":["Horizon Therapeutics USA, Inc."],"product_ndc":["75987-050"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GLYCEROL PHENYLBUTYRATE"],"rxcui":["1368453","1368459"],"spl_id":["a58b617c-635a-4a67-9f27-f9c93f8cba22"],"spl_set_id":["900e7dc0-9afe-4f50-80de-90567bb78519"],"package_ndc":["75987-050-06","75987-050-07"],"unii":["ZH6F1VCV7B"]},"update_date":"09/01/2026","therapeutic_category":["Inborn Errors"],"presentation":"RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-06)","company_name":"Amgen Inc.","status":"To Be Discontinued"},{"discontinued_date":"01/13/2026","update_type":"New","initial_posting_date":"01/13/2026","package_ndc":"61314-517-36","generic_name":"Adalimumab-adaz Injection","contact_info":"800-525-8747","related_info":"Equivalent Sandoz format is available.","openfda":{"application_number":["BLA761071"],"brand_name":["HYRIMOZ"],"generic_name":["ADALIMUMAB-ADAZ"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["61314-517","61314-454","61314-473","61314-476","61314-509","61314-531"],"product_type":["HUMAN PRESCRIPTION DRUG"],"rxcui":["2641644","2641650","2641653","2641654","2641655","2641658","2641660","2641661","2641662","2641663","2641664","2641665","2641666","2641667","2641668","2641669","2641670","2641671","2641672","2641673"],"spl_id":["48b7e44a-945f-487d-b2fd-3da13d6d6fdb"],"spl_set_id":["1ac7d061-3380-468c-b077-c05f8dfbc829"],"package_ndc":["61314-454-20","61314-454-36","61314-454-68","61314-473-64","61314-473-20","61314-473-92","61314-476-64","61314-509-64","61314-517-36","61314-454-96","61314-473-96","61314-531-64","61314-454-94","61314-473-94"],"nui":["N0000175610","N0000175451","M0001357"],"pharm_class_epc":["Tumor Necrosis Factor Blocker [EPC]"],"pharm_class_moa":["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"],"pharm_class_cs":["Antibodies, Monoclonal [CS]"],"unii":["FYS6T7F842"]},"update_date":"01/13/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Hyrimoz, Injection, Kit (NDC 61314-517-36)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"70436-203-80","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"Slate Run Pharmaceuticals, LLC: 844-529-8988","availability":"Available","related_info":"Distributed by Slate Run Pharmaceuticals, LLC, 1-844-529-8988","openfda":{"application_number":["ANDA216131"],"brand_name":["DOBUTAMINE"],"generic_name":["DOBUTAMINE"],"manufacturer_name":["Slate Run Pharmaceuticals"],"product_ndc":["70436-203"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"rxcui":["1812168"],"spl_id":["49562559-8e19-fb8a-e063-6394a90a0966"],"spl_set_id":["ee09a55f-9992-48bb-b8d6-1184bd548536"],"package_ndc":["70436-203-80","70436-203-82"],"unii":["0WR771DJXV"]},"update_date":"10/21/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride, Injection, 250 mg/20 mL (NDC 70436-203-80)","company_name":"Hainan Poly Pharm. Co., Ltd.","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"61703-339-50","generic_name":"Carboplatin Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA076517"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-339"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["0ddf4411-7138-412a-908a-fadf22bdfb79"],"spl_set_id":["c3ae9880-44bb-4f4e-93d8-8a5e21708a30"],"package_ndc":["61703-339-18","61703-339-22","61703-339-50","61703-339-56"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/09/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 450 mg/45 mL (10 mg/mL) (NDC 61703-339-50)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"23155-601-42","generic_name":"Midazolam Hydrochloride Injection","contact_info":"855-228-9470","availability":"Available","openfda":{"application_number":["ANDA090850"],"brand_name":["MIDAZOLAM HYDROCHLORIDE"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."],"product_ndc":["23155-601"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311702"],"spl_id":["e20feff9-3aca-4bc1-a5c3-44fff8a9459c"],"spl_set_id":["843cc25e-45ea-4372-ae34-843f805fa869"],"package_ndc":["23155-601-31","23155-601-41","23155-601-32","23155-601-42"],"unii":["W7TTW573JJ"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42)","company_name":"Avet Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/26/2023","package_ndc":"57664-608-88","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-818-4555","availability":"Unavailable","related_info":"Currently not marketed","update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 36 mg (NDC 57664-608-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"0409-1283-37","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA200403"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1283","0409-1312","0409-4264","0409-1805","0409-2552","0409-3356","0409-2540","0409-3365","0409-1304"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1724383","1724644","2675350","897653","897753","897758","1724276"],"spl_id":["766e302a-2d03-4d93-b237-2348b57ee517","a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"],"spl_set_id":["f9ca2ef5-46d8-475a-a26e-f7c8becd6db7","e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"],"package_ndc":["0409-1283-17","0409-1283-37","0409-1312-16","0409-1312-36","0409-4264-11","0409-4264-01","0409-1805-10","0409-1805-01","0409-2552-11","0409-2552-01","0409-3356-11","0409-3356-01","0409-2540-11","0409-2540-01","0409-3365-11","0409-3365-01","0409-3365-10","0409-1283-03","0409-1283-31","0409-1312-03","0409-1312-30","0409-1304-03","0409-1304-31"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 1 mg/1 mL (NDC 0409-1283-37)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"0527-0766-37","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"844-834-0530","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA215565"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-0766","0527-0760","0527-0761","0527-0762","0527-0763","0527-0764","0527-0765"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["391d7c4a-47df-41ce-b1ba-3c4758adf87f"],"spl_set_id":["f92497b5-baea-4760-b615-45a0b6184402"],"package_ndc":["0527-0760-37","0527-0761-37","0527-0762-37","0527-0763-37","0527-0764-37","0527-0765-37","0527-0766-37"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 0527-0766-37)","company_name":"Lannett Company, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0338-1005-02","generic_name":"Dopamine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA019615"],"brand_name":["DOPAMINE HYDROCHLORIDE AND DEXTROSE"],"generic_name":["DOPAMINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1005","0338-1007","0338-1009"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1292887","1743869","1743871","1743877","1743879"],"spl_id":["edc9a091-4cb5-4ec7-b6f9-44d2d588bab9"],"spl_set_id":["cb97d4a0-89ed-407c-a763-209386b6f75c"],"package_ndc":["0338-1005-02","0338-1005-03","0338-1007-02","0338-1007-03","0338-1009-02"],"unii":["7L3E358N9L"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 80 mg/100 mL (NDC 0338-1005-02)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/17/2015","package_ndc":"0143-9935-01","generic_name":"Cefotaxime Sodium Powder, for Solution","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA065071"],"brand_name":["CEFOTAXIME"],"generic_name":["CEFOTAXIME"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9935"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CEFOTAXIME SODIUM"],"rxcui":["309065"],"spl_id":["e25af43f-54cb-4526-a8a5-6bef0a7939c7"],"spl_set_id":["ef1a6dc6-bc3d-4f09-8f92-7ff328f56561"],"package_ndc":["0143-9935-01"],"unii":["258J72S7TZ"]},"update_date":"10/14/2026","therapeutic_category":["Anti-Infective","Pediatric"],"dosage_form":"Powder, For Solution","presentation":"Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7112-12","generic_name":"Morphine Sulfate Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7112","0574-7110","0574-7114","0574-7116"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892516","892603","892678","894807"],"spl_id":["fa18ac09-a625-47aa-8cde-7051dc4d0c49"],"spl_set_id":["649d731b-962a-45df-b043-7e0781e8a530"],"package_ndc":["0574-7110-12","0574-7112-12","0574-7114-12","0574-7116-12"],"unii":["X3P646A2J0"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Suppository","presentation":"Morphine Sulfate, Suppository, 10 mg (NDC 0574-7112-12)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/15/2021","package_ndc":"55150-314-01","generic_name":"Methylprednisolone Acetate Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA211930"],"brand_name":["METHYLPREDNISOLONE ACETATE"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-314","55150-313"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358610","1358617"],"spl_id":["25c5133c-ee17-4be0-88a3-d0231e38f5a0"],"spl_set_id":["a0cbcdb5-f657-49f7-8f86-cc5959d69db0"],"package_ndc":["55150-313-25","55150-313-01","55150-314-25","55150-314-01"],"unii":["43502P7F0P"]},"update_date":"10/19/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 55150-314-01)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"01/01/2026","update_type":"New","initial_posting_date":"03/24/2026","package_ndc":"55513-810-60","generic_name":"Ivabradine Hydrochloride Tablet","contact_info":"1-800-772-6436","related_info":"Discontinuation of the manufacture of the drug product","openfda":{"application_number":["NDA206143"],"brand_name":["CORLANOR"],"generic_name":["IVABRADINE"],"manufacturer_name":["Amgen Inc"],"product_ndc":["55513-810","55513-800","55513-813"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["IVABRADINE HYDROCHLORIDE"],"rxcui":["1649485","1649491","1649493","1649495","2168592","2168596"],"spl_id":["8ab000cd-0258-489a-b1bb-4cc1ca359d6c"],"spl_set_id":["92018a65-38f6-45f7-91d4-a34921b81d0d"],"package_ndc":["55513-800-60","55513-800-99","55513-810-60","55513-813-01","55513-813-28"],"unii":["TP19837BZK"]},"update_date":"03/24/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Corlanor, Tablet, eq. 7.5 mg base (NDC 55513-810-60)","company_name":"Amgen Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/14/2016","package_ndc":"63323-481-57","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-481","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"09/24/2019","package_ndc":"48102-053-05","generic_name":"Echothiophate Iodide Ophthalmic Solution","contact_info":"516-277-1449","availability":"Available","related_info":"Available through limited distribution by Walgreens Specialty Pharmacy.","openfda":{"application_number":["NDA011963"],"brand_name":["PHOSPHOLINE IODIDE"],"generic_name":["ECHOTHIOPHATE IODIDE FOR OPHTHALMIC SOLUTION"],"manufacturer_name":["Fera Pharmaceuticals, LLC"],"product_ndc":["48102-053"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["OPHTHALMIC"],"rxcui":["205739","310049"],"spl_id":["66abcfcf-b16e-4181-b1db-96bfba0ab95e"],"spl_set_id":["8afc8951-db76-4f27-8752-7c0d6aa47244"],"package_ndc":["48102-053-05","48102-054-05","48102-055-05"]},"update_date":"11/02/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Ophthalmic Solution","presentation":"Phospholine Iodide, Ophthalmic Solution, 0.125% (NDC 48102-053-05)","company_name":"Fera Pharmaceuticals","status":"Current"},{"discontinued_date":"02/25/2026","update_type":"New","initial_posting_date":"02/25/2026","package_ndc":"0009-0331-02","generic_name":"Clindamycin Hydrochloride Capsule","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050162"],"brand_name":["CLEOCIN HYDROCHLORIDE"],"generic_name":["CLINDAMYCIN HYDROCHLORIDE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0331","0009-0225","0009-0395"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLINDAMYCIN HYDROCHLORIDE"],"rxcui":["197518","284215","309329","748746","748748","748750"],"spl_id":["3cdb1eb4-26cd-495d-b9d2-0ad980fadc2b"],"spl_set_id":["df9a2a41-b132-4f43-8940-b2d773b1369a"],"package_ndc":["0009-0331-02","0009-0225-02","0009-0395-14"],"unii":["T20OQ1YN1W"]},"update_date":"02/25/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-355-05","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-05)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/25/2022","change_date":"08/27/2026","package_ndc":"64980-642-03","generic_name":"Albuterol Sulfate Solution","contact_info":"201-961-9000","resolved_note":"Available","openfda":{"application_number":["ANDA075664"],"brand_name":["ALBUTEROL SULFATE"],"generic_name":["ALBUTEROL SULFATE"],"manufacturer_name":["Rising Pharma Holdings, Inc."],"product_ndc":["64980-642"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RESPIRATORY (INHALATION)"],"substance_name":["ALBUTEROL SULFATE"],"rxcui":["245314"],"spl_id":["56c00cc1-5ed0-8ff5-e063-6394a90a132b"],"spl_set_id":["3236f82c-14e9-dfd4-e063-6294a90ac43d"],"package_ndc":["64980-642-03"],"unii":["021SEF3731"]},"update_date":"08/27/2026","therapeutic_category":["Pediatric","Pulmonary/Allergy"],"dosage_form":"Solution","presentation":"Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03)","company_name":"Rising Pharma Holdings, Inc.","status":"Resolved"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-4713-32","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: August 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA080408"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4713","0409-4278","0409-4279","0409-4776","0409-4282","0409-4277","0409-4276","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/2 mL (1%; 10 mg/mL) (NDC 0409-4713-32)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"0143-9506-10","generic_name":"Etomidate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional product will be made available as it is released.","openfda":{"application_number":["ANDA202354"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9506","0143-9507"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["98560882-bfdf-404e-ab8b-3ee2a6875830"],"spl_set_id":["75bf0494-7cb9-4e8a-8edd-af62f035d236"],"package_ndc":["0143-9506-01","0143-9506-10","0143-9507-01","0143-9507-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 0143-9506-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-8018-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-8018","0075-8013","0075-8014","0075-8016","0075-8020","0075-8030","0075-8022","0075-8025"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["006561fa-e16d-4129-9dde-89c109b51d8f"],"spl_set_id":["de6fb917-a94a-41ea-9d7d-937d4080ffcd"],"package_ndc":["0075-8013-01","0075-8013-10","0075-8014-01","0075-8014-10","0075-8016-01","0075-8016-10","0075-8018-01","0075-8018-10","0075-8020-01","0075-8020-10","0075-8030-01","0075-8022-01","0075-8022-10","0075-8025-01","0075-8025-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 80 mg/.8 mL (NDC 0075-8018-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"59651-722-99","generic_name":"Clonazepam Tablet","contact_info":"866-850-2876","resolved_note":"Available","openfda":{"application_number":["ANDA075150"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["59651-722","59651-723","59651-724"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"spl_set_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"package_ndc":["59651-722-01","59651-722-99","59651-723-01","59651-723-99","59651-724-01","59651-724-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 59651-722-99)","company_name":"Aurobindo Pharma USA","status":"Resolved"},{"discontinued_date":"06/29/2026","update_type":"New","initial_posting_date":"06/29/2026","package_ndc":"25021-233-10","generic_name":"Oxaliplatin Injection","contact_info":"Sagent Pharmaceuticals: 866-625-1618","related_info":"Marketed by Sagent Pharmaceuticals; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA203869"],"brand_name":["OXALIPLATIN"],"generic_name":["OXALIPLATIN"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-233"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["OXALIPLATIN"],"rxcui":["1736776","1736781"],"spl_id":["c159050a-e588-4091-b9ee-ea502e1b9529"],"spl_set_id":["29a5d098-bfa7-4a65-bb4f-5daa1fef1c2f"],"package_ndc":["25021-233-10","25021-233-20"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["04ZR38536J"]},"update_date":"06/29/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Oxaliplatin, Injection, 5 mg/1 mL (NDC 25021-233-10)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/01/2020","package_ndc":"76329-3340-1","generic_name":"Atropine Sulfate Injection","contact_info":"800-423-4136","availability":"Available","openfda":{"application_number":["ANDA212461"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["International Medication Systems, Limited"],"product_ndc":["76329-3340"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190546"],"spl_id":["697aa53c-f31f-463a-a752-d2faaad354db"],"spl_set_id":["b72d0a82-6163-460f-965a-12f6da47370a"],"package_ndc":["76329-3340-1"],"unii":["03J5ZE7KA5"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, .1 mg/1 mL (NDC 76329-3340-1)","company_name":"Amphastar Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"47781-566-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA214547"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-566","47781-562","47781-563","47781-564","47781-565","47781-567","47781-568"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["db02ec6b-f17f-ab22-b671-e1ddb90e017c"],"spl_set_id":["7f2dd6ee-3363-c87c-9693-ed838942556c"],"package_ndc":["47781-562-01","47781-563-01","47781-564-01","47781-565-01","47781-566-01","47781-567-01","47781-568-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 47781-566-01)","company_name":"Alvogen","status":"Current"},{"discontinued_date":"04/08/2026","update_type":"New","initial_posting_date":"04/08/2026","package_ndc":"63323-972-10","generic_name":"Fosaprepitant Dimeglumine Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA206197"],"brand_name":["FOSAPREPITANT"],"generic_name":["FOSAPREPITANT"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-972"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FOSAPREPITANT DIMEGLUMINE"],"rxcui":["1731077"],"spl_id":["864bb02f-d50d-4ae2-ad9c-82bb1e9aed2c"],"spl_set_id":["ffee61d1-c1c6-4224-871c-ab7ff6cd01e5"],"package_ndc":["63323-972-10"],"unii":["D35FM8T64X"]},"update_date":"04/08/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"discontinued_date":"04/28/2026","update_type":"New","initial_posting_date":"04/28/2026","package_ndc":"10147-0570-1","generic_name":"Etravirine Tablet","contact_info":"800-526-7736","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA022187"],"brand_name":["ETRAVIRINE"],"generic_name":["ETRAVIRINE"],"manufacturer_name":["Patriot Pharmaceuticals"],"product_ndc":["10147-0570","10147-0571"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ETRAVIRINE"],"rxcui":["754761","1052658"],"spl_id":["31cddc7a-0154-c49a-e063-6394a90a1a49"],"spl_set_id":["50ca19cb-0f43-4d7b-8c9e-8b3aaded0546"],"package_ndc":["10147-0570-1","10147-0571-1"],"nui":["N0000175463","N0000175460","N0000009948","N0000190118","N0000185504","N0000182140","N0000185503"],"pharm_class_epc":["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"],"pharm_class_moa":["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]","Cytochrome P450 3A Inducers [MoA]","Cytochrome P450 2C9 Inhibitors [MoA]","Cytochrome P450 2C19 Inhibitors [MoA]","P-Glycoprotein Inhibitors [MoA]"],"unii":["0C50HW4FO1"]},"update_date":"04/28/2026","therapeutic_category":["Antiviral"],"dosage_form":"Tablet","presentation":"Etravirine, Tablet, 100 mg (NDC 10147-0570-1)","company_name":"Janssen Research and Development","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"0406-8892-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-325-8888","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040440"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE AND AMPHETAMINE ASPARTATE AND DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-8892","0406-8891","0406-8884","0406-8885","0406-8893","0406-8894"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["0d3fb5ba-ff79-4862-bc1d-45b8343e115b"],"spl_set_id":["72ddd1c9-ddbd-4c95-acd9-003189a353a3"],"package_ndc":["0406-8891-01","0406-8884-01","0406-8892-01","0406-8885-01","0406-8893-01","0406-8894-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 0406-8892-01)","company_name":"SpecGx LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/21/2023","package_ndc":"0641-6082-25","generic_name":"Promethazine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA083312"],"brand_name":["PHENERGAN"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6082","0641-6083"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992460","992462","992858","992876"],"spl_id":["a64f0625-8d56-4994-8908-13614ca7b09f"],"spl_set_id":["6f7e47cc-f823-4336-8107-f980e3049617"],"package_ndc":["0641-6082-01","0641-6082-25","0641-6083-01","0641-6083-25"],"unii":["R61ZEH7I1I"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Pediatric","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Phenergan, Injection, 25 mg/1 mL (NDC 0641-6082-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0006-5055-06","generic_name":"Molnupiravir Capsule","contact_info":"800-672-6372","related_info":"Discontinuation of the manufacture of the drug","update_date":"10/20/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Lagevrio, Capsule, 200 mg (NDC 0006-5055-06)","company_name":"Merck Sharp & Dohme LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"65162-027-09","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA202830"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["65162-027","65162-023","65162-024","65162-025","65162-026","65162-028"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850"],"spl_id":["4cc5e658-25c6-4a58-a93a-6e35242d6de4"],"spl_set_id":["c11cb3b6-3dff-477b-a249-b4c3118edc5f"],"package_ndc":["65162-023-09","65162-024-09","65162-025-09","65162-026-09","65162-027-09","65162-028-09"],"unii":["SJT761GEGS"]},"update_date":"10/06/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 65162-027-09)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"25021-311-02","generic_name":"Furosemide Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Furosemide%20Injection&st=d","contact_info":"866-625-1618","availability":"Unavailable","related_info":"Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product","openfda":{"application_number":["ANDA213902"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-311"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["222ce48f-2856-4be2-b16f-6fca38c0dceb"],"spl_set_id":["d63c1277-dd7e-4d21-9e80-68143f55e2dc"],"package_ndc":["25021-311-02","25021-311-04","25021-311-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"10/21/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-02)","company_name":"Gland Pharma Limited","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/20/2023","package_ndc":"0641-6024-10","generic_name":"Fentanyl Citrate Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Inventory available in vial presentations.","update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6024-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"43547-406-10","generic_name":"Clonazepam Tablet","contact_info":"For orders, Solco Healthcare 866-931-9829","resolved_note":"Available","openfda":{"application_number":["ANDA077856"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Solco Healthcare LLC"],"product_ndc":["43547-406","43547-407","43547-408"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["dc17b9d4-2890-4f6c-8476-daa39d0cbc9c"],"spl_set_id":["4acbb7a9-4db5-4497-b8db-9f358b3f6fb4"],"package_ndc":["43547-406-10","43547-406-50","43547-406-11","43547-407-10","43547-407-50","43547-407-11","43547-408-10","43547-408-50"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 43547-406-10)","company_name":"Prinston Pharmaceutical, Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"68180-558-09","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-587-4617","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA077690"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Lupin Pharmaceuticals, Inc."],"product_ndc":["68180-558","68180-556","68180-557","68180-554","68180-559"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["a9598a21-6f99-4c86-ace6-b5638da2bec8"],"spl_set_id":["8ded0773-3aec-4e89-9836-d22a5a84abf0"],"package_ndc":["68180-556-09","68180-557-09","68180-557-03","68180-558-09","68180-558-03","68180-554-09","68180-554-03","68180-559-03","68180-559-09"],"unii":["33067B3N2M"]},"update_date":"10/13/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 20 mg (NDC 68180-558-09)","company_name":"Lupin Pharmaceuticals, Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"63323-451-01","generic_name":"Morphine Sulfate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA204223"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-451","63323-452","63323-454","63323-455","63323-458"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731993","1732006","1732011","1732136","2003714"],"spl_id":["f5584ff8-f338-4d14-b29e-e37b3978b747"],"spl_set_id":["582f42e5-444e-4246-af8c-e7e28097c69a"],"package_ndc":["63323-452-00","63323-452-01","63323-454-00","63323-454-01","63323-455-00","63323-455-01","63323-458-00","63323-458-01","63323-451-00","63323-451-01"],"unii":["X3P646A2J0"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 10 mg/1 mL (NDC 63323-451-01)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"59417-106-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"877-TAKEDA-7 (1-877-825-3327)","availability":"Available","openfda":{"application_number":["NDA021977"],"brand_name":["VYVANSE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["59417-106","59417-101","59417-102","59417-103","59417-104","59417-105","59417-107","59417-115","59417-116","59417-117","59417-118","59417-119","59417-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854832","854834","854836","854838","854840","854842","854844","854846","854848","854850","854852","1593856","1593858","1871456","1871459","1871460","1871461","1871462","1871463","1871464","1871465","1871466","1871467","1871468","1871469"],"spl_id":["81d087b6-4cb4-466a-9693-679edeb062e2"],"spl_set_id":["704e4378-ca83-445c-8b45-3cfa51c1ecad"],"package_ndc":["59417-101-10","59417-102-10","59417-103-10","59417-104-10","59417-105-10","59417-106-10","59417-107-10","59417-115-01","59417-116-01","59417-117-01","59417-118-01","59417-119-01","59417-120-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Vyvanse, Capsule, 60 mg (NDC 59417-106-10)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/14/2017","package_ndc":"0338-0433-04","generic_name":"Heparin Sodium Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA018609"],"brand_name":["HEPARIN SODIUM IN SODIUM CHLORIDE"],"generic_name":["HEPARIN SODIUM"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0433","0338-0431","0338-0424","0338-0428"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["HEPARIN SODIUM"],"rxcui":["1658690","1658692"],"spl_id":["d28ff87a-c535-49db-ba0c-48080149936b"],"spl_set_id":["0d929726-76c3-48fc-b4e7-fd06409f9fb3"],"package_ndc":["0338-0431-03","0338-0433-04","0338-0424-18","0338-0428-12"],"unii":["ZZ45AB24CA"]},"update_date":"11/03/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"23155-473-41","generic_name":"Furosemide Injection","contact_info":"855-228-9470","availability":"Available","openfda":{"application_number":["ANDA203428"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."],"product_ndc":["23155-473"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["c14acada-333e-43bb-b1cf-81d569e3e918"],"spl_set_id":["1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec"],"package_ndc":["23155-473-31","23155-473-41","23155-473-32","23155-473-42","23155-473-43","23155-473-33","23155-473-44","23155-473-45"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/02/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-41)","company_name":"Avet Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/14/2022","package_ndc":"66220-160-10","generic_name":"Conivaptan Hydrochloride Injection","contact_info":"800-706-5575","availability":"Unavailable","related_info":"Estimated recovery: TBD","update_date":"10/15/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Vaprisol Dextrose In Plastic Container, Injection, 20 mg/100 mL (NDC 66220-160-10)","company_name":"Cumberland Pharmaceuticals Inc.","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/18/2020","package_ndc":"43598-305-62","generic_name":"Azacitidine Injection","contact_info":"866-732-3952","availability":"Available","related_info":"Available to existing customers","openfda":{"application_number":["ANDA201537"],"brand_name":["AZACITIDINE"],"generic_name":["AZACITIDINE"],"manufacturer_name":["Dr. Reddy's Laboratories Inc."],"product_ndc":["43598-305"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["AZACITIDINE"],"rxcui":["485246"],"spl_id":["35e92030-ae2f-04b2-c3de-69f8c8da6b82"],"spl_set_id":["71d8d758-86c9-b571-aed1-719654fd4b82"],"package_ndc":["43598-305-62"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["M801H13NRU"]},"update_date":"10/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Azacitidine, Injection, 100 mg (NDC 43598-305-62)","company_name":"Dr. Reddy's Laboratories, Inc.","status":"Current"},{"discontinued_date":"03/24/2026","update_type":"New","initial_posting_date":"03/24/2026","package_ndc":"0074-7098-03","generic_name":"Pilocarpine Hydrochloride Ophthalmic Solution","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/24/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Ophthalmic Solution","presentation":"Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-03)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"discontinued_date":"07/24/2026","update_type":"New","initial_posting_date":"07/24/2026","package_ndc":"0074-4014-12","generic_name":"Lopinavir and Ritonavir Tablet","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA021906"],"brand_name":["KALETRA"],"generic_name":["LOPINAVIR AND RITONAVIR"],"manufacturer_name":["AbbVie Inc."],"product_ndc":["0074-4014","0074-3956","0074-3008"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LOPINAVIR","RITONAVIR"],"rxcui":["311369","597730","746645","847741","847745","847749"],"spl_id":["36abdfba-ddc2-43ae-9173-903d66a23b23"],"spl_set_id":["8290add3-4449-4e58-6c97-8fe1eec972e3"],"package_ndc":["0074-3956-46","0074-4014-12","0074-3008-60"],"nui":["N0000000246","N0000175889","N0000185503","N0000190114","N0000190107","N0000191001","N0000182137","N0000185607","N0000190118","N0000190113","N0000182141","N0000191266","N0000185507","N0000187064","N0000190117"],"pharm_class_moa":["HIV Protease Inhibitors [MoA]","P-Glycoprotein Inhibitors [MoA]","Cytochrome P450 3A Inhibitors [MoA]","Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]","Cytochrome P450 2D6 Inhibitors [MoA]","Cytochrome P450 2C19 Inducers [MoA]","Cytochrome P450 3A Inducers [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]","Cytochrome P450 3A4 Inhibitors [MoA]","Cytochrome P450 1A2 Inducers [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 2B6 Inducers [MoA]","UDP Glucuronosyltransferases Inducers [MoA]"],"pharm_class_epc":["Protease Inhibitor [EPC]","Cytochrome P450 3A Inhibitor [EPC]"],"unii":["2494G1JF75","O3J8G9O825"]},"update_date":"07/24/2026","therapeutic_category":["Antiviral"],"dosage_form":"Tablet","presentation":"Kaletra, Tablet, 200 mg; 50 mg (NDC 0074-4014-12)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-1304-31","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA200403"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1304","0409-2552","0409-3356","0409-2540","0409-3365","0409-1283","0409-1312"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897653","897753","897756","897757","897758","1724276","1724383","1724644"],"spl_id":["a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"],"spl_set_id":["e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"],"package_ndc":["0409-2552-11","0409-2552-01","0409-3356-11","0409-3356-01","0409-2540-11","0409-2540-01","0409-3365-11","0409-3365-01","0409-3365-10","0409-1283-03","0409-1283-31","0409-1312-03","0409-1312-30","0409-1304-03","0409-1304-31"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 4 mg/1 mL Syringes (NDC 0409-1304-31)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"57844-115-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["ADDERALL"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["57844-115","57844-105","57844-117","57844-110","57844-112","57844-120","57844-130"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541365","541878","541879","541892","541894","577957","577960","577961","577962","687043","687045","1009145","1009147"],"spl_id":["79af1dc6-c7cf-41b1-a750-e9b47c2187ff"],"spl_set_id":["f22635fe-821d-4cde-aa12-419f8b53db81"],"package_ndc":["57844-105-01","57844-117-01","57844-110-01","57844-112-01","57844-115-01","57844-120-01","57844-130-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Adderall, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 57844-115-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"02/20/2026","update_type":"New","initial_posting_date":"02/20/2026","package_ndc":"50742-430-01","generic_name":"Decitabine Injection","contact_info":"866-321-5031","related_info":"Discontinuation of the manufacture of the drug","update_date":"02/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Decitabine, Injection, 50 mg (NDC 50742-430-01)","company_name":"Ingenus Pharmaceuticals LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/22/2021","package_ndc":"42806-799-01","generic_name":"Rifampin Capsule","contact_info":"(718) 276-8600 ext. 3","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA064150"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["EPIC PHARMA, LLC"],"product_ndc":["42806-799","42806-801"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAMPIN"],"rxcui":["198201","198202"],"spl_id":["a4ac02e8-68ac-4e79-8ca5-0939dd002c87"],"spl_set_id":["0391f1e1-70d4-4b15-8b58-055bb6a385b8"],"package_ndc":["42806-801-30","42806-801-01","42806-799-30","42806-799-60","42806-799-01","42806-799-05"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Rifampin, Capsule, 300 mg (NDC 42806-799-01)","company_name":"Epic Pharma, LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"discontinued_date":"11/21/2025","update_type":"New","initial_posting_date":"11/21/2025","package_ndc":"62037-720-05","generic_name":"Potassium Chloride Tablet, Extended Release","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA075604"],"brand_name":["POTASSIUM CHLORIDE"],"generic_name":["POTASSIUM CHLORIDE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["62037-720","62037-710"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["POTASSIUM CHLORIDE"],"rxcui":["1801294","1801298"],"spl_id":["01fbdb24-0987-40f6-a920-f36349f6ba61"],"spl_set_id":["db002ae3-f54c-40a4-9cb4-e5681bf426e3"],"package_ndc":["62037-710-01","62037-720-01","62037-720-05","62037-720-10"],"unii":["660YQ98I10"]},"update_date":"11/21/2025","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology"],"dosage_form":"Tablet","presentation":"Potassium Chloride, Tablet, Extended Release, 20 meq (NDC 62037-720-05)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/13/2023","package_ndc":"61703-161-05","generic_name":"Methotrexate Sodium Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: July 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA011719"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-161","61703-124"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1655956","1946772"],"spl_id":["46b278e8-a016-4a68-b1c1-570d1bbdc10e"],"spl_set_id":["bd287e89-32f9-4396-95fa-4b562869f476"],"package_ndc":["61703-124-40","61703-161-02","61703-161-05"],"unii":["3IG1E710ZN"]},"update_date":"11/09/2026","therapeutic_category":["Oncology","Rheumatology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) Multiple Dose Vial PREMIERProRx (NDC 61703-161-05)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/06/2018","package_ndc":"0641-6042-25","generic_name":"Ketorolac Tromethamine Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA075772"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6042","0641-6043","0641-6041"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["25d6c438-45d2-4162-91c2-b5caa0f86bf3"],"spl_set_id":["0c2c75c9-ed7b-46a8-9543-429bf2d8f090"],"package_ndc":["0641-6043-01","0641-6043-25","0641-6042-01","0641-6042-25","0641-6041-01","0641-6041-25"],"unii":["4EVE5946BQ"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6042-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"01/05/2026","update_type":"New","initial_posting_date":"01/05/2026","package_ndc":"0093-2401-01","generic_name":"Hydroxychloroquine Sulfate Tablet","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA040081"],"brand_name":["HYDROXYCHLOROQUINE SULFATE"],"generic_name":["HYDROXYCHLOROQUINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-2401"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["HYDROXYCHLOROQUINE SULFATE"],"rxcui":["979092"],"spl_id":["0c6c28a5-e86f-4643-bb22-f7eb5b1f440d"],"spl_set_id":["5f3e49b2-dc11-40a9-b366-c88e36a471e5"],"package_ndc":["0093-2401-01"],"unii":["8Q2869CNVH"]},"update_date":"01/05/2026","therapeutic_category":["Anti-Infective","Other","Rheumatology"],"dosage_form":"Tablet","presentation":"Hydroxychloroquine Sulfate, Tablet, 200 mg (NDC 0093-2401-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"42023-186-20","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"800-828-9393","availability":"Unavailable","related_info":"Estimated recovery: TBD; Please check wholesalers for inventory","openfda":{"application_number":["ANDA208266"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["42023-186","42023-146","42023-187"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710","1718906","1718909"],"spl_id":["54174211-6684-4fb9-a605-be12b94e2948"],"spl_set_id":["1ee59985-4c1d-48f7-b8f9-5584c2d55e08"],"package_ndc":["42023-146-25","42023-186-20","42023-187-10"],"unii":["1018WH7F9I"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20)","company_name":"Par Health, USA LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"0781-3220-95","generic_name":"Rocuronium Bromide Injection","contact_info":"800-525-8747","availability":"Available","openfda":{"application_number":["ANDA079195"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-3220"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["eaf32464-7950-434a-e053-2a95a90aa2dc"],"spl_set_id":["cb28d869-6510-4402-9462-f6bb25fa0fa8"],"package_ndc":["0781-3220-70","0781-3220-92","0781-3220-75","0781-3220-95"],"unii":["I65MW4OFHZ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-95)","company_name":"Sandoz Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/22/2021","package_ndc":"42806-801-30","generic_name":"Rifampin Capsule","contact_info":"(718) 276-8600 ext. 3","availability":"Available","openfda":{"application_number":["ANDA064150"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["EPIC PHARMA, LLC"],"product_ndc":["42806-801","42806-799"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAMPIN"],"rxcui":["198201","198202"],"spl_id":["a4ac02e8-68ac-4e79-8ca5-0939dd002c87"],"spl_set_id":["0391f1e1-70d4-4b15-8b58-055bb6a385b8"],"package_ndc":["42806-801-30","42806-801-01","42806-799-30","42806-799-60","42806-799-01","42806-799-05"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Rifampin, Capsule, 150 mg (NDC 42806-801-30)","company_name":"Epic Pharma, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"16729-277-35","generic_name":"Methotrexate Sodium Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Short dated inventory with expiry of 8/31/2027 available; Estimated recovery: Jan 2027","openfda":{"application_number":["ANDA040716"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-277"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL","INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS"],"substance_name":["METHOTREXATE"],"rxcui":["1655956","1655959","1655960"],"spl_id":["5aa89975-d1a1-19f1-e063-6294a90a4b3e"],"spl_set_id":["dd035a9f-cd40-4314-b9d8-2294b8a924e2"],"package_ndc":["16729-277-30","16729-277-03","16729-277-35"],"nui":["N0000175584","N0000000111"],"pharm_class_epc":["Folate Analog Metabolic Inhibitor [EPC]"],"pharm_class_moa":["Folic Acid Metabolism Inhibitors [MoA]"],"unii":["YL5FZ2Y5U1"]},"update_date":"11/02/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 16729-277-35)","company_name":"Accord Healthcare Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"76045-105-20","generic_name":"Ketorolac Tromethamine Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA203242"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-105","76045-104","76045-107","76045-209"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860113","860114","860115"],"spl_id":["0dab642d-7fcf-4301-8ac9-10e64a040c6b"],"spl_set_id":["3d88cbe6-5230-47aa-80af-0c41283d1f00"],"package_ndc":["76045-104-10","76045-105-20","76045-107-10","76045-209-00","76045-209-10"],"unii":["4EVE5946BQ"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 60 mg/2 mL (NDC 76045-105-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"New","initial_posting_date":"06/12/2026","package_ndc":"21586-211-02","generic_name":"Ifosfamide Injection","related_info_link":"https://www.fda.gov/media/194567/download","contact_info":"877-373-4657","availability":"Available","related_info":"To place an order, please contact GlobalRX at info@globalrx.com or (919) 245-8418","openfda":{"brand_name":["IFOSFAMIDE"],"generic_name":["IFOSFAMIDE FOR INJECTION"],"manufacturer_name":["SteriMax Inc."],"product_ndc":["21586-211"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IFOSFAMIDE"],"rxcui":["1791593"],"spl_id":["28dd8f2a-6b41-4b8b-bb70-23fe0b58c665"],"spl_set_id":["98798c5e-8384-4990-a1b5-60dfb1e667bb"],"package_ndc":["21586-211-01","21586-211-02"],"nui":["N0000000236","N0000175558"],"pharm_class_moa":["Alkylating Activity [MoA]"],"pharm_class_epc":["Alkylating Drug [EPC]"],"unii":["UM20QQM95Y"]},"update_date":"09/08/2026","therapeutic_category":["Oncology","Pediatric"],"dosage_form":"Injection","presentation":"Ifosfamide, Injection, 1 g/1 (NDC 21586-211-02)","company_name":"SteriMax, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0781-3493-95","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"See Related Information section below for customer service information","availability":"Available","related_info":"Marketed by Sandoz Inc.; Customer service: 800-525-8747","openfda":{"application_number":["ANDA209065"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"manufacturer_name":["Sandoz Inc."],"product_ndc":["0781-3493","0781-3494","0781-3495"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718900","1718906","1718909"],"spl_id":["5a0d944c-af38-a3fd-e063-6294a90aed62"],"spl_set_id":["809e8f77-390f-4cc8-8c8a-4f67a249c9df"],"package_ndc":["0781-3493-95","0781-3494-95","0781-3495-95"],"unii":["1018WH7F9I"]},"update_date":"10/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/22/2020","package_ndc":"43066-027-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","related_info":"Check wholesalers for inventory; Marketed by Baxter","openfda":{"application_number":["ANDA212808"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["43066-027","43066-015","43066-019","43066-023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734084","1734207","1734475","1734483"],"spl_id":["a8d08579-825f-40d9-b1e3-e47b73765ae6"],"spl_set_id":["781d4b7f-7556-4695-8d48-7772d7a0d8e9"],"package_ndc":["43066-015-01","43066-015-10","43066-019-01","43066-019-10","43066-023-01","43066-023-10","43066-027-01","43066-027-10"],"unii":["V910P86109"]},"update_date":"06/10/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 43066-027-10)","company_name":"Caplin Steriles, Ltd.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"67457-228-10","generic_name":"Rocuronium Bromide Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA079199"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-228"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["b65fbcab-781e-4706-a60b-a8eb4aeae0c1"],"spl_set_id":["f58803b0-f173-4997-b2f8-0f415b94dacf"],"package_ndc":["67457-228-00","67457-228-05","67457-228-99","67457-228-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-10)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-0280-52","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0280","0009-0274","0009-0306"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358510","1358512","1358610","1358612","1358617","1358619"],"spl_id":["267dd735-f800-4735-ba1c-d39d00f0cee5"],"spl_set_id":["823b0010-2b57-4e76-b5ac-4a8c2963438f"],"package_ndc":["0009-0274-01","0009-0280-02","0009-0280-51","0009-0280-03","0009-0280-52","0009-0306-02","0009-0306-12"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-0280-52)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"06/08/2026","update_type":"New","initial_posting_date":"06/08/2026","package_ndc":"0955-1737-30","generic_name":"Leflunomide Tablet","contact_info":"800-981-2491","related_info":"Discontinuation of the manufacture of the drug","update_date":"06/08/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Tablet","presentation":"Leflunomide, Tablet, 20 mg (NDC 0955-1737-30)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"76045-107-10","generic_name":"Ketorolac Tromethamine Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA203242"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-107","76045-104","76045-105","76045-209"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860113","860114","860115"],"spl_id":["0dab642d-7fcf-4301-8ac9-10e64a040c6b"],"spl_set_id":["3d88cbe6-5230-47aa-80af-0c41283d1f00"],"package_ndc":["76045-104-10","76045-105-20","76045-107-10","76045-209-00","76045-209-10"],"unii":["4EVE5946BQ"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 76045-107-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"11534-192-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"732-382-6085 Monday to Friday 9 am to 3:45 pm","availability":"Available","openfda":{"application_number":["ANDA209799"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["SUNRISE PHARMACEUTICAL, INC."],"product_ndc":["11534-192","11534-190","11534-191","11534-193","11534-194","11534-195","11534-196"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["60dcfbf6-d07a-4010-ae77-8a9ae4529828"],"spl_set_id":["ac102599-3a5b-4154-899e-6ff262be7ff7"],"package_ndc":["11534-190-01","11534-190-03","11534-191-01","11534-191-03","11534-192-01","11534-192-03","11534-193-01","11534-193-03","11534-194-01","11534-194-03","11534-195-01","11534-195-03","11534-196-01","11534-196-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/01/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 11534-192-01)","company_name":"Sunrise Pharmaceutical, Inc.","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"63459-390-08","generic_name":"Bendamustine Hydrochloride Injection, Solution","contact_info":"(610) 344-0200","related_info":"A business decision has been made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA022249"],"brand_name":["TREANDA"],"generic_name":["BENDAMUSTINE HYDROCHLORIDE"],"manufacturer_name":["Cephalon, LLC"],"product_ndc":["63459-390","63459-395","63459-396","63459-391"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["BENDAMUSTINE HYDROCHLORIDE"],"rxcui":["1805001","1805004","1805007","1805009","1805011","1805012","1805015","1805016"],"spl_id":["6f14f826-ae33-48f7-8a5a-413412030c2d"],"spl_set_id":["39d53698-57fa-7c99-fc5b-f52a55684826"],"package_ndc":["63459-395-02","63459-396-02","63459-390-08","63459-391-20"],"unii":["981Y8SX18M"]},"update_date":"07/23/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Treanda, Injection, Solution, 25 mg/5 mL, 1 vial, Single-Dose in 1 carton (NDC 63459-390-08)","company_name":"Cephalon, LLC (a wholly owned subsidiary of Teva Pharmaceutical Industries, Ltd.)","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-285-13","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release not available at this time.  Check wholesalers for inventory.","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-285","63323-286","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"45963-709-11","generic_name":"Metoprolol Succinate Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA204161"],"brand_name":["METOPROLOL SUCCINATE"],"generic_name":["METOPROLOL SUCCINATE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["45963-709","45963-676","45963-677","45963-678"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METOPROLOL SUCCINATE"],"rxcui":["866412","866419","866427","866436"],"spl_id":["a7e9a234-a8a6-4afe-ba8e-d569772bc39a"],"spl_set_id":["b798601e-a369-4c8b-8235-08900e1b751d"],"package_ndc":["45963-709-11","45963-709-96","45963-676-11","45963-676-96","45963-677-11","45963-677-96","45963-678-11"],"unii":["TH25PD4CCB"]},"update_date":"08/31/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Metoprolol Succinate, Tablet, Extended Release, 25 mg (NDC 45963-709-11)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-493-91","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-493","63323-492","63323-496"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737636","1737637","1737640","1737641","1737763","1737764"],"spl_id":["fa12a8e8-09fd-496f-8cc6-ffe0eb02e2df"],"spl_set_id":["d5e0d06f-ba1e-44d4-aa89-39d6c146dc23"],"package_ndc":["63323-492-08","63323-492-97","63323-493-03","63323-493-97","63323-493-01","63323-493-91","63323-496-03","63323-496-97"],"unii":["EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 15 mg/1 mL (NDC 63323-493-91)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"64850-502-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"888-852-6657","availability":"Available","openfda":{"application_number":["ANDA211352"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-502","64850-500","64850-501","64850-503","64850-504","64850-505","64850-506"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["a41cf8e5-cb1b-488c-96b3-3bef8283d6c4"],"spl_set_id":["e677690f-790f-4626-ad78-097cdb6ea540"],"package_ndc":["64850-500-01","64850-500-05","64850-500-30","64850-501-01","64850-501-05","64850-501-30","64850-502-01","64850-502-05","64850-502-30","64850-503-01","64850-503-05","64850-503-30","64850-504-01","64850-504-05","64850-504-30","64850-505-01","64850-505-05","64850-505-30","64850-506-01","64850-506-05","64850-506-30"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 64850-502-01)","company_name":"Elite Laboratories, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0078-20","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0078","0338-9651","0338-9649","0338-9655","0338-9653","0338-0062","0338-0074","0338-0066","0338-0070","0338-0082"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795607","1795609","1795610","1795612","1795616"],"spl_id":["b28d6bb9-8496-48bd-b6aa-f67996d0829c"],"spl_set_id":["36e9478c-5df0-4b47-b97d-de3626d7cb29"],"package_ndc":["0338-9651-75","0338-9649-75","0338-9655-60","0338-9653-60","0338-0078-20","0338-0062-30","0338-0074-30","0338-0066-20","0338-0070-10","0338-0070-12","0338-0082-10","0338-0082-12"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0078-20)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/23/2021","package_ndc":"0409-4887-99","generic_name":"Sterile Water Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018801"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4887"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["055437a7-5be5-414a-a97a-946e2730fe12"],"spl_set_id":["2b9ea23a-f9e9-48a8-25b7-519e3bbd6828"],"package_ndc":["0409-4887-25","0409-4887-99","0409-4887-31","0409-4887-05","0409-4887-17","0409-4887-10","0409-4887-32","0409-4887-34","0409-4887-23","0409-4887-20","0409-4887-24","0409-4887-50"],"unii":["059QF0KO0R"]},"update_date":"11/09/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-99)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-063-25","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-063","70069-061","70069-062","70069-064","70069-065","70069-066","70069-067"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 70069-063-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"44567-610-10","generic_name":"Midazolam Hydrochloride Injection","contact_info":"888-493-0861","availability":"Available","related_info":"Please check wholesalers and distributors for inventory.","openfda":{"application_number":["NDA211844"],"brand_name":["MIDAZOLAM IN SODIUM CHLORIDE"],"generic_name":["MIDAZOLAM"],"manufacturer_name":["WG Critical Care, LLC."],"product_ndc":["44567-610","44567-611"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MIDAZOLAM"],"rxcui":["2541170","2541171"],"spl_id":["eedc698f-65b8-4d19-9194-234f05634f71"],"spl_set_id":["f051776f-94c5-4e34-80ed-f45b9c36881e"],"package_ndc":["44567-610-01","44567-610-10","44567-611-01","44567-611-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["R60L0SM5BC"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10)","company_name":"WG Critical Care","status":"Current"},{"discontinued_date":"02/25/2026","update_type":"New","initial_posting_date":"02/25/2026","package_ndc":"0009-0104-04","generic_name":"Lincomycin Hydrochloride Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050317"],"brand_name":["LINCOCIN"],"generic_name":["LINCOMYCIN HYDROCHLORIDE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0104","0009-0555","0009-0107"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCONJUNCTIVAL"],"substance_name":["LINCOMYCIN HYDROCHLORIDE"],"rxcui":["102787","239212"],"spl_id":["7e2f3780-88ee-4971-a4ab-3d6cd972c42c"],"spl_set_id":["c01906fa-2c73-4c13-9765-2fd06628d263"],"package_ndc":["0009-0555-01","0009-0104-04","0009-0107-04"],"unii":["M6T05Z2B68"]},"update_date":"02/25/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Lincocin, Injection, 2 mL multiple dose vial (NDC 0009-0104-04)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-163-30","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203082"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-163","55150-161","55150-162","55150-164","55150-165"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737562","1737566","1737568","1737757","1737761"],"spl_id":["bab2ea79-0aed-4f48-8b4e-f864f8b82fb8","d95a0a28-804f-44d2-aa31-01df376a3154"],"spl_set_id":["9916b09d-a116-469d-92d5-60e50ea9782b","89701fac-7536-4f16-87fb-f4cc121e74ee"],"package_ndc":["55150-161-09","55150-162-09","55150-163-00","55150-163-24","55150-164-09","55150-165-09","55150-161-02","55150-162-05","55150-163-30","55150-163-25","55150-164-02","55150-165-05"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-488-17","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE MPF"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-488","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-8126-10","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-8126","0409-5738","0409-3812","0409-1541","0409-4208","0409-6581"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1672917","1672919","1673242","1673243","1867594","1867596","1867612","1867614"],"spl_id":["14ec85dc-0263-44d1-9267-66fa072cff8d"],"spl_set_id":["93cf0914-de08-4ec6-8f8c-d663243b9958"],"package_ndc":["0409-5738-01","0409-5738-10","0409-3812-01","0409-1541-01","0409-1541-10","0409-8126-01","0409-8126-10","0409-4208-01","0409-4208-10","0409-6581-01"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine™ 0.5% 50 mg/10 mL (5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial Novaplus (NDC 0409-8126-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"0409-7299-73","generic_name":"Sodium Acetate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018893"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7299"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["1859490"],"spl_id":["013001c4-5584-4d8c-8bf6-917d2a919aa4","10c75a24-9542-431a-84f8-44611bc916df"],"spl_set_id":["ce9a7469-c4ba-4f60-8f7a-47ef0974316e","c91ede49-c7cc-47b7-0f93-e6841dd5916a"],"package_ndc":["0409-7299-45","0409-7299-25","0409-7299-83","0409-7299-73"],"unii":["NVG71ZZ7P0"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"0409-1890-23","generic_name":"Morphine Sulfate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA202515"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1890","0409-1891","0409-1892","0409-1893","0409-1894"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["998212","998213","1729197","1732014"],"spl_id":["07b4be5d-af82-43ff-a6d2-0df0d5c495ee"],"spl_set_id":["be420e8b-bcb0-49b5-bb4d-1df8b9959809"],"package_ndc":["0409-1890-03","0409-1890-01","0409-1890-13","0409-1890-23","0409-1891-03","0409-1891-01","0409-1891-13","0409-1891-23","0409-1892-03","0409-1892-01","0409-1892-13","0409-1892-23","0409-1893-03","0409-1893-01","0409-1893-13","0409-1893-23","0409-1894-03","0409-1894-01"],"unii":["X3P646A2J0"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 2 mg/1 mL (NDC 0409-1890-23)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"05/15/2026","update_type":"New","initial_posting_date":"05/15/2026","package_ndc":"0574-0520-74","generic_name":"Activated Charcoal Oral Suspension","contact_info":"866-634-9120","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["M023"],"brand_name":["ACTIDOSE"],"generic_name":["ACTIVATED CHARCOAL"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-0520"],"product_type":["HUMAN OTC DRUG"],"route":["ORAL"],"substance_name":["ACTIVATED CHARCOAL"],"rxcui":["309150","1251411"],"spl_id":["cf3da077-fe7d-4685-8c5c-f773bc88c88d"],"spl_set_id":["76e4fe6a-afd4-4f68-b12d-0b094f750615"],"package_ndc":["0574-0520-74","0574-0520-76"],"unii":["2P3VWU3H10"]},"update_date":"05/15/2026","therapeutic_category":["Other"],"dosage_form":"Oral Suspension","presentation":"Actidose, Oral Suspension, 208 mg/1 mL (NDC 0574-0520-74)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/25/2017","package_ndc":"0338-0411-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA018461"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND DEXTROSE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0411","0338-0409"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737723","1737742","1737744"],"spl_id":["9e9121a0-25dd-46ba-a2b7-6f71fc3ff9cd"],"spl_set_id":["f21512ea-c7c3-4766-b976-b2c0b5616bf0"],"package_ndc":["0338-0409-03","0338-0409-02","0338-0411-02"],"unii":["V13007Z41A"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-482-57","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-482","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0338-0502-03","generic_name":"Amino Acid Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA020512"],"brand_name":["CLINISOL"],"generic_name":["LYSINE, LEUCINE, PHENYLALANINE, VALINE, HISTIDINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, TYROSINE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0502"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LYSINE ACETATE","LEUCINE","PHENYLALANINE","VALINE","HISTIDINE","ISOLEUCINE","METHIONINE","THREONINE","TRYPTOPHAN","ALANINE","ARGININE","GLYCINE","PROLINE","GLUTAMIC ACID","SERINE","ASPARTIC ACID","TYROSINE"],"rxcui":["800584","800588"],"spl_id":["dfb5b2ef-1ef5-4a8b-bb77-13d85708e50f"],"spl_set_id":["65ffc962-7538-41ea-9afb-4af5fbce4c5b"],"package_ndc":["0338-0502-03","0338-0502-06"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["TTL6G7LIWZ","GMW67QNF9C","47E5O17Y3R","HG18B9YRS7","4QD397987E","04Y7590D77","AE28F7PNPL","2ZD004190S","8DUH1N11BX","OF5P57N2ZX","94ZLA3W45F","TE7660XO1C","9DLQ4CIU6V","3KX376GY7L","452VLY9402","30KYC7MIAI","42HK56048U"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Clinisol 15% Sulfite Free In Plastic Container, Injection, 0.15 (NDC 0338-0502-03)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"05/03/2022","package_ndc":"17478-050-05","generic_name":"Sufentanil Citrate Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Not currently manufactured","update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Sufentanil Citrate, Injection, 50 mcg/1 mL (NDC 17478-050-05)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"02/25/2026","update_type":"New","initial_posting_date":"02/25/2026","package_ndc":"63323-750-10","generic_name":"Oxaliplatin Injection","contact_info":"847-550-2300","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"02/25/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Oxaliplatin, Injection, 5 mg/mL (NDC 63323-750-10)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0378-6858-77","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA202835"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-6858","0378-6854","0378-6855","0378-6856","0378-6857","0378-6859","0378-6860"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["6e77cd71-95ae-4fa8-830b-ab62b714e4b9"],"spl_set_id":["efbde0f6-b848-4664-b741-c6c630e66108"],"package_ndc":["0378-6854-77","0378-6855-77","0378-6856-77","0378-6857-77","0378-6858-77","0378-6859-77","0378-6860-77"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 0378-6858-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/18/2023","package_ndc":"0480-3667-22","generic_name":"Liraglutide Injection","contact_info":"833-493-4689","availability":"Available","related_info":"Distributed by Teva","openfda":{"application_number":["NDA022341"],"brand_name":["LIRAGLUTIDE"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0480-3667"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["897122"],"spl_id":["57c9f463-a1b8-4efa-8982-40175cf6cf4f"],"spl_set_id":["14bf9812-14ee-46ce-93b1-686e4906cbbc"],"package_ndc":["0480-3667-19","0480-3667-22","0480-3667-20"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"09/22/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Liraglutide, Injection, 6 mg/1 mL (NDC 0480-3667-22)","company_name":"Novo Nordisk, Inc.","status":"Current"},{"discontinued_date":"10/01/2026","update_type":"New","initial_posting_date":"10/07/2026","package_ndc":"0603-3581-28","generic_name":"Felodipine Tablet, Extended Release","contact_info":"(800) 828-9393","related_info":"Discontinuation in the manufacturing of the drug product","openfda":{"application_number":["ANDA200815"],"brand_name":["FELODIPINE"],"generic_name":["FELODIPINE"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["0603-3581","0603-3582","0603-3583"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FELODIPINE"],"rxcui":["402695","402696","402698"],"spl_id":["02151da2-890e-4f84-94c8-6ce767d9ff12"],"spl_set_id":["55637724-8757-11de-8a39-0800200c9a66"],"package_ndc":["0603-3581-28","0603-3581-21","0603-3582-21","0603-3582-28","0603-3583-28","0603-3583-21"],"nui":["N0000000069","N0000175421","M0006414"],"pharm_class_moa":["Calcium Channel Antagonists [MoA]"],"pharm_class_epc":["Dihydropyridine Calcium Channel Blocker [EPC]"],"pharm_class_cs":["Dihydropyridines [CS]"],"unii":["OL961R6O2C"]},"update_date":"10/07/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Felodipine, Tablet, Extended Release, 2.5 mg (NDC 0603-3581-28)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"54288-167-01","generic_name":"Carboplatin Injection","contact_info":"Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270","availability":"Limited Availability","related_info":"Recovery estimated in late Q4 2026; Distributed by BPI Labs, LLC","openfda":{"application_number":["ANDA207324"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["BPI Labs LLC"],"product_ndc":["54288-167","54288-165","54288-166","54288-164"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["c0a7463c-d90f-4060-a54e-6a4888e8af0e"],"spl_set_id":["5484d2f0-0cc2-4bba-8f26-c7f6539a9606"],"package_ndc":["54288-165-01","54288-166-01","54288-167-01","54288-164-01"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/21/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 600 mg/65 mL (NDC 54288-167-01)","company_name":"Gland Pharma Limited","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"07/07/2026","update_type":"New","initial_posting_date":"07/07/2026","package_ndc":"0378-9651-32","generic_name":"Travoprost Ophthalmic Solution","contact_info":"877-446-3679","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA205050"],"brand_name":["TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"],"generic_name":["TRAVOPROST OPHTHALMIC SOLUTION, 0.004%"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-9651"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["OPHTHALMIC"],"substance_name":["TRAVOPROST"],"rxcui":["284008"],"spl_id":["d78c5705-68ac-4363-b9ae-5facc60e2b79"],"spl_set_id":["00dc284f-fd96-423b-bb8f-b90ee13439bf"],"package_ndc":["0378-9651-32","0378-9651-50"],"nui":["N0000175454","M0017805"],"pharm_class_epc":["Prostaglandin Analog [EPC]"],"pharm_class_cs":["Prostaglandins [CS]"],"unii":["WJ68R08KX9"]},"update_date":"07/07/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Ophthalmic Solution","presentation":"Travoprost, Ophthalmic Solution, 0.004%, 2.5 mL (NDC 0378-9651-32)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/21/2023","package_ndc":"0641-6084-25","generic_name":"Promethazine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA083312"],"brand_name":["PHENERGAN"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6084","0641-6085"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992460","992462","992858","992876"],"spl_id":["7d6e64fc-bbf2-4ea9-b866-8115c448e687"],"spl_set_id":["481866da-a712-48a5-853f-8e84aacaab6d"],"package_ndc":["0641-6084-01","0641-6084-25","0641-6085-01","0641-6085-25"],"unii":["R61ZEH7I1I"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Pediatric","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Phenergan, Injection, 25 mg/1 mL (NDC 0641-6084-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"70010-113-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"877-770-3183","availability":"Unavailable","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA215771"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Granules Pharmaceuticals Inc."],"product_ndc":["70010-113","70010-111","70010-112","70010-114","70010-115","70010-116","70010-117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["56c7c921-e560-c5ad-e063-6294a90a4c81"],"spl_set_id":["b0b4eccc-34c7-483d-966f-82d588358e1b"],"package_ndc":["70010-111-01","70010-111-03","70010-112-01","70010-112-03","70010-113-01","70010-113-03","70010-114-01","70010-114-03","70010-115-01","70010-115-03","70010-116-01","70010-116-03","70010-117-01","70010-117-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/28/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 70010-113-01)","company_name":"Granules Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"0527-4664-37","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-4664","0527-4661","0527-4662","0527-4663","0527-4665","0527-4666","0527-4667"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["164b5658-3c14-44f5-b10a-839909184984"],"spl_set_id":["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"],"package_ndc":["0527-4661-37","0527-4662-37","0527-4663-37","0527-4664-37","0527-4665-37","0527-4666-37","0527-4667-37"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0527-4664-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"08/03/2022","package_ndc":"0378-4415-01","generic_name":"Flurazepam Hydrochloride Capsule","contact_info":"1-844-874-7464","availability":"Unavailable","related_info":"Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.","update_date":"09/01/2026","therapeutic_category":["Neurology","Other"],"dosage_form":"Capsule","presentation":"Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)","company_name":"Rising Pharma Holdings, Inc.","shortage_reason":"Regulatory delay","status":"Current"},{"discontinued_date":"01/12/2026","update_type":"New","initial_posting_date":"01/12/2026","package_ndc":"63323-358-10","generic_name":"Caspofungin Acetate Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA206110"],"brand_name":["CASPOFUNGIN ACETATE"],"generic_name":["CASPOFUNGIN ACETATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-358","63323-356"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CASPOFUNGIN ACETATE"],"rxcui":["828539","828755"],"spl_id":["7cdf103b-418f-42a8-bd1b-ebfd8027124a"],"spl_set_id":["e76d8d83-3691-451c-a32c-d91448c54d16"],"package_ndc":["63323-356-01","63323-356-10","63323-358-01","63323-358-10"],"unii":["VUW370O5QE"]},"update_date":"01/12/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Caspofungin Acetate, Injection, 7 mg/1 mL (NDC 63323-358-10)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-167-10","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203895"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-167","55150-168","55150-169","55150-170","55150-171","55150-172","55150-249","55150-250"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404","1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["39649703-e633-4a20-ba71-0c04dbf8ff2a"],"spl_set_id":["ffecf450-1f01-4721-8e10-251385852612"],"package_ndc":["55150-167-10","55150-168-30","55150-169-10","55150-170-30","55150-171-10","55150-172-30","55150-249-50","55150-250-50"],"unii":["7TQO7W3VT8"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-167-10)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/18/2020","package_ndc":"63323-771-39","generic_name":"Azacitidine Injection","contact_info":"1-888-386-1300","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA207518"],"brand_name":["AZACITIDINE"],"generic_name":["AZACITIDINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-771"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["AZACITIDINE"],"rxcui":["485246"],"spl_id":["4becda8d-8042-4cf1-bef3-c0ec3c23eebe"],"spl_set_id":["3b594aba-e798-4105-b801-0b0d970747c1"],"package_ndc":["63323-771-39"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["M801H13NRU"]},"update_date":"11/03/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Azacitidine, Injection, 100 mg/30 mL (NDC 63323-771-39)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"64850-553-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-852-6657","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA218604"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-553","64850-550","64850-551","64850-552","64850-554","64850-555","64850-556"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["2d33f701-8067-4a48-98cc-4e7dacaf3cc4"],"spl_set_id":["0e024b69-567c-4b40-9c3e-a2daec34256c"],"package_ndc":["64850-550-01","64850-551-01","64850-552-01","64850-553-01","64850-554-01","64850-555-01","64850-556-01"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 64850-553-01)","company_name":"Elite Laboratories, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-048-88","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-818-4555","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA214484"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-048","57664-047","57664-046","57664-049","57664-050","57664-051","57664-052","57664-083","57664-084","57664-085","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 57664-048-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"11/12/2025","update_type":"New","initial_posting_date":"11/12/2025","package_ndc":"0603-3718-34","generic_name":"Frovatriptan Succinate Tablet","contact_info":"800-828-9393","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"11/12/2025","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Frova, Tablet, 2.5 mg (NDC 0603-3718-34)","company_name":"Endo Pharmaceuticals, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"72888-152-01","generic_name":"Clonazepam Tablet","contact_info":"sales@advagenpharma.com","resolved_note":"Available","openfda":{"application_number":["ANDA075468"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Advagen Pharma Ltd"],"product_ndc":["72888-152","72888-497","72888-153","72888-154"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529","204892"],"spl_id":["5510f17b-a980-f412-e063-6394a90ae1c4"],"spl_set_id":["30d674f9-f1b3-4c2d-a8e9-3bc8e476f1ec"],"package_ndc":["72888-497-01","72888-497-02","72888-497-03","72888-497-04","72888-152-30","72888-152-01","72888-152-05","72888-152-00","72888-153-30","72888-153-01","72888-153-05","72888-153-00","72888-154-30","72888-154-01","72888-154-05","72888-154-00"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 72888-152-01)","company_name":"Rubicon Research Private Limited","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1165-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070585"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1165","0409-1159","0409-1160","0409-1162","0409-1163","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"68180-556-09","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-587-4617","availability":"Unavailable","related_info":"Estimated recovery: TBD","update_date":"10/13/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 5 mg (NDC 68180-556-09)","company_name":"Lupin Pharmaceuticals, Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"62175-310-37","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA091695"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Lannett Company, Inc."],"product_ndc":["62175-310","62175-311","62175-312","62175-313"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["2001564","2001565","2001566","2001568"],"spl_id":["8b133cd2-e3c6-4742-b402-2393b56ffc93"],"spl_set_id":["3d1f5aff-5d39-496c-b5ed-7f3c70ec641c"],"package_ndc":["62175-310-37","62175-311-37","62175-312-37","62175-313-37"],"unii":["4B3SC438HI"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 62175-310-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"43547-606-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-931-9829","availability":"Limited Availability","related_info":"On allocation","openfda":{"application_number":["ANDA216266"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE CAPSULES"],"manufacturer_name":["Solco Healthcare US,LLC"],"product_ndc":["43547-606","43547-602","43547-603","43547-604","43547-605","43547-607","43547-608"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["d6435613-e052-4b4f-8bf7-4acb7458d8df"],"spl_set_id":["68b10d9f-ca3e-493d-a309-45f1d7e08061"],"package_ndc":["43547-602-10","43547-603-10","43547-604-10","43547-605-10","43547-606-10","43547-607-10","43547-608-10"],"unii":["SJT761GEGS"]},"update_date":"06/29/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 50 mg (NDC 43547-606-10)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"09/01/2026","update_type":"New","initial_posting_date":"09/01/2026","package_ndc":"75987-050-07","generic_name":"Glycerol Phenylbutyrate Oral Liquid","contact_info":"800-772-6436","related_info":"Discontinuation in the manufacturing of the drug product","openfda":{"application_number":["NDA203284"],"brand_name":["RAVICTI"],"generic_name":["GLYCEROL PHENYLBUTYRATE"],"manufacturer_name":["Horizon Therapeutics USA, Inc."],"product_ndc":["75987-050"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GLYCEROL PHENYLBUTYRATE"],"rxcui":["1368453","1368459"],"spl_id":["a58b617c-635a-4a67-9f27-f9c93f8cba22"],"spl_set_id":["900e7dc0-9afe-4f50-80de-90567bb78519"],"package_ndc":["75987-050-06","75987-050-07"],"unii":["ZH6F1VCV7B"]},"update_date":"09/01/2026","therapeutic_category":["Inborn Errors"],"presentation":"RAVICTI, Oral Liquid, 1.1 g/1 mL (NDC 75987-050-07)","company_name":"Amgen Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"59651-724-01","generic_name":"Clonazepam Tablet","contact_info":"866-850-2876","resolved_note":"Available","openfda":{"application_number":["ANDA075150"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["59651-724","59651-722","59651-723"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"spl_set_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"package_ndc":["59651-722-01","59651-722-99","59651-723-01","59651-723-99","59651-724-01","59651-724-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 2 mg (NDC 59651-724-01)","company_name":"Aurobindo Pharma USA","status":"Resolved"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-1761-10","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA018692"],"brand_name":["MARCAINE SPINAL"],"generic_name":["BUPIVACAINE HYDROCHLORIDE IN DEXTROSE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1761"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBARACHNOID"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724784","1724792"],"spl_id":["ef77810e-d05c-4501-9512-10dbe0bc7f00"],"spl_set_id":["9679cc05-2f8a-4e88-53b5-6e9122c8b8c0"],"package_ndc":["0409-1761-19","0409-1761-02","0409-1761-18","0409-1761-62","0409-1761-05","0409-1761-10"],"unii":["7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, 0.75% 15 mg/2 mL (7.5 mg/mL) in Dextrose 8.25% (NDC 0409-1761-10)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"25021-687-05","generic_name":"Rocuronium Bromide Injection","contact_info":"866-625-1618","availability":"Available","openfda":{"application_number":["ANDA205656"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-687"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["46df7a65-7a07-4cf2-9c3d-b0efece06f8b"],"spl_set_id":["01825411-be08-4402-b101-cb546291c972"],"package_ndc":["25021-687-05","25021-687-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 25021-687-05)","company_name":"Sagent Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"13811-710-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Allocation to current contracted customers","openfda":{"application_number":["ANDA205327"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Trigen Laboratories, LLC"],"product_ndc":["13811-710","13811-709","13811-706","13811-707","13811-708"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461"],"spl_id":["0944cf70-d59a-483b-9698-e96ef955a65a"],"spl_set_id":["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"],"package_ndc":["13811-709-10","13811-706-10","13811-707-10","13811-708-10","13811-710-10","13811-710-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)","company_name":"Trigen Laboratories, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0054-0371-25","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Available on allocation","openfda":{"application_number":["ANDA202827"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0054-0371","0054-0660","0054-0370","0054-0372","0054-0373","0054-0374","0054-0375"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["ccd9e87c-bd03-4fe0-8129-41c1ced49c8d"],"spl_set_id":["6740a621-9bec-4178-a4fc-a3fc89f34e0a"],"package_ndc":["0054-0660-25","0054-0370-25","0054-0371-25","0054-0372-25","0054-0373-25","0054-0374-25","0054-0375-25"],"unii":["SJT761GEGS"]},"update_date":"10/14/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0054-0371-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"0409-1312-36","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA200403"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1312","0409-1283","0409-4264","0409-1805","0409-2552","0409-3356","0409-2540","0409-3365","0409-1304"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["897756","897757","1433251","1724383","1724644","2675350","897653","897753","897758","1724276"],"spl_id":["766e302a-2d03-4d93-b237-2348b57ee517","a3ebafac-648e-47b1-a6f5-1e3bff1e3e08"],"spl_set_id":["f9ca2ef5-46d8-475a-a26e-f7c8becd6db7","e9c9ef18-7dfc-4322-b2fc-29b934c30f8b"],"package_ndc":["0409-1283-17","0409-1283-37","0409-1312-16","0409-1312-36","0409-4264-11","0409-4264-01","0409-1805-10","0409-1805-01","0409-2552-11","0409-2552-01","0409-3356-11","0409-3356-01","0409-2540-11","0409-2540-01","0409-3365-11","0409-3365-01","0409-3365-10","0409-1283-03","0409-1283-31","0409-1312-03","0409-1312-30","0409-1304-03","0409-1304-31"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 2 mg/1 mL (NDC 0409-1312-36)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"42806-344-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(718) 276-8600 ext. 3","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040444"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Epic Pharma, LLC"],"product_ndc":["42806-344","42806-339","42806-341","42806-343","42806-345"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961"],"spl_id":["f11301e2-3b5d-468d-b44c-45839e7e5dfb"],"spl_set_id":["1757e132-061d-4773-89ed-fdc77f69008f"],"package_ndc":["42806-339-01","42806-341-01","42806-343-01","42806-344-01","42806-345-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 5 mg; 5 mg; 5 mg; 5 mg (NDC 42806-344-01)","company_name":"Epic Pharma, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0426-53","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020163"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0426","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 1.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0426-53)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/22/2020","package_ndc":"43066-019-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","related_info":"Check wholesalers for inventory; Marketed by Baxter","openfda":{"application_number":["ANDA212808"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["43066-019","43066-015","43066-023","43066-027"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734084","1734207","1734475","1734483"],"spl_id":["a8d08579-825f-40d9-b1e3-e47b73765ae6"],"spl_set_id":["781d4b7f-7556-4695-8d48-7772d7a0d8e9"],"package_ndc":["43066-015-01","43066-015-10","43066-019-01","43066-019-10","43066-023-01","43066-023-10","43066-027-01","43066-027-10"],"unii":["V910P86109"]},"update_date":"06/10/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 43066-019-10)","company_name":"Caplin Steriles, Ltd.","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-3073-22","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: November 2026; Estimated Recovery: December 2026","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-3073","0009-3475"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE","INTRA-ARTICULAR"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743781","1743855","1743856"],"spl_id":["e4917f75-3e1c-4f3c-803d-d9ec65df06c7","742fcec7-8db3-4cc6-b276-42587a993810"],"spl_set_id":["bf1b104d-85cb-414d-a366-78068c82c883","9a7b3837-e038-48bf-97e9-78ad463760dc"],"package_ndc":["0009-3073-22","0009-3073-23","0009-3475-22","0009-3475-23","0009-3073-01","0009-3073-03","0009-3475-01","0009-3475-03"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-22)","company_name":"Pfizer Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"05/30/2025","package_ndc":"0409-1176-30","generic_name":"Meperidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021171"],"brand_name":["DEMEROL"],"generic_name":["MEPERIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1176","0409-1181","0409-1178","0409-1179","0409-1180","0409-1362","0409-1418"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["MEPERIDINE HYDROCHLORIDE"],"rxcui":["860792","861463","861473","861493","861494","861522","861529","861617","1242106","1242503","2539186","2539188","2539191","2539192"],"spl_id":["b6935f73-7b93-496d-871b-de6f9b379649"],"spl_set_id":["b31d1308-28c3-43f4-e0a6-2f3ed76b8975"],"package_ndc":["0409-1181-30","0409-1176-03","0409-1176-30","0409-1178-03","0409-1178-30","0409-1179-03","0409-1179-30","0409-1180-59","0409-1180-69","0409-1362-11","0409-1362-01","0409-1418-11","0409-1418-01"],"unii":["N8E7F7Q170"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Demerol, Injection, 25 mg/1 mL (NDC 0409-1176-30)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"01/01/2026","update_type":"New","initial_posting_date":"03/24/2026","package_ndc":"55513-813-28","generic_name":"Ivabradine Solution","contact_info":"1-800-772-6436","related_info":"Discontinuation of the manufacture of the drug product","openfda":{"application_number":["NDA209964"],"brand_name":["CORLANOR"],"generic_name":["IVABRADINE"],"manufacturer_name":["Amgen Inc"],"product_ndc":["55513-813","55513-800","55513-810"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["IVABRADINE HYDROCHLORIDE"],"rxcui":["1649485","1649491","1649493","1649495","2168592","2168596"],"spl_id":["8ab000cd-0258-489a-b1bb-4cc1ca359d6c"],"spl_set_id":["92018a65-38f6-45f7-91d4-a34921b81d0d"],"package_ndc":["55513-800-60","55513-800-99","55513-810-60","55513-813-01","55513-813-28"],"unii":["TP19837BZK"]},"update_date":"03/24/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Solution","presentation":"Corlanor, Solution, 5 mg/5 mL (NDC 55513-813-28)","company_name":"Amgen Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/03/2023","package_ndc":"69784-200-96","generic_name":"Cromolyn Sodium Concentrate","contact_info":"Distributed by Omnivium Pharmaceuticals LLC (888) 807-9195 or customerservice@omniviumpharma.com","availability":"Limited Availability","related_info":"No longer manufactured, some supplies still available in supply chain. Distributed by Woodward Pharma Services LLC (248) 308-1120 Ext 2","update_date":"11/02/2026","therapeutic_category":["Pulmonary/Allergy"],"dosage_form":"Concentrate","presentation":"Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 69784-200-96)","company_name":"Ailex Pharmaceuticals","shortage_reason":"Other","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0433-51","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020183"],"brand_name":["DIANEAL LOW CALCIUM WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0433","0941-0411","0941-0413","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL Low Calcium with Dextrose, Intraperitoneal Injection, Solution, 18.3 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0433-51)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7045-04","generic_name":"Belladonna and Opium Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["BELLADONNA AND OPIUM"],"generic_name":["ATROPA BELLADONNA AND OPIUM"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7045","0574-7040"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["ATROPA BELLADONNA","OPIUM"],"rxcui":["312104","312107"],"spl_id":["7b45a1d7-c3a5-4434-a848-45638cedd6e1"],"spl_set_id":["8301e76b-134a-43d2-a7dc-c600ccf2695c"],"package_ndc":["0574-7040-12","0574-7040-04","0574-7045-12","0574-7045-04"],"unii":["37M3MZ001L","WQZ3G9PF0H"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Suppository","presentation":"Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-04)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"63323-411-10","generic_name":"Midazolam Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA075154"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-411","63323-412"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["9814447b-a93e-42ad-b57e-5db0a5b7f552"],"spl_set_id":["a91ce254-14a3-4cbf-8ab8-5da252aa3fdc"],"package_ndc":["63323-411-22","63323-411-27","63323-411-15","63323-411-12","63323-411-18","63323-411-25","63323-411-13","63323-411-10","63323-412-18","63323-412-25","63323-412-03","63323-412-02","63323-412-06","63323-412-05","63323-412-13","63323-412-10"],"unii":["W7TTW573JJ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0480-3565-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA202802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Teva Pharmaceuticals, Inc."],"product_ndc":["0480-3565","0480-3566","0480-3567","0480-3568","0480-3569","0480-3570","0480-3564"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["7a1feaa2-6b58-4aff-a45b-533ee3174e53"],"spl_set_id":["c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fc"],"package_ndc":["0480-3565-01","0480-3566-01","0480-3567-01","0480-3568-01","0480-3569-01","0480-3570-01","0480-3564-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0480-3565-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4276-01","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA088299"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4276","0409-4713","0409-4278","0409-4279","0409-4776","0409-4282","0409-4277","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride In Plastic Container, Injection, 200 mg/20 mL (1%; 10 mg/mL) (NDC 0409-4276-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"70069-759-04","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA218112"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-759","70069-758"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1788947"],"spl_id":["6a1a2c33-1467-4eb0-adc6-6e21771fbf6b"],"spl_set_id":["649e777b-9b30-4f1e-9fb9-6bba57580976"],"package_ndc":["70069-758-04","70069-759-04"],"unii":["1018WH7F9I"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"61703-339-56","generic_name":"Carboplatin Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA076517"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-339"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["0ddf4411-7138-412a-908a-fadf22bdfb79"],"spl_set_id":["c3ae9880-44bb-4f4e-93d8-8a5e21708a30"],"package_ndc":["61703-339-18","61703-339-22","61703-339-50","61703-339-56"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/09/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 600 mg/60 mL (10 mg/mL) (NDC 61703-339-56)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/24/2017","package_ndc":"51754-5001-5","generic_name":"Sodium Bicarbonate Injection","contact_info":"828-758-5474 ext. 154","availability":"Available","openfda":{"application_number":["ANDA211091"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["Exela Pharma Sciences, LLC"],"product_ndc":["51754-5001","51754-5011","51754-5002","51754-5012"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["807284","1868486","1923484","2198792"],"spl_id":["4da0ba66-756d-4b4d-8018-81ca16578ef1"],"spl_set_id":["e9698a4f-1a95-4f28-a945-e8009d1d6dd4"],"package_ndc":["51754-5001-5","51754-5001-4","51754-5011-4","51754-5002-5","51754-5012-4"],"unii":["8MDF5V39QO"]},"update_date":"10/15/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5)","company_name":"Exela Pharma Sciences, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/02/2020","package_ndc":"0409-2308-01","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2026","openfda":{"application_number":["ANDA075857"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2308","0409-2305","0409-0001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666800","1666814","1666823","1666798"],"spl_id":["2f69c5b1-6505-42dc-8bb3-edbd9b6c0781","8954486a-8512-4831-8178-0b49f1efb73e"],"spl_set_id":["b95415fa-17c2-42ab-a6b0-e628d01c94ed","1abda8b8-48a8-4995-af86-39220d1aa240"],"package_ndc":["0409-2305-55","0409-2305-50","0409-2308-69","0409-2308-49","0409-2308-70","0409-2308-50","0409-2305-16","0409-2305-17","0409-2305-04","0409-2305-05","0409-2308-21","0409-2308-01","0409-2308-22","0409-2308-02","0409-0001-01","0409-0001-25"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/13/2023","package_ndc":"61703-350-38","generic_name":"Methotrexate Sodium Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA011719"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["61703-350","61703-408"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1655956","1946772"],"spl_id":["6d38984b-4deb-42c3-bf1d-4e0b0c8887e6","db79ea57-58c9-4bd4-86df-9a23f3294ac8"],"spl_set_id":["0d63ba29-b692-41b4-87e8-351265c8273f","0e30eaef-5a09-4104-8a11-c32933eadeab"],"package_ndc":["61703-350-37","61703-350-38","61703-408-41","61703-350-09","61703-350-10","61703-408-25"],"unii":["3IG1E710ZN"]},"update_date":"11/09/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium, Injection, 50 mg/2 mL (25 mg/mL) (NDC 61703-350-38)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"63323-208-05","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["NDA017584"],"brand_name":["LIDOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-208"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737761"],"spl_id":["289524c2-d0be-443d-aedf-39d621f217a5"],"spl_set_id":["f1b26274-a55e-4321-b96c-ce0df830f205"],"package_ndc":["63323-208-01","63323-208-05"],"unii":["V13007Z41A"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride Preservative Free, Injection, 20 mg/1 mL (NDC 63323-208-05)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"44567-601-04","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"WG Critical Care 888-493-0861","availability":"Available","related_info":"Marketed by WG Critical Care","openfda":{"application_number":["NDA206628"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["WG Critical Care, LLC"],"product_ndc":["44567-601","44567-600","44567-602","44567-603"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909","1788947"],"spl_id":["ee503974-3f79-46d7-845f-2d15444dc0b8"],"spl_set_id":["0d2710f2-ee47-4114-ab5c-8dca74cdcb8d"],"package_ndc":["44567-600-04","44567-601-04","44567-602-01","44567-602-24","44567-603-01","44567-603-24"],"unii":["1018WH7F9I"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04)","company_name":"HQ Specialty Pharma","status":"Current"},{"discontinued_date":"02/25/2026","update_type":"New","initial_posting_date":"02/25/2026","package_ndc":"0009-0225-02","generic_name":"Clindamycin Hydrochloride Capsule","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050162"],"brand_name":["CLEOCIN HYDROCHLORIDE"],"generic_name":["CLINDAMYCIN HYDROCHLORIDE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0225","0009-0331","0009-0395"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLINDAMYCIN HYDROCHLORIDE"],"rxcui":["197518","284215","309329","748746","748748","748750"],"spl_id":["3cdb1eb4-26cd-495d-b9d2-0ad980fadc2b"],"spl_set_id":["df9a2a41-b132-4f43-8940-b2d773b1369a"],"package_ndc":["0009-0331-02","0009-0225-02","0009-0395-14"],"unii":["T20OQ1YN1W"]},"update_date":"02/25/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/23/2021","package_ndc":"0409-4887-20","generic_name":"Sterile Water Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018801"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4887"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["055437a7-5be5-414a-a97a-946e2730fe12"],"spl_set_id":["2b9ea23a-f9e9-48a8-25b7-519e3bbd6828"],"package_ndc":["0409-4887-25","0409-4887-99","0409-4887-31","0409-4887-05","0409-4887-17","0409-4887-10","0409-4887-32","0409-4887-34","0409-4887-23","0409-4887-20","0409-4887-24","0409-4887-50"],"unii":["059QF0KO0R"]},"update_date":"11/09/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water, Injection, 1 mL/1 mL (NDC 0409-4887-20)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-356-01","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 20 mg (NDC 13668-356-01)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"70010-117-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"877-770-3183","availability":"Unavailable","related_info":"Estimated recovery: November 2026","openfda":{"application_number":["ANDA215771"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Granules Pharmaceuticals Inc."],"product_ndc":["70010-117","70010-111","70010-112","70010-113","70010-114","70010-115","70010-116"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE","DEXTROAMPHETAMINE SACCHARATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["56c7c921-e560-c5ad-e063-6294a90a4c81"],"spl_set_id":["b0b4eccc-34c7-483d-966f-82d588358e1b"],"package_ndc":["70010-111-01","70010-111-03","70010-112-01","70010-112-03","70010-113-01","70010-113-03","70010-114-01","70010-114-03","70010-115-01","70010-115-03","70010-116-01","70010-116-03","70010-117-01","70010-117-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/28/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 70010-117-01)","company_name":"Granules Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"47781-567-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-842-8672 and email: CustomerService-US@alvogen.com","availability":"Available","openfda":{"application_number":["ANDA214547"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Alvogen Inc."],"product_ndc":["47781-567","47781-562","47781-563","47781-564","47781-565","47781-566","47781-568"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["db02ec6b-f17f-ab22-b671-e1ddb90e017c"],"spl_set_id":["7f2dd6ee-3363-c87c-9693-ed838942556c"],"package_ndc":["47781-562-01","47781-563-01","47781-564-01","47781-565-01","47781-566-01","47781-567-01","47781-568-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 47781-567-01)","company_name":"Alvogen","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0070-10","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0070","0338-9651","0338-9649","0338-9655","0338-9653","0338-0078","0338-0062","0338-0074","0338-0066","0338-0082"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795607","1795609","1795610","1795612","1795616"],"spl_id":["b28d6bb9-8496-48bd-b6aa-f67996d0829c"],"spl_set_id":["36e9478c-5df0-4b47-b97d-de3626d7cb29"],"package_ndc":["0338-9651-75","0338-9649-75","0338-9655-60","0338-9653-60","0338-0078-20","0338-0062-30","0338-0074-30","0338-0066-20","0338-0070-10","0338-0070-12","0338-0082-10","0338-0082-12"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"25021-115-02","generic_name":"Clindamycin Phosphate Injection","contact_info":"866-625-1618","availability":"Limited Availability","related_info":"Selling through remaining short-dated inventory (Dec 2026).","openfda":{"application_number":["ANDA090108"],"brand_name":["CLINDAMYCIN"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-115"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["1737244","1737578","1737581"],"spl_id":["ca8ce6e9-feae-4a33-a380-64061313d704"],"spl_set_id":["7a6967b3-5563-4bed-9eee-d400f800e799"],"package_ndc":["25021-115-02","25021-115-04","25021-115-06"],"unii":["EH6D7113I8"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate, Injection, 150 mg/1 mL (NDC 25021-115-02)","company_name":"Sagent Pharmaceuticals","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"discontinued_date":"10/16/2026","update_type":"New","initial_posting_date":"10/16/2026","package_ndc":"0054-0652-25","generic_name":"Vigabatrin Tablet","contact_info":"800-631-2174","related_info":"The decision to discontinue this drug product was due to a business decision and not due to any reasons of safety or effectiveness.","openfda":{"application_number":["ANDA213104"],"brand_name":["VIGABATRIN"],"generic_name":["VIGABATRIN"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc"],"product_ndc":["0054-0652"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["VIGABATRIN"],"rxcui":["199521"],"spl_id":["f575e137-5300-4e13-a40e-5573f6c8a066"],"spl_set_id":["5ed8d293-b7d8-4c66-9c31-8075e6f99092"],"package_ndc":["0054-0652-25"],"nui":["N0000175753"],"pharm_class_epc":["Anti-epileptic Agent [EPC]"],"unii":["GR120KRT6K"]},"update_date":"10/16/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Vigabatrin, Tablet, 500 mg (NDC 0054-0652-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"04/22/2026","update_type":"New","initial_posting_date":"04/22/2026","package_ndc":"0069-0188-21","generic_name":"Palbociclib Capsule","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacturing of the capsule presentation. 100 mg Tablet NDC 0069-0486-03 will continue to be manufactured.","openfda":{"application_number":["NDA207103"],"brand_name":["IBRANCE"],"generic_name":["PALBOCICLIB"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0069-0188","0069-0187","0069-0189"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["PALBOCICLIB"],"rxcui":["1601380","1601386","1601388","1601390","1601392","1601394"],"spl_id":["7dcc9b87-0aa4-4a00-aced-96be3553e8ac"],"spl_set_id":["e0e6412f-50b4-4fd4-9364-62818d121a07"],"package_ndc":["0069-0187-21","0069-0188-21","0069-0189-21"],"nui":["N0000175605","N0000175082","N0000190114"],"pharm_class_epc":["Kinase Inhibitor [EPC]"],"pharm_class_moa":["Kinase Inhibitors [MoA]","Cytochrome P450 3A Inhibitors [MoA]"],"unii":["G9ZF61LE7G"]},"update_date":"04/22/2026","therapeutic_category":["Oncology"],"dosage_form":"Capsule","presentation":"Ibrance, Capsule, 100 mg (NDC 0069-0188-21)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"70121-1573-1","generic_name":"Methylprednisolone Acetate Injection","contact_info":"866-525-7270","availability":"Limited Availability","related_info":"Estimated recovery: late October 2026/November 2026","openfda":{"application_number":["ANDA210043"],"brand_name":["METHYLPREDNISOLONE ACETATE"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["70121-1573","70121-1574"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743855"],"spl_id":["af4215ff-94ca-44f8-8506-3024e738cd13"],"spl_set_id":["d944240d-2c19-46ba-ad4f-3fbee7b8629c"],"package_ndc":["70121-1573-1","70121-1573-5","70121-1574-1","70121-1574-5"],"unii":["43502P7F0P"]},"update_date":"10/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 70121-1573-1)","company_name":"Amneal Pharmaceuticals","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0406-5117-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-325-8888","availability":"Available","openfda":{"application_number":["ANDA211840"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["SpecGx LLC"],"product_ndc":["0406-5117","0406-5111","0406-5112","0406-5113","0406-5114","0406-5115","0406-5116"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["77f4cd3a-dca3-4995-8992-042e1dc91a00"],"spl_set_id":["806a1c15-0842-4787-b2ad-09a21fd96b37"],"package_ndc":["0406-5111-01","0406-5112-01","0406-5113-01","0406-5114-01","0406-5115-01","0406-5116-01","0406-5117-01"],"unii":["SJT761GEGS"]},"update_date":"08/20/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 0406-5117-01)","company_name":"SpecGx LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0143-9252-25","generic_name":"Dopamine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Product temporarily on backorder. Additional lots will be available in the February 2027 timeframe.","openfda":{"application_number":["ANDA207707"],"brand_name":["DOPAMINE HYDROCHLORIDE"],"generic_name":["DOPAMINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9252","0143-9253","0143-9254","0143-9255"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1743938","1743941","1743950","1743953"],"spl_id":["67349236-e8e3-45ec-a76d-2a0a150d8d59"],"spl_set_id":["0e499952-46c7-4172-8c70-186312e240a3"],"package_ndc":["0143-9252-01","0143-9252-25","0143-9253-01","0143-9253-25","0143-9254-01","0143-9254-25","0143-9255-01","0143-9255-25"],"unii":["7L3E358N9L"]},"update_date":"10/14/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride, Injection, 40 mg/1 mL (NDC 0143-9252-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"67457-421-30","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA040803"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-421","67457-423","67457-422","67457-420"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRAVENOUS","SOFT TISSUE"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696","1116927","1812194"],"spl_id":["dd5c82b6-a194-462c-9626-34a9b410cfea"],"spl_set_id":["dff598e8-e662-411f-978d-4ba3fb8ef7db"],"package_ndc":["67457-423-00","67457-423-12","67457-422-00","67457-422-54","67457-421-00","67457-421-30","67457-420-00","67457-420-10"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 67457-421-30)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"70069-752-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Unavailable","related_info":"Estimated recovery: June 2027","openfda":{"application_number":["ANDA217792"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-752","70069-753"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404"],"spl_id":["2b24af95-6f20-4945-bf8c-742f1d6f2721"],"spl_set_id":["bcaab86f-20f0-4482-8d73-e29b36dced58"],"package_ndc":["70069-752-25","70069-752-10","70069-752-01","70069-753-25","70069-753-01","70069-753-10"],"unii":["7TQO7W3VT8"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 70069-752-01)","company_name":"Somerset Therapeutics, LLC","shortage_reason":"Other","status":"Current"},{"discontinued_date":"03/10/2026","update_type":"New","initial_posting_date":"03/10/2026","package_ndc":"49230-206-94","generic_name":"Peritoneal Dialysis Solution","contact_info":"800-323-5188","related_info":"The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.","openfda":{"application_number":["NDA020171"],"brand_name":["DELFLEX"],"generic_name":["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"],"manufacturer_name":["Fresenius Medical Care Renal Therapies Group, LLC"],"product_ndc":["49230-206","49230-209","49230-212"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"spl_id":["5f14a0ea-a325-a154-e063-6294a90adf59","5f1497fe-4e1c-9711-e063-6294a90a75e5"],"spl_set_id":["bbc5b820-4973-11e2-a192-0002a5d5c51b","c29bdfa0-4976-11e2-939b-0002a5d5c51b"],"package_ndc":["49230-206-30","49230-206-32","49230-206-50","49230-206-52","49230-206-62","49230-209-30","49230-209-32","49230-209-50","49230-209-52","49230-209-62","49230-212-30","49230-212-32","49230-212-50","49230-212-52","49230-212-62","49230-206-92","49230-206-94","49230-206-95","49230-209-92","49230-209-94","49230-209-95","49230-212-92","49230-212-94","49230-212-95"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"03/10/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DELFLEX® w/Dextrose, Solution, 1.5% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 49230-206-94)","company_name":"Fresenius Medical Care North America","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-083-88","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"800-818-4555","availability":"Available","openfda":{"application_number":["ANDA214134"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-083","57664-047","57664-046","57664-048","57664-049","57664-050","57664-051","57664-052","57664-084","57664-085","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88)","company_name":"Sun Pharmaceutical Industries, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"65162-023-09","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-525-7270","availability":"Available","openfda":{"application_number":["ANDA202830"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Amneal Pharmaceuticals LLC"],"product_ndc":["65162-023","65162-024","65162-025","65162-026","65162-027","65162-028"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850"],"spl_id":["4cc5e658-25c6-4a58-a93a-6e35242d6de4"],"spl_set_id":["c11cb3b6-3dff-477b-a249-b4c3118edc5f"],"package_ndc":["65162-023-09","65162-024-09","65162-025-09","65162-026-09","65162-027-09","65162-028-09"],"unii":["SJT761GEGS"]},"update_date":"10/06/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 65162-023-09)","company_name":"Amneal Pharmaceuticals","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-8030-01","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-8030","0075-8013","0075-8014","0075-8016","0075-8018","0075-8020","0075-8022","0075-8025"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["006561fa-e16d-4129-9dde-89c109b51d8f"],"spl_set_id":["de6fb917-a94a-41ea-9d7d-937d4080ffcd"],"package_ndc":["0075-8013-01","0075-8013-10","0075-8014-01","0075-8014-10","0075-8016-01","0075-8016-10","0075-8018-01","0075-8018-10","0075-8020-01","0075-8020-10","0075-8030-01","0075-8022-01","0075-8022-10","0075-8025-01","0075-8025-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 300 mg/3 mL (NDC 0075-8030-01)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-7853-24","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7853","0409-1660","0409-1638","0409-1434","0409-1596","0409-7838","0409-7875"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["284397","309710","1718900","1718902","1718906","1718907","1718909","1718910","2396891","2396892"],"spl_id":["3c5274fd-6597-4b88-babc-92e4e16c6329"],"spl_set_id":["548a88c0-afda-427e-75ac-5af0cfa2224c"],"package_ndc":["0409-1660-55","0409-1660-50","0409-1660-35","0409-1660-10","0409-1660-22","0409-1660-20","0409-1638-32","0409-1638-02","0409-1434-01","0409-1596-01","0409-1596-10","0409-7838-01","0409-7838-24","0409-7853-01","0409-7853-24","0409-7875-01","0409-7875-12"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-4208-10","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE WITH EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4208","0409-5738","0409-3812","0409-1541","0409-8126","0409-6581"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012381","1012384","1012388","1672917","1672919","1673242","1673243","1867594","1867596","1867612","1867614"],"spl_id":["14ec85dc-0263-44d1-9267-66fa072cff8d"],"spl_set_id":["93cf0914-de08-4ec6-8f8c-d663243b9958"],"package_ndc":["0409-5738-01","0409-5738-10","0409-3812-01","0409-1541-01","0409-1541-10","0409-8126-01","0409-8126-10","0409-4208-01","0409-4208-10","0409-6581-01"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine with Epinephrine, Injection, Marcaine™ 0.5% 150 mg/30 mL (5 mg/mL) with Epinephrine 1:200,000 (as bitartrate) Single Dose Vial Novaplus (NDC 0409-4208-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"65862-618-90","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-850-2876","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA202725"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL HYDROCHLORIDE"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["65862-618","65862-617","65862-619","65862-620"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["5263abd5-ce46-4918-9bb0-9632861bcbc9"],"spl_set_id":["93e6e668-5306-4f26-81d8-cbc3a7a5e787"],"package_ndc":["65862-617-30","65862-617-90","65862-617-99","65862-617-55","65862-617-10","65862-617-78","65862-618-30","65862-618-90","65862-618-99","65862-618-55","65862-618-10","65862-618-78","65862-619-30","65862-619-90","65862-619-99","65862-619-19","65862-619-10","65862-619-78","65862-620-30","65862-620-90","65862-620-99","65862-620-39","65862-620-10","65862-620-78"],"unii":["33067B3N2M"]},"update_date":"11/04/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 10 mg (NDC 65862-618-90)","company_name":"Aurobindo Pharma USA","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"discontinued_date":"09/11/2026","update_type":"New","initial_posting_date":"09/11/2026","package_ndc":"42023-229-10","generic_name":"Micafungin Sodium Injection","contact_info":"800-828-9393","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"09/11/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Micafungin Sodium, Injection, 10 mg/1 mL (NDC 42023-229-10)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"discontinued_date":"07/24/2026","update_type":"New","initial_posting_date":"07/24/2026","package_ndc":"0074-3956-46","generic_name":"Lopinavir and Ritonavir Oral Solution","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA021251"],"brand_name":["KALETRA"],"generic_name":["LOPINAVIR AND RITONAVIR"],"manufacturer_name":["AbbVie Inc."],"product_ndc":["0074-3956","0074-4014","0074-3008"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LOPINAVIR","RITONAVIR"],"rxcui":["311369","597730","746645","847741","847745","847749"],"spl_id":["36abdfba-ddc2-43ae-9173-903d66a23b23"],"spl_set_id":["8290add3-4449-4e58-6c97-8fe1eec972e3"],"package_ndc":["0074-3956-46","0074-4014-12","0074-3008-60"],"nui":["N0000000246","N0000175889","N0000185503","N0000190114","N0000190107","N0000191001","N0000182137","N0000185607","N0000190118","N0000190113","N0000182141","N0000191266","N0000185507","N0000187064","N0000190117"],"pharm_class_moa":["HIV Protease Inhibitors [MoA]","P-Glycoprotein Inhibitors [MoA]","Cytochrome P450 3A Inhibitors [MoA]","Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]","Cytochrome P450 2D6 Inhibitors [MoA]","Cytochrome P450 2C19 Inducers [MoA]","Cytochrome P450 3A Inducers [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]","Cytochrome P450 3A4 Inhibitors [MoA]","Cytochrome P450 1A2 Inducers [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 2B6 Inducers [MoA]","UDP Glucuronosyltransferases Inducers [MoA]"],"pharm_class_epc":["Protease Inhibitor [EPC]","Cytochrome P450 3A Inhibitor [EPC]"],"unii":["2494G1JF75","O3J8G9O825"]},"update_date":"07/24/2026","therapeutic_category":["Antiviral"],"dosage_form":"Oral Solution","presentation":"Kaletra, Oral Solution, 80 mg/1 mL; 20 mg/1 mL (NDC 0074-3956-46)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"discontinued_date":"03/02/2026","update_type":"New","initial_posting_date":"03/02/2026","package_ndc":"0093-7768-24","generic_name":"Everolimus Tablet","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/02/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, 7.5 mg (NDC 0093-7768-24)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/01/2022","package_ndc":"63323-824-75","generic_name":"Dextrose Monohydrate 10% Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA209448"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-824"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481"],"spl_id":["0591ab74-99a6-40ee-af96-80bc2ef423dc"],"spl_set_id":["3b8f2692-4371-4f1a-95af-b41842131fdd"],"package_ndc":["63323-824-24","63323-824-74","63323-824-25","63323-824-75","63323-824-26","63323-824-76"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0338-0644-04","generic_name":"Amino Acid Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA018931"],"brand_name":["TRAVASOL"],"generic_name":["LEUCINE, PHENYLALANINE, LYSINE HYDROCHLORIDE, METHIONINE, ISOLEUCINE, VALINE, HISTIDINE, THREONINE, TRYPTOPHAN, ALANINE, GLYCINE, ARGININE, PROLINE, TYROSINE, SERINE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0644"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LEUCINE","PHENYLALANINE","LYSINE HYDROCHLORIDE","METHIONINE","ISOLEUCINE","VALINE","HISTIDINE","THREONINE","TRYPTOPHAN","ALANINE","GLYCINE","ARGININE","PROLINE","TYROSINE","SERINE"],"spl_id":["7a8e7bd6-f743-4779-907a-ad2917c2d341"],"spl_set_id":["8543b5be-0f43-4891-9e56-d7c39fe839b5"],"package_ndc":["0338-0644-03","0338-0644-04","0338-0644-06"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["GMW67QNF9C","47E5O17Y3R","JNJ23Q2COM","AE28F7PNPL","04Y7590D77","HG18B9YRS7","4QD397987E","2ZD004190S","8DUH1N11BX","OF5P57N2ZX","TE7660XO1C","94ZLA3W45F","9DLQ4CIU6V","42HK56048U","452VLY9402"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-04)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/22/2021","package_ndc":"68180-659-06","generic_name":"Rifampin Capsule","contact_info":"866-587-4617","availability":"Available","openfda":{"application_number":["ANDA090034"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["Lupin Pharmaceuticals, Inc."],"product_ndc":["68180-659","68180-658"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAMPIN"],"rxcui":["198201","198202"],"spl_id":["5ed1edac-e11e-4f87-b390-e770a69a9b37"],"spl_set_id":["b56004f0-f23d-47f6-80c7-39884fccbccc"],"package_ndc":["68180-658-06","68180-658-01","68180-659-06","68180-659-07","68180-659-01"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"10/13/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Rifampin, Capsule, 300 mg (NDC 68180-659-06)","company_name":"Lupin Pharmaceuticals, Inc.","status":"Current"},{"discontinued_date":"06/15/2026","update_type":"New","initial_posting_date":"06/15/2026","package_ndc":"0069-0227-03","generic_name":"Lorlatinib Tablet","contact_info":"800-533-4535","related_info":"Supply expected to exhaust 6/30/2026; NDC 0069-0227-01 25 mg; 30 tablets bottle with a child-resistant closure will continue to be manufactured; Discontinuation of the manufacture of this presentation","openfda":{"application_number":["NDA210868"],"brand_name":["LORBRENA"],"generic_name":["LORLATINIB"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0069-0227","0069-0231"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LORLATINIB"],"rxcui":["2103169","2103175","2103177","2103179"],"spl_id":["46cb56ce-da15-49af-b72b-f9e377cae4a6"],"spl_set_id":["2b34d62d-e02a-4af3-bc0d-1571dd4ee76d"],"package_ndc":["0069-0227-01","0069-0227-03","0069-0231-01"],"nui":["N0000175605","N0000175082","N0000190118","N0000191264","N0000187064","N0000191265","N0000190111","N0000191423","N0000190113"],"pharm_class_epc":["Kinase Inhibitor [EPC]"],"pharm_class_moa":["Kinase Inhibitors [MoA]","Cytochrome P450 3A Inducers [MoA]","P-Glycoprotein Inducers [MoA]","Cytochrome P450 2B6 Inducers [MoA]","Organic Cation Transporter 1 Inhibitors [MoA]","Organic Anion Transporter 3 Inhibitors [MoA]","Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]","Breast Cancer Resistance Protein Inhibitors [MoA]"],"unii":["OSP71S83EU"]},"update_date":"06/15/2026","therapeutic_category":["Oncology"],"dosage_form":"Tablet","presentation":"Lorbrena, Tablet, 25 mg; 120 tablets bottle with a child-resistant closure (NDC 0069-0227-03)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"05/03/2018","package_ndc":"0409-1985-30","generic_name":"Lorazepam Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery and Estimated Recovery: June 2027","openfda":{"application_number":["ANDA074243"],"brand_name":["LORAZEPAM"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1985","0409-1539"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["763028","763029"],"spl_id":["0280cc35-0696-4091-a000-2314f292feb2"],"spl_set_id":["20140b19-846b-425f-b191-670e17809945"],"package_ndc":["0409-1539-03","0409-1539-31","0409-1985-03","0409-1985-30"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"11/09/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Lorazepam, Injection, 2 mg/1 mL Syringes (NDC 0409-1985-30)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"10/01/2026","update_type":"New","initial_posting_date":"10/07/2026","package_ndc":"0603-3583-21","generic_name":"Felodipine Tablet, Film Coated, Extended Release","contact_info":"(800) 828-9393","related_info":"Discontinuation in the manufacturing of the drug product","openfda":{"application_number":["ANDA200815"],"brand_name":["FELODIPINE"],"generic_name":["FELODIPINE"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["0603-3583","0603-3581","0603-3582"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FELODIPINE"],"rxcui":["402695","402696","402698"],"spl_id":["02151da2-890e-4f84-94c8-6ce767d9ff12"],"spl_set_id":["55637724-8757-11de-8a39-0800200c9a66"],"package_ndc":["0603-3581-28","0603-3581-21","0603-3582-21","0603-3582-28","0603-3583-28","0603-3583-21"],"nui":["N0000000069","N0000175421","M0006414"],"pharm_class_moa":["Calcium Channel Antagonists [MoA]"],"pharm_class_epc":["Dihydropyridine Calcium Channel Blocker [EPC]"],"pharm_class_cs":["Dihydropyridines [CS]"],"unii":["OL961R6O2C"]},"update_date":"10/07/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Felodipine, Tablet, Film Coated, Extended Release, 10 mg (NDC 0603-3583-21)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"discontinued_date":"08/13/2026","update_type":"New","initial_posting_date":"08/13/2026","package_ndc":"0228-2551-06","generic_name":"Diclofenac Sodium Tablet, Delayed Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA074514"],"brand_name":["DICLOFENAC SODIUM"],"generic_name":["DICLOFENAC SODIUM"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2551","0228-2550"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DICLOFENAC SODIUM"],"rxcui":["855906","855926"],"spl_id":["a1fbc994-b8a6-4759-be76-1cfd98275ca6"],"spl_set_id":["a57b897e-0cbe-4ac3-969f-b00357a0cfa8"],"package_ndc":["0228-2550-06","0228-2550-11","0228-2550-96","0228-2551-06","0228-2551-11","0228-2551-96"],"unii":["QTG126297Q"]},"update_date":"08/13/2026","therapeutic_category":["Musculoskeletal","Rheumatology"],"dosage_form":"Tablet","presentation":"Diclofenac Sodium, Tablet, Delayed Release, 75 mg (NDC 0228-2551-06)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"54288-165-01","generic_name":"Carboplatin Injection","contact_info":"Distributed by BPI Labs, LLC; Customer service number: (727) 471-0850 Ext 270","availability":"Available","related_info":"Distributed by BPI Labs, LLC","openfda":{"application_number":["ANDA207324"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["BPI Labs LLC"],"product_ndc":["54288-165","54288-166","54288-167","54288-164"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["c0a7463c-d90f-4060-a54e-6a4888e8af0e"],"spl_set_id":["5484d2f0-0cc2-4bba-8f26-c7f6539a9606"],"package_ndc":["54288-165-01","54288-166-01","54288-167-01","54288-164-01"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/21/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 150mg/15mL (NDC 54288-165-01)","company_name":"Gland Pharma Limited","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/27/2018","package_ndc":"25021-671-82","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"Sagent: 866-625-1618","availability":"Available","related_info":"Marketed by Sagent Pharmaceuticals","openfda":{"application_number":["ANDA206166"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-671","25021-652"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734347","1734355","1734479","1734481"],"spl_id":["41f4446a-ca6e-465e-9a79-8c4f99eb1ac3","22d83514-0f7b-4671-ae6a-7ca47449c184"],"spl_set_id":["8c5c762f-d266-4b1a-809e-f11bfc89bc2d","9572b3de-684c-4028-a577-5aa69ba6b02d"],"package_ndc":["25021-671-82","25021-671-87","25021-652-82","25021-652-87","25021-671-66","25021-671-67"],"unii":["V910P86109"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82)","company_name":"InfoRLife SA","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-1891-01","generic_name":"Morphine Sulfate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA202515"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1891","0409-1890","0409-1892","0409-1893","0409-1894"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["998212","998213","1729197","1732014"],"spl_id":["07b4be5d-af82-43ff-a6d2-0df0d5c495ee"],"spl_set_id":["be420e8b-bcb0-49b5-bb4d-1df8b9959809"],"package_ndc":["0409-1890-03","0409-1890-01","0409-1890-13","0409-1890-23","0409-1891-03","0409-1891-01","0409-1891-13","0409-1891-23","0409-1892-03","0409-1892-01","0409-1892-13","0409-1892-23","0409-1893-03","0409-1893-01","0409-1893-13","0409-1893-23","0409-1894-03","0409-1894-01"],"unii":["X3P646A2J0"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 4 mg/1 mL Syringes (NDC 0409-1891-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"09/16/2026","update_type":"New","initial_posting_date":"09/16/2026","package_ndc":"54092-191-12","generic_name":"Mesalamine Capsule, Extended Release","contact_info":"877 825 3327","related_info":"Product is anticipated to be available until December 31, 2027","openfda":{"application_number":["NDA020049"],"brand_name":["PENTASA"],"generic_name":["MESALAMINE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["54092-191","54092-189"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MESALAMINE"],"rxcui":["206791","314092","476362","580286"],"spl_id":["d98da9dd-6bcf-469c-bf7c-080565f146ce"],"spl_set_id":["e39d9a3d-5d3a-4bb6-aab1-fdbb2a598606"],"package_ndc":["54092-189-81","54092-191-12"],"nui":["N0000175781","M0000971"],"pharm_class_epc":["Aminosalicylate [EPC]"],"pharm_class_cs":["Aminosalicylic Acids [CS]"],"unii":["4Q81I59GXC"]},"update_date":"09/16/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Capsule, Extended Release","presentation":"Pentasa, Capsule, Extended Release, 500 mg (NDC 54092-191-12)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/20/2023","package_ndc":"0641-6028-25","generic_name":"Fentanyl Citrate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.","openfda":{"application_number":["NDA019101"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6028","0641-6024","0641-6027","0641-6025","0641-6026","0641-6029","0641-6030","0641-6247","0641-6248","0641-6249"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270","2474269","2629337"],"spl_id":["4eb40afd-eae7-4006-8934-4e1d43d59ea7"],"spl_set_id":["ce5db1c2-feb1-4ad2-847a-d02e865bd47e"],"package_ndc":["0641-6024-01","0641-6024-10","0641-6027-01","0641-6027-25","0641-6025-01","0641-6025-10","0641-6028-01","0641-6028-10","0641-6028-25","0641-6026-01","0641-6026-05","0641-6029-01","0641-6029-25","0641-6030-01","0641-6247-01","0641-6247-25","0641-6248-01","0641-6248-10","0641-6249-01","0641-6249-10"],"unii":["MUN5LYG46H"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6028-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0409-2344-02","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA074086"],"brand_name":["DOBUTAMINE"],"generic_name":["DOBUTAMINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2344"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"rxcui":["1812168"],"spl_id":["e71e9520-871b-479d-9652-1857fceca863","f6a67673-07a7-44e4-b05c-1f7e63326f79"],"spl_set_id":["dc537761-d5f4-488d-24ab-b2bcd2b17b7a","89becb0c-da60-4f43-0a98-29ff7a9eca58"],"package_ndc":["0409-2344-01","0409-2344-62","0409-2344-02","0409-2344-68","0409-2344-88"],"unii":["0WR771DJXV"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride, Injection, 250 mg/20mL (12.5 mg/1 mL) (NDC 0409-2344-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"0781-3421-94","generic_name":"Caspofungin Acetate Injection","contact_info":"Sandoz: 800-525-8747","related_info":"Marketed by Sandoz, Inc.; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA200833"],"brand_name":["CASPOFUNGIN ACETATE"],"generic_name":["CASPOFUNGIN ACETATE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-3421","0781-3423"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CASPOFUNGIN ACETATE"],"rxcui":["828539","828755"],"spl_id":["d70d52c0-6601-f632-e053-2995a90a9291"],"spl_set_id":["722facc6-d4ea-4975-b83e-3ae63df69ed2"],"package_ndc":["0781-3421-01","0781-3421-94","0781-3423-01","0781-3423-94"],"unii":["VUW370O5QE"]},"update_date":"06/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Caspofungin Acetate, Injection, 5 mg/1 mL (NDC 0781-3421-94)","company_name":"Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-288-20","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-288","63323-286","63323-287","63323-285"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","905191","1734084","1734086","1734090","1734091","1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484"],"spl_id":["cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c","75465ceb-e894-487d-aa80-671fa0841fce"],"spl_set_id":["23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6","56dfabf7-f7a8-4601-b17a-cb16fb995b0f"],"package_ndc":["63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95","63323-288-25","63323-288-27"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"50458-587-01","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-JANSSEN (1-800-526-7736) Monday through Friday from 9:00 AM to 8:00 PM ET","availability":"Available","openfda":{"application_number":["NDA021121"],"brand_name":["CONCERTA"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Janssen Pharmaceuticals, Inc."],"product_ndc":["50458-587","50458-585","50458-588","50458-586"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091157","1091170","1091172","1091185","1091187","1091210","1091212"],"spl_id":["64d7c1e1-e7ed-4d74-a44d-13b4da64af9a"],"spl_set_id":["1a88218c-5b18-4220-8f56-526de1a276cd"],"package_ndc":["50458-585-01","50458-588-01","50458-586-01","50458-587-01"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Concerta, Tablet, Extended Release, 54 mg (NDC 50458-587-01)","company_name":"Janssen Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"68025-088-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Available","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-088","68025-089","68025-095","68025-096","68025-097","68025-084","68025-098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)","company_name":"Vertical Pharmaceuticals, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"08/03/2022","package_ndc":"62135-737-30","generic_name":"Flurazepam Hydrochloride Capsule","contact_info":"845-268-5000 Ext. 510","availability":"Available","openfda":{"application_number":["ANDA072369"],"brand_name":["FLURAZEPAM HYDROCHLORIDE"],"generic_name":["FLURAZEPAM HYDROCHLORIDE"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-737","62135-736"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FLURAZEPAM HYDROCHLORIDE"],"rxcui":["1298088","1298091"],"spl_id":["25893c92-c8f1-567a-e063-6294a90a00d4"],"spl_set_id":["8f476891-1346-4e8c-ac1b-f8cbdc64f5a1"],"package_ndc":["62135-736-30","62135-736-90","62135-737-30","62135-737-90"],"unii":["756RDM536M"]},"update_date":"09/15/2026","therapeutic_category":["Neurology","Other"],"dosage_form":"Capsule","presentation":"Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-0620-40","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-633-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-0620","0075-0624","0075-0621","0075-0622","0075-0623","0075-0626","0075-2912","0075-2915"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["cdb74d6d-1a74-4156-a52a-710c55cb2927"],"spl_set_id":["5017a927-2a24-4f27-89f9-27c805bf7d59"],"package_ndc":["0075-0624-01","0075-0624-30","0075-0620-01","0075-0620-40","0075-0621-01","0075-0621-60","0075-0622-01","0075-0622-80","0075-0623-03","0075-0623-00","0075-0626-03","0075-2912-00","0075-2912-01","0075-2915-00","0075-2915-01"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 40 mg/.4 mL (NDC 0075-0620-40)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"72572-076-24","generic_name":"Clindamycin Phosphate Injection","contact_info":"800-525-8747","availability":"Available","related_info":"Civica Label","openfda":{"application_number":["ANDA201692"],"brand_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"generic_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"manufacturer_name":["Civica, Inc."],"product_ndc":["72572-076","72572-074"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN"],"rxcui":["309335","309336"],"spl_id":["4711c157-19a5-4886-b468-8739876e67be"],"spl_set_id":["80217bd6-2bc4-401c-9345-22532b36a24f"],"package_ndc":["72572-074-01","72572-074-24","72572-076-01","72572-076-24"],"nui":["N0000009982","N0000175443","M0515779","N0000175731"],"pharm_class_pe":["Decreased Sebaceous Gland Activity [PE]","Neuromuscular Blockade [PE]"],"pharm_class_epc":["Lincosamide Antibacterial [EPC]"],"pharm_class_cs":["Lincosamides [CS]"],"unii":["3U02EL437C"]},"update_date":"11/09/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 18 mg/1 mL (NDC 72572-076-24)","company_name":"Sandoz Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/23/2021","package_ndc":"63323-185-50","generic_name":"Sterile Water Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA088400"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-185"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["42c6c812-706a-425b-b8cb-931006e40484"],"spl_set_id":["e71c6c83-d518-496c-b2ab-efd5987e4783"],"package_ndc":["63323-185-07","63323-185-10","63323-185-09","63323-185-50","63323-185-08","63323-185-20","63323-185-04","63323-185-05"],"unii":["059QF0KO0R"]},"update_date":"11/03/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-50)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"12/22/2025","update_type":"New","initial_posting_date":"12/22/2025","package_ndc":"0832-0274-11","generic_name":"Morphine Sulfate Tablet","contact_info":"763-315-2000","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA210610"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Upsher-Smith Laboratories, LLC"],"product_ndc":["0832-0274","0832-0273"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892582","892672"],"spl_id":["46a682fc-0430-5a66-e063-6294a90a6179"],"spl_set_id":["5ceb3205-2f8d-4ba3-9f27-dc328bab4fa1"],"package_ndc":["0832-0273-11","0832-0274-11"],"unii":["X3P646A2J0"]},"update_date":"12/22/2025","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Tablet","presentation":"Morphine Sulfate, Tablet, 30 mg (NDC 0832-0274-11)","company_name":"Upsher-Smith Laboratories, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"70069-631-25","generic_name":"Atropine Sulfate Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA215969"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-631","70069-641"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190795","1666781"],"spl_id":["7a8a5552-fe21-4d36-8396-b7c99f41b4c4"],"spl_set_id":["a6fac578-c7bc-4b3c-a454-7889cc819118"],"package_ndc":["70069-631-01","70069-631-25","70069-641-01","70069-641-25"],"unii":["03J5ZE7KA5"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-631-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"0409-6102-04","generic_name":"Furosemide Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018667"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["e598e8a6-c854-48f5-a412-fb6a6783774a","981d5143-60cd-4987-9b47-dec24c10de42"],"spl_set_id":["aaced7a8-c3d7-4d66-8c07-aa407b8b3f35","39fd32f2-6bb7-4a65-d298-e48d26bc80c7"],"package_ndc":["0409-6102-35","0409-6102-25","0409-6102-36","0409-6102-26","0409-6102-37","0409-6102-27","0409-6102-19","0409-6102-02","0409-6102-18","0409-6102-04","0409-6102-20","0409-6102-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 40 mg/4 mL (10 mg/1 mL) (NDC 0409-6102-04)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/14/2016","package_ndc":"63323-482-27","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE,EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-482","63323-492","63323-491","63323-495","63323-485","63323-486","63323-484","63323-489","63323-488","63323-481","63323-483","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","EPINEPHRINE BITARTRATE"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428","0ff12fe1-0ad7-4ae0-83bf-30f11e3adb33"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17","4dd52202-8eef-4136-92dd-ada573b7cf74"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31","63323-492-41","63323-492-16","63323-492-43","63323-492-36","63323-492-45","63323-492-26","63323-485-41","63323-485-26","63323-486-41","63323-486-26","63323-482-41","63323-482-26","63323-495-41","63323-495-26"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"59651-723-01","generic_name":"Clonazepam Tablet","contact_info":"866-850-2876","resolved_note":"Available","openfda":{"application_number":["ANDA075150"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["59651-723","59651-722","59651-724"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"spl_set_id":["b1582eb7-af35-45d5-a52e-0e380d08527d"],"package_ndc":["59651-722-01","59651-722-99","59651-723-01","59651-723-99","59651-724-01","59651-724-05"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, 1 mg (NDC 59651-723-01)","company_name":"Aurobindo Pharma USA","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0264-2101-00","generic_name":"Sterile Water Irrigant","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA016734"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-2101"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["IRRIGATION"],"substance_name":["WATER"],"rxcui":["150985"],"spl_id":["17177669-a426-414d-b0b8-ec70dad03197"],"spl_set_id":["f4284eb6-e553-46d4-90d8-efc80a90a480"],"package_ndc":["0264-2101-00","0264-2101-10","0264-2101-50","0264-2101-70"],"unii":["059QF0KO0R"]},"update_date":"11/10/2026","therapeutic_category":["Gastroenterology","Other","Pediatric"],"dosage_form":"Irrigant","presentation":"Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-00)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"70069-481-10","generic_name":"Atropine Sulfate Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA215005"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE MONOHYDRATE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-481"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ENDOTRACHEAL","INTRAMEDULLARY","INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190776"],"spl_id":["125328fe-c82b-42fd-bb3b-ba3f6c125ced"],"spl_set_id":["84ba1689-3030-48d5-9cce-70b5a24a4033"],"package_ndc":["70069-481-01","70069-481-10"],"unii":["03J5ZE7KA5"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, .4 mg/1 mL (NDC 70069-481-10)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/15/2021","package_ndc":"0009-0274-01","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0274","0009-0280","0009-0306"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358510","1358512","1358610","1358612","1358617","1358619"],"spl_id":["267dd735-f800-4735-ba1c-d39d00f0cee5"],"spl_set_id":["823b0010-2b57-4e76-b5ac-4a8c2963438f"],"package_ndc":["0009-0274-01","0009-0280-02","0009-0280-51","0009-0280-03","0009-0280-52","0009-0306-02","0009-0306-12"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 20 mg/1 mL (NDC 0009-0274-01)","company_name":"Pfizer Inc.","status":"Current"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"65219-086-20","generic_name":"Gadoterate Meglumine Injection","contact_info":"888-386-1800","related_info":"Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA215304"],"brand_name":["GADOTERATE MEGLUMINE"],"generic_name":["GADOTERATE MEGLUMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-086","65219-080","65219-082","65219-084"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOTERATE MEGLUMINE"],"spl_id":["f05922b7-99d4-48c7-972a-7966bbbbc3b4"],"spl_set_id":["e0655aac-9508-4141-94f5-fcca6af1c41d"],"package_ndc":["65219-080-01","65219-080-05","65219-082-01","65219-082-10","65219-084-01","65219-084-15","65219-086-01","65219-086-20"],"unii":["L0ND3981AG"]},"update_date":"06/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-086-20)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"72516-016-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"855-257-0292","availability":"Unavailable","related_info":"Estimated recovery: April 2027","openfda":{"application_number":["ANDA210293"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Oryza Pharmaceuticals Inc."],"product_ndc":["72516-016","72516-015","72516-014","72516-013","72516-012","72516-011"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","1009145"],"spl_id":["5734011d-5044-b490-e063-6394a90a3174"],"spl_set_id":["acd27181-a3f3-4c38-85d8-029a4a82e7c2"],"package_ndc":["72516-016-01","72516-015-01","72516-014-01","72516-013-01","72516-012-01","72516-011-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.25 mg; 1.25 mg; 1.25 mg; 1.25 mg (NDC 72516-016-01)","company_name":"Oryza Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"76045-210-10","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203129"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["76045-210"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRAVENOUS","SOFT TISSUE"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["1812095"],"spl_id":["9af24370-ee9f-4005-b1e9-96eef58fbde5"],"spl_set_id":["ce25183b-cd67-4997-8de9-df59b750883b"],"package_ndc":["76045-210-00","76045-210-10"],"unii":["AI9376Y64P"]},"update_date":"11/03/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/31/2018","change_date":"09/30/2026","package_ndc":"25021-321-10","generic_name":"Bumetanide Injection","contact_info":"866-625-1618","resolved_note":"Available","openfda":{"application_number":["ANDA074441"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-321"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["88a191ea-bf0d-4c27-a33c-91a126ff1aba"],"spl_set_id":["c38a404d-a919-4a2c-9fbb-d0655dee9516"],"package_ndc":["25021-321-04","25021-321-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-10)","company_name":"Sagent Pharmaceuticals","status":"Resolved"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"16729-525-08","generic_name":"Atropine Sulfate Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Estimated availability: December 2026","openfda":{"application_number":["NDA214652"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-525","16729-526"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190795","1666781"],"spl_id":["5e4be5c3-5fca-2d0e-e063-6394a90a81c1"],"spl_set_id":["d5e07279-48ca-4f83-9633-299e65a7f821"],"package_ndc":["16729-525-63","16729-525-03","16729-525-08","16729-526-63","16729-526-03","16729-526-08"],"unii":["03J5ZE7KA5"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, .4 mg/1 mL (NDC 16729-525-08)","company_name":"Accord Healthcare Inc.","shortage_reason":"Requirements related to complying with good manufacturing practices","status":"Current"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"45963-676-96","generic_name":"Metoprolol Succinate Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA204161"],"brand_name":["METOPROLOL SUCCINATE"],"generic_name":["METOPROLOL SUCCINATE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["45963-676","45963-709","45963-677","45963-678"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METOPROLOL SUCCINATE"],"rxcui":["866412","866419","866427","866436"],"spl_id":["a7e9a234-a8a6-4afe-ba8e-d569772bc39a"],"spl_set_id":["b798601e-a369-4c8b-8235-08900e1b751d"],"package_ndc":["45963-709-11","45963-709-96","45963-676-11","45963-676-96","45963-677-11","45963-677-96","45963-678-11"],"unii":["TH25PD4CCB"]},"update_date":"08/31/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Metoprolol Succinate, Tablet, Extended Release, 50 mg (NDC 45963-676-96)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/14/2017","package_ndc":"0409-1005-20","generic_name":"Heparin Sodium Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA018916"],"brand_name":["HEPARIN SODIUM"],"generic_name":["HEPARIN SODIUM"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1005","0409-7620","0409-2222"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["HEPARIN SODIUM"],"rxcui":["1658690","1658691","1658692"],"spl_id":["ecaae7d2-a76e-4eca-b045-6c88d7c2ab8f"],"spl_set_id":["32e34077-aff1-4ec7-f9b0-b8e240768fb8"],"package_ndc":["0409-7620-13","0409-7620-03","0409-7620-49","0409-7620-59","0409-1005-01","0409-1005-20","0409-2222-01","0409-2222-12"],"unii":["ZZ45AB24CA"]},"update_date":"11/09/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"0143-9507-10","generic_name":"Etomidate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional product will be made available as it is released.","openfda":{"application_number":["ANDA202354"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9507","0143-9506"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["98560882-bfdf-404e-ab8b-3ee2a6875830"],"spl_set_id":["75bf0494-7cb9-4e8a-8edd-af62f035d236"],"package_ndc":["0143-9506-01","0143-9506-10","0143-9507-01","0143-9507-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 0143-9507-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"63323-421-02","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA201072"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-421"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710"],"spl_id":["56e0af34-aeb5-4b37-8c61-2e90b2c8ca6c"],"spl_set_id":["c1b8eb58-596b-481d-beb6-ba9d2237abf4"],"package_ndc":["63323-421-01","63323-421-02"],"unii":["1018WH7F9I"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-464-37","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA070552","NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-464","63323-466","63323-462","63323-465","63323-467","63323-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724880","1724881","1725078","1725175","1724884","1724885","1725082","1725177","1672917","1672919","1673296","1673298","1012391","1012396","1012404","1012421","1012455","1012457"],"spl_id":["b41b5dbd-7aff-4d97-ac97-f4355393ee4e","d3ba9fb9-63c8-4597-bb0a-cd01d31a24b6","13a48007-3784-46f2-bd4d-da1004186b81","2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["e700eb7b-8b14-49c9-96b2-331f18776e45","b6bfc04a-1868-4630-9ca1-8c027af97ce3","dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175","eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-464-01","63323-464-17","63323-466-03","63323-466-17","63323-464-08","63323-464-38","63323-466-08","63323-466-38","63323-462-03","63323-462-38","63323-464-09","63323-464-39","63323-466-09","63323-466-39","63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/02/2020","package_ndc":"0409-2587-05","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: January 2027; Estimated Recovery: March 2027","openfda":{"application_number":["ANDA075293"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2587","0409-2596"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["6c075a2d-b68b-41a7-aa0c-bcf9894e3f76"],"spl_set_id":["affecd4d-1f78-4bbe-5a8d-86849bbdc520"],"package_ndc":["0409-2587-04","0409-2587-05","0409-2596-13","0409-2596-03","0409-2596-15","0409-2596-05"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/03/2017","package_ndc":"0641-6040-01","generic_name":"Morphine Sulfate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["NDA018565"],"brand_name":["INFUMORPH 500"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6040","0641-6039"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRATHECAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892652","1731522","1731998","1731999"],"spl_id":["b1c060cb-5c5b-495f-90b5-044e04f2a3f2"],"spl_set_id":["db9ac9e3-d761-4a99-9f34-4946ebe8f255"],"package_ndc":["0641-6039-01","0641-6040-01"],"unii":["X3P646A2J0"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Infumorph 500 (Preservative-Free Morphine Sulfate Sterile Solution), Injection, 25 mg/1 mL (NDC 0641-6040-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"09/01/2026","update_type":"New","initial_posting_date":"09/01/2026","package_ndc":"0002-7752-05","generic_name":"Insulin Lispro Injection","contact_info":"800-545-5979","related_info":"A business decision was made to discontinue manufacture of the drug. Distribution projected to end June 2027. If patients or prescribers have any questions, the Lilly Answers Center (1-800-545-5979) is available Monday through Friday from 9am to 8pm for assistance.","openfda":{"application_number":["BLA020563"],"brand_name":["INSULIN LISPRO JUNIOR KWIKPEN"],"generic_name":["INSULIN LISPRO"],"manufacturer_name":["Eli Lilly and Company"],"product_ndc":["0002-7752","0002-7737","0002-8222"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["INSULIN LISPRO"],"rxcui":["242120","1652639","1926331"],"spl_id":["6329aa6b-3571-4196-83b0-fc99de56f3ab"],"spl_set_id":["97d5e596-aae1-42c9-ae89-c3780959c467"],"package_ndc":["0002-7737-01","0002-8222-01","0002-8222-59","0002-7752-01","0002-7752-05"],"nui":["N0000004931","N0000175453"],"pharm_class_cs":["Insulin [Chemical/Ingredient]"],"pharm_class_epc":["Insulin Analog [EPC]"],"unii":["GFX7QIS1II"]},"update_date":"09/01/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Insulin Lispro Junior KwikPen, Injection, 100 [iU]/1 mL (NDC 0002-7752-05)","company_name":"Eli Lilly and Co.","status":"To Be Discontinued"},{"discontinued_date":"01/13/2026","update_type":"New","initial_posting_date":"01/13/2026","package_ndc":"61314-473-64","generic_name":"Adalimumab-adaz Injection","contact_info":"800-525-8747","related_info":"Equivalent Sandoz format is available.","openfda":{"application_number":["BLA761071"],"brand_name":["HYRIMOZ"],"generic_name":["ADALIMUMAB-ADAZ"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["61314-473","61314-454","61314-476","61314-509","61314-517","61314-531"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ADALIMUMAB"],"rxcui":["2641644","2641650","2641653","2641654","2641655","2641658","2641660","2641661","2641662","2641663","2641664","2641665","2641666","2641667","2641668","2641669","2641670","2641671","2641672","2641673"],"spl_id":["48b7e44a-945f-487d-b2fd-3da13d6d6fdb"],"spl_set_id":["1ac7d061-3380-468c-b077-c05f8dfbc829"],"package_ndc":["61314-454-20","61314-454-36","61314-454-68","61314-473-64","61314-473-20","61314-473-92","61314-476-64","61314-509-64","61314-517-36","61314-454-96","61314-473-96","61314-531-64","61314-454-94","61314-473-94"],"nui":["N0000175610","N0000175451","M0001357"],"pharm_class_epc":["Tumor Necrosis Factor Blocker [EPC]"],"pharm_class_moa":["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"],"pharm_class_cs":["Antibodies, Monoclonal [CS]"],"unii":["FYS6T7F842"]},"update_date":"01/13/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Hyrimoz, Injection, 40 mg/.4 mL (NDC 61314-473-64)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0990-7923-13","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA016367"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["ICU Medical, Inc."],"product_ndc":["0990-7923","0990-7922","0990-7930"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618","1795621"],"spl_id":["06e4d957-1a56-4adb-a42b-fe0773b2fa97"],"spl_set_id":["8b25b7e0-703e-4b43-a4eb-52863511602d"],"package_ndc":["0990-7923-20","0990-7923-23","0990-7923-36","0990-7923-37","0990-7923-13","0990-7922-02","0990-7922-03","0990-7922-09","0990-7922-53","0990-7922-55","0990-7922-61","0990-7930-02","0990-7930-03","0990-7930-09"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7923-13)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-9043-01","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA071167"],"brand_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9043","0409-1159","0409-1160","0409-1162","0409-1163","0409-1165","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride with Epinephrine, Injection, 125 mg/50 mL (2.5 mg/mL) (NDC 0409-9043-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"04/28/2023","update_type":"New","initial_posting_date":"04/28/2023","change_date":"04/28/2023","package_ndc":"0069-4380-71","generic_name":"Prazosin Hydrochloride Capsule","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacture of the drug. Supply expected to exhaust in September 2023","update_date":"04/28/2023","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Minipress, Capsule, 5 mg (NDC 0069-4380-71)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"10/31/2017","package_ndc":"0409-1896-20","generic_name":"Morphine Sulfate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA202515"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1896","0409-2022"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731537","1731545"],"spl_id":["6f2d5741-5543-4bea-8d1d-7e4889b634a0"],"spl_set_id":["ee8057d1-ed12-4e18-9efa-d83504abf612"],"package_ndc":["0409-1896-20","0409-2022-01"],"unii":["X3P646A2J0"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 50 mg/1 mL (NDC 0409-1896-20)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-484-57","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA006488"],"brand_name":["XYLOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-484","63323-492","63323-491","63323-495","63323-485","63323-486","63323-489","63323-488","63323-481","63323-483","63323-482","63323-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS"],"rxcui":["1010033","1010035","1010671","1010673","1010688","1010692","1010745","1010749","1010751","1010755","1010759","1010763","1010900","1010902","1737343","1737345","1737562","1737563","1737566","1737567","1737568","1737569","1737570","1737571","1737757","1737758","1737761","1737762","1867938","1867940","1867943","1867944","1867992","1867993","1867996","1867997","1868028","1868029"],"spl_id":["ea480a68-5927-4278-9deb-2956961da428"],"spl_set_id":["ba082c2f-64f4-419d-9c88-74f203316e17"],"package_ndc":["63323-492-04","63323-492-27","63323-492-09","63323-492-57","63323-492-07","63323-492-37","63323-492-03","63323-492-31","63323-491-01","63323-491-57","63323-495-09","63323-495-27","63323-495-04","63323-495-07","63323-485-01","63323-485-27","63323-485-03","63323-485-57","63323-486-01","63323-486-17","63323-486-02","63323-486-27","63323-486-05","63323-486-57","63323-484-57","63323-489-02","63323-489-27","63323-489-03","63323-489-21","63323-489-01","63323-489-17","63323-488-07","63323-488-37","63323-488-03","63323-488-31","63323-488-01","63323-488-17","63323-481-01","63323-481-57","63323-483-03","63323-483-27","63323-483-01","63323-483-57","63323-482-01","63323-482-17","63323-482-03","63323-482-27","63323-482-05","63323-482-57","63323-487-01","63323-487-17","63323-487-07","63323-487-37","63323-487-03","63323-487-31"],"unii":["30Q7KI53AK","EC2CNF7XFP"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Xylocaine, Injection, 5 mg/1 mL (NDC 63323-484-57)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"25021-311-04","generic_name":"Furosemide Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Furosemide%20Injection&st=d","contact_info":"866-625-1618","availability":"Unavailable","related_info":"Distributed by Sagent Pharmaceuticals: 1-866-625-1618, Discontinued product","openfda":{"application_number":["ANDA213902"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-311"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["222ce48f-2856-4be2-b16f-6fca38c0dceb"],"spl_set_id":["d63c1277-dd7e-4d21-9e80-68143f55e2dc"],"package_ndc":["25021-311-02","25021-311-04","25021-311-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"10/21/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 25021-311-04)","company_name":"Gland Pharma Limited","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-9666-35","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA020179"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-9666","0338-9664"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795609","1795616"],"spl_id":["a6356cbf-8553-405f-9c27-57a301e43fc9"],"spl_set_id":["bfc4224a-2fc9-4137-b4c6-9d2d6d948413"],"package_ndc":["0338-9664-40","0338-9666-35"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-9666-35)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-462-17","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-462","63323-464","63323-466","63323-465","63323-467","63323-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1672917","1672919","1673296","1673298","1724880","1724881","1724884","1724885","1725078","1725082","1725175","1725177","1012391","1012396","1012404","1012421","1012455","1012457"],"spl_id":["13a48007-3784-46f2-bd4d-da1004186b81","2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175","eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-462-03","63323-462-38","63323-464-09","63323-464-39","63323-466-09","63323-466-39","63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 5 mg/1 mL; .005 mg/1 mL (NDC 63323-462-17)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"01/12/2026","update_type":"New","initial_posting_date":"01/12/2026","package_ndc":"63323-413-10","generic_name":"Neostigmine Methylsulfate Injection","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA203629"],"brand_name":["NEOSTIGMINE METHYLSULFATE"],"generic_name":["NEOSTIGMINE METHYLSULFATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-413","63323-415"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["NEOSTIGMINE METHYLSULFATE"],"rxcui":["311935","311936"],"spl_id":["3abc0611-0e8c-49f9-9678-e4b2fda3d8ed","1efedce1-b2c3-4652-a289-6ea596b039e2"],"spl_set_id":["6448229c-e650-47ba-bb00-cba3604502c5","d0e11e4c-41c3-4874-b567-579db655fba3"],"package_ndc":["63323-413-01","63323-413-10","63323-415-01","63323-415-10","63323-413-36","63323-415-36"],"unii":["98IMH7M386"]},"update_date":"01/12/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Neostigmine Methylsulfate, Injection, .5 mg/1 mL (NDC 63323-413-10)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/01/2020","package_ndc":"16729-484-45","generic_name":"Atropine Sulfate Injection","contact_info":"866-941-7875, option 2","availability":"Available","openfda":{"application_number":["ANDA212868"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Accord Healthcare, Inc.,"],"product_ndc":["16729-484","16729-483"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190546","1190551","1190552"],"spl_id":["4082a1cf-1e1b-6f40-e063-6294a90aec06"],"spl_set_id":["c82cb295-ffce-47d6-97ad-a8aa723f4e4f"],"package_ndc":["16729-483-03","16729-483-31","16729-484-90","16729-484-31","16729-484-45","16729-484-03"],"unii":["03J5ZE7KA5"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, 0.1 mg/1 mL (NDC 16729-484-45)","company_name":"Accord Healthcare Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"08/15/2023","package_ndc":"64850-506-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"888-852-6657","availability":"Available","openfda":{"application_number":["ANDA211352"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-506","64850-500","64850-501","64850-502","64850-503","64850-504","64850-505"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["a41cf8e5-cb1b-488c-96b3-3bef8283d6c4"],"spl_set_id":["e677690f-790f-4626-ad78-097cdb6ea540"],"package_ndc":["64850-500-01","64850-500-05","64850-500-30","64850-501-01","64850-501-05","64850-501-30","64850-502-01","64850-502-05","64850-502-30","64850-503-01","64850-503-05","64850-503-30","64850-504-01","64850-504-05","64850-504-30","64850-505-01","64850-505-05","64850-505-30","64850-506-01","64850-506-05","64850-506-30"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 64850-506-01)","company_name":"Elite Laboratories, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/14/2017","package_ndc":"0338-0431-03","generic_name":"Heparin Sodium Injection","contact_info":"888-229-0001","availability":"Unavailable","related_info":"Estimated recovery: January 2027","openfda":{"application_number":["NDA018609"],"brand_name":["HEPARIN SODIUM IN SODIUM CHLORIDE"],"generic_name":["HEPARIN SODIUM"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0431","0338-0433","0338-0424","0338-0428"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["HEPARIN SODIUM"],"rxcui":["1658690","1658692"],"spl_id":["d28ff87a-c535-49db-ba0c-48080149936b"],"spl_set_id":["0d929726-76c3-48fc-b4e7-fd06409f9fb3"],"package_ndc":["0338-0431-03","0338-0433-04","0338-0424-18","0338-0428-12"],"unii":["ZZ45AB24CA"]},"update_date":"11/03/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03)","company_name":"Baxter Healthcare","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/06/2017","package_ndc":"0409-5820-01","generic_name":"Dopamine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: February 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA018132"],"brand_name":["DOPAMINE HYDROCHLORIDE"],"generic_name":["DOPAMINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-5820","0409-9104"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1743938","1743941"],"spl_id":["7a125e39-1ecb-4c76-931a-efc9b5921d1c"],"spl_set_id":["1f306ad2-3606-4525-5a8a-ce78f426c1a2"],"package_ndc":["0409-5820-11","0409-5820-01","0409-9104-21","0409-9104-20"],"unii":["7L3E358N9L"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride, Injection, 200 mg/5mL (40 mg/1 mL) (NDC 0409-5820-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"10/30/2026","update_type":"New","initial_posting_date":"10/30/2026","package_ndc":"0338-3508-41","generic_name":"Cefazolin in Dextrose Injection","contact_info":"888-229-0001","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA207131"],"brand_name":["CEFAZOLIN"],"generic_name":["CEFAZOLIN SODIUM"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-3508","0338-3503","0338-0096"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CEFAZOLIN SODIUM"],"rxcui":["1665050","1665060","2630753"],"spl_id":["092b9ea3-0c78-4236-80c9-ff97d09fa14e"],"spl_set_id":["d91a8d13-99a0-4d87-88dc-71cbd37922b4"],"package_ndc":["0338-3508-41","0338-3503-41","0338-0096-06"],"unii":["P380M0454Z"]},"update_date":"10/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cefazolin in Dextrose, Injection, 2g/100mL (NDC 0338-3508-41)","company_name":"Baxter Healthcare","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"62135-484-60","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"845-268-5000 x 510 or Chartwell Customer service at cs@chartwellpharma.com","availability":"Available","openfda":{"application_number":["ANDA076803"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL"],"manufacturer_name":["Chartwell RX, LLC"],"product_ndc":["62135-484","62135-485","62135-486","62135-487"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["09cd5cb9-4fdf-f133-e063-6294a90af691"],"spl_set_id":["dbc43dbd-94aa-40e2-a9ea-766110cc8687"],"package_ndc":["62135-484-60","62135-485-90","62135-486-90","62135-487-90"],"unii":["33067B3N2M"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 5 mg (NDC 62135-484-60)","company_name":"Chartwell Molecular Holdings LLC","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-0601-15","generic_name":"Podophyllum Resin Topical Tincture","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["PODOCON 25"],"generic_name":["PODOPHYLLUM RESIN"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-0601"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TOPICAL"],"substance_name":["PODOPHYLLUM RESIN"],"spl_id":["e2ac9612-bded-4eea-a664-f941416583fa"],"spl_set_id":["de96dc6e-e6d1-4383-9ce1-4d06bac08e00"],"package_ndc":["0574-0601-15"],"unii":["16902YVY2B"]},"update_date":"07/23/2026","therapeutic_category":["Dermatology"],"presentation":"Podocon 25, Topical Tincture, 1 mg/4 mL (NDC 0574-0601-15)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"42858-162-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-827-0616","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA215330"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Rhodes Pharmaceuticals LLC"],"product_ndc":["42858-162","42858-161","42858-163","42858-164","42858-165","42858-166","42858-167"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0002e227-1109-4ecc-a8c5-4b4f11fac3cc"],"spl_set_id":["d918b40d-a461-41bc-b6c0-83dc76c28e32"],"package_ndc":["42858-161-01","42858-162-01","42858-163-01","42858-164-01","42858-165-01","42858-166-01","42858-167-01"],"unii":["SJT761GEGS"]},"update_date":"06/24/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 42858-162-01)","company_name":"Rhodes Pharmaceuticals L.P.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-2634-01","generic_name":"Hydromorphone Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA078591"],"brand_name":["HYDROMORPHONE HYDROCHLORIDE"],"generic_name":["HYDROMORPHONE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2634"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["HYDROMORPHONE HYDROCHLORIDE"],"rxcui":["1724338","1724340","1724341"],"spl_id":["50886ad5-eeca-4fe7-beb0-01305f92c65d"],"spl_set_id":["3832ede8-d3fc-455d-ecab-3b77be5869f5"],"package_ndc":["0409-2634-10","0409-2634-01","0409-2634-25","0409-2634-05","0409-2634-50"],"unii":["L960UP2KRW"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0409-2634-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"06/17/2026","update_type":"New","initial_posting_date":"06/17/2026","package_ndc":"61958-0602-1","generic_name":"Emtricitabine Oral Solution","contact_info":"800-445-3235","related_info":"Product expected to be available until March 2027","openfda":{"application_number":["NDA021896"],"brand_name":["EMTRIVA"],"generic_name":["EMTRICITABINE"],"manufacturer_name":["Gilead Sciences, Inc."],"product_ndc":["61958-0602","61958-0601"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["EMTRICITABINE"],"spl_id":["5fa131e8-fb3b-f4ac-e063-6294a90a2136"],"spl_set_id":["d6599395-3944-44f9-97f2-e0424c6b6a1f"],"package_ndc":["61958-0601-1","61958-0602-1"],"nui":["N0000175462","M0015066","N0000009947"],"pharm_class_epc":["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"],"pharm_class_cs":["Nucleosides [CS]"],"pharm_class_moa":["Nucleoside Reverse Transcriptase Inhibitors [MoA]"],"unii":["G70B4ETF4S"]},"update_date":"06/17/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Oral Solution","presentation":"Emtriva, Oral Solution, 10 mg/1 mL (NDC 61958-0602-1)","company_name":"Gilead Sciences, Inc.","status":"To Be Discontinued"},{"discontinued_date":"10/30/2026","update_type":"New","initial_posting_date":"10/30/2026","package_ndc":"0338-5003-41","generic_name":"Ceftriaxone Sodium Injection","contact_info":"888-229-0001","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA065224"],"brand_name":["CEFTRIAXONE"],"generic_name":["CEFTRIAXONE SODIUM"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-5003","0338-5002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CEFTRIAXONE SODIUM"],"rxcui":["1665021","1665046"],"spl_id":["e6debc12-1f25-437c-970e-607f4953c7f7"],"spl_set_id":["4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1"],"package_ndc":["0338-5002-41","0338-5003-41"],"unii":["023Z5BR09K"]},"update_date":"10/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Ceftriaxone Sodium in Plastic Container, Injection, 2g/100 mL (NDC 0338-5003-41)","company_name":"Baxter Healthcare","status":"To Be Discontinued"},{"discontinued_date":"12/01/2025","update_type":"New","initial_posting_date":"12/01/2025","package_ndc":"59212-001-02","generic_name":"Phenoxybenzamine Hydrochloride Capsule","contact_info":"847-283-7921","related_info":"Discontinuation of the manufacture of the drug","update_date":"12/01/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Dibenzyline, Capsule, 10 mg (NDC 59212-001-02)","company_name":"Advanz Pharma (US) Corp.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"11/21/2023","package_ndc":"0641-0928-25","generic_name":"Promethazine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA083312"],"brand_name":["PROMETHAZINE HYDROCHLORIDE"],"generic_name":["PROMETHAZINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-0928","0641-0929"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["PROMETHAZINE HYDROCHLORIDE"],"rxcui":["992460","992858"],"spl_id":["9f14d3f5-ad01-44b5-a2b7-16ed5f501f87"],"spl_set_id":["4bf3912c-8339-401e-9711-dad6acf15f11"],"package_ndc":["0641-0928-21","0641-0928-25","0641-0929-21","0641-0929-25"],"unii":["R61ZEH7I1I"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Gastroenterology","Pediatric","Pulmonary/Allergy"],"dosage_form":"Injection","presentation":"Promethazine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-0928-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0378-6857-77","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA202835"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-6857","0378-6854","0378-6855","0378-6856","0378-6858","0378-6859","0378-6860"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["6e77cd71-95ae-4fa8-830b-ab62b714e4b9"],"spl_set_id":["efbde0f6-b848-4664-b741-c6c630e66108"],"package_ndc":["0378-6854-77","0378-6855-77","0378-6856-77","0378-6857-77","0378-6858-77","0378-6859-77","0378-6860-77"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 0378-6857-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/06/2018","package_ndc":"0641-6043-25","generic_name":"Ketorolac Tromethamine Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA075772"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6043","0641-6042","0641-6041"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["25d6c438-45d2-4162-91c2-b5caa0f86bf3"],"spl_set_id":["0c2c75c9-ed7b-46a8-9543-429bf2d8f090"],"package_ndc":["0641-6043-01","0641-6043-25","0641-6042-01","0641-6042-25","0641-6041-01","0641-6041-25"],"unii":["4EVE5946BQ"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 30 mg/1 mL (NDC 0641-6043-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0075-8022-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["LOVENOX"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0075-8022","0075-8013","0075-8014","0075-8016","0075-8018","0075-8020","0075-8030","0075-8025"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854232","854235","854236","854238","854239","854241","854242","854245","854247","854248","854249","854252","854253","854255","854256"],"spl_id":["006561fa-e16d-4129-9dde-89c109b51d8f"],"spl_set_id":["de6fb917-a94a-41ea-9d7d-937d4080ffcd"],"package_ndc":["0075-8013-01","0075-8013-10","0075-8014-01","0075-8014-10","0075-8016-01","0075-8016-10","0075-8018-01","0075-8018-10","0075-8020-01","0075-8020-10","0075-8030-01","0075-8022-01","0075-8022-10","0075-8025-01","0075-8025-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Lovenox, Injection, 120 mg/.8 mL (NDC 0075-8022-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"16729-136-16","generic_name":"Clonazepam Tablet","contact_info":"866-941-7875, option 2","resolved_note":"Available","openfda":{"application_number":["ANDA077147"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-136","16729-137","16729-138"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["0e1e7f41-f78b-27cf-e063-6394a90a1ae0"],"spl_set_id":["ebc11109-e7bf-452d-b675-4b3236d54164"],"package_ndc":["16729-136-00","16729-136-16","16729-137-00","16729-137-16","16729-138-00","16729-138-16"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 16729-136-16)","company_name":"Accord Healthcare Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"0143-9250-10","generic_name":"Rocuronium Bromide Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be available.  Product will be made available as it is released.","openfda":{"application_number":["ANDA204679"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9250","0143-9251"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["51fc5473-b651-4c85-83ff-7edc65a6cef2"],"spl_set_id":["d3a172a5-01ab-47d8-92ac-a8539b1d4dc4"],"package_ndc":["0143-9250-01","0143-9250-10","0143-9251-01","0143-9251-10"],"unii":["I65MW4OFHZ"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0143-9250-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"71288-700-06","generic_name":"Rocuronium Bromide Injection","contact_info":"844-824-8426","availability":"Available","openfda":{"application_number":["ANDA213453"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-700","71288-718"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["aad39c88-2e2c-49a6-aa13-de852483661f","37295b13-65a4-40fa-8d6c-53aeb45e2939"],"spl_set_id":["b23aa80e-2af2-4a66-92ed-b1c8863be704","b9abaf64-760d-43e0-8669-a9ca70feab11"],"package_ndc":["71288-700-91","71288-700-92","71288-718-91","71288-718-92","71288-700-05","71288-700-06","71288-718-10","71288-718-11"],"unii":["I65MW4OFHZ"]},"update_date":"08/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 71288-700-06)","company_name":"Meitheal Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"10/12/2022","package_ndc":"70010-112-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"877-770-3183","availability":"Unavailable","related_info":"Estimated recovery: December 2026","openfda":{"application_number":["ANDA215771"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Granules Pharmaceuticals Inc."],"product_ndc":["70010-112","70010-111","70010-113","70010-114","70010-115","70010-116","70010-117"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["56c7c921-e560-c5ad-e063-6294a90a4c81"],"spl_set_id":["b0b4eccc-34c7-483d-966f-82d588358e1b"],"package_ndc":["70010-111-01","70010-111-03","70010-112-01","70010-112-03","70010-113-01","70010-113-03","70010-114-01","70010-114-03","70010-115-01","70010-115-03","70010-116-01","70010-116-03","70010-117-01","70010-117-03"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"10/28/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 1.875 mg; 1.875 mg; 1.875 mg; 1.875 mg (NDC 70010-112-01)","company_name":"Granules Pharmaceuticals Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"04/20/2026","update_type":"New","initial_posting_date":"04/20/2026","package_ndc":"0378-1134-01","generic_name":"Ketorolac Tromethamine Tablet","contact_info":"877-446-3679","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA074761"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-1134"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["834022"],"spl_id":["fa08c7fb-128c-4b41-acac-de47c51a36c7"],"spl_set_id":["2837a082-3a34-6f81-5e43-45a70295686b"],"package_ndc":["0378-1134-01"],"unii":["4EVE5946BQ"]},"update_date":"04/20/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Tablet","presentation":"Ketorolac Tromethamine, Tablet, 10 mg (NDC 0378-1134-01)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"discontinued_date":"03/02/2026","update_type":"New","initial_posting_date":"03/02/2026","package_ndc":"0093-7766-24","generic_name":"Everolimus Tablet","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/02/2026","therapeutic_category":["Transplant"],"dosage_form":"Tablet","presentation":"Everolimus, Tablet, 2.5 mg (NDC 0093-7766-24)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/03/2023","package_ndc":"42571-132-52","generic_name":"Cromolyn Sodium Concentrate","contact_info":"(908) 484-7410","availability":"Available","openfda":{"application_number":["ANDA202745"],"brand_name":["CROMOLYN SODIUM"],"generic_name":["CROMOLYN SODIUM"],"manufacturer_name":["Micro Labs Limited"],"product_ndc":["42571-132"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CROMOLYN SODIUM"],"rxcui":["831261"],"spl_id":["5f46e975-121e-7435-e063-6394a90afe4c"],"spl_set_id":["93f80edb-3b38-423e-8cd6-5b5cb4393ec2"],"package_ndc":["42571-132-21","42571-132-52"],"unii":["Q2WXR1I0PK"]},"update_date":"11/02/2026","therapeutic_category":["Pulmonary/Allergy"],"dosage_form":"Concentrate","presentation":"Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 42571-132-52)","company_name":"Micro Labs LTD","status":"Current"},{"discontinued_date":"12/02/2025","update_type":"New","initial_posting_date":"12/02/2025","package_ndc":"0085-4331-01","generic_name":"Posaconazole Injection","contact_info":"800-672-6372","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA205596"],"brand_name":["NOXAFIL"],"generic_name":["POSACONAZOLE"],"manufacturer_name":["Merck Sharp & Dohme LLC"],"product_ndc":["0085-4331","0085-1328","0085-4324","0085-2224"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["POSACONAZOLE"],"rxcui":["665019","665022","1482908","1482912","1492043","1492047","2558603","2558607"],"spl_id":["56740f7d-3b29-4786-b5c7-eea6c0f14400"],"spl_set_id":["b073b082-7b57-4423-8c06-4fd4263d6f84"],"package_ndc":["0085-1328-01","0085-4324-02","0085-4331-01","0085-2224-01","0085-2224-02"],"nui":["N0000175487","M0002083"],"pharm_class_epc":["Azole Antifungal [EPC]"],"pharm_class_cs":["Azoles [CS]"],"unii":["6TK1G07BHZ"]},"update_date":"12/02/2025","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Noxafil, Injection, 18 mg/1 mL (NDC 0085-4331-01)","company_name":"Merck Sharp & Dohme Corp.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"63323-426-05","generic_name":"Rocuronium Bromide Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA078651"],"brand_name":["ROCURONIUM"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-426"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["d6e2ff8d-838d-4c27-8e73-230548b09d63","3f4d5e11-2c14-4406-8954-04dba2fc65ff"],"spl_set_id":["f1933332-1ae0-4dc1-be4c-694849e6c9f9","fb9524b2-c353-4747-8954-7ca2529eabb2"],"package_ndc":["63323-426-02","63323-426-05","63323-426-01","63323-426-10","63323-426-12","63323-426-15"],"unii":["I65MW4OFHZ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 63323-426-05)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"64850-552-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"888-852-6657","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA218604"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-552","64850-550","64850-551","64850-553","64850-554","64850-555","64850-556"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["2d33f701-8067-4a48-98cc-4e7dacaf3cc4"],"spl_set_id":["0e024b69-567c-4b40-9c3e-a2daec34256c"],"package_ndc":["64850-550-01","64850-551-01","64850-552-01","64850-553-01","64850-554-01","64850-555-01","64850-556-01"],"unii":["SJT761GEGS"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 64850-552-01)","company_name":"Elite Laboratories, Inc.","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"70121-2537-6","generic_name":"Leuprolide Acetate Injection","contact_info":"866.525.7270","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"10/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Leuprolide Acetate, Injection, 14 mg/2.8 mL (1 mg/0.2 mL) (NDC 70121-2537-6)","company_name":"Amneal Pharmaceuticals","status":"To Be Discontinued"},{"discontinued_date":"10/01/2026","update_type":"New","initial_posting_date":"10/07/2026","package_ndc":"0603-3582-21","generic_name":"Felodipine Tablet, Extended Release","contact_info":"(800) 828-9393","related_info":"Discontinuation in the manufacturing of the drug product","openfda":{"application_number":["ANDA200815"],"brand_name":["FELODIPINE"],"generic_name":["FELODIPINE"],"manufacturer_name":["Par Health USA, LLC"],"product_ndc":["0603-3582","0603-3581","0603-3583"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["FELODIPINE"],"rxcui":["402695","402696","402698"],"spl_id":["02151da2-890e-4f84-94c8-6ce767d9ff12"],"spl_set_id":["55637724-8757-11de-8a39-0800200c9a66"],"package_ndc":["0603-3581-28","0603-3581-21","0603-3582-21","0603-3582-28","0603-3583-28","0603-3583-21"],"nui":["N0000000069","N0000175421","M0006414"],"pharm_class_moa":["Calcium Channel Antagonists [MoA]"],"pharm_class_epc":["Dihydropyridine Calcium Channel Blocker [EPC]"],"pharm_class_cs":["Dihydropyridines [CS]"],"unii":["OL961R6O2C"]},"update_date":"10/07/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Felodipine, Tablet, Extended Release, 5 mg (NDC 0603-3582-21)","company_name":"Par Health, USA LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"42806-345-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(718) 276-8600 ext. 3","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040444"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Epic Pharma, LLC"],"product_ndc":["42806-345","42806-339","42806-341","42806-343","42806-344"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961"],"spl_id":["f11301e2-3b5d-468d-b44c-45839e7e5dfb"],"spl_set_id":["1757e132-061d-4773-89ed-fdc77f69008f"],"package_ndc":["42806-339-01","42806-341-01","42806-343-01","42806-344-01","42806-345-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 42806-345-01)","company_name":"Epic Pharma, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/18/2020","package_ndc":"71288-115-30","generic_name":"Azacitidine Injection","contact_info":"844-824-8426","availability":"Available","openfda":{"application_number":["ANDA212128"],"brand_name":["AZACITIDINE"],"generic_name":["AZACITIDINE"],"manufacturer_name":["Meitheal Pharmaceuticals Inc."],"product_ndc":["71288-115"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["AZACITIDINE"],"rxcui":["485246"],"spl_id":["bad343f5-0c12-47de-93e7-9b2af3670b7c"],"spl_set_id":["97b0917a-03fa-4cc4-91cf-1bed57a988c9"],"package_ndc":["71288-115-30"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["M801H13NRU"]},"update_date":"08/27/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Azacitidine, Injection, 100 mg/30 mL (NDC 71288-115-30)","company_name":"Meitheal Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"65219-632-20","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","openfda":{"application_number":["ANDA212808"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["FRESENIUS KABI USA, LLC"],"product_ndc":["65219-632"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734347","1734355"],"spl_id":["7203f32f-2e48-4924-b882-d4f3863ae952"],"spl_set_id":["da4a7675-97bf-4d2a-9fdc-c1b4b2999126"],"package_ndc":["65219-632-02","65219-632-10","65219-632-04","65219-632-20"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/28/2025","package_ndc":"0574-2430-65","generic_name":"Methylphenidate Film, Extended Release","contact_info":"800-455-8070","availability":"Available","related_info":"Distributed by Padagis US LLC","openfda":{"application_number":["NDA021514"],"brand_name":["METHYLPHENIDATE TRANSDERMAL SYSTEM"],"generic_name":["METHYLPHENIDATE"],"manufacturer_name":["PADAGIS US LLC"],"product_ndc":["0574-2430","0574-2410","0574-2415","0574-2420"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["TRANSDERMAL"],"substance_name":["METHYLPHENIDATE"],"rxcui":["753436","753438","753440","753441"],"spl_id":["b743ef45-2fc0-4086-8a02-6078e6a09eaa"],"spl_set_id":["7bcff873-1fc2-45bc-a8e4-5db4edeb9bfb"],"package_ndc":["0574-2410-65","0574-2415-65","0574-2420-65","0574-2430-65"],"nui":["N0000175739","N0000175729"],"pharm_class_epc":["Central Nervous System Stimulant [EPC]"],"pharm_class_pe":["Central Nervous System Stimulation [PE]"],"unii":["207ZZ9QZ49"]},"update_date":"10/16/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Film, Extended Release","presentation":"Methylphenidate, Film, Extended Release, 30 mg (NDC 0574-2430-65)","company_name":"Noven Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"06/13/2018","package_ndc":"55150-251-10","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA207182"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-251","55150-252","55150-254","55150-255","55150-253","55150-256"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671"],"spl_id":["ccc38d8a-43fd-44c0-985e-32af9ed956ab","0b1f03c2-db2f-4f90-acc0-d73abd731bf6"],"spl_set_id":["ccc38d8a-43fd-44c0-985e-32af9ed956ab","ef782e5e-e2d7-465a-99c6-b12611f3158c"],"package_ndc":["55150-251-24","55150-252-24","55150-254-24","55150-255-24","55150-251-10","55150-252-20","55150-253-50","55150-254-10","55150-255-20","55150-256-50"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/20/2023","package_ndc":"0641-6026-05","generic_name":"Fentanyl Citrate Injection","contact_info":"800-631-2174","availability":"Unavailable","related_info":"Inventory available in vial presentations.","update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 50 ug/1 mL (NDC 0641-6026-05)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"67457-251-02","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"800-796-9526","availability":"Available","openfda":{"application_number":["ANDA202881"],"brand_name":["DEXMEDETOMIDINE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-251"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710"],"spl_id":["afa561b9-9d6c-47b3-87e6-8d049597a0ed"],"spl_set_id":["ebdfe2e8-30ca-4f18-935a-41bcbbce4937"],"package_ndc":["67457-251-00","67457-251-02"],"unii":["1018WH7F9I"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)","company_name":"Mylan Institutional, a Viatris Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"65862-162-90","generic_name":"Quinapril/Hydrochlorothiazide Tablet","contact_info":"866-850-2876","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA078450"],"brand_name":["QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"],"generic_name":["QUINAPRIL HYDROCHLORIDE/HYDROCHLOROTHIAZIDE"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["65862-162","65862-161","65862-163"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE","HYDROCHLOROTHIAZIDE"],"rxcui":["310796","310797","310809"],"spl_id":["5842ecc2-874a-481b-8997-afa9d862dc5d"],"spl_set_id":["50a58159-9572-4445-9859-b392632597da"],"package_ndc":["65862-161-90","65862-162-30","65862-162-90","65862-163-90"],"nui":["N0000175359","N0000175419","M0471776"],"pharm_class_pe":["Increased Diuresis [PE]"],"pharm_class_epc":["Thiazide Diuretic [EPC]"],"pharm_class_cs":["Thiazides [CS]"],"unii":["0J48LPH2TH","33067B3N2M"]},"update_date":"11/04/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride And Hydrochlorothiazide, Tablet, 12.5 mg; 20 mg (NDC 65862-162-90)","company_name":"Aurobindo Pharma USA","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/01/2017","package_ndc":"0409-5555-02","generic_name":"Sodium Bicarbonate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027","openfda":{"application_number":["ANDA202981"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-5555"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["1868469"],"spl_id":["e3a44e63-8594-40b6-a3fa-d135b3149661","bcb3a2dc-1a3f-4ac7-8ea2-426f0771c246"],"spl_set_id":["0c24b592-4bc8-456f-acac-9c9525844a06","ea9f4498-0d43-4043-8dd1-f22537841c21"],"package_ndc":["0409-5555-11","0409-5555-01","0409-5555-12","0409-5555-02"],"unii":["8MDF5V39QO"]},"update_date":"11/09/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/15/2021","package_ndc":"0009-3073-03","generic_name":"Methylprednisolone Acetate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA011757"],"brand_name":["DEPO-MEDROL"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-3073","0009-3475"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE","INTRA-ARTICULAR"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1743779","1743781","1743855","1743856"],"spl_id":["e4917f75-3e1c-4f3c-803d-d9ec65df06c7","742fcec7-8db3-4cc6-b276-42587a993810"],"spl_set_id":["bf1b104d-85cb-414d-a366-78068c82c883","9a7b3837-e038-48bf-97e9-78ad463760dc"],"package_ndc":["0009-3073-22","0009-3073-23","0009-3475-22","0009-3475-23","0009-3073-01","0009-3073-03","0009-3475-01","0009-3475-03"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Depo-medrol, Injection, 40 mg/1 mL (NDC 0009-3073-03)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"63323-202-02","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA088586"],"brand_name":["LIDOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-202","63323-201"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1737757"],"spl_id":["d19c26f4-1214-40f7-9680-43c885613306"],"spl_set_id":["cddb2b22-fce3-8967-6e54-dca3df5ac4b3"],"package_ndc":["63323-201-01","63323-201-02","63323-201-03","63323-201-10","63323-202-01","63323-202-02"],"unii":["V13007Z41A"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 63323-202-02)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/07/2020","package_ndc":"23155-473-44","generic_name":"Furosemide Injection","contact_info":"855-228-9470","availability":"Available","openfda":{"application_number":["ANDA203428"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."],"product_ndc":["23155-473"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["c14acada-333e-43bb-b1cf-81d569e3e918"],"spl_set_id":["1b9117d5-0dd9-4577-a1fd-bb0aaf7e68ec"],"package_ndc":["23155-473-31","23155-473-41","23155-473-32","23155-473-42","23155-473-43","23155-473-33","23155-473-44","23155-473-45"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/02/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 23155-473-44)","company_name":"Avet Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"55150-296-10","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA210321"],"brand_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-296","55150-209","55150-297"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["309710","1718906","1718909"],"spl_id":["a1eab62d-fcef-4b83-9266-3c5f7a05927b"],"spl_set_id":["8c162541-986b-4b30-866c-b2631ba2c975"],"package_ndc":["55150-209-02","55150-296-10","55150-297-10"],"unii":["1018WH7F9I"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"0409-7037-10","generic_name":"Rocuronium Bromide Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA205656"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7037","0409-3189"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["c96726ef-f1fa-4ebb-ba33-3479c3902a8e"],"spl_set_id":["c96726ef-f1fa-4ebb-ba33-3479c3902a8e"],"package_ndc":["0409-3189-05","0409-3189-10","0409-7037-01","0409-7037-10"],"unii":["I65MW4OFHZ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 100 mg/10 mL (10 mg/mL) (NDC 0409-7037-10)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"04/15/2026","update_type":"New","initial_posting_date":"04/15/2026","package_ndc":"0093-5030-56","generic_name":"Tiagabine Hydrochloride Tablet","contact_info":"888-838-2872","related_info":"Discontinuation of the manufacture of the drug","update_date":"04/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Tablet","presentation":"Tiagabine Hydrochloride, Tablet, 2mg 30 count (NDC 0093-5030-56)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"23155-600-41","generic_name":"Midazolam Hydrochloride Injection","contact_info":"855-228-9470","availability":"Available","openfda":{"application_number":["ANDA090696"],"brand_name":["MIDAZOLAM HYDROCHLORIDE"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc."],"product_ndc":["23155-600"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666798"],"spl_id":["611a9500-e5bd-4525-803a-962957bedd0a"],"spl_set_id":["8b690f5c-2923-4c34-a8f7-11af5f546b62"],"package_ndc":["23155-600-31","23155-600-41"],"unii":["W7TTW573JJ"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41)","company_name":"Avet Pharmaceuticals, Inc.","status":"Current"},{"discontinued_date":"03/26/2026","update_type":"New","initial_posting_date":"03/26/2026","package_ndc":"39822-0350-2","generic_name":"Lincomycin Hydrochloride Injection","contact_info":"866-390-4411","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA201746"],"brand_name":["LINCOMYCIN"],"generic_name":["LINCOMYCIN HYDROCHLORIDE"],"manufacturer_name":["XGen Pharmaceuticals DJB, Inc."],"product_ndc":["39822-0350","39822-0353"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCONJUNCTIVAL"],"substance_name":["LINCOMYCIN HYDROCHLORIDE"],"rxcui":["239212"],"spl_id":["df369d62-f1a4-1a53-e053-2995a90abbf9"],"spl_set_id":["61f4851d-d919-400d-912a-05eb9dca11d4"],"package_ndc":["39822-0350-1","39822-0350-2","39822-0353-6"],"unii":["M6T05Z2B68"]},"update_date":"03/26/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Lincomycin Hydrochloride, Injection, 600 mg/2 mL vial x 10 count (NDC 39822-0350-2)","company_name":"XGen Pharmaceuticals DJB, Inc.","status":"To Be Discontinued"},{"discontinued_date":"06/30/2026","update_type":"New","initial_posting_date":"06/30/2026","package_ndc":"65219-082-10","generic_name":"Gadoterate Meglumine Injection","contact_info":"888-386-1800","related_info":"Marketed by Fresenius Kabi, USA; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA215304"],"brand_name":["GADOTERATE MEGLUMINE"],"generic_name":["GADOTERATE MEGLUMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-082","65219-080","65219-084","65219-086"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOTERATE MEGLUMINE"],"spl_id":["f05922b7-99d4-48c7-972a-7966bbbbc3b4"],"spl_set_id":["e0655aac-9508-4141-94f5-fcca6af1c41d"],"package_ndc":["65219-080-01","65219-080-05","65219-082-01","65219-082-10","65219-084-01","65219-084-15","65219-086-01","65219-086-20"],"unii":["L0ND3981AG"]},"update_date":"06/30/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-082-10)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0264-7510-10","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019626"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-7510","0264-7520"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE, UNSPECIFIED FORM"],"rxcui":["1795477","1795480","1795481","1795607","1795610","1795612"],"spl_id":["4acb5988-64ad-4f83-bc8d-6f2117dfebbe"],"spl_set_id":["085614c7-ada4-4e2c-87c0-c9bc2f18365a"],"package_ndc":["0264-7510-00","0264-7510-10","0264-7510-20","0264-7520-00","0264-7520-10","0264-7520-20"],"unii":["IY9XDZ35W2"]},"update_date":"10/19/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose Monohydrate 5%, Injection, 5 g/100 mL (NDC 0264-7510-10)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"06/28/2022","package_ndc":"63323-724-05","generic_name":"Remifentanil Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA206223"],"brand_name":["REMIFENTANIL HYDROCHLORIDE"],"generic_name":["REMIFENTANIL HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-724","63323-723","63323-725"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["REMIFENTANIL HYDROCHLORIDE"],"rxcui":["1729578","1729584","1729710"],"spl_id":["2f27e51f-2b55-47ee-bd4a-001b71c60622"],"spl_set_id":["d2374b84-81c9-44f9-a4a9-1071281b2531"],"package_ndc":["63323-723-01","63323-723-03","63323-724-01","63323-724-05","63323-725-01","63323-725-10"],"unii":["5V444H5WIC"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Remifentanil Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-724-05)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"11/19/2025","update_type":"New","initial_posting_date":"11/19/2025","package_ndc":"0378-5814-77","generic_name":"Valsartan Tablet","contact_info":"800-796-9526","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA090866"],"brand_name":["VALSARTAN"],"generic_name":["VALSARTAN"],"manufacturer_name":["Mylan Pharmaceuticals Inc."],"product_ndc":["0378-5814","0378-5807","0378-5813","0378-5815"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["VALSARTAN"],"rxcui":["349199","349200","349201","349483"],"spl_id":["db5a1e1d-200e-4a60-a392-98e24e5dbc29"],"spl_set_id":["73e01dc6-7dd4-421a-a4f6-137e75f69f9a"],"package_ndc":["0378-5807-93","0378-5813-77","0378-5814-77","0378-5815-77"],"nui":["N0000000070","N0000175561"],"pharm_class_moa":["Angiotensin 2 Receptor Antagonists [MoA]"],"pharm_class_epc":["Angiotensin 2 Receptor Blocker [EPC]"],"unii":["80M03YXJ7I"]},"update_date":"11/19/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Valsartan, Tablet, 160 mg (NDC 0378-5814-77)","company_name":"Mylan Pharmaceuticals Inc., a Viatris Company","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"04/02/2020","package_ndc":"0409-2305-05","generic_name":"Midazolam Hydrochloride Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: March 2027","openfda":{"application_number":["ANDA075857"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2305","0409-2308","0409-0001"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["1666800","1666814","1666823","1666798"],"spl_id":["2f69c5b1-6505-42dc-8bb3-edbd9b6c0781","8954486a-8512-4831-8178-0b49f1efb73e"],"spl_set_id":["b95415fa-17c2-42ab-a6b0-e628d01c94ed","1abda8b8-48a8-4995-af86-39220d1aa240"],"package_ndc":["0409-2305-55","0409-2305-50","0409-2308-69","0409-2308-49","0409-2308-70","0409-2308-50","0409-2305-16","0409-2305-17","0409-2305-04","0409-2305-05","0409-2308-21","0409-2308-01","0409-2308-22","0409-2308-02","0409-0001-01","0409-0001-25"],"unii":["W7TTW573JJ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0527-4661-37","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-4661","0527-4662","0527-4663","0527-4664","0527-4665","0527-4666","0527-4667"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["164b5658-3c14-44f5-b10a-839909184984"],"spl_set_id":["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"],"package_ndc":["0527-4661-37","0527-4662-37","0527-4663-37","0527-4664-37","0527-4665-37","0527-4666-37","0527-4667-37"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 10 mg (NDC 0527-4661-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"57844-130-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["ADDERALL"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["57844-130","57844-105","57844-117","57844-110","57844-112","57844-115","57844-120"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541365","541878","541879","541892","541894","577957","577960","577961","577962","687043","687045","1009145","1009147"],"spl_id":["79af1dc6-c7cf-41b1-a750-e9b47c2187ff"],"spl_set_id":["f22635fe-821d-4cde-aa12-419f8b53db81"],"package_ndc":["57844-105-01","57844-117-01","57844-110-01","57844-112-01","57844-115-01","57844-120-01","57844-130-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Adderall, Tablet, 7.5 mg; 7.5 mg; 7.5 mg; 7.5 mg (NDC 57844-130-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/11/2024","package_ndc":"0990-7918-19","generic_name":"Dextrose Monohydrate 70% Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA018561"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE"],"manufacturer_name":["ICU Medical Inc."],"product_ndc":["0990-7918","0990-7935","0990-7936","0990-7937","0990-8004"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["237649","237650","237656","242694","1795518"],"spl_id":["98e136db-75df-429c-8d33-03bfae8f511e"],"spl_set_id":["b5cb7a5a-bbe8-4217-a82e-da818f7771c9"],"package_ndc":["0990-7918-19","0990-7935-19","0990-7936-19","0990-7937-19","0990-8004-15"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7918-19)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"discontinued_date":"06/04/2026","update_type":"New","initial_posting_date":"06/04/2026","package_ndc":"0169-4314-30","generic_name":"Semaglutide Tablet","contact_info":"833-493-4689","related_info":"Discontinuation of the manufacture of the drug. These products will be replaced by Ozempic (semaglutide) tablets.","openfda":{"application_number":["NDA213051"],"brand_name":["RYBELSUS"],"generic_name":["ORAL SEMAGLUTIDE"],"manufacturer_name":["Novo Nordisk Pharmaceutical Industries, LP"],"product_ndc":["0169-4314","0169-1715","0169-1704","0169-1709","0169-4303","0169-4307","0169-4815","0169-4804","0169-4809"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["SEMAGLUTIDE"],"rxcui":["2200644","2200650","2200652","2200654","2200656","2200658","2707547","2707549","2707551","2707553","2707555","2707557","2736944","2736946","2736948"],"spl_id":["6834044a-22f1-4f35-b846-b3448ee84c16"],"spl_set_id":["27f15fac-7d98-4114-a2ec-92494a91da98"],"package_ndc":["0169-1715-30","0169-1715-90","0169-1704-30","0169-1709-30","0169-4303-01","0169-4303-13","0169-4303-90","0169-4303-93","0169-4303-30","0169-4303-99","0169-4307-01","0169-4307-13","0169-4307-30","0169-4314-01","0169-4314-13","0169-4314-30","0169-4815-30","0169-4815-90","0169-4804-30","0169-4809-30"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["53AXN4NNHX"]},"update_date":"06/04/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Tablet","presentation":"Rybelsus, Tablet, 14 mg (NDC 0169-4314-30)","company_name":"Novo Nordisk, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-1159-02","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA070583"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1159","0409-1160","0409-1162","0409-1163","0409-1165","0409-9043","0409-9046","0409-9045","0409-9042"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1725078","1725082","1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1867594","1867596"],"spl_id":["fb58e702-b0da-4fa9-91f2-4580b2305950","6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["bb44c7e1-d911-4788-908f-09b7b271969b","02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-09","0409-1159-10","0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-1159-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"07/23/2026","update_type":"New","initial_posting_date":"07/23/2026","package_ndc":"0574-7116-12","generic_name":"Morphine Sulfate Suppository","contact_info":"(800) 775-2054","related_info":"Discontinuation of the manufacture of the drug","openfda":{"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Padagis US LLC"],"product_ndc":["0574-7116","0574-7110","0574-7112","0574-7114"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RECTAL"],"substance_name":["MORPHINE SULFATE"],"rxcui":["892516","892603","892678","894807"],"spl_id":["fa18ac09-a625-47aa-8cde-7051dc4d0c49"],"spl_set_id":["649d731b-962a-45df-b043-7e0781e8a530"],"package_ndc":["0574-7110-12","0574-7112-12","0574-7114-12","0574-7116-12"],"unii":["X3P646A2J0"]},"update_date":"07/23/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Suppository","presentation":"Morphine Sulfate, Suppository, 30 mg (NDC 0574-7116-12)","company_name":"Padagis US LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-086-88","generic_name":"Lisdexamfetamine Dimesylate Tablet, Chewable","contact_info":"800-818-4555","availability":"Available","openfda":{"application_number":["ANDA214134"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-086","57664-047","57664-046","57664-048","57664-049","57664-050","57664-051","57664-052","57664-083","57664-084","57664-085","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet, Chewable","presentation":"Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88)","company_name":"Sun Pharmaceutical Industries, Inc.","status":"Current"},{"discontinued_date":"05/07/2026","update_type":"New","initial_posting_date":"05/07/2026","package_ndc":"63323-574-93","generic_name":"Icatibant Acetate Injection","contact_info":"847-550-2300","related_info":"Discontinuation of the manufacturer of the drug","openfda":{"application_number":["ANDA208317"],"brand_name":["ICATIBANT"],"generic_name":["ICATIBANT"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-574"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ICATIBANT ACETATE"],"rxcui":["1148141"],"spl_id":["d1c9afa7-c4ac-4739-85f1-2ae82440210c"],"spl_set_id":["52c12c15-c00b-4efc-952d-1425c907706a"],"package_ndc":["63323-574-01","63323-574-86","63323-574-93"],"unii":["325O8467XK"]},"update_date":"05/07/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Icatibant Acetate, Injection, 10 mg/1 mL (NDC 63323-574-93)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0955-1006-10","generic_name":"Enoxaparin Sodium Injection","contact_info":"800-631-1610","related_info":"Discontinuation of the manufacture of the drug for the U.S. market. This decision is not related to product safety or quality concerns. FDA-approved generic enoxaparin products and other treatment options are available. Remaining inventory may continue to be available through wholesalers and other distribution channels until existing supplies are depleted. Availability may vary by presentation with last lot expected to expire in March 2029.","openfda":{"application_number":["NDA020164"],"brand_name":["ENOXAPARIN SODIUM"],"generic_name":["ENOXAPARIN SODIUM"],"manufacturer_name":["Sanofi-Aventis U.S. LLC"],"product_ndc":["0955-1006","0955-1003","0955-1004","0955-1008","0955-1010","0955-1016","0955-1012","0955-1015"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["ENOXAPARIN SODIUM"],"rxcui":["854228","854235","854238","854241","854245","854248","854252","854255"],"spl_id":["8f06a411-badb-483f-852d-8e6124acfa44"],"spl_set_id":["20635579-c92d-4f6c-a332-1096d51002f2"],"package_ndc":["0955-1003-01","0955-1003-10","0955-1004-01","0955-1004-10","0955-1006-01","0955-1006-10","0955-1008-01","0955-1008-10","0955-1010-01","0955-1010-10","0955-1016-01","0955-1012-01","0955-1012-10","0955-1015-01","0955-1015-10"],"unii":["8NZ41MIK1O"]},"update_date":"10/20/2026","therapeutic_category":["Hematology"],"dosage_form":"Injection","presentation":"Enoxaparin Sodium, Injection, 60 mg/.6 mL (NDC 0955-1006-10)","company_name":"Sanofi-Aventis U.S. LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/17/2021","package_ndc":"67457-445-60","generic_name":"Rifampin Injection","contact_info":"800-796-9526","availability":"Unavailable","related_info":"Estimated recovery: Q4 2026","openfda":{"application_number":["ANDA065421"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["Mylan Institutional LLC"],"product_ndc":["67457-445"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["RIFAMPIN"],"rxcui":["312821"],"spl_id":["2e65f8eb-0189-46db-9458-98ef7f67a156"],"spl_set_id":["8be91604-d7cd-4f2b-997d-e3364e4092e5"],"package_ndc":["67457-445-60"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Rifampin, Injection, 600 mg (NDC 67457-445-60)","company_name":"Mylan Institutional, a Viatris Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0338-1130-06","generic_name":"Amino Acid Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA075880"],"brand_name":["PREMASOL - SULFITE-FREE (AMINO ACID)"],"generic_name":["LEUCINE, LYSINE, ISOLEUCINE, VALINE, HISTIDINE, PHENYLALANINE, THREONINE, METHIONINE, TRYPTOPHAN, TYROSINE, N-ACETYL-TYROSINE, ARGININE, PROLINE, ALANINE, GLUTAMIC ACIDE, SERINE, GLYCINE, ASPARTIC ACID, TAURINE, CYSTEINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-1130","0338-1131"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LEUCINE","LYSINE ACETATE","ISOLEUCINE","VALINE","HISTIDINE","PHENYLALANINE","THREONINE","METHIONINE","TRYPTOPHAN","TYROSINE","ARGININE","PROLINE","ALANINE","GLUTAMIC ACID","SERINE","GLYCINE","ASPARTIC ACID","TAURINE","CYSTEINE HYDROCHLORIDE"],"rxcui":["801395","801398","801403","801405"],"spl_id":["c874a813-b145-4f7f-833e-97d6c4dd727c"],"spl_set_id":["9afdcc3e-0d06-47f4-86ca-40da48b2b02b"],"package_ndc":["0338-1130-03","0338-1130-04","0338-1130-06","0338-1131-03"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["GMW67QNF9C","TTL6G7LIWZ","04Y7590D77","HG18B9YRS7","4QD397987E","47E5O17Y3R","2ZD004190S","AE28F7PNPL","8DUH1N11BX","42HK56048U","94ZLA3W45F","9DLQ4CIU6V","OF5P57N2ZX","3KX376GY7L","452VLY9402","TE7660XO1C","30KYC7MIAI","1EQV5MLY3D","ZT934N0X4W"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Premasol 10% Sulfite Free in VIAFLEX Plastic Container, Injection, 0.1 (NDC 0338-1130-06)","company_name":"Baxter Healthcare","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-355-90","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 10 mg (NDC 13668-355-90)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"05/30/2025","package_ndc":"0641-6052-25","generic_name":"Meperidine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["ANDA080445"],"brand_name":["MEPERIDINE HYDROCHLORIDE"],"generic_name":["MEPERIDINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6052","0641-6053","0641-6054"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["MEPERIDINE HYDROCHLORIDE"],"rxcui":["861476","1665685","1665697"],"spl_id":["9566d54d-7343-4695-94ff-8b5f2d384c81"],"spl_set_id":["e0e998da-f056-4fce-be8e-ed60cf3b461b"],"package_ndc":["0641-6053-01","0641-6053-25","0641-6054-01","0641-6054-25","0641-6052-01","0641-6052-25"],"unii":["N8E7F7Q170"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Meperidine Hydrochloride, Injection, 25 mg/1 mL (NDC 0641-6052-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"09/09/2026","update_type":"New","initial_posting_date":"09/09/2026","package_ndc":"0006-3856-02","generic_name":"Imipenem Anhydrous, Cilastatin, and Relebactam Anhydrous Injection","contact_info":"800-672-6372","related_info":"To be discontinued on or near late September 2026.","openfda":{"application_number":["NDA212819"],"brand_name":["RECARBRIO"],"generic_name":["IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS"],"manufacturer_name":["Merck Sharp & Dohme LLC"],"product_ndc":["0006-3856"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["IMIPENEM ANHYDROUS","CILASTATIN","RELEBACTAM ANHYDROUS"],"rxcui":["2184142","2184147"],"spl_id":["128d22eb-7136-4c07-8827-21a27fb99ede"],"spl_set_id":["be32f468-738b-40df-a425-591e12f65159"],"package_ndc":["0006-3856-01","0006-3856-02"],"nui":["M0024174","N0000175496","N0000175513","N0000175514","N0000175930","N0000000202"],"pharm_class_cs":["Carbapenems [CS]"],"pharm_class_epc":["Penem Antibacterial [EPC]","Renal Dehydropeptidase Inhibitor [EPC]","beta Lactamase Inhibitor [EPC]"],"pharm_class_moa":["Dipeptidase Inhibitors [MoA]","beta Lactamase Inhibitors [MoA]"],"unii":["Q20IM7HE75","141A6AMN38","1OQF7TT3PF"]},"update_date":"09/09/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"RECARBRIO, Injection, 500 mg/100 mL; 500 mg/100 mL; 250 mg/100 mL (NDC 0006-3856-02)","company_name":"Merck Sharp & Dohme LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"0409-1209-01","generic_name":"Epinephrine Bitartrate, Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery: January 2027; Estimated Recovery: March 2027; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA088571"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1209","0409-3177","0409-3178","0409-3181","0409-3182","0409-3183","0409-0007","0409-0147"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE","EPINEPHRINE"],"rxcui":["1010688","1010745","1010751","1010759","1867996","1867998"],"spl_id":["2bf70cff-3f29-4938-8728-b3bb31f04475"],"spl_set_id":["2f94f711-14c4-48ec-c5a3-c5ec4b8e8729"],"package_ndc":["0409-1209-10","0409-1209-01","0409-1209-05","0409-1209-70","0409-1209-65","0409-3177-16","0409-3177-01","0409-3178-16","0409-3178-01","0409-3178-17","0409-3178-02","0409-3178-18","0409-3178-03","0409-3181-11","0409-3181-01","0409-3182-11","0409-3182-01","0409-3182-21","0409-3182-02","0409-3182-31","0409-3182-03","0409-3183-11","0409-3183-01","0409-0007-01","0409-0007-10","0409-0147-01","0409-0147-10"],"nui":["N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"pharm_class_epc":["alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]"],"pharm_class_cs":["Catecholamines [CS]"],"unii":["V13007Z41A","YKH834O4BH"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"12/03/2025","update_type":"New","initial_posting_date":"12/03/2025","package_ndc":"0409-7101-66","generic_name":"Sodium Chloride 0.9% Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA019465"],"brand_name":["SODIUM CHLORIDE"],"generic_name":["SODIUM CHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-7101","0409-7132"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM CHLORIDE"],"rxcui":["1807547","1807631","1807632","1807633"],"spl_id":["147cbba6-2ead-49c4-bce7-4e9c65b303c9"],"spl_set_id":["a2a964f7-c3ec-4dfb-e3a0-6d8136a80397"],"package_ndc":["0409-7101-68","0409-7101-66","0409-7101-69","0409-7101-67","0409-7101-04","0409-7101-02","0409-7132-68","0409-7132-66","0409-7132-69","0409-7132-67","0409-7132-04","0409-7132-02"],"unii":["451W47IQ8X"]},"update_date":"12/03/2025","therapeutic_category":["Gastroenterology","Other","Renal"],"dosage_form":"Injection","presentation":"Sodium Chloride 0.9%, Injection, 50 mL  ADD-Vantage® Flexible Container (NDC 0409-7101-66)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"update_type":"New","initial_posting_date":"02/20/2018","package_ndc":"31722-277-32","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"732-529-0430, customerservice@camberpharma.com","availability":"Available","openfda":{"application_number":["ANDA217821"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Camber Pharmaceuticals, Inc."],"product_ndc":["31722-277","31722-275","31722-276"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["4ea16f8e-77de-3ba7-e063-6394a90a5667"],"spl_set_id":["0e552e3a-cf52-4d74-9381-6cc1b29b4c90"],"package_ndc":["31722-275-10","31722-275-31","31722-275-32","31722-275-30","31722-275-33","31722-275-34","31722-275-35","31722-276-10","31722-276-31","31722-276-32","31722-276-30","31722-276-33","31722-276-34","31722-277-10","31722-277-31","31722-277-32","31722-277-30","31722-277-33","31722-277-34"],"unii":["7TQO7W3VT8"]},"update_date":"07/17/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 31722-277-32)","company_name":"Aspiro Pharma Limited","status":"Current"},{"discontinued_date":"04/22/2026","update_type":"New","initial_posting_date":"04/22/2026","package_ndc":"0069-0187-21","generic_name":"Palbociclib Capsule","contact_info":"800-533-4535","related_info":"Discontinuation of the manufacturing of the capsule presentation. 75 mg Tablet \nNDC 0069-0284-03 will continue to be manufactured.","openfda":{"application_number":["NDA207103"],"brand_name":["IBRANCE"],"generic_name":["PALBOCICLIB"],"manufacturer_name":["Pfizer Laboratories Div Pfizer Inc"],"product_ndc":["0069-0187","0069-0188","0069-0189"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["PALBOCICLIB"],"rxcui":["1601380","1601386","1601388","1601390","1601392","1601394"],"spl_id":["7dcc9b87-0aa4-4a00-aced-96be3553e8ac"],"spl_set_id":["e0e6412f-50b4-4fd4-9364-62818d121a07"],"package_ndc":["0069-0187-21","0069-0188-21","0069-0189-21"],"nui":["N0000175605","N0000175082","N0000190114"],"pharm_class_epc":["Kinase Inhibitor [EPC]"],"pharm_class_moa":["Kinase Inhibitors [MoA]","Cytochrome P450 3A Inhibitors [MoA]"],"unii":["G9ZF61LE7G"]},"update_date":"04/22/2026","therapeutic_category":["Oncology"],"dosage_form":"Capsule","presentation":"Ibrance, Capsule, 75 mg (NDC 0069-0187-21)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/13/2023","package_ndc":"0703-3671-01","generic_name":"Methotrexate Sodium Injection","contact_info":"800-545-8800","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040843"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-3671","0703-3675","0703-3678"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL","INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1655956","1655959","1655960"],"spl_id":["e81074cc-12b4-4ac9-a5bb-749188989b2c"],"spl_set_id":["346ec9ce-dc98-4a55-b55e-d3af11f2d703"],"package_ndc":["0703-3671-01","0703-3675-01","0703-3678-01"],"unii":["3IG1E710ZN"]},"update_date":"11/02/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3671-01)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"55150-165-05","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: mid-November 2026; Check wholesalers for inventory","openfda":{"application_number":["ANDA203082"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-165","55150-161","55150-162","55150-163","55150-164"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1737562","1737566","1737568","1737757","1737761"],"spl_id":["bab2ea79-0aed-4f48-8b4e-f864f8b82fb8","d95a0a28-804f-44d2-aa31-01df376a3154"],"spl_set_id":["9916b09d-a116-469d-92d5-60e50ea9782b","89701fac-7536-4f16-87fb-f4cc121e74ee"],"package_ndc":["55150-161-09","55150-162-09","55150-163-00","55150-163-24","55150-164-09","55150-165-09","55150-161-02","55150-162-05","55150-163-30","55150-163-25","55150-164-02","55150-165-05"],"unii":["V13007Z41A"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/20/2023","package_ndc":"0641-6247-25","generic_name":"Fentanyl Citrate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be scheduled for manufacturing to meet demand.  Product will be made available as it is released.","openfda":{"application_number":["NDA019101"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6247","0641-6024","0641-6027","0641-6025","0641-6028","0641-6026","0641-6029","0641-6030","0641-6248","0641-6249"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270","2474269","2629337"],"spl_id":["4eb40afd-eae7-4006-8934-4e1d43d59ea7"],"spl_set_id":["ce5db1c2-feb1-4ad2-847a-d02e865bd47e"],"package_ndc":["0641-6024-01","0641-6024-10","0641-6027-01","0641-6027-25","0641-6025-01","0641-6025-10","0641-6028-01","0641-6028-10","0641-6028-25","0641-6026-01","0641-6026-05","0641-6029-01","0641-6029-25","0641-6030-01","0641-6247-01","0641-6247-25","0641-6248-01","0641-6248-10","0641-6249-01","0641-6249-10"],"unii":["MUN5LYG46H"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 50 mcg/1 mL (NDC 0641-6247-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"65219-065-05","generic_name":"Rocuronium Bromide Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA078651"],"brand_name":["ROCURONIUM"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-065"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["68f8f5e7-46a8-47f9-a622-6339df1a3d1b"],"spl_set_id":["209a654d-f92d-4242-bfef-2dcc90a30d3f"],"package_ndc":["65219-065-02","65219-065-05"],"unii":["I65MW4OFHZ"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 65219-065-05)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"discontinued_date":"08/03/2026","update_type":"New","initial_posting_date":"08/03/2026","package_ndc":"0941-0413-07","generic_name":"Calcium Chloride; Dextrose; Magnesium Chloride; Sodium Chloride; Sodium Lactate Intraperitoneal Injection, Solution","contact_info":"800-284-4060","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA017512"],"brand_name":["DIANEAL PD-2 WITH DEXTROSE"],"generic_name":["SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE AND DEXTROSE"],"manufacturer_name":["Vantive US Healthcare LLC"],"product_ndc":["0941-0413","0941-0411","0941-0415","0941-0409","0941-0457","0941-0459","0941-0426","0941-0427","0941-0429","0941-0424","0941-0430","0941-0433","0941-0484","0941-0487","0941-0490"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"rxcui":["799999","800003","800057","800061","800062","800064","800066","800074","800111","800115","800472","800474"],"spl_id":["194f41a6-655b-456a-955f-7566eb429b7b"],"spl_set_id":["aa268d3f-7389-4f25-801f-5d4825495f08"],"package_ndc":["0941-0411-05","0941-0411-06","0941-0411-07","0941-0411-04","0941-0411-11","0941-0413-05","0941-0413-06","0941-0413-07","0941-0413-01","0941-0413-04","0941-0415-05","0941-0415-06","0941-0415-04","0941-0415-07","0941-0415-01","0941-0409-06","0941-0409-05","0941-0409-07","0941-0409-01","0941-0457-08","0941-0457-02","0941-0457-05","0941-0457-01","0941-0459-08","0941-0459-02","0941-0459-05","0941-0459-01","0941-0426-52","0941-0426-53","0941-0427-52","0941-0427-53","0941-0429-52","0941-0429-53","0941-0424-51","0941-0424-52","0941-0424-53","0941-0430-51","0941-0430-52","0941-0430-53","0941-0433-51","0941-0433-52","0941-0433-53","0941-0484-01","0941-0487-01","0941-0490-01"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"08/03/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DIANEAL PD-2 with Dextrose, Intraperitoneal Injection, Solution, 25.7 mg/100 mL; 2.5 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 0941-0413-07)","company_name":"Vantive US Healthcare LLC","status":"To Be Discontinued"},{"discontinued_date":"03/10/2026","update_type":"New","initial_posting_date":"03/10/2026","package_ndc":"46163-212-94","generic_name":"Peritoneal Dialysis Solution","contact_info":"800-323-5188","related_info":"The NDC codes are being discontinued, to be replaced with NDC labeler code #46163.","openfda":{"application_number":["NDA020171"],"brand_name":["DELFLEX"],"generic_name":["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"],"manufacturer_name":["Fresenius Medical Care de Mexico, S.A. de C.V."],"product_ndc":["46163-212","46163-209","46163-206"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAPERITONEAL"],"substance_name":["DEXTROSE MONOHYDRATE","SODIUM CHLORIDE","SODIUM LACTATE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"spl_id":["5f14959c-adcd-923c-e063-6294a90ab6de"],"spl_set_id":["a98facd6-9daa-4d37-8209-63a0599dbfaa"],"package_ndc":["46163-209-92","46163-209-94","46163-209-95","46163-212-95","46163-212-92","46163-212-94","46163-206-92","46163-206-94","46163-206-95"],"unii":["LX22YL083G","M4I0D6VV5M","TU7HW0W0QT","451W47IQ8X","02F3473H9O"]},"update_date":"03/10/2026","therapeutic_category":["Renal"],"dosage_form":"Solution","presentation":"DELFLEX® w/Dextrose, Solution, 4.25% Low Mg/Low Ca 2.5L/3L, 5/cs (NDC 46163-212-94)","company_name":"Fresenius Medical Care North America","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"68025-095-30","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Available","openfda":{"application_number":["NDA216117"],"brand_name":["RELEXXII"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Vertical Pharmaceuticals, LLC"],"product_ndc":["68025-095","68025-088","68025-089","68025-096","68025-097","68025-084","68025-098"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461","2052826","2605796","2605798","2605943","2605946","2668496","2668499","2668502","2668505"],"spl_id":["86f477e9-07fc-466b-913e-1a4434c91df4"],"spl_set_id":["22d5fa47-b5b9-4fd9-980c-4eb88e95ae5d"],"package_ndc":["68025-088-30","68025-089-30","68025-095-10","68025-095-30","68025-096-10","68025-096-30","68025-097-10","68025-097-30","68025-084-30","68025-098-10","68025-098-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)","company_name":"Vertical Pharmaceuticals, LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"64850-504-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"888-852-6657","availability":"Available","openfda":{"application_number":["ANDA211352"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Elite Laboratories, Inc."],"product_ndc":["64850-504","64850-500","64850-501","64850-502","64850-503","64850-505","64850-506"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["a41cf8e5-cb1b-488c-96b3-3bef8283d6c4"],"spl_set_id":["e677690f-790f-4626-ad78-097cdb6ea540"],"package_ndc":["64850-500-01","64850-500-05","64850-500-30","64850-501-01","64850-501-05","64850-501-30","64850-502-01","64850-502-05","64850-502-30","64850-503-01","64850-503-05","64850-503-30","64850-504-01","64850-504-05","64850-504-30","64850-505-01","64850-505-05","64850-505-30","64850-506-01","64850-506-05","64850-506-30"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 64850-504-01)","company_name":"Elite Laboratories, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"63323-806-20","generic_name":"Fentanyl Citrate Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release December 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA210762"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-806"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735007","1735008","1735013","2168270"],"spl_id":["341b092a-1f6f-40f1-98f2-9346bf2e1242"],"spl_set_id":["38d0c14a-a0c1-44cc-a939-0304eb8037d6"],"package_ndc":["63323-806-11","63323-806-01","63323-806-12","63323-806-02","63323-806-13","63323-806-05","63323-806-14","63323-806-20","63323-806-50"],"unii":["MUN5LYG46H"]},"update_date":"11/03/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate Preservative Free, Injection, .05 mg/1 mL (NDC 63323-806-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/30/2020","package_ndc":"0143-9785-10","generic_name":"Valproate Sodium Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be available.  Product will be made available as it is released.","openfda":{"application_number":["ANDA078523"],"brand_name":["VALPROATE SODIUM"],"generic_name":["VALPROATE SODIUM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0143-9785"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["VALPROATE SODIUM"],"rxcui":["1099648"],"spl_id":["0610e50d-6447-4a0e-bc36-dc0bffa95c7d"],"spl_set_id":["bcf57b31-4811-4104-82b3-46fb91a53ee0"],"package_ndc":["0143-9785-01","0143-9785-10"],"unii":["5VOM6GYJ0D"]},"update_date":"10/14/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Valproate Sodium, Injection, 500 mg/5 mL (NDC 0143-9785-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"02/20/2026","update_type":"New","initial_posting_date":"02/20/2026","package_ndc":"50742-448-60","generic_name":"Carboplatin Injection","contact_info":"866-321-5031","related_info":"Discontinuation of the manufacture of the drug","update_date":"02/20/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 600 mg/60 mL (NDC 50742-448-60)","company_name":"Ingenus Pharmaceuticals LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"01/19/2023","package_ndc":"65862-617-90","generic_name":"Quinapril Hydrochloride Tablet","contact_info":"866-850-2876","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA202725"],"brand_name":["QUINAPRIL"],"generic_name":["QUINAPRIL HYDROCHLORIDE"],"manufacturer_name":["Aurobindo Pharma Limited"],"product_ndc":["65862-617","65862-618","65862-619","65862-620"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["QUINAPRIL HYDROCHLORIDE"],"rxcui":["312748","312749","312750","314203"],"spl_id":["5263abd5-ce46-4918-9bb0-9632861bcbc9"],"spl_set_id":["93e6e668-5306-4f26-81d8-cbc3a7a5e787"],"package_ndc":["65862-617-30","65862-617-90","65862-617-99","65862-617-55","65862-617-10","65862-617-78","65862-618-30","65862-618-90","65862-618-99","65862-618-55","65862-618-10","65862-618-78","65862-619-30","65862-619-90","65862-619-99","65862-619-19","65862-619-10","65862-619-78","65862-620-30","65862-620-90","65862-620-99","65862-620-39","65862-620-10","65862-620-78"],"unii":["33067B3N2M"]},"update_date":"11/04/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Quinapril Hydrochloride, Tablet, 5 mg (NDC 65862-617-90)","company_name":"Aurobindo Pharma USA","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/15/2021","package_ndc":"25021-820-05","generic_name":"Methylprednisolone Acetate Injection","contact_info":"866-625-1618","availability":"Available","openfda":{"application_number":["ANDA201835"],"brand_name":["METHYLPREDNISOLONE ACETATE"],"generic_name":["METHYLPREDNISOLONE ACETATE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-820","25021-821"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRASYNOVIAL","SOFT TISSUE"],"substance_name":["METHYLPREDNISOLONE ACETATE"],"rxcui":["1358610","1358617"],"spl_id":["f73618f0-0723-4d8b-8a8d-b9081acb44f9"],"spl_set_id":["f98314ea-a4e4-4f78-987b-3e9b45a08bb4"],"package_ndc":["25021-820-05","25021-820-10","25021-821-05"],"unii":["43502P7F0P"]},"update_date":"11/06/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 40 mg/1 mL (NDC 25021-820-05)","company_name":"Sagent Pharmaceuticals","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/25/2017","package_ndc":"0264-9594-20","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA019830"],"brand_name":["LIDOCAINE HYDROCHLORIDE AND DEXTROSE"],"generic_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS AND DEXTROSE MONOHYDRATE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-9594","0264-9598"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LIDOCAINE HYDROCHLORIDE ANHYDROUS","DEXTROSE MONOHYDRATE"],"rxcui":["1737723","1737742","1737744"],"spl_id":["9e352802-107c-4f90-babe-4f69c7dc892e"],"spl_set_id":["7dff29d9-522d-40eb-a9d9-42377912d640"],"package_ndc":["0264-9598-20","0264-9594-20","0264-9594-10"],"unii":["LX22YL083G","EC2CNF7XFP"]},"update_date":"11/10/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)","company_name":"B. Braun Medical Inc.","status":"Current"},{"discontinued_date":"07/27/2026","update_type":"New","initial_posting_date":"07/27/2026","package_ndc":"0173-0715-22","generic_name":"Fluticasone Propionate and Salmeterol Xinafoate Aerosol, Metered","contact_info":"888-825-5249","related_info":"The anticipated date that GSK will cease distribution of the presentation is approximately December 31, 2026.  The 120 dose presentation of this product will still be available.","openfda":{"application_number":["NDA021254"],"brand_name":["ADVAIR HFA"],"generic_name":["FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE"],"manufacturer_name":["GlaxoSmithKline LLC"],"product_ndc":["0173-0715","0173-0716","0173-0717"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["RESPIRATORY (INHALATION)"],"substance_name":["FLUTICASONE PROPIONATE","SALMETEROL XINAFOATE"],"rxcui":["896231","896235","896236","896237","896239","896243","896244","896245","896267","896271","896272","896273"],"spl_id":["bea52e57-aa75-4dce-8cfb-a163bbc22be2"],"spl_set_id":["dfaca6f9-3277-47b2-319d-1377917cb54c"],"package_ndc":["0173-0715-20","0173-0715-22","0173-0716-20","0173-0716-22","0173-0717-20","0173-0717-22"],"unii":["6EW8Q962A5","O2GMZ0LF5W"]},"update_date":"07/27/2026","therapeutic_category":["Pulmonary/Allergy"],"presentation":"Advair HFA, Aerosol, Metered, 45 ug; 21 ug (NDC 0173-0715-22)","company_name":"GlaxoSmithKline","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-285-64","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-285","63323-286","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"0009-4073-04","generic_name":"Clindamycin Phosphate Injection","contact_info":"844-646-4398","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA050441"],"brand_name":["CLEOCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-4073","0009-3051","0009-5095"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["1737244","1737245","1737578","1737579","1737581","1737582"],"spl_id":["8d0dac99-6ec9-4648-8ae1-0cc2894d56cf"],"spl_set_id":["a0a2eff7-b7de-42fe-8e5a-0cfbed38bb4b"],"package_ndc":["0009-3051-01","0009-3051-02","0009-4073-03","0009-4073-04","0009-5095-05","0009-5095-06"],"unii":["EH6D7113I8"]},"update_date":"06/01/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cleocin Phosphate, Injection, 600 mg/4 mL (150 mg/mL); 4 mL Vial NovaPlus (NDC 0009-4073-04)","company_name":"Pfizer Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/22/2021","package_ndc":"68180-658-06","generic_name":"Rifampin Capsule","contact_info":"866-587-4617","availability":"Available","openfda":{"application_number":["ANDA090034"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["Lupin Pharmaceuticals, Inc."],"product_ndc":["68180-658","68180-659"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAMPIN"],"rxcui":["198201","198202"],"spl_id":["5ed1edac-e11e-4f87-b390-e770a69a9b37"],"spl_set_id":["b56004f0-f23d-47f6-80c7-39884fccbccc"],"package_ndc":["68180-658-06","68180-658-01","68180-659-06","68180-659-07","68180-659-01"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"10/13/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Rifampin, Capsule, 150 mg (NDC 68180-658-06)","company_name":"Lupin Pharmaceuticals, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/13/2022","package_ndc":"47335-993-01","generic_name":"Metronidazole Injection","contact_info":"Distributed by Sun Pharma","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA212435"],"brand_name":["METRONIDAZOLE"],"generic_name":["METRONIDAZOLE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["47335-993"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["METRONIDAZOLE"],"rxcui":["311683"],"spl_id":["53cfb044-6f56-f028-e063-6394a90a53f2"],"spl_set_id":["7187779a-1f4c-4607-af53-4119e324aad5"],"package_ndc":["47335-993-01"],"nui":["N0000175435","M0014907"],"pharm_class_epc":["Nitroimidazole Antimicrobial [EPC]"],"pharm_class_cs":["Nitroimidazoles [CS]"],"unii":["140QMO216E"]},"update_date":"10/21/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Metronidazole In Plastic Container, Injection, 500 mg/100 mL (NDC 47335-993-01)","company_name":"Gland Pharma Limited","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/18/2023","package_ndc":"0169-4060-13","generic_name":"Liraglutide Injection","contact_info":"833-493-4689","availability":"Limited Availability","related_info":"Estimated shortage duration: TBD","openfda":{"application_number":["NDA022341"],"brand_name":["VICTOZA"],"generic_name":["LIRAGLUTIDE"],"manufacturer_name":["Novo Nordisk"],"product_ndc":["0169-4060"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBCUTANEOUS"],"substance_name":["LIRAGLUTIDE"],"rxcui":["897122","897126"],"spl_id":["0d10d10e-0fe0-47ee-b9da-628e34907e98"],"spl_set_id":["5a9ef4ea-c76a-4d34-a604-27c5b505f5a4"],"package_ndc":["0169-4060-13","0169-4060-12","0169-4060-90","0169-4060-97","0169-4060-98","0169-4060-99"],"nui":["N0000178480","M0160181","N0000020058"],"pharm_class_epc":["GLP-1 Receptor Agonist [EPC]"],"pharm_class_cs":["Glucagon-Like Peptide 1 [CS]"],"pharm_class_moa":["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"],"unii":["839I73S42A"]},"update_date":"09/22/2026","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Injection","presentation":"Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)","company_name":"Novo Nordisk, Inc.","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"discontinued_date":"05/21/2026","update_type":"New","initial_posting_date":"05/21/2026","package_ndc":"65219-084-15","generic_name":"Gadoterate Meglumine Injection","contact_info":"Marketed by Fresenius Kabi, USA; Customer service: 888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA215304"],"brand_name":["GADOTERATE MEGLUMINE"],"generic_name":["GADOTERATE MEGLUMINE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["65219-084","65219-080","65219-082","65219-086"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["GADOTERATE MEGLUMINE"],"spl_id":["f05922b7-99d4-48c7-972a-7966bbbbc3b4"],"spl_set_id":["e0655aac-9508-4141-94f5-fcca6af1c41d"],"package_ndc":["65219-080-01","65219-080-05","65219-082-01","65219-082-10","65219-084-01","65219-084-15","65219-086-01","65219-086-20"],"unii":["L0ND3981AG"]},"update_date":"05/21/2026","therapeutic_category":["Medical Imaging"],"dosage_form":"Injection","presentation":"Gadoterate Meglumine, Injection, 376.9 mg/1 mL (NDC 65219-084-15)","company_name":"Jiangsu Hengrui Pharmaceuticals Co., Ltd.","status":"To Be Discontinued"},{"discontinued_date":"02/19/2026","update_type":"New","initial_posting_date":"02/19/2026","package_ndc":"0591-5544-05","generic_name":"Allopurinol Tablet","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA018877"],"brand_name":["ALLOPURINOL"],"generic_name":["ALLOPURINOL"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0591-5544","0591-5543"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ALLOPURINOL"],"rxcui":["197319","197320"],"spl_id":["f7e04d88-1d9b-47e6-a9ad-deb08af3c098"],"spl_set_id":["a80fe56f-8d03-423f-8e2a-7ec8c9e5045b"],"package_ndc":["0591-5543-01","0591-5543-10","0591-5544-01","0591-5544-05"],"nui":["N0000175698","N0000000206"],"pharm_class_epc":["Xanthine Oxidase Inhibitor [EPC]"],"pharm_class_moa":["Xanthine Oxidase Inhibitors [MoA]"],"unii":["63CZ7GJN5I"]},"update_date":"02/19/2026","therapeutic_category":["Oncology","Renal","Rheumatology"],"dosage_form":"Tablet","presentation":"Allopurinol, Tablet, 300 mg (NDC 0591-5544-05)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"0781-3288-09","generic_name":"Clindamycin Phosphate Injection","contact_info":"800-525-8747","availability":"Available","openfda":{"application_number":["ANDA201692"],"brand_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"generic_name":["CLINDAMYCIN IN 5 PERCENT DEXTROSE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-3288","0781-3289","0781-3290"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN"],"rxcui":["309335","309336","309339"],"spl_id":["b553b8ab-ef4d-40ae-a5fb-a6242f2ad30a"],"spl_set_id":["231d95a6-5e5f-4a45-a92b-d3d16ef0a7ca"],"package_ndc":["0781-3288-91","0781-3288-09","0781-3289-91","0781-3289-09","0781-3290-91","0781-3290-09"],"nui":["N0000009982","N0000175443","M0515779","N0000175731"],"pharm_class_pe":["Decreased Sebaceous Gland Activity [PE]","Neuromuscular Blockade [PE]"],"pharm_class_epc":["Lincosamide Antibacterial [EPC]"],"pharm_class_cs":["Lincosamides [CS]"],"unii":["3U02EL437C"]},"update_date":"11/09/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate In 5% Dextrose In Plastic Container, Injection, 6 mg/1 mL (NDC 0781-3288-09)","company_name":"Sandoz Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/27/2018","package_ndc":"25021-652-87","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"Sagent: 866-625-1618","availability":"Available","related_info":"Marketed by Sagent Pharmaceuticals","openfda":{"application_number":["ANDA206166"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-652","25021-671"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734347","1734355","1734479","1734481"],"spl_id":["41f4446a-ca6e-465e-9a79-8c4f99eb1ac3"],"spl_set_id":["8c5c762f-d266-4b1a-809e-f11bfc89bc2d"],"package_ndc":["25021-671-82","25021-671-87","25021-652-82","25021-652-87"],"unii":["V910P86109"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)","company_name":"InfoRLife SA","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/01/2012","package_ndc":"0409-9630-05","generic_name":"Atropine Sulfate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021146"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9630","0409-1630","0409-4910","0409-4911"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190546","1190551","1190552"],"spl_id":["3f33c683-46fb-40db-af0d-9211bc29d2a7"],"spl_set_id":["ad8916e7-206e-409e-2582-30d072845dd4"],"package_ndc":["0409-1630-15","0409-1630-10","0409-9630-15","0409-9630-05","0409-4910-11","0409-4910-34","0409-4911-11","0409-4911-34"],"unii":["03J5ZE7KA5"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/01/2023","package_ndc":"60505-4745-1","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-706-5575","availability":"Available","openfda":{"application_number":["ANDA216944"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-4745","60505-4739","60505-4740","60505-4741","60505-4742","60505-4743","60505-4744"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["0190bec9-05e4-0977-9548-2cc150b53e74"],"spl_set_id":["ecad4442-a644-18e3-6ff2-fdbac45eec47"],"package_ndc":["60505-4739-1","60505-4740-1","60505-4741-1","60505-4742-1","60505-4743-1","60505-4744-1","60505-4745-1"],"unii":["SJT761GEGS"]},"update_date":"10/15/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 60505-4745-1)","company_name":"Apotex Corp.","status":"Current"},{"discontinued_date":"11/13/2025","update_type":"New","initial_posting_date":"11/13/2025","package_ndc":"0228-2851-11","generic_name":"Guanfacine Hydrochloride Tablet, Extended Release","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["ANDA200881"],"brand_name":["GUANFACINE"],"generic_name":["GUANFACINE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0228-2851","0228-2850","0228-2853","0228-2855"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["GUANFACINE HYDROCHLORIDE"],"rxcui":["862006","862013","862019","862025"],"spl_id":["00143252-2b74-4b11-86ed-9b864635f129"],"spl_set_id":["3a171942-37af-430d-8b9d-bb678ca2be4b"],"package_ndc":["0228-2850-11","0228-2851-11","0228-2853-11","0228-2855-11"],"unii":["PML56A160O"]},"update_date":"11/13/2025","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Guanfacine Hydrochloride, Tablet, Extended Release, 2 mg (NDC 0228-2851-11)","company_name":"Actavis Pharma, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/03/2016","package_ndc":"0641-6262-01","generic_name":"Sodium Acetate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots will be available.  Product will be made available as it is released.","openfda":{"application_number":["ANDA216920"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6262","0641-6263"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE ANHYDROUS"],"rxcui":["237371"],"spl_id":["777b7564-f07b-401a-a042-0cd512ae3b25"],"spl_set_id":["7ee23a1c-bc99-4ff6-b2e7-d2aa42744553"],"package_ndc":["0641-6262-01","0641-6263-01","0641-6263-10"],"unii":["NVG71ZZ7P0"]},"update_date":"10/14/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric","Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"55150-304-25","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA210966"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-304"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["1812079"],"spl_id":["5d97a8a3-fd79-4fd1-8a0f-c8cf95d40964"],"spl_set_id":["29947f67-7868-40af-8ad2-a61f7149b44c"],"package_ndc":["55150-304-01","55150-304-25"],"unii":["AI9376Y64P"]},"update_date":"10/19/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 10 mg/1 mL (NDC 55150-304-25)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/23/2021","package_ndc":"63323-185-20","generic_name":"Sterile Water Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA088400"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-185"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["WATER"],"spl_id":["42c6c812-706a-425b-b8cb-931006e40484"],"spl_set_id":["e71c6c83-d518-496c-b2ab-efd5987e4783"],"package_ndc":["63323-185-07","63323-185-10","63323-185-09","63323-185-50","63323-185-08","63323-185-20","63323-185-04","63323-185-05"],"unii":["059QF0KO0R"]},"update_date":"11/03/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Sterile Water For Injection In Plastic Container, Injection, 1 mL/1 mL (NDC 63323-185-20)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"11/03/2017","package_ndc":"0641-6126-25","generic_name":"Morphine Sulfate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA205758"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6126","0641-6127","0641-6125"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["1731993","1732006","1732011"],"spl_id":["fb513d10-94f4-45f5-8b30-fa82ef83e4e2"],"spl_set_id":["6023606c-150c-40c5-9175-598efe2a56c3"],"package_ndc":["0641-6126-01","0641-6126-25","0641-6127-01","0641-6127-25","0641-6125-01","0641-6125-25"],"unii":["X3P646A2J0"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 8 mg/1 mL (NDC 0641-6126-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"57664-052-88","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-818-4555","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA214484"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Sun Pharmaceutical Industries, Inc."],"product_ndc":["57664-052","57664-047","57664-046","57664-048","57664-049","57664-050","57664-051","57664-083","57664-084","57664-085","57664-086","57664-087","57664-088"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856","1871456","1871460","1871462","1871464","1871466","1871468"],"spl_id":["560b4c9e-9cce-4717-e063-6294a90a58c9"],"spl_set_id":["da3148af-f9b6-4725-adae-3595b4c7dc4b"],"package_ndc":["57664-047-88","57664-046-88","57664-048-88","57664-049-88","57664-050-88","57664-051-88","57664-052-88","57664-083-88","57664-084-88","57664-085-88","57664-086-88","57664-087-88","57664-088-88"],"unii":["SJT761GEGS"]},"update_date":"10/30/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 70 mg (NDC 57664-052-88)","company_name":"Sun Pharmaceutical Industries, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"11/19/2025","update_type":"New","initial_posting_date":"11/19/2025","package_ndc":"0591-0347-05","generic_name":"Hydrochlorothiazide Capsule","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug.","openfda":{"application_number":["NDA020504"],"brand_name":["HYDROCHLOROTHIAZIDE"],"generic_name":["HYDROCHLOROTHIAZIDE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0591-0347"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["HYDROCHLOROTHIAZIDE"],"rxcui":["199903"],"spl_id":["aea91439-5b06-44b8-a92f-e75c13847c5d"],"spl_set_id":["a3eb7294-f913-434b-896c-da028bfebc73"],"package_ndc":["0591-0347-01","0591-0347-05"],"nui":["N0000175359","N0000175419","M0471776"],"pharm_class_pe":["Increased Diuresis [PE]"],"pharm_class_epc":["Thiazide Diuretic [EPC]"],"pharm_class_cs":["Thiazides [CS]"],"unii":["0J48LPH2TH"]},"update_date":"11/19/2025","therapeutic_category":["Cardiovascular"],"dosage_form":"Capsule","presentation":"Microzide, Capsule, 12.5 mg (NDC 0591-0347-05)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-2253-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","related_info":"Historical NDC: 0409-1582-29","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2253","0409-1746","0409-1749","0409-1752","0409-1755","0409-2510","0409-7535","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, Marcaine 225 mg/30 mL (7.5 mg/mL) (NDC 0409-2253-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/08/2019","package_ndc":"0641-6146-25","generic_name":"Dexamethasone Sodium Phosphate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional product will be made available as it is released.","openfda":{"application_number":["ANDA084282"],"brand_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"generic_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6146","0641-0367","0641-6145"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTICULAR","INTRALESIONAL","INTRAMUSCULAR","INTRAVENOUS","SOFT TISSUE"],"substance_name":["DEXAMETHASONE SODIUM PHOSPHATE"],"rxcui":["309696","1116927","1812194"],"spl_id":["02bf3273-f0c8-448c-9f74-eb009fee9299"],"spl_set_id":["0277cc0a-2fd4-4605-a310-b613be84ee26"],"package_ndc":["0641-0367-21","0641-0367-25","0641-6145-01","0641-6145-25","0641-6146-01","0641-6146-10","0641-6146-25"],"unii":["AI9376Y64P"]},"update_date":"10/14/2026","therapeutic_category":["Dermatology","Endocrinology/Metabolism","Gastroenterology","Hematology","Neurology","Oncology","Ophthalmology","Other","Pulmonary/Allergy","Rheumatology"],"dosage_form":"Injection","presentation":"Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 0641-6146-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"01/31/2018","change_date":"09/30/2026","package_ndc":"25021-321-04","generic_name":"Bumetanide Injection","contact_info":"866-625-1618","resolved_note":"Available","openfda":{"application_number":["ANDA074441"],"brand_name":["BUMETANIDE"],"generic_name":["BUMETANIDE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-321"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["BUMETANIDE"],"rxcui":["282486","1727569"],"spl_id":["88a191ea-bf0d-4c27-a33c-91a126ff1aba"],"spl_set_id":["c38a404d-a919-4a2c-9fbb-d0655dee9516"],"package_ndc":["25021-321-04","25021-321-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["0Y2S3XUQ5H"]},"update_date":"09/30/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Bumetanide, Injection, .25 mg/1 mL (NDC 25021-321-04)","company_name":"Sagent Pharmaceuticals","status":"Resolved"},{"discontinued_date":"08/31/2026","update_type":"New","initial_posting_date":"08/31/2026","package_ndc":"65219-258-10","generic_name":"Potassium Chloride, Sodium Chloride, Calcium Chloride, and Magnesium Chloride Injection, Solution","contact_info":"888-386-1300","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA214623"],"brand_name":["CARDIOPLEGIC SOLUTION"],"generic_name":["POTASSIUM CHLORIDE, SODIUM CHLORIDE, CALCIUM CHLORIDE, AND MAGNESIUM CHLORIDE"],"manufacturer_name":["Fresenius Kabi, USA, LLC"],"product_ndc":["65219-258"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL"],"substance_name":["POTASSIUM CHLORIDE","SODIUM CHLORIDE","CALCIUM CHLORIDE","MAGNESIUM CHLORIDE"],"spl_id":["9c1af4dc-3653-49cb-baa5-e916369a4e0a"],"spl_set_id":["eb360dc4-88d6-4b28-9b61-bc359e16bd22"],"package_ndc":["65219-258-01","65219-258-10"],"unii":["660YQ98I10","451W47IQ8X","M4I0D6VV5M","02F3473H9O"]},"update_date":"08/31/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Cardioplegic Solution, Injection, Solution, 17.6 mg/100 mL; 325.3 mg/100 mL; 119.3 mg/100 mL; 643 mg/100 mL (NDC 65219-258-10)","company_name":"Fresenius Kabi USA, LLC","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"0480-3570-01","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA202802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Teva Pharmaceuticals, Inc."],"product_ndc":["0480-3570","0480-3565","0480-3566","0480-3567","0480-3568","0480-3569","0480-3564"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["7a1feaa2-6b58-4aff-a45b-533ee3174e53"],"spl_set_id":["c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fc"],"package_ndc":["0480-3565-01","0480-3566-01","0480-3567-01","0480-3568-01","0480-3569-01","0480-3570-01","0480-3564-01"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 60 mg (NDC 0480-3570-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"02/24/2026","update_type":"New","initial_posting_date":"02/24/2026","package_ndc":"50742-402-05","generic_name":"Irinotecan Hydrochloride Injection","contact_info":"866-321-5031","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"02/24/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Irinotecan Hydrochloride, Injection, 100 mg/5 mL (NDC 50742-402-05)","company_name":"Ingenus Pharmaceuticals LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"05/03/2022","package_ndc":"0409-3382-21","generic_name":"Sufentanil Citrate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA074534"],"brand_name":["SUFENTANIL CITRATE"],"generic_name":["SUFENTANIL CITRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3382"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRAVENOUS"],"substance_name":["SUFENTANIL CITRATE"],"rxcui":["1809097"],"spl_id":["2f400934-519c-4d94-a8d5-bad870eaa1a6"],"spl_set_id":["20293943-46ff-4345-1aa4-929b4e017a25"],"package_ndc":["0409-3382-11","0409-3382-21"],"unii":["S9ZFX8403R"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Sufentanil Citrate, Injection, 50 ug/1 mL (NDC 0409-3382-21)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"0409-0155-02","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA021038"],"brand_name":["PRECEDEX"],"generic_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-0155","0409-4596"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718907","1718909","1718910"],"spl_id":["b62d8928-1ce3-488e-a89f-d7085c5510a7"],"spl_set_id":["92b7ddaa-e45a-4b64-a802-bb5df8771dd6"],"package_ndc":["0409-4596-01","0409-4596-20","0409-0155-01","0409-0155-02"],"unii":["1018WH7F9I"]},"update_date":"11/06/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02)","company_name":"Pfizer Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0264-2101-10","generic_name":"Sterile Water Irrigant","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["NDA016734"],"brand_name":["STERILE WATER"],"generic_name":["WATER"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-2101"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["IRRIGATION"],"substance_name":["WATER"],"rxcui":["150985"],"spl_id":["17177669-a426-414d-b0b8-ec70dad03197"],"spl_set_id":["f4284eb6-e553-46d4-90d8-efc80a90a480"],"package_ndc":["0264-2101-00","0264-2101-10","0264-2101-50","0264-2101-70"],"unii":["059QF0KO0R"]},"update_date":"11/10/2026","therapeutic_category":["Gastroenterology","Other","Pediatric"],"dosage_form":"Irrigant","presentation":"Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0264-2101-10)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/22/2021","package_ndc":"42806-799-30","generic_name":"Rifampin Capsule","contact_info":"(718) 276-8600 ext. 3","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA064150"],"brand_name":["RIFAMPIN"],"generic_name":["RIFAMPIN"],"manufacturer_name":["EPIC PHARMA, LLC"],"product_ndc":["42806-799","42806-801"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RIFAMPIN"],"rxcui":["198201","198202"],"spl_id":["a4ac02e8-68ac-4e79-8ca5-0939dd002c87"],"spl_set_id":["0391f1e1-70d4-4b15-8b58-055bb6a385b8"],"package_ndc":["42806-801-30","42806-801-01","42806-799-30","42806-799-60","42806-799-01","42806-799-05"],"nui":["N0000175500","M0019113"],"pharm_class_epc":["Rifamycin Antibacterial [EPC]"],"pharm_class_cs":["Rifamycins [CS]"],"unii":["VJT6J7R4TR"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Capsule","presentation":"Rifampin, Capsule, 300 mg (NDC 42806-799-30)","company_name":"Epic Pharma, LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"09/05/2018","package_ndc":"0641-6001-25","generic_name":"Lorazepam Injection","contact_info":"800-631-2174","availability":"Limited Availability","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["NDA018140"],"brand_name":["ATIVAN"],"generic_name":["LORAZEPAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6001","0641-6003","0641-6002","0641-6000"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["LORAZEPAM"],"rxcui":["206819","206820","238100","238101","1665188","1665190","1665326","1665327"],"spl_id":["fb40dcce-9da3-49b4-9bde-e01a17abeae6"],"spl_set_id":["5fc0e987-61c9-40c4-b0d5-fcea07c8733e"],"package_ndc":["0641-6003-01","0641-6003-25","0641-6002-01","0641-6002-10","0641-6001-01","0641-6001-25","0641-6000-01","0641-6000-10"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["O26FZP769L"]},"update_date":"10/14/2026","therapeutic_category":["Neurology"],"dosage_form":"Injection","presentation":"Ativan, Injection, 2 mg/1 mL (NDC 0641-6001-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"25021-700-01","generic_name":"Ketorolac Tromethamine Injection","contact_info":"833-291-9645","availability":"Available","openfda":{"application_number":["ANDA204216"],"brand_name":["KETOROLAC TROMETHAMINE"],"generic_name":["KETOROLAC TROMETHAMINE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-700","25021-701"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["KETOROLAC TROMETHAMINE"],"rxcui":["860092","1665459","1665461"],"spl_id":["cb23332a-48fa-458b-93ab-c4eef189a051"],"spl_set_id":["62591551-a644-4b2c-a0de-982e906fabc3"],"package_ndc":["25021-700-01","25021-701-01","25021-701-02"],"unii":["4EVE5946BQ"]},"update_date":"10/21/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Ketorolac Tromethamine, Injection, 15 mg/1 mL (NDC 25021-700-01)","company_name":"Gland Pharma Limited","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-2253-25","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","related_info":"Historical NDC: 0409-1582-29","openfda":{"application_number":["NDA016964"],"brand_name":["MARCAINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-2253","0409-1746","0409-1749","0409-1752","0409-1755","0409-2510","0409-7535","0409-1250","0409-5010","0409-1530","0409-0525","0409-7510"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","RETROBULBAR"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012377","1012381","1012384","1012388","1012396","1012400","1012404","1012406","1672917","1672919","1673242","1673243","1724786","1724787","1724794","1724796","1724880","1724884","1725044","1725046","1725078","1725079","1725082","1725083","1867594","1867596","1867612","1867614"],"spl_id":["b57ce3de-b2db-496b-99f8-3f42c637c5ea"],"spl_set_id":["67578b56-7540-487e-1fba-481255620e78"],"package_ndc":["0409-1746-70","0409-1746-10","0409-1746-71","0409-1746-30","0409-1749-70","0409-1749-10","0409-1749-71","0409-1749-29","0409-1752-50","0409-1755-50","0409-2510-01","0409-2510-25","0409-7535-01","0409-7535-25","0409-1250-01","0409-1250-25","0409-5010-01","0409-5010-25","0409-1530-01","0409-1530-25","0409-0525-01","0409-0525-25","0409-7510-01","0409-7510-25","0409-2253-01","0409-2253-25"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Marcaine, Injection, 225 mg/30 mL (NDC 0409-2253-25)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/14/2022","package_ndc":"65219-462-10","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-386-1300","availability":"Limited Availability","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA207449"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["FRESENIUS KABI USA, LLC"],"product_ndc":["65219-462","65219-456","65219-464","65219-458","65219-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795607","1795609","1795610","1795612","1795616"],"spl_id":["efc3b0c9-518a-47db-bb3e-ebdfd4646e9b"],"spl_set_id":["576a22d8-5f2f-497e-80ad-1842ca74bb53"],"package_ndc":["65219-456-05","65219-456-60","65219-464-05","65219-464-50","65219-458-05","65219-458-30","65219-460-05","65219-460-20","65219-462-05","65219-462-10"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-462-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"0409-9042-17","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["ANDA071165"],"brand_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9042","0409-1159","0409-1160","0409-1162","0409-1163","0409-1165","0409-9043","0409-9046","0409-9045"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1012377","1012384","1012396","1012404","1672917","1672919","1724786","1724787","1724880","1724884","1725078","1725082","1867594","1867596"],"spl_id":["6e442bfd-d3da-4913-8585-ce3485644364"],"spl_set_id":["02a845c3-4521-4926-e397-25ab536e7cf6"],"package_ndc":["0409-1159-18","0409-1159-01","0409-1159-19","0409-1159-02","0409-1160-18","0409-1160-01","0409-1162-18","0409-1162-01","0409-1162-19","0409-1162-02","0409-1163-18","0409-1163-01","0409-1165-18","0409-1165-01","0409-1165-19","0409-1165-02","0409-9043-11","0409-9043-01","0409-9046-11","0409-9046-01","0409-9045-11","0409-9045-01","0409-9045-16","0409-9045-17","0409-9042-11","0409-9042-01","0409-9042-16","0409-9042-17"],"unii":["30Q7KI53AK","7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride with Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"discontinued_date":"02/19/2026","update_type":"New","initial_posting_date":"02/19/2026","package_ndc":"0591-5543-01","generic_name":"Allopurinol Tablet","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA018832"],"brand_name":["ALLOPURINOL"],"generic_name":["ALLOPURINOL"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0591-5543","0591-5544"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["ALLOPURINOL"],"rxcui":["197319","197320"],"spl_id":["f7e04d88-1d9b-47e6-a9ad-deb08af3c098"],"spl_set_id":["a80fe56f-8d03-423f-8e2a-7ec8c9e5045b"],"package_ndc":["0591-5543-01","0591-5543-10","0591-5544-01","0591-5544-05"],"nui":["N0000175698","N0000000206"],"pharm_class_epc":["Xanthine Oxidase Inhibitor [EPC]"],"pharm_class_moa":["Xanthine Oxidase Inhibitors [MoA]"],"unii":["63CZ7GJN5I"]},"update_date":"02/19/2026","therapeutic_category":["Oncology","Renal","Rheumatology"],"dosage_form":"Tablet","presentation":"Allopurinol, Tablet, 100 mg (NDC 0591-5543-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"discontinued_date":"12/08/2025","update_type":"New","initial_posting_date":"12/08/2025","package_ndc":"0781-9413-92","generic_name":"Ampicillin Sodium Injection","contact_info":"800-525-8747","related_info":"Discontinuation of private label only","openfda":{"application_number":["ANDA062738"],"brand_name":["AMPICILLIN"],"generic_name":["AMPICILLIN SODIUM"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-9413","0781-9412"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["AMPICILLIN SODIUM"],"rxcui":["1721475","1721476"],"spl_id":["f1afd007-8e8c-40e2-b353-8def35a0ce8b"],"spl_set_id":["f77db491-31c4-4a7c-a114-0f3244c97090"],"package_ndc":["0781-9412-15","0781-9412-92","0781-9413-15","0781-9413-92"],"unii":["JFN36L5S8K"]},"update_date":"12/08/2025","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Ampicillin Sodium, Injection, 2 g (NDC 0781-9413-92)","company_name":"Sandoz Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"02/22/2012","package_ndc":"63323-201-10","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Next release November 2026. Check wholesalers for inventory.","openfda":{"application_number":["ANDA088586"],"brand_name":["LIDOCAINE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-201","63323-202"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1737757"],"spl_id":["d19c26f4-1214-40f7-9680-43c885613306"],"spl_set_id":["cddb2b22-fce3-8967-6e54-dca3df5ac4b3"],"package_ndc":["63323-201-01","63323-201-02","63323-201-03","63323-201-10","63323-202-01","63323-202-02"],"unii":["V13007Z41A"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 63323-201-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-466-31","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA070553","NDA018304"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-466","63323-464","63323-462","63323-465","63323-467","63323-460"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL","PERINEURAL","INFILTRATION"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724880","1724881","1725078","1725175","1724884","1724885","1725082","1725177","1672917","1672919","1673296","1673298","1012391","1012396","1012404","1012421","1012455","1012457"],"spl_id":["b41b5dbd-7aff-4d97-ac97-f4355393ee4e","d3ba9fb9-63c8-4597-bb0a-cd01d31a24b6","13a48007-3784-46f2-bd4d-da1004186b81","2b1a1f80-cb29-4ac1-9e72-20225ed45715"],"spl_set_id":["e700eb7b-8b14-49c9-96b2-331f18776e45","b6bfc04a-1868-4630-9ca1-8c027af97ce3","dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175","eb6d8fee-def4-4c96-9972-695e8cea8ea8"],"package_ndc":["63323-464-01","63323-464-17","63323-466-03","63323-466-17","63323-464-08","63323-464-38","63323-466-08","63323-466-38","63323-462-03","63323-462-38","63323-464-09","63323-464-39","63323-466-09","63323-466-39","63323-465-01","63323-465-57","63323-467-01","63323-467-57","63323-460-01","63323-460-37","63323-464-02","63323-464-37","63323-464-03","63323-464-31","63323-466-01","63323-466-37","63323-466-02","63323-466-31","63323-462-04","63323-462-17","63323-462-01","63323-462-37","63323-462-02","63323-462-31"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Delay in shipping of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0338-1075-02","generic_name":"Dobutamine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA020255"],"brand_name":["DOBUTAMINE HYDROCHLORIDE IN DEXTROSE"],"generic_name":["DOBUTAMINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1075","0338-1073","0338-1077"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOBUTAMINE HYDROCHLORIDE"],"rxcui":["309985","309986","309987"],"spl_id":["34c787c1-46f7-4264-951d-c88a34dca533"],"spl_set_id":["6b17b98b-e06d-42ed-925f-69aa2699dead"],"package_ndc":["0338-1073-02","0338-1075-02","0338-1077-02"],"unii":["0WR771DJXV"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular","Pediatric","Renal"],"dosage_form":"Injection","presentation":"Dobutamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 200 mg/100 mL (NDC 0338-1075-02)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"63323-468-37","generic_name":"Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesaler for inventory","openfda":{"application_number":["ANDA070966"],"brand_name":["SENSORCAINE MPF"],"generic_name":["BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-468","63323-472","63323-463","63323-461"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","INTRACAUDAL","PERINEURAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE","EPINEPHRINE BITARTRATE"],"rxcui":["1867594","1867596","1867618","1867620","1012377","1012384","1012413","1012417","1724786","1724787","1724809","1724810"],"spl_id":["b671015d-f620-4930-a890-5e27a40ae42f","cc1f6507-eb3e-4398-a1d3-0c56a2099e6b"],"spl_set_id":["b671015d-f620-4930-a890-5e27a40ae42f","bc61a9a6-0a4e-48a9-b908-e5e66b9f23eb"],"package_ndc":["63323-468-08","63323-468-38","63323-472-03","63323-472-17","63323-472-01","63323-472-37","63323-463-01","63323-463-57","63323-461-01","63323-461-57","63323-468-02","63323-468-37","63323-468-01","63323-468-17"],"unii":["7TQO7W3VT8","30Q7KI53AK"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Sensorcaine, Injection, 2.5 mg/1 mL; .005 mg/1 mL (NDC 63323-468-37)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"update_type":"Revised","initial_posting_date":"12/18/2020","package_ndc":"72485-201-01","generic_name":"Azacitidine Injection","contact_info":"732-637-1971","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA207518"],"brand_name":["AZACITIDINE"],"generic_name":["AZACITIDINE"],"manufacturer_name":["Armas Pharmaceuticals Inc."],"product_ndc":["72485-201"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["AZACITIDINE"],"rxcui":["485246"],"spl_id":["ca345575-17a6-43a3-aa02-3d4bb9d136c5"],"spl_set_id":["5c0a2d5f-8c34-4c04-8425-7543965cedd4"],"package_ndc":["72485-201-01"],"nui":["N0000000233","N0000175595"],"pharm_class_moa":["Nucleic Acid Synthesis Inhibitors [MoA]"],"pharm_class_epc":["Nucleoside Metabolic Inhibitor [EPC]"],"unii":["M801H13NRU"]},"update_date":"06/08/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Azacitidine, Injection, 100 mg (NDC 72485-201-01)","company_name":"Armas Pharmaceuticals Inc","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/26/2023","package_ndc":"13811-707-10","generic_name":"Methylphenidate Hydrochloride Tablet, Extended Release","contact_info":"800-541-4802","availability":"Limited Availability","related_info":"Allocation to current contracted customers","openfda":{"application_number":["ANDA205327"],"brand_name":["METHYLPHENIDATE HYDROCHLORIDE"],"generic_name":["METHYLPHENIDATE HYDROCHLORIDE"],"manufacturer_name":["Trigen Laboratories, LLC"],"product_ndc":["13811-707","13811-709","13811-706","13811-708","13811-710"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["METHYLPHENIDATE HYDROCHLORIDE"],"rxcui":["1091155","1091170","1091185","1091210","1995461"],"spl_id":["0944cf70-d59a-483b-9698-e96ef955a65a"],"spl_set_id":["c45dc1de-adfa-4b3c-a7dc-cffbc8eac74f"],"package_ndc":["13811-709-10","13811-706-10","13811-707-10","13811-708-10","13811-710-10","13811-710-30"],"unii":["4B3SC438HI"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Methylphenidate Hydrochloride, Tablet, Extended Release, 27 mg (NDC 13811-707-10)","company_name":"Trigen Laboratories, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/22/2012","package_ndc":"0409-4277-01","generic_name":"Lidocaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA088327"],"brand_name":["LIDOCAINE HYDROCHLORIDE"],"generic_name":["LIDOCAINE HYDROCHLORIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-4277","0409-4713","0409-4278","0409-4279","0409-4776","0409-4282","0409-4276","0409-4275","0409-0200","0409-0002"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INFILTRATION","PERINEURAL"],"substance_name":["LIDOCAINE HYDROCHLORIDE"],"rxcui":["1010033","1010671","1010900","1737343","1737562","1737566","1737568","1737636","1737757","1737763"],"spl_id":["b9e7ccb4-f683-4267-aa5e-497a7250f39b"],"spl_set_id":["3b2dd84e-cee8-4e58-d494-395a65a353a0"],"package_ndc":["0409-4713-12","0409-4713-26","0409-4713-02","0409-4713-72","0409-4713-62","0409-4713-75","0409-4713-65","0409-4713-42","0409-4713-25","0409-4713-32","0409-4713-04","0409-4713-10","0409-4713-30","0409-4278-16","0409-4278-01","0409-4279-16","0409-4279-02","0409-4776-10","0409-4776-01","0409-4282-11","0409-4282-25","0409-4282-01","0409-4282-12","0409-4282-02","0409-4282-04","0409-4282-14","0409-4282-24","0409-4277-16","0409-4277-01","0409-4277-17","0409-4277-02","0409-4276-16","0409-4276-01","0409-4276-17","0409-4276-02","0409-4275-16","0409-4275-01","0409-0200-05","0409-0200-30","0409-0200-80","0409-0002-01","0409-0002-05","0409-0002-10"],"unii":["V13007Z41A"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia","Pediatric"],"dosage_form":"Injection","presentation":"Lidocaine Hydrochloride In Plastic Container, Injection, 400 mg/20 mL (2%; 20 mg/mL) (NDC 0409-4277-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"discontinued_date":"12/19/2025","update_type":"New","initial_posting_date":"12/19/2025","package_ndc":"54092-173-12","generic_name":"Carbamazepine Capsule, Extended Release","contact_info":"855-268-1825","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA020712"],"brand_name":["CARBATROL"],"generic_name":["CARBAMAZEPINE"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["54092-173","54092-171","54092-172"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CARBAMAZEPINE"],"rxcui":["200131","200133","308977","313931","388311","404742"],"spl_id":["4186c118-9875-4b12-b652-3fbfaf4e6622"],"spl_set_id":["bc03e499-5bac-4293-bff4-6864153a624d"],"package_ndc":["54092-171-12","54092-172-12","54092-173-12"],"nui":["N0000008486","N0000175751","N0000185506","N0000191266","N0000187064","N0000185507","N0000185607"],"pharm_class_pe":["Decreased Central Nervous System Disorganized Electrical Activity [PE]"],"pharm_class_epc":["Mood Stabilizer [EPC]"],"pharm_class_moa":["Cytochrome P450 3A4 Inducers [MoA]","Cytochrome P450 1A2 Inducers [MoA]","Cytochrome P450 2B6 Inducers [MoA]","Cytochrome P450 2C9 Inducers [MoA]","Cytochrome P450 2C19 Inducers [MoA]"],"unii":["33CM23913M"]},"update_date":"12/19/2025","therapeutic_category":["Neurology"],"dosage_form":"Capsule, Extended Release","presentation":"Carbatrol, Capsule, Extended Release, 300 mg (NDC 54092-173-12)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"11/06/2017","package_ndc":"0338-1007-02","generic_name":"Dopamine Hydrochloride Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA019615"],"brand_name":["DOPAMINE HYDROCHLORIDE AND DEXTROSE"],"generic_name":["DOPAMINE HYDROCHLORIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-1007","0338-1005","0338-1009"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DOPAMINE HYDROCHLORIDE"],"rxcui":["1292887","1743869","1743871","1743877","1743879"],"spl_id":["edc9a091-4cb5-4ec7-b6f9-44d2d588bab9"],"spl_set_id":["cb97d4a0-89ed-407c-a763-209386b6f75c"],"package_ndc":["0338-1005-02","0338-1005-03","0338-1007-02","0338-1007-03","0338-1009-02"],"unii":["7L3E358N9L"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 160 mg/100 mL (NDC 0338-1007-02)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"55150-386-01","generic_name":"Carboplatin Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA205487"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-386","55150-333","55150-334","55150-335"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["6029d051-ee8d-44cc-8dae-b91c3385d4c3","5abfcb87-bb02-4384-9c9d-7d0e3e809311"],"spl_set_id":["f5fe9a20-47a5-45b9-ab06-c6158d9b6aca","5abfcb87-bb02-4384-9c9d-7d0e3e809311"],"package_ndc":["55150-333-01","55150-334-01","55150-335-01","55150-386-01","55150-335-00","55150-386-00"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"10/19/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 600 mg/60 mL (NDC 55150-386-01)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"55150-225-05","generic_name":"Rocuronium Bromide Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA206206"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-225","55150-226"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["1bb59a7e-d219-466c-abae-8a0680af9b8c"],"spl_set_id":["116385ea-69fc-4f44-b463-6210291032df"],"package_ndc":["55150-225-05","55150-226-10"],"unii":["I65MW4OFHZ"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 50 mg/5 mL (NDC 55150-225-05)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/02/2020","package_ndc":"0641-6059-01","generic_name":"Midazolam Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured. Product will be made available as it is released.","openfda":{"application_number":["ANDA075243"],"brand_name":["MIDAZOLAM"],"generic_name":["MIDAZOLAM"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6059","0641-6057","0641-6056","0641-6061","0641-6063","0641-6060"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["MIDAZOLAM HYDROCHLORIDE"],"rxcui":["311700","311702"],"spl_id":["559c03fb-24ea-4b7b-8afd-e33cb3a2340a"],"spl_set_id":["575d8bf0-7af7-427c-a231-966e2a5e070d"],"package_ndc":["0641-6057-01","0641-6057-10","0641-6057-25","0641-6059-01","0641-6059-10","0641-6056-01","0641-6056-10","0641-6061-01","0641-6061-10","0641-6061-25","0641-6063-01","0641-6063-10","0641-6063-25","0641-6060-01","0641-6060-10"],"unii":["W7TTW573JJ"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia","Neurology"],"dosage_form":"Injection","presentation":"Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"13107-070-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(866) 850-2876 or CustomerService@AurobindoUSA.com","availability":"Unavailable","related_info":"Estimated availability: April 2027","openfda":{"application_number":["ANDA202424"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Aurolife Pharma, LLC"],"product_ndc":["13107-070","13107-068","13107-069","13107-071","13107-072","13107-073","13107-074"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961","687043","1009145"],"spl_id":["44a9eb77-0896-4b62-9953-7121d97d6ffd"],"spl_set_id":["a582d57f-d191-4ca5-b105-585b2d8a0e3e"],"package_ndc":["13107-068-50","13107-068-01","13107-068-25","13107-068-05","13107-068-99","13107-069-50","13107-069-01","13107-069-25","13107-069-05","13107-069-99","13107-070-50","13107-070-01","13107-070-25","13107-070-05","13107-070-99","13107-071-50","13107-071-01","13107-071-25","13107-071-05","13107-071-99","13107-072-50","13107-072-01","13107-072-25","13107-072-05","13107-072-99","13107-073-50","13107-073-01","13107-073-25","13107-073-05","13107-073-99","13107-074-50","13107-074-01","13107-074-25","13107-074-05","13107-074-99"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/04/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 13107-070-01)","company_name":"Aurobindo Pharma USA","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"Revised","initial_posting_date":"02/20/2018","package_ndc":"71288-728-32","generic_name":"Bupivacaine Hydrochloride Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Bupivacaine%20Hydrochloride%20Injection&st=d","contact_info":"844-824-8426","availability":"Limited Availability","related_info":"Meitheal Pharmaceuticals is distributor/labeler","update_date":"05/05/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 71288-728-32)","company_name":"Kindos Pharmaceuticals Co. Ltd.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"discontinued_date":"07/30/2026","update_type":"New","initial_posting_date":"07/30/2026","package_ndc":"0591-4575-60","generic_name":"Doxycycline Hyclate Tablet, Delayed Release","contact_info":"800-545-8800","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA090134"],"brand_name":["DOXYCYCLINE HYCLATE"],"generic_name":["DOXYCYCLINE HYCLATE"],"manufacturer_name":["Actavis Pharma, Inc."],"product_ndc":["0591-4575","0591-4550"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DOXYCYCLINE HYCLATE"],"rxcui":["1423080","1653433"],"spl_id":["304ae0bb-5f05-4389-8952-5a99391b8047"],"spl_set_id":["c2b08332-3256-4658-965a-ede3d973a388"],"package_ndc":["0591-4550-22","0591-4575-60"],"unii":["19XTS3T51U"]},"update_date":"07/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Tablet","presentation":"Doxycycline Hyclate, Tablet, Delayed Release, 200 mg (NDC 0591-4575-60)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0264-4500-00","generic_name":"Amino Acid Injection","contact_info":"800-227-2862","availability":"Available","openfda":{"application_number":["ANDA091112"],"brand_name":["PLENAMINE"],"generic_name":["LYSINE ACETATE, LEUCINE, PHENYLALANINE, VALINE, ISOLEUCINE, METHIONINE, THREONINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, HISTIDINE, PROLINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID, AND TYROSINE"],"manufacturer_name":["B. Braun Medical Inc."],"product_ndc":["0264-4500"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["LYSINE ACETATE","LEUCINE","PHENYLALANINE","VALINE","ISOLEUCINE","METHIONINE","THREONINE","TRYPTOPHAN","ALANINE","ARGININE","GLYCINE","HISTIDINE","PROLINE","GLUTAMIC ACID","SERINE","ASPARTIC ACID","TYROSINE"],"rxcui":["800584","1601982"],"spl_id":["905f7c55-bf0d-4150-90ef-e8f1a5455bc1"],"spl_set_id":["a3244d1a-45b0-4e4c-bd96-f0632d761a1f"],"package_ndc":["0264-4500-00","0264-4500-05"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["TTL6G7LIWZ","GMW67QNF9C","47E5O17Y3R","HG18B9YRS7","04Y7590D77","AE28F7PNPL","2ZD004190S","8DUH1N11BX","OF5P57N2ZX","94ZLA3W45F","TE7660XO1C","4QD397987E","9DLQ4CIU6V","3KX376GY7L","452VLY9402","30KYC7MIAI","42HK56048U"]},"update_date":"11/10/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Plenamine, Injection, 0.15 (NDC 0264-4500-00)","company_name":"B. Braun Medical Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/15/2023","package_ndc":"0781-3220-92","generic_name":"Rocuronium Bromide Injection","contact_info":"800-525-8747","availability":"Available","openfda":{"application_number":["ANDA079195"],"brand_name":["ROCURONIUM BROMIDE"],"generic_name":["ROCURONIUM BROMIDE"],"manufacturer_name":["Sandoz Inc"],"product_ndc":["0781-3220"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ROCURONIUM BROMIDE"],"rxcui":["1234995"],"spl_id":["eaf32464-7950-434a-e053-2a95a90aa2dc"],"spl_set_id":["cb28d869-6510-4402-9462-f6bb25fa0fa8"],"package_ndc":["0781-3220-70","0781-3220-92","0781-3220-75","0781-3220-95"],"unii":["I65MW4OFHZ"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 0781-3220-92)","company_name":"Sandoz Inc.","status":"Current"},{"discontinued_date":"10/20/2026","update_type":"New","initial_posting_date":"10/20/2026","package_ndc":"0006-5055-09","generic_name":"Molnupiravir Capsule","contact_info":"800-672-6372","related_info":"Discontinuation of the manufacture of the drug","update_date":"10/20/2026","therapeutic_category":["Antiviral"],"dosage_form":"Capsule","presentation":"Lagevrio, Capsule, 200 mg (NDC 0006-5055-09)","company_name":"Merck Sharp & Dohme LLC","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"07/14/2023","package_ndc":"0527-4663-37","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"844-834-0530","availability":"Available","openfda":{"application_number":["ANDA215802"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE"],"manufacturer_name":["Lannett Company, LLC"],"product_ndc":["0527-4663","0527-4661","0527-4662","0527-4664","0527-4665","0527-4666","0527-4667"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["164b5658-3c14-44f5-b10a-839909184984"],"spl_set_id":["2cedb4c2-1e40-4bc4-b9f4-127150c4afbd"],"package_ndc":["0527-4661-37","0527-4662-37","0527-4663-37","0527-4664-37","0527-4665-37","0527-4666-37","0527-4667-37"],"unii":["SJT761GEGS"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 30 mg (NDC 0527-4663-37)","company_name":"Lannett Company, Inc.","status":"Current"},{"update_type":"Revised","initial_posting_date":"04/28/2023","package_ndc":"16729-295-12","generic_name":"Carboplatin Injection","contact_info":"866-941-7875, option 2","availability":"Unavailable","related_info":"Discontinuation of the manufacture of the drug and SKU is non-Exempt by FDA","openfda":{"application_number":["ANDA206775"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Accord Healthcare, Inc."],"product_ndc":["16729-295"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"spl_id":["5f9d65c8-75c4-6fb3-e063-6394a90a87cf"],"spl_set_id":["48aa7ef3-9f44-2a08-e054-00144ff88e88"],"package_ndc":["16729-295-31","16729-295-33","16729-295-34","16729-295-12","16729-295-38"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"11/02/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12)","company_name":"Accord Healthcare Inc.","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"55150-221-10","generic_name":"Etomidate Injection","contact_info":"888-238-7880","availability":"Unavailable","related_info":"On backorder. Recovery: TBD. Check wholesalers for inventory","openfda":{"application_number":["ANDA206126"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-221","55150-222"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["278b160e-cdc4-451e-9405-cb001f443680"],"spl_set_id":["0820f15a-046b-4185-a2b3-2e4051ee3d82"],"package_ndc":["55150-221-10","55150-222-20"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 20 mg/10 mL (NDC 55150-221-10)","company_name":"Eugia US LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"discontinued_date":"10/30/2026","update_type":"New","initial_posting_date":"10/30/2026","package_ndc":"0338-3503-41","generic_name":"Cefazolin in Dextrose Injection","contact_info":"888-229-0001","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["NDA207131"],"brand_name":["CEFAZOLIN"],"generic_name":["CEFAZOLIN SODIUM"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-3503","0338-3508","0338-0096"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CEFAZOLIN SODIUM"],"rxcui":["1665050","1665060","2630753"],"spl_id":["092b9ea3-0c78-4236-80c9-ff97d09fa14e"],"spl_set_id":["d91a8d13-99a0-4d87-88dc-71cbd37922b4"],"package_ndc":["0338-3508-41","0338-3503-41","0338-0096-06"],"unii":["P380M0454Z"]},"update_date":"10/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cefazolin in Dextrose, Injection, 1g/50 mL (NDC 0338-3503-41)","company_name":"Baxter Healthcare","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-286-35","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-286","63323-285","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION","PERINEURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cb6583ff-cde4-4280-aa5b-0bea2b844792","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","cb6583ff-cde4-4280-aa5b-0bea2b844792","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-51","63323-286-55","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 5 mg/1 mL (NDC 63323-286-35)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"03/25/2026","update_type":"New","initial_posting_date":"03/25/2026","package_ndc":"13668-354-90","generic_name":"Nebivolol Hydrochloride Tablet","contact_info":"908-280-3333","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/25/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Tablet","presentation":"Nebivolol Hydrochloride, Tablet, 5 mg (NDC 13668-354-90)","company_name":"Torrent Pharmaceuticals Limited","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"07/14/2023","package_ndc":"43547-605-10","generic_name":"Lisdexamfetamine Dimesylate Capsule","contact_info":"866-931-9829","availability":"Limited Availability","related_info":"On allocation","openfda":{"application_number":["ANDA216266"],"brand_name":["LISDEXAMFETAMINE DIMESYLATE"],"generic_name":["LISDEXAMFETAMINE DIMESYLATE CAPSULES"],"manufacturer_name":["Solco Healthcare US,LLC"],"product_ndc":["43547-605","43547-602","43547-603","43547-604","43547-606","43547-607","43547-608"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["LISDEXAMFETAMINE DIMESYLATE"],"rxcui":["854830","854834","854838","854842","854846","854850","1593856"],"spl_id":["d6435613-e052-4b4f-8bf7-4acb7458d8df"],"spl_set_id":["68b10d9f-ca3e-493d-a309-45f1d7e08061"],"package_ndc":["43547-602-10","43547-603-10","43547-604-10","43547-605-10","43547-606-10","43547-607-10","43547-608-10"],"unii":["SJT761GEGS"]},"update_date":"06/29/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Capsule","presentation":"Lisdexamfetamine Dimesylate, Capsule, 40 mg (NDC 43547-605-10)","company_name":"Solco Healthcare US, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"discontinued_date":"12/04/2025","update_type":"New","initial_posting_date":"12/04/2025","package_ndc":"0093-7352-01","generic_name":"Calcitriol Capsule","contact_info":"800-545-8800","related_info":"A business decision was made to discontinue manufacture of the drug","openfda":{"application_number":["ANDA075765"],"brand_name":["CALCITRIOL"],"generic_name":["CALCITRIOL"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["0093-7352","0093-7353"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CALCITRIOL"],"rxcui":["308867","308868"],"spl_id":["9e6df585-e3d1-4a89-bc02-8e4b223578c4"],"spl_set_id":["ec93b667-aad2-4e3a-adc6-952f070a0c0a"],"package_ndc":["0093-7352-01","0093-7353-01"],"nui":["M0004229","N0000175908"],"pharm_class_cs":["Cholecalciferol [CS]"],"pharm_class_epc":["Vitamin D3 Analog [EPC]"],"unii":["FXC9231JVH"]},"update_date":"12/04/2025","therapeutic_category":["Endocrinology/Metabolism"],"dosage_form":"Capsule","presentation":"Calcitriol, Capsule, .25 ug (NDC 0093-7352-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"10/05/2022","package_ndc":"72572-160-10","generic_name":"Etomidate Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Distributed by Civica","openfda":{"application_number":["ANDA202354"],"brand_name":["ETOMIDATE"],"generic_name":["ETOMIDATE"],"manufacturer_name":["Civica, Inc."],"product_ndc":["72572-160","72572-161"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ETOMIDATE"],"rxcui":["1654006","1654008"],"spl_id":["380f0c88-03f8-4cfa-8823-4766c2f7700c"],"spl_set_id":["98002094-f065-4b5f-963f-2c34b5241316"],"package_ndc":["72572-160-01","72572-160-10","72572-161-01","72572-161-10"],"nui":["N0000175975","N0000175681"],"pharm_class_pe":["General Anesthesia [PE]"],"pharm_class_epc":["General Anesthetic [EPC]"],"unii":["Z22628B598"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Etomidate, Injection, 2 mg/1 mL (NDC 72572-160-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"10/30/2026","update_type":"New","initial_posting_date":"10/30/2026","package_ndc":"0338-5002-41","generic_name":"Ceftriaxone Sodium Injection","contact_info":"888-229-0001","related_info":"Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA065224"],"brand_name":["CEFTRIAXONE"],"generic_name":["CEFTRIAXONE SODIUM"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-5002","0338-5003"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CEFTRIAXONE SODIUM"],"rxcui":["1665021","1665046"],"spl_id":["e6debc12-1f25-437c-970e-607f4953c7f7"],"spl_set_id":["4c5c2d3f-5038-41a1-a2fe-4dcd048dbac1"],"package_ndc":["0338-5002-41","0338-5003-41"],"unii":["023Z5BR09K"]},"update_date":"10/30/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Ceftriaxone Sodium in Plastic Container, Injection, 1g/50mL (NDC 0338-5002-41)","company_name":"Baxter Healthcare","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"70069-067-25","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"732-554-1037","availability":"Available","openfda":{"application_number":["ANDA207636"],"brand_name":["ROPIVACAINE HYDROCHLORIDE"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Somerset Therapeutics, LLC"],"product_ndc":["70069-067","70069-061","70069-062","70069-063","70069-064","70069-065","70069-066"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["905189","1734084","1734090","1734203","1734207","1734475","1734483"],"spl_id":["79b226f0-c08a-4f84-bf2b-ae5c60e01d67"],"spl_set_id":["ffeadbbf-4ca6-4ed8-94c1-6e0adf7fbe64"],"package_ndc":["70069-061-01","70069-061-25","70069-061-10","70069-062-01","70069-062-25","70069-062-10","70069-063-01","70069-063-25","70069-064-01","70069-064-10","70069-064-25","70069-065-01","70069-065-25","70069-066-01","70069-066-25","70069-066-10","70069-067-01","70069-067-25","70069-067-10"],"unii":["V910P86109"]},"update_date":"10/27/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Ropivacaine Hydrochloride, Injection, 10 mg/1 mL (NDC 70069-067-25)","company_name":"Somerset Therapeutics, LLC","status":"Current"},{"discontinued_date":"03/23/2026","update_type":"New","initial_posting_date":"03/23/2026","package_ndc":"39822-3050-2","generic_name":"Pentamidine Isethionate Injection","contact_info":"866-390-4411","related_info":"A business decision was made to discontinue manufacture of the drug.","update_date":"03/23/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Pentamidine Isethionate, Injection, 300 mg/3 mL (NDC 39822-3050-2)","company_name":"XGen Pharmaceuticals DJB, Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"05/30/2025","package_ndc":"0641-6054-25","generic_name":"Meperidine Hydrochloride Injection","contact_info":"800-631-2174","availability":"Available","related_info":"Additional lots are scheduled to be manufactured.  Product will be made available as it is released.","openfda":{"application_number":["ANDA080445"],"brand_name":["MEPERIDINE HYDROCHLORIDE"],"generic_name":["MEPERIDINE HYDROCHLORIDE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6054","0641-6053","0641-6052"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["MEPERIDINE HYDROCHLORIDE"],"rxcui":["861476","1665685","1665697"],"spl_id":["9566d54d-7343-4695-94ff-8b5f2d384c81"],"spl_set_id":["e0e998da-f056-4fce-be8e-ed60cf3b461b"],"package_ndc":["0641-6053-01","0641-6053-25","0641-6054-01","0641-6054-25","0641-6052-01","0641-6052-25"],"unii":["N8E7F7Q170"]},"update_date":"10/14/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Meperidine Hydrochloride, Injection, 100 mg/1 mL (NDC 0641-6054-25)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"},{"discontinued_date":"06/01/2026","update_type":"New","initial_posting_date":"06/01/2026","package_ndc":"60505-6282-1","generic_name":"Carboplatin Injection","contact_info":"Apotex Inc.: 800-706-5575","related_info":"Wholesaler & Distributor through Marketing partner (Apotex Inc.); Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA077861"],"brand_name":["CARBOPLATIN"],"generic_name":["CARBOPLATIN"],"manufacturer_name":["Apotex Corp."],"product_ndc":["60505-6282"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CARBOPLATIN"],"rxcui":["597195"],"spl_id":["0e68e276-b0df-4f03-e063-6394a90a22b9"],"spl_set_id":["1c275825-0275-4c73-b650-e4c1519f13b8"],"package_ndc":["60505-6282-1","60505-6282-3","60505-6282-6","60505-6282-7"],"nui":["N0000175413","N0000175073"],"pharm_class_epc":["Platinum-based Drug [EPC]"],"unii":["BG3F62OND5"]},"update_date":"06/01/2026","therapeutic_category":["Oncology"],"dosage_form":"Injection","presentation":"Carboplatin, Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial (NDC 60505-6282-1)","company_name":"Teyro Labs","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"01/01/2012","package_ndc":"0409-9094-31","generic_name":"Fentanyl Citrate Injection","contact_info":"844-646-4398","availability":"Limited Availability","related_info":"Limited Supply Available. Next Delivery: November 2026; Estimated Recovery: December 2026","openfda":{"application_number":["NDA019115"],"brand_name":["FENTANYL CITRATE"],"generic_name":["FENTANYL CITRATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-9094","0409-9093"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FENTANYL CITRATE"],"rxcui":["1735003","1735004","1735006","1735007","1735008","1735013"],"spl_id":["8ff8b8cf-1a31-46dc-b350-2b9cc700e6a6"],"spl_set_id":["bfa8018a-4cbc-434b-e09e-782872b0340a"],"package_ndc":["0409-9093-41","0409-9093-36","0409-9093-31","0409-9093-38","0409-9094-12","0409-9094-22","0409-9094-18","0409-9094-25","0409-9094-17","0409-9094-28","0409-9094-16","0409-9094-31","0409-9094-41","0409-9094-61","0409-9094-44","0409-9094-55"],"unii":["MUN5LYG46H"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction","Pediatric"],"dosage_form":"Injection","presentation":"Fentanyl Citrate, Injection, 1000 mcg/20 mL (50 ug/1 mL) (NDC 0409-9094-31)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/10/2023","change_date":"11/04/2026","package_ndc":"16729-136-00","generic_name":"Clonazepam Tablet","contact_info":"866-941-7875, option 2","resolved_note":"Available","openfda":{"application_number":["ANDA077147"],"brand_name":["CLONAZEPAM"],"generic_name":["CLONAZEPAM"],"manufacturer_name":["Accord Healthcare Inc."],"product_ndc":["16729-136","16729-137","16729-138"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CLONAZEPAM"],"rxcui":["197527","197528","197529"],"spl_id":["0e1e7f41-f78b-27cf-e063-6394a90a1ae0"],"spl_set_id":["ebc11109-e7bf-452d-b675-4b3236d54164"],"package_ndc":["16729-136-00","16729-136-16","16729-137-00","16729-137-16","16729-138-00","16729-138-16"],"nui":["N0000175694","M0002356"],"pharm_class_epc":["Benzodiazepine [EPC]"],"pharm_class_cs":["Benzodiazepines [CS]"],"unii":["5PE9FDE8GB"]},"update_date":"11/04/2026","therapeutic_category":["Neurology","Pediatric","Psychiatry"],"dosage_form":"Tablet","presentation":"Clonazepam, Tablet, .5 mg (NDC 16729-136-00)","company_name":"Accord Healthcare Inc.","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"03/23/2016","package_ndc":"71357-007-10","generic_name":"Sodium Acetate Injection","contact_info":"833-251-8463","availability":"Available","openfda":{"application_number":["ANDA214805"],"brand_name":["SODIUM ACETATE"],"generic_name":["SODIUM ACETATE"],"manufacturer_name":["MILLA PHARMACEUTICALS INC."],"product_ndc":["71357-007","71357-008","71357-009"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM ACETATE"],"rxcui":["237371","312965"],"spl_id":["47d8d0e7-6db5-950d-e063-6294a90ab1bf"],"spl_set_id":["1ea1466d-a492-4056-e063-6394a90a80bf"],"package_ndc":["71357-007-01","71357-007-10","71357-008-01","71357-008-10","71357-009-01","71357-009-10"],"unii":["4550K0SC9B"]},"update_date":"10/15/2026","therapeutic_category":["Total Parenteral Nutrition"],"dosage_form":"Injection","presentation":"Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)","company_name":"Milla Pharmaceuticals","status":"Current"},{"discontinued_date":"03/24/2026","update_type":"New","initial_posting_date":"03/24/2026","package_ndc":"0074-7098-05","generic_name":"Pilocarpine Hydrochloride Ophthalmic Solution","contact_info":"800-633-9110","related_info":"Discontinuation of the manufacture of the drug","update_date":"03/24/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Ophthalmic Solution","presentation":"Vuity, Ophthalmic Solution, 12.5 mg/1 mL (NDC 0074-7098-05)","company_name":"AbbVie Inc.","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"03/13/2023","package_ndc":"0703-3678-01","generic_name":"Methotrexate Sodium Injection","contact_info":"800-545-8800","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040843"],"brand_name":["METHOTREXATE"],"generic_name":["METHOTREXATE"],"manufacturer_name":["Teva Parenteral Medicines, Inc."],"product_ndc":["0703-3678","0703-3671","0703-3675"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRA-ARTERIAL","INTRAMUSCULAR","INTRATHECAL","INTRAVENOUS"],"substance_name":["METHOTREXATE SODIUM"],"rxcui":["1655956","1655959","1655960"],"spl_id":["e81074cc-12b4-4ac9-a5bb-749188989b2c"],"spl_set_id":["346ec9ce-dc98-4a55-b55e-d3af11f2d703"],"package_ndc":["0703-3671-01","0703-3675-01","0703-3678-01"],"unii":["3IG1E710ZN"]},"update_date":"11/02/2026","therapeutic_category":["Rheumatology","Oncology"],"dosage_form":"Injection","presentation":"Methotrexate Sodium Preservative Free, Injection, 25 mg/1 mL (NDC 0703-3678-01)","company_name":"Teva Pharmaceuticals USA, Inc.","shortage_reason":"Other","status":"Current"},{"discontinued_date":"09/11/2026","update_type":"New","initial_posting_date":"09/11/2026","package_ndc":"0409-1098-02","generic_name":"Cisatracurium Besylate Injection","contact_info":"844-646-4398","related_info":"Supply expected to exhaust November  2026; Discontinuation of the manufacture of the drug","openfda":{"application_number":["ANDA203236"],"brand_name":["CISATRACURIUM BESYLATE"],"generic_name":["CISATRACURIUM BESYLATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1098","0409-1103","0409-1208"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CISATRACURIUM BESYLATE"],"rxcui":["199211","199212","1730194"],"spl_id":["55a7aed0-96b5-426a-a234-0a4418ade4f2"],"spl_set_id":["67908e20-044d-454d-9c51-bf106e817bd0"],"package_ndc":["0409-1098-12","0409-1098-02","0409-1103-11","0409-1103-01","0409-1208-11","0409-1208-01"],"unii":["80YS8O1MBS"]},"update_date":"09/11/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Cisatracurium Besylate, Injection, 10 mg/5ml (2 mg/mL) Single Dose Vial (NDC 0409-1098-02)","company_name":"Hospira, Inc., a Pfizer Company","status":"To Be Discontinued"},{"update_type":"Revised","initial_posting_date":"04/07/2020","package_ndc":"0409-6102-27","generic_name":"Furosemide Injection","contact_info":"844-646-4398","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA018667"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-6102"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["e598e8a6-c854-48f5-a412-fb6a6783774a","981d5143-60cd-4987-9b47-dec24c10de42"],"spl_set_id":["aaced7a8-c3d7-4d66-8c07-aa407b8b3f35","39fd32f2-6bb7-4a65-d298-e48d26bc80c7"],"package_ndc":["0409-6102-35","0409-6102-25","0409-6102-36","0409-6102-26","0409-6102-37","0409-6102-27","0409-6102-19","0409-6102-02","0409-6102-18","0409-6102-04","0409-6102-20","0409-6102-10"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/09/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 100 mg/ 10mL (10 mg/1 mL) (NDC 0409-6102-27)","company_name":"Hospira, Inc., a Pfizer Company","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/03/2023","package_ndc":"16571-600-96","generic_name":"Cromolyn Sodium Concentrate","contact_info":"(201) 961-9000 or contact@risingpharma.com","availability":"Available","openfda":{"application_number":["ANDA202583"],"brand_name":["CROMOLYN SODIUM"],"generic_name":["CROMOLYN SODIUM"],"manufacturer_name":["Rising Pharma Holdings, Inc."],"product_ndc":["16571-600"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["CROMOLYN SODIUM"],"rxcui":["831261"],"spl_id":["ca2c72ae-db00-4694-9fd0-d4b6b45f8108"],"spl_set_id":["61c9cb85-129e-4490-b5f7-357307fcecbf"],"package_ndc":["16571-600-96"],"unii":["Q2WXR1I0PK"]},"update_date":"09/01/2026","therapeutic_category":["Pulmonary/Allergy"],"dosage_form":"Concentrate","presentation":"Cromolyn Sodium, Concentrate, 100 mg/5 mL (NDC 16571-600-96)","company_name":"Rising Pharma Holdings, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"07/24/2017","package_ndc":"63323-089-50","generic_name":"Sodium Bicarbonate Injection","contact_info":"888-386-1300","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA206688"],"brand_name":["SODIUM BICARBONATE"],"generic_name":["SODIUM BICARBONATE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-089","63323-083"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["SODIUM BICARBONATE"],"rxcui":["1868469","1868486"],"spl_id":["9def795c-abcf-483c-8b1d-e4374666efb2"],"spl_set_id":["0ab55004-bb63-436d-ad77-cd3796905370"],"package_ndc":["63323-083-03","63323-083-05","63323-089-25","63323-089-50"],"unii":["8MDF5V39QO"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Pediatric"],"dosage_form":"Injection","presentation":"Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50)","company_name":"Fresenius Kabi USA, LLC","status":"Current"},{"discontinued_date":"03/19/2026","update_type":"New","initial_posting_date":"03/19/2026","package_ndc":"64764-805-10","generic_name":"Ramelteon Tablet","contact_info":"877-825-3327","related_info":"Product is expected to be available through February 2027.","openfda":{"application_number":["NDA021782"],"brand_name":["ROZEREM"],"generic_name":["RAMELTEON"],"manufacturer_name":["Takeda Pharmaceuticals America, Inc."],"product_ndc":["64764-805"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RAMELTEON"],"rxcui":["577348","603162"],"spl_id":["2021e7fb-108a-4783-9a37-8bc05bf28b28"],"spl_set_id":["9de82310-70e8-47b9-b1fc-6c6848b99455"],"package_ndc":["64764-805-30","64764-805-10","64764-805-22"],"nui":["N0000175743","N0000000250"],"pharm_class_epc":["Melatonin Receptor Agonist [EPC]"],"pharm_class_moa":["Melatonin Receptor Agonists [MoA]"],"unii":["901AS54I69"]},"update_date":"03/19/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Rozerem, Tablet, 8 mg (NDC 64764-805-10)","company_name":"Takeda Pharmaceuticals USA Inc.","status":"To Be Discontinued"},{"update_type":"Reverified","initial_posting_date":"06/16/2022","package_ndc":"42023-240-01","generic_name":"Methylprednisolone Acetate Injection","contact_info":"800-828-9393","availability":"Unavailable","related_info":"Estimated recovery: TBD","update_date":"11/02/2026","therapeutic_category":["Rheumatology"],"dosage_form":"Injection","presentation":"Methylprednisolone Acetate, Injection, 80 mg/1 mL (NDC 42023-240-01)","company_name":"Par Health, USA LLC","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/08/2020","package_ndc":"0990-7172-17","generic_name":"Amino Acid Injection","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Available","related_info":"This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","openfda":{"application_number":["NDA020015"],"brand_name":["AMINOSYN II"],"generic_name":["ISOLEUCINE, LEUCINE, LYSINE ACETATE, METHIONINE, PHENYLALANINE, THREONINE, TRYPTOPHAN, VALINE, ALANINE, ARGININE, ASPARTIC ACID, GLUTAMIC ACID, HISTIDINE, PROLINE, SERINE, N-ACETYLTYROSINE, AND GLYCINE"],"manufacturer_name":["ICU Medical Inc."],"product_ndc":["0990-7172","0990-7171"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["ISOLEUCINE","LEUCINE","LYSINE ACETATE","METHIONINE","PHENYLALANINE","THREONINE","TRYPTOPHAN","VALINE","ALANINE","ARGININE","ASPARTIC ACID","GLUTAMIC ACID","HISTIDINE","PROLINE","SERINE","ACETYL L-TYROSINE","GLYCINE"],"rxcui":["800188","800192","800237","800241"],"spl_id":["0c99ec81-2c27-4352-8dbe-d7ec9e0e80e4"],"spl_set_id":["5b426208-f090-4650-86c3-89040ba45c2d"],"package_ndc":["0990-7172-17","0990-7171-17"],"nui":["N0000175780","M0000922"],"pharm_class_epc":["Amino Acid [EPC]"],"pharm_class_cs":["Amino Acids [CS]"],"unii":["2ZD004190S","AE28F7PNPL","9DLQ4CIU6V","GMW67QNF9C","HG18B9YRS7","452VLY9402","TE7660XO1C","3KX376GY7L","30KYC7MIAI","4QD397987E","DA8G610ZO5","94ZLA3W45F","OF5P57N2ZX","8DUH1N11BX","TTL6G7LIWZ","47E5O17Y3R","04Y7590D77"]},"update_date":"11/03/2026","therapeutic_category":["Gastroenterology"],"dosage_form":"Injection","presentation":"Aminosyn II 10% In Plastic Container, Injection, 0.1 (NDC 0990-7172-17)","company_name":"Otsuka ICU Medical LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"57844-110-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"800-545-8800","availability":"Available","openfda":{"application_number":["ANDA040422"],"brand_name":["ADDERALL"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE"],"manufacturer_name":["Teva Pharmaceuticals USA, Inc."],"product_ndc":["57844-110","57844-105","57844-117","57844-112","57844-115","57844-120","57844-130"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541365","541878","541879","541892","541894","577957","577960","577961","577962","687043","687045","1009145","1009147"],"spl_id":["79af1dc6-c7cf-41b1-a750-e9b47c2187ff"],"spl_set_id":["f22635fe-821d-4cde-aa12-419f8b53db81"],"package_ndc":["57844-105-01","57844-117-01","57844-110-01","57844-112-01","57844-115-01","57844-120-01","57844-130-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/02/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01)","company_name":"Teva Pharmaceuticals USA, Inc.","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/12/2022","package_ndc":"42806-343-01","generic_name":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet","contact_info":"(718) 276-8600 ext. 3","availability":"Limited Availability","related_info":"Estimated recovery: TBD","openfda":{"application_number":["ANDA040444"],"brand_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"generic_name":["DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE"],"manufacturer_name":["Epic Pharma, LLC"],"product_ndc":["42806-343","42806-339","42806-341","42806-344","42806-345"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["DEXTROAMPHETAMINE SACCHARATE","AMPHETAMINE ASPARTATE MONOHYDRATE","DEXTROAMPHETAMINE SULFATE","AMPHETAMINE SULFATE"],"rxcui":["541363","541878","541892","577957","577961"],"spl_id":["f11301e2-3b5d-468d-b44c-45839e7e5dfb"],"spl_set_id":["1757e132-061d-4773-89ed-fdc77f69008f"],"package_ndc":["42806-339-01","42806-341-01","42806-343-01","42806-344-01","42806-345-01"],"unii":["6DPV8NK46S","O1ZPV620O4","G83415V073","JJ768O327N"]},"update_date":"11/03/2026","therapeutic_category":["Psychiatry"],"dosage_form":"Tablet","presentation":"Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate, Tablet, 3.75 mg; 3.75 mg; 3.75 mg; 3.75 mg (NDC 42806-343-01)","company_name":"Epic Pharma, LLC","shortage_reason":"Shortage of an active ingredient","status":"Current"},{"update_type":"New","initial_posting_date":"09/27/2021","change_date":"07/31/2026","package_ndc":"82667-800-01","generic_name":"Triamcinolone Acetonide Injection","contact_info":"(615) 733-4734","openfda":{"application_number":["NDA022048"],"brand_name":["TRIESENCE"],"generic_name":["TRIAMCINOLONE ACETONIDE"],"manufacturer_name":["Harrow Eye, LLC"],"product_ndc":["82667-800"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["OPHTHALMIC"],"substance_name":["TRIAMCINOLONE ACETONIDE"],"rxcui":["1086259","1792144"],"spl_id":["5386eec5-c123-04b8-e063-6294a90a2952"],"spl_set_id":["2267978c-72ad-9229-e063-6394a90a09d0"],"package_ndc":["82667-800-01"],"nui":["N0000175576","N0000175450"],"pharm_class_epc":["Corticosteroid [EPC]"],"pharm_class_moa":["Corticosteroid Hormone Receptor Agonists [MoA]"],"unii":["F446C597KA"]},"update_date":"07/31/2026","therapeutic_category":["Ophthalmology"],"dosage_form":"Injection","presentation":"Triesence, Injection, 40 mg/1 mL (NDC 82667-800-01)","company_name":"Harrow Eye, LLC","status":"Resolved"},{"update_type":"Reverified","initial_posting_date":"01/26/2024","package_ndc":"70726-0306-1","generic_name":"Riluzole Oral Suspension","related_info_link":"https://www.fda.gov/media/185612/download?attachment","contact_info":"610-937-6172","availability":"Available","openfda":{"brand_name":["TEGLUTIK"],"generic_name":["RILUZOLE"],"manufacturer_name":["EDW PHARMA"],"product_ndc":["70726-0306"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ORAL"],"substance_name":["RILUZOLE"],"rxcui":["2058147","2675565"],"spl_id":["4746bb53-bb35-7aa0-e063-6394a90a647b"],"spl_set_id":["1a3aeb59-d589-8d12-e063-6394a90a0a3a"],"package_ndc":["70726-0306-1"],"nui":["N0000175740","M0483511"],"pharm_class_epc":["Benzothiazole [EPC]"],"pharm_class_cs":["Benzothiazoles [CS]"],"unii":["7LJ087RS6F"]},"update_date":"10/15/2026","therapeutic_category":["Neurology"],"dosage_form":"Oral Suspension","presentation":"Teglutik, Oral Suspension, 5 mg/1 mL (NDC 70726-0306-1)","company_name":"EDW Pharma, Inc. (formerly Italfarmaco Pharma, Inc.)","status":"Current"},{"update_type":"Reverified","initial_posting_date":"01/13/2022","package_ndc":"25021-131-82","generic_name":"Metronidazole Injection","contact_info":"Sagent: 866-625-1618","availability":"Limited Availability","related_info":"Estimated recovery: November 2026; Marketed by Sagent Pharmaceuticals","openfda":{"application_number":["ANDA206191"],"brand_name":["METRONIDAZOLE"],"generic_name":["METRONIDAZOLE"],"manufacturer_name":["Sagent Pharmaceuticals"],"product_ndc":["25021-131"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["METRONIDAZOLE"],"rxcui":["311683"],"spl_id":["630e05cd-e000-4b75-8a65-fe2bbabee11d"],"spl_set_id":["d46870f5-e2b1-46bd-8413-4a0a8bcf3175"],"package_ndc":["25021-131-82"],"nui":["N0000175435","M0014907"],"pharm_class_epc":["Nitroimidazole Antimicrobial [EPC]"],"pharm_class_cs":["Nitroimidazoles [CS]"],"unii":["140QMO216E"]},"update_date":"11/02/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Metronidazole, Injection, 500 mg/100 mL (NDC 25021-131-82)","company_name":"InfoRLife SA","shortage_reason":"Other","status":"Current"},{"update_type":"Revised","initial_posting_date":"03/21/2023","package_ndc":"0009-0870-26","generic_name":"Clindamycin Phosphate Injection","related_info_link":"https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm?AI=Clindamycin%20Phosphate%20Injection&st=d","contact_info":"800-533-4535","availability":"Unavailable","related_info":"Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay","openfda":{"application_number":["NDA050441"],"brand_name":["CLEOCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Pharmacia & Upjohn Company LLC"],"product_ndc":["0009-0870","0009-0775","0009-0902","0009-0728","0009-3124","0009-3447","0009-3381","0009-3375","0009-3382","0009-6582"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAMUSCULAR","INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309339","685574","685576","685578","706461","1737244","1737245","1737578","1737579","1737581","1737582","205964","309335","309336"],"spl_id":["fa11e62e-4625-4e9c-8676-f318b1cb890f"],"spl_set_id":["05a75685-0af5-407c-ac57-e380c882b49d"],"package_ndc":["0009-0870-21","0009-0870-26","0009-0775-20","0009-0775-26","0009-0902-11","0009-0902-18","0009-0728-05","0009-0728-09","0009-3124-01","0009-3124-03","0009-3447-01","0009-3447-03","0009-3381-01","0009-3381-02","0009-3375-01","0009-3375-02","0009-3382-01","0009-3382-02","0009-6582-02","0009-6582-01"],"unii":["EH6D7113I8"]},"update_date":"11/06/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Cleocin Phosphate, Injection, Cleocin Phosphate 300 mg/2 mL (150 mg/mL) (NDC 0009-0870-26)","company_name":"Pfizer Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/07/2020","package_ndc":"36000-282-25","generic_name":"Furosemide Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["ANDA202747"],"brand_name":["FUROSEMIDE"],"generic_name":["FUROSEMIDE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["36000-282","36000-063","36000-064","36000-065","36000-283","36000-284"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["FUROSEMIDE"],"rxcui":["1719286","1719290","1719291"],"spl_id":["b4c1ae97-0f6c-4ae1-858a-4e0ab8f1ce53"],"spl_set_id":["c71371a7-75c5-45b8-b762-8d782d4c71bc"],"package_ndc":["36000-063-05","36000-064-05","36000-065-05","36000-282-25","36000-283-25","36000-284-25"],"nui":["N0000175366","N0000175590"],"pharm_class_pe":["Increased Diuresis at Loop of Henle [PE]"],"pharm_class_epc":["Loop Diuretic [EPC]"],"unii":["7LXU5N7ZO5"]},"update_date":"11/03/2026","therapeutic_category":["Cardiovascular"],"dosage_form":"Injection","presentation":"Furosemide, Injection, 10 mg/1 mL (NDC 36000-282-25)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/10/2020","package_ndc":"44567-603-24","generic_name":"Dexmedetomidine Hydrochloride Injection","contact_info":"WG Critical Care 888-493-0861","availability":"Available","related_info":"Marketed by WG Critical Care","openfda":{"application_number":["NDA206628"],"brand_name":["DEXMEDETOMIDINE IN DEXTROSE"],"generic_name":["DEXMEDETOMIDINE"],"manufacturer_name":["WG Critical Care, LLC"],"product_ndc":["44567-603","44567-600","44567-601","44567-602"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXMEDETOMIDINE HYDROCHLORIDE"],"rxcui":["1718906","1718909","1788947"],"spl_id":["ee503974-3f79-46d7-845f-2d15444dc0b8"],"spl_set_id":["0d2710f2-ee47-4114-ab5c-8dca74cdcb8d"],"package_ndc":["44567-600-04","44567-601-04","44567-602-01","44567-602-24","44567-603-01","44567-603-24"],"unii":["1018WH7F9I"]},"update_date":"11/02/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24)","company_name":"HQ Specialty Pharma","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"55150-169-10","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"888-238-7880","availability":"Available","related_info":"Check wholesalers for inventory","openfda":{"application_number":["ANDA203895"],"brand_name":["BUPIVACAINE HYDROCHLORIDE"],"generic_name":["BUPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Eugia US LLC"],"product_ndc":["55150-169","55150-167","55150-168","55150-170","55150-171","55150-172","55150-249","55150-250"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INTRACAUDAL"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1012396","1012404","1724786","1724787","1724880","1724884","1725078","1725082"],"spl_id":["39649703-e633-4a20-ba71-0c04dbf8ff2a"],"spl_set_id":["ffecf450-1f01-4721-8e10-251385852612"],"package_ndc":["55150-167-10","55150-168-30","55150-169-10","55150-170-30","55150-171-10","55150-172-30","55150-249-50","55150-250-50"],"unii":["7TQO7W3VT8"]},"update_date":"10/19/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-169-10)","company_name":"Eugia US LLC","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/23/2018","package_ndc":"63323-285-10","generic_name":"Ropivacaine Hydrochloride Injection","contact_info":"888-386-1300","availability":"Unavailable","related_info":"Estimated recovery: TBD","openfda":{"application_number":["NDA020533"],"brand_name":["NAROPIN"],"generic_name":["ROPIVACAINE HYDROCHLORIDE"],"manufacturer_name":["Fresenius Kabi USA, LLC"],"product_ndc":["63323-285","63323-286","63323-287","63323-288"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["EPIDURAL","INFILTRATION"],"substance_name":["ROPIVACAINE HYDROCHLORIDE"],"rxcui":["1734203","1734204","1734207","1734208","1734347","1734348","1734355","1734356","1734475","1734476","1734479","1734480","1734481","1734482","1734483","1734484","905189","905191","1734084","1734086","1734090","1734091"],"spl_id":["324532ac-4e54-4659-a1a2-9ade22a1ed3f","cdcd6c58-85cf-4d7e-9d97-b7c282a4f6b9","73218c89-8925-468c-84bf-9960b4b3dc3c"],"spl_set_id":["dff4a1e4-4b2a-4a64-b6d8-ea470dee88f7","23d2d448-a744-4877-9f2d-7e57c198da89","c6613708-c1f7-4f5c-91a3-ebbc1d7905c6"],"package_ndc":["63323-286-41","63323-286-27","63323-286-43","63323-286-38","63323-285-41","63323-285-28","63323-285-53","63323-285-68","63323-285-59","63323-285-73","63323-286-01","63323-286-20","63323-286-05","63323-286-23","63323-286-09","63323-286-31","63323-286-11","63323-286-35","63323-286-03","63323-286-00","63323-286-33","63323-286-63","63323-286-30","63323-287-01","63323-287-20","63323-287-03","63323-287-21","63323-288-01","63323-288-10","63323-288-06","63323-288-20","63323-288-03","63323-288-11","63323-288-07","63323-288-21","63323-285-01","63323-285-10","63323-285-06","63323-285-20","63323-285-03","63323-285-13","63323-285-07","63323-285-23","63323-285-57","63323-285-64","63323-285-51","63323-285-65","63323-285-02","63323-285-61","63323-285-04","63323-285-63","63323-285-55","63323-285-67","63323-288-23","63323-288-29","63323-286-93","63323-286-95"],"unii":["V910P86109"]},"update_date":"11/03/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)","company_name":"Fresenius Kabi USA, LLC","shortage_reason":"Demand increase for the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"10/31/2017","package_ndc":"0409-1890-01","generic_name":"Morphine Sulfate Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["NDA202515"],"brand_name":["MORPHINE SULFATE"],"generic_name":["MORPHINE SULFATE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-1890","0409-1891","0409-1892","0409-1893","0409-1894"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["MORPHINE SULFATE"],"rxcui":["998212","998213","1729197","1732014"],"spl_id":["07b4be5d-af82-43ff-a6d2-0df0d5c495ee"],"spl_set_id":["be420e8b-bcb0-49b5-bb4d-1df8b9959809"],"package_ndc":["0409-1890-03","0409-1890-01","0409-1890-13","0409-1890-23","0409-1891-03","0409-1891-01","0409-1891-13","0409-1891-23","0409-1892-03","0409-1892-01","0409-1892-13","0409-1892-23","0409-1893-03","0409-1893-01","0409-1893-13","0409-1893-23","0409-1894-03","0409-1894-01"],"unii":["X3P646A2J0"]},"update_date":"11/09/2026","therapeutic_category":["Analgesia/Addiction"],"dosage_form":"Injection","presentation":"Morphine Sulfate, Injection, 2 mg/1 mL Syringes (NDC 0409-1890-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"03/21/2023","package_ndc":"0338-9553-50","generic_name":"Clindamycin Phosphate Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA208083"],"brand_name":["CLINDAMYCIN PHOSPHATE"],"generic_name":["CLINDAMYCIN PHOSPHATE"],"manufacturer_name":["Baxter Healthcare Company"],"product_ndc":["0338-9553","0338-9545","0338-9549"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["CLINDAMYCIN PHOSPHATE"],"rxcui":["309335","309336","309339"],"spl_id":["b0a47c5e-911b-4b12-a0d1-a4425f173eec"],"spl_set_id":["44fa506b-90ac-42de-831b-5f3f1a500fc0"],"package_ndc":["0338-9545-50","0338-9545-24","0338-9549-50","0338-9549-24","0338-9553-50","0338-9553-24"],"unii":["EH6D7113I8"]},"update_date":"11/03/2026","therapeutic_category":["Anti-Infective"],"dosage_form":"Injection","presentation":"Clindamycin Phosphate, Injection, 900 mg/50 mL (NDC 0338-9553-50)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"11/04/2024","package_ndc":"50633-310-11","generic_name":"Hydroxocobalamin Injection","related_info_link":"https://www.fda.gov/media/185400/download","contact_info":"1 877 377 3784","availability":"Limited Availability","related_info":"Cyanokit is available to order. To address the drug shortage, BTG International Inc (a SERB Pharmaceuticals company) coordinated with the U.S. Food and Drug Administration (FDA) to make the following impacted batches available to U.S. patients during this period of shortage.","openfda":{"application_number":["NDA022041"],"brand_name":["CYANOKIT"],"generic_name":["HYDROXOCOBALAMIN"],"manufacturer_name":["BTG INTERNATIONAL INC."],"product_ndc":["50633-310"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["HYDROXOCOBALAMIN"],"rxcui":["700496","700499"],"spl_id":["9955075c-c059-4b63-b387-e98ef13e60dc"],"spl_set_id":["d56fcc8d-bd64-46ab-b0c0-2124bd745a6b"],"package_ndc":["50633-310-11"],"nui":["N0000175429"],"pharm_class_epc":["Antidote [EPC]"],"unii":["Q40X8H422O"]},"update_date":"11/02/2026","therapeutic_category":["Other"],"dosage_form":"Injection","presentation":"Cyanokit, Injection, 5 g/250mL (NDC 50633-310-11)","company_name":"BTG International Inc.","shortage_reason":"Other","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/14/2022","package_ndc":"0338-0017-03","generic_name":"Dextrose Monohydrate 5% Injection","contact_info":"888-229-0001","availability":"Available","openfda":{"application_number":["NDA016673"],"brand_name":["DEXTROSE"],"generic_name":["DEXTROSE MONOHYDRATE"],"manufacturer_name":["Baxter Healthcare Corporation"],"product_ndc":["0338-0017","0338-0023"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["INTRAVENOUS"],"substance_name":["DEXTROSE MONOHYDRATE"],"rxcui":["1795477","1795480","1795481","1795607","1795609","1795610","1795612","1795616","1795618"],"spl_id":["9c644eb4-5844-415a-8c01-4459d98af222"],"spl_set_id":["3bb406a9-f5cb-403a-b1bb-5c4facbea3d5"],"package_ndc":["0338-0017-10","0338-0017-41","0338-0017-11","0338-0017-31","0338-0017-48","0338-0017-18","0338-0017-38","0338-0017-02","0338-0017-03","0338-0017-04","0338-0023-02","0338-0023-03","0338-0023-04"],"unii":["LX22YL083G"]},"update_date":"11/03/2026","therapeutic_category":["Endocrinology/Metabolism","Gastroenterology","Other","Pediatric"],"dosage_form":"Injection","presentation":"Dextrose 5% In Plastic Container, Injection, 50 g/1000 mL (NDC 0338-0017-03)","company_name":"Baxter Healthcare","status":"Current"},{"update_type":"Reverified","initial_posting_date":"02/20/2018","package_ndc":"0409-3613-01","generic_name":"Bupivacaine Hydrochloride Injection","contact_info":"844-646-4398","availability":"Available","openfda":{"application_number":["ANDA071810"],"brand_name":["BUPIVACAINE SPINAL"],"generic_name":["BUPIVACAINE HYDROCHLORIDE IN DEXTROSE"],"manufacturer_name":["Hospira, Inc."],"product_ndc":["0409-3613"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["SUBARACHNOID"],"substance_name":["BUPIVACAINE HYDROCHLORIDE"],"rxcui":["1724784"],"spl_id":["7a09a90d-26da-42bd-bb54-2d2102eb8c1c"],"spl_set_id":["7a8d2539-4422-4312-0298-207ef1a2948e"],"package_ndc":["0409-3613-11","0409-3613-01"],"unii":["7TQO7W3VT8"]},"update_date":"11/09/2026","therapeutic_category":["Anesthesia"],"dosage_form":"Injection","presentation":"Bupivacaine Hydrochloride, Injection, Bupivacaine Spinal 15 mg/2 mL (7.5 mg/mL in 8.25% dextrose) (NDC 0409-3613-01)","company_name":"Hospira, Inc., a Pfizer Company","status":"Current"},{"update_type":"Reverified","initial_posting_date":"04/28/2023","package_ndc":"0990-7139-36","generic_name":"Sterile Water Irrigant","related_info_link":"https://www.fda.gov/media/182619/download?attachment","contact_info":"1-866-829-9025 or ProductAvailability@icumed.com","availability":"Unavailable","related_info":"Product temporarily unavailable. Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.","update_date":"11/03/2026","therapeutic_category":["Gastroenterology","Other","Pediatric"],"dosage_form":"Irrigant","presentation":"Sterile Water In Plastic Container, Irrigant, 1 mL/1 mL (NDC 0990-7139-36)","company_name":"Otsuka ICU Medical LLC","shortage_reason":"Discontinuation of the manufacture of the drug","status":"Current"},{"update_type":"Reverified","initial_posting_date":"12/20/2023","package_ndc":"0641-6251-10","generic_name":"Atropine Sulfate Injection","contact_info":"800-631-2174","availability":"Available","openfda":{"application_number":["ANDA213561"],"brand_name":["ATROPINE SULFATE"],"generic_name":["ATROPINE SULFATE"],"manufacturer_name":["Hikma Pharmaceuticals USA Inc."],"product_ndc":["0641-6251"],"product_type":["HUMAN PRESCRIPTION DRUG"],"route":["ENDOTRACHEAL","INTRAMEDULLARY","INTRAMUSCULAR","INTRAVENOUS","SUBCUTANEOUS"],"substance_name":["ATROPINE SULFATE"],"rxcui":["1190776"],"spl_id":["f5ca4281-8c89-4efc-80b1-2fbcf61c7c55"],"spl_set_id":["4c15d3cc-7888-4c82-b3f8-a5d93c5523df"],"package_ndc":["0641-6251-10"],"unii":["03J5ZE7KA5"]},"update_date":"10/14/2026","therapeutic_category":["Anesthesia","Neurology","Pediatric"],"dosage_form":"Injection","presentation":"Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)","company_name":"Hikma Pharmaceuticals USA, Inc.","status":"Current"}]